Column1 Column2 Column3 Column4 Column5 Column6 Column7 Column8 Column9 Column10 Column11 Column12 Column13 Column14 Entry Entry name Gene ontology IDs Interacts with Cross-reference (GO) Gene ontology (GO) Status InterPro Pathway Protein names Gene names Organism Length SPID GOID GO_id term GOSlim_bin aspect ConsensusfromContig4183 sp A0JMD0 CLU_DANRE 89.32 206 22 0 23 640 958 1163 4E-112 356 A0JMD0 CLU_DANRE GO:0005737; GO:0048312 cytoplasm; intracellular distribution of mitochondria reviewed IPR027523; IPR025697; IPR028275; IPR023231; IPR011990; Clustered mitochondria protein homolog cluh zgc:152873 Danio rerio (Zebrafish) (Brachydanio rerio) 1400 A0JMD0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4183 sp A0JMD0 CLU_DANRE 89.32 206 22 0 23 640 958 1163 4E-112 356 A0JMD0 CLU_DANRE GO:0005737; GO:0048312 cytoplasm; intracellular distribution of mitochondria reviewed IPR027523; IPR025697; IPR028275; IPR023231; IPR011990; Clustered mitochondria protein homolog cluh zgc:152873 Danio rerio (Zebrafish) (Brachydanio rerio) 1400 A0JMD0 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig4183 sp A0JMD0 CLU_DANRE 89.32 206 22 0 23 640 958 1163 4E-112 356 A0JMD0 CLU_DANRE GO:0005737; GO:0048312 cytoplasm; intracellular distribution of mitochondria reviewed IPR027523; IPR025697; IPR028275; IPR023231; IPR011990; Clustered mitochondria protein homolog cluh zgc:152873 Danio rerio (Zebrafish) (Brachydanio rerio) 1400 A0JMD0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig5299 sp A0JMK5 MTMR2_DANRE 84.21 114 18 0 19 360 481 594 4E-63 208 A0JMK5 MTMR2_DANRE GO:0005737; GO:0016020; GO:0035335; GO:0004725 cytoplasm; membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity reviewed IPR004182; IPR010569; IPR017906; IPR011993; IPR000387; IPR016130; Myotubularin-related protein 2 (EC 3.1.3.-) mtmr2 si:dkey-110k5.3 Danio rerio (Zebrafish) (Brachydanio rerio) 620 A0JMK5 GO:0035335 ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0004814 GO:0004814 arginine-tRNA ligase activity other molecular function F ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0006420 GO:0006420 arginyl-tRNA aminoacylation protein metabolism P ConsensusfromContig998 sp A0JML8 DALD3_DANRE 62.77 137 50 1 2 412 85 220 9E-54 184 A0JML8 DALD3_DANRE GO:0005524; GO:0004814; GO:0006420 ATP binding; arginine-tRNA ligase activity; arginyl-tRNA aminoacylation reviewed IPR008909; IPR009080; DALR anticodon-binding domain-containing protein 3 dalrd3 zgc:153958 Danio rerio (Zebrafish) (Brachydanio rerio) 558 A0JML8 GO:0006420 GO:0006420 arginyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000245 GO:0000245 spliceosome assembly RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000245 GO:0000245 spliceosome assembly cell organization and biogenesis P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000381 GO:0000381 "regulation of alternative nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 71.72 198 53 2 844 1437 634 828 7E-106 266 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000245 GO:0000245 spliceosome assembly RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000245 GO:0000245 spliceosome assembly cell organization and biogenesis P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0000381 GO:0000381 "regulation of alternative nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig6098 sp A0JMV4 RBM5A_XENLA 59.51 205 62 5 207 770 413 613 7E-106 140 A0JMV4 RBM5A_XENLA GO:0003729; GO:0000166; GO:0005634; GO:0043065; GO:0000381; GO:0005681; GO:0000245; GO:0008270 mRNA binding; nucleotide binding; nucleus; positive regulation of apoptotic process; regulation of alternative mRNA splicing, via spliceosome; spliceosomal complex; spliceosomal complex assembly; zinc ion binding reviewed IPR000467; IPR012677; IPR000504; IPR007087; IPR015880; IPR001876; RNA-binding protein 5-A (RNA-binding motif protein 5-A) rbm5-a rbm5 Xenopus laevis (African clawed frog) 833 A0JMV4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0001635 GO:0001635 calcitonin gene-related polypeptide receptor activity signal transduction activity F ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0006383 GO:0006383 transcription from RNA polymerase III promoter RNA metabolism P ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0007218 GO:0007218 neuropeptide signaling pathway signal transduction P ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0009360 GO:0009360 DNA polymerase III complex other cellular component C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0009615 GO:0009615 response to virus other biological processes P ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig535 sp A0JN61 RPC9_BOVIN 76.6 141 30 2 508 89 1 139 2E-56 181 A0JN61 RPC9_BOVIN GO:0009360; GO:0003899; GO:0001669; GO:0001635; GO:0051607; GO:0045087; GO:0007218; GO:0000166; GO:0005634; GO:0005886; GO:0006383 DNA polymerase III complex; DNA-directed RNA polymerase activity; acrosomal vesicle; calcitonin gene-related polypeptide receptor activity; defense response to virus; innate immune response; neuropeptide signaling pathway; nucleotide binding; nucleus; plasma membrane; transcription from RNA polymerase III promoter reviewed IPR010997; IPR005574; IPR006590; DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) CRCP Bos taurus (Bovine) 148 A0JN61 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig901 sp A0JP70 WDR90_XENTR 51.08 186 90 1 2 559 1651 1835 2E-55 196 A0JP70 WDR90_XENTR reviewed IPR007714; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 90 wdr90 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1848 ConsensusfromContig6341 sp A0JPD7 F213A_XENTR 61.03 213 82 1 225 863 10 221 9E-87 267 A0JPD7 F213A_XENTR GO:0016209; GO:0005737 antioxidant activity; cytoplasm reviewed IPR012336; Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) fam213a pamm Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 227 A0JPD7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6341 sp A0JPD7 F213A_XENTR 61.03 213 82 1 225 863 10 221 9E-87 267 A0JPD7 F213A_XENTR GO:0016209; GO:0005737 antioxidant activity; cytoplasm reviewed IPR012336; Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) fam213a pamm Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 227 A0JPD7 GO:0016209 GO:0016209 antioxidant activity other molecular function F ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0000080 GO:0000080 G1 phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005680 GO:0005680 anaphase-promoting complex nucleus C ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007080 GO:0007080 mitotic metaphase plate congression cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007080 GO:0007080 mitotic metaphase plate congression cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.16 398 72 2 1335 142 203 597 0 652 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0070979 ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0000080 GO:0000080 G1 phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0005680 GO:0005680 anaphase-promoting complex nucleus C ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007080 GO:0007080 mitotic metaphase plate congression cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0007080 GO:0007080 mitotic metaphase plate congression cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell cycle and proliferation P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell organization and biogenesis P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6084 sp A1A4R8 CDC23_BOVIN 81.19 101 19 0 1630 1328 105 205 0 170 A1A4R8 CDC23_BOVIN GO:0005680; GO:0051301; GO:0007080; GO:0070979; GO:0030071 anaphase-promoting complex; cell division; mitotic metaphase plate congression; protein K11-linked ubiquitination; regulation of mitotic metaphase/anaphase transition reviewed IPR007192; IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein ubiquitination. Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8) CDC23 ANAPC8 Bos taurus (Bovine) 597 A1A4R8 GO:0070979 ConsensusfromContig6253 sp A1A5V9 ELP5_DANRE 62.22 180 66 1 1263 730 98 277 5E-68 224 A1A5V9 ELP5_DANRE GO:0033588; GO:0005737; GO:0005634; GO:0030335; GO:0006355; GO:0006351 Elongator holoenzyme complex; cytoplasm; nucleus; positive regulation of cell migration; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR019519; Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12) elp5 derp6 Rai12 zgc:158278 zgc:158285 Danio rerio (Zebrafish) (Brachydanio rerio) 296 A1A5V9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6253 sp A1A5V9 ELP5_DANRE 62.22 180 66 1 1263 730 98 277 5E-68 224 A1A5V9 ELP5_DANRE GO:0033588; GO:0005737; GO:0005634; GO:0030335; GO:0006355; GO:0006351 Elongator holoenzyme complex; cytoplasm; nucleus; positive regulation of cell migration; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR019519; Elongator complex protein 5 (Dermal papilla-derived protein 6 homolog) (Retinoic acid-induced protein 12) elp5 derp6 Rai12 zgc:158278 zgc:158285 Danio rerio (Zebrafish) (Brachydanio rerio) 296 A1A5V9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig2731 sp A1L1R6 ZN423_DANRE 86.89 206 23 2 2 619 1151 1352 7E-121 381 A1L1R6 ZN423_DANRE GO:0003677; GO:0030154; GO:0046872; GO:0007399; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 423 znf423 si:ch211-216l23.1 zgc:158272 Danio rerio (Zebrafish) (Brachydanio rerio) 1365 A1L1R6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig2306 sp A1L251 ENASE_DANRE 82.48 137 24 0 412 2 102 238 2E-75 243 A1L251 ENASE_DANRE GO:0005829; GO:0033925 cytosol; mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity reviewed IPR005201; Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96) engase zgc:158649 Danio rerio (Zebrafish) (Brachydanio rerio) 713 A1L251 GO:0033925 GO:0033925 mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity other molecular function F ConsensusfromContig128 sp A1L252 RANB9_DANRE 97.86 140 3 0 421 2 1 140 2E-92 291 A1L252 RANB9_DANRE GO:0005737; GO:0005634 cytoplasm; nucleus reviewed IPR001870; IPR008985; IPR013144; IPR024964; IPR006595; IPR006594; IPR013720; IPR027713; IPR018355; IPR003877; Ran-binding protein 9 (RanBP9) ranbp9 zgc:158650 Danio rerio (Zebrafish) (Brachydanio rerio) 597 A1L252 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig128 sp A1L252 RANB9_DANRE 97.86 140 3 0 421 2 1 140 2E-92 291 A1L252 RANB9_DANRE GO:0005737; GO:0005634 cytoplasm; nucleus reviewed IPR001870; IPR008985; IPR013144; IPR024964; IPR006595; IPR006594; IPR013720; IPR027713; IPR018355; IPR003877; Ran-binding protein 9 (RanBP9) ranbp9 zgc:158650 Danio rerio (Zebrafish) (Brachydanio rerio) 597 A1L252 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig128 sp A1L252 RANB9_DANRE 97.86 140 3 0 421 2 1 140 2E-92 291 A1L252 RANB9_DANRE GO:0005737; GO:0005634 cytoplasm; nucleus reviewed IPR001870; IPR008985; IPR013144; IPR024964; IPR006595; IPR006594; IPR013720; IPR027713; IPR018355; IPR003877; Ran-binding protein 9 (RanBP9) ranbp9 zgc:158650 Danio rerio (Zebrafish) (Brachydanio rerio) 597 A1L252 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3400 sp A1L314 MPEG1_MOUSE 51.21 289 136 3 69 920 50 338 5E-99 313 A1L314 MPEG1_MOUSE GO:0016021 integral to membrane reviewed IPR020864; Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Protein MPS1) Mpeg1 Mus musculus (Mouse) 713 A1L314 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3400 sp A1L314 MPEG1_MOUSE 51.21 289 136 3 69 920 50 338 5E-99 313 A1L314 MPEG1_MOUSE GO:0016021 integral to membrane reviewed IPR020864; Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1) (Protein MPS1) Mpeg1 Mus musculus (Mouse) 713 A1L314 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0001104 ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0003712 GO:0003712 transcription cofactor activity transcription regulatory activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter cell organization and biogenesis P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0030518 GO:0030518 steroid hormone receptor signaling pathway signal transduction P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0030521 GO:0030521 androgen receptor signaling pathway signal transduction P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 84.82 191 27 2 936 364 1182 1370 2E-110 289 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0046966 GO:0046966 thyroid hormone receptor binding signal transduction activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0001104 ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0003712 GO:0003712 transcription cofactor activity transcription regulatory activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter cell organization and biogenesis P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0030518 GO:0030518 steroid hormone receptor signaling pathway signal transduction P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0030521 GO:0030521 androgen receptor signaling pathway signal transduction P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig15 sp A2ABV5 MED14_MOUSE 73.33 90 23 1 367 101 1370 1459 2E-110 132 A2ABV5 MED14_MOUSE GO:0001104; GO:0030521; GO:0016592; GO:0045944; GO:0004872; GO:0019827; GO:0003713; GO:0006367 RNA polymerase II transcription cofactor activity; androgen receptor signaling pathway; mediator complex; positive regulation of transcription from RNA polymerase II promoter; receptor activity; stem cell maintenance; transcription coactivator activity; transcription initiation from RNA polymerase II promoter reviewed IPR013947; Mediator of RNA polymerase II transcription subunit 14 (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) Med14 Crsp2 Gm641 Trap170 Mus musculus (Mouse) 1459 A2ABV5 GO:0046966 GO:0046966 thyroid hormone receptor binding signal transduction activity F ConsensusfromContig5232 sp A2AHJ4 BRWD3_MOUSE 79.64 167 32 1 1 501 161 325 8E-93 301 A2AHJ4 BRWD3_MOUSE GO:0007010; GO:0008360 cytoskeleton organization; regulation of cell shape reviewed IPR001487; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 3 Brwd3 Gm596 Mus musculus (Mouse) 1799 A2AHJ4 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5232 sp A2AHJ4 BRWD3_MOUSE 79.64 167 32 1 1 501 161 325 8E-93 301 A2AHJ4 BRWD3_MOUSE GO:0007010; GO:0008360 cytoskeleton organization; regulation of cell shape reviewed IPR001487; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 3 Brwd3 Gm596 Mus musculus (Mouse) 1799 A2AHJ4 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5232 sp A2AHJ4 BRWD3_MOUSE 79.64 167 32 1 1 501 161 325 8E-93 301 A2AHJ4 BRWD3_MOUSE GO:0007010; GO:0008360 cytoskeleton organization; regulation of cell shape reviewed IPR001487; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 3 Brwd3 Gm596 Mus musculus (Mouse) 1799 A2AHJ4 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig5232 sp A2AHJ4 BRWD3_MOUSE 79.64 167 32 1 1 501 161 325 8E-93 301 A2AHJ4 BRWD3_MOUSE GO:0007010; GO:0008360 cytoskeleton organization; regulation of cell shape reviewed IPR001487; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 3 Brwd3 Gm596 Mus musculus (Mouse) 1799 A2AHJ4 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005903 GO:0005903 brush border other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006766 GO:0006766 vitamin metabolic process other metabolic processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 32.83 332 171 7 968 117 2965 3292 6E-70 171 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005903 GO:0005903 brush border other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006766 GO:0006766 vitamin metabolic process other metabolic processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 37.01 254 128 11 1737 1027 2700 2938 6E-70 116 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005903 GO:0005903 brush border other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006766 GO:0006766 vitamin metabolic process other metabolic processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 34.83 290 160 13 1851 1027 3555 3830 1E-55 129 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005903 GO:0005903 brush border other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006766 GO:0006766 vitamin metabolic process other metabolic processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig6269 sp A2ARV4 LRP2_MOUSE 28.49 351 211 12 962 3 3856 4197 1E-55 111 A2ARV4 LRP2_MOUSE GO:0005794; GO:0016324; GO:0031526; GO:0005509; GO:0008283; GO:0005905; GO:0030139; GO:0005783; GO:0005768; GO:0030900; GO:0016021; GO:0004872; GO:0006898; GO:0006766 P97318; Q62108; Q9Z0G0; Q9WVI9; Q9ERE9; Q9D6K5 Golgi apparatus; apical plasma membrane; brush border membrane; calcium ion binding; cell proliferation; coated pit; endocytic vesicle; endoplasmic reticulum; endosome; forebrain development; integral to membrane; receptor activity; receptor-mediated endocytosis; vitamin metabolic process reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin) Lrp2 Mus musculus (Mouse) 4660 A2ARV4 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0000387 GO:0000387 spliceosomal snRNP biogenesis RNA metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0006349 GO:0006349 genetic imprinting other metabolic processes P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0006479 GO:0006479 protein amino acid methylation protein metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0008276 GO:0008276 protein methyltransferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0008469 GO:0008469 histone-arginine N-methyltransferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0016277 GO:0016277 [myelin basic protein]-arginine N-methyltransferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0018216 GO:0018216 peptidyl-arginine methylation protein metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0019918 GO:0019918 "peptidyl-arginine methylation, to symmetrical-dimethyl arginine" protein metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0034969 GO:0034969 histone arginine methylation protein metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0034969 GO:0034969 histone arginine methylation cell organization and biogenesis P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0035243 GO:0035243 protein-arginine omega-N symmetric methyltransferase activity other molecular function F ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0043046 GO:0043046 DNA methylation during gametogenesis DNA metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0043985 GO:0043985 histone H4-R3 methylation protein metabolism P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0043985 GO:0043985 histone H4-R3 methylation cell organization and biogenesis P ConsensusfromContig229 sp A2AV36 ANM7_DANRE 72.73 253 69 0 1 759 406 658 9E-137 407 A2AV36 ANM7_DANRE GO:0043046; GO:0016277; GO:0030154; GO:0005829; GO:0044020; GO:0005634; GO:0035243; GO:0006349; GO:0006355; GO:0000387; GO:0006351 DNA methylation involved in gamete generation; [myelin basic protein]-arginine N-methyltransferase activity; cell differentiation; cytosol; histone methyltransferase activity (H4-R3 specific); nucleus; protein-arginine omega-N symmetric methyltransferase activity; regulation of gene expression by genetic imprinting; regulation of transcription, DNA-dependent; spliceosomal snRNP assembly; transcription, DNA-dependent reviewed IPR025799; IPR025801; IPR014644; IPR010456; Protein arginine N-methyltransferase 7 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT7) (EC 2.1.1.125) ([Myelin basic protein]-arginine N-methyltransferase PRMT7) (EC 2.1.1.126) prmt7 ch211-51l3.2 Danio rerio (Zebrafish) (Brachydanio rerio) 683 A2AV36 GO:0044020 GO:0044020 histone methyltransferase activity (H4-R3 specific) other molecular function F ConsensusfromContig764 sp A2BIJ3 BSDC1_DANRE 83.02 106 18 0 21 338 15 120 1E-55 184 A2BIJ3 BSDC1_DANRE reviewed IPR005607; BSD domain-containing protein 1 bsdc1 si:ch211-51n3.2 zgc:100785 Danio rerio (Zebrafish) (Brachydanio rerio) 412 ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0004396 GO:0004396 hexokinase activity kinase activity F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 86.26 131 18 0 407 15 640 770 5E-73 239 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0004396 GO:0004396 hexokinase activity kinase activity F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4328 sp A2PYL6 HXK2_HORSE 65.65 131 45 0 407 15 192 322 2E-54 187 A2PYL6 HXK2_HORSE GO:0005524; GO:0006096; GO:0004396 ATP binding; glycolysis; hexokinase activity reviewed IPR001312; IPR022673; IPR019807; IPR022672; Carbohydrate metabolism; hexose metabolism. Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) HK2 Equus caballus (Horse) 917 A2PYL6 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig2988 sp A2VCU8 NELL2_XENTR 71.43 133 38 0 1 399 514 646 3E-62 209 A2VCU8 NELL2_XENTR GO:0005509; GO:0005576 calcium ion binding; extracellular region reviewed IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR001791; IPR001007; Protein kinase C-binding protein NELL2 (NEL-like protein 2) nell2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 814 A2VCU8 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig2988 sp A2VCU8 NELL2_XENTR 71.43 133 38 0 1 399 514 646 3E-62 209 A2VCU8 NELL2_XENTR GO:0005509; GO:0005576 calcium ion binding; extracellular region reviewed IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR001791; IPR001007; Protein kinase C-binding protein NELL2 (NEL-like protein 2) nell2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 814 A2VCU8 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2988 sp A2VCU8 NELL2_XENTR 71.43 133 38 0 1 399 514 646 3E-62 209 A2VCU8 NELL2_XENTR GO:0005509; GO:0005576 calcium ion binding; extracellular region reviewed IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR001791; IPR001007; Protein kinase C-binding protein NELL2 (NEL-like protein 2) nell2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 814 A2VCU8 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2988 sp A2VCU8 NELL2_XENTR 71.43 133 38 0 1 399 514 646 3E-62 209 A2VCU8 NELL2_XENTR GO:0005509; GO:0005576 calcium ion binding; extracellular region reviewed IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR001791; IPR001007; Protein kinase C-binding protein NELL2 (NEL-like protein 2) nell2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 814 A2VCU8 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0001104 ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig277 sp A2VCZ5 MD13L_DANRE 54.63 216 89 7 796 167 619 831 5E-64 223 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0001104 ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6161 sp A2VCZ5 MD13L_DANRE 75.3 494 105 4 1664 183 1572 2048 0 739 A2VCZ5 MD13L_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009401; IPR021643; Mediator of RNA polymerase II transcription subunit 13-like (Thyroid hormone receptor-associated protein complex 240 kDa component-like protein) zgc:153454 Danio rerio (Zebrafish) (Brachydanio rerio) 2102 A2VCZ5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0001540 GO:0001540 beta-amyloid binding other molecular function F ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0005765 GO:0005765 lysosomal membrane other cytoplasmic organelle C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0005765 GO:0005765 lysosomal membrane other membranes C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0010977 GO:0010977 negative regulation of neuron projection development developmental processes P ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0010977 GO:0010977 negative regulation of neuron projection development cell organization and biogenesis P ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0012502 GO:0012502 induction of programmed cell death death P ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig5664 sp A2VDN0 ITM2C_BOVIN 64.32 213 71 2 4 642 61 268 5E-82 265 A2VDN0 ITM2C_BOVIN GO:0005524; GO:0005794; GO:0001540; GO:0016021; GO:0005765; GO:0005764; GO:0010977; GO:0030182; GO:0048471; GO:0005886; GO:2001238 ATP binding; Golgi apparatus; beta-amyloid binding; integral to membrane; lysosomal membrane; lysosome; negative regulation of neuron projection development; neuron differentiation; perinuclear region of cytoplasm; plasma membrane; positive regulation of extrinsic apoptotic signaling pathway reviewed IPR007084; Integral membrane protein 2C [Cleaved into: CT-BRI3] ITM2C Bos taurus (Bovine) 271 A2VDN0 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2879 sp A2VDX9 TM158_BOVIN 58.68 167 46 3 1 432 85 251 2E-61 199 A2VDX9 TM158_BOVIN GO:0016021 integral to membrane reviewed Transmembrane protein 158 (Ras-induced senescence protein 1) TMEM158 RIS1 Bos taurus (Bovine) 291 A2VDX9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2879 sp A2VDX9 TM158_BOVIN 58.68 167 46 3 1 432 85 251 2E-61 199 A2VDX9 TM158_BOVIN GO:0016021 integral to membrane reviewed Transmembrane protein 158 (Ras-induced senescence protein 1) TMEM158 RIS1 Bos taurus (Bovine) 291 A2VDX9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 69.72 426 107 8 2270 1032 842 1258 0 526 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 69.72 426 107 8 2270 1032 842 1258 0 526 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 69.72 426 107 8 2270 1032 842 1258 0 526 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 82.41 108 19 0 1051 728 1253 1360 0 198 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 82.41 108 19 0 1051 728 1253 1360 0 198 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5678 sp A3KN83 SBNO1_HUMAN 82.41 108 19 0 1051 728 1253 1360 0 198 A3KN83 SBNO1_HUMAN GO:0006355 regulation of transcription, DNA-dependent reviewed IPR027417; IPR026937; IPR026741; Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3) SBNO1 MOP3 Homo sapiens (Human) 1393 A3KN83 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0001104 ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2194 sp A3KNK7 MED11_DANRE 83.33 114 19 0 361 20 1 114 1E-64 202 A3KNK7 MED11_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR019404; Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11) med11 Danio rerio (Zebrafish) (Brachydanio rerio) 114 A3KNK7 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig20 sp A3KP37 NDUF5_DANRE 71.21 132 38 0 1 396 33 164 3E-63 202 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3952 sp A3KP37 NDUF5_DANRE 82.71 133 23 0 1 399 165 297 2E-77 238 A3KP37 NDUF5_DANRE GO:0008168; GO:0005743 methyltransferase activity; mitochondrial inner membrane reviewed IPR013216; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5 (Probable methyltransferase C20orf7 homolog, mitochondrial) (EC 2.1.1.-) ndufaf5 zgc:162919 Danio rerio (Zebrafish) (Brachydanio rerio) 321 A3KP37 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0006479 GO:0006479 protein amino acid methylation protein metabolism P ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0008276 GO:0008276 protein methyltransferase activity other molecular function F ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3203 sp A3KP85 MET20_DANRE 70 150 43 1 4 447 108 257 2E-72 226 A3KP85 MET20_DANRE GO:0005737; GO:0008276 cytoplasm; protein methyltransferase activity reviewed IPR010456; Methyltransferase-like protein 20 (EC 2.1.1.-) mettl20 Danio rerio (Zebrafish) (Brachydanio rerio) 258 A3KP85 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0000932 GO:0000932 cytoplasmic mRNA processing body other cellular component C ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0006402 GO:0006402 mRNA catabolic process RNA metabolism P ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig3539 sp A3KPK0 AGO3_DANRE 98.1 105 2 0 3 317 756 860 1E-65 221 A3KPK0 AGO3_DANRE GO:0003723; GO:0000932; GO:0006402; GO:0035278 RNA binding; cytoplasmic mRNA processing body; mRNA catabolic process; negative regulation of translation involved in gene silencing by miRNA reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-3 (Argonaute3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3) ago3 eif2c3 si:dkey-3n22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 860 A3KPK0 GO:0035278 GO:0035278 "gene silencing by miRNA, negative regulation of translation" protein metabolism P ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5104 sp A3QK15 AACS_DANRE 89.43 123 13 0 1 369 522 644 4E-72 233 A3QK15 AACS_DANRE GO:0005524; GO:0030729; GO:0005829; GO:0006631 ATP binding; acetoacetate-CoA ligase activity; cytosol; fatty acid metabolic process reviewed IPR005914; IPR020845; IPR000873; Acetoacetyl-CoA synthetase (EC 6.2.1.16) aacs si:dkey-215k6.2 zgc:56105 Danio rerio (Zebrafish) (Brachydanio rerio) 673 A3QK15 GO:0030729 GO:0030729 acetoacetate-CoA ligase activity other molecular function F ConsensusfromContig123 sp A4D1B5 GSAP_HUMAN 40.62 288 161 3 17 877 537 815 6E-60 209 A4D1B5 GSAP_HUMAN GO:0005794; GO:0001540; GO:0034205; GO:0030162; GO:0005802 Golgi apparatus; beta-amyloid binding; beta-amyloid formation; regulation of proteolysis; trans-Golgi network reviewed IPR028010; IPR026172; Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)] GSAP PION Homo sapiens (Human) 854 A4D1B5 GO:0001540 GO:0001540 beta-amyloid binding other molecular function F ConsensusfromContig123 sp A4D1B5 GSAP_HUMAN 40.62 288 161 3 17 877 537 815 6E-60 209 A4D1B5 GSAP_HUMAN GO:0005794; GO:0001540; GO:0034205; GO:0030162; GO:0005802 Golgi apparatus; beta-amyloid binding; beta-amyloid formation; regulation of proteolysis; trans-Golgi network reviewed IPR028010; IPR026172; Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)] GSAP PION Homo sapiens (Human) 854 A4D1B5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig123 sp A4D1B5 GSAP_HUMAN 40.62 288 161 3 17 877 537 815 6E-60 209 A4D1B5 GSAP_HUMAN GO:0005794; GO:0001540; GO:0034205; GO:0030162; GO:0005802 Golgi apparatus; beta-amyloid binding; beta-amyloid formation; regulation of proteolysis; trans-Golgi network reviewed IPR028010; IPR026172; Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)] GSAP PION Homo sapiens (Human) 854 A4D1B5 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig123 sp A4D1B5 GSAP_HUMAN 40.62 288 161 3 17 877 537 815 6E-60 209 A4D1B5 GSAP_HUMAN GO:0005794; GO:0001540; GO:0034205; GO:0030162; GO:0005802 Golgi apparatus; beta-amyloid binding; beta-amyloid formation; regulation of proteolysis; trans-Golgi network reviewed IPR028010; IPR026172; Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)] GSAP PION Homo sapiens (Human) 854 A4D1B5 GO:0030162 GO:0030162 regulation of proteolysis protein metabolism P ConsensusfromContig123 sp A4D1B5 GSAP_HUMAN 40.62 288 161 3 17 877 537 815 6E-60 209 A4D1B5 GSAP_HUMAN GO:0005794; GO:0001540; GO:0034205; GO:0030162; GO:0005802 Golgi apparatus; beta-amyloid binding; beta-amyloid formation; regulation of proteolysis; trans-Golgi network reviewed IPR028010; IPR026172; Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)] GSAP PION Homo sapiens (Human) 854 A4D1B5 GO:0034205 GO:0034205 beta-amyloid formation other metabolic processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007140 GO:0007140 male meiosis cell cycle and proliferation P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0034587 GO:0034587 piRNA metabolic process RNA metabolism P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0043046 GO:0043046 DNA methylation during gametogenesis DNA metabolism P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 56.69 157 68 0 3 473 56 212 2E-73 189 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0071546 ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007140 GO:0007140 male meiosis cell cycle and proliferation P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0034587 GO:0034587 piRNA metabolic process RNA metabolism P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0043046 GO:0043046 DNA methylation during gametogenesis DNA metabolism P ConsensusfromContig5811 sp A4D7T3 ASZ1_MACEU 31.6 212 143 2 478 1107 215 426 2E-73 109 A4D7T3 ASZ1_MACEU GO:0043046; GO:0030154; GO:0031047; GO:0007140; GO:0007275; GO:0071546; GO:0034587; GO:0007283 DNA methylation involved in gamete generation; cell differentiation; gene silencing by RNA; male meiosis; multicellular organismal development; pi-body; piRNA metabolic process; spermatogenesis reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR011510; Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein) ASZ1 GASZ Macropus eugenii (Tammar wallaby) 475 A4D7T3 GO:0071546 ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 87.93 116 14 0 430 83 191 306 7E-68 221 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig2612 sp A4FUD3 U5S1_BOVIN 79.31 29 6 0 87 1 305 333 7E-68 55.8 A4FUD3 U5S1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0008380; GO:0006397; GO:0005681 GTP binding; GTP catabolic process; GTPase activity; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; 116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain protein 2) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa) EFTUD2 SNRP116 Bos taurus (Bovine) 972 A4FUD3 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0043526 GO:0043526 neuroprotection death P ConsensusfromContig2490 sp A4IF63 TRIM2_BOVIN 92.7 137 10 0 413 3 572 708 4E-83 264 A4IF63 TRIM2_BOVIN GO:0005737; GO:0043523; GO:0004842; GO:0008270 cytoplasm; regulation of neuron apoptotic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011042; IPR003649; IPR001298; IPR017868; IPR013783; IPR014756; IPR001258; IPR013017; IPR000315; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Tripartite motif-containing protein 2 (EC 6.3.2.-) (E3 ubiquitin-protein ligase TRIM2) TRIM2 Bos taurus (Bovine) 744 A4IF63 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 34.93 229 145 2 690 10 587 813 3E-63 156 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 28.11 185 94 1 1255 701 438 583 3E-63 93.2 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6006 sp A4IFA3 GT2D2_BOVIN 42.5 40 22 1 1370 1251 401 439 3E-63 36.6 A4IFA3 GT2D2_BOVIN GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004212; IPR012337; IPR015880; General transcription factor II-I repeat domain-containing protein 2 (GTF2I repeat domain-containing protein 2) (Transcription factor GTF2IRD2) GTF2IRD2 Bos taurus (Bovine) 950 A4IFA3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig240 sp A4IFW2 PTPRF_DANRE 98.99 99 1 0 17 313 1808 1906 3E-62 211 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0035335 ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 96.43 84 3 0 262 11 1826 1909 2E-66 174 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0035335 ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig3648 sp A4IFW2 PTPRF_DANRE 97.78 45 1 0 387 253 1784 1828 2E-66 97.8 A4IFW2 PTPRF_DANRE GO:0007155; GO:0008201; GO:0016021; GO:0035335; GO:0004725; GO:0097374 cell adhesion; heparin binding; integral to membrane; peptidyl-tyrosine dephosphorylation; protein tyrosine phosphatase activity; sensory neuron axon guidance reviewed IPR003961; IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR000387; IPR016130; IPR000242; Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) ptprf si:dkey-21k10.1 Danio rerio (Zebrafish) (Brachydanio rerio) 1909 A4IFW2 GO:0035335 ConsensusfromContig4879 sp A4IG66 TM201_DANRE 94.9 98 3 1 296 3 77 172 8E-59 196 A4IG66 TM201_DANRE GO:0016021 integral to membrane reviewed IPR018861; IPR018617; Transmembrane protein 201 tmem201 zgc:162289 Danio rerio (Zebrafish) (Brachydanio rerio) 651 A4IG66 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig4879 sp A4IG66 TM201_DANRE 94.9 98 3 1 296 3 77 172 8E-59 196 A4IG66 TM201_DANRE GO:0016021 integral to membrane reviewed IPR018861; IPR018617; Transmembrane protein 201 tmem201 zgc:162289 Danio rerio (Zebrafish) (Brachydanio rerio) 651 A4IG66 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig4879 sp A4IG66 TM201_DANRE 94.9 98 3 1 296 3 77 172 8E-59 196 A4IG66 TM201_DANRE GO:0016021 integral to membrane reviewed IPR018861; IPR018617; Transmembrane protein 201 tmem201 zgc:162289 Danio rerio (Zebrafish) (Brachydanio rerio) 651 A4IG66 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4879 sp A4IG66 TM201_DANRE 94.9 98 3 1 296 3 77 172 8E-59 196 A4IG66 TM201_DANRE GO:0016021 integral to membrane reviewed IPR018861; IPR018617; Transmembrane protein 201 tmem201 zgc:162289 Danio rerio (Zebrafish) (Brachydanio rerio) 651 A4IG66 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig804 sp A4IHD2 ARIP4_XENTR 82.51 183 26 1 549 19 727 909 2E-99 318 A4IHD2 ARIP4_XENTR GO:0005524; GO:0003677; GO:0004386; GO:0005634 ATP binding; DNA binding; helicase activity; nucleus reviewed IPR014001; IPR001650; IPR027417; IPR000330; Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2) rad54l2 arip4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1396 A4IHD2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 49.05 210 96 4 793 170 247 447 5E-75 194 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 49.05 210 96 4 793 170 247 447 5E-75 194 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 49.05 210 96 4 793 170 247 447 5E-75 194 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 49.05 210 96 4 793 170 247 447 5E-75 194 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 49.05 210 96 4 793 170 247 447 5E-75 194 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 55.29 85 38 0 1032 778 165 249 5E-75 109 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 55.29 85 38 0 1032 778 165 249 5E-75 109 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 55.29 85 38 0 1032 778 165 249 5E-75 109 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 55.29 85 38 0 1032 778 165 249 5E-75 109 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5854 sp A4IHS0 MRRP1_XENTR 55.29 85 38 0 1032 778 165 249 5E-75 109 A4IHS0 MRRP1_XENTR GO:0008168; GO:0005739; GO:0008033 methyltransferase activity; mitochondrion; tRNA processing reviewed IPR025812; IPR016009; IPR007356; Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (tRNA methyltransferase 10 homolog C) trmt10c mrpp1 rg9mtd1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 448 A4IHS0 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0000463 GO:0000463 "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" RNA metabolism P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0051726 GO:0051726 regulation of cell cycle cell cycle and proliferation P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 81.5 173 32 0 701 183 557 729 2E-136 313 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0070545 GO:0070545 PeBoW complex nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0000463 GO:0000463 "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" RNA metabolism P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0051726 GO:0051726 regulation of cell cycle cell cycle and proliferation P ConsensusfromContig6368 sp A4IHS2 BOP1_XENTR 58.06 155 64 1 1141 677 411 564 2E-136 195 A4IHS2 BOP1_XENTR GO:0070545; GO:0000463; GO:0005654; GO:0051726 PeBoW complex; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; regulation of cell cycle reviewed IPR012953; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein bop1 (Block of proliferation 1 protein) bop1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 729 A4IHS2 GO:0070545 GO:0070545 PeBoW complex nucleus C ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0004019 GO:0004019 adenylosuccinate synthase activity other molecular function F ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0006164 GO:0006164 purine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6079 sp A4Z6H1 PURA2_PIG 75.33 227 56 0 18 698 230 456 1E-110 344 A4Z6H1 PURA2_PIG GO:0044208; GO:0005525; GO:0004019; GO:0005737; GO:0000287 'de novo' AMP biosynthetic process; GTP binding; adenylosuccinate synthase activity; cytoplasm; magnesium ion binding reviewed IPR018220; IPR001114; IPR027529; IPR027417; Purine metabolism; AMP biosynthesis via de novo pathway; AMP from IMP: step 1/2. Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2) ADSS ADSS2 Sus scrofa (Pig) 456 A4Z6H1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0001616 GO:0001616 growth hormone secretagogue receptor activity signal transduction activity F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0004930 GO:0004930 G-protein coupled receptor activity signal transduction activity F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0008154 GO:0008154 actin polymerization or depolymerization cell organization and biogenesis P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0008343 GO:0008343 adult feeding behavior other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0009725 GO:0009725 response to hormone stimulus other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0009755 GO:0009755 hormone-mediated signaling signal transduction P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0016520 GO:0016520 growth hormone-releasing hormone receptor activity signal transduction activity F ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0030252 GO:0030252 growth hormone secretion transport P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0030252 GO:0030252 growth hormone secretion cell-cell signaling P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0032094 GO:0032094 response to food other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0032100 GO:0032100 positive regulation of appetite other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0032691 GO:0032691 negative regulation of interleukin-1 beta production other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0032869 GO:0032869 cellular response to insulin stimulus other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0040018 GO:0040018 positive regulation of multicellular organism growth other biological processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0042536 GO:0042536 negative regulation of tumor necrosis factor biosynthetic process other metabolic processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0043005 GO:0043005 neuron projection other cellular component C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0043568 GO:0043568 positive regulation of insulin-like growth factor receptor signaling pathway signal transduction P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0045409 GO:0045409 negative regulation of interleukin-6 biosynthetic process other metabolic processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0046697 GO:0046697 decidualization developmental processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0050728 GO:0050728 negative regulation of inflammatory response stress response P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0051963 GO:0051963 regulation of synaptogenesis developmental processes P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0051963 GO:0051963 regulation of synaptogenesis cell organization and biogenesis P ConsensusfromContig3365 sp A5A4K9 GHSR_RABIT 74.23 194 50 0 15 596 35 228 5E-105 313 A5A4K9 GHSR_RABIT GO:0008154; GO:0008343; GO:0009986; GO:0032869; GO:0046697; GO:0001616; GO:0030252; GO:0016520; GO:0009755; GO:0016021; GO:0045121; GO:0050728; GO:0032691; GO:0045409; GO:0042536; GO:0043005; GO:0005886; GO:0032100; GO:0043568; GO:0040018; GO:0051963; GO:0032094 actin polymerization or depolymerization; adult feeding behavior; cell surface; cellular response to insulin stimulus; decidualization; growth hormone secretagogue receptor activity; growth hormone secretion; growth hormone-releasing hormone receptor activity; hormone-mediated signaling pathway; integral to membrane; membrane raft; negative regulation of inflammatory response; negative regulation of interleukin-1 beta production; negative regulation of interleukin-6 biosynthetic process; negative regulation of tumor necrosis factor biosynthetic process; neuron projection; plasma membrane; positive regulation of appetite; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of multicellular organism growth; regulation of synapse assembly; response to food reviewed IPR003905; IPR000276; IPR017452; Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor) GHSR Oryctolagus cuniculus (Rabbit) 366 A5A4K9 GO:0051963 GO:0051963 regulation of synaptogenesis cell-cell signaling P ConsensusfromContig6167 sp A5A6P2 ASAH1_PANTR 62.77 368 137 0 1450 347 28 395 2E-171 497 A5A6P2 ASAH1_PANTR GO:0017040; GO:0006629; GO:0005764 ceramidase activity; lipid metabolic process; lysosome reviewed IPR016699; IPR003199; Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) ASAH1 Pan troglodytes (Chimpanzee) 395 A5A6P2 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig6167 sp A5A6P2 ASAH1_PANTR 62.77 368 137 0 1450 347 28 395 2E-171 497 A5A6P2 ASAH1_PANTR GO:0017040; GO:0006629; GO:0005764 ceramidase activity; lipid metabolic process; lysosome reviewed IPR016699; IPR003199; Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) ASAH1 Pan troglodytes (Chimpanzee) 395 A5A6P2 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig6167 sp A5A6P2 ASAH1_PANTR 62.77 368 137 0 1450 347 28 395 2E-171 497 A5A6P2 ASAH1_PANTR GO:0017040; GO:0006629; GO:0005764 ceramidase activity; lipid metabolic process; lysosome reviewed IPR016699; IPR003199; Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) ASAH1 Pan troglodytes (Chimpanzee) 395 A5A6P2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6167 sp A5A6P2 ASAH1_PANTR 62.77 368 137 0 1450 347 28 395 2E-171 497 A5A6P2 ASAH1_PANTR GO:0017040; GO:0006629; GO:0005764 ceramidase activity; lipid metabolic process; lysosome reviewed IPR016699; IPR003199; Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) ASAH1 Pan troglodytes (Chimpanzee) 395 A5A6P2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6167 sp A5A6P2 ASAH1_PANTR 62.77 368 137 0 1450 347 28 395 2E-171 497 A5A6P2 ASAH1_PANTR GO:0017040; GO:0006629; GO:0005764 ceramidase activity; lipid metabolic process; lysosome reviewed IPR016699; IPR003199; Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) ASAH1 Pan troglodytes (Chimpanzee) 395 A5A6P2 GO:0017040 GO:0017040 ceramidase activity other molecular function F ConsensusfromContig6182 sp A5PLF5 TM2D3_DANRE 65.86 249 80 2 48 794 1 244 1E-94 296 A5PLF5 TM2D3_DANRE GO:0016021 integral to membrane reviewed IPR007829; TM2 domain-containing protein 3 tm2d3 zgc:165591 Danio rerio (Zebrafish) (Brachydanio rerio) 244 A5PLF5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6182 sp A5PLF5 TM2D3_DANRE 65.86 249 80 2 48 794 1 244 1E-94 296 A5PLF5 TM2D3_DANRE GO:0016021 integral to membrane reviewed IPR007829; TM2 domain-containing protein 3 tm2d3 zgc:165591 Danio rerio (Zebrafish) (Brachydanio rerio) 244 A5PLF5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0006829 GO:0006829 zinc ion transport transport P ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0008324 GO:0008324 cation transmembrane transporter activity transporter activity F ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1341 sp A5PMX1 ZNT7_DANRE 94.59 148 8 0 167 610 1 148 1E-82 257 A5PMX1 ZNT7_DANRE GO:0005794; GO:0016021; GO:0005385 Golgi apparatus; integral to membrane; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) slc30a7 znt7 si:ch211-190n7.2 si:dkey-6p9.3 Danio rerio (Zebrafish) (Brachydanio rerio) 387 A5PMX1 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6290 sp A5WW21 RASEF_DANRE 60.91 197 75 2 615 1199 465 661 1E-72 251 A5WW21 RASEF_DANRE GO:0005525; GO:0005509; GO:0048471; GO:0015031; GO:0007264 GTP binding; calcium ion binding; perinuclear region of cytoplasm; protein transport; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR002048; IPR027417; IPR005225; IPR001806; IPR003579; Ras and EF-hand domain-containing protein rasef si:ch211-39k3.1 zgc:162879 Danio rerio (Zebrafish) (Brachydanio rerio) 663 A5WW21 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1720 sp A6H8I0 UBP22_DANRE 94.74 95 5 0 287 3 126 220 5E-59 194 A6H8I0 UBP22_DANRE GO:0007049; GO:0016568; GO:0008234; GO:0005634; GO:0006355; GO:0006351; GO:0004221; GO:0006511; GO:0008270 cell cycle; chromatin modification; cysteine-type peptidase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22) usp22 zgc:136342 Danio rerio (Zebrafish) (Brachydanio rerio) 506 A6H8I0 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0006888 GO:0006888 ER to Golgi vesicle-mediated transport transport P ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0030127 GO:0030127 COPII vesicle coat ER/Golgi C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0030127 GO:0030127 COPII vesicle coat other membranes C ConsensusfromContig5626 sp A6QNT8 SC24A_BOVIN 78.88 606 127 1 2 1819 495 1099 0 1033 A6QNT8 SC24A_BOVIN GO:0030127; GO:0006888; GO:0000139; GO:0005789; GO:0006886; GO:0048471; GO:0008270 COPII vesicle coat; ER to Golgi vesicle-mediated transport; Golgi membrane; endoplasmic reticulum membrane; intracellular protein transport; perinuclear region of cytoplasm; zinc ion binding reviewed IPR007123; IPR006900; IPR006896; IPR012990; IPR002035; IPR006895; Protein transport protein Sec24A (SEC24-related protein A) SEC24A Bos taurus (Bovine) 1099 A6QNT8 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2196 sp A6QPF8 T120B_BOVIN 77.07 157 36 0 540 70 183 339 5E-70 223 A6QPF8 T120B_BOVIN GO:0016021 integral to membrane reviewed IPR012926; Transmembrane protein 120B TMEM120B Bos taurus (Bovine) 339 A6QPF8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2196 sp A6QPF8 T120B_BOVIN 77.07 157 36 0 540 70 183 339 5E-70 223 A6QPF8 T120B_BOVIN GO:0016021 integral to membrane reviewed IPR012926; Transmembrane protein 120B TMEM120B Bos taurus (Bovine) 339 A6QPF8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0016579 GO:0016579 protein deubiquitination protein metabolism P ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0031397 GO:0031397 negative regulation of protein ubiquitination protein metabolism P ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0031647 GO:0031647 regulation of protein stability protein metabolism P ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0031685 GO:0031685 adenosine receptor binding signal transduction activity F ConsensusfromContig117 sp A6QR55 UBP4_BOVIN 79.12 182 38 0 39 584 373 554 3E-97 308 A6QR55 UBP4_BOVIN GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) USP4 Bos taurus (Bovine) 963 A6QR55 GO:0034394 GO:0034394 protein localization at cell surface other biological processes P ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig458 sp A7KII6 PB6LB_SALSA 87.27 110 14 0 373 44 108 217 9E-56 179 A7KII6 PB6LB_SALSA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR000243; IPR016050; IPR001353; IPR023333; Proteasome subunit beta type-6-B like protein (EC 3.4.25.1) (Low molecular mass protein 2-delta-B) psmb6l-b lmp2-delta-b Salmo salar (Atlantic salmon) 217 A7KII6 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig5570 sp A7MB16 EIF3B_BOVIN 85.8 324 46 0 2 973 460 783 0 598 A7MB16 EIF3B_BOVIN GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR011042; IPR011400; IPR012677; IPR000504; IPR013979; IPR015943; Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (eIF-3-eta) EIF3B EIF3S9 Bos taurus (Bovine) 786 A7MB16 GO:0006446 GO:0006446 regulation of translational initiation protein metabolism P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0008199 GO:0008199 ferric iron binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0019310 GO:0019310 inositol catabolic process other metabolic processes P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0050113 GO:0050113 inositol oxygenase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 71.23 73 21 0 393 175 55 127 1E-51 117 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0008199 GO:0008199 ferric iron binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0019310 GO:0019310 inositol catabolic process other metabolic processes P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0050113 GO:0050113 inositol oxygenase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 67.8 59 19 0 178 2 127 185 1E-51 89.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0008199 GO:0008199 ferric iron binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0019310 GO:0019310 inositol catabolic process other metabolic processes P ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0050113 GO:0050113 inositol oxygenase activity other molecular function F ConsensusfromContig2735 sp A7MBE4 MIOX_BOVIN 69.57 23 7 0 458 390 33 55 1E-51 37.4 A7MBE4 MIOX_BOVIN GO:0005737; GO:0008199; GO:0019310; GO:0050113 cytoplasm; ferric iron binding; inositol catabolic process; inositol oxygenase activity reviewed IPR007828; Polyol metabolism; myo-inositol degradation into D-glucuronate; D-glucuronate from myo-inositol: step 1/1. Inositol oxygenase (EC 1.13.99.1) (Myo-inositol oxygenase) (MI oxygenase) MIOX Bos taurus (Bovine) 285 A7MBE4 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5564 sp A7TX81 CSN6_PIG 93.45 168 11 0 414 917 147 314 8E-158 326 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5564 sp A7TX81 CSN6_PIG 93.45 168 11 0 414 917 147 314 8E-158 326 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5564 sp A7TX81 CSN6_PIG 93.45 168 11 0 414 917 147 314 8E-158 326 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig5564 sp A7TX81 CSN6_PIG 86.23 138 19 0 5 418 10 147 8E-158 253 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5564 sp A7TX81 CSN6_PIG 86.23 138 19 0 5 418 10 147 8E-158 253 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5564 sp A7TX81 CSN6_PIG 86.23 138 19 0 5 418 10 147 8E-158 253 A7TX81 CSN6_PIG GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000555; IPR024969; COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) COPS6 Sus scrofa (Pig) 323 A7TX81 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig5587 sp A8E7D2 BN3D2_DANRE 65.14 218 74 1 760 113 37 254 3E-97 291 A8E7D2 BN3D2_DANRE GO:0008171; GO:0008173; GO:0005737; GO:0010586; GO:2000632 O-methyltransferase activity; RNA methyltransferase activity; cytoplasm; miRNA metabolic process; negative regulation of pre-miRNA processing reviewed IPR010675; IPR024160; Pre-miRNA 5'-monophosphate methyltransferase (EC 2.1.1.-) (BCDIN3 domain-containing protein) bcdin3d si:dkey-222f2.2 Danio rerio (Zebrafish) (Brachydanio rerio) 254 A8E7D2 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5587 sp A8E7D2 BN3D2_DANRE 65.14 218 74 1 760 113 37 254 3E-97 291 A8E7D2 BN3D2_DANRE GO:0008171; GO:0008173; GO:0005737; GO:0010586; GO:2000632 O-methyltransferase activity; RNA methyltransferase activity; cytoplasm; miRNA metabolic process; negative regulation of pre-miRNA processing reviewed IPR010675; IPR024160; Pre-miRNA 5'-monophosphate methyltransferase (EC 2.1.1.-) (BCDIN3 domain-containing protein) bcdin3d si:dkey-222f2.2 Danio rerio (Zebrafish) (Brachydanio rerio) 254 A8E7D2 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 92.75 69 5 0 450 244 576 644 3E-62 139 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2666 sp A9JRZ0 SMUF2_DANRE 88.71 62 7 0 238 53 647 708 3E-62 119 A9JRZ0 SMUF2_DANRE GO:0005737; GO:0045121; GO:0005634; GO:0005886; GO:0004842 cytoplasm; membrane raft; nucleus; plasma membrane; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase SMURF2 (EC 6.3.2.-) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2) smurf2 Danio rerio (Zebrafish) (Brachydanio rerio) 765 A9JRZ0 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0043130 GO:0043130 ubiquitin binding other molecular function F ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0071600 ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0071797 ConsensusfromContig1208 sp A9JTG5 HOIL1_DANRE 64.19 215 70 4 630 1 1 213 5E-69 230 A9JTG5 HOIL1_DANRE GO:0003677; GO:0071797; GO:0048701; GO:0071600; GO:0043123; GO:0097039; GO:0006351; GO:0043130; GO:0004842; GO:0008270 DNA binding; LUBAC complex; embryonic cranial skeleton morphogenesis; otic vesicle morphogenesis; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein linear polyubiquitination; transcription, DNA-dependent; ubiquitin binding; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR026261; IPR000626; IPR002867; IPR001876; IPR001841; IPR017907; RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 6.3.2.-) (Heme-oxidized IRP2 ubiquitin ligase 1 homolog) (HOIL-1) rbck1 zgc:175152 Danio rerio (Zebrafish) (Brachydanio rerio) 714 A9JTG5 GO:0097039 ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 75.23 109 25 2 219 545 533 639 5E-75 164 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2743 sp B0JZG0 S23A2_XENTR 90.91 77 7 0 1 231 460 536 5E-75 138 B0JZG0 S23A2_XENTR GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR006042; IPR006043; Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) slc23a2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 649 B0JZG0 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0016817 GO:0016817 "hydrolase activity, acting on acid anhydrides" other molecular function F ConsensusfromContig5839 sp B0R0I6 CHD8_DANRE 74.05 343 77 4 1713 697 2177 2511 6E-130 426 B0R0I6 CHD8_DANRE GO:0005524; GO:0003677; GO:0071339; GO:0016055; GO:0003682; GO:0016568; GO:0004386; GO:0006355; GO:0006351 ATP binding; DNA binding; MLL1 complex; Wnt receptor signaling pathway; chromatin binding; chromatin modification; helicase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006576; IPR023780; IPR000953; IPR016197; IPR014001; IPR001650; IPR027417; IPR001005; IPR000330; Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) chd8 si:ch211-10e2.6 wu:fi45h08 Danio rerio (Zebrafish) (Brachydanio rerio) 2511 B0R0I6 GO:0071339 ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0030433 GO:0030433 ER-associated protein catabolic process protein metabolism P ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig772 sp B0UXS1 FXRD2_DANRE 78.38 185 40 0 1 555 475 659 4E-106 326 B0UXS1 FXRD2_DANRE GO:0030433; GO:0005788; GO:0050660; GO:0016491 ER-associated protein catabolic process; endoplasmic reticulum lumen; flavin adenine dinucleotide binding; oxidoreductase activity reviewed FAD-dependent oxidoreductase domain-containing protein 2 foxred2 si:dkeyp-69e1.5 zgc:153216 Danio rerio (Zebrafish) (Brachydanio rerio) 687 B0UXS1 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5724 sp B0UYI1 TEAN2_DANRE 69.19 211 58 3 315 935 1 208 3E-96 292 B0UYI1 TEAN2_DANRE GO:0003677; GO:0005634; GO:0006351 DNA binding; nucleus; transcription, DNA-dependent reviewed IPR003618; IPR017923; Transcription elongation factor A N-terminal and central domain-containing protein 2 tceanc2 si:dkey-63k7.9 Danio rerio (Zebrafish) (Brachydanio rerio) 210 B0UYI1 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5724 sp B0UYI1 TEAN2_DANRE 69.19 211 58 3 315 935 1 208 3E-96 292 B0UYI1 TEAN2_DANRE GO:0003677; GO:0005634; GO:0006351 DNA binding; nucleus; transcription, DNA-dependent reviewed IPR003618; IPR017923; Transcription elongation factor A N-terminal and central domain-containing protein 2 tceanc2 si:dkey-63k7.9 Danio rerio (Zebrafish) (Brachydanio rerio) 210 B0UYI1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5724 sp B0UYI1 TEAN2_DANRE 69.19 211 58 3 315 935 1 208 3E-96 292 B0UYI1 TEAN2_DANRE GO:0003677; GO:0005634; GO:0006351 DNA binding; nucleus; transcription, DNA-dependent reviewed IPR003618; IPR017923; Transcription elongation factor A N-terminal and central domain-containing protein 2 tceanc2 si:dkey-63k7.9 Danio rerio (Zebrafish) (Brachydanio rerio) 210 B0UYI1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0008409 GO:0008409 5'-3' exonuclease activity other molecular function F ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031627 GO:0031627 telomeric loop formation DNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031627 GO:0031627 telomeric loop formation cell organization and biogenesis P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031848 GO:0031848 protection from non-homologous end joining at telomere stress response P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031848 GO:0031848 protection from non-homologous end joining at telomere DNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031848 GO:0031848 protection from non-homologous end joining at telomere cell organization and biogenesis P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031860 GO:0031860 telomeric 3' overhang formation DNA metabolism P ConsensusfromContig1912 sp B0V2S2 DCR1B_DANRE 62.66 158 56 1 1 474 204 358 5E-58 195 B0V2S2 DCR1B_DANRE GO:0008409; GO:0006281; GO:0000075; GO:0005813; GO:0000781; GO:0005634; GO:0031848; GO:0031860; GO:0031627 5'-3' exonuclease activity; DNA repair; cell cycle checkpoint; centrosome; chromosome, telomeric region; nucleus; protection from non-homologous end joining at telomere; telomeric 3' overhang formation; telomeric loop formation reviewed IPR001279; IPR011084; 5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) dclre1b snm1b si:dkey-73i4.1 zgc:154089 Danio rerio (Zebrafish) (Brachydanio rerio) 571 B0V2S2 GO:0031860 GO:0031860 telomeric 3' overhang formation cell organization and biogenesis P ConsensusfromContig6247 sp B1AZ99 OTUD3_MOUSE 72.22 198 51 2 183 764 1 198 4E-80 265 B1AZ99 OTUD3_MOUSE GO:0035871; GO:0044313; GO:0006508; GO:0004843 protein K11-linked deubiquitination; protein K6-linked deubiquitination; proteolysis; ubiquitin-specific protease activity reviewed IPR003323; OTU domain-containing protein 3 (EC 3.4.19.12) Otud3 Mus musculus (Mouse) 396 B1AZ99 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6247 sp B1AZ99 OTUD3_MOUSE 72.22 198 51 2 183 764 1 198 4E-80 265 B1AZ99 OTUD3_MOUSE GO:0035871; GO:0044313; GO:0006508; GO:0004843 protein K11-linked deubiquitination; protein K6-linked deubiquitination; proteolysis; ubiquitin-specific protease activity reviewed IPR003323; OTU domain-containing protein 3 (EC 3.4.19.12) Otud3 Mus musculus (Mouse) 396 B1AZ99 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6247 sp B1AZ99 OTUD3_MOUSE 72.22 198 51 2 183 764 1 198 4E-80 265 B1AZ99 OTUD3_MOUSE GO:0035871; GO:0044313; GO:0006508; GO:0004843 protein K11-linked deubiquitination; protein K6-linked deubiquitination; proteolysis; ubiquitin-specific protease activity reviewed IPR003323; OTU domain-containing protein 3 (EC 3.4.19.12) Otud3 Mus musculus (Mouse) 396 B1AZ99 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0000785 GO:0000785 chromatin other cellular component C ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0032116 GO:0032116 cohesin loading complex nucleus C ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0034088 GO:0034088 maintenance of mitotic sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0034088 GO:0034088 maintenance of mitotic sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig2893 sp B1H1Z8 SCC4_XENTR 96.49 114 4 0 344 3 359 472 5E-74 236 B1H1Z8 SCC4_XENTR GO:0032116; GO:0051301; GO:0000785; GO:0034088; GO:0005654 SMC loading complex; cell division; chromatin; maintenance of mitotic sister chromatid cohesion; nucleoplasm reviewed IPR019440; IPR011990; MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog) mau2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 604 B1H1Z8 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0016579 GO:0016579 protein deubiquitination protein metabolism P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0031397 GO:0031397 negative regulation of protein ubiquitination protein metabolism P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0031647 GO:0031647 regulation of protein stability protein metabolism P ConsensusfromContig5749 sp B2GUZ1 UBP4_RAT 63.12 320 98 6 1395 475 649 961 5E-112 364 B2GUZ1 UBP4_RAT GO:0005737; GO:0046872; GO:0031397; GO:0005634; GO:0016579; GO:0034394; GO:0031647; GO:0004221; GO:0006511; GO:0004843 cytoplasm; metal ion binding; negative regulation of protein ubiquitination; nucleus; protein deubiquitination; protein localization to cell surface; regulation of protein stability; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR006615; IPR018200; IPR001394; IPR028135; IPR028134; Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) Usp4 Rattus norvegicus (Rat) 961 B2GUZ1 GO:0034394 GO:0034394 protein localization at cell surface other biological processes P ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2512 sp B2KI79 DOPP1_RHIFE 71.96 107 30 0 73 393 1 107 2E-54 176 B2KI79 DOPP1_RHIFE GO:0047874; GO:0005789; GO:0016021; GO:0006486 dolichyldiphosphatase activity; endoplasmic reticulum membrane; integral to membrane; protein glycosylation reviewed IPR000326; Protein modification; protein glycosylation. Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1) DOLPP1 Rhinolophus ferrumequinum (Greater horseshoe bat) 238 B2KI79 GO:0047874 GO:0047874 dolichyldiphosphatase activity other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0001816 GO:0001816 cytokine production other biological processes P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0010586 GO:0010586 miRNA metabolic process RNA metabolism P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0010587 GO:0010587 miRNA catabolic process RNA metabolism P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0019827 GO:0019827 stem cell maintenance other biological processes P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0031054 GO:0031054 pre-microRNA processing RNA metabolism P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0031123 GO:0031123 RNA 3'-end processing RNA metabolism P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0031664 GO:0031664 regulation of lipopolysaccharide-mediated signaling pathway signal transduction P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0032088 GO:0032088 negative regulation of NF-kappaB transcription factor activity RNA metabolism P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0032755 GO:0032755 positive regulation of interleukin-6 production other biological processes P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0050265 GO:0050265 RNA uridylyltransferase activity other molecular function F ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0070102 GO:0070102 interleukin-6-mediated signaling pathway signal transduction P ConsensusfromContig6285 sp B2RX14 TUT4_MOUSE 67.44 172 46 2 1470 979 1210 1379 3E-63 229 B2RX14 TUT4_MOUSE GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005634; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) Zcchc11 Kiaa0191 Tut4 Mus musculus (Mouse) 1644 B2RX14 GO:0071044 ConsensusfromContig6075 sp B5RI54 EIF3H_SALSA 91.2 250 22 0 1066 317 95 344 1E-139 412 B5RI54 EIF3H_SALSA GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR027524; IPR000555; Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) eif3h eif3s3 Salmo salar (Atlantic salmon) 344 B5RI54 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig6075 sp B5RI54 EIF3H_SALSA 91.2 250 22 0 1066 317 95 344 1E-139 412 B5RI54 EIF3H_SALSA GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR027524; IPR000555; Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) eif3h eif3s3 Salmo salar (Atlantic salmon) 344 B5RI54 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6075 sp B5RI54 EIF3H_SALSA 91.2 250 22 0 1066 317 95 344 1E-139 412 B5RI54 EIF3H_SALSA GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR027524; IPR000555; Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) eif3h eif3s3 Salmo salar (Atlantic salmon) 344 B5RI54 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig6075 sp B5RI54 EIF3H_SALSA 91.2 250 22 0 1066 317 95 344 1E-139 412 B5RI54 EIF3H_SALSA GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR027524; IPR000555; Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) eif3h eif3s3 Salmo salar (Atlantic salmon) 344 B5RI54 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6075 sp B5RI54 EIF3H_SALSA 91.2 250 22 0 1066 317 95 344 1E-139 412 B5RI54 EIF3H_SALSA GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR027524; IPR000555; Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit) eif3h eif3s3 Salmo salar (Atlantic salmon) 344 B5RI54 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0005216 GO:0005216 ion channel activity transporter activity F ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0005244 GO:0005244 voltage-gated ion channel activity transporter activity F ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1768 sp B5X1G3 GPHR_SALSA 95.45 176 8 0 528 1 47 222 6E-106 317 B5X1G3 GPHR_SALSA GO:0000139; GO:0016021; GO:0015031; GO:0005244 Golgi membrane; integral to membrane; protein transport; voltage-gated ion channel activity reviewed IPR025969; IPR022535; IPR015672; Golgi pH regulator (Protein gpr89) gpr89 gphr Salmo salar (Atlantic salmon) 455 B5X1G3 GO:0034765 GO:0034765 regulation of transmembrane ion transport transport P ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0008967 GO:0008967 phosphoglycolate phosphatase activity other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0009086 GO:0009086 methionine biosynthetic process other metabolic processes P ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0019509 GO:0019509 methionine salvage other metabolic processes P ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0043715 GO:0043715 "2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity" other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0043716 GO:0043716 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0043874 GO:0043874 acireductone synthase activity other molecular function F ConsensusfromContig6330 sp B5X2D1 ENOPH_SALSA 81.89 127 23 0 2 382 133 259 2E-57 194 B5X2D1 ENOPH_SALSA GO:0019509; GO:0043874; GO:0005737; GO:0000287; GO:0005634 L-methionine salvage from methylthioadenosine; acireductone synthase activity; cytoplasm; magnesium ion binding; nucleus reviewed IPR023943; IPR027511; IPR023214; IPR006439; Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 3/6. Amino-acid biosynthesis; L-methionine biosynthesis via salvage pathway; L-methionine from S-methyl-5-thio-alpha-D-ribose 1-phosphate: step 4/6. Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog) enoph1 masa Salmo salar (Atlantic salmon) 261 B5X2D1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6018 sp B5X9P2 CIO1A_SALSA 66.46 316 96 3 236 1171 1 310 9E-124 373 B5X9P2 CIO1A_SALSA GO:0097361; GO:0016226 CIA complex; iron-sulfur cluster assembly reviewed IPR015943; IPR001680; IPR019775; IPR017986; Probable cytosolic iron-sulfur protein assembly protein ciao1-A (WD repeat-containing protein 39-A) ciao1a Salmo salar (Atlantic salmon) 330 B5X9P2 GO:0016226 GO:0016226 iron-sulfur cluster assembly other metabolic processes P ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0004061 GO:0004061 arylformamidase activity other molecular function F ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0006569 GO:0006569 tryptophan catabolic process other metabolic processes P ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3838 sp B5XB27 KFA_SALSA 83.59 128 21 0 385 2 118 245 7E-62 198 B5XB27 KFA_SALSA GO:0034354; GO:0004061; GO:0005829; GO:0005634; GO:0019441 'de novo' NAD biosynthetic process from tryptophan; arylformamidase activity; cytosol; nucleus; tryptophan catabolic process to kynurenine reviewed IPR013094; IPR027519; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 2/2. Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF) afmid Salmo salar (Atlantic salmon) 294 B5XB27 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007140 GO:0007140 male meiosis cell cycle and proliferation P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0009566 GO:0009566 fertilization other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0034587 GO:0034587 piRNA metabolic process RNA metabolism P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0043046 GO:0043046 DNA methylation during gametogenesis DNA metabolism P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.89 380 157 2 1380 247 964 1342 1E-164 422 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0071547 ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007140 GO:0007140 male meiosis cell cycle and proliferation P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0009566 GO:0009566 fertilization other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0034587 GO:0034587 piRNA metabolic process RNA metabolism P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0043046 GO:0043046 DNA methylation during gametogenesis DNA metabolism P ConsensusfromContig6264 sp B8A4F4 TDRD9_DANRE 57.22 187 73 5 1945 1388 781 961 1E-164 181 B8A4F4 TDRD9_DANRE GO:0005524; GO:0008026; GO:0043046; GO:0030154; GO:0009566; GO:0031047; GO:0007140; GO:0007275; GO:0003676; GO:0005634; GO:0071547; GO:0034587; GO:0007283 ATP binding; ATP-dependent helicase activity; DNA methylation involved in gamete generation; cell differentiation; fertilization; gene silencing by RNA; male meiosis; multicellular organismal development; nucleic acid binding; nucleus; piP-body; piRNA metabolic process; spermatogenesis reviewed IPR011545; IPR002464; IPR007502; IPR014001; IPR001650; IPR027417; IPR002999; Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) tdrd9 si:dkey-15f17.9 Danio rerio (Zebrafish) (Brachydanio rerio) 1342 B8A4F4 GO:0071547 ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0006999 GO:0006999 nuclear pore organization cell organization and biogenesis P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007080 GO:0007080 mitotic metaphase plate congression cell cycle and proliferation P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0007080 GO:0007080 mitotic metaphase plate congression cell organization and biogenesis P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0031080 GO:0031080 Nup107-160 complex nucleus C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0031080 GO:0031080 Nup107-160 complex other membranes C ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0051315 GO:0051315 attachment of spindle microtubules to kinetochore during mitosis cell organization and biogenesis P ConsensusfromContig2479 sp C1BK83 SEH1_OSMMO 97.83 138 3 0 152 565 1 138 1E-93 285 C1BK83 SEH1_OSMMO GO:0051315; GO:0051301; GO:0000777; GO:0051028; GO:0007080; GO:0006999; GO:0031080; GO:0015031 attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation; cell division; condensed chromosome kinetochore; mRNA transport; mitotic metaphase plate congression; nuclear pore organization; nuclear pore outer ring; protein transport reviewed IPR020472; IPR015943; IPR001680; IPR017986; Nucleoporin seh1 (Nup107-160 subcomplex subunit seh1) seh1l Osmerus mordax (Rainbow smelt) (Atherina mordax) 364 C1BK83 GO:0051315 GO:0051315 attachment of spindle microtubules to kinetochore during mitosis cell cycle and proliferation P ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0003858 GO:0003858 3-hydroxybutyrate dehydrogenase activity other molecular function F ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0016628 GO:0016628 "oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0019290 GO:0019290 siderophore biosynthetic process other metabolic processes P ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0042168 GO:0042168 heme metabolic process other metabolic processes P ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0055072 GO:0055072 iron ion homeostasis other biological processes P ConsensusfromContig3429 sp C1C4R8 BDH2_LITCT 91.74 109 9 0 329 3 126 234 9E-70 215 C1C4R8 BDH2_LITCT GO:0003858; GO:0005737; GO:0042168; GO:0055072; GO:0016628; GO:0019290 3-hydroxybutyrate dehydrogenase activity; cytoplasm; heme metabolic process; iron ion homeostasis; oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor; siderophore biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Siderophore biosynthesis. 3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (R-beta-hydroxybutyrate dehydrogenase) bdh2 Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 245 C1C4R8 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0010212 GO:0010212 response to ionizing radiation other biological processes P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0031571 GO:0031571 G1 DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0031571 GO:0031571 G1 DNA damage checkpoint signal transduction P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0031571 GO:0031571 G1 DNA damage checkpoint stress response P ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5941 sp D2HWM5 RFWD3_AILME 57.11 443 174 5 1285 2 275 716 8E-157 469 D2HWM5 RFWD3_AILME GO:0006281; GO:0097371; GO:0016605; GO:0005737; GO:0031571; GO:0005634; GO:0002039; GO:0010212; GO:0004842; GO:0008270 DNA repair; MDM2/MDM4 family protein binding; PML body; cytoplasm; mitotic G1 DNA damage checkpoint; nucleus; p53 binding; response to ionizing radiation; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR015943; IPR001680; IPR017986; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RFWD3 (EC 6.3.2.-) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) RFWD3 RNF201 PANDA_016934 Ailuropoda melanoleuca (Giant panda) 773 D2HWM5 GO:0070215 GO:0070215 MDM2 binding other molecular function F ConsensusfromContig2103 sp D3YZP9 CCDC6_MOUSE 89.72 107 11 0 322 2 182 288 1E-59 196 D3YZP9 CCDC6_MOUSE GO:0005737; GO:0005856 cytoplasm; cytoskeleton reviewed IPR019152; Coiled-coil domain-containing protein 6 Ccdc6 Mus musculus (Mouse) 469 D3YZP9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2103 sp D3YZP9 CCDC6_MOUSE 89.72 107 11 0 322 2 182 288 1E-59 196 D3YZP9 CCDC6_MOUSE GO:0005737; GO:0005856 cytoplasm; cytoskeleton reviewed IPR019152; Coiled-coil domain-containing protein 6 Ccdc6 Mus musculus (Mouse) 469 D3YZP9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2103 sp D3YZP9 CCDC6_MOUSE 89.72 107 11 0 322 2 182 288 1E-59 196 D3YZP9 CCDC6_MOUSE GO:0005737; GO:0005856 cytoplasm; cytoskeleton reviewed IPR019152; Coiled-coil domain-containing protein 6 Ccdc6 Mus musculus (Mouse) 469 D3YZP9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0005760 GO:0005760 gamma DNA polymerase complex mitochondrion C ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0006264 GO:0006264 mitochondrial DNA replication DNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0006264 GO:0006264 mitochondrial DNA replication cell organization and biogenesis P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0006284 GO:0006284 base-excision repair stress response P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0006284 GO:0006284 base-excision repair DNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0016890 GO:0016890 "site-specific endodeoxyribonuclease activity, specific for altered base" other molecular function F ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0017108 GO:0017108 5'-flap endonuclease activity other molecular function F ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0042645 GO:0042645 mitochondrial nucleoid mitochondrion C ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0043137 GO:0043137 "DNA replication, removal of RNA primer" RNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0043137 GO:0043137 "DNA replication, removal of RNA primer" DNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0043504 GO:0043504 mitochondrial DNA repair stress response P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0043504 GO:0043504 mitochondrial DNA repair DNA metabolism P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0043504 GO:0043504 mitochondrial DNA repair cell organization and biogenesis P ConsensusfromContig5734 sp E1BMP7 DNA2_BOVIN 68.92 399 122 2 1532 339 654 1051 1E-176 533 E1BMP7 DNA2_BOVIN GO:0051539; GO:0043139; GO:0017108; GO:0005524; GO:0003677; GO:0000729; GO:0000076; GO:0033567; GO:0043137; GO:0006284; GO:0005760; GO:0046872; GO:0043504; GO:0006264; GO:0042645; GO:0005634; GO:0045740; GO:0043142; GO:0016890 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; 5'-flap endonuclease activity; ATP binding; DNA binding; DNA double-strand break processing; DNA replication checkpoint; DNA replication, Okazaki fragment processing; DNA replication, removal of RNA primer; base-excision repair; gamma DNA polymerase complex; metal ion binding; mitochondrial DNA repair; mitochondrial DNA replication; mitochondrial nucleoid; nucleus; positive regulation of DNA replication; single-stranded DNA-dependent ATPase activity; site-specific endodeoxyribonuclease activity, specific for altered base reviewed IPR026851; IPR014808; IPR027417; DNA replication ATP-dependent helicase/nuclease DNA2 (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)] DNA2 Bos taurus (Bovine) 1061 E1BMP7 GO:0045740 GO:0045740 positive regulation of DNA replication DNA metabolism P ConsensusfromContig3579 sp E1BZ85 MARF1_CHICK 77.78 117 26 0 3 353 789 905 1E-56 195 E1BZ85 MARF1_CHICK GO:0003723; GO:0010923; GO:0000166; GO:0048477; GO:0005777; GO:0010468 RNA binding; negative regulation of phosphatase activity; nucleotide binding; oogenesis; peroxisome; regulation of gene expression reviewed IPR024582; IPR024768; IPR012677; IPR021139; IPR025605; IPR000504; Meiosis arrest female protein 1 homolog (Limkain-b1) MARF1 LKAP Gallus gallus (Chicken) 1741 E1BZ85 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3579 sp E1BZ85 MARF1_CHICK 77.78 117 26 0 3 353 789 905 1E-56 195 E1BZ85 MARF1_CHICK GO:0003723; GO:0010923; GO:0000166; GO:0048477; GO:0005777; GO:0010468 RNA binding; negative regulation of phosphatase activity; nucleotide binding; oogenesis; peroxisome; regulation of gene expression reviewed IPR024582; IPR024768; IPR012677; IPR021139; IPR025605; IPR000504; Meiosis arrest female protein 1 homolog (Limkain-b1) MARF1 LKAP Gallus gallus (Chicken) 1741 E1BZ85 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig3579 sp E1BZ85 MARF1_CHICK 77.78 117 26 0 3 353 789 905 1E-56 195 E1BZ85 MARF1_CHICK GO:0003723; GO:0010923; GO:0000166; GO:0048477; GO:0005777; GO:0010468 RNA binding; negative regulation of phosphatase activity; nucleotide binding; oogenesis; peroxisome; regulation of gene expression reviewed IPR024582; IPR024768; IPR012677; IPR021139; IPR025605; IPR000504; Meiosis arrest female protein 1 homolog (Limkain-b1) MARF1 LKAP Gallus gallus (Chicken) 1741 E1BZ85 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006284 GO:0006284 base-excision repair stress response P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006284 GO:0006284 base-excision repair DNA metabolism P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0034644 GO:0034644 cellular response to UV other biological processes P ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0035520 ConsensusfromContig495 sp E1C1R4 UBP47_CHICK 85.19 162 24 0 2 487 1209 1370 7E-63 216 E1C1R4 UBP47_CHICK GO:0006284; GO:0005737; GO:0035520; GO:0004221; GO:0006511; GO:0004843 base-excision repair; cytoplasm; monoubiquitinated protein deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR027933; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Gallus gallus (Chicken) 1375 E1C1R4 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0021551 GO:0021551 central nervous system morphogenesis developmental processes P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0035871 ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6026 sp E7F6T8 UBP37_DANRE 78.92 593 115 4 1784 9 354 937 0 860 E7F6T8 UBP37_DANRE GO:0000082; GO:0051301; GO:0004197; GO:0007067; GO:0035871; GO:0071108; GO:0004221; GO:0006511; GO:0004843 G1/S transition of mitotic cell cycle; cell division; cysteine-type endopeptidase activity; mitosis; protein K11-linked deubiquitination; protein K48-linked deubiquitination; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; IPR003903; Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37) usp37 zgc:152882 zgc:153999 Danio rerio (Zebrafish) (Brachydanio rerio) 937 E7F6T8 GO:0071108 ConsensusfromContig5905 sp F1Q575 NNRD_DANRE 84.04 213 32 1 1292 654 21 231 1E-134 378 F1Q575 NNRD_DANRE GO:0005524; GO:0047453 ATP binding; ATP-dependent NAD(P)H-hydrate dehydratase activity reviewed IPR017953; IPR026599; IPR000631; ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) zgc:171429 Danio rerio (Zebrafish) (Brachydanio rerio) 330 ConsensusfromContig5905 sp F1Q575 NNRD_DANRE 75.31 81 15 3 586 347 254 330 1E-134 116 F1Q575 NNRD_DANRE GO:0005524; GO:0047453 ATP binding; ATP-dependent NAD(P)H-hydrate dehydratase activity reviewed IPR017953; IPR026599; IPR000631; ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) zgc:171429 Danio rerio (Zebrafish) (Brachydanio rerio) 330 ConsensusfromContig5905 sp F1Q575 NNRD_DANRE 63.16 19 7 0 663 607 229 247 1E-134 30.8 F1Q575 NNRD_DANRE GO:0005524; GO:0047453 ATP binding; ATP-dependent NAD(P)H-hydrate dehydratase activity reviewed IPR017953; IPR026599; IPR000631; ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) zgc:171429 Danio rerio (Zebrafish) (Brachydanio rerio) 330 ConsensusfromContig525 sp F1Q8W0 CATIN_DANRE 98.97 97 1 0 3 293 739 835 4E-64 216 F1Q8W0 CATIN_DANRE GO:0045087; GO:0007399; GO:0005634 innate immune response; nervous system development; nucleus reviewed IPR019134; IPR018816; Cactin (zCactin) cactin si:dkey-158a20.4 zgc:158620 Danio rerio (Zebrafish) (Brachydanio rerio) 835 ConsensusfromContig6346 sp F1Q8W0 CATIN_DANRE 66.53 239 67 3 705 1 511 740 2E-79 261 F1Q8W0 CATIN_DANRE GO:0045087; GO:0007399; GO:0005634 innate immune response; nervous system development; nucleus reviewed IPR019134; IPR018816; Cactin (zCactin) cactin si:dkey-158a20.4 zgc:158620 Danio rerio (Zebrafish) (Brachydanio rerio) 835 ConsensusfromContig2694 sp F1R2X6 PSM4B_DANRE 89.34 122 13 0 1 366 1704 1825 7E-60 209 F1R2X6 PSM4B_DANRE GO:0006281; GO:0005829; GO:0070577; GO:0016607; GO:0005634; GO:0016504; GO:0010499; GO:0035093; GO:1990111 DNA repair; cytosol; histone acetyl-lysine binding; nuclear speck; nucleus; peptidase activator activity; proteasomal ubiquitin-independent protein catabolic process; spermatogenesis, exchange of chromosomal proteins; spermatoproteasome complex reviewed IPR011989; IPR016024; IPR021843; Proteasome activator complex subunit 4B (Proteasome activator PA200-B) psme4b Danio rerio (Zebrafish) (Brachydanio rerio) 1825 F1R2X6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 95.73 117 5 0 96 446 1325 1441 2E-62 188 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 95.73 117 5 0 96 446 1325 1441 2E-62 188 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 95.73 117 5 0 96 446 1325 1441 2E-62 188 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 95.73 117 5 0 96 446 1325 1441 2E-62 188 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 90.91 33 3 0 2 100 1293 1325 2E-62 71.2 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 90.91 33 3 0 2 100 1293 1325 2E-62 71.2 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 90.91 33 3 0 2 100 1293 1325 2E-62 71.2 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2189 sp F1RCR6 TRIPC_DANRE 90.91 33 3 0 2 100 1293 1325 2E-62 71.2 F1RCR6 TRIPC_DANRE GO:0006281; GO:0009790; GO:2000780; GO:1901315; GO:0005654; GO:0042787; GO:0006974; GO:0004842 DNA repair; embryo development; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleoplasm; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-protein ligase activity reviewed IPR011989; IPR016024; IPR000569; IPR004170; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRIP12 (EC 6.3.2.-) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12) trip12 si:ch211-272f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 2026 F1RCR6 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig6103 sp F6P3G4 PS11A_DANRE 93.51 416 27 0 1692 445 6 421 0 739 F6P3G4 PS11A_DANRE GO:0005829; GO:0005634; GO:0022624; GO:0043248; GO:0048863; GO:0006511 cytosol; nucleus; proteasome accessory complex; proteasome assembly; stem cell differentiation; ubiquitin-dependent protein catabolic process reviewed IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 11A (26S proteasome regulatory subunit RPN6-A) psmd11a Danio rerio (Zebrafish) (Brachydanio rerio) 421 ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0006904 GO:0006904 vesicle docking during exocytosis transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0017075 GO:0017075 syntaxin-1 binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0019905 GO:0019905 syntaxin binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0030347 GO:0030347 syntaxin-2 binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0031091 GO:0031091 platelet alpha granule other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0042581 GO:0042581 specific granule other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0043312 GO:0043312 neutrophil degranulation transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0045955 GO:0045955 negative regulation of calcium ion-dependent exocytosis transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070527 GO:0070527 platelet aggregation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070527 GO:0070527 platelet aggregation cell adhesion P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 60.41 341 127 5 2117 1113 7 345 0 401 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070820 GO:0070820 other cellular component ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0006904 GO:0006904 vesicle docking during exocytosis transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0017075 GO:0017075 syntaxin-1 binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0019905 GO:0019905 syntaxin binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0030347 GO:0030347 syntaxin-2 binding other molecular function F ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0031091 GO:0031091 platelet alpha granule other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0042581 GO:0042581 specific granule other cellular component C ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0043312 GO:0043312 neutrophil degranulation transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0045955 GO:0045955 negative regulation of calcium ion-dependent exocytosis transport P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070527 GO:0070527 platelet aggregation stress response P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070527 GO:0070527 platelet aggregation cell adhesion P ConsensusfromContig5556 sp O00186 STXB3_HUMAN 56.45 248 99 5 1138 407 337 579 0 270 O00186 STXB3_HUMAN GO:0016324; GO:0016323; GO:0005829; GO:0045955; GO:0043312; GO:0005634; GO:0005886; GO:0070527; GO:0031091; GO:0051291; GO:0015031; GO:0042581; GO:0070820; GO:0006904 apical plasma membrane; basolateral plasma membrane; cytosol; negative regulation of calcium ion-dependent exocytosis; neutrophil degranulation; nucleus; plasma membrane; platelet aggregation; platelet alpha granule; protein heterooligomerization; protein transport; specific granule; tertiary granule; vesicle docking involved in exocytosis reviewed IPR027482; IPR001619; Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C) STXBP3 Homo sapiens (Human) 592 O00186 GO:0070820 GO:0070820 other cellular component ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005942 GO:0005942 phosphoinositide 3-kinase complex cytosol C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006661 GO:0006661 phosphatidylinositol biosynthetic process other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006887 GO:0006887 exocytosis transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0014829 GO:0014829 vascular smooth muscle contraction other biological processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016303 GO:0016303 1-phosphatidylinositol-3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0030136 GO:0030136 clathrin-coated vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0031982 GO:0031982 vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035004 GO:0035004 phosphoinositide 3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035005 GO:0035005 phosphatidylinositol-4-phosphate 3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048008 GO:0048008 platelet-derived growth factor receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048268 GO:0048268 clathrin coat assembly transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 86.46 96 13 0 289 2 1130 1225 9E-75 186 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048268 GO:0048268 clathrin coat assembly cell organization and biogenesis P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0005942 GO:0005942 phosphoinositide 3-kinase complex cytosol C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006661 GO:0006661 phosphatidylinositol biosynthetic process other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006887 GO:0006887 exocytosis transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0014829 GO:0014829 vascular smooth muscle contraction other biological processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016303 GO:0016303 1-phosphatidylinositol-3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0030136 GO:0030136 clathrin-coated vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0031982 GO:0031982 vesicle other cellular component C ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035004 GO:0035004 phosphoinositide 3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035005 GO:0035005 phosphatidylinositol-4-phosphate 3-kinase activity kinase activity F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048008 GO:0048008 platelet-derived growth factor receptor signaling pathway signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048268 GO:0048268 clathrin coat assembly transport P ConsensusfromContig175 sp O00443 P3C2A_HUMAN 73.91 69 18 0 491 285 1062 1130 9E-75 114 O00443 P3C2A_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0005794; GO:0048268; GO:0030136; GO:0006897; GO:0007173; GO:0006887; GO:0008286; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0048008; GO:0044281; GO:0014829; GO:0031982 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; Golgi apparatus; clathrin coat assembly; clathrin-coated vesicle; endocytosis; epidermal growth factor receptor signaling pathway; exocytosis; insulin receptor signaling pathway; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; platelet-derived growth factor receptor signaling pathway; small molecule metabolic process; vascular smooth muscle contraction; vesicle reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha) PIK3C2A Homo sapiens (Human) 1686 O00443 GO:0048268 GO:0048268 clathrin coat assembly cell organization and biogenesis P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0001948 GO:0001948 glycoprotein binding other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005109 GO:0005109 frizzled binding signal transduction activity F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005137 GO:0005137 interleukin-5 receptor binding signal transduction activity F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005895 GO:0005895 interleukin-5 receptor complex plasma membrane C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005895 GO:0005895 interleukin-5 receptor complex other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005912 GO:0005912 adherens junction plasma membrane C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005912 GO:0005912 adherens junction other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0006612 GO:0006612 protein targeting to membrane transport P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0006930 GO:0006930 "substrate-bound cell migration, cell extension" cell organization and biogenesis P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0007265 GO:0007265 Ras protein signal transduction signal transduction P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0008093 GO:0008093 cytoskeletal adaptor activity cytoskeletal activity F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0019838 GO:0019838 growth factor binding other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0035556 ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0042327 GO:0042327 positive regulation of phosphorylation other metabolic processes P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0045545 GO:0045545 syndecan binding other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0046330 GO:0046330 positive regulation of JNK cascade signal transduction P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0046330 GO:0046330 positive regulation of JNK cascade stress response P ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0046875 GO:0046875 ephrin receptor binding signal transduction activity F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig6094 sp O00560 SDCB1_HUMAN 63.19 307 99 5 167 1072 1 298 4E-136 399 O00560 SDCB1_HUMAN GO:0007265; GO:0030036; GO:0005912; GO:0007411; GO:0008093; GO:0005856; GO:0005829; GO:0005789; GO:0070062; GO:0005925; GO:0005137; GO:0005895; GO:0035556; GO:0042470; GO:0005634; GO:0046330; GO:0042327; GO:0006612; GO:0006930; GO:0007268; GO:0045545 Itself; O75084 Ras protein signal transduction; actin cytoskeleton organization; adherens junction; axon guidance; cytoskeletal adaptor activity; cytoskeleton; cytosol; endoplasmic reticulum membrane; extracellular vesicular exosome; focal adhesion; interleukin-5 receptor binding; interleukin-5 receptor complex; intracellular signal transduction; melanosome; nucleus; positive regulation of JNK cascade; positive regulation of phosphorylation; protein targeting to membrane; substrate-dependent cell migration, cell extension; synaptic transmission; syndecan binding reviewed IPR001478; Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) SDCBP MDA9 SYCL Homo sapiens (Human) 298 O00560 GO:0050839 GO:0050839 cell adhesion molecule binding other molecular function F ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0000375 GO:0000375 "RNA splicing, via transesterification reactions" RNA metabolism P ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0005732 GO:0005732 small nucleolar ribonucleoprotein complex other cellular component C ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0010923 GO:0010923 negative regulation of phosphatase activity other metabolic processes P ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5584 sp O00566 MPP10_HUMAN 66.17 334 112 1 95 1096 323 655 5E-119 372 O00566 MPP10_HUMAN GO:0000375; GO:0005694; GO:0010923; GO:0005730; GO:0006364; GO:0005732 P62136 RNA splicing, via transesterification reactions; chromosome; negative regulation of phosphatase activity; nucleolus; rRNA processing; small nucleolar ribonucleoprotein complex reviewed IPR007151; IPR012173; U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10) MPHOSPH10 MPP10 Homo sapiens (Human) 681 O00566 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0004004 GO:0004004 ATP-dependent RNA helicase activity other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1363 sp O00571 DDX3X_HUMAN 92.73 110 8 0 2 331 272 381 6E-69 224 O00571 DDX3X_HUMAN GO:0005524; GO:0004003; GO:0004004; GO:0003677; GO:0010501; GO:0035613; GO:0071243; GO:0071470; GO:0007059; GO:0010494; GO:0008190; GO:0008625; GO:0045087; GO:0007243; GO:0097193; GO:0048027; GO:0042256; GO:0005741; GO:0019048; GO:0043066; GO:0030308; GO:0043154; GO:2001243; GO:0031333; GO:0017148; GO:0016607; GO:0005634; GO:0008143; GO:1900087; GO:0043065; GO:0030307; GO:0071651; GO:0043280; GO:0032728; GO:0045944; GO:0045948; GO:0009615; GO:0043024; GO:0034063; GO:0008134; GO:0006351 Q99IB8; O95786; P05198; P55884; Q99613; Q04637; Q14164; P68467; Q7Z434; Q15003; Q9UBU9; P11940 ATP binding; ATP-dependent DNA helicase activity; ATP-dependent RNA helicase activity; DNA binding; RNA secondary structure unwinding; RNA stem-loop binding; cellular response to arsenic-containing substance; cellular response to osmotic stress; chromosome segregation; cytoplasmic stress granule; eukaryotic initiation factor 4E binding; extrinsic apoptotic signaling pathway via death domain receptors; innate immune response; intracellular protein kinase cascade; intrinsic apoptotic signaling pathway; mRNA 5'-UTR binding; mature ribosome assembly; mitochondrial outer membrane; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of cell growth; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; negative regulation of protein complex assembly; negative regulation of translation; nuclear speck; nucleus; poly(A) RNA binding; positive regulation of G1/S transition of mitotic cell cycle; positive regulation of apoptotic process; positive regulation of cell growth; positive regulation of chemokine (C-C motif) ligand 5 production; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interferon-beta production; positive regulation of transcription from RNA polymerase II promoter; positive regulation of translational initiation; response to virus; ribosomal small subunit binding; stress granule assembly; transcription factor binding; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2) DDX3X DBX DDX3 Homo sapiens (Human) 662 O00571 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0001727 GO:0001727 lipid kinase activity kinase activity F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0005942 GO:0005942 phosphoinositide 3-kinase complex cytosol C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016303 GO:0016303 1-phosphatidylinositol-3-kinase activity kinase activity F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0035004 GO:0035004 phosphoinositide 3-kinase activity kinase activity F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0035005 GO:0035005 phosphatidylinositol-4-phosphate 3-kinase activity kinase activity F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0043491 GO:0043491 protein kinase B signaling cascade signal transduction P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0046834 GO:0046834 lipid phosphorylation other metabolic processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig5676 sp O00750 P3C2B_HUMAN 66.67 240 78 1 1774 1055 1391 1628 2E-97 331 O00750 P3C2B_HUMAN GO:0016303; GO:0035005; GO:0005524; GO:0030139; GO:0005783; GO:0043231; GO:0001727; GO:0005634; GO:0005942; GO:0035091; GO:0048015; GO:0005886; GO:0043491; GO:0044281 P00533; P04626; P62993; P16333; P14373 1-phosphatidylinositol-3-kinase activity; 1-phosphatidylinositol-4-phosphate 3-kinase activity; ATP binding; endocytic vesicle; endoplasmic reticulum; intracellular membrane-bounded organelle; lipid kinase activity; nucleus; phosphatidylinositol 3-kinase complex; phosphatidylinositol binding; phosphatidylinositol-mediated signaling; plasma membrane; protein kinase B signaling cascade; small molecule metabolic process reviewed IPR016024; IPR000008; IPR011009; IPR001683; IPR000403; IPR018936; IPR002420; IPR000341; IPR015433; IPR001263; Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) PIK3C2B Homo sapiens (Human) 1634 O00750 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0004430 GO:0004430 1-phosphatidylinositol 4-kinase activity kinase activity F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0035004 GO:0035004 phosphoinositide 3-kinase activity kinase activity F ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig2216 sp O02811 PI4KA_BOVIN 81.82 121 22 0 3 365 1666 1786 6E-62 211 O02811 PI4KA_BOVIN GO:0004430; GO:0005524; GO:0048015 1-phosphatidylinositol 4-kinase activity; ATP binding; phosphatidylinositol-mediated signaling reviewed IPR016024; IPR011009; IPR000403; IPR018936; IPR015433; IPR001263; Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) PI4KA PIK4CA Bos taurus (Bovine) 2043 O02811 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0004709 GO:0004709 MAP kinase kinase kinase activity signal transduction activity F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0004709 GO:0004709 MAP kinase kinase kinase activity kinase activity F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0019100 GO:0019100 male germ-line sex determination developmental processes P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0043507 GO:0043507 positive regulation of JUN kinase activity signal transduction P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0043507 GO:0043507 positive regulation of JUN kinase activity stress response P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0043507 GO:0043507 positive regulation of JUN kinase activity protein metabolism P ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1320 sp O08648 M3K4_MOUSE 95.3 149 7 0 447 1 1304 1452 3E-98 314 O08648 M3K4_MOUSE GO:0005524; GO:0004709; GO:0000165; GO:0000186; GO:0060718; GO:0005737; GO:0048263; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0004672; GO:0010468 ATP binding; MAP kinase kinase kinase activity; MAPK cascade; activation of MAPKK activity; chorionic trophoblast cell differentiation; cytoplasm; determination of dorsal identity; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; protein kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) Map3k4 Mekk4 Mus musculus (Mouse) 1597 O08648 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0001541 GO:0001541 ovarian follicle development developmental processes P ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0001553 GO:0001553 luteinization developmental processes P ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0004198 GO:0004198 calcium-dependent cysteine-type endopeptidase activity other molecular function F ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2285 sp O08688 CAN5_MOUSE 83.61 122 20 0 3 368 191 312 5E-66 216 O08688 CAN5_MOUSE GO:0004198; GO:0009986; GO:0005622; GO:0006508 calcium-dependent cysteine-type endopeptidase activity; cell surface; intracellular; proteolysis reviewed IPR000008; IPR022684; IPR022682; IPR022683; IPR000169; IPR001300; Calpain-5 (EC 3.4.22.-) (New calpain 3) (nCL-3) Capn5 Ncl3 Mus musculus (Mouse) 640 O08688 GO:0060014 GO:0060014 granulosa cell differentiation other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000441 GO:0000441 SSL2-core TFIIH complex other cellular component C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005675 GO:0005675 holo TFIIH complex nucleus C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0007568 GO:0007568 aging other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008094 GO:0008094 DNA-dependent ATPase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009650 GO:0009650 UV protection other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009791 GO:0009791 post-embryonic development developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016817 GO:0016817 "hydrolase activity, acting on acid anhydrides" other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0019907 GO:0019907 cyclin-dependent protein kinase activating kinase holoenzyme complex nucleus C ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0021510 GO:0021510 spinal cord development developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0022405 GO:0022405 hair cycle process other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0030282 GO:0030282 bone mineralization developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0032289 GO:0032289 myelin formation in the central nervous system developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0032289 GO:0032289 myelin formation in the central nervous system cell organization and biogenesis P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0035264 GO:0035264 multicellular organism growth other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0035315 GO:0035315 hair cell differentiation developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0040016 GO:0040016 embryonic cleavage developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043139 GO:0043139 5'-3' DNA helicase activity other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043249 GO:0043249 erythrocyte maturation developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043388 GO:0043388 positive regulation of DNA binding other biological processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043588 GO:0043588 skin development developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0048820 GO:0048820 hair follicle maturation developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0060218 GO:0060218 hemopoietic stem cell differentiation developmental processes P ConsensusfromContig426 sp O08811 ERCC2_MOUSE 80.09 216 43 0 649 2 300 515 9E-123 372 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0071817 ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0000441 GO:0000441 SSL2-core TFIIH complex other cellular component C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005675 GO:0005675 holo TFIIH complex nucleus C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0007568 GO:0007568 aging other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008094 GO:0008094 DNA-dependent ATPase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009650 GO:0009650 UV protection other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0009791 GO:0009791 post-embryonic development developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016817 GO:0016817 "hydrolase activity, acting on acid anhydrides" other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0019907 GO:0019907 cyclin-dependent protein kinase activating kinase holoenzyme complex nucleus C ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0021510 GO:0021510 spinal cord development developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0022405 GO:0022405 hair cycle process other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0030282 GO:0030282 bone mineralization developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0032289 GO:0032289 myelin formation in the central nervous system developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0032289 GO:0032289 myelin formation in the central nervous system cell organization and biogenesis P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0035264 GO:0035264 multicellular organism growth other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0035315 GO:0035315 hair cell differentiation developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0040016 GO:0040016 embryonic cleavage developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043139 GO:0043139 5'-3' DNA helicase activity other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043249 GO:0043249 erythrocyte maturation developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043388 GO:0043388 positive regulation of DNA binding other biological processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0043588 GO:0043588 skin development developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0048820 GO:0048820 hair follicle maturation developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0060218 GO:0060218 hemopoietic stem cell differentiation developmental processes P ConsensusfromContig6345 sp O08811 ERCC2_MOUSE 87.56 209 26 0 1041 415 551 759 1E-114 357 O08811 ERCC2_MOUSE GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0008353; GO:0009650; GO:0007568; GO:0006915; GO:0030282; GO:0000075; GO:0008283; GO:0032289; GO:0007059; GO:0019907; GO:0005737; GO:0040016; GO:0043249; GO:0030198; GO:0035315; GO:0048820; GO:0060218; GO:0005675; GO:0001701; GO:0046872; GO:0035264; GO:0033683; GO:0043388; GO:0045944; GO:0009791; GO:0006979; GO:0021510; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; RNA polymerase II carboxy-terminal domain kinase activity; UV protection; aging; apoptotic process; bone mineralization; cell cycle checkpoint; cell proliferation; central nervous system myelin formation; chromosome segregation; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytoplasm; embryonic cleavage; erythrocyte maturation; extracellular matrix organization; hair cell differentiation; hair follicle maturation; hematopoietic stem cell differentiation; holo TFIIH complex; in utero embryonic development; metal ion binding; multicellular organism growth; nucleotide-excision repair, DNA incision; positive regulation of DNA binding; positive regulation of transcription from RNA polymerase II promoter; post-embryonic development; response to oxidative stress; spinal cord development; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) Ercc2 Xpd Mus musculus (Mouse) 760 O08811 GO:0071817 ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0006368 GO:0006368 RNA elongation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0008023 GO:0008023 transcription elongation factor complex nucleus C ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0010923 GO:0010923 negative regulation of phosphatase activity other metabolic processes P ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0015030 GO:0015030 Cajal body nucleus C ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig2209 sp O08856 ELL_MOUSE 67.14 140 45 1 94 513 463 601 4E-55 189 O08856 ELL_MOUSE GO:0015030; GO:0001701; GO:0010923; GO:0016607; GO:0019902; GO:0006355; GO:0008023; GO:0006368 Cajal body; in utero embryonic development; negative regulation of phosphatase activity; nuclear speck; phosphatase binding; regulation of transcription, DNA-dependent; transcription elongation factor complex; transcription elongation from RNA polymerase II promoter reviewed IPR010844; IPR019464; RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein) Ell Mus musculus (Mouse) 602 O08856 GO:0019902 GO:0019902 phosphatase binding other molecular function F ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0008021 GO:0008021 synaptic vesicle other cellular component C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0030141 GO:0030141 secretory granule other cellular component C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5772 sp O09117 SYPL1_MOUSE 45.85 229 116 5 1261 590 19 244 8E-57 194 O09117 SYPL1_MOUSE GO:0030659; GO:0016021; GO:0042470; GO:0016020; GO:0030141; GO:0008021; GO:0005215 cytoplasmic vesicle membrane; integral to membrane; melanosome; membrane; secretory granule; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 1 (Pantophysin) Sypl1 Pphn Sypl Mus musculus (Mouse) 261 O09117 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig6036 sp O13035 SAP_CHICK 53.55 211 95 1 918 286 311 518 2E-71 238 O13035 SAP_CHICK GO:0005764; GO:0006665 lysosome; sphingolipid metabolic process reviewed IPR003119; IPR007856; IPR008138; IPR008373; IPR011001; IPR021165; IPR008139; Proactivator polypeptide [Cleaved into: Saposin-A; Saposin-B; Saposin-C; Saposin-D] PSAP Gallus gallus (Chicken) 518 O13035 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig6036 sp O13035 SAP_CHICK 53.55 211 95 1 918 286 311 518 2E-71 238 O13035 SAP_CHICK GO:0005764; GO:0006665 lysosome; sphingolipid metabolic process reviewed IPR003119; IPR007856; IPR008138; IPR008373; IPR011001; IPR021165; IPR008139; Proactivator polypeptide [Cleaved into: Saposin-A; Saposin-B; Saposin-C; Saposin-D] PSAP Gallus gallus (Chicken) 518 O13035 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig6036 sp O13035 SAP_CHICK 53.55 211 95 1 918 286 311 518 2E-71 238 O13035 SAP_CHICK GO:0005764; GO:0006665 lysosome; sphingolipid metabolic process reviewed IPR003119; IPR007856; IPR008138; IPR008373; IPR011001; IPR021165; IPR008139; Proactivator polypeptide [Cleaved into: Saposin-A; Saposin-B; Saposin-C; Saposin-D] PSAP Gallus gallus (Chicken) 518 O13035 GO:0006665 GO:0006665 sphingolipid metabolic process other metabolic processes P ConsensusfromContig6160 sp O13166 TLE2_DANRE 89.05 201 20 2 581 1180 1 200 3E-82 275 O13166 TLE2_DANRE GO:0005634; GO:0006355 nucleus; regulation of transcription, DNA-dependent reviewed IPR005617; IPR009146; IPR015943; IPR001680; IPR019775; IPR017986; Protein groucho-2 (Groucho-related Grg2) gro2 grg2 groucho2 Danio rerio (Zebrafish) (Brachydanio rerio) 761 O13166 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6160 sp O13166 TLE2_DANRE 89.05 201 20 2 581 1180 1 200 3E-82 275 O13166 TLE2_DANRE GO:0005634; GO:0006355 nucleus; regulation of transcription, DNA-dependent reviewed IPR005617; IPR009146; IPR015943; IPR001680; IPR019775; IPR017986; Protein groucho-2 (Groucho-related Grg2) gro2 grg2 groucho2 Danio rerio (Zebrafish) (Brachydanio rerio) 761 O13166 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6160 sp O13166 TLE2_DANRE 89.05 201 20 2 581 1180 1 200 3E-82 275 O13166 TLE2_DANRE GO:0005634; GO:0006355 nucleus; regulation of transcription, DNA-dependent reviewed IPR005617; IPR009146; IPR015943; IPR001680; IPR019775; IPR017986; Protein groucho-2 (Groucho-related Grg2) gro2 grg2 groucho2 Danio rerio (Zebrafish) (Brachydanio rerio) 761 O13166 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response signal transduction P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response stress response P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response other metabolic processes P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0008420 GO:0008420 CTD phosphatase activity other molecular function F ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response signal transduction P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response stress response P ConsensusfromContig6172 sp O14595 CTDS2_HUMAN 83.51 194 32 0 3 584 78 271 1E-107 317 O14595 CTDS2_HUMAN GO:0008420; GO:0006987; GO:0046872; GO:0005654; GO:0006470 P10275 CTD phosphatase activity; activation of signaling protein activity involved in unfolded protein response; metal ion binding; nucleoplasm; protein dephosphorylation reviewed IPR011948; IPR023214; IPR004274; Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2) CTDSP2 NIF2 OS4 SCP2 Homo sapiens (Human) 271 O14595 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0005778 GO:0005778 peroxisomal membrane other cytoplasmic organelle C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0005778 GO:0005778 peroxisomal membrane other membranes C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0006810 GO:0006810 transport transport P ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0042626 GO:0042626 "ATPase activity, coupled to transmembrane movement of substances" transporter activity F ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0043190 GO:0043190 ATP-binding cassette (ABC) transporter complex other membranes C ConsensusfromContig753 sp O14678 ABCD4_HUMAN 73.28 131 35 0 522 130 474 604 4E-63 210 O14678 ABCD4_HUMAN GO:0005524; GO:0006200; GO:0043190; GO:0042626; GO:0009235; GO:0005789; GO:0016021; GO:0005778; GO:0005777 ATP binding; ATP catabolic process; ATP-binding cassette (ABC) transporter complex; ATPase activity, coupled to transmembrane movement of substances; cobalamin metabolic process; endoplasmic reticulum membrane; integral to membrane; peroxisomal membrane; peroxisome reviewed IPR003593; IPR011527; IPR010509; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69) ABCD4 PXMP1L Homo sapiens (Human) 606 O14678 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000216 GO:0000216 M/G1 transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0002474 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0002479 GO:0002479 "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006521 GO:0006521 regulation of amino acid metabolic process other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" signal transduction P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" stress response P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016071 GO:0016071 mRNA metabolic process RNA metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0019773 GO:0019773 "proteasome core complex, alpha-subunit complex" other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0031145 GO:0031145 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042590 GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0044281 ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051436 GO:0051436 negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051437 GO:0051437 positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051439 GO:0051439 regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76.19 105 25 0 147 461 125 229 2E-60 178 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000216 GO:0000216 M/G1 transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0002474 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0002479 GO:0002479 "antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006521 GO:0006521 regulation of amino acid metabolic process other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" signal transduction P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" stress response P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016071 GO:0016071 mRNA metabolic process RNA metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0019773 GO:0019773 "proteasome core complex, alpha-subunit complex" other cellular component C ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0031145 GO:0031145 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042590 GO:0042590 antigen processing and presentation of exogenous peptide antigen via MHC class I other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0044281 ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051436 GO:0051436 negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051437 GO:0051437 positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051439 GO:0051439 regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1749 sp O14818 PSA7_HUMAN 76 50 11 1 2 148 67 116 2E-60 74.7 O14818 PSA7_HUMAN GO:0006977; GO:0000082; GO:0031145; GO:0002479; GO:0006915; GO:0005829; GO:0010467; GO:0016071; GO:0019048; GO:0043066; GO:0051436; GO:0005654; GO:0051437; GO:0005839; GO:0019773; GO:0000209; GO:0006521; GO:0044281; GO:0004298; GO:0016032 Itself; P25786; P25787; P25788; P25789; P28066; P60900 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; G1/S transition of mitotic cell cycle; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent; apoptotic process; cytosol; gene expression; mRNA metabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; proteasome core complex; proteasome core complex, alpha-subunit complex; protein polyubiquitination; regulation of cellular amino acid metabolic process; small molecule metabolic process; threonine-type endopeptidase activity; viral process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7) PSMA7 HSPC Homo sapiens (Human) 248 O14818 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1933 sp O15062 ZBTB5_HUMAN 88.5 113 12 1 72 407 565 677 1E-62 210 O15062 ZBTB5_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 5 ZBTB5 KIAA0354 Homo sapiens (Human) 677 O15062 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005814 GO:0005814 centriole cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0005932 GO:0005932 microtubule basal body cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0007098 GO:0007098 centrosome cycle cell cycle and proliferation P ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0007098 GO:0007098 centrosome cycle cell organization and biogenesis P ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0032391 GO:0032391 photoreceptor connecting cilium other cellular component C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0045111 GO:0045111 intermediate filament cytoskeleton cytoskeleton C ConsensusfromContig5682 sp O15182 CETN3_HUMAN 85.54 166 24 0 40 537 1 166 2E-82 256 O15182 CETN3_HUMAN GO:0005509; GO:0051301; GO:0005814; GO:0007098; GO:0045111; GO:0005932; GO:0007067; GO:0032391 calcium ion binding; cell division; centriole; centrosome cycle; intermediate filament cytoskeleton; microtubule basal body; mitosis; photoreceptor connecting cilium reviewed IPR011992; IPR018247; IPR002048; Centrin-3 CETN3 CEN3 Homo sapiens (Human) 167 O15182 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0016235 GO:0016235 aggresome other cellular component C ConsensusfromContig6322 sp O15381 NVL_HUMAN 75.66 341 74 1 1217 195 524 855 2E-175 522 O15381 NVL_HUMAN GO:0005524; GO:0016235; GO:0005737; GO:0005730; GO:0017111 ATP binding; aggresome; cytoplasm; nucleolus; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein) NVL Homo sapiens (Human) 856 O15381 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 63.57 140 49 1 422 3 148 285 1E-55 180 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0055037 GO:0055037 recycling endosome other cytoplasmic organelle C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4490 sp O18973 RABX5_BOVIN 64.29 42 15 0 528 403 113 154 1E-55 57.4 O18973 RABX5_BOVIN GO:0003677; GO:0005769; GO:0006897; GO:1900235; GO:0046580; GO:0050728; GO:1900165; GO:0002686; GO:0043305; GO:0001933; GO:0048261; GO:0015031; GO:0055037; GO:0060368; GO:0004842; GO:0031982; GO:0008270 Q9UJY5 DNA binding; early endosome; endocytosis; negative regulation of Kit signaling pathway; negative regulation of Ras protein signal transduction; negative regulation of inflammatory response; negative regulation of interleukin-6 secretion; negative regulation of leukocyte migration; negative regulation of mast cell degranulation; negative regulation of protein phosphorylation; negative regulation of receptor-mediated endocytosis; protein transport; recycling endosome; regulation of Fc receptor mediated stimulatory signaling pathway; ubiquitin-protein ligase activity; vesicle; zinc ion binding reviewed IPR003123; IPR013995; IPR002653; Rab5 GDP/GTP exchange factor (Rabex-5) RABGEF1 RABEX5 Bos taurus (Bovine) 492 O18973 GO:0055037 GO:0055037 recycling endosome other cytoplasmic organelle C ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig3113 sp O35343 IMA3_MOUSE 100 98 0 0 294 1 133 230 5E-64 207 O35343 IMA3_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4) Kpna4 Qip1 Mus musculus (Mouse) 521 O35343 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0004712 GO:0004712 protein serine/threonine/tyrosine kinase activity kinase activity F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0018108 GO:0018108 peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0043484 GO:0043484 regulation of RNA splicing RNA metabolism P ConsensusfromContig5847 sp O35493 CLK4_MOUSE 71.39 346 99 0 1207 170 136 481 0 540 O35493 CLK4_MOUSE GO:0005524; GO:0005634; GO:0046777; GO:0004674; GO:0004712; GO:0004713; GO:0043484 ATP binding; nucleus; protein autophosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; regulation of RNA splicing reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4) Clk4 Mus musculus (Mouse) 481 O35493 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0004467 GO:0004467 long-chain-fatty-acid-CoA ligase activity other molecular function F ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0060136 GO:0060136 embryonic process involved in female pregnancy developmental processes P ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0060996 ConsensusfromContig2619 sp O35547 ACSL4_RAT 77.6 183 41 0 596 48 420 602 2E-101 313 O35547 ACSL4_RAT GO:0005524; GO:0047676; GO:0060996; GO:0060136; GO:0015908; GO:0008610; GO:0005811; GO:0004467; GO:0031966; GO:0032307; GO:0043025; GO:0005777; GO:0030307; GO:0070672; GO:0007584; GO:0006641; GO:0031957 ATP binding; arachidonate-CoA ligase activity; dendritic spine development; embryonic process involved in female pregnancy; fatty acid transport; lipid biosynthetic process; lipid particle; long-chain fatty acid-CoA ligase activity; mitochondrial membrane; negative regulation of prostaglandin secretion; neuronal cell body; peroxisome; positive regulation of cell growth; response to interleukin-15; response to nutrient; triglyceride metabolic process; very long-chain fatty acid-CoA ligase activity reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4) Acsl4 Acs4 Facl4 Rattus norvegicus (Rat) 670 O35547 GO:0070672 GO:0070672 response to interleukin-15 other biological processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0003360 ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0003937 GO:0003937 IMP cyclohydrolase activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0004643 GO:0004643 phosphoribosylaminoimidazolecarboxamide formyltransferase activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0006164 GO:0006164 purine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0006189 GO:0006189 'de novo' IMP biosynthetic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0009116 GO:0009116 nucleoside metabolic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0009235 GO:0009235 cobalamin metabolic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0009259 GO:0009259 ribonucleotide metabolic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0010035 GO:0010035 response to inorganic substance other biological processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0021549 GO:0021549 cerebellum development developmental processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0021987 GO:0021987 cerebral cortex development developmental processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0031100 GO:0031100 organ regeneration developmental processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0046452 GO:0046452 dihydrofolate metabolic process other metabolic processes P ConsensusfromContig5882 sp O35567 PUR9_RAT 79.9 592 118 1 67 1839 1 592 0 1003 O35567 PUR9_RAT GO:0006189; GO:0003937; GO:0003360; GO:0021549; GO:0021987; GO:0009235; GO:0046452; GO:0005739; GO:0009116; GO:0031100; GO:0004643; GO:0042803; GO:0010035; GO:0046654 'de novo' IMP biosynthetic process; IMP cyclohydrolase activity; brainstem development; cerebellum development; cerebral cortex development; cobalamin metabolic process; dihydrofolate metabolic process; mitochondrion; nucleoside metabolic process; organ regeneration; phosphoribosylaminoimidazolecarboxamide formyltransferase activity; protein homodimerization activity; response to inorganic substance; tetrahydrofolate biosynthetic process reviewed IPR024051; IPR024050; IPR002695; IPR016193; IPR011607; Purine metabolism; IMP biosynthesis via de novo pathway; 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide from 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide (10-formyl THF route): step 1/1. Purine metabolism; IMP biosynthesis via de novo pathway; IMP from 5-formamido-1-(5-phospho-D-ribosyl)imidazole-4-carboxamide: step 1/1. Bifunctional purine biosynthesis protein PURH [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)] Atic Purh Rattus norvegicus (Rat) 592 O35567 GO:0046654 GO:0046654 tetrahydrofolate biosynthetic process other metabolic processes P ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3103 sp O35594 IFT81_MOUSE 81.9 116 21 0 356 9 455 570 2E-57 193 O35594 IFT81_MOUSE GO:0030154; GO:0005813; GO:0030990; GO:0007275; GO:0097225; GO:0097228; GO:0007283 cell differentiation; centrosome; intraflagellar transport particle; multicellular organismal development; sperm midpiece; sperm principal piece; spermatogenesis reviewed Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1) Ift81 Cdv-1 Cdv1 Mus musculus (Mouse) 676 O35594 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6086 sp O43257 ZNHI1_HUMAN 75.97 154 36 1 77 538 2 154 2E-71 226 O43257 ZNHI1_HUMAN GO:0003682; GO:0046872; GO:0070317; GO:0000122; GO:0005634; GO:0042129; GO:0031063 Q9GZN1; P0C0S5; Q15759; Q16539; Q12888 chromatin binding; metal ion binding; negative regulation of G0 to G1 transition; negative regulation of transcription from RNA polymerase II promoter; nucleus; regulation of T cell proliferation; regulation of histone deacetylation reviewed IPR007529; Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet) ZNHIT1 CGBP1 ZNFN4A1 Homo sapiens (Human) 154 O43257 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6086 sp O43257 ZNHI1_HUMAN 75.97 154 36 1 77 538 2 154 2E-71 226 O43257 ZNHI1_HUMAN GO:0003682; GO:0046872; GO:0070317; GO:0000122; GO:0005634; GO:0042129; GO:0031063 Q9GZN1; P0C0S5; Q15759; Q16539; Q12888 chromatin binding; metal ion binding; negative regulation of G0 to G1 transition; negative regulation of transcription from RNA polymerase II promoter; nucleus; regulation of T cell proliferation; regulation of histone deacetylation reviewed IPR007529; Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet) ZNHIT1 CGBP1 ZNFN4A1 Homo sapiens (Human) 154 O43257 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0000827 GO:0000827 "inositol 1,3,4,5,6-pentakisphosphate kinase activity" kinase activity F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0000832 GO:0000832 inositol hexakisphosphate 5-kinase activity kinase activity F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0003993 GO:0003993 acid phosphatase activity other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0006020 GO:0006020 inositol metabolic process other metabolic processes P ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0033857 GO:0033857 diphosphoinositol-pentakisphosphate kinase activity other molecular function F ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0052723 ConsensusfromContig2126 sp O43314 VIP2_HUMAN 85.06 174 25 1 523 2 619 791 9E-98 313 O43314 VIP2_HUMAN GO:0005524; GO:0003993; GO:0005829; GO:0033857; GO:0052723; GO:0052724; GO:0000832; GO:0006020; GO:0043647; GO:0000827 ATP binding; acid phosphatase activity; cytosol; diphosphoinositol-pentakisphosphate kinase activity; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol metabolic process; inositol phosphate metabolic process; inositol-1,3,4,5,6-pentakisphosphate kinase activity reviewed IPR000560; Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2) PPIP5K2 HISPPD1 KIAA0433 VIP2 Homo sapiens (Human) 1243 O43314 GO:0052724 ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0030530 GO:0030530 heterogeneous nuclear ribonucleoprotein complex nucleus C ConsensusfromContig5266 sp O43390 HNRPR_HUMAN 93.88 98 6 0 1 294 158 255 2E-59 197 O43390 HNRPR_HUMAN GO:0003723; GO:0071013; GO:0005737; GO:0000398; GO:0005654; GO:0000166 P16333 RNA binding; catalytic step 2 spliceosome; cytoplasm; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein R (hnRNP R) HNRNPR HNRPR Homo sapiens (Human) 633 O43390 GO:0071013 GO:0071013 nucleus ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0008091 GO:0008091 spectrin cytoskeleton C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0019898 GO:0019898 extrinsic to membrane other membranes C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0030507 GO:0030507 spectrin binding cytoskeletal activity F ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0030866 GO:0030866 cortical actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig4760 sp O43491 E41L2_HUMAN 64.58 144 51 0 2 433 256 399 1E-56 195 O43491 E41L2_HUMAN GO:0030054; GO:0030866; GO:0019898; GO:0005634; GO:0005886; GO:0008091; GO:0005198 cell junction; cortical actin cytoskeleton organization; extrinsic to membrane; nucleus; plasma membrane; spectrin; structural molecule activity reviewed IPR008379; IPR019749; IPR019750; IPR021187; IPR000798; IPR014847; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR011993; IPR007477; Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G) EPB41L2 Homo sapiens (Human) 1005 O43491 GO:0042731 GO:0042731 PH domain binding other molecular function F ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0005732 GO:0005732 small nucleolar ribonucleoprotein complex other cellular component C ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6220 sp O43818 U3IP2_HUMAN 70.69 331 97 0 1199 207 136 466 2E-179 515 O43818 U3IP2_HUMAN GO:0003723; GO:0006364; GO:0030532; GO:0005732 RNA binding; rRNA processing; small nuclear ribonucleoprotein complex; small nucleolar ribonucleoprotein complex reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K) RRP9 RNU3IP2 U355K Homo sapiens (Human) 475 O43818 GO:0030532 GO:0030532 small nuclear ribonucleoprotein complex nucleus C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0002102 GO:0002102 podosome cytoskeleton C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig2924 sp O46385 SVIL_BOVIN 85.58 104 15 0 485 174 1559 1662 3E-58 202 O46385 SVIL_BOVIN GO:0030054; GO:0005737; GO:0007010; GO:0071437; GO:0005886; GO:0002102 Q7LZ83; P51807; Q15058; Q9UHB6; P35579; Q15654 cell junction; cytoplasm; cytoskeleton organization; invadopodium; plasma membrane; podosome reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) SVIL Bos taurus (Bovine) 2194 O46385 GO:0071437 ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0008478 GO:0008478 pyridoxal kinase activity kinase activity F ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0009443 GO:0009443 pyridoxal 5'-phosphate salvage other metabolic processes P ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2912 sp O46560 PDXK_PIG 73.1 171 42 1 545 45 73 243 1E-82 255 O46560 PDXK_PIG GO:0005524; GO:0005737; GO:0046872; GO:0009443; GO:0008478 ATP binding; cytoplasm; metal ion binding; pyridoxal 5'-phosphate salvage; pyridoxal kinase activity reviewed IPR011611; IPR004625; Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase) PDXK PKH Sus scrofa (Pig) 322 O46560 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005388 GO:0005388 calcium-transporting ATPase activity transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016529 GO:0016529 sarcoplasmic reticulum ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 83.59 128 21 0 591 208 1 128 1E-66 202 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005388 GO:0005388 calcium-transporting ATPase activity transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016529 GO:0016529 sarcoplasmic reticulum ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig3739 sp O46674 AT2A2_CANFA 91.43 35 3 0 235 131 120 154 1E-66 72.8 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005388 GO:0005388 calcium-transporting ATPase activity transporter activity F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016529 GO:0016529 sarcoplasmic reticulum ER/Golgi C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig3989 sp O46674 AT2A2_CANFA 97.39 115 3 0 348 4 682 796 3E-70 231 O46674 AT2A2_CANFA GO:0005524; GO:0006984; GO:0005388; GO:0006874; GO:0016021; GO:0046872; GO:0045822; GO:0002026; GO:0033017 ATP binding; ER-nucleus signaling pathway; calcium-transporting ATPase activity; cellular calcium ion homeostasis; integral to membrane; metal ion binding; negative regulation of heart contraction; regulation of the force of heart contraction; sarcoplasmic reticulum membrane reviewed IPR005782; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase) ATP2A2 Canis familiaris (Dog) (Canis lupus familiaris) 997 O46674 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0005736 GO:0005736 DNA-directed RNA polymerase I complex nucleus C ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0009303 GO:0009303 rRNA transcription RNA metabolism P ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig2117 sp O54889 RPA1_RAT 65.03 143 49 1 428 3 1126 1268 8E-56 194 O54889 RPA1_RAT GO:0003677; GO:0005736; GO:0003899; GO:0009303; GO:0006360; GO:0008270 DNA binding; DNA-directed RNA polymerase I complex; DNA-directed RNA polymerase activity; rRNA transcription; transcription from RNA polymerase I promoter; zinc ion binding reviewed IPR015699; IPR000722; IPR006592; IPR007080; IPR007066; IPR007083; IPR007081; DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (A194) (RPA194) Polr1a Rpa1 Rpo1-4 Rattus norvegicus (Rat) 1716 O54889 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1717 sp O57683 SF3B1_XENLA 98.46 195 3 0 586 2 488 682 6E-124 386 O57683 SF3B1_XENLA GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR011989; IPR016024; IPR015016; Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) sf3b1 Xenopus laevis (African clawed frog) 1307 O57683 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1717 sp O57683 SF3B1_XENLA 98.46 195 3 0 586 2 488 682 6E-124 386 O57683 SF3B1_XENLA GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR011989; IPR016024; IPR015016; Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) sf3b1 Xenopus laevis (African clawed frog) 1307 O57683 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1717 sp O57683 SF3B1_XENLA 98.46 195 3 0 586 2 488 682 6E-124 386 O57683 SF3B1_XENLA GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR011989; IPR016024; IPR015016; Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) sf3b1 Xenopus laevis (African clawed frog) 1307 O57683 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig1717 sp O57683 SF3B1_XENLA 98.46 195 3 0 586 2 488 682 6E-124 386 O57683 SF3B1_XENLA GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR011989; IPR016024; IPR015016; Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) sf3b1 Xenopus laevis (African clawed frog) 1307 O57683 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig1717 sp O57683 SF3B1_XENLA 98.46 195 3 0 586 2 488 682 6E-124 386 O57683 SF3B1_XENLA GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR011989; IPR016024; IPR015016; Splicing factor 3B subunit 1 (146 kDa nuclear protein) (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155) sf3b1 Xenopus laevis (African clawed frog) 1307 O57683 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005521 GO:0005521 lamin binding other molecular function F ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005740 GO:0005740 mitochondrial envelope mitochondrion C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0008634 GO:0008634 negative regulation of survival gene product expression other metabolic processes P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0008634 GO:0008634 negative regulation of survival gene product expression death P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0031224 GO:0031224 intrinsic to membrane other membranes C ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0035694 ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig1712 sp O60238 BNI3L_HUMAN 66 150 47 2 45 482 61 210 3E-52 172 O60238 BNI3L_HUMAN GO:0006915; GO:0051607; GO:0005783; GO:0016021; GO:0031224; GO:0005521; GO:0005741; GO:0035694; GO:0019048; GO:0043066; GO:0005635; GO:0043065; GO:0046982; GO:0042803 Itself; Q9NQ11; Q92934; P10415; Q12983; P03247 apoptotic process; defense response to virus; endoplasmic reticulum; integral to membrane; intrinsic to membrane; lamin binding; mitochondrial outer membrane; mitochondrial protein catabolic process; modulation by virus of host morphology or physiology; negative regulation of apoptotic process; nuclear envelope; positive regulation of apoptotic process; protein heterodimerization activity; protein homodimerization activity reviewed IPR010548; BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L) BNIP3L BNIP3A BNIP3H NIX Homo sapiens (Human) 219 O60238 GO:0051607 GO:0051607 defense response to virus stress response P ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0004860 GO:0004860 protein kinase inhibitor activity enzyme regulator activity F ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig3988 sp O60239 3BP5_HUMAN 73.23 127 32 1 392 12 184 308 4E-56 187 O60239 3BP5_HUMAN GO:0005737; GO:0035556; GO:0005739; GO:0004860 Q06187 cytoplasm; intracellular signal transduction; mitochondrion; protein kinase inhibitor activity reviewed IPR007940; SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK) SH3BP5 SAB Homo sapiens (Human) 455 O60239 GO:0035556 ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0070934 ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0070937 ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0071013 GO:0071013 nucleus ConsensusfromContig4283 sp O60506 HNRPQ_HUMAN 92.37 118 9 0 3 356 124 241 1E-72 233 O60506 HNRPQ_HUMAN GO:0070937; GO:0070934; GO:0003723; GO:0071013; GO:0071346; GO:0005783; GO:0071204; GO:0000398; GO:0019048; GO:0017148; GO:0005654; GO:0000166; GO:0008143 Q5JVS0; Q14103-4; Q99873; Q9NR22 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA binding; catalytic step 2 spliceosome; cellular response to interferon-gamma; endoplasmic reticulum; histone pre-mRNA 3'end processing complex; mRNA splicing, via spliceosome; modulation by virus of host morphology or physiology; negative regulation of translation; nucleoplasm; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) SYNCRIP HNRPQ NSAP1 Homo sapiens (Human) 623 O60506 GO:0071204 ConsensusfromContig6068 sp O60645 EXOC3_HUMAN 65.38 156 52 1 824 363 589 744 7E-63 216 O60645 EXOC3_HUMAN GO:0044267; GO:0000145; GO:0006887; GO:0015031; GO:0030667 cellular protein metabolic process; exocyst; exocytosis; protein transport; secretory granule membrane reviewed IPR010326; Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) 756 O60645 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6068 sp O60645 EXOC3_HUMAN 65.38 156 52 1 824 363 589 744 7E-63 216 O60645 EXOC3_HUMAN GO:0044267; GO:0000145; GO:0006887; GO:0015031; GO:0030667 cellular protein metabolic process; exocyst; exocytosis; protein transport; secretory granule membrane reviewed IPR010326; Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) 756 O60645 GO:0006887 GO:0006887 exocytosis transport P ConsensusfromContig6068 sp O60645 EXOC3_HUMAN 65.38 156 52 1 824 363 589 744 7E-63 216 O60645 EXOC3_HUMAN GO:0044267; GO:0000145; GO:0006887; GO:0015031; GO:0030667 cellular protein metabolic process; exocyst; exocytosis; protein transport; secretory granule membrane reviewed IPR010326; Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) 756 O60645 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6068 sp O60645 EXOC3_HUMAN 65.38 156 52 1 824 363 589 744 7E-63 216 O60645 EXOC3_HUMAN GO:0044267; GO:0000145; GO:0006887; GO:0015031; GO:0030667 cellular protein metabolic process; exocyst; exocytosis; protein transport; secretory granule membrane reviewed IPR010326; Exocyst complex component 3 (Exocyst complex component Sec6) EXOC3 SEC6 SEC6L1 Homo sapiens (Human) 756 O60645 GO:0030667 GO:0030667 secretory granule membrane other membranes C ConsensusfromContig6125 sp O70340 NPTX2_MOUSE 73.16 231 60 1 693 1 116 344 5E-115 342 O70340 NPTX2_MOUSE GO:0005576; GO:0046872 extracellular region; metal ion binding reviewed IPR008985; IPR013320; IPR001759; Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II) Nptx2 Mus musculus (Mouse) 429 O70340 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig6125 sp O70340 NPTX2_MOUSE 73.16 231 60 1 693 1 116 344 5E-115 342 O70340 NPTX2_MOUSE GO:0005576; GO:0046872 extracellular region; metal ion binding reviewed IPR008985; IPR013320; IPR001759; Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II) Nptx2 Mus musculus (Mouse) 429 O70340 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6125 sp O70340 NPTX2_MOUSE 73.16 231 60 1 693 1 116 344 5E-115 342 O70340 NPTX2_MOUSE GO:0005576; GO:0046872 extracellular region; metal ion binding reviewed IPR008985; IPR013320; IPR001759; Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II) Nptx2 Mus musculus (Mouse) 429 O70340 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0019773 GO:0019773 "proteasome core complex, alpha-subunit complex" other cellular component C ConsensusfromContig1864 sp O73672 PSA2_CARAU 93.88 147 9 0 441 1 34 180 7E-100 293 O73672 PSA2_CARAU GO:0005737; GO:0005634; GO:0005839; GO:0019773; GO:0004298; GO:0006511 cytoplasm; nucleus; proteasome core complex; proteasome core complex, alpha-subunit complex; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-2 (EC 3.4.25.1) psma2 Carassius auratus (Goldfish) 234 O73672 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0004867 GO:0004867 serine-type endopeptidase inhibitor activity enzyme regulator activity F ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0008201 GO:0008201 heparin binding other molecular function F ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0010466 GO:0010466 negative regulation of peptidase activity other biological processes P ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0030414 GO:0030414 peptidase inhibitor activity enzyme regulator activity F ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5865 sp O73683 A4_TETFL 82.52 326 53 3 1064 96 452 776 3E-169 498 O73683 A4_TETFL GO:0008201; GO:0016021; GO:0004867; GO:0046914 heparin binding; integral to membrane; serine-type endopeptidase inhibitor activity; transition metal ion binding reviewed IPR008155; IPR013803; IPR011178; IPR024329; IPR008154; IPR019744; IPR015849; IPR019745; IPR019543; IPR002223; Amyloid beta A4 protein (ABPP) (APP) (Alzheimer disease amyloid A4 protein homolog) [Cleaved into: Beta-amyloid protein (A-beta) (Beta-APP)] app Tetraodon fluviatilis (Green pufferfish) (Chelonodon fluviatilis) 780 O73683 GO:0046914 GO:0046914 transition metal ion binding other molecular function F ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0004392 GO:0004392 heme oxygenase (decyclizing) activity other molecular function F ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0006788 GO:0006788 heme oxidation other metabolic processes P ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig140 sp O73688 HMOX_TAKRU 70 160 48 0 3 482 72 231 3E-70 220 O73688 HMOX_TAKRU GO:0005783; GO:0006788; GO:0004392; GO:0046872 endoplasmic reticulum; heme oxidation; heme oxygenase (decyclizing) activity; metal ion binding reviewed IPR002051; IPR016053; IPR016084; IPR018207; Heme oxygenase (HO) (EC 1.14.99.3) hmox Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 277 O73688 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0000226 GO:0000226 microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1855 sp O73787 GCP3_XENLA 81.43 140 26 0 421 2 266 405 8E-74 241 O73787 GCP3_XENLA GO:0005737; GO:0005874; GO:0007020; GO:0005815; GO:0000922 cytoplasm; microtubule; microtubule nucleation; microtubule organizing center; spindle pole reviewed IPR015697; IPR007259; Gamma-tubulin complex component 3 homolog (Gamma-ring complex protein 109) (Xgrip109) (x109p) tubgcp3 Xenopus laevis (African clawed frog) 906 O73787 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig2438 sp O75064 DEN4B_HUMAN 71.57 204 57 1 3 611 185 388 1E-96 312 O75064 DEN4B_HUMAN GO:0005794; GO:0017112; GO:0032483 Golgi apparatus; Rab guanyl-nucleotide exchange factor activity; regulation of Rab protein signal transduction reviewed IPR005112; IPR001194; IPR023341; IPR002885; IPR005113; DENN domain-containing protein 4B DENND4B KIAA0476 Homo sapiens (Human) 1496 ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6115 sp O75132 ZBED4_HUMAN 66.67 357 112 4 83 1153 822 1171 8E-162 496 O75132 ZBED4_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634 DNA binding; cytoplasm; metal ion binding; nucleus reviewed IPR008906; IPR012337; IPR003656; Zinc finger BED domain-containing protein 4 ZBED4 KIAA0637 Homo sapiens (Human) 1171 O75132 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0016577 GO:0016577 histone demethylation protein metabolism P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0016577 GO:0016577 histone demethylation cell organization and biogenesis P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0051864 GO:0051864 histone demethylase activity (H3-K36 specific) other molecular function F ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0070544 GO:0070544 histone H3-K36 demethylation protein metabolism P ConsensusfromContig5904 sp O75164 KDM4A_HUMAN 64.77 352 121 3 1054 2 664 1013 4E-158 478 O75164 KDM4A_HUMAN GO:0014898; GO:0005813; GO:0005737; GO:0051864; GO:0035064; GO:0019048; GO:0045892; GO:0005730; GO:0006351; GO:0008270 P68431; P62805; Q16695 cardiac muscle hypertrophy in response to stress; centrosome; cytoplasm; histone demethylase activity (H3-K36 specific); methylated histone residue binding; modulation by virus of host morphology or physiology; negative regulation of transcription, DNA-dependent; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR003349; IPR002999; IPR011011; IPR001965; IPR013083; Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A) KDM4A JHDM3A JMJD2 JMJD2A KIAA0677 Homo sapiens (Human) 1064 O75164 GO:0070544 GO:0070544 histone H3-K36 demethylation cell organization and biogenesis P ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0006919 GO:0006919 activation of caspase activity death P ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0048306 GO:0048306 calcium-dependent protein binding other molecular function F ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0051592 GO:0051592 response to calcium ion other biological processes P ConsensusfromContig2567 sp O75340 PDCD6_HUMAN 86 150 21 0 142 591 24 173 6E-92 273 O75340 PDCD6_HUMAN GO:0006919; GO:0001525; GO:0097190; GO:0060090; GO:0005509; GO:0033554; GO:0031410; GO:0005783; GO:0005789; GO:0005768; GO:0006886; GO:0032007; GO:0051898; GO:0030948; GO:0031965; GO:0005634; GO:0045766; GO:0010595; GO:0001938; GO:0051592; GO:0036324 P53355; P35968; Q8WUM4; Q9NRY6; Q9H3S7; O94979 activation of cysteine-type endopeptidase activity involved in apoptotic process; angiogenesis; apoptotic signaling pathway; binding, bridging; calcium ion binding; cellular response to stress; cytoplasmic vesicle; endoplasmic reticulum; endoplasmic reticulum membrane; endosome; intracellular protein transport; negative regulation of TOR signaling cascade; negative regulation of protein kinase B signaling cascade; negative regulation of vascular endothelial growth factor receptor signaling pathway; nuclear membrane; nucleus; positive regulation of angiogenesis; positive regulation of endothelial cell migration; positive regulation of endothelial cell proliferation; response to calcium ion; vascular endothelial growth factor receptor-2 signaling pathway reviewed IPR011992; IPR018247; IPR002048; Programmed cell death protein 6 (Apoptosis-linked gene 2 protein) (Probable calcium-binding protein ALG-2) PDCD6 ALG2 Homo sapiens (Human) 191 O75340 GO:0060090 GO:0060090 molecular adaptor activity other molecular function F ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2861 sp O75534 CSDE1_HUMAN 87.58 161 17 2 1 480 169 327 2E-89 283 O75534 CSDE1_HUMAN GO:0070937; GO:0003677; GO:0003723; GO:0008584; GO:0070966; GO:0006355 CRD-mediated mRNA stability complex; DNA binding; RNA binding; male gonad development; nuclear-transcribed mRNA catabolic process, no-go decay; regulation of transcription, DNA-dependent reviewed IPR019844; IPR011129; IPR002059; IPR012340; IPR024642; Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR) CSDE1 D1S155E KIAA0885 NRU UNR Homo sapiens (Human) 798 O75534 GO:0008584 GO:0008584 male gonad development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001702 GO:0001702 gastrulation with mouth forming second developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001756 GO:0001756 somitogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001843 GO:0001843 neural tube closure developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001933 GO:0001933 negative regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001947 GO:0001947 heart looping developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0002009 GO:0002009 morphogenesis of an epithelium developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0002053 GO:0002053 positive regulation of mesenchymal cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0003344 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0003401 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005041 GO:0005041 low-density lipoprotein receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005109 GO:0005109 frizzled binding signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005901 GO:0005901 caveola plasma membrane C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005901 GO:0005901 caveola other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006469 GO:0006469 negative regulation of protein kinase activity other metabolic processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009880 GO:0009880 embryonic pattern specification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009950 GO:0009950 dorsal/ventral axis specification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009952 GO:0009952 anterior/posterior pattern formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014029 GO:0014029 neural crest formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014029 GO:0014029 neural crest formation cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014033 GO:0014033 neural crest cell differentiation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0017147 GO:0017147 Wnt-protein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0019210 GO:0019210 kinase inhibitor activity enzyme regulator activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0019534 GO:0019534 toxin transporter activity transporter activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021587 GO:0021587 cerebellum morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021794 GO:0021794 thalamus development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021795 GO:0021795 cerebral cortex cell migration developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021861 GO:0021861 radial glial cell differentiation in the forebrain developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021872 GO:0021872 generation of neurons in the forebrain developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021915 GO:0021915 neural tube development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021943 GO:0021943 formation of radial glial scaffolds developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021943 GO:0021943 formation of radial glial scaffolds cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021987 GO:0021987 cerebral cortex development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030178 GO:0030178 negative regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030278 GO:0030278 regulation of ossification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030326 GO:0030326 embryonic limb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030901 GO:0030901 midbrain development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030917 GO:0030917 midbrain-hindbrain boundary development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0034185 GO:0034185 apolipoprotein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0034392 GO:0034392 negative regulation of smooth muscle cell apoptosis death P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035108 GO:0035108 limb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035115 GO:0035115 embryonic forelimb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035116 GO:0035116 embryonic hindlimb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035121 GO:0035121 tail morphogenesis other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035261 GO:0035261 external genitalia morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042074 GO:0042074 cell migration involved in gastrulation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042475 GO:0042475 odontogenesis of dentine-containing tooth developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042813 GO:0042813 Wnt receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043235 GO:0043235 receptor complex other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044332 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044335 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044340 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045202 GO:0045202 synapse other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045598 GO:0045598 regulation of fat cell differentiation other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045599 GO:0045599 negative regulation of fat cell differentiation other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045778 GO:0045778 positive regulation of ossification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045780 GO:0045780 positive regulation of bone resorption other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0046849 GO:0046849 bone remodeling other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048596 GO:0048596 embryonic camera-type eye morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048699 GO:0048699 generation of neurons developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048705 GO:0048705 skeletal system morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0050680 GO:0050680 negative regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0051091 GO:0051091 positive regulation of transcription factor activity RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0051593 GO:0051593 response to folic acid other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060021 GO:0060021 palate development other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060026 GO:0060026 convergent extension developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060042 GO:0060042 retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060059 GO:0060059 embryonic retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060070 GO:0060070 Wnt receptor signaling pathway through beta-catenin signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060284 GO:0060284 regulation of cell development other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060325 GO:0060325 face morphogenesis other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060349 GO:0060349 bone morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060444 GO:0060444 branching involved in mammary gland duct morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060535 GO:0060535 trachea cartilage morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060596 GO:0060596 mammary placode formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060603 GO:0060603 mammary gland duct morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0061310 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0061324 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071397 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071542 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071901 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071936 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090009 GO:0090009 developmental processes ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090118 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090244 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090245 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090263 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000051 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000055 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000149 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000151 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000162 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000164 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000166 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 77.06 109 25 0 3 329 941 1049 3E-70 177 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000168 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001702 GO:0001702 gastrulation with mouth forming second developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001756 GO:0001756 somitogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001843 GO:0001843 neural tube closure developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001933 GO:0001933 negative regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0001947 GO:0001947 heart looping developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0002009 GO:0002009 morphogenesis of an epithelium developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0002053 GO:0002053 positive regulation of mesenchymal cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0003344 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0003401 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005041 GO:0005041 low-density lipoprotein receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005109 GO:0005109 frizzled binding signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005901 GO:0005901 caveola plasma membrane C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0005901 GO:0005901 caveola other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006469 GO:0006469 negative regulation of protein kinase activity other metabolic processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009880 GO:0009880 embryonic pattern specification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009950 GO:0009950 dorsal/ventral axis specification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009952 GO:0009952 anterior/posterior pattern formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014029 GO:0014029 neural crest formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014029 GO:0014029 neural crest formation cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0014033 GO:0014033 neural crest cell differentiation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0017147 GO:0017147 Wnt-protein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0019210 GO:0019210 kinase inhibitor activity enzyme regulator activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0019534 GO:0019534 toxin transporter activity transporter activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021587 GO:0021587 cerebellum morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021794 GO:0021794 thalamus development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021795 GO:0021795 cerebral cortex cell migration developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021861 GO:0021861 radial glial cell differentiation in the forebrain developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021872 GO:0021872 generation of neurons in the forebrain developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021874 GO:0021874 Wnt receptor signaling pathway in forebrain neuroblast division developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021915 GO:0021915 neural tube development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021943 GO:0021943 formation of radial glial scaffolds developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021943 GO:0021943 formation of radial glial scaffolds cell organization and biogenesis P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0021987 GO:0021987 cerebral cortex development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030178 GO:0030178 negative regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030278 GO:0030278 regulation of ossification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030326 GO:0030326 embryonic limb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030900 GO:0030900 forebrain development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030901 GO:0030901 midbrain development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0030917 GO:0030917 midbrain-hindbrain boundary development developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0034185 GO:0034185 apolipoprotein binding other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0034392 GO:0034392 negative regulation of smooth muscle cell apoptosis death P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035108 GO:0035108 limb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035115 GO:0035115 embryonic forelimb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035116 GO:0035116 embryonic hindlimb morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035121 GO:0035121 tail morphogenesis other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0035261 GO:0035261 external genitalia morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042074 GO:0042074 cell migration involved in gastrulation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042475 GO:0042475 odontogenesis of dentine-containing tooth developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0042813 GO:0042813 Wnt receptor activity signal transduction activity F ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0043235 GO:0043235 receptor complex other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044332 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044335 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0044340 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045202 GO:0045202 synapse other cellular component C ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045598 GO:0045598 regulation of fat cell differentiation other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045599 GO:0045599 negative regulation of fat cell differentiation other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045778 GO:0045778 positive regulation of ossification developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045780 GO:0045780 positive regulation of bone resorption other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0046849 GO:0046849 bone remodeling other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048596 GO:0048596 embryonic camera-type eye morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048699 GO:0048699 generation of neurons developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0048705 GO:0048705 skeletal system morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0050680 GO:0050680 negative regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0051091 GO:0051091 positive regulation of transcription factor activity RNA metabolism P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0051593 GO:0051593 response to folic acid other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060021 GO:0060021 palate development other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060026 GO:0060026 convergent extension developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060042 GO:0060042 retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060059 GO:0060059 embryonic retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060070 GO:0060070 Wnt receptor signaling pathway through beta-catenin signal transduction P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060284 GO:0060284 regulation of cell development other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060325 GO:0060325 face morphogenesis other biological processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060349 GO:0060349 bone morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060444 GO:0060444 branching involved in mammary gland duct morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060535 GO:0060535 trachea cartilage morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060596 GO:0060596 mammary placode formation developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0060603 GO:0060603 mammary gland duct morphogenesis developmental processes P ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0061310 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0061324 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071397 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071542 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071901 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0071936 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090009 GO:0090009 developmental processes ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090118 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090244 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090245 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:0090263 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000051 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000055 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000149 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000151 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000162 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000164 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000166 ConsensusfromContig4447 sp O75581 LRP6_HUMAN 92.16 51 4 0 329 481 1050 1100 3E-70 107 O75581 LRP6_HUMAN GO:0044332; GO:0021874; GO:0090244; GO:0042813; GO:0034185; GO:0090245; GO:0060349; GO:0046849; GO:0060444; GO:0061310; GO:0044335; GO:0061324; GO:0044340; GO:0042074; GO:0009986; GO:0071397; GO:0021587; GO:0021795; GO:0021987; GO:0060026; GO:0071936; GO:0031410; GO:0071542; GO:0005769; GO:0048596; GO:0042733; GO:0035115; GO:0035116; GO:0030326; GO:0009880; GO:0060059; GO:0005783; GO:0035261; GO:0060325; GO:0021861; GO:0021943; GO:0001947; GO:0016021; GO:0019210; GO:0005041; GO:0060596; GO:0030901; GO:0030917; GO:0050680; GO:0045599; GO:2000151; GO:2000162; GO:2000168; GO:2000164; GO:2000166; GO:2000149; GO:0071901; GO:0034392; GO:0014029; GO:0001843; GO:0043025; GO:0042475; GO:0060021; GO:0003344; GO:0005886; GO:2000055; GO:0043065; GO:0045780; GO:0090263; GO:0045787; GO:0002053; GO:0045778; GO:0051091; GO:0045944; GO:0036342; GO:0090009; GO:0043235; GO:0090118; GO:0060284; GO:0045598; GO:0030278; GO:0051593; GO:0045202; GO:0007268; GO:0021794; GO:0019534; GO:0060535 Q9Y4X0; Q9H6X2; O70239; Q03135; P98082; P49840; P49841; Q5S007; Q9ERE8 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt receptor signaling pathway involved in forebrain neuroblast division; Wnt receptor signaling pathway involved in somitogenesis; Wnt-activated receptor activity; apolipoprotein binding; axis elongation involved in somitogenesis; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway involved in cardiac neural crest cell differentiation involved in heart development; canonical Wnt receptor signaling pathway involved in neural crest cell differentiation; canonical Wnt receptor signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation; canonical Wnt receptor signaling pathway involved in regulation of cell proliferation; cell migration involved in gastrulation; cell surface; cellular response to cholesterol; cerebellum morphogenesis; cerebral cortex cell migration; cerebral cortex development; convergent extension; coreceptor activity involved in Wnt receptor signaling pathway; cytoplasmic vesicle; dopaminergic neuron differentiation; early endosome; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic forelimb morphogenesis; embryonic hindlimb morphogenesis; embryonic limb morphogenesis; embryonic pattern specification; embryonic retina morphogenesis in camera-type eye; endoplasmic reticulum; external genitalia morphogenesis; face morphogenesis; forebrain radial glial cell differentiation; formation of radial glial scaffolds; heart looping; integral to membrane; kinase inhibitor activity; low-density lipoprotein receptor activity; mammary placode formation; midbrain development; midbrain-hindbrain boundary development; negative regulation of epithelial cell proliferation; negative regulation of fat cell differentiation; negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis; negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis; negative regulation of planar cell polarity pathway involved in neural tube closure; negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis; negative regulation of planar cell polarity pathway involved in pericardium morphogenesis; negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis; negative regulation of protein serine/threonine kinase activity; negative regulation of smooth muscle cell apoptotic process; neural crest formation; neural tube closure; neuronal cell body; odontogenesis of dentin-containing tooth; palate development; pericardium morphogenesis; plasma membrane; positive regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification; positive regulation of apoptotic process; positive regulation of bone resorption; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of cell cycle; positive regulation of mesenchymal cell proliferation; positive regulation of ossification; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; post-anal tail morphogenesis; primitive streak formation; receptor complex; receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport; regulation of cell development; regulation of fat cell differentiation; regulation of ossification; response to folic acid; synapse; synaptic transmission; thalamus development; toxin transporter activity; trachea cartilage morphogenesis reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 6 (LRP-6) LRP6 Homo sapiens (Human) 1613 O75581 GO:2000168 ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005313 GO:0005313 L-glutamate transmembrane transporter activity transporter activity F ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0006094 GO:0006094 gluconeogenesis other metabolic processes P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0015183 GO:0015183 L-aspartate transmembrane transporter activity transporter activity F ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0015810 GO:0015810 aspartate transport transport P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0015813 GO:0015813 L-glutamate transport transport P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0043490 GO:0043490 malate-aspartate shuttle transport P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0043490 GO:0043490 malate-aspartate shuttle other metabolic processes P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0044281 ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0051592 GO:0051592 response to calcium ion other biological processes P ConsensusfromContig2358 sp O75746 CMC1_HUMAN 64.86 148 51 1 93 536 1 147 9E-63 211 O75746 CMC1_HUMAN GO:0015183; GO:0005313; GO:0005509; GO:0006094; GO:0016021; GO:0043490; GO:0005743; GO:0051592; GO:0044281 L-aspartate transmembrane transporter activity; L-glutamate transmembrane transporter activity; calcium ion binding; gluconeogenesis; integral to membrane; malate-aspartate shuttle; mitochondrial inner membrane; response to calcium ion; small molecule metabolic process reviewed IPR011992; IPR018247; IPR002048; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12) SLC25A12 ARALAR1 Homo sapiens (Human) 678 O75746 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0003714 GO:0003714 transcription corepressor activity transcription regulatory activity F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0007259 GO:0007259 JAK-STAT cascade signal transduction P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0019789 GO:0019789 SUMO ligase activity other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0030521 GO:0030521 androgen receptor signaling pathway signal transduction P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0031625 GO:0031625 ubiquitin protein ligase binding other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0033235 GO:0033235 positive regulation of protein sumoylation protein metabolism P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0050681 GO:0050681 androgen receptor binding signal transduction activity F ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0060333 GO:0060333 interferon-gamma-mediated signaling pathway signal transduction P ConsensusfromContig5421 sp O75925 PIAS1_HUMAN 96.55 87 3 0 3 263 172 258 8E-52 177 O75925 PIAS1_HUMAN GO:0003677; GO:0007259; GO:0016605; GO:0019789; GO:0050681; GO:0030521; GO:0060333; GO:0000122; GO:0016607; GO:0005654; GO:0032436; GO:0033235; GO:0051152; GO:0045893; GO:0016925; GO:0065004; GO:0042127; GO:0060334; GO:0007283; GO:0003713; GO:0003714; GO:0006351; GO:0008270 Q9UKL3; Q9UIS9; O75626; P04637 DNA binding; JAK-STAT cascade; PML body; SUMO ligase activity; androgen receptor binding; androgen receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of transcription from RNA polymerase II promoter; nuclear speck; nucleoplasm; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of protein sumoylation; positive regulation of smooth muscle cell differentiation; positive regulation of transcription, DNA-dependent; protein sumoylation; protein-DNA complex assembly; regulation of cell proliferation; regulation of interferon-gamma-mediated signaling pathway; spermatogenesis; transcription coactivator activity; transcription corepressor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR027227; IPR023321; IPR003034; IPR004181; Protein modification; protein sumoylation. E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein) PIAS1 DDXBP1 Homo sapiens (Human) 651 O75925 GO:0060334 GO:0060334 regulation of interferon-gamma-mediated signaling pathway signal transduction P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000086 GO:0000086 G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005869 GO:0005869 dynactin complex cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0005875 GO:0005875 microtubule associated complex cytoskeleton C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0007017 GO:0007017 microtubule-based process other biological processes P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2885 sp O75935 DCTN3_HUMAN 58.05 174 71 1 32 553 1 172 2E-63 204 O75935 DCTN3_HUMAN GO:0000086; GO:0019886; GO:0005813; GO:0032154; GO:0000777; GO:0000910; GO:0005829; GO:0005869; GO:0007017; GO:0030496; GO:0007067; GO:0048471; GO:0005819; GO:0005198 P40425 G2/M transition of mitotic cell cycle; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cleavage furrow; condensed chromosome kinetochore; cytokinesis; cytosol; dynactin complex; microtubule-based process; midbody; mitosis; perinuclear region of cytoplasm; spindle; structural molecule activity reviewed IPR009991; Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22) DCTN3 DCTN22 Homo sapiens (Human) 186 O75935 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0001944 GO:0001944 vasculature development developmental processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0003016 GO:0003016 respiratory system process other biological processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0010761 GO:0010761 fibroblast migration other biological processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0048008 GO:0048008 platelet-derived growth factor receptor signaling pathway signal transduction P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0048705 GO:0048705 skeletal system morphogenesis developmental processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0048745 GO:0048745 smooth muscle tissue development developmental processes P ConsensusfromContig5841 sp O76080 ZFAN5_HUMAN 55.05 218 89 4 880 239 1 213 8E-69 221 O76080 ZFAN5_HUMAN GO:0003677; GO:0005737; GO:0060324; GO:0010761; GO:0001701; GO:0048008; GO:0003016; GO:0048705; GO:0048745; GO:0001944; GO:0008270 P0CG48 DNA binding; cytoplasm; face development; fibroblast migration; in utero embryonic development; platelet-derived growth factor receptor signaling pathway; respiratory system process; skeletal system morphogenesis; smooth muscle tissue development; vasculature development; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216) ZFAND5 ZA20D2 ZNF216 Homo sapiens (Human) 213 O76080 GO:0060324 GO:0060324 face development other biological processes P ConsensusfromContig6243 sp O77681 GDF9_SHEEP 41.78 371 191 8 196 1242 60 427 5E-68 236 O77681 GDF9_SHEEP GO:0005615 extracellular space reviewed IPR015617; IPR001839; IPR015615; IPR017948; Growth/differentiation factor 9 (GDF-9) GDF9 Ovis aries (Sheep) 453 O77681 GO:0005125 GO:0005125 cytokine activity signal transduction activity F ConsensusfromContig6243 sp O77681 GDF9_SHEEP 41.78 371 191 8 196 1242 60 427 5E-68 236 O77681 GDF9_SHEEP GO:0005615 extracellular space reviewed IPR015617; IPR001839; IPR015615; IPR017948; Growth/differentiation factor 9 (GDF-9) GDF9 Ovis aries (Sheep) 453 O77681 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6243 sp O77681 GDF9_SHEEP 41.78 371 191 8 196 1242 60 427 5E-68 236 O77681 GDF9_SHEEP GO:0005615 extracellular space reviewed IPR015617; IPR001839; IPR015615; IPR017948; Growth/differentiation factor 9 (GDF-9) GDF9 Ovis aries (Sheep) 453 O77681 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig6243 sp O77681 GDF9_SHEEP 41.78 371 191 8 196 1242 60 427 5E-68 236 O77681 GDF9_SHEEP GO:0005615 extracellular space reviewed IPR015617; IPR001839; IPR015615; IPR017948; Growth/differentiation factor 9 (GDF-9) GDF9 Ovis aries (Sheep) 453 O77681 GO:0008083 GO:0008083 growth factor activity signal transduction activity F ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0000079 GO:0000079 regulation of cyclin-dependent protein kinase activity cell cycle and proliferation P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0000079 GO:0000079 regulation of cyclin-dependent protein kinase activity other metabolic processes P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5933 sp O88874 CCNK_MOUSE 75.38 130 15 1 2009 1671 163 292 5E-55 202 O88874 CCNK_MOUSE GO:0008353; GO:0051301; GO:0004693; GO:0001701; GO:0007067; GO:0071157; GO:0000079; GO:0006355; GO:0006351 RNA polymerase II carboxy-terminal domain kinase activity; cell division; cyclin-dependent protein serine/threonine kinase activity; in utero embryonic development; mitosis; negative regulation of cell cycle arrest; regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-K Ccnk Mus musculus (Mouse) 554 O88874 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0004114 GO:0004114 "3',5'-cyclic-nucleotide phosphodiesterase activity" other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0004115 GO:0004115 "3',5'-cyclic-AMP phosphodiesterase activity" other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0006198 GO:0006198 cAMP catabolic process other metabolic processes P ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0008081 GO:0008081 phosphoric diester hydrolase activity other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1153 sp O89084 PDE4A_MOUSE 93.98 133 8 0 442 44 467 599 2E-81 262 O89084 PDE4A_MOUSE GO:0004115; GO:0006198; GO:0035690; GO:0005737; GO:0046872; GO:0048471; GO:0043949; GO:0010738; GO:0007608; GO:0007165 3',5'-cyclic-AMP phosphodiesterase activity; cAMP catabolic process; cellular response to drug; cytoplasm; metal ion binding; perinuclear region of cytoplasm; regulation of cAMP-mediated signaling; regulation of protein kinase A signaling cascade; sensory perception of smell; signal transduction reviewed IPR003607; IPR023088; IPR002073; IPR023174; Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) Pde4a Mus musculus (Mouse) 844 O89084 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0006874 GO:0006874 cellular calcium ion homeostasis other biological processes P ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0008021 GO:0008021 synaptic vesicle other cellular component C ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6242 sp O89104 SYPL2_MOUSE 50.48 210 100 2 1412 795 31 240 5E-67 223 O89104 SYPL2_MOUSE GO:0006874; GO:0016021; GO:0008021; GO:0005215 cellular calcium ion homeostasis; integral to membrane; synaptic vesicle; transporter activity reviewed IPR008253; IPR001285; Synaptophysin-like protein 2 (Mitsugumin-29) (Mg29) Sypl2 Mg29 Mus musculus (Mouse) 264 O89104 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 85.27 129 19 0 710 1096 165 293 4E-119 231 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6204 sp O93434 RCN1_TAKRU 85.27 129 19 0 710 1096 165 293 4E-119 231 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 85.27 129 19 0 710 1096 165 293 4E-119 231 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 71.28 94 25 2 270 545 17 110 4E-119 136 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6204 sp O93434 RCN1_TAKRU 71.28 94 25 2 270 545 17 110 4E-119 136 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 71.28 94 25 2 270 545 17 110 4E-119 136 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 83.64 55 9 0 547 711 111 165 4E-119 101 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6204 sp O93434 RCN1_TAKRU 83.64 55 9 0 547 711 111 165 4E-119 101 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 83.64 55 9 0 547 711 111 165 4E-119 101 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 61.54 13 5 0 1095 1133 293 305 4E-119 24.6 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6204 sp O93434 RCN1_TAKRU 61.54 13 5 0 1095 1133 293 305 4E-119 24.6 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6204 sp O93434 RCN1_TAKRU 61.54 13 5 0 1095 1133 293 305 4E-119 24.6 O93434 RCN1_TAKRU GO:0005509; GO:0005788 calcium ion binding; endoplasmic reticulum lumen reviewed IPR011992; IPR018247; IPR002048; IPR027241; Reticulocalbin-1 rcn1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 322 O93434 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig3345 sp O94915 FRYL_HUMAN 80.56 108 21 0 331 8 750 857 3E-55 192 O94915 FRYL_HUMAN GO:0006355; GO:0006351 Q16611; P31946; P61981 regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011989; IPR016024; IPR025614; IPR025481; Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRYL AF4P12 KIAA0826 Homo sapiens (Human) 3013 O94915 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3345 sp O94915 FRYL_HUMAN 80.56 108 21 0 331 8 750 857 3E-55 192 O94915 FRYL_HUMAN GO:0006355; GO:0006351 Q16611; P31946; P61981 regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011989; IPR016024; IPR025614; IPR025481; Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRYL AF4P12 KIAA0826 Homo sapiens (Human) 3013 O94915 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3345 sp O94915 FRYL_HUMAN 80.56 108 21 0 331 8 750 857 3E-55 192 O94915 FRYL_HUMAN GO:0006355; GO:0006351 Q16611; P31946; P61981 regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011989; IPR016024; IPR025614; IPR025481; Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein) FRYL AF4P12 KIAA0826 Homo sapiens (Human) 3013 O94915 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1639 sp O94967 WDR47_HUMAN 81.7 153 28 0 11 469 147 299 2E-66 222 O94967 WDR47_HUMAN GO:0005737; GO:0005874; GO:0007275 cytoplasm; microtubule; multicellular organismal development reviewed IPR006595; IPR006594; IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin) WDR47 KIAA0893 Homo sapiens (Human) 919 ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0033160 GO:0033160 "positive regulation of protein import into nucleus, translocation" transport P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0034450 GO:0034450 ubiquitin-ubiquitin ligase activity other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0035413 ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0043130 GO:0043130 ubiquitin binding other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0050847 GO:0050847 progesterone receptor signaling pathway signal transduction P ConsensusfromContig2094 sp O95071 UBR5_HUMAN 94.8 173 9 0 576 58 2139 2311 5E-105 339 O95071 UBR5_HUMAN GO:0006281; GO:0003723; GO:0008283; GO:0005737; GO:2000780; GO:1901315; GO:0005634; GO:0090263; GO:0035413; GO:0033160; GO:0050847; GO:0000209; GO:0042787; GO:0006974; GO:0034450; GO:0008270 Q9BPZ3 DNA repair; RNA binding; cell proliferation; cytoplasm; negative regulation of double-strand break repair; negative regulation of histone H2A K63-linked ubiquitination; nucleus; positive regulation of canonical Wnt receptor signaling pathway; positive regulation of catenin import into nucleus; positive regulation of protein import into nucleus, translocation; progesterone receptor signaling pathway; protein polyubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to DNA damage stimulus; ubiquitin-ubiquitin ligase activity; zinc ion binding reviewed IPR024725; IPR000569; IPR002004; IPR009091; IPR003126; IPR013993; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR5 (EC 6.3.2.-) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein) UBR5 EDD EDD1 HYD KIAA0896 Homo sapiens (Human) 2799 O95071 GO:0090263 ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0003222 ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0031175 GO:0031175 neuron projection development developmental processes P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0031175 GO:0031175 neuron projection development cell organization and biogenesis P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0034450 GO:0034450 ubiquitin-ubiquitin ligase activity other molecular function F ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0034976 GO:0034976 response to endoplasmic reticulum stress stress response P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig542 sp O95155 UBE4B_HUMAN 77.97 118 25 1 360 7 119 235 4E-53 189 O95155 UBE4B_HUMAN GO:0005737; GO:0019899; GO:0008626; GO:0043161; GO:0042787; GO:0009411; GO:0000151; GO:0006511; GO:0034450 cytoplasm; enzyme binding; granzyme-mediated apoptotic signaling pathway; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-ubiquitin ligase activity reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Homozygously deleted in neuroblastoma 1) (Ubiquitin fusion degradation protein 2) UBE4B HDNB1 KIAA0684 UFD2 Homo sapiens (Human) 1302 O95155 GO:0044257 GO:0044257 cellular protein catabolic process protein metabolism P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0001578 GO:0001578 microtubule bundle formation cell organization and biogenesis P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 40.97 554 266 15 656 2191 152 686 4E-119 347 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0001578 GO:0001578 microtubule bundle formation cell organization and biogenesis P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5557 sp O95235 KI20A_HUMAN 52.22 90 43 0 390 659 63 152 4E-119 105 O95235 KI20A_HUMAN GO:0005524; GO:0005794; GO:0000910; GO:0005871; GO:0005874; GO:0001578; GO:0003777; GO:0007018; GO:0000278; GO:0005654; GO:0015031; GO:0005819; GO:0005215; GO:0016192 ATP binding; Golgi apparatus; cytokinesis; kinesin complex; microtubule; microtubule bundle formation; microtubule motor activity; microtubule-based movement; mitotic cell cycle; nucleoplasm; protein transport; spindle; transporter activity; vesicle-mediated transport reviewed IPR027326; IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6) KIF20A MKLP2 RAB6KIFL Homo sapiens (Human) 890 O95235 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5940 sp O95671 ASML_HUMAN 53.97 302 133 2 34 936 323 619 2E-108 337 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5940 sp O95671 ASML_HUMAN 53.97 302 133 2 34 936 323 619 2E-108 337 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5940 sp O95671 ASML_HUMAN 53.97 302 133 2 34 936 323 619 2E-108 337 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5940 sp O95671 ASML_HUMAN 53.97 302 133 2 34 936 323 619 2E-108 337 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5940 sp O95671 ASML_HUMAN 53.97 302 133 2 34 936 323 619 2E-108 337 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0008171 GO:0008171 O-methyltransferase activity other molecular function F ConsensusfromContig1185 sp O95671 ASML_HUMAN 74.87 199 49 1 68 664 1 198 5E-96 300 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1185 sp O95671 ASML_HUMAN 74.87 199 49 1 68 664 1 198 5E-96 300 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1185 sp O95671 ASML_HUMAN 74.87 199 49 1 68 664 1 198 5E-96 300 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1185 sp O95671 ASML_HUMAN 74.87 199 49 1 68 664 1 198 5E-96 300 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1185 sp O95671 ASML_HUMAN 74.87 199 49 1 68 664 1 198 5E-96 300 O95671 ASML_HUMAN GO:0008171; GO:0005737 O-methyltransferase activity; cytoplasm reviewed IPR025772; IPR003697; IPR001077; IPR011991; N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-) ASMTL Homo sapiens (Human) 621 O95671 GO:0008171 GO:0008171 O-methyltransferase activity other molecular function F ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0006810 GO:0006810 transport transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0006895 GO:0006895 Golgi to endosome transport transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030122 GO:0030122 AP-2 adaptor complex plasma membrane C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030122 GO:0030122 AP-2 adaptor complex other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030130 GO:0030130 clathrin coat of trans-Golgi network vesicle ER/Golgi C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030130 GO:0030130 clathrin coat of trans-Golgi network vesicle other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030131 GO:0030131 clathrin adaptor complex other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0030666 GO:0030666 endocytic vesicle membrane other membranes C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0042059 GO:0042059 negative regulation of epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig613 sp O95782 AP2A1_HUMAN 76.26 139 33 0 551 135 833 971 1E-60 207 O95782 AP2A1_HUMAN GO:0030122; GO:0006895; GO:0019886; GO:0016324; GO:0007411; GO:0016323; GO:0030130; GO:0005829; GO:0006897; GO:0007173; GO:0006886; GO:0042059; GO:0048011; GO:0008565; GO:0050690; GO:0007268; GO:0016032 AP-2 adaptor complex; Golgi to endosome transport; antigen processing and presentation of exogenous peptide antigen via MHC class II; apical plasma membrane; axon guidance; basolateral plasma membrane; clathrin coat of trans-Golgi network vesicle; cytosol; endocytosis; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway; neurotrophin TRK receptor signaling pathway; protein transporter activity; regulation of defense response to virus by virus; synaptic transmission; viral process reviewed IPR017104; IPR011989; IPR016024; IPR002553; IPR013038; IPR003164; IPR008152; IPR015873; IPR009028; IPR013041; AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adapter-related protein complex 2 subunit alpha-1) (Adaptor protein complex AP-2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit) AP2A1 ADTAA CLAPA1 Homo sapiens (Human) 977 O95782 GO:0050690 GO:0050690 regulation of defense response to virus by virus stress response P ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0003725 GO:0003725 double-stranded RNA binding nucleic acid binding activity F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005791 GO:0005791 rough endoplasmic reticulum ER/Golgi C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005875 GO:0005875 microtubule associated complex cytoskeleton C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0008298 GO:0008298 intracellular mRNA localization other biological processes P ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0010494 GO:0010494 stress granule other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 71.71 152 42 1 1550 1095 377 527 3E-78 228 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0003725 GO:0003725 double-stranded RNA binding nucleic acid binding activity F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005791 GO:0005791 rough endoplasmic reticulum ER/Golgi C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0005875 GO:0005875 microtubule associated complex cytoskeleton C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0008298 GO:0008298 intracellular mRNA localization other biological processes P ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0010494 GO:0010494 stress granule other cellular component C ConsensusfromContig6028 sp O95793 STAU1_HUMAN 85.71 49 5 1 1095 955 528 576 3E-78 87.4 O95793 STAU1_HUMAN GO:0010494; GO:0003725; GO:0008298; GO:0005875; GO:0005791 P03496; P62424; P05388; Q92900 cytoplasmic stress granule; double-stranded RNA binding; intracellular mRNA localization; microtubule associated complex; rough endoplasmic reticulum reviewed IPR014720; Double-stranded RNA-binding protein Staufen homolog 1 STAU1 STAU Homo sapiens (Human) 577 O95793 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016049 GO:0016049 cell growth other biological processes P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3353 sp O96013 PAK4_HUMAN 87.68 138 16 1 415 2 449 585 4E-79 251 O96013 PAK4_HUMAN GO:0005524; GO:0005794; GO:0006915; GO:0007049; GO:0016049; GO:0016477; GO:0008283; GO:0007010; GO:0004672; GO:0004674; GO:0007165 P60953 ATP binding; Golgi apparatus; apoptotic process; cell cycle; cell growth; cell migration; cell proliferation; cytoskeleton organization; protein kinase activity; protein serine/threonine kinase activity; signal transduction reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4) PAK4 KIAA1142 Homo sapiens (Human) 591 O96013 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0009653 GO:0009653 anatomical structure morphogenesis other biological processes P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 78.29 327 69 1 1336 2310 1001 1327 0 512 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0009653 GO:0009653 anatomical structure morphogenesis other biological processes P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig5616 sp O96028 NSD2_HUMAN 62.29 358 123 4 266 1306 634 990 0 481 O96028 NSD2_HUMAN GO:0003677; GO:0009653; GO:0003289; GO:0003290; GO:0060348; GO:0003682; GO:0005694; GO:0005737; GO:0018024; GO:0003149; GO:0000122; GO:0031965; GO:0005730; GO:0006351; GO:0008270 P10275 DNA binding; anatomical structure morphogenesis; atrial septum primum morphogenesis; atrial septum secundum morphogenesis; bone development; chromatin binding; chromosome; cytoplasm; histone-lysine N-methyltransferase activity; membranous septum morphogenesis; negative regulation of transcription from RNA polymerase II promoter; nuclear membrane; nucleolus; transcription, DNA-dependent; zinc ion binding reviewed IPR006560; IPR009071; IPR003616; IPR000313; IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (NSD2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein) (WHSC1) WHSC1 KIAA1090 MMSET NSD2 TRX5 Homo sapiens (Human) 1365 O96028 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0004198 GO:0004198 calcium-dependent cysteine-type endopeptidase activity other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2277 sp P00789 CANX_CHICK 75.26 190 47 0 1 570 187 376 1E-98 306 P00789 CANX_CHICK GO:0005509; GO:0004198; GO:0005737; GO:0005886; GO:0006508; GO:0032801 calcium ion binding; calcium-dependent cysteine-type endopeptidase activity; cytoplasm; plasma membrane; proteolysis; receptor catabolic process reviewed IPR022684; IPR022682; IPR022683; IPR011992; IPR018247; IPR002048; IPR000169; IPR001300; Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase) (CANP) (Calpain-1 large subunit) (Mu/M-type) Gallus gallus (Chicken) 705 P00789 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005201 GO:0005201 extracellular matrix structural constituent extracellular structural activity F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005581 GO:0005581 collagen extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005587 GO:0005587 collagen type IV extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007528 GO:0007528 neuromuscular junction development developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007528 GO:0007528 neuromuscular junction development cell organization and biogenesis P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0030855 GO:0030855 epithelial cell differentiation developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0048407 GO:0048407 platelet-derived growth factor binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 88.04 92 11 0 3 278 1496 1587 3E-60 189 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0071230 ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005201 GO:0005201 extracellular matrix structural constituent extracellular structural activity F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005581 GO:0005581 collagen extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005587 GO:0005587 collagen type IV extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007528 GO:0007528 neuromuscular junction development developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0007528 GO:0007528 neuromuscular junction development cell organization and biogenesis P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0030855 GO:0030855 epithelial cell differentiation developmental processes P ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0048407 GO:0048407 platelet-derived growth factor binding other molecular function F ConsensusfromContig2695 sp P02462 CO4A1_HUMAN 90.32 31 3 0 292 384 1592 1622 3E-60 62.8 P02462 CO4A1_HUMAN GO:0001525; GO:0007411; GO:0071230; GO:0030574; GO:0005587; GO:0005788; GO:0022617; GO:0005201; GO:0005576; GO:0007528; GO:0048407 P08572 angiogenesis; axon guidance; cellular response to amino acid stimulus; collagen catabolic process; collagen type IV; endoplasmic reticulum lumen; extracellular matrix disassembly; extracellular matrix structural constituent; extracellular region; neuromuscular junction development; platelet-derived growth factor binding reviewed IPR016187; IPR008160; IPR001442; Collagen alpha-1(IV) chain [Cleaved into: Arresten] COL4A1 Homo sapiens (Human) 1669 P02462 GO:0071230 ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0002576 GO:0002576 platelet degranulation transport P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005577 GO:0005577 fibrinogen complex non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0030674 GO:0030674 "protein binding, bridging" other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0031091 GO:0031091 platelet alpha granule other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0031093 GO:0031093 platelet alpha granule lumen other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0043499 GO:0043499 eukaryotic cell surface binding other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051258 GO:0051258 protein polymerization cell organization and biogenesis P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 71.43 273 77 1 655 1470 218 490 2E-142 406 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051592 GO:0051592 response to calcium ion other biological processes P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0002576 GO:0002576 platelet degranulation transport P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005577 GO:0005577 fibrinogen complex non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0030674 GO:0030674 "protein binding, bridging" other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0031091 GO:0031091 platelet alpha granule other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0031093 GO:0031093 platelet alpha granule lumen other cellular component C ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0043499 GO:0043499 eukaryotic cell surface binding other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051258 GO:0051258 protein polymerization cell organization and biogenesis P ConsensusfromContig5615 sp P02675 FIBB_HUMAN 38.64 176 106 2 117 644 41 214 2E-142 123 P02675 FIBB_HUMAN GO:0072562; GO:0005938; GO:0009897; GO:0005577; GO:0030168; GO:0031093; GO:0002576; GO:0051258; GO:0051592; GO:0007165 P27958 blood microparticle; cell cortex; external side of plasma membrane; fibrinogen complex; platelet activation; platelet alpha granule lumen; platelet degranulation; protein polymerization; response to calcium ion; signal transduction reviewed IPR014716; IPR014715; IPR002181; IPR012290; IPR020837; Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain] FGB Homo sapiens (Human) 491 P02675 GO:0051592 GO:0051592 response to calcium ion other biological processes P ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0003746 GO:0003746 translation elongation factor activity nucleic acid binding activity F ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0006414 GO:0006414 translational elongation protein metabolism P ConsensusfromContig2818 sp P05197 EF2_RAT 88.07 109 13 0 1 327 581 689 3E-63 211 P05197 EF2_RAT GO:0005525; GO:0003924; GO:0005737; GO:0005844; GO:0003746 GTP binding; GTPase activity; cytoplasm; polysome; translation elongation factor activity reviewed IPR000795; IPR009022; IPR000640; IPR027417; IPR020568; IPR014721; IPR005225; IPR009000; IPR005517; IPR004161; Elongation factor 2 (EF-2) Eef2 Rattus norvegicus (Rat) 858 P05197 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0006400 GO:0006400 tRNA modification RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0008334 GO:0008334 histone mRNA metabolic process RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 60.54 147 57 1 85 522 5 151 2E-84 175 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0006400 GO:0006400 tRNA modification RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0008334 GO:0008334 histone mRNA metabolic process RNA metabolism P ConsensusfromContig5989 sp P05455 LA_HUMAN 52.31 260 115 5 524 1297 153 405 2E-84 161 P05455 LA_HUMAN GO:0008334; GO:0003729; GO:0000166; GO:0005634; GO:0030529; GO:0000049; GO:0006400 histone mRNA metabolic process; mRNA binding; nucleotide binding; nucleus; ribonucleoprotein complex; tRNA binding; tRNA modification reviewed IPR002344; IPR006630; IPR012677; IPR014886; IPR000504; IPR011991; Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B) SSB Homo sapiens (Human) 408 P05455 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000978 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000979 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000981 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000982 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0000987 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0001077 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0001078 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0001822 GO:0001822 kidney development developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003404 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003409 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0007605 GO:0007605 sensory perception of sound other biological processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0010628 GO:0010628 positive regulation of gene expression other metabolic processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0010842 GO:0010842 retina layer formation developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0010944 GO:0010944 negative regulation of transcription by competitive promoter binding RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0021559 GO:0021559 trigeminal nerve development developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0021623 GO:0021623 oculomotor nerve formation developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0030501 GO:0030501 positive regulation of bone mineralization developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0035115 GO:0035115 embryonic forelimb morphogenesis developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0042472 GO:0042472 inner ear morphogenesis developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0043525 GO:0043525 positive regulation of neuron apoptosis death P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0044212 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0045595 GO:0045595 regulation of cell differentiation other biological processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0060021 GO:0060021 palate development other biological processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0060349 GO:0060349 bone morphogenesis developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0061029 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0070172 GO:0070172 positive regulation of tooth mineralization developmental processes P ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:0071281 ConsensusfromContig1083 sp P05549 AP2A_HUMAN 83.92 143 22 1 441 16 295 437 6E-79 251 P05549 AP2A_HUMAN GO:0005794; GO:0000978; GO:0001078; GO:0001077; GO:0000979; GO:0000980; GO:0001105; GO:0001106; GO:0021506; GO:0071711; GO:0060349; GO:0071281; GO:0005813; GO:0003682; GO:0061303; GO:0010172; GO:0048701; GO:0035115; GO:0009880; GO:0048730; GO:0061029; GO:0060325; GO:0021884; GO:0042472; GO:0003334; GO:0001822; GO:0060235; GO:0072210; GO:0043066; GO:0008285; GO:0042059; GO:2000378; GO:0010944; GO:0014032; GO:0005634; GO:0021623; GO:0003409; GO:0003404; GO:0003151; GO:0060021; GO:0030501; GO:0030335; GO:0043525; GO:0070172; GO:0042803; GO:0045595; GO:0045664; GO:0010842; GO:0007605; GO:0043565; GO:0048485; GO:0003713; GO:0021559 Q09472; P06748 Golgi apparatus; RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription; RNA polymerase II core promoter sequence-specific DNA binding; RNA polymerase II distal enhancer sequence-specific DNA binding; RNA polymerase II transcription coactivator activity; RNA polymerase II transcription corepressor activity; anterior neuropore closure; basement membrane organization; bone morphogenesis; cellular response to iron ion; centrosome; chromatin binding; cornea development in camera-type eye; embryonic body morphogenesis; embryonic cranial skeleton morphogenesis; embryonic forelimb morphogenesis; embryonic pattern specification; epidermis morphogenesis; eyelid development in camera-type eye; face morphogenesis; forebrain neuron development; inner ear morphogenesis; keratinocyte development; kidney development; lens induction in camera-type eye; metanephric nephron development; negative regulation of apoptotic process; negative regulation of cell proliferation; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of reactive oxygen species metabolic process; negative regulation of transcription by competitive promoter binding; neural crest cell development; nucleus; oculomotor nerve formation; optic cup structural organization; optic vesicle morphogenesis; outflow tract morphogenesis; palate development; positive regulation of bone mineralization; positive regulation of cell migration; positive regulation of neuron apoptotic process; positive regulation of tooth mineralization; protein homodimerization activity; regulation of cell differentiation; regulation of neuron differentiation; retina layer formation; sensory perception of sound; sequence-specific DNA binding; sympathetic nervous system development; transcription coactivator activity; trigeminal nerve development reviewed IPR004979; IPR008121; IPR013854; Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) TFAP2A AP2TF TFAP2 Homo sapiens (Human) 437 P05549 GO:2000378 ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0002060 GO:0002060 purine binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0004645 GO:0004645 phosphorylase activity other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005536 GO:0005536 glucose binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005977 GO:0005977 glycogen metabolic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0005980 GO:0005980 glycogen catabolic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0006015 GO:0006015 5-phosphoribose 1-diphosphate biosynthetic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0008184 GO:0008184 glycogen phosphorylase activity other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0016208 GO:0016208 AMP binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0019842 GO:0019842 vitamin binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0030170 GO:0030170 pyridoxal phosphate binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0032052 GO:0032052 bile acid binding other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0042593 GO:0042593 glucose homeostasis other biological processes P ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5787 sp P06737 PYGL_HUMAN 82.06 262 47 0 2 787 573 834 3E-150 458 P06737 PYGL_HUMAN GO:0006015; GO:0016208; GO:0005524; GO:0032052; GO:0005829; GO:0008144; GO:0005536; GO:0042593; GO:0006006; GO:0005980; GO:0008184; GO:0005886; GO:0042803; GO:0002060; GO:0030170; GO:0044281; GO:0019842 5-phosphoribose 1-diphosphate biosynthetic process; AMP binding; ATP binding; bile acid binding; cytosol; drug binding; glucose binding; glucose homeostasis; glucose metabolic process; glycogen catabolic process; glycogen phosphorylase activity; plasma membrane; protein homodimerization activity; purine nucleobase binding; pyridoxal phosphate binding; small molecule metabolic process; vitamin binding reviewed IPR011833; IPR000811; Glycogen phosphorylase, liver form (EC 2.4.1.1) PYGL Homo sapiens (Human) 847 P06737 GO:0044281 ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0001501 GO:0001501 skeletal system development developmental processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0004563 GO:0004563 beta-N-acetylhexosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006044 GO:0006044 N-acetylglucosamine metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006665 GO:0006665 sphingolipid metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006687 GO:0006687 glycosphingolipid metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006689 GO:0006689 ganglioside catabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006874 GO:0006874 cellular calcium ion homeostasis other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007040 GO:0007040 lysosome organization cell organization and biogenesis P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007338 GO:0007338 single fertilization other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007341 GO:0007341 penetration of zona pellucida other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007605 GO:0007605 sensory perception of sound other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007626 GO:0007626 locomotory behavior other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008049 GO:0008049 male courtship behavior other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008219 GO:0008219 cell death death P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008654 GO:0008654 phospholipid biosynthetic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0009313 GO:0009313 oligosaccharide catabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0015929 GO:0015929 hexosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016231 GO:0016231 beta-N-acetylglucosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0019915 GO:0019915 lipid storage other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0019953 GO:0019953 sexual reproduction other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0030203 GO:0030203 glycosaminoglycan metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0031323 GO:0031323 regulation of cellular metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0042552 GO:0042552 myelination developmental processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0043169 GO:0043169 cation binding other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0043202 GO:0043202 lysosomal lumen other cytoplasmic organelle C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0044281 ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0048477 GO:0048477 oogenesis other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0050885 GO:0050885 neuromuscular process controlling balance other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 58.54 287 108 2 988 128 279 554 9E-115 360 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0050905 GO:0050905 neuromuscular process other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0001501 GO:0001501 skeletal system development developmental processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0004563 GO:0004563 beta-N-acetylhexosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006044 GO:0006044 N-acetylglucosamine metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006665 GO:0006665 sphingolipid metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006687 GO:0006687 glycosphingolipid metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006689 GO:0006689 ganglioside catabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0006874 GO:0006874 cellular calcium ion homeostasis other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007040 GO:0007040 lysosome organization cell organization and biogenesis P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007338 GO:0007338 single fertilization other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007341 GO:0007341 penetration of zona pellucida other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007605 GO:0007605 sensory perception of sound other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0007626 GO:0007626 locomotory behavior other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008049 GO:0008049 male courtship behavior other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008219 GO:0008219 cell death death P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0008654 GO:0008654 phospholipid biosynthetic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0009313 GO:0009313 oligosaccharide catabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0015929 GO:0015929 hexosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016231 GO:0016231 beta-N-acetylglucosaminidase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0019915 GO:0019915 lipid storage other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0019953 GO:0019953 sexual reproduction other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0030203 GO:0030203 glycosaminoglycan metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0031323 GO:0031323 regulation of cellular metabolic process other metabolic processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0042552 GO:0042552 myelination developmental processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0043169 GO:0043169 cation binding other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0043202 GO:0043202 lysosomal lumen other cytoplasmic organelle C ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0044281 ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0048477 GO:0048477 oogenesis other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0050885 GO:0050885 neuromuscular process controlling balance other biological processes P ConsensusfromContig6265 sp P07686 HEXB_HUMAN 59.46 259 101 2 1647 871 55 309 2E-101 326 P07686 HEXB_HUMAN GO:0001669; GO:0043615; GO:0004563; GO:0005975; GO:0008219; GO:0006874; GO:0044267; GO:0030207; GO:0006689; GO:0006687; GO:0030214; GO:0042340; GO:0019915; GO:0007626; GO:0043202; GO:0007040; GO:0008049; GO:0016020; GO:0042552; GO:0050885; GO:0009313; GO:0048477; GO:0007341; GO:0008654; GO:0045944; GO:0046982; GO:0042803; GO:0008360; GO:0007605; GO:0001501 acrosomal vesicle; astrocyte cell migration; beta-N-acetylhexosaminidase activity; carbohydrate metabolic process; cell death; cellular calcium ion homeostasis; cellular protein metabolic process; chondroitin sulfate catabolic process; ganglioside catabolic process; glycosphingolipid metabolic process; hyaluronan catabolic process; keratan sulfate catabolic process; lipid storage; locomotory behavior; lysosomal lumen; lysosome organization; male courtship behavior; membrane; myelination; neuromuscular process controlling balance; oligosaccharide catabolic process; oogenesis; penetration of zona pellucida; phospholipid biosynthetic process; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; regulation of cell shape; sensory perception of sound; skeletal system development reviewed IPR025705; IPR015883; IPR013781; IPR017853; Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A] HEXB HCC7 Homo sapiens (Human) 556 P07686 GO:0050905 GO:0050905 neuromuscular process other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0001889 GO:0001889 liver development developmental processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0004301 GO:0004301 epoxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006725 GO:0006725 cellular aromatic compound metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006805 GO:0006805 xenobiotic metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0009636 GO:0009636 response to toxin other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019439 GO:0019439 aromatic compound catabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0033961 GO:0033961 cis-stilbene-oxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071310 ConsensusfromContig5806 sp P07687 HYEP_RAT 58.9 236 95 1 1300 593 222 455 5E-148 290 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071385 ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0001889 GO:0001889 liver development developmental processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0004301 GO:0004301 epoxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006725 GO:0006725 cellular aromatic compound metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006805 GO:0006805 xenobiotic metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0009636 GO:0009636 response to toxin other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019439 GO:0019439 aromatic compound catabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0033961 GO:0033961 cis-stilbene-oxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071310 ConsensusfromContig5806 sp P07687 HYEP_RAT 58.88 197 71 4 1929 1369 3 199 5E-148 239 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071385 ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0001889 GO:0001889 liver development developmental processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0004301 GO:0004301 epoxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006725 GO:0006725 cellular aromatic compound metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0006805 GO:0006805 xenobiotic metabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0009636 GO:0009636 response to toxin other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019439 GO:0019439 aromatic compound catabolic process other metabolic processes P ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0033961 GO:0033961 cis-stilbene-oxide hydrolase activity other molecular function F ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071310 ConsensusfromContig5806 sp P07687 HYEP_RAT 54.55 33 15 0 1379 1281 196 228 5E-148 40.8 P07687 HYEP_RAT GO:0019439; GO:0071385; GO:0033961; GO:0005789; GO:0004301; GO:0016021; GO:0043231; GO:0001889; GO:0009636; GO:0006805 aromatic compound catabolic process; cellular response to glucocorticoid stimulus; cis-stilbene-oxide hydrolase activity; endoplasmic reticulum membrane; epoxide hydrolase activity; integral to membrane; intracellular membrane-bounded organelle; liver development; response to toxic substance; xenobiotic metabolic process reviewed IPR000073; IPR000639; IPR010497; IPR016292; Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase) Ephx1 Eph-1 Rattus norvegicus (Rat) 455 P07687 GO:0071385 ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0004364 GO:0004364 glutathione transferase activity other molecular function F ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005778 GO:0005778 peroxisomal membrane other cytoplasmic organelle C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005778 GO:0005778 peroxisomal membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0006749 GO:0006749 glutathione metabolic process other metabolic processes P ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0010243 GO:0010243 response to organic nitrogen other biological processes P ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0032496 GO:0032496 response to lipopolysaccharide other biological processes P ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0033327 GO:0033327 Leydig cell differentiation developmental processes P ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0043295 GO:0043295 glutathione binding other molecular function F ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig5732 sp P08011 MGST1_RAT 57.89 152 64 0 330 785 4 155 5E-56 187 P08011 MGST1_RAT GO:0033327; GO:0045177; GO:0071449; GO:0005783; GO:0005789; GO:0043295; GO:0006749; GO:0004602; GO:0004364; GO:0016021; GO:0005743; GO:0005741; GO:0005739; GO:0005634; GO:0005778; GO:0042803; GO:0070207; GO:0042493; GO:0032496; GO:0010243 Leydig cell differentiation; apical part of cell; cellular response to lipid hydroperoxide; endoplasmic reticulum; endoplasmic reticulum membrane; glutathione binding; glutathione metabolic process; glutathione peroxidase activity; glutathione transferase activity; integral to membrane; mitochondrial inner membrane; mitochondrial outer membrane; mitochondrion; nucleus; peroxisomal membrane; protein homodimerization activity; protein homotrimerization; response to drug; response to lipopolysaccharide; response to organonitrogen compound reviewed IPR023352; IPR001129; Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I) Mgst1 Gst12 Rattus norvegicus (Rat) 155 P08011 GO:0070207 GO:0070207 protein homotrimerization cell organization and biogenesis P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005834 GO:0005834 heterotrimeric G-protein complex plasma membrane C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005834 GO:0005834 heterotrimeric G-protein complex other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0006906 GO:0006906 vesicle fusion transport P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0006906 GO:0006906 vesicle fusion cell organization and biogenesis P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling signal transduction P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling other metabolic processes P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0019001 GO:0019001 guanyl nucleotide binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane plasma membrane C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0031821 GO:0031821 metabotropic serotonin receptor binding signal transduction activity F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0042588 GO:0042588 zymogen granule other cellular component C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0051048 GO:0051048 negative regulation of secretion transport P ConsensusfromContig6281 sp P08753 GNAI3_RAT 95.8 238 10 0 161 874 117 354 2E-168 487 P08753 GNAI3_RAT GO:0031683; GO:0005525; GO:0003924; GO:0000139; GO:0007193; GO:0007049; GO:0051301; GO:0005813; GO:0005834; GO:0045121; GO:0046872; GO:0030496; GO:0051048; GO:0004871; GO:0006906; GO:0042588 P49795; Q5BJU7 G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Golgi membrane; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; cell cycle; cell division; centrosome; heterotrimeric G-protein complex; membrane raft; metal ion binding; midbody; negative regulation of secretion; signal transducer activity; vesicle fusion; zymogen granule reviewed IPR001408; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3) Gnai3 Gnai-3 Rattus norvegicus (Rat) 354 P08753 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0003988 GO:0003988 acetyl-CoA C-acyltransferase activity other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0005782 GO:0005782 peroxisomal matrix other cytoplasmic organelle C ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0006091 GO:0006091 generation of precursor metabolites and energy other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0033540 GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig4072 sp P09110 THIK_HUMAN 75.45 167 37 1 490 2 40 206 3E-84 261 P09110 THIK_HUMAN GO:0003988; GO:0036109; GO:0008206; GO:0033540; GO:0016401; GO:0005782; GO:0000038 acetyl-CoA C-acyltransferase activity; alpha-linolenic acid metabolic process; bile acid metabolic process; fatty acid beta-oxidation using acyl-CoA oxidase; palmitoyl-CoA oxidase activity; peroxisomal matrix; very long-chain fatty acid metabolic process reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid metabolism. 3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase) ACAA1 ACAA PTHIO Homo sapiens (Human) 424 P09110 GO:0044281 ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0007017 GO:0007017 microtubule-based process other biological processes P ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig626 sp P09642 TBA3_CHICK 96.47 85 3 0 504 758 179 263 1E-52 179 P09642 TBA3_CHICK GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha-3 chain (Fragment) Gallus gallus (Chicken) 322 P09642 GO:0051258 GO:0051258 protein polymerization cell organization and biogenesis P ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0035064 GO:0035064 methylated histone residue binding other molecular function F ConsensusfromContig4005 sp P0C606 SGF29_RAT 76.15 130 29 2 390 1 128 255 1E-62 200 P0C606 SGF29_RAT GO:0005671; GO:0070461; GO:0043966; GO:0035064; GO:0006355; GO:0006351 Ada2/Gcn5/Ada3 transcription activator complex; SAGA-type complex; histone H3 acetylation; methylated histone residue binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR010750; SAGA-associated factor 29 homolog (rSGF29) (Coiled-coil domain-containing protein 101) Ccdc101 Sgf29 Rattus norvegicus (Rat) 293 P0C606 GO:0070461 GO:0070461 SAGA-type complex nucleus C ConsensusfromContig5637 sp P0CB49 YLPM1_RAT 64.04 228 77 1 320 1003 1030 1252 3E-88 293 P0CB49 YLPM1_RAT GO:0016607; GO:0006355; GO:0006351 nuclear speck; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027417; IPR026314; YLP motif-containing protein 1 (Nuclear protein ZAP3) Ylpm1 Zap Zap3 Rattus norvegicus (Rat) 1376 P0CB49 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5637 sp P0CB49 YLPM1_RAT 64.04 228 77 1 320 1003 1030 1252 3E-88 293 P0CB49 YLPM1_RAT GO:0016607; GO:0006355; GO:0006351 nuclear speck; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027417; IPR026314; YLP motif-containing protein 1 (Nuclear protein ZAP3) Ylpm1 Zap Zap3 Rattus norvegicus (Rat) 1376 P0CB49 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5637 sp P0CB49 YLPM1_RAT 64.04 228 77 1 320 1003 1030 1252 3E-88 293 P0CB49 YLPM1_RAT GO:0016607; GO:0006355; GO:0006351 nuclear speck; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027417; IPR026314; YLP motif-containing protein 1 (Nuclear protein ZAP3) Ylpm1 Zap Zap3 Rattus norvegicus (Rat) 1376 P0CB49 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5637 sp P0CB49 YLPM1_RAT 64.04 228 77 1 320 1003 1030 1252 3E-88 293 P0CB49 YLPM1_RAT GO:0016607; GO:0006355; GO:0006351 nuclear speck; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027417; IPR026314; YLP motif-containing protein 1 (Nuclear protein ZAP3) Ylpm1 Zap Zap3 Rattus norvegicus (Rat) 1376 P0CB49 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5637 sp P0CB49 YLPM1_RAT 64.04 228 77 1 320 1003 1030 1252 3E-88 293 P0CB49 YLPM1_RAT GO:0016607; GO:0006355; GO:0006351 nuclear speck; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027417; IPR026314; YLP motif-containing protein 1 (Nuclear protein ZAP3) Ylpm1 Zap Zap3 Rattus norvegicus (Rat) 1376 P0CB49 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0032454 GO:0032454 histone demethylase activity (H3-K9 specific) other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0033169 GO:0033169 histone H3-K9 demethylation protein metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0033169 GO:0033169 histone H3-K9 demethylation cell organization and biogenesis P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0035064 GO:0035064 methylated histone residue binding other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0035574 ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0035575 ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0045943 GO:0045943 positive regulation of transcription from RNA polymerase I promoter RNA metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0051864 GO:0051864 histone demethylase activity (H3-K36 specific) other molecular function F ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0061188 ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0070544 GO:0070544 histone H3-K36 demethylation protein metabolism P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0070544 GO:0070544 histone H3-K36 demethylation cell organization and biogenesis P ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0071557 ConsensusfromContig3189 sp P0CH95 PHF8_DANRE 96.03 126 5 0 3 380 292 417 7E-84 270 P0CH95 PHF8_DANRE GO:0000082; GO:0007420; GO:0003682; GO:0071558; GO:0051864; GO:0032454; GO:0035575; GO:0035064; GO:0061188; GO:0005730; GO:0045943; GO:0006351; GO:0008270 G1/S transition of mitotic cell cycle; brain development; chromatin binding; histone demethylase activity (H3-K27 specific); histone demethylase activity (H3-K36 specific); histone demethylase activity (H3-K9 specific); histone demethylase activity (H4-K20 specific); methylated histone residue binding; negative regulation of chromatin silencing at rDNA; nucleolus; positive regulation of transcription from RNA polymerase I promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR003347; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone lysine demethylase PHF8 (EC 1.14.11.-) (PHD finger protein 8) (zPHF8) phf8 Danio rerio (Zebrafish) (Brachydanio rerio) 1032 P0CH95 GO:0071558 ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005518 GO:0005518 collagen binding other molecular function F ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005605 GO:0005605 basal lamina extracellular matrix C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0007160 GO:0007160 cell-matrix adhesion cell adhesion P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0010811 GO:0010811 positive regulation of cell-substrate adhesion cell adhesion P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0031012 GO:0031012 extracellular matrix non-structural extracellular C ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0032836 GO:0032836 glomerular basement membrane development developmental processes P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0032836 GO:0032836 glomerular basement membrane development cell organization and biogenesis P ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0043237 GO:0043237 laminin-1 binding other molecular function F ConsensusfromContig5073 sp P10493 NID1_MOUSE 67.21 122 40 0 3 368 994 1115 5E-53 186 P10493 NID1_MOUSE GO:0005605; GO:0005509; GO:0071944; GO:0007160; GO:0005518; GO:0032836; GO:0043237; GO:0010811 basal lamina; calcium ion binding; cell periphery; cell-matrix adhesion; collagen binding; glomerular basement membrane development; laminin-1 binding; positive regulation of cell-substrate adhesion reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR024731; IPR006605; IPR009017; IPR023413; IPR009030; IPR000033; IPR003886; IPR000716; Nidogen-1 (NID-1) (Entactin) Nid1 Ent Mus musculus (Mouse) 1245 P10493 GO:0050840 GO:0050840 extracellular matrix binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005859 GO:0005859 muscle myosin complex cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0006939 GO:0006939 smooth muscle contraction other biological processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0008307 GO:0008307 structural constituent of muscle other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030016 GO:0030016 myofibril other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030241 GO:0030241 muscle thick filament assembly developmental processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030241 GO:0030241 muscle thick filament assembly cell organization and biogenesis P ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030485 GO:0030485 smooth muscle contractile fiber other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0032982 GO:0032982 myosin filament cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0048251 GO:0048251 elastic fiber assembly cell organization and biogenesis P ConsensusfromContig5956 sp P10587 MYH11_CHICK 71.94 196 55 0 398 985 1756 1951 6E-96 244 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0048739 GO:0048739 cardiac muscle fiber development developmental processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0005859 GO:0005859 muscle myosin complex cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0006939 GO:0006939 smooth muscle contraction other biological processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0008307 GO:0008307 structural constituent of muscle other molecular function F ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030016 GO:0030016 myofibril other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030241 GO:0030241 muscle thick filament assembly developmental processes P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030241 GO:0030241 muscle thick filament assembly cell organization and biogenesis P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0030485 GO:0030485 smooth muscle contractile fiber other cellular component C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0032982 GO:0032982 myosin filament cytoskeleton C ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0048251 GO:0048251 elastic fiber assembly cell organization and biogenesis P ConsensusfromContig5956 sp P10587 MYH11_CHICK 65.14 109 38 0 15 341 1629 1737 6E-96 130 P10587 MYH11_CHICK GO:0005524; GO:0048739; GO:0048251; GO:0003774; GO:0030016; GO:0032982; GO:0030241; GO:0006939; GO:0008307 P02607 ATP binding; cardiac muscle fiber development; elastic fiber assembly; motor activity; myofibril; myosin filament; skeletal muscle myosin thick filament assembly; smooth muscle contraction; structural constituent of muscle reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, gizzard smooth muscle) MYH11 Gallus gallus (Chicken) 1979 P10587 GO:0048739 GO:0048739 cardiac muscle fiber development developmental processes P ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0008746 GO:0008746 NAD(P) transhydrogenase activity other molecular function F ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0008750 GO:0008750 NAD(P)+ transhydrogenase (AB-specific) activity other molecular function F ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0050661 GO:0050661 NADP or NADPH binding other molecular function F ConsensusfromContig3404 sp P11024 NNTM_BOVIN 89.63 135 14 0 406 2 772 906 2E-66 222 P11024 NNTM_BOVIN GO:0008750; GO:0050661; GO:0016021; GO:0005743; GO:0015992; GO:0072593 NAD(P)+ transhydrogenase (AB-specific) activity; NADP binding; integral to membrane; mitochondrial inner membrane; proton transport; reactive oxygen species metabolic process reviewed IPR008142; IPR008143; IPR007886; IPR007698; IPR012136; IPR026255; IPR024605; NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase) NNT Bos taurus (Bovine) 1086 P11024 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0007030 GO:0007030 Golgi organization cell organization and biogenesis P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030118 GO:0030118 clathrin coat other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030130 GO:0030130 clathrin coat of trans-Golgi network vesicle ER/Golgi C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030130 GO:0030130 clathrin coat of trans-Golgi network vesicle other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030132 GO:0030132 clathrin coat of coated pit plasma membrane C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030132 GO:0030132 clathrin coat of coated pit other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030315 GO:0030315 T-tubule plasma membrane C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030315 GO:0030315 T-tubule other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030506 GO:0030506 ankyrin binding cytoskeletal activity F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0030669 GO:0030669 clathrin-coated endocytic vesicle membrane other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0042383 GO:0042383 sarcolemma plasma membrane C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0042383 GO:0042383 sarcolemma other membranes C ConsensusfromContig2577 sp P11442 CLH1_RAT 97.71 175 4 0 527 3 310 484 2E-98 317 P11442 CLH1_RAT GO:0007030; GO:0030315; GO:0030506; GO:0030118; GO:0030132; GO:0030130; GO:0030669; GO:0031072; GO:0006886; GO:0042470; GO:0007067; GO:0042277; GO:0006898; GO:0005819; GO:0005198 Q01968 Golgi organization; T-tubule; ankyrin binding; clathrin coat; clathrin coat of coated pit; clathrin coat of trans-Golgi network vesicle; clathrin-coated endocytic vesicle membrane; heat shock protein binding; intracellular protein transport; melanosome; mitosis; peptide binding; receptor-mediated endocytosis; spindle; structural molecule activity reviewed IPR016024; IPR000547; IPR016025; IPR015348; IPR001473; IPR022365; IPR016341; IPR011990; Clathrin heavy chain 1 Cltc Rattus norvegicus (Rat) 1675 P11442 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0003407 ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005388 GO:0005388 calcium-transporting ATPase activity transporter activity F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006874 GO:0006874 cellular calcium ion homeostasis other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0006996 GO:0006996 organelle organization cell organization and biogenesis P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0007595 GO:0007595 lactation developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0007605 GO:0007605 sensory perception of sound other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0007626 GO:0007626 locomotory behavior other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0008361 GO:0008361 regulation of cell size other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0021549 GO:0021549 cerebellum development developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0021692 GO:0021692 cerebellar Purkinje cell layer morphogenesis developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0021702 GO:0021702 cerebellar Purkinje cell differentiation developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0021707 GO:0021707 cerebellar granule cell differentiation developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0030165 GO:0030165 PDZ domain binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0030899 GO:0030899 calcium-dependent ATPase activity other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0035254 GO:0035254 glutamate receptor binding signal transduction activity F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0040011 GO:0040011 locomotion other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0042428 GO:0042428 serotonin metabolic process other metabolic processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0042472 GO:0042472 inner ear morphogenesis developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0045299 GO:0045299 otolith mineralization developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0046068 GO:0046068 cGMP metabolic process other metabolic processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0048167 GO:0048167 regulation of synaptic plasticity cell-cell signaling P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0048839 GO:0048839 inner ear development developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0050808 GO:0050808 synapse organization cell organization and biogenesis P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0050885 GO:0050885 neuromuscular process controlling balance other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0050910 GO:0050910 detection of mechanical stimulus involved in sensory perception of sound other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0051480 GO:0051480 cytosolic calcium ion homeostasis other biological processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0051928 GO:0051928 positive regulation of calcium ion transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0060088 GO:0060088 auditory receptor cell stereocilium organization developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0060088 GO:0060088 auditory receptor cell stereocilium organization cell organization and biogenesis P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0060113 GO:0060113 inner ear receptor cell differentiation developmental processes P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0070588 GO:0070588 transmembrane calcium ion transport transport P ConsensusfromContig2972 sp P11506 AT2B2_RAT 73.89 180 43 1 2 529 988 1167 3E-86 280 P11506 AT2B2_RAT GO:0005524; GO:0030165; GO:0033130; GO:0016324; GO:0007420; GO:0005509; GO:1901660; GO:0005388; GO:0005516; GO:0005737; GO:0030425; GO:0016021; GO:0045121; GO:0046872; GO:0003407; GO:0030182; GO:0032809; GO:0005886; GO:0008022; GO:0007605 ATP binding; PDZ domain binding; acetylcholine receptor binding; apical plasma membrane; brain development; calcium ion binding; calcium ion export; calcium-transporting ATPase activity; calmodulin binding; cytoplasm; dendrite; integral to membrane; membrane raft; metal ion binding; neural retina development; neuron differentiation; neuronal cell body membrane; plasma membrane; protein C-terminus binding; sensory perception of sound reviewed IPR022141; IPR006408; IPR006068; IPR004014; IPR023299; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2) Atp2b2 Rattus norvegicus (Rat) 1243 P11506 GO:0090102 ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0004601 GO:0004601 peroxidase activity other molecular function F ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0020037 GO:0020037 heme binding other molecular function F ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0042744 GO:0042744 hydrogen peroxide catabolic process stress response P ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0042744 GO:0042744 hydrogen peroxide catabolic process other metabolic processes P ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5533 sp P11678 PERE_HUMAN 53.11 386 174 4 1861 704 337 715 3E-137 424 P11678 PERE_HUMAN GO:0002215; GO:0072677; GO:0020037; GO:0042744; GO:0046872; GO:0032693; GO:0032714; GO:0004601; GO:0032753 defense response to nematode; eosinophil migration; heme binding; hydrogen peroxide catabolic process; metal ion binding; negative regulation of interleukin-10 production; negative regulation of interleukin-5 production; peroxidase activity; positive regulation of interleukin-4 production reviewed IPR010255; IPR002007; IPR019791; Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain] EPX EPER EPO EPP Homo sapiens (Human) 715 P11678 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0004683 GO:0004683 calmodulin-dependent protein kinase activity kinase activity F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0005954 GO:0005954 calcium- and calmodulin-dependent protein kinase complex other cellular component C ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016529 GO:0016529 sarcoplasmic reticulum ER/Golgi C ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig3442 sp P11730 KCC2G_RAT 92.16 102 8 0 3 308 426 527 5E-65 211 P11730 KCC2G_RAT GO:0005524; GO:0005954; GO:0004683; GO:0030154; GO:0007399; GO:0046777; GO:0048169; GO:0001666; GO:0006979; GO:0033017 ATP binding; calcium- and calmodulin-dependent protein kinase complex; calmodulin-dependent protein kinase activity; cell differentiation; nervous system development; protein autophosphorylation; regulation of long-term neuronal synaptic plasticity; response to hypoxia; response to oxidative stress; sarcoplasmic reticulum membrane reviewed IPR020636; IPR013543; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17) Camk2g Rattus norvegicus (Rat) 527 P11730 GO:0048169 GO:0048169 regulation of long-term neuronal synaptic plasticity cell-cell signaling P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0003995 GO:0003995 acyl-CoA dehydrogenase activity other molecular function F ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0006551 GO:0006551 leucine metabolic process other metabolic processes P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0006552 GO:0006552 leucine catabolic process other metabolic processes P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0008470 GO:0008470 isovaleryl-CoA dehydrogenase activity other molecular function F ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0016627 GO:0016627 "oxidoreductase activity, acting on the CH-CH group of donors" other molecular function F ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0033539 GO:0033539 fatty acid beta-oxidation using acyl-CoA dehydrogenase other metabolic processes P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig859 sp P12007 IVD_RAT 79.14 139 27 1 1 411 91 229 2E-72 229 P12007 IVD_RAT GO:0033539; GO:0050660; GO:0008470; GO:0006552; GO:0005759; GO:0031966; GO:0051260 fatty acid beta-oxidation using acyl-CoA dehydrogenase; flavin adenine dinucleotide binding; isovaleryl-CoA dehydrogenase activity; leucine catabolic process; mitochondrial matrix; mitochondrial membrane; protein homooligomerization reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 1/3. Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4) Ivd Rattus norvegicus (Rat) 424 P12007 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0004828 GO:0004828 serine-tRNA ligase activity other molecular function F ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006434 GO:0006434 seryl-tRNA aminoacylation protein metabolism P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006434 GO:0006434 seryl-tRNA aminoacylation RNA metabolism P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell cycle and proliferation P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell organization and biogenesis P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0044281 ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig6237 sp P12270 TPR_HUMAN 62.14 206 66 5 1026 409 2105 2298 9E-55 211 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0004828 GO:0004828 serine-tRNA ligase activity other molecular function F ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006434 GO:0006434 seryl-tRNA aminoacylation protein metabolism P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006434 GO:0006434 seryl-tRNA aminoacylation RNA metabolism P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell cycle and proliferation P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell organization and biogenesis P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0044281 ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig1555 sp P12270 TPR_HUMAN 74.83 143 35 1 445 17 420 561 1E-51 182 P12270 TPR_HUMAN GO:0005524; GO:0000189; GO:0006404; GO:0005975; GO:0051301; GO:0035457; GO:0003682; GO:0019221; GO:0005868; GO:0070840; GO:0019898; GO:0015758; GO:0031072; GO:0000776; GO:0003729; GO:0031990; GO:0051019; GO:0007067; GO:0007077; GO:0072686; GO:0007094; GO:0046832; GO:0000122; GO:0045947; GO:0042405; GO:0031965; GO:0034399; GO:0044615; GO:0006999; GO:0005487; GO:0005654; GO:0031453; GO:0090267; GO:0046827; GO:0042307; GO:0042803; GO:0010827; GO:0010965; GO:1901673; GO:0070849; GO:0004828; GO:0006434; GO:0044281; GO:0055085; GO:0015631; GO:0016032 ATP binding; MAPK import into nucleus; RNA import into nucleus; carbohydrate metabolic process; cell division; cellular response to interferon-alpha; chromatin binding; cytokine-mediated signaling pathway; cytoplasmic dynein complex; dynein complex binding; extrinsic to membrane; glucose transport; heat shock protein binding; kinetochore; mRNA binding; mRNA export from nucleus in response to heat stress; mitogen-activated protein kinase binding; mitosis; mitotic nuclear envelope disassembly; mitotic spindle; mitotic spindle assembly checkpoint; negative regulation of RNA export from nucleus; negative regulation of transcription from RNA polymerase II promoter; negative regulation of translational initiation; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore nuclear basket; nuclear pore organization; nucleocytoplasmic transporter activity; nucleoplasm; positive regulation of heterochromatin assembly; positive regulation of mitotic cell cycle spindle assembly checkpoint; positive regulation of protein export from nucleus; positive regulation of protein import into nucleus; protein homodimerization activity; regulation of glucose transport; regulation of mitotic sister chromatid separation; regulation of spindle assembly involved in mitosis; response to epidermal growth factor stimulus; serine-tRNA ligase activity; seryl-tRNA aminoacylation; small molecule metabolic process; transmembrane transport; tubulin binding; viral process reviewed IPR015866; IPR012929; Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein) TPR Homo sapiens (Human) 2363 P12270 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0004111 GO:0004111 creatine kinase activity kinase activity F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0006600 GO:0006600 creatine metabolic process other metabolic processes P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0030644 GO:0030644 cellular chloride ion homeostasis other biological processes P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig5712 sp P12277 KCRB_HUMAN 85.83 381 54 0 1460 318 1 381 0 653 P12277 KCRB_HUMAN GO:0005524; GO:0007420; GO:0030644; GO:0034641; GO:0004111; GO:0006600; GO:0005829; GO:0005739 Q96DX5 ATP binding; brain development; cellular chloride ion homeostasis; cellular nitrogen compound metabolic process; creatine kinase activity; creatine metabolic process; cytosol; mitochondrion reviewed IPR022415; IPR022414; IPR022413; IPR014746; Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain) CKB CKBB Homo sapiens (Human) 381 P12277 GO:0044281 ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5753 sp P12965 MOS_XENLA 52.23 337 150 4 38 1027 1 333 2E-112 343 P12965 MOS_XENLA GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase mos (EC 2.7.11.1) (pp39-mos) mos Xenopus laevis (African clawed frog) 359 P12965 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1394 sp P13944 COCA1_CHICK 64.2 162 58 0 487 2 2473 2634 3E-72 243 P13944 COCA1_CHICK GO:0007155; GO:0005581 cell adhesion; collagen reviewed IPR008160; IPR008985; IPR013320; IPR003961; IPR013783; IPR001791; IPR002035; Collagen alpha-1(XII) chain (Fibrochimerin) COL12A1 Gallus gallus (Chicken) 3124 P13944 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig1394 sp P13944 COCA1_CHICK 64.2 162 58 0 487 2 2473 2634 3E-72 243 P13944 COCA1_CHICK GO:0007155; GO:0005581 cell adhesion; collagen reviewed IPR008160; IPR008985; IPR013320; IPR003961; IPR013783; IPR001791; IPR002035; Collagen alpha-1(XII) chain (Fibrochimerin) COL12A1 Gallus gallus (Chicken) 3124 P13944 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1394 sp P13944 COCA1_CHICK 64.2 162 58 0 487 2 2473 2634 3E-72 243 P13944 COCA1_CHICK GO:0007155; GO:0005581 cell adhesion; collagen reviewed IPR008160; IPR008985; IPR013320; IPR003961; IPR013783; IPR001791; IPR002035; Collagen alpha-1(XII) chain (Fibrochimerin) COL12A1 Gallus gallus (Chicken) 3124 P13944 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig1394 sp P13944 COCA1_CHICK 64.2 162 58 0 487 2 2473 2634 3E-72 243 P13944 COCA1_CHICK GO:0007155; GO:0005581 cell adhesion; collagen reviewed IPR008160; IPR008985; IPR013320; IPR003961; IPR013783; IPR001791; IPR002035; Collagen alpha-1(XII) chain (Fibrochimerin) COL12A1 Gallus gallus (Chicken) 3124 P13944 GO:0005581 GO:0005581 collagen extracellular matrix C ConsensusfromContig1394 sp P13944 COCA1_CHICK 64.2 162 58 0 487 2 2473 2634 3E-72 243 P13944 COCA1_CHICK GO:0007155; GO:0005581 cell adhesion; collagen reviewed IPR008160; IPR008985; IPR013320; IPR003961; IPR013783; IPR001791; IPR002035; Collagen alpha-1(XII) chain (Fibrochimerin) COL12A1 Gallus gallus (Chicken) 3124 P13944 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0018279 GO:0018279 protein amino acid N-linked glycosylation via asparagine protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 60.91 220 85 1 267 923 65 284 3E-89 281 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0018279 GO:0018279 protein amino acid N-linked glycosylation via asparagine protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6059 sp P14314 GLU2B_HUMAN 72.5 40 11 0 112 231 13 52 3E-89 70.1 P14314 GLU2B_HUMAN GO:0006491; GO:0003723; GO:0005509; GO:0005788; GO:0001701; GO:0045087; GO:0007243; GO:0001889; GO:0010977; GO:0006807; GO:0043687; GO:0018279; GO:0006457; GO:0051291; GO:0072001 N-glycan processing; RNA binding; calcium ion binding; endoplasmic reticulum lumen; in utero embryonic development; innate immune response; intracellular protein kinase cascade; liver development; negative regulation of neuron projection development; nitrogen compound metabolic process; post-translational protein modification; protein N-linked glycosylation via asparagine; protein folding; protein heterooligomerization; renal system development reviewed IPR018247; IPR002048; IPR026874; IPR002172; IPR009011; IPR028146; Glycan metabolism; N-glycan metabolism. Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH) PRKCSH G19P1 Homo sapiens (Human) 528 P14314 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0008290 GO:0008290 F-actin capping protein complex cytoskeleton C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0022604 GO:0022604 regulation of cell morphogenesis cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0030030 GO:0030030 cell projection organization cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0030863 GO:0030863 cortical cytoskeleton cytoskeleton C ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0051693 GO:0051693 actin filament capping protein metabolism P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0051693 GO:0051693 actin filament capping cell organization and biogenesis P ConsensusfromContig2152 sp P14315 CAPZB_CHICK 94.85 136 6 1 409 2 91 225 1E-87 263 P14315 CAPZB_CHICK GO:0008290; GO:0071203; GO:0030018; GO:0030036; GO:0051693; GO:0007010; GO:0005829; GO:0022604 F-actin capping protein complex; WASH complex; Z disc; actin cytoskeleton organization; actin filament capping; cytoskeleton organization; cytosol; regulation of cell morphogenesis reviewed IPR001698; IPR019771; F-actin-capping protein subunit beta isoforms 1 and 2 (Beta-actinin subunit II) (CapZ 36/32) (CapZ B1 and B2) CAPZB Gallus gallus (Chicken) 277 P14315 GO:0071203 ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0005786 GO:0005786 "signal recognition particle, endoplasmic reticulum targeting" translational apparatus C ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0006614 GO:0006614 SRP-dependent cotranslational protein targeting to membrane transport P ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0008312 GO:0008312 7S RNA binding nucleic acid binding activity F ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5894 sp P14576 SRP54_MOUSE 95.5 489 22 0 195 1661 1 489 0 954 P14576 SRP54_MOUSE GO:0008312; GO:0005525; GO:0006184; GO:0003924; GO:0006614; GO:0016607; GO:0005786 7S RNA binding; GTP binding; GTP catabolic process; GTPase activity; SRP-dependent cotranslational protein targeting to membrane; nuclear speck; signal recognition particle, endoplasmic reticulum targeting reviewed IPR003593; IPR027417; IPR013822; IPR004125; IPR022941; IPR006325; IPR000897; Signal recognition particle 54 kDa protein (SRP54) Srp54 Mus musculus (Mouse) 504 P14576 GO:0048500 GO:0048500 signal recognition particle other cellular component C ConsensusfromContig5758 sp P14685 PSMD3_MOUSE 81.05 306 45 1 879 1 31 336 2E-165 478 P14685 PSMD3_MOUSE GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR013586; IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Psmd3 P91a Tstap91a Mus musculus (Mouse) 530 P14685 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig5758 sp P14685 PSMD3_MOUSE 81.05 306 45 1 879 1 31 336 2E-165 478 P14685 PSMD3_MOUSE GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR013586; IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Psmd3 P91a Tstap91a Mus musculus (Mouse) 530 P14685 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5758 sp P14685 PSMD3_MOUSE 81.05 306 45 1 879 1 31 336 2E-165 478 P14685 PSMD3_MOUSE GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR013586; IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Psmd3 P91a Tstap91a Mus musculus (Mouse) 530 P14685 GO:0030234 GO:0030234 enzyme regulator activity enzyme regulator activity F ConsensusfromContig5758 sp P14685 PSMD3_MOUSE 81.05 306 45 1 879 1 31 336 2E-165 478 P14685 PSMD3_MOUSE GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR013586; IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Psmd3 P91a Tstap91a Mus musculus (Mouse) 530 P14685 GO:0042176 GO:0042176 regulation of protein catabolic process protein metabolism P ConsensusfromContig5758 sp P14685 PSMD3_MOUSE 81.05 306 45 1 879 1 31 336 2E-165 478 P14685 PSMD3_MOUSE GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR013586; IPR013143; IPR000717; IPR011990; IPR011991; 26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58) (Transplantation antigen P91A) (Tum-P91A antigen) Psmd3 P91a Tstap91a Mus musculus (Mouse) 530 P14685 GO:0050790 GO:0050790 regulation of catalytic activity other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0002020 GO:0002020 protease binding other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0002709 GO:0002709 regulation of T cell mediated immunity other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0004177 GO:0004177 aminopeptidase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005518 GO:0005518 collagen binding other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0008239 GO:0008239 dipeptidyl-peptidase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0010716 GO:0010716 negative regulation of extracellular matrix disassembly cell organization and biogenesis P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0031258 GO:0031258 lamellipodium membrane plasma membrane C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0031258 GO:0031258 lamellipodium membrane other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0031295 GO:0031295 T cell costimulation other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0033632 GO:0033632 regulation of cell-cell adhesion mediated by integrin cell adhesion P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0043542 GO:0043542 endothelial cell migration other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0046581 GO:0046581 intercellular canaliculus plasma membrane C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0046581 GO:0046581 intercellular canaliculus other membranes C ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0051234 GO:0051234 establishment of localization other biological processes P ConsensusfromContig3098 sp P14740 DPP4_RAT 76.27 118 26 1 348 1 604 721 7E-59 198 P14740 DPP4_RAT GO:0005794; GO:0031295; GO:0004177; GO:0016324; GO:0007155; GO:0030054; GO:0009986; GO:0005518; GO:0008239; GO:0030139; GO:0005783; GO:0043542; GO:0051234; GO:0005576; GO:0016021; GO:0071438; GO:0030027; GO:0031258; GO:0045121; GO:0010716; GO:0042277; GO:0008284; GO:0002020; GO:0042803; GO:0006508; GO:0005102; GO:0002709; GO:0004252 Golgi apparatus; T cell costimulation; aminopeptidase activity; apical plasma membrane; cell adhesion; cell junction; cell surface; collagen binding; dipeptidyl-peptidase activity; endocytic vesicle; endoplasmic reticulum; endothelial cell migration; establishment of localization; extracellular region; integral to membrane; invadopodium membrane; lamellipodium; lamellipodium membrane; membrane raft; negative regulation of extracellular matrix disassembly; peptide binding; positive regulation of cell proliferation; protease binding; protein homodimerization activity; proteolysis; receptor binding; regulation of T cell mediated immunity; serine-type endopeptidase activity reviewed IPR002471; IPR001375; IPR002469; Dipeptidyl peptidase 4 (EC 3.4.14.5) (Bile canaliculus domain-specific membrane glycoprotein) (Dipeptidyl peptidase IV) (DPP IV) (GP110 glycoprotein) (T-cell activation antigen CD26) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form); Dipeptidyl peptidase 4 60 kDa soluble form (Dipeptidyl peptidase IV 60 kDa soluble form)] Dpp4 Cd26 Rattus norvegicus (Rat) 767 P14740 GO:0071438 ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0004075 GO:0004075 biotin carboxylase activity other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0004658 GO:0004658 propionyl-CoA carboxylase activity other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0009062 GO:0009062 fatty acid catabolic process other metabolic processes P ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0009063 GO:0009063 cellular amino acid catabolic process other metabolic processes P ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3383 sp P14882 PCCA_RAT 90.57 106 10 0 320 3 218 323 8E-57 192 P14882 PCCA_RAT GO:0005524; GO:0004075; GO:0009063; GO:0009062; GO:0046872; GO:0005759; GO:0005739; GO:0004658 ATP binding; biotin carboxylase activity; cellular amino acid catabolic process; fatty acid catabolic process; metal ion binding; mitochondrial matrix; mitochondrion; propionyl-CoA carboxylase activity reviewed IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR005479; IPR016185; IPR011054; IPR011053; Metabolic intermediate metabolism; propanoyl-CoA degradation; succinyl-CoA from propanoyl-CoA: step 1/3. Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) Pcca Rattus norvegicus (Rat) 737 P14882 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0000138 GO:0000138 Golgi trans cisterna ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002064 GO:0002064 epithelial cell development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002526 GO:0002526 acute inflammatory response stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003831 GO:0003831 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003945 GO:0003945 N-acetyllactosamine synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0004461 GO:0004461 lactose synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005989 GO:0005989 lactose biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006012 GO:0006012 galactose metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007339 GO:0007339 binding of sperm to zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007341 GO:0007341 penetration of zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008378 GO:0008378 galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009101 GO:0009101 glycoprotein biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009312 GO:0009312 oligosaccharide biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030112 GO:0030112 glycocalyx other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030879 GO:0030879 mammary gland development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0035250 GO:0035250 UDP-galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0045136 GO:0045136 development of secondary sexual characteristics developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048754 GO:0048754 branching morphogenesis of a tube developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0051270 GO:0051270 regulation of cell motion other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060046 GO:0060046 regulation of acrosome reaction transport P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 77.61 67 15 0 2 202 229 295 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0000138 GO:0000138 Golgi trans cisterna ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002064 GO:0002064 epithelial cell development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002526 GO:0002526 acute inflammatory response stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003831 GO:0003831 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003945 GO:0003945 N-acetyllactosamine synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0004461 GO:0004461 lactose synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005989 GO:0005989 lactose biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006012 GO:0006012 galactose metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007339 GO:0007339 binding of sperm to zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007341 GO:0007341 penetration of zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008378 GO:0008378 galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009101 GO:0009101 glycoprotein biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009312 GO:0009312 oligosaccharide biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030112 GO:0030112 glycocalyx other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030879 GO:0030879 mammary gland development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0035250 GO:0035250 UDP-galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0045136 GO:0045136 development of secondary sexual characteristics developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048754 GO:0048754 branching morphogenesis of a tube developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0051270 GO:0051270 regulation of cell motion other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060046 GO:0060046 regulation of acrosome reaction transport P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 79.37 63 13 0 177 365 287 349 6E-59 117 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0000138 GO:0000138 Golgi trans cisterna ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002064 GO:0002064 epithelial cell development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0002526 GO:0002526 acute inflammatory response stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003831 GO:0003831 "beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0003945 GO:0003945 N-acetyllactosamine synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0004461 GO:0004461 lactose synthase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0005989 GO:0005989 lactose biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006012 GO:0006012 galactose metabolic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007339 GO:0007339 binding of sperm to zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0007341 GO:0007341 penetration of zona pellucida other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0008378 GO:0008378 galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009101 GO:0009101 glycoprotein biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009312 GO:0009312 oligosaccharide biosynthetic process other metabolic processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030057 GO:0030057 desmosome other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030112 GO:0030112 glycocalyx other cellular component C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030198 GO:0030198 extracellular matrix organization cell organization and biogenesis P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0030879 GO:0030879 mammary gland development developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0035250 GO:0035250 UDP-galactosyltransferase activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0045136 GO:0045136 development of secondary sexual characteristics developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0048754 GO:0048754 branching morphogenesis of a tube developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0051270 GO:0051270 regulation of cell motion other biological processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060046 GO:0060046 regulation of acrosome reaction transport P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing cell cycle and proliferation P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060054 GO:0060054 positive regulation of epithelial cell proliferation involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing stress response P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060055 GO:0060055 angiogenesis involved in wound healing developmental processes P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution death P ConsensusfromContig1314 sp P15535 B4GT1_MOUSE 72.73 22 6 0 352 417 346 367 6E-59 34.7 P15535 B4GT1_MOUSE GO:0005794; GO:0032580; GO:0000138; GO:0003945; GO:0002526; GO:0060055; GO:0016323; GO:0003831; GO:0007339; GO:0048754; GO:0031526; GO:0007155; GO:0009986; GO:0008092; GO:0030057; GO:0045136; GO:0002064; GO:0009897; GO:0030198; GO:0005576; GO:0006012; GO:0030112; GO:0016021; GO:0005989; GO:0004461; GO:0050900; GO:0030879; GO:0046872; GO:0008285; GO:0009312; GO:0007341; GO:0005886; GO:0060058; GO:0060054; GO:0006486; GO:0060046; GO:0051270 Golgi apparatus; Golgi cisterna membrane; Golgi trans cisterna; N-acetyllactosamine synthase activity; acute inflammatory response; angiogenesis involved in wound healing; basolateral plasma membrane; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity; binding of sperm to zona pellucida; branching morphogenesis of an epithelial tube; brush border membrane; cell adhesion; cell surface; cytoskeletal protein binding; desmosome; development of secondary sexual characteristics; epithelial cell development; external side of plasma membrane; extracellular matrix organization; extracellular region; galactose metabolic process; glycocalyx; integral to membrane; lactose biosynthetic process; lactose synthase activity; leukocyte migration; mammary gland development; metal ion binding; negative regulation of cell proliferation; oligosaccharide biosynthetic process; penetration of zona pellucida; plasma membrane; positive regulation of apoptotic process involved in mammary gland involution; positive regulation of epithelial cell proliferation involved in wound healing; protein glycosylation; regulation of acrosome reaction; regulation of cellular component movement reviewed IPR003859; IPR027791; IPR027995; Protein modification; protein glycosylation. Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)] B4galt1 Ggtb Ggtb2 Mus musculus (Mouse) 399 P15535 GO:0060058 GO:0060058 positive regulation of apoptosis involved in mammary gland involution developmental processes P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000216 GO:0000216 M/G1 transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000722 GO:0000722 telomere maintenance via recombination DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000722 GO:0000722 telomere maintenance via recombination cell organization and biogenesis P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000724 GO:0000724 double-strand break repair via homologous recombination stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000724 GO:0000724 double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000730 GO:0000730 DNA recombinase assembly stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000730 GO:0000730 DNA recombinase assembly DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0000730 GO:0000730 DNA recombinase assembly cell organization and biogenesis P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0005662 GO:0005662 DNA replication factor A complex nucleus C ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006261 GO:0006261 DNA-dependent DNA replication DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006271 GO:0006271 DNA strand elongation during DNA replication DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0010569 GO:0010569 regulation of double-strand break repair via homologous recombination stress response P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0010569 GO:0010569 regulation of double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0019903 GO:0019903 protein phosphatase binding other molecular function F ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0032201 GO:0032201 telomere maintenance via semi-conservative replication DNA metabolism P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0032201 GO:0032201 telomere maintenance via semi-conservative replication cell organization and biogenesis P ConsensusfromContig5658 sp P15927 RFA2_HUMAN 56.87 262 100 1 1137 352 22 270 7E-94 292 P15927 RFA2_HUMAN GO:0000730; GO:0005662; GO:0006271; GO:0000082; GO:0016605; GO:0005654; GO:0000718; GO:0006297; GO:0010569; GO:0003697; GO:0000722; GO:0032201; GO:0006283 O75419; O60516; P04406; P27694; P35244; P23025 DNA recombinase assembly; DNA replication factor A complex; DNA strand elongation involved in DNA replication; G1/S transition of mitotic cell cycle; PML body; nucleoplasm; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA gap filling; regulation of double-strand break repair via homologous recombination; single-stranded DNA binding; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR012340; IPR004365; IPR014646; IPR014892; IPR011991; Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34) RPA2 REPA2 RPA32 RPA34 Homo sapiens (Human) 270 P15927 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig1866 sp P15975 UBP53_MOUSE 77.95 127 28 0 70 450 62 188 2E-66 221 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1866 sp P15975 UBP53_MOUSE 77.95 127 28 0 70 450 62 188 2E-66 221 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig1866 sp P15975 UBP53_MOUSE 77.95 127 28 0 70 450 62 188 2E-66 221 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1866 sp P15975 UBP53_MOUSE 77.95 127 28 0 70 450 62 188 2E-66 221 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1866 sp P15975 UBP53_MOUSE 77.95 127 28 0 70 450 62 188 2E-66 221 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1866 sp P15975 UBP53_MOUSE 92 25 2 0 2 76 39 63 2E-66 51.6 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1866 sp P15975 UBP53_MOUSE 92 25 2 0 2 76 39 63 2E-66 51.6 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig1866 sp P15975 UBP53_MOUSE 92 25 2 0 2 76 39 63 2E-66 51.6 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1866 sp P15975 UBP53_MOUSE 92 25 2 0 2 76 39 63 2E-66 51.6 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1866 sp P15975 UBP53_MOUSE 92 25 2 0 2 76 39 63 2E-66 51.6 P15975 UBP53_MOUSE GO:0006511 ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53) (Per-hexamer repeat protein 3) Usp53 Phxr3 Mus musculus (Mouse) 1069 P15975 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0004090 GO:0004090 carbonyl reductase (NADPH) activity other molecular function F ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0017144 GO:0017144 drug metabolic process other metabolic processes P ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0042373 GO:0042373 vitamin K metabolic process other metabolic processes P ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0047021 GO:0047021 15-hydroxyprostaglandin dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0050221 GO:0050221 prostaglandin-E2 9-reductase activity other molecular function F ConsensusfromContig5888 sp P16152 CBR1_HUMAN 65.2 273 93 2 1182 364 7 277 1E-120 358 P16152 CBR1_HUMAN GO:0047021; GO:0004090; GO:0019371; GO:0005829; GO:0017144; GO:0016655; GO:0050221; GO:0042373 15-hydroxyprostaglandin dehydrogenase (NADP+) activity; carbonyl reductase (NADPH) activity; cyclooxygenase pathway; cytosol; drug metabolic process; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor; prostaglandin-E2 9-reductase activity; vitamin K metabolic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) CBR1 CBR CRN Homo sapiens (Human) 277 P16152 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0000050 GO:0000050 urea cycle other metabolic processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0000053 GO:0000053 argininosuccinate metabolic process other metabolic processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0001101 GO:0001101 response to acid other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0001822 GO:0001822 kidney development developmental processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0001889 GO:0001889 liver development developmental processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0004055 GO:0004055 argininosuccinate synthase activity other molecular function F ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0006526 GO:0006526 arginine biosynthetic process other metabolic processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0006953 GO:0006953 acute-phase response stress response P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0007494 GO:0007494 midgut development developmental processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0007568 GO:0007568 aging other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0009607 GO:0009607 response to biotic stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0010043 GO:0010043 response to zinc ion other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0010046 GO:0010046 response to mycotoxin other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0014075 GO:0014075 response to amine stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0015643 GO:0015643 toxin binding other molecular function F ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0032355 GO:0032355 response to estradiol stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0032496 GO:0032496 response to lipopolysaccharide other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0043005 GO:0043005 neuron projection other cellular component C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0043200 GO:0043200 response to amino acid stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0043204 GO:0043204 perikaryon other cellular component C ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0043434 GO:0043434 response to peptide hormone stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0048545 GO:0048545 response to steroid hormone stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0051384 GO:0051384 response to glucocorticoid stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0060416 GO:0060416 response to growth hormone stimulus other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0060539 GO:0060539 diaphragm development developmental processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0070542 GO:0070542 response to fatty acid other biological processes P ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0070852 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071222 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071230 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071242 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071320 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071346 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071356 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071377 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071400 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071418 ConsensusfromContig3106 sp P16460 ASSY_MOUSE 75 148 37 0 466 23 219 366 3E-79 246 P16460 ASSY_MOUSE GO:0005524; GO:0006526; GO:0004055; GO:0005739; GO:0000050 ATP binding; arginine biosynthetic process; argininosuccinate synthase activity; mitochondrion; urea cycle reviewed IPR001518; IPR018223; IPR023434; IPR024074; IPR014729; Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase) Ass1 Ass Mus musculus (Mouse) 412 P16460 GO:0071549 ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005916 GO:0005916 fascia adherens plasma membrane C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005916 GO:0005916 fascia adherens other membranes C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0016328 GO:0016328 lateral plasma membrane plasma membrane C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0016328 GO:0016328 lateral plasma membrane other membranes C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0030018 GO:0030018 Z disc other cellular component C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0030507 GO:0030507 spectrin binding cytoskeletal activity F ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0030863 GO:0030863 cortical cytoskeleton cytoskeleton C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0032437 GO:0032437 cuticular plate cytoskeleton C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0033270 GO:0033270 paranode region of axon other cellular component C ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0051693 GO:0051693 actin filament capping protein metabolism P ConsensusfromContig5517 sp P16546 SPTN1_MOUSE 94.33 388 22 0 1166 3 2082 2469 0 738 P16546 SPTN1_MOUSE GO:0030018; GO:0051693; GO:0005509; GO:0032437; GO:0005916; GO:0016328; GO:0033270; GO:0046982; GO:0030507 Z disc; actin filament capping; calcium ion binding; cuticular plate; fascia adherens; lateral plasma membrane; paranode region of axon; protein heterodimerization activity; spectrin binding reviewed IPR011992; IPR014837; IPR018247; IPR002048; IPR001452; IPR018159; IPR013315; IPR002017; Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) Sptan1 Spna2 Spta2 Mus musculus (Mouse) 2472 P16546 GO:0051693 GO:0051693 actin filament capping cell organization and biogenesis P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0004726 GO:0004726 non-membrane spanning protein tyrosine phosphatase activity other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0035335 ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0060333 GO:0060333 interferon-gamma-mediated signaling pathway signal transduction P ConsensusfromContig6185 sp P17706 PTN2_HUMAN 62.66 391 134 5 147 1319 3 381 2E-168 512 P17706 PTN2_HUMAN GO:0030183; GO:0030217; GO:0005783; GO:0005793; GO:0030218; GO:0042593; GO:0008286; GO:0060333; GO:0070373; GO:0050860; GO:0008285; GO:0050922; GO:0042059; GO:0050728; GO:0046627; GO:0060336; GO:1902206; GO:1902215; GO:0070104; GO:0010888; GO:1902227; GO:0045650; GO:2000587; GO:1902233; GO:1902212; GO:0010804; GO:0060339; GO:0042512; GO:0042518; GO:0042524; GO:0042527; GO:0004726; GO:0005654; GO:0005634; GO:0005886; GO:0045722; GO:0004725; GO:1902202 P10912; P49755; Q9BVK6 B cell differentiation; T cell differentiation; endoplasmic reticulum; endoplasmic reticulum-Golgi intermediate compartment; erythrocyte differentiation; glucose homeostasis; insulin receptor signaling pathway; interferon-gamma-mediated signaling pathway; negative regulation of ERK1 and ERK2 cascade; negative regulation of T cell receptor signaling pathway; negative regulation of cell proliferation; negative regulation of chemotaxis; negative regulation of epidermal growth factor receptor signaling pathway; negative regulation of inflammatory response; negative regulation of insulin receptor signaling pathway; negative regulation of interferon-gamma-mediated signaling pathway; negative regulation of interleukin-2-mediated signaling pathway; negative regulation of interleukin-4-mediated signaling pathway; negative regulation of interleukin-6-mediated signaling pathway; negative regulation of lipid storage; negative regulation of macrophage colony-stimulating factor signaling pathway; negative regulation of macrophage differentiation; negative regulation of platelet-derived growth factor receptor-beta signaling pathway; negative regulation of positive thymic T cell selection; negative regulation of prolactin signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; negative regulation of type I interferon-mediated signaling pathway; negative regulation of tyrosine phosphorylation of Stat1 protein; negative regulation of tyrosine phosphorylation of Stat3 protein; negative regulation of tyrosine phosphorylation of Stat5 protein; negative regulation of tyrosine phosphorylation of Stat6 protein; non-membrane spanning protein tyrosine phosphatase activity; nucleoplasm; nucleus; plasma membrane; positive regulation of gluconeogenesis; protein tyrosine phosphatase activity; regulation of hepatocyte growth factor receptor signaling pathway reviewed IPR012265; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP) PTPN2 PTPT Homo sapiens (Human) 415 P17706 GO:0060334 GO:0060334 regulation of interferon-gamma-mediated signaling pathway signal transduction P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0005770 GO:0005770 late endosome other cytoplasmic organelle C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0007174 GO:0007174 epidermal growth factor ligand processing signal transduction P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0007174 GO:0007174 epidermal growth factor ligand processing protein metabolism P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0008333 GO:0008333 endosome to lysosome transport transport P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0019003 GO:0019003 GDP binding other molecular function F ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig5845 sp P18067 RAB7A_CANFA 92.89 197 12 2 226 810 1 197 2E-128 374 P18067 RAB7A_CANFA GO:0005525; GO:0003924; GO:0005794; GO:0045022; GO:0008333; GO:0007174; GO:0005770; GO:0005764; GO:0042470; GO:0045335; GO:0030670; GO:0090383; GO:0090385; GO:0006622; GO:0007264 GTP binding; GTPase activity; Golgi apparatus; early endosome to late endosome transport; endosome to lysosome transport; epidermal growth factor catabolic process; late endosome; lysosome; melanosome; phagocytic vesicle; phagocytic vesicle membrane; phagosome acidification; phagosome-lysosome fusion; protein targeting to lysosome; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-7a RAB7A RAB7 Canis familiaris (Dog) (Canis lupus familiaris) 207 P18067 GO:0045335 GO:0045335 phagocytic vesicle other cellular component C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0003987 GO:0003987 acetate-CoA ligase activity other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0004467 GO:0004467 long-chain-fatty-acid-CoA ligase activity other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005778 GO:0005778 peroxisomal membrane other cytoplasmic organelle C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005778 GO:0005778 peroxisomal membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0010033 GO:0010033 response to organic substance other biological processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0033211 GO:0033211 adiponectin-mediated signaling pathway signal transduction P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0034201 GO:0034201 response to oleic acid other biological processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0042178 GO:0042178 xenobiotic catabolic process other metabolic processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig3268 sp P18163 ACSL1_RAT 74.17 120 30 1 1 360 334 452 2E-55 188 P18163 ACSL1_RAT GO:0005524; GO:0003987; GO:0005783; GO:0005789; GO:0015908; GO:0016021; GO:0008610; GO:0044539; GO:0004467; GO:0005741; GO:0005778; GO:0005886; GO:0042493; GO:0007584; GO:0034201; GO:0014070; GO:0006641; GO:0042178 ATP binding; acetate-CoA ligase activity; endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid transport; integral to membrane; lipid biosynthetic process; long-chain fatty acid import; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane; plasma membrane; response to drug; response to nutrient; response to oleic acid; response to organic cyclic compound; triglyceride metabolic process; xenobiotic catabolic process reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain-fatty-acid--CoA ligase, liver isozyme) Acsl1 Acs1 Acsl2 Facl2 Rattus norvegicus (Rat) 699 P18163 GO:0071902 ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0030424 GO:0030424 axon other cellular component C ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0032513 GO:0032513 negative regulation of protein phosphatase type 2B activity other metabolic processes P ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig5555 sp P18203 FKB1A_BOVIN 84.16 101 16 0 199 501 1 101 2E-55 186 P18203 FKB1A_BOVIN GO:0005528; GO:0042110; GO:0030424; GO:0005829; GO:0032513; GO:0003755; GO:0006457; GO:0060314; GO:0033017 FK506 binding; T cell activation; axon; cytosol; negative regulation of protein phosphatase type 2B activity; peptidyl-prolyl cis-trans isomerase activity; protein folding; regulation of ryanodine-sensitive calcium-release channel activity; sarcoplasmic reticulum membrane reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase) FKBP1A FKBP1 Bos taurus (Bovine) 108 P18203 GO:0060314 GO:0060314 regulation of ryanodine-sensitive calcium-release channel activity transport P ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0007017 GO:0007017 microtubule-based process other biological processes P ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig4397 sp P18288 TBAT_ONCMY 93.81 113 7 0 3 341 60 172 5E-62 201 P18288 TBAT_ONCMY GO:0005525; GO:0003924; GO:0005737; GO:0005874; GO:0007017; GO:0051258; GO:0005200 GTP binding; GTPase activity; cytoplasm; microtubule; microtubule-based process; protein polymerization; structural constituent of cytoskeleton reviewed IPR002452; IPR008280; IPR000217; IPR018316; IPR023123; IPR017975; IPR003008; Tubulin alpha chain, testis-specific Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 450 P18288 GO:0051258 GO:0051258 protein polymerization cell organization and biogenesis P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0000790 GO:0000790 nuclear chromatin nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0000794 GO:0000794 condensed nuclear chromosome nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005087 GO:0005087 Ran guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007052 GO:0007052 mitotic spindle organization cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007052 GO:0007052 mitotic spindle organization cell organization and biogenesis P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007088 GO:0007088 regulation of mitosis cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007088 GO:0007088 regulation of mitosis cell organization and biogenesis P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0007090 GO:0007090 regulation of S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0031492 GO:0031492 nucleosomal DNA binding nucleic acid binding activity F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0051225 GO:0051225 spindle assembly cell cycle and proliferation P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0051225 GO:0051225 spindle assembly cell organization and biogenesis P ConsensusfromContig6110 sp P18754 RCC1_HUMAN 73.95 380 95 2 1389 262 42 421 0 551 P18754 RCC1_HUMAN GO:0000082; GO:0005087; GO:0051301; GO:0007059; GO:0000794; GO:0005737; GO:0042393; GO:0007067; GO:0007052; GO:0000790; GO:0031965; GO:0005654; GO:0031492; GO:0007088; GO:0051225; GO:0016032 P62826; Q9H6Z4 G1/S transition of mitotic cell cycle; Ran guanyl-nucleotide exchange factor activity; cell division; chromosome segregation; condensed nuclear chromosome; cytoplasm; histone binding; mitosis; mitotic spindle organization; nuclear chromatin; nuclear membrane; nucleoplasm; nucleosomal DNA binding; regulation of mitosis; spindle assembly; viral process reviewed IPR009091; IPR000408; Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1) RCC1 CHC1 Homo sapiens (Human) 421 P18754 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0007050 GO:0007050 cell cycle arrest cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0007265 GO:0007265 Ras protein signal transduction signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0007569 GO:0007569 cell aging other biological processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008542 GO:0008542 visual learning other biological processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0008629 GO:0008629 induction of apoptosis by intracellular signals death P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0031575 GO:0031575 G1/S transition checkpoint cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0032228 GO:0032228 "regulation of synaptic transmission, GABAergic" cell-cell signaling P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0035022 GO:0035022 positive regulation of Rac protein signal transduction signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0035176 GO:0035176 social behavior other biological processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0043410 GO:0043410 positive regulation of MAPKKK cascade signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0043524 GO:0043524 negative regulation of neuron apoptosis death P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0045740 GO:0045740 positive regulation of DNA replication DNA metabolism P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0046579 GO:0046579 positive regulation of Ras protein signal transduction signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0048169 GO:0048169 regulation of long-term neuronal synaptic plasticity cell-cell signaling P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0050679 GO:0050679 positive regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0051146 GO:0051146 striated muscle cell differentiation developmental processes P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0070374 GO:0070374 positive regulation of ERK1 and ERK2 cascade signal transduction P ConsensusfromContig6227 sp P20171 RASH_RAT 90.96 166 15 0 105 602 1 166 2E-92 297 P20171 RASH_RAT GO:0005525; GO:0003924; GO:0005794; GO:0000139; GO:0007265; GO:0006915; GO:0007050; GO:0008283; GO:0090398; GO:0006897; GO:0097193; GO:0007093; GO:0034259; GO:0008285; GO:0010629; GO:0005886; GO:0045740; GO:0070374; GO:0046330; GO:0043406; GO:0032855; GO:0046579; GO:2000251; GO:0030335; GO:0050679; GO:2000630; GO:1900029; GO:0045944; GO:0090303; GO:0051291; GO:0035176 GTP binding; GTPase activity; Golgi apparatus; Golgi membrane; Ras protein signal transduction; apoptotic process; cell cycle arrest; cell proliferation; cellular senescence; endocytosis; intrinsic apoptotic signaling pathway; mitotic cell cycle checkpoint; negative regulation of Rho GTPase activity; negative regulation of cell proliferation; negative regulation of gene expression; plasma membrane; positive regulation of DNA replication; positive regulation of ERK1 and ERK2 cascade; positive regulation of JNK cascade; positive regulation of MAP kinase activity; positive regulation of Rac GTPase activity; positive regulation of Ras protein signal transduction; positive regulation of actin cytoskeleton reorganization; positive regulation of cell migration; positive regulation of epithelial cell proliferation; positive regulation of miRNA metabolic process; positive regulation of ruffle assembly; positive regulation of transcription from RNA polymerase II promoter; positive regulation of wound healing; protein heterooligomerization; social behavior reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase HRas (H-Ras-1) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed] Hras1 Hras Rattus norvegicus (Rat) 189 P20171 GO:0090398 ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0001948 GO:0001948 glycoprotein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0002576 GO:0002576 platelet degranulation transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017160 GO:0017160 Ral GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034329 GO:0034329 cell junction assembly cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034394 GO:0034394 protein localization at cell surface other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034988 GO:0034988 Fc-gamma receptor I complex binding signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042177 GO:0042177 negative regulation of protein catabolic process protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042993 GO:0042993 positive regulation of transcription factor import into nucleus transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043433 GO:0043433 negative regulation of transcription factor activity RNA metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045022 GO:0045022 early endosome to late endosome transport transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045184 GO:0045184 establishment of protein localization other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0048365 GO:0048365 Rac GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051220 GO:0051220 cytoplasmic sequestering of protein transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 84.01 419 67 0 2337 1081 2228 2646 0 731 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051764 GO:0051764 actin crosslink formation cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0001948 GO:0001948 glycoprotein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0002576 GO:0002576 platelet degranulation transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017160 GO:0017160 Ral GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034329 GO:0034329 cell junction assembly cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034394 GO:0034394 protein localization at cell surface other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034988 GO:0034988 Fc-gamma receptor I complex binding signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042177 GO:0042177 negative regulation of protein catabolic process protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042993 GO:0042993 positive regulation of transcription factor import into nucleus transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043433 GO:0043433 negative regulation of transcription factor activity RNA metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045022 GO:0045022 early endosome to late endosome transport transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045184 GO:0045184 establishment of protein localization other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0048365 GO:0048365 Rac GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051220 GO:0051220 cytoplasmic sequestering of protein transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 33.58 408 224 9 2298 1081 1868 2230 4E-57 218 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051764 GO:0051764 actin crosslink formation cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0001948 GO:0001948 glycoprotein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0002576 GO:0002576 platelet degranulation transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007195 GO:0007195 inhibition of adenylate cyclase activity by dopamine receptor signaling pathway other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0017160 GO:0017160 Ral GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034329 GO:0034329 cell junction assembly cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034394 GO:0034394 protein localization at cell surface other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0034988 GO:0034988 Fc-gamma receptor I complex binding signal transduction activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042177 GO:0042177 negative regulation of protein catabolic process protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0042993 GO:0042993 positive regulation of transcription factor import into nucleus transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0043433 GO:0043433 negative regulation of transcription factor activity RNA metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045022 GO:0045022 early endosome to late endosome transport transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0045184 GO:0045184 establishment of protein localization other biological processes P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0048365 GO:0048365 Rac GTPase binding other molecular function F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051220 GO:0051220 cytoplasmic sequestering of protein transport P ConsensusfromContig6183 sp P21333 FLNA_HUMAN 35.1 416 231 8 2313 1072 2045 2423 3E-55 212 P21333 FLNA_HUMAN GO:0034988; GO:0031523; GO:0048365; GO:0017160; GO:0051764; GO:0015629; GO:0031532; GO:0051015; GO:0007195; GO:0005938; GO:0034329; GO:0042384; GO:0051220; GO:0005829; GO:0045022; GO:0001837; GO:0045184; GO:0070062; GO:0001948; GO:0042177; GO:0043433; GO:0005634; GO:0005886; GO:0030168; GO:0002576; GO:0043123; GO:0042993; GO:0042803; GO:0034394; GO:0050821; GO:0043113; GO:0004871; GO:0090307; GO:0005802 Q9WMX2; Q8N264; O95067; P46108; O75369; Q12948; P62993; P05556; P07228; P26010; O14786; P35372; Q86SQ0 Fc-gamma receptor I complex binding; Myb complex; Rac GTPase binding; Ral GTPase binding; actin crosslink formation; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; adenylate cyclase-inhibiting dopamine receptor signaling pathway; cell cortex; cell junction assembly; cilium assembly; cytoplasmic sequestering of protein; cytosol; early endosome to late endosome transport; epithelial to mesenchymal transition; establishment of protein localization; extracellular vesicular exosome; glycoprotein binding; negative regulation of protein catabolic process; negative regulation of sequence-specific DNA binding transcription factor activity; nucleus; plasma membrane; platelet activation; platelet degranulation; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of transcription factor import into nucleus; protein homodimerization activity; protein localization to cell surface; protein stabilization; receptor clustering; signal transducer activity; spindle assembly involved in mitosis; trans-Golgi network reviewed IPR001589; IPR001715; IPR001298; IPR017868; IPR013783; IPR014756; Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin) FLNA FLN FLN1 Homo sapiens (Human) 2647 P21333 GO:0051764 GO:0051764 actin crosslink formation cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0000080 GO:0000080 G1 phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0000117 GO:0000117 regulation of transcription during G2/M-phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0000117 GO:0000117 regulation of transcription during G2/M-phase of mitotic cell cycle RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0004402 GO:0004402 histone acetyltransferase activity other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005669 GO:0005669 transcription factor TFIID complex nucleus C ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006352 GO:0006352 transcription initiation RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006352 GO:0006352 transcription initiation cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006368 GO:0006368 RNA elongation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016573 GO:0016573 histone acetylation protein metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016573 GO:0016573 histone acetylation cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0017025 GO:0017025 TATA-binding protein binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0018107 GO:0018107 peptidyl-threonine phosphorylation protein metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0032436 GO:0032436 positive regulation of proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0044212 ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0051123 GO:0051123 transcriptional preinitiation complex assembly RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0051123 GO:0051123 transcriptional preinitiation complex assembly cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0060261 GO:0060261 positive regulation of transcription initiation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0060261 GO:0060261 positive regulation of transcription initiation from RNA polymerase II promoter cell organization and biogenesis P ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0070577 GO:0070577 histone acetyl-lysine binding other molecular function F ConsensusfromContig610 sp P21675 TAF1_HUMAN 89.27 177 19 0 531 1 1135 1311 2E-67 229 P21675 TAF1_HUMAN GO:0005524; GO:0003677; GO:0006352; GO:0071339; GO:0051123; GO:0070577; GO:0004402; GO:0000080; GO:0019048; GO:0005634; GO:0018105; GO:0018107; GO:0032436; GO:0045944; GO:0060261; GO:0046777; GO:0004674; GO:0000117; GO:0006355; GO:0006974; GO:0043565; GO:0003713; GO:0006368; GO:0005669; GO:0016032 P03255; P35269; P20226 ATP binding; DNA binding; DNA-dependent transcription, initiation; MLL1 complex; RNA polymerase II transcriptional preinitiation complex assembly; histone acetyl-lysine binding; histone acetyltransferase activity; mitotic G1 phase; modulation by virus of host morphology or physiology; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription initiation from RNA polymerase II promoter; protein autophosphorylation; protein serine/threonine kinase activity; regulation of transcription involved in G2/M transition of mitotic cell cycle; regulation of transcription, DNA-dependent; response to DNA damage stimulus; sequence-specific DNA binding; transcription coactivator activity; transcription elongation from RNA polymerase II promoter; transcription factor TFIID complex; viral process reviewed IPR001487; IPR018359; IPR011177; IPR009067; IPR022591; Transcription initiation factor TFIID subunit 1 (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) TAF1 BA2R CCG1 CCGS TAF2A Homo sapiens (Human) 1872 P21675 GO:0071339 ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5805 sp P22232 FBRL_XENLA 91.56 237 20 0 55 765 87 323 1E-160 460 P22232 FBRL_XENLA GO:0003723; GO:0008168; GO:0005730; GO:0006364; GO:0030529; GO:0008033 RNA binding; methyltransferase activity; nucleolus; rRNA processing; ribonucleoprotein complex; tRNA processing reviewed IPR000692; IPR020813; rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) fbl Xenopus laevis (African clawed frog) 323 P22232 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0008219 GO:0008219 cell death death P ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0008641 GO:0008641 small protein activating enzyme activity other molecular function F ConsensusfromContig696 sp P22314 UBA1_HUMAN 74.68 154 39 0 463 2 16 169 6E-74 248 P22314 UBA1_HUMAN GO:0005524; GO:0008219; GO:0016874; GO:0016567; GO:0008641 Q76353; Q9H2C0; P63279 ATP binding; cell death; ligase activity; protein ubiquitination; small protein activating enzyme activity reviewed IPR009036; IPR016040; IPR000594; IPR018965; IPR023280; IPR000127; IPR019572; IPR018075; IPR018074; IPR000011; Protein modification; protein ubiquitination. Ubiquitin-like modifier-activating enzyme 1 (Protein A1S9) (Ubiquitin-activating enzyme E1) UBA1 A1S9T UBE1 Homo sapiens (Human) 1058 P22314 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0030131 GO:0030131 clathrin adaptor complex other membranes C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0030665 GO:0030665 clathrin coated vesicle membrane other membranes C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0044431 GO:0044431 Golgi apparatus part ER/Golgi C ConsensusfromContig1519 sp P22892 AP1G1_MOUSE 81.06 132 25 0 398 3 213 344 2E-59 201 P22892 AP1G1_MOUSE GO:0005794; GO:0030131; GO:0030136; GO:0030665; GO:0006897; GO:0006886; GO:0048471; GO:0008565; GO:0005802; GO:0016192 P35585; Q14677 Golgi apparatus; clathrin adaptor complex; clathrin-coated vesicle; clathrin-coated vesicle membrane; endocytosis; intracellular protein transport; perinuclear region of cytoplasm; protein transporter activity; trans-Golgi network; vesicle-mediated transport reviewed IPR017107; IPR011989; IPR016024; IPR002553; IPR008152; IPR008153; IPR013041; AP-1 complex subunit gamma-1 (Adapter-related protein complex 1 subunit gamma-1) (Adaptor protein complex AP-1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma-adaptin) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1) Ap1g1 Adtg Clapg1 Mus musculus (Mouse) 822 P22892 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0003746 GO:0003746 translation elongation factor activity nucleic acid binding activity F ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006354 GO:0006354 RNA elongation RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006368 GO:0006368 RNA elongation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0006414 GO:0006414 translational elongation protein metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0030218 GO:0030218 erythrocyte differentiation developmental processes P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0032784 GO:0032784 regulation of RNA elongation RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5778 sp P23193 TCEA1_HUMAN 73.68 304 76 2 96 1007 2 301 1E-146 432 P23193 TCEA1_HUMAN GO:0003677; GO:0030218; GO:0005730; GO:0005654; GO:0045944; GO:0050434; GO:0032784; GO:0006368; GO:0006283; GO:0016032; GO:0008270 Q8WVC0; Q8N7H5 DNA binding; erythrocyte differentiation; nucleolus; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; positive regulation of viral transcription; regulation of DNA-dependent transcription, elongation; transcription elongation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process; zinc ion binding reviewed IPR016492; IPR003617; IPR003618; IPR017923; IPR017890; IPR006289; IPR001222; Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o) TCEA1 GTF2S TFIIS Homo sapiens (Human) 301 P23193 GO:0050434 GO:0050434 positive regulation of viral transcription RNA metabolism P ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0019001 GO:0019001 guanyl nucleotide binding other molecular function F ConsensusfromContig2647 sp P24799 GNAS_XENLA 76.8 125 29 0 386 12 69 193 4E-67 214 P24799 GNAS_XENLA GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0005886; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; plasma membrane; signal transducer activity reviewed IPR000367; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) gnas Xenopus laevis (African clawed frog) 379 P24799 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0005902 GO:0005902 microvillus other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0019898 GO:0019898 extrinsic to membrane other membranes C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0030033 GO:0030033 microvillus assembly cell organization and biogenesis P ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0030175 GO:0030175 filopodium other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0032420 GO:0032420 stereocilium other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0045176 GO:0045176 apical protein localization other biological processes P ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0045177 GO:0045177 apical part of cell other cellular component C ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0051693 GO:0051693 actin filament capping protein metabolism P ConsensusfromContig5937 sp P26043 RADI_MOUSE 84.36 179 21 1 94 609 405 583 1E-67 230 P26043 RADI_MOUSE GO:0051693; GO:0045177; GO:0045176; GO:0032154; GO:0005737; GO:0005856; GO:0019898; GO:0030175; GO:0005925; GO:0030027; GO:0030033; GO:0005886; GO:0001726; GO:0032420 actin filament capping; apical part of cell; apical protein localization; cleavage furrow; cytoplasm; cytoskeleton; extrinsic to membrane; filopodium; focal adhesion; lamellipodium; microvillus assembly; plasma membrane; ruffle; stereocilium reviewed IPR019749; IPR019750; IPR011174; IPR011259; IPR000798; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR018980; IPR008954; IPR011993; Radixin (ESP10) Rdx Mus musculus (Mouse) 583 P26043 GO:0051693 GO:0051693 actin filament capping cell organization and biogenesis P ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0004022 GO:0004022 alcohol dehydrogenase activity other molecular function F ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig567 sp P26325 ADH1_GADMC 75.8 157 38 0 473 3 165 321 4E-69 220 P26325 ADH1_GADMC GO:0004022; GO:0005737; GO:0008270 alcohol dehydrogenase (NAD) activity; cytoplasm; zinc ion binding reviewed IPR013149; IPR013154; IPR002085; IPR002328; IPR011032; IPR016040; Alcohol dehydrogenase 1 (EC 1.1.1.1) Gadus morhua subsp. callarias (Baltic cod) (Gadus callarias) 375 P26325 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0004829 GO:0004829 threonine-tRNA ligase activity other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0006435 GO:0006435 threonyl-tRNA aminoacylation protein metabolism P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0006435 GO:0006435 threonyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0016876 GO:0016876 "ligase activity, forming aminoacyl-tRNA and related compounds" other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig2406 sp P26639 SYTC_HUMAN 93.57 140 9 0 462 43 210 349 3E-89 281 P26639 SYTC_HUMAN GO:0005524; GO:0015629; GO:0005829; GO:0042803; GO:0004829; GO:0006435 ATP binding; actin cytoskeleton; cytosol; protein homodimerization activity; threonine-tRNA ligase activity; threonyl-tRNA aminoacylation reviewed IPR002314; IPR006195; IPR004154; IPR012675; IPR004095; IPR012676; IPR002320; IPR018163; IPR012947; Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) TARS Homo sapiens (Human) 723 P26639 GO:0043039 GO:0043039 tRNA aminoacylation RNA metabolism P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0030866 GO:0030866 cortical actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0031527 GO:0031527 filopodium membrane plasma membrane C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0031527 GO:0031527 filopodium membrane other membranes C ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0031529 GO:0031529 ruffle organization cell organization and biogenesis P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0035020 GO:0035020 regulation of Rac protein signal transduction signal transduction P ConsensusfromContig6365 sp P26990 ARF6_CHICK 99.43 175 1 0 921 1445 1 175 5E-120 364 P26990 ARF6_CHICK GO:0005525; GO:0005794; GO:0006915; GO:0005938; GO:0030866; GO:0030139; GO:0005768; GO:0010008; GO:0090162; GO:0031527; GO:0001889; GO:0005886; GO:0030838; GO:0090004; GO:0034394; GO:0015031; GO:0035020; GO:0060998; GO:0051489; GO:0001726; GO:0031529; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; apoptotic process; cell cortex; cortical actin cytoskeleton organization; endocytic vesicle; endosome; endosome membrane; establishment of epithelial cell polarity; filopodium membrane; liver development; plasma membrane; positive regulation of actin filament polymerization; positive regulation of establishment of protein localization to plasma membrane; protein localization to cell surface; protein transport; regulation of Rac protein signal transduction; regulation of dendritic spine development; regulation of filopodium assembly; ruffle; ruffle organization; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 6 ARF6 CPS1 Gallus gallus (Chicken) 175 P26990 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0000105 GO:0000105 histidine biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004329 GO:0004329 formate-tetrahydrofolate ligase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004477 GO:0004477 methenyltetrahydrofolate cyclohydrolase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004486 GO:0004486 methylenetetrahydrofolate dehydrogenase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004488 GO:0004488 methylenetetrahydrofolate dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0006164 GO:0006164 purine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009086 GO:0009086 methionine biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009117 GO:0009117 nucleotide metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009396 GO:0009396 folic acid and derivative biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0046653 GO:0046653 tetrahydrofolate metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 81.29 326 61 0 2 979 510 835 0 508 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0000105 GO:0000105 histidine biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004329 GO:0004329 formate-tetrahydrofolate ligase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004477 GO:0004477 methenyltetrahydrofolate cyclohydrolase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004486 GO:0004486 methylenetetrahydrofolate dehydrogenase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0004488 GO:0004488 methylenetetrahydrofolate dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0006164 GO:0006164 purine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009086 GO:0009086 methionine biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009117 GO:0009117 nucleotide metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0009396 GO:0009396 folic acid and derivative biosynthetic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0046653 GO:0046653 tetrahydrofolate metabolic process other metabolic processes P ConsensusfromContig5691 sp P27653 C1TC_RAT 86 100 14 0 979 1278 836 935 0 188 P27653 C1TC_RAT GO:0005524; GO:0005829; GO:0009396; GO:0004329; GO:0000105; GO:0004477; GO:0009086; GO:0004488; GO:0004486; GO:0009117; GO:0006730; GO:0006164; GO:0035999; GO:0046653 ATP binding; cytosol; folic acid-containing compound biosynthetic process; formate-tetrahydrofolate ligase activity; histidine biosynthetic process; methenyltetrahydrofolate cyclohydrolase activity; methionine biosynthetic process; methylenetetrahydrofolate dehydrogenase (NADP+) activity; methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity; nucleotide metabolic process; one-carbon metabolic process; purine nucleotide biosynthetic process; tetrahydrofolate interconversion; tetrahydrofolate metabolic process reviewed IPR000559; IPR020628; IPR016040; IPR027417; IPR000672; IPR020630; IPR020867; IPR020631; One-carbon metabolism; tetrahydrofolate interconversion. C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)] Mthfd1 Mthfd Rattus norvegicus (Rat) 935 P27653 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6251 sp P28024 PSB4_XENLA 81.63 245 37 1 69 803 6 242 2E-149 427 P28024 PSB4_XENLA GO:0005737; GO:0005634; GO:0005839; GO:0051603; GO:0004298 cytoplasm; nucleus; proteasome core complex; proteolysis involved in cellular protein catabolic process; threonine-type endopeptidase activity reviewed IPR016050; IPR016295; IPR001353; IPR023333; Proteasome subunit beta type-4 (EC 3.4.25.1) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (Fragment) psmb4 Xenopus laevis (African clawed frog) 242 P28024 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0004470 GO:0004470 malic enzyme activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0004473 GO:0004473 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0006108 GO:0006108 malate metabolic process other metabolic processes P ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016619 GO:0016619 malate dehydrogenase (oxaloacetate-decarboxylating) activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 72.38 239 66 0 590 1306 157 395 2E-105 330 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0004470 GO:0004470 malic enzyme activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0004473 GO:0004473 malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0006108 GO:0006108 malate metabolic process other metabolic processes P ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0016619 GO:0016619 malate dehydrogenase (oxaloacetate-decarboxylating) activity other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig6022 sp P28227 MAOX_ANAPL 80.86 162 31 0 153 638 11 172 5E-89 287 P28227 MAOX_ANAPL GO:0051287; GO:0004473; GO:0016619; GO:0006108; GO:0030145; GO:0005739; GO:0051262 NAD binding; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; malate dehydrogenase (oxaloacetate-decarboxylating) activity; malate metabolic process; manganese ion binding; mitochondrion; protein tetramerization reviewed IPR015884; IPR012301; IPR012302; IPR001891; IPR016040; NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) ME1 Anas platyrhynchos (Domestic duck) (Anas boschas) 557 P28227 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig1792 sp P30042 ES1_HUMAN 62.94 170 61 2 1 504 65 234 1E-67 213 P30042 ES1_HUMAN GO:0005739 mitochondrion reviewed IPR002818; ES1 protein homolog, mitochondrial (Protein GT335) (Protein KNP-I) C21orf33 HES1 KNPI Homo sapiens (Human) 268 P30042 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0005665 GO:0005665 "DNA-directed RNA polymerase II, core complex" nucleus C ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006367 GO:0006367 transcription initiation from RNA polymerase II promoter cell organization and biogenesis P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006368 GO:0006368 RNA elongation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006370 GO:0006370 mRNA capping RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0032549 GO:0032549 ribonucleoside binding other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4207 sp P30876 RPB2_HUMAN 95.65 92 4 0 278 3 151 242 4E-57 195 P30876 RPB2_HUMAN GO:0006370; GO:0003677; GO:0005665; GO:0003899; GO:0003682; GO:0000398; GO:0046872; GO:0050434; GO:0032549; GO:0006368; GO:0006367; GO:0006283; GO:0016032 7-methylguanosine mRNA capping; DNA binding; DNA-directed RNA polymerase II, core complex; DNA-directed RNA polymerase activity; chromatin binding; mRNA splicing, via spliceosome; metal ion binding; positive regulation of viral transcription; ribonucleoside binding; transcription elongation from RNA polymerase II promoter; transcription initiation from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair; viral process reviewed IPR015712; IPR007120; IPR007121; IPR007644; IPR007642; IPR007645; IPR007646; IPR007647; IPR007641; IPR014724; DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2) POLR2B Homo sapiens (Human) 1174 P30876 GO:0050434 GO:0050434 positive regulation of viral transcription RNA metabolism P ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0003948 GO:0003948 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity other molecular function F ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0006517 GO:0006517 protein deglycosylation protein metabolism P ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0015630 GO:0015630 microtubule cytoskeleton cytoskeleton C ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0033345 GO:0033345 asparagine catabolic process via L-aspartate other metabolic processes P ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0043621 GO:0043621 protein self-association other molecular function F ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0045111 GO:0045111 intermediate filament cytoskeleton cytoskeleton C ConsensusfromContig1543 sp P30919 ASPG_RAT 58.77 211 86 1 1 633 132 341 1E-73 233 P30919 ASPG_RAT GO:0003948; GO:0005783; GO:0005764; GO:0008233; GO:0006517; GO:0051604; GO:0043621; GO:0006508 N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity; endoplasmic reticulum; lysosome; peptidase activity; protein deglycosylation; protein maturation; protein self-association; proteolysis reviewed IPR000246; N(4)-(Beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (AGA) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain] Aga Rattus norvegicus (Rat) 345 P30919 GO:0051604 GO:0051604 protein maturation protein metabolism P ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5874 sp P30946 HS90A_RABIT 81.86 656 68 3 156 2123 90 694 0 1025 P30946 HS90A_RABIT GO:0005524; GO:0016887; GO:0051131; GO:0042470; GO:0030235; GO:0045429; GO:0006457; GO:0045040; GO:0006950 ATP binding; ATPase activity; chaperone-mediated protein complex assembly; melanosome; nitric-oxide synthase regulator activity; positive regulation of nitric oxide biosynthetic process; protein folding; protein import into mitochondrial outer membrane; response to stress reviewed IPR003594; IPR019805; IPR001404; IPR020575; IPR020568; Heat shock protein HSP 90-alpha HSP90AA1 HSPCA Oryctolagus cuniculus (Rabbit) 694 P30946 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003690 GO:0003690 double-stranded DNA binding nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003705 GO:0003705 "RNA polymerase II transcription factor activity, enhancer binding" transcription regulatory activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0003705 GO:0003705 "RNA polymerase II transcription factor activity, enhancer binding" nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0005667 GO:0005667 transcription factor complex nucleus C ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0007389 GO:0007389 pattern specification process developmental processes P ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0008301 GO:0008301 DNA bending activity nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0009888 GO:0009888 tissue development developmental processes P ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig2559 sp P32314 FOXN2_HUMAN 52.45 204 68 4 550 5 119 315 2E-54 185 P32314 FOXN2_HUMAN GO:0005634; GO:0043565; GO:0003700; GO:0035914; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; skeletal muscle cell differentiation; transcription, DNA-dependent reviewed IPR001766; IPR018122; IPR011991; Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor) FOXN2 HTLF Homo sapiens (Human) 431 P32314 GO:0051090 GO:0051090 regulation of transcription factor activity RNA metabolism P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0006692 GO:0006692 prostanoid metabolic process other metabolic processes P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0006810 GO:0006810 transport transport P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0019370 GO:0019370 leukotriene biosynthetic process other metabolic processes P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0042626 GO:0042626 "ATPase activity, coupled to transmembrane movement of substances" transporter activity F ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0044281 ConsensusfromContig95 sp P33527 MRP1_HUMAN 76.19 168 40 0 506 3 1018 1185 2E-84 277 P33527 MRP1_HUMAN GO:0005524; GO:0042626; GO:0005794; GO:0019369; GO:0009235; GO:0005887; GO:0006691; GO:0005634; GO:0042493 ATP binding; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; arachidonic acid metabolic process; cobalamin metabolic process; integral to plasma membrane; leukotriene metabolic process; nucleus; response to drug reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR005292; IPR027417; Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter) ABCC1 MRP MRP1 Homo sapiens (Human) 1531 P33527 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0008137 GO:0008137 NADH dehydrogenase (ubiquinone) activity other molecular function F ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0042773 GO:0042773 ATP synthesis coupled electron transport other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 85.24 332 49 0 149 1144 59 390 0 501 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0070469 GO:0070469 respiratory chain other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0008137 GO:0008137 NADH dehydrogenase (ubiquinone) activity other molecular function F ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0042773 GO:0042773 ATP synthesis coupled electron transport other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5560 sp P34195 NU5M_FORLA 74.76 206 52 0 1141 1758 390 595 0 258 P34195 NU5M_FORLA GO:0042773; GO:0008137; GO:0016021; GO:0005743; GO:0070469 ATP synthesis coupled electron transport; NADH dehydrogenase (ubiquinone) activity; integral to membrane; mitochondrial inner membrane; respiratory chain reviewed IPR010934; IPR001750; IPR001516; IPR003945; NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5) MT-ND5 MTND5 NADH5 ND5 Formosania lacustris (Oriental stream loach) (Crossostoma lacustre) 612 P34195 GO:0070469 GO:0070469 respiratory chain other membranes C ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000722 GO:0000722 telomere maintenance via recombination DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000722 GO:0000722 telomere maintenance via recombination cell organization and biogenesis P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0003689 GO:0003689 DNA clamp loader activity nucleic acid binding activity F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0005663 GO:0005663 DNA replication factor C complex other cellular component C ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006271 GO:0006271 DNA strand elongation during DNA replication DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" stress response P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0032201 GO:0032201 telomere maintenance via semi-conservative replication DNA metabolism P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0032201 GO:0032201 telomere maintenance via semi-conservative replication cell organization and biogenesis P ConsensusfromContig5856 sp P35249 RFC4_HUMAN 67.36 242 79 0 829 104 121 362 4E-119 352 P35249 RFC4_HUMAN GO:0005524; GO:0003677; GO:0005663; GO:0006271; GO:0000278; GO:0005654; GO:0017111; GO:0006297; GO:0048015; GO:0000722; GO:0032201; GO:0006283 P35250; P40938; P40937 ATP binding; DNA binding; DNA replication factor C complex; DNA strand elongation involved in DNA replication; mitotic cell cycle; nucleoplasm; nucleoside-triphosphatase activity; nucleotide-excision repair, DNA gap filling; phosphatidylinositol-mediated signaling; telomere maintenance via recombination; telomere maintenance via semi-conservative replication; transcription-coupled nucleotide-excision repair reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37) RFC4 Homo sapiens (Human) 363 P35249 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig5634 sp P35521 ICLN_CANFA 60.71 252 80 3 342 1091 1 235 5E-90 281 P35521 ICLN_CANFA GO:0006884; GO:0006821; GO:0005737; GO:0005634 cell volume homeostasis; chloride transport; cytoplasm; nucleus reviewed IPR003521; Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) CLNS1A ICLN Canis familiaris (Dog) (Canis lupus familiaris) 235 P35521 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5634 sp P35521 ICLN_CANFA 60.71 252 80 3 342 1091 1 235 5E-90 281 P35521 ICLN_CANFA GO:0006884; GO:0006821; GO:0005737; GO:0005634 cell volume homeostasis; chloride transport; cytoplasm; nucleus reviewed IPR003521; Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) CLNS1A ICLN Canis familiaris (Dog) (Canis lupus familiaris) 235 P35521 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5634 sp P35521 ICLN_CANFA 60.71 252 80 3 342 1091 1 235 5E-90 281 P35521 ICLN_CANFA GO:0006884; GO:0006821; GO:0005737; GO:0005634 cell volume homeostasis; chloride transport; cytoplasm; nucleus reviewed IPR003521; Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) CLNS1A ICLN Canis familiaris (Dog) (Canis lupus familiaris) 235 P35521 GO:0006821 GO:0006821 chloride transport transport P ConsensusfromContig5634 sp P35521 ICLN_CANFA 60.71 252 80 3 342 1091 1 235 5E-90 281 P35521 ICLN_CANFA GO:0006884; GO:0006821; GO:0005737; GO:0005634 cell volume homeostasis; chloride transport; cytoplasm; nucleus reviewed IPR003521; Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) CLNS1A ICLN Canis familiaris (Dog) (Canis lupus familiaris) 235 P35521 GO:0006884 GO:0006884 cell volume homeostasis other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000146 GO:0000146 microfilament motor activity cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000212 GO:0000212 meiotic spindle organization cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000212 GO:0000212 meiotic spindle organization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000904 GO:0000904 cell morphogenesis involved in differentiation cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001768 GO:0001768 establishment of T cell polarity cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001772 GO:0001772 immunological synapse plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001772 GO:0001772 immunological synapse other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001931 GO:0001931 uropod other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005826 GO:0005826 contractile ring cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005913 GO:0005913 cell-cell adherens junction plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005913 GO:0005913 cell-cell adherens junction other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006509 GO:0006509 membrane protein ectodomain proteolysis protein metabolism P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007132 GO:0007132 meiotic metaphase I cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007229 GO:0007229 integrin-mediated signaling pathway signal transduction P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007520 GO:0007520 myoblast fusion developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007520 GO:0007520 myoblast fusion cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008305 GO:0008305 integrin complex plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008305 GO:0008305 integrin complex other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016337 GO:0016337 cell-cell adhesion cell adhesion P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016460 GO:0016460 myosin II complex cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030048 GO:0030048 actin filament-based movement transport P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030220 GO:0030220 platelet formation developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030224 GO:0030224 monocyte differentiation developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030863 GO:0030863 cortical cytoskeleton cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030898 GO:0030898 actin-dependent ATPase activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031252 GO:0031252 cell leading edge other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031594 GO:0031594 neuromuscular junction other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0032796 GO:0032796 uropod organization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0038032 ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043495 GO:0043495 protein anchor other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043531 GO:0043531 ADP binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043534 GO:0043534 blood vessel endothelial cell migration other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051295 GO:0051295 establishment of meiotic spindle localization cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 68.86 350 109 0 1222 173 965 1314 2E-88 290 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051295 GO:0051295 establishment of meiotic spindle localization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000146 GO:0000146 microfilament motor activity cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000212 GO:0000212 meiotic spindle organization cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000212 GO:0000212 meiotic spindle organization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000904 GO:0000904 cell morphogenesis involved in differentiation cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001768 GO:0001768 establishment of T cell polarity cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001772 GO:0001772 immunological synapse plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001772 GO:0001772 immunological synapse other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0001931 GO:0001931 uropod other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005826 GO:0005826 contractile ring cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005913 GO:0005913 cell-cell adherens junction plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005913 GO:0005913 cell-cell adherens junction other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006509 GO:0006509 membrane protein ectodomain proteolysis protein metabolism P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007132 GO:0007132 meiotic metaphase I cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007229 GO:0007229 integrin-mediated signaling pathway signal transduction P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007520 GO:0007520 myoblast fusion developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0007520 GO:0007520 myoblast fusion cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008305 GO:0008305 integrin complex plasma membrane C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008305 GO:0008305 integrin complex other membranes C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016337 GO:0016337 cell-cell adhesion cell adhesion P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016460 GO:0016460 myosin II complex cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030048 GO:0030048 actin filament-based movement transport P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030220 GO:0030220 platelet formation developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030224 GO:0030224 monocyte differentiation developmental processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030863 GO:0030863 cortical cytoskeleton cytoskeleton C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0030898 GO:0030898 actin-dependent ATPase activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031252 GO:0031252 cell leading edge other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0031594 GO:0031594 neuromuscular junction other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0032796 GO:0032796 uropod organization cell organization and biogenesis P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0038032 ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043495 GO:0043495 protein anchor other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043531 GO:0043531 ADP binding other molecular function F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0043534 GO:0043534 blood vessel endothelial cell migration other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051295 GO:0051295 establishment of meiotic spindle localization cell cycle and proliferation P ConsensusfromContig6236 sp P35579 MYH9_HUMAN 64.15 53 19 0 167 9 1316 1368 2E-88 58.5 P35579 MYH9_HUMAN GO:0043531; GO:0005524; GO:0015629; GO:0031532; GO:0051015; GO:0030048; GO:0030898; GO:0005826; GO:0001525; GO:0007411; GO:0043534; GO:0000904; GO:0005913; GO:0016337; GO:0006928; GO:0032154; GO:0030863; GO:0000910; GO:0005737; GO:0005829; GO:0001768; GO:0051295; GO:0070062; GO:0001772; GO:0001701; GO:0007229; GO:0050900; GO:0000212; GO:0006509; GO:0000146; GO:0030224; GO:0003774; GO:0007520; GO:0016460; GO:0016459; GO:0031594; GO:0005634; GO:0005886; GO:0030220; GO:0043495; GO:0043234; GO:0042803; GO:0015031; GO:0008360; GO:0001726; GO:0005819; GO:0001725; GO:0038032; GO:0001931; GO:0032796 P61073; P62993; O00255; P19338; O46385 ADP binding; ATP binding; actin cytoskeleton; actin cytoskeleton reorganization; actin filament binding; actin filament-based movement; actin-dependent ATPase activity; actomyosin contractile ring; angiogenesis; axon guidance; blood vessel endothelial cell migration; cell morphogenesis involved in differentiation; cell-cell adherens junction; cell-cell adhesion; cellular component movement; cleavage furrow; cortical cytoskeleton; cytokinesis; cytoplasm; cytosol; establishment of T cell polarity; establishment of meiotic spindle localization; extracellular vesicular exosome; immunological synapse; in utero embryonic development; integrin-mediated signaling pathway; leukocyte migration; meiotic spindle organization; membrane protein ectodomain proteolysis; microfilament motor activity; monocyte differentiation; motor activity; myoblast fusion; myosin II complex; myosin complex; neuromuscular junction; nucleus; plasma membrane; platelet formation; protein anchor; protein complex; protein homodimerization activity; protein transport; regulation of cell shape; ruffle; spindle; stress fiber; termination of G-protein coupled receptor signaling pathway; uropod; uropod organization reviewed IPR000048; IPR027401; IPR001609; IPR004009; IPR002928; IPR027417; IPR016137; Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA) MYH9 Homo sapiens (Human) 1960 P35579 GO:0051295 GO:0051295 establishment of meiotic spindle localization cell organization and biogenesis P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006921 GO:0006921 cell structure disassembly during apoptosis cell organization and biogenesis P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006921 GO:0006921 cell structure disassembly during apoptosis death P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response signal transduction P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response stress response P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response other metabolic processes P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0008290 GO:0008290 F-actin capping protein complex cytoskeleton C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0030507 GO:0030507 spectrin binding cytoskeletal activity F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response signal transduction P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response stress response P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0032092 GO:0032092 positive regulation of protein binding other biological processes P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0051016 GO:0051016 barbed-end actin filament capping protein metabolism P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0051016 GO:0051016 barbed-end actin filament capping cell organization and biogenesis P ConsensusfromContig2451 sp P35611 ADDA_HUMAN 91.87 123 10 0 1 369 219 341 3E-75 243 P35611 ADDA_HUMAN GO:0008290; GO:0051015; GO:0051017; GO:0006987; GO:0051016; GO:0000902; GO:0006884; GO:0006921; GO:0044267; GO:0071300; GO:0005829; GO:0043197; GO:0030218; GO:0020027; GO:0048873; GO:0001701; GO:0035264; GO:0005634; GO:0048471; GO:0005886; GO:0045766; GO:0045807; GO:0032092; GO:0014069; GO:0030507; GO:0005198 F-actin capping protein complex; actin filament binding; actin filament bundle assembly; activation of signaling protein activity involved in unfolded protein response; barbed-end actin filament capping; cell morphogenesis; cell volume homeostasis; cellular component disassembly involved in execution phase of apoptosis; cellular protein metabolic process; cellular response to retinoic acid; cytosol; dendritic spine; erythrocyte differentiation; hemoglobin metabolic process; homeostasis of number of cells within a tissue; in utero embryonic development; multicellular organism growth; nucleus; perinuclear region of cytoplasm; plasma membrane; positive regulation of angiogenesis; positive regulation of endocytosis; positive regulation of protein binding; postsynaptic density; spectrin binding; structural molecule activity reviewed IPR027766; IPR001303; Alpha-adducin (Erythrocyte adducin subunit alpha) ADD1 ADDA Homo sapiens (Human) 737 P35611 GO:0051017 GO:0051017 actin filament bundle formation cell organization and biogenesis P ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0006415 GO:0006415 translational termination protein metabolism P ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0006415 GO:0006415 translational termination cell organization and biogenesis P ConsensusfromContig5743 sp P35615 ERF1_XENLA 92.78 443 26 1 1833 505 1 437 0 846 P35615 ERF1_XENLA GO:0005737; GO:0000184; GO:0016149 cytoplasm; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; translation release factor activity, codon specific reviewed IPR005140; IPR005141; IPR005142; IPR004403; IPR024049; Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Omnipotent suppressor protein 1 homolog) (SUP1 homolog) etf1 cl1 erf1 Xenopus laevis (African clawed frog) 437 P35615 GO:0016149 GO:0016149 "translation release factor activity, codon specific" nucleic acid binding activity F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0004372 GO:0004372 glycine hydroxymethyltransferase activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006544 GO:0006544 glycine metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006563 GO:0006563 L-serine metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 82.84 268 46 0 1463 660 5 272 0 480 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0030170 GO:0030170 pyridoxal phosphate binding other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0004372 GO:0004372 glycine hydroxymethyltransferase activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006544 GO:0006544 glycine metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006563 GO:0006563 L-serine metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5846 sp P35623 GLYC_SHEEP 76.19 189 45 0 666 100 271 459 0 304 P35623 GLYC_SHEEP GO:0006563; GO:0005737; GO:0004372; GO:0006544; GO:0030170; GO:0035999 L-serine metabolic process; cytoplasm; glycine hydroxymethyltransferase activity; glycine metabolic process; pyridoxal phosphate binding; tetrahydrofolate interconversion reviewed IPR015424; IPR015421; IPR015422; IPR001085; IPR019798; One-carbon metabolism; tetrahydrofolate interconversion. Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase) SHMT1 Ovis aries (Sheep) 484 P35623 GO:0030170 GO:0030170 pyridoxal phosphate binding other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0000506 GO:0000506 glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex ER/Golgi C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0006501 GO:0006501 C-terminal protein lipidation protein metabolism P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0006506 GO:0006506 GPI anchor biosynthetic process protein metabolism P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0008194 GO:0008194 UDP-glycosyltransferase activity other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0009058 GO:0009058 biosynthetic process other metabolic processes P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0009893 GO:0009893 positive regulation of metabolic process other metabolic processes P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0016254 GO:0016254 preassembly of GPI anchor in ER membrane protein metabolism P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0017176 GO:0017176 phosphatidylinositol N-acetylglucosaminyltransferase activity other molecular function F ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig1308 sp P37287 PIGA_HUMAN 68 225 72 0 6 680 234 458 2E-90 281 P37287 PIGA_HUMAN GO:0006501; GO:0005789; GO:0000506; GO:0016021; GO:0017176; GO:0009893; GO:0016254 C-terminal protein lipidation; endoplasmic reticulum membrane; glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex; integral to membrane; phosphatidylinositol N-acetylglucosaminyltransferase activity; positive regulation of metabolic process; preassembly of GPI anchor in ER membrane reviewed IPR001296; IPR013234; Glycolipid biosynthesis; glycosylphosphatidylinositol-anchor biosynthesis. Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A) PIGA Homo sapiens (Human) 484 P37287 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0005884 GO:0005884 actin filament cytoskeleton C ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0014069 GO:0014069 postsynaptic density cytoskeleton C ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0030674 GO:0030674 "protein binding, bridging" other molecular function F ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0031032 GO:0031032 actomyosin structure organization cell organization and biogenesis P ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0032780 GO:0032780 negative regulation of ATPase activity other biological processes P ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig6124 sp P37397 CNN3_RAT 79.52 332 63 3 1877 891 1 330 5E-172 502 P37397 CNN3_RAT GO:0005884; GO:0031032; GO:0043197; GO:0005874; GO:0008017; GO:0032780; GO:0043025; GO:0014069; GO:0030674 actin filament; actomyosin structure organization; dendritic spine; microtubule; microtubule binding; negative regulation of ATPase activity; neuronal cell body; postsynaptic density; protein binding, bridging reviewed IPR001997; IPR000557; IPR001715; IPR003096; Calponin-3 (Calponin, acidic isoform) (Calponin, non-muscle isoform) Cnn3 Rattus norvegicus (Rat) 330 P37397 GO:0043197 GO:0043197 dendritic spine other cellular component C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0002790 GO:0002790 peptide secretion transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005548 GO:0005548 phospholipid transporter activity transporter activity F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006497 GO:0006497 protein amino acid lipidation protein metabolism P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006820 GO:0006820 anion transport transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006911 GO:0006911 "phagocytosis, engulfment" transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0006911 GO:0006911 "phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0007040 GO:0007040 lysosome organization cell organization and biogenesis P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0008509 GO:0008509 anion transmembrane transporter activity transporter activity F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0010875 GO:0010875 positive regulation of cholesterol efflux transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0016197 GO:0016197 endosome transport transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0017127 GO:0017127 cholesterol transporter activity transporter activity F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0030349 GO:0030349 syntaxin-13 binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0030819 GO:0030819 positive regulation of cAMP biosynthetic process other metabolic processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0032367 GO:0032367 intracellular cholesterol transport transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0032488 GO:0032488 Cdc42 protein signal transduction signal transduction P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0033344 GO:0033344 cholesterol efflux transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0033700 GO:0033700 phospholipid efflux transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0034185 GO:0034185 apolipoprotein binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0034186 GO:0034186 apolipoprotein A-I binding other molecular function F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0034188 GO:0034188 apolipoprotein A-I receptor activity signal transduction activity F ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0034380 GO:0034380 high-density lipoprotein particle assembly cell organization and biogenesis P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0038027 ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0042157 GO:0042157 lipoprotein metabolic process other metabolic processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0042158 GO:0042158 lipoprotein biosynthetic process other metabolic processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0042632 GO:0042632 cholesterol homeostasis other biological processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0043691 GO:0043691 reverse cholesterol transport transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0045332 GO:0045332 phospholipid translocation transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0045332 GO:0045332 phospholipid translocation cell organization and biogenesis P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0045335 GO:0045335 phagocytic vesicle other cellular component C ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0050702 GO:0050702 interleukin-1 beta secretion transport P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0055091 GO:0055091 phospholipid homeostasis other biological processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0055099 GO:0055099 response to high density lipoprotein stimulus other biological processes P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0060155 GO:0060155 platelet dense granule organization cell organization and biogenesis P ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0071222 ConsensusfromContig1181 sp P41233 ABCA1_MOUSE 77.5 160 36 0 2 481 2102 2261 1E-78 265 P41233 ABCA1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0007186; GO:0005794; GO:0008509; GO:0034188; GO:0071222; GO:0071300; GO:0033344; GO:0042632; GO:0008203; GO:0017127; GO:0016197; GO:0034380; GO:0005887; GO:0050702; GO:0032367; GO:0007040; GO:0045121; GO:0002790; GO:0045335; GO:0006911; GO:0033700; GO:0055091; GO:0045332; GO:0005548; GO:0060155; GO:0030819; GO:0010875; GO:0006497; GO:0032489; GO:0034616; GO:0055098; GO:0043691 ATP binding; ATP catabolic process; ATPase activity; G-protein coupled receptor signaling pathway; Golgi apparatus; anion transmembrane transporter activity; apolipoprotein A-I receptor activity; cellular response to lipopolysaccharide; cellular response to retinoic acid; cholesterol efflux; cholesterol homeostasis; cholesterol metabolic process; cholesterol transporter activity; endosomal transport; high-density lipoprotein particle assembly; integral to plasma membrane; interleukin-1 beta secretion; intracellular cholesterol transport; lysosome organization; membrane raft; peptide secretion; phagocytic vesicle; phagocytosis, engulfment; phospholipid efflux; phospholipid homeostasis; phospholipid translocation; phospholipid transporter activity; platelet dense granule organization; positive regulation of cAMP biosynthetic process; positive regulation of cholesterol efflux; protein lipidation; regulation of Cdc42 protein signal transduction; response to laminar fluid shear stress; response to low-density lipoprotein particle stimulus; reverse cholesterol transport reviewed IPR003593; IPR026082; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) Abca1 Abc1 Mus musculus (Mouse) 2261 P41233 GO:0071300 ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0004822 GO:0004822 isoleucine-tRNA ligase activity other molecular function F ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0006428 GO:0006428 isoleucyl-tRNA aminoacylation protein metabolism P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0006428 GO:0006428 isoleucyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig4084 sp P41252 SYIC_HUMAN 73.37 184 49 0 3 554 171 354 5E-92 296 P41252 SYIC_HUMAN GO:0005524; GO:0002161; GO:0005829; GO:0004822; GO:0006428; GO:0005634; GO:0006450; GO:0006418 P07814 ATP binding; aminoacyl-tRNA editing activity; cytosol; isoleucine-tRNA ligase activity; isoleucyl-tRNA aminoacylation; nucleus; regulation of translational fidelity; tRNA aminoacylation for protein translation reviewed IPR001412; IPR002300; IPR002301; IPR023586; IPR014729; IPR009080; IPR013155; IPR009008; Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS) IARS Homo sapiens (Human) 1262 P41252 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig446 sp P41732 TSN7_HUMAN 68.83 247 77 0 99 839 3 249 3E-104 314 P41732 TSN7_HUMAN GO:0005887; GO:0019048 integral to plasma membrane; modulation by virus of host morphology or physiology reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) 249 P41732 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig446 sp P41732 TSN7_HUMAN 68.83 247 77 0 99 839 3 249 3E-104 314 P41732 TSN7_HUMAN GO:0005887; GO:0019048 integral to plasma membrane; modulation by virus of host morphology or physiology reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) 249 P41732 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig446 sp P41732 TSN7_HUMAN 68.83 247 77 0 99 839 3 249 3E-104 314 P41732 TSN7_HUMAN GO:0005887; GO:0019048 integral to plasma membrane; modulation by virus of host morphology or physiology reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) 249 P41732 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig446 sp P41732 TSN7_HUMAN 68.83 247 77 0 99 839 3 249 3E-104 314 P41732 TSN7_HUMAN GO:0005887; GO:0019048 integral to plasma membrane; modulation by virus of host morphology or physiology reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) 249 P41732 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig446 sp P41732 TSN7_HUMAN 68.83 247 77 0 99 839 3 249 3E-104 314 P41732 TSN7_HUMAN GO:0005887; GO:0019048 integral to plasma membrane; modulation by virus of host morphology or physiology reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231) TSPAN7 A15 DXS1692E MXS1 TM4SF2 Homo sapiens (Human) 249 P41732 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1804 sp P42025 ACTY_HUMAN 93.9 164 10 0 492 1 67 230 3E-112 331 P42025 ACTY_HUMAN GO:0005524; GO:0019886; GO:0005813; GO:0005829; GO:0005869 Q9QZB7 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; cytosol; dynactin complex reviewed IPR004000; IPR020902; IPR004001; Beta-centractin (Actin-related protein 1B) (ARP1B) ACTR1B CTRN2 Homo sapiens (Human) 376 P42025 GO:0005869 GO:0005869 dynactin complex cytoskeleton C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001030 ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001031 ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001032 ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001156 ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001934 GO:0001934 positive regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0001938 GO:0001938 positive regulation of endothelial cell proliferation cell cycle and proliferation P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0005979 GO:0005979 regulation of glycogen biosynthetic process other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0006109 GO:0006109 regulation of carbohydrate metabolic process other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0007281 GO:0007281 germ cell development other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0010507 GO:0010507 negative regulation of autophagy other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0010592 GO:0010592 positive regulation of lamellipodium assembly cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0012505 GO:0012505 endomembrane system other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016242 GO:0016242 negative regulation of macroautophagy stress response P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016242 GO:0016242 negative regulation of macroautophagy other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0018107 GO:0018107 peptidyl-threonine phosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0030030 GO:0030030 cell projection organization cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031529 GO:0031529 ruffle organization cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031669 GO:0031669 cellular response to nutrient levels other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031929 GO:0031929 TOR signaling pathway signal transduction P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031931 GO:0031931 TORC1 complex other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031932 GO:0031932 TORC2 complex other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0031998 GO:0031998 regulation of fatty acid beta-oxidation other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0032095 GO:0032095 regulation of response to food other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0032314 GO:0032314 regulation of Rac GTPase activity signal transduction P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0032868 GO:0032868 response to insulin stimulus other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0032956 GO:0032956 regulation of actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0043022 GO:0043022 ribosome binding translation activity F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0043200 GO:0043200 response to amino acid stimulus other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0043610 GO:0043610 regulation of carbohydrate utilization other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0045727 GO:0045727 positive regulation of translation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0045792 GO:0045792 negative regulation of cell size other biological processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0045859 GO:0045859 regulation of protein kinase activity other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0045945 GO:0045945 positive regulation of transcription from RNA polymerase III promoter RNA metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0046889 GO:0046889 positive regulation of lipid biosynthetic process other metabolic processes P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0050731 GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0051219 GO:0051219 phosphoprotein binding other molecular function F ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0051496 GO:0051496 positive regulation of stress fiber formation cell organization and biogenesis P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0051534 GO:0051534 negative regulation of NFAT protein import into nucleus transport P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0051897 GO:0051897 positive regulation of protein kinase B signaling cascade signal transduction P ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0070438 GO:0070438 mTOR-FKBP12 complex other cellular component C ConsensusfromContig2008 sp P42346 MTOR_RAT 82.35 119 21 0 1 357 1000 1118 2E-59 204 P42346 MTOR_RAT GO:0005524; GO:0000082; GO:0000139; GO:0016605; GO:0001030; GO:0001031; GO:0001032; GO:0031929; GO:0031931; GO:0031932; GO:0030030; GO:0071456; GO:0031669; GO:0005829; GO:0008144; GO:0005789; GO:0007281; GO:0005764; GO:0070438; GO:0005741; GO:0051534; GO:0010507; GO:0045792; GO:0016242; GO:0005634; GO:0018105; GO:0018107; GO:0030838; GO:0001938; GO:0010592; GO:0046889; GO:0010831; GO:0050731; GO:0051897; GO:0051496; GO:0045945; GO:0045727; GO:0046777; GO:0004674; GO:0032314; GO:0043610; GO:0031998; GO:0005979; GO:0045859; GO:0032095; GO:0043200; GO:0032868; GO:0043022; GO:0031529 Q8TB45 ATP binding; G1/S transition of mitotic cell cycle; Golgi membrane; PML body; RNA polymerase III type 1 promoter DNA binding; RNA polymerase III type 2 promoter DNA binding; RNA polymerase III type 3 promoter DNA binding; TOR signaling cascade; TORC1 complex; TORC2 complex; cell projection organization; cellular response to hypoxia; cellular response to nutrient levels; cytosol; drug binding; endoplasmic reticulum membrane; germ cell development; lysosome; mTOR-FKBP12-rapamycin complex; mitochondrial outer membrane; negative regulation of NFAT protein import into nucleus; negative regulation of autophagy; negative regulation of cell size; negative regulation of macroautophagy; nucleus; peptidyl-serine phosphorylation; peptidyl-threonine phosphorylation; positive regulation of actin filament polymerization; positive regulation of endothelial cell proliferation; positive regulation of lamellipodium assembly; positive regulation of lipid biosynthetic process; positive regulation of myotube differentiation; positive regulation of peptidyl-tyrosine phosphorylation; positive regulation of protein kinase B signaling cascade; positive regulation of stress fiber assembly; positive regulation of transcription from RNA polymerase III promoter; positive regulation of translation; protein autophosphorylation; protein serine/threonine kinase activity; regulation of Rac GTPase activity; regulation of carbohydrate utilization; regulation of fatty acid beta-oxidation; regulation of glycogen biosynthetic process; regulation of protein kinase activity; regulation of response to food; response to amino acid stimulus; response to insulin stimulus; ribosome binding; ruffle organization reviewed IPR011989; IPR016024; IPR024585; IPR003152; IPR011009; IPR000403; IPR018936; IPR003151; IPR014009; IPR009076; IPR026683; IPR011990; Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin target protein 1) (RAPT1) Mtor Frap1 Raft1 Rattus norvegicus (Rat) 2549 P42346 GO:0071456 ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0003785 GO:0003785 actin monomer binding cytoskeletal activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0004715 GO:0004715 non-membrane spanning protein tyrosine kinase activity kinase activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0010506 GO:0010506 regulation of autophagy other metabolic processes P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0010976 GO:0010976 positive regulation of neuron projection development developmental processes P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0010976 GO:0010976 positive regulation of neuron projection development cell organization and biogenesis P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0018108 GO:0018108 peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0030100 GO:0030100 regulation of endocytosis transport P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0030100 GO:0030100 regulation of endocytosis cell organization and biogenesis P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0030155 GO:0030155 regulation of cell adhesion cell adhesion P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0051353 GO:0051353 positive regulation of oxidoreductase activity other biological processes P ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:0071300 ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:2000145 ConsensusfromContig4118 sp P42684 ABL2_HUMAN 95.58 113 5 0 341 3 207 319 5E-58 198 P42684 ABL2_HUMAN GO:0005524; GO:0015629; GO:0051015; GO:0051017; GO:0003785; GO:0007411; GO:0007155; GO:0071300; GO:0005829; GO:0000287; GO:0030145; GO:0004715; GO:0010976; GO:0051353; GO:2000249; GO:0010506; GO:0030155; GO:2000145; GO:0030100; GO:0007165 Q8IZP0; P46108; P00533; P04626; P21860; Q15303; P06241; P62993; P16333; P27986; P19174; Q13671; P12931 ATP binding; actin cytoskeleton; actin filament binding; actin filament bundle assembly; actin monomer binding; axon guidance; cell adhesion; cellular response to retinoic acid; cytosol; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; positive regulation of neuron projection development; positive regulation of oxidoreductase activity; regulation of actin cytoskeleton reorganization; regulation of autophagy; regulation of cell adhesion; regulation of cell motility; regulation of endocytosis; signal transduction reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) ABL2 ABLL ARG Homo sapiens (Human) 1182 P42684 GO:2000249 ConsensusfromContig6117 sp P42696 RBM34_HUMAN 51.43 245 112 3 2401 1688 119 363 2E-67 238 P42696 RBM34_HUMAN GO:0003723; GO:0005730; GO:0000166 RNA binding; nucleolus; nucleotide binding reviewed IPR012677; IPR000504; RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) 430 P42696 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6117 sp P42696 RBM34_HUMAN 51.43 245 112 3 2401 1688 119 363 2E-67 238 P42696 RBM34_HUMAN GO:0003723; GO:0005730; GO:0000166 RNA binding; nucleolus; nucleotide binding reviewed IPR012677; IPR000504; RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) 430 P42696 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6117 sp P42696 RBM34_HUMAN 51.43 245 112 3 2401 1688 119 363 2E-67 238 P42696 RBM34_HUMAN GO:0003723; GO:0005730; GO:0000166 RNA binding; nucleolus; nucleotide binding reviewed IPR012677; IPR000504; RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) 430 P42696 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6117 sp P42696 RBM34_HUMAN 51.43 245 112 3 2401 1688 119 363 2E-67 238 P42696 RBM34_HUMAN GO:0003723; GO:0005730; GO:0000166 RNA binding; nucleolus; nucleotide binding reviewed IPR012677; IPR000504; RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) 430 P42696 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6117 sp P42696 RBM34_HUMAN 51.43 245 112 3 2401 1688 119 363 2E-67 238 P42696 RBM34_HUMAN GO:0003723; GO:0005730; GO:0000166 RNA binding; nucleolus; nucleotide binding reviewed IPR012677; IPR000504; RNA-binding protein 34 (RNA-binding motif protein 34) RBM34 KIAA0117 Homo sapiens (Human) 430 P42696 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0004137 GO:0004137 deoxycytidine kinase activity kinase activity F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0006220 GO:0006220 pyrimidine nucleotide metabolic process other metabolic processes P ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0009165 GO:0009165 nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0017144 GO:0017144 drug metabolic process other metabolic processes P ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0019206 GO:0019206 nucleoside kinase activity kinase activity F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0032548 GO:0032548 pyrimidine deoxyribonucleoside binding other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5686 sp P43346 DCK_MOUSE 71.86 263 69 2 84 866 1 260 1E-143 412 P43346 DCK_MOUSE GO:0005524; GO:0004137; GO:0008144; GO:0005634; GO:0016773; GO:0006220 ATP binding; deoxycytidine kinase activity; drug binding; nucleus; phosphotransferase activity, alcohol group as acceptor; pyrimidine nucleotide metabolic process reviewed IPR002624; IPR027417; Deoxycytidine kinase (dCK) (EC 2.7.1.74) Dck Mus musculus (Mouse) 260 P43346 GO:0046092 GO:0046092 deoxycytidine metabolic process other metabolic processes P ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0004725 GO:0004725 protein tyrosine phosphatase activity other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0004726 GO:0004726 non-membrane spanning protein tyrosine phosphatase activity other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0035335 ConsensusfromContig6201 sp P43378 PTN9_HUMAN 65.99 247 83 1 957 220 339 585 2E-113 347 P43378 PTN9_HUMAN GO:0005737; GO:0004726 P10912; P46459 cytoplasm; non-membrane spanning protein tyrosine phosphatase activity reviewed IPR001251; IPR011074; IPR000387; IPR016130; IPR000242; Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2) PTPN9 Homo sapiens (Human) 593 P43378 GO:0044444 GO:0044444 cytoplasmic part other cellular component C ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig6111 sp P45878 FKBP2_MOUSE 79.29 140 25 2 717 310 1 140 1E-73 228 P45878 FKBP2_MOUSE GO:0005528; GO:0005789; GO:0016020; GO:0003755; GO:0006457 FK506 binding; endoplasmic reticulum membrane; membrane; peptidyl-prolyl cis-trans isomerase activity; protein folding reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase) Fkbp2 Fkbp13 Mus musculus (Mouse) 140 P45878 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005536 GO:0005536 glucose binding other molecular function F ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005978 GO:0005978 glycogen biosynthetic process other metabolic processes P ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0005980 GO:0005980 glycogen catabolic process other metabolic processes P ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0008466 GO:0008466 glycogenin glucosyltransferase activity other molecular function F ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0044281 ConsensusfromContig3728 sp P46976 GLYG_HUMAN 61.11 162 62 1 483 1 102 263 9E-72 226 P46976 GLYG_HUMAN GO:0005829; GO:0005536; GO:0006006; GO:0005978; GO:0005980; GO:0008466; GO:0046872; GO:0044281 P13807 cytosol; glucose binding; glucose metabolic process; glycogen biosynthetic process; glycogen catabolic process; glycogenin glucosyltransferase activity; metal ion binding; small molecule metabolic process reviewed IPR002495; Glycan biosynthesis; glycogen biosynthesis. Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186) GYG1 GYG Homo sapiens (Human) 350 P46976 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0004832 GO:0004832 valine-tRNA ligase activity other molecular function F ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0006438 GO:0006438 valyl-tRNA aminoacylation protein metabolism P ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0006438 GO:0006438 valyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig1916 sp P49696 SYVC_TAKRU 76.74 172 40 0 521 6 817 988 2E-86 280 P49696 SYVC_TAKRU GO:0005524; GO:0002161; GO:0005737; GO:0006450; GO:0004832; GO:0006438 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; regulation of translational fidelity; valine-tRNA ligase activity; valyl-tRNA aminoacylation reviewed IPR001412; IPR002300; IPR010987; IPR004046; IPR014729; IPR010978; IPR009080; IPR013155; IPR019499; IPR009008; IPR002303; Valine--tRNA ligase (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) vars vars1 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 1217 P49696 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008536 GO:0008536 Ran GTPase binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0044281 ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 50.96 314 122 6 875 9 175 481 7E-83 234 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008536 GO:0008536 Ran GTPase binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0044281 ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig6275 sp P49790 NU153_HUMAN 44.07 177 74 8 1395 883 15 172 7E-83 96.3 P49790 NU153_HUMAN GO:0003677; GO:0005975; GO:0019221; GO:0005737; GO:0015758; GO:0051028; GO:0007077; GO:0019048; GO:0046832; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005487; GO:0005730; GO:0005654; GO:0043495; GO:0015031; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0046718; GO:0075732; GO:0016032; GO:0008270 Itself; P29323; Q16539-3 DNA binding; carbohydrate metabolic process; cytokine-mediated signaling pathway; cytoplasm; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; modulation by virus of host morphology or physiology; negative regulation of RNA export from nucleus; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleocytoplasmic transporter activity; nucleolus; nucleoplasm; protein anchor; protein transport; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral entry into host cell; viral penetration into host nucleus; viral process; zinc ion binding reviewed IPR026054; IPR013913; IPR018892; IPR001876; Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) NUP153 Homo sapiens (Human) 1475 P49790 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0031080 GO:0031080 Nup107-160 complex nucleus C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0031080 GO:0031080 Nup107-160 complex other membranes C ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig1448 sp P49793 NUP98_RAT 72.58 124 34 0 377 6 730 853 2E-60 207 P49793 NUP98_RAT GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0031080; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nuclear pore outer ring; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Rattus norvegicus (Rat) 1816 P49793 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0003707 GO:0003707 steroid hormone receptor activity signal transduction activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0004883 GO:0004883 glucocorticoid receptor activity signal transduction activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0005496 GO:0005496 steroid binding other molecular function F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0042921 GO:0042921 glucocorticoid receptor signaling pathway signal transduction P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0043401 GO:0043401 steroid hormone mediated signaling signal transduction P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0043402 GO:0043402 glucocorticoid mediated signaling signal transduction P ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig3583 sp P49843 GCR_ONCMY 93.33 105 7 0 345 31 646 750 3E-61 204 P49843 GCR_ONCMY GO:0016568; GO:0005737; GO:0004883; GO:0005634; GO:0043565; GO:0003700; GO:0005496; GO:0006351; GO:0008270 chromatin modification; cytoplasm; glucocorticoid receptor activity; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid binding; transcription, DNA-dependent; zinc ion binding reviewed IPR001409; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1) nr3c1 grl Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 758 P49843 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0003921 GO:0003921 GMP synthase activity other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0003922 GO:0003922 GMP synthase (glutamine-hydrolyzing) activity other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0006144 GO:0006144 purine base metabolic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0006164 GO:0006164 purine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0006177 GO:0006177 GMP biosynthetic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0006541 GO:0006541 glutamine metabolic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0009113 GO:0009113 purine base biosynthetic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0009168 GO:0009168 purine ribonucleoside monophosphate biosynthetic process other metabolic processes P ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0044281 ConsensusfromContig6033 sp P49915 GUAA_HUMAN 85.16 620 91 1 223 2079 1 620 0 1073 P49915 GUAA_HUMAN GO:0005524; GO:0003922; GO:0003921; GO:0005829; GO:0006541; GO:0009113; GO:0016462 ATP binding; GMP synthase (glutamine-hydrolyzing) activity; GMP synthase activity; cytosol; glutamine metabolic process; purine nucleobase biosynthetic process; pyrophosphatase activity reviewed IPR017926; IPR001674; IPR004739; IPR025777; IPR022310; IPR014729; Purine metabolism; GMP biosynthesis; GMP from XMP (L-Gln route): step 1/1. GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase) GMPS Homo sapiens (Human) 693 P49915 GO:0055086 GO:0055086 "nucleobase, nucleoside and nucleotide metabolic process" other metabolic processes P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0003909 GO:0003909 DNA ligase activity other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0003910 GO:0003910 DNA ligase (ATP) activity other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006266 GO:0006266 DNA ligation DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006284 GO:0006284 base-excision repair stress response P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006284 GO:0006284 base-excision repair DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0007131 GO:0007131 reciprocal meiotic recombination cell cycle and proliferation P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0007131 GO:0007131 reciprocal meiotic recombination DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0033151 GO:0033151 V(D)J recombination developmental processes P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0033151 GO:0033151 V(D)J recombination DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0051103 GO:0051103 DNA ligation during DNA repair stress response P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0051103 GO:0051103 DNA ligation during DNA repair DNA metabolism P ConsensusfromContig1847 sp P49916 DNLI3_HUMAN 81.21 149 27 1 3 446 615 763 3E-79 258 P49916 DNLI3_HUMAN GO:0005524; GO:0003677; GO:0003910; GO:0051103; GO:0006284; GO:0051301; GO:0005694; GO:0006303; GO:0006273; GO:0043504; GO:0045910; GO:0005654; GO:0006289; GO:0007131; GO:0007283; GO:0000795; GO:0008270 ATP binding; DNA binding; DNA ligase (ATP) activity; DNA ligation involved in DNA repair; base-excision repair; cell division; chromosome; double-strand break repair via nonhomologous end joining; lagging strand elongation; mitochondrial DNA repair; negative regulation of DNA recombination; nucleoplasm; nucleotide-excision repair; reciprocal meiotic recombination; spermatogenesis; synaptonemal complex; zinc ion binding reviewed IPR001357; IPR000977; IPR012309; IPR012310; IPR016059; IPR012308; IPR012340; IPR001510; DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) LIG3 Homo sapiens (Human) 1009 P49916 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0001676 GO:0001676 long-chain fatty acid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0004095 GO:0004095 carnitine O-palmitoyltransferase activity other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006641 GO:0006641 triglyceride metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006853 GO:0006853 carnitine shuttle transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0032000 GO:0032000 positive regulation of fatty acid beta-oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042755 GO:0042755 eating behavior other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0044281 ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0046320 GO:0046320 regulation of fatty acid oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0050796 GO:0050796 regulation of insulin secretion transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0050796 GO:0050796 regulation of insulin secretion cell-cell signaling P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 75 140 34 1 1818 1402 575 714 2E-77 219 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0001676 GO:0001676 long-chain fatty acid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0004095 GO:0004095 carnitine O-palmitoyltransferase activity other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006641 GO:0006641 triglyceride metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0006853 GO:0006853 carnitine shuttle transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0032000 GO:0032000 positive regulation of fatty acid beta-oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042755 GO:0042755 eating behavior other biological processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0044281 ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0046320 GO:0046320 regulation of fatty acid oxidation other metabolic processes P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0050796 GO:0050796 regulation of insulin secretion transport P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0050796 GO:0050796 regulation of insulin secretion cell-cell signaling P ConsensusfromContig5999 sp P50416 CPT1A_HUMAN 68.42 57 18 0 1420 1250 709 765 2E-77 92.8 P50416 CPT1A_HUMAN GO:0004095; GO:0009437; GO:0006853; GO:0042755; GO:0006635; GO:0006006; GO:0031307; GO:0001676; GO:0005743; GO:0032000; GO:0051260; GO:0050796; GO:0042493; GO:0014070; GO:0006641 carnitine O-palmitoyltransferase activity; carnitine metabolic process; carnitine shuttle; eating behavior; fatty acid beta-oxidation; glucose metabolic process; integral to mitochondrial outer membrane; long-chain fatty acid metabolic process; mitochondrial inner membrane; positive regulation of fatty acid beta-oxidation; protein homooligomerization; regulation of insulin secretion; response to drug; response to organic cyclic compound; triglyceride metabolic process reviewed IPR000542; Lipid metabolism; fatty acid beta-oxidation. Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) CPT1A CPT1 Homo sapiens (Human) 773 P50416 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0006810 GO:0006810 transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0006885 GO:0006885 regulation of pH other biological processes P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0008104 GO:0008104 protein localization other biological processes P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0015297 GO:0015297 antiporter activity transporter activity F ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0015299 GO:0015299 solute:hydrogen antiporter activity transporter activity F ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0015385 GO:0015385 sodium:hydrogen antiporter activity transporter activity F ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig748 sp P50482 SL9A2_RABIT 65.92 179 61 0 539 3 165 343 3E-64 216 P50482 SL9A2_RABIT GO:0016021; GO:0006885; GO:0015385 integral to membrane; regulation of pH; sodium:hydrogen antiporter activity reviewed IPR006153; IPR018422; IPR001953; IPR004709; Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2) SLC9A2 NHE2 Oryctolagus cuniculus (Rabbit) 809 P50482 GO:0071436 ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0005902 GO:0005902 microvillus other cellular component C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0015991 GO:0015991 ATP hydrolysis coupled proton transport transport P ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0016469 GO:0016469 proton-transporting two-sector ATPase complex other membranes C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0033178 GO:0033178 "proton-transporting two-sector ATPase complex, catalytic domain" other membranes C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0033180 GO:0033180 "proton-transporting V-type ATPase, V1 domain" other membranes C ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0046933 GO:0046933 "hydrogen ion transporting ATP synthase activity, rotational mechanism" transporter activity F ConsensusfromContig6112 sp P50516 VATA_MOUSE 94.3 491 28 0 3 1475 123 613 0 973 P50516 VATA_MOUSE GO:0005524; GO:0015991; GO:0016324; GO:0005829; GO:0005902; GO:0005739; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; apical plasma membrane; cytosol; microvillus; mitochondrion; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) Atp6v1a Atp6a1 Atp6a2 Atp6v1a1 Mus musculus (Mouse) 617 P50516 GO:0046961 GO:0046961 "proton-transporting ATPase activity, rotational mechanism" transporter activity F ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0007062 GO:0007062 sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0007062 GO:0007062 sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0030261 GO:0030261 chromosome condensation cell organization and biogenesis P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0051276 GO:0051276 chromosome organization cell organization and biogenesis P ConsensusfromContig6369 sp P50533 SMC2_XENLA 72.85 523 142 0 1569 1 369 891 0 745 P50533 SMC2_XENLA GO:0005524; GO:0006310; GO:0006281; GO:0051301; GO:0000796; GO:0005829; GO:0007076; GO:0005634; GO:0007062 ATP binding; DNA recombination; DNA repair; cell division; condensin complex; cytosol; mitotic chromosome condensation; nucleus; sister chromatid cohesion reviewed IPR027417; IPR003395; IPR024704; IPR027120; IPR010935; Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome assembly protein XCAP-E) (Chromosome-associated protein E) smc2 cape smc2l1 Xenopus laevis (African clawed frog) 1203 P50533 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0004177 GO:0004177 aminopeptidase activity other molecular function F ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0008235 GO:0008235 metalloexopeptidase activity other molecular function F ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0009987 GO:0009987 cellular process other biological processes P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0016485 GO:0016485 protein processing protein metabolism P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0018206 GO:0018206 peptidyl-methionine modification protein metabolism P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0031365 GO:0031365 N-terminal protein amino acid modification protein metabolism P ConsensusfromContig5553 sp P50579 MAP2_HUMAN 91.11 371 33 0 509 1621 108 478 0 729 P50579 MAP2_HUMAN GO:0031365; GO:0004177; GO:0005829; GO:0046872; GO:0008235; GO:0018206; GO:0016485; GO:0006508; GO:0022400; GO:0016056 N-terminal protein amino acid modification; aminopeptidase activity; cytosol; metal ion binding; metalloexopeptidase activity; peptidyl-methionine modification; protein processing; proteolysis; regulation of rhodopsin mediated signaling pathway; rhodopsin mediated signaling pathway reviewed IPR001714; IPR000994; IPR002468; IPR018349; IPR011991; Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M) METAP2 MNPEP P67EIF2 Homo sapiens (Human) 478 P50579 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0004652 GO:0004652 polynucleotide adenylyltransferase activity other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0043631 GO:0043631 RNA polyadenylation RNA metabolism P ConsensusfromContig2688 sp P51006 PAPO3_XENLA 88.17 279 30 1 852 25 110 388 5E-173 491 P51006 PAPO3_XENLA GO:0005524; GO:0003723; GO:0043631; GO:0006397; GO:0046872; GO:0005634; GO:0004652 ATP binding; RNA binding; RNA polyadenylation; mRNA processing; metal ion binding; nucleus; polynucleotide adenylyltransferase activity reviewed IPR002934; IPR007012; IPR014492; Poly(A) polymerase type 3 (PAP) (EC 2.7.7.19) (Polynucleotide adenylyltransferase) (Fragment) Xenopus laevis (African clawed frog) 400 P51006 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2635 sp P51112 HD_TAKRU 92.36 157 12 0 568 98 2992 3148 5E-94 306 P51112 HD_TAKRU GO:0005737; GO:0005634; GO:0048513; GO:0008134 cytoplasm; nucleus; organ development; transcription factor binding reviewed IPR011989; IPR016024; IPR021133; IPR000091; IPR024613; Huntingtin (Huntington disease protein homolog) (HD protein homolog) htt hd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 3148 P51112 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2635 sp P51112 HD_TAKRU 92.36 157 12 0 568 98 2992 3148 5E-94 306 P51112 HD_TAKRU GO:0005737; GO:0005634; GO:0048513; GO:0008134 cytoplasm; nucleus; organ development; transcription factor binding reviewed IPR011989; IPR016024; IPR021133; IPR000091; IPR024613; Huntingtin (Huntington disease protein homolog) (HD protein homolog) htt hd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 3148 P51112 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2635 sp P51112 HD_TAKRU 92.36 157 12 0 568 98 2992 3148 5E-94 306 P51112 HD_TAKRU GO:0005737; GO:0005634; GO:0048513; GO:0008134 cytoplasm; nucleus; organ development; transcription factor binding reviewed IPR011989; IPR016024; IPR021133; IPR000091; IPR024613; Huntingtin (Huntington disease protein homolog) (HD protein homolog) htt hd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 3148 P51112 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2635 sp P51112 HD_TAKRU 92.36 157 12 0 568 98 2992 3148 5E-94 306 P51112 HD_TAKRU GO:0005737; GO:0005634; GO:0048513; GO:0008134 cytoplasm; nucleus; organ development; transcription factor binding reviewed IPR011989; IPR016024; IPR021133; IPR000091; IPR024613; Huntingtin (Huntington disease protein homolog) (HD protein homolog) htt hd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 3148 P51112 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig2635 sp P51112 HD_TAKRU 92.36 157 12 0 568 98 2992 3148 5E-94 306 P51112 HD_TAKRU GO:0005737; GO:0005634; GO:0048513; GO:0008134 cytoplasm; nucleus; organ development; transcription factor binding reviewed IPR011989; IPR016024; IPR021133; IPR000091; IPR024613; Huntingtin (Huntington disease protein homolog) (HD protein homolog) htt hd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 3148 P51112 GO:0048513 GO:0048513 organ development developmental processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0010628 GO:0010628 positive regulation of gene expression other metabolic processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0019046 GO:0019046 reactivation of latent virus other biological processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0043254 GO:0043254 regulation of protein complex assembly cell organization and biogenesis P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0048188 GO:0048188 Set1C/COMPASS complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070461 GO:0070461 SAGA-type complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070688 GO:0070688 MLL5-L complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 90.71 140 13 0 420 1 162 301 2E-86 270 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0071339 ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0010628 GO:0010628 positive regulation of gene expression other metabolic processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0019046 GO:0019046 reactivation of latent virus other biological processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0043254 GO:0043254 regulation of protein complex assembly cell organization and biogenesis P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0048188 GO:0048188 Set1C/COMPASS complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070461 GO:0070461 SAGA-type complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070688 GO:0070688 MLL5-L complex nucleus C ConsensusfromContig3705 sp P51610 HCFC1_HUMAN 100 29 0 0 502 416 135 163 2E-86 70.1 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0071339 ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0010628 GO:0010628 positive regulation of gene expression other metabolic processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0019046 GO:0019046 reactivation of latent virus other biological processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0043254 GO:0043254 regulation of protein complex assembly cell organization and biogenesis P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0048188 GO:0048188 Set1C/COMPASS complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070461 GO:0070461 SAGA-type complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070688 GO:0070688 MLL5-L complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 85.59 118 17 0 356 3 210 327 3E-69 231 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0071339 ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0010628 GO:0010628 positive regulation of gene expression other metabolic processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0019046 GO:0019046 reactivation of latent virus other biological processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0043254 GO:0043254 regulation of protein complex assembly cell organization and biogenesis P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0048188 GO:0048188 Set1C/COMPASS complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070461 GO:0070461 SAGA-type complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0070688 GO:0070688 MLL5-L complex nucleus C ConsensusfromContig3678 sp P51610 HCFC1_HUMAN 70.59 34 7 1 450 349 182 212 3E-69 50.4 P51610 HCFC1_HUMAN GO:0071339; GO:0070688; GO:0048188; GO:0007049; GO:0003682; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0005739; GO:0019048; GO:0000122; GO:0043025; GO:0045787; GO:0010628; GO:0050821; GO:0043254; GO:0019046; GO:0003700; GO:0003713; GO:0006366 Itself; Q9UBL3; O43889; O43889-2; Q9NS37; O43524; Q06546; Q06547; Q06547-2; Q13547; Q92769; O15294; O15047; Q96ST3; Q96EB6; P08047; Q9H7L9; Q96EK4; P61964; Q13105 MLL1 complex; MLL5-L complex; Set1C/COMPASS complex; cell cycle; chromatin binding; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; mitochondrion; modulation by virus of host morphology or physiology; negative regulation of transcription from RNA polymerase II promoter; neuronal cell body; positive regulation of cell cycle; positive regulation of gene expression; protein stabilization; regulation of protein complex assembly; release from viral latency; sequence-specific DNA binding transcription factor activity; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR003961; IPR015916; IPR013783; IPR015915; IPR006652; Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6] HCFC1 HCF1 HFC1 Homo sapiens (Human) 2035 P51610 GO:0071339 ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5998 sp P51643 ARF1_XENLA 97.25 109 3 0 1840 1514 73 181 4E-68 226 P51643 ARF1_XENLA GO:0005525; GO:0005794; GO:0015031; GO:0007264; GO:0016192 GTP binding; Golgi apparatus; protein transport; small GTPase mediated signal transduction; vesicle-mediated transport reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor 1 arf1 Xenopus laevis (African clawed frog) 181 P51643 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0000038 GO:0000038 very-long-chain fatty acid metabolic process other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0032934 GO:0032934 sterol binding other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0033989 GO:0033989 "3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity" other molecular function F ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig430 sp P51660 DHB4_MOUSE 66.5 197 66 0 1 591 512 708 2E-86 276 P51660 DHB4_MOUSE GO:0033989; GO:0060009; GO:0006635; GO:0016853; GO:0005739; GO:0016616; GO:0005777; GO:0032934; GO:0000038 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity; Sertoli cell development; fatty acid beta-oxidation; isomerase activity; mitochondrion; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; peroxisome; sterol binding; very long-chain fatty acid metabolic process reviewed IPR002198; IPR002347; IPR002539; IPR016040; IPR020904; IPR003033; Lipid metabolism; fatty acid beta-oxidation. Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)] Hsd17b4 Edh17b4 Mus musculus (Mouse) 735 P51660 GO:0060009 GO:0060009 Sertoli cell development developmental processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0001501 GO:0001501 skeletal system development developmental processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002224 GO:0002224 toll-like receptor signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002224 GO:0002224 toll-like receptor signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002756 GO:0002756 MyD88-independent toll-like receptor signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0002756 GO:0002756 MyD88-independent toll-like receptor signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0008063 GO:0008063 Toll signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0030307 GO:0030307 positive regulation of cell growth other biological processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0032496 GO:0032496 response to lipopolysaccharide other biological processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034130 GO:0034130 toll-like receptor 1 signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034130 GO:0034130 toll-like receptor 1 signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034134 GO:0034134 toll-like receptor 2 signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034134 GO:0034134 toll-like receptor 2 signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034138 GO:0034138 toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034138 GO:0034138 toll-like receptor 3 signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034142 GO:0034142 toll-like receptor 4 signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0034142 GO:0034142 toll-like receptor 4 signaling pathway stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0035666 ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043027 GO:0043027 caspase inhibitor activity enzyme regulator activity F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043154 GO:0043154 negative regulation of caspase activity death P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043555 GO:0043555 regulation of translation in response to stress stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043555 GO:0043555 regulation of translation in response to stress protein metabolism P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043620 GO:0043620 regulation of transcription in response to stress stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0043620 GO:0043620 regulation of transcription in response to stress RNA metabolism P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0045597 GO:0045597 positive regulation of cell differentiation other biological processes P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0051403 GO:0051403 stress-activated MAPK cascade signal transduction P ConsensusfromContig234 sp P51812 KS6A3_HUMAN 86.78 121 16 0 2 364 235 355 1E-68 226 P51812 KS6A3_HUMAN GO:0005524; GO:0002755; GO:0035666; GO:0007411; GO:0007049; GO:0007417; GO:0043027; GO:0005829; GO:0045087; GO:0000287; GO:0043066; GO:0048011; GO:0005654; GO:0045597; GO:0030307; GO:0045944; GO:0004674; GO:0043620; GO:0043555; GO:0032496; GO:0001501; GO:0051403; GO:0007268; GO:0034166; GO:0034134; GO:0034138; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124 ATP binding; MyD88-dependent toll-like receptor signaling pathway; TRIF-dependent toll-like receptor signaling pathway; axon guidance; cell cycle; central nervous system development; cysteine-type endopeptidase inhibitor activity involved in apoptotic process; cytosol; innate immune response; magnesium ion binding; negative regulation of apoptotic process; neurotrophin TRK receptor signaling pathway; nucleoplasm; positive regulation of cell differentiation; positive regulation of cell growth; positive regulation of transcription from RNA polymerase II promoter; protein serine/threonine kinase activity; regulation of DNA-dependent transcription in response to stress; regulation of translation in response to stress; response to lipopolysaccharide; skeletal system development; stress-activated MAPK cascade; synaptic transmission; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 3 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway reviewed IPR000961; IPR011009; IPR017892; IPR000719; IPR017441; IPR016239; IPR002290; IPR008271; Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2) RPS6KA3 ISPK1 MAPKAPK1B RSK2 Homo sapiens (Human) 740 P51812 GO:0051403 GO:0051403 stress-activated MAPK cascade stress response P ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0004016 GO:0004016 adenylate cyclase activity other molecular function F ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0006171 GO:0006171 cAMP biosynthetic process other metabolic processes P ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0007190 GO:0007190 activation of adenylate cyclase activity other metabolic processes P ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0009190 GO:0009190 cyclic nucleotide biosynthetic process other metabolic processes P ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0016849 GO:0016849 phosphorus-oxygen lyase activity other molecular function F ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0035556 ConsensusfromContig4063 sp P51830 ADCY9_MOUSE 89.22 102 11 0 306 1 411 512 6E-62 209 P51830 ADCY9_MOUSE GO:0005524; GO:0007190; GO:0004016; GO:0016021; GO:0035556; GO:0046872; GO:0005886 ATP binding; activation of adenylate cyclase activity; adenylate cyclase activity; integral to membrane; intracellular signal transduction; metal ion binding; plasma membrane reviewed IPR001054; IPR018297; Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (Adenylyl cyclase 9) (Adenylyl cyclase type 10) (ACTP10) Adcy9 Mus musculus (Mouse) 1353 P51830 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0005313 GO:0005313 L-glutamate transmembrane transporter activity transporter activity F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0006835 GO:0006835 dicarboxylic acid transport transport P ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0015501 GO:0015501 glutamate:sodium symporter activity transporter activity F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0015813 GO:0015813 L-glutamate transport transport P ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0016595 GO:0016595 glutamate binding other molecular function F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0017153 GO:0017153 sodium:dicarboxylate symporter activity transporter activity F ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0051938 GO:0051938 L-glutamate import transport P ConsensusfromContig1582 sp P51906 EAA3_MOUSE 77.25 167 35 3 610 119 357 523 9E-80 253 P51906 EAA3_MOUSE GO:0070779; GO:0051938; GO:0016595; GO:0015501; GO:0016021; GO:0005886; GO:0051260; GO:0017153 P53702 D-aspartate import; L-glutamate import; glutamate binding; glutamate:sodium symporter activity; integral to membrane; plasma membrane; protein homooligomerization; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1) Slc1a1 Eaac1 Eaat3 Mus musculus (Mouse) 523 P51906 GO:0070779 GO:0070779 transport ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0006835 GO:0006835 dicarboxylic acid transport transport P ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0017153 GO:0017153 sodium:dicarboxylate symporter activity transporter activity F ConsensusfromContig2766 sp P51912 AAAT_MOUSE 87.41 135 16 1 2 403 364 498 4E-72 232 P51912 AAAT_MOUSE GO:0016021; GO:0042470; GO:0015175; GO:0017153 integral to membrane; melanosome; neutral amino acid transmembrane transporter activity; sodium:dicarboxylate symporter activity reviewed IPR001991; IPR018107; Neutral amino acid transporter B(0) (ATB(0)) (ASC-like Na(+)-dependent neutral amino acid transporter ASCT2) (Insulin-activated amino acid transporter) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5) Slc1a5 Aaat Asct2 Slc1a7 Mus musculus (Mouse) 553 P51912 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0030424 GO:0030424 axon other cellular component C ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig632 sp P51956 NEK3_HUMAN 69.71 175 51 1 520 2 33 207 4E-88 273 P51956 NEK3_HUMAN GO:0005524; GO:0030424; GO:0051301; GO:0005737; GO:0046872; GO:0007067; GO:0005634; GO:0004674 P52735 ATP binding; axon; cell division; cytoplasm; metal ion binding; mitosis; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3) NEK3 Homo sapiens (Human) 506 P51956 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig6195 sp P52293 IMA1_MOUSE 73.48 509 133 2 50 1576 13 519 0 768 P52293 IMA1_MOUSE GO:0005737; GO:0005634; GO:0006606; GO:0008565 P03070; P01580; P29034; Q3SYU7 cytoplasm; nucleus; protein import into nucleus; protein transporter activity reviewed IPR011989; IPR016024; IPR000225; IPR002652; IPR024931; Importin subunit alpha-1 (Importin alpha P1) (Karyopherin subunit alpha-2) (Pendulin) (Pore targeting complex 58 kDa subunit) (PTAC58) (RAG cohort protein 1) (SRP1-alpha) Kpna2 Rch1 Mus musculus (Mouse) 529 P52293 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0004222 GO:0004222 metalloendopeptidase activity other molecular function F ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0008237 GO:0008237 metallopeptidase activity other molecular function F ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig5868 sp P52888 THOP1_HUMAN 77.43 607 136 1 2081 261 84 689 0 1000 P52888 THOP1_HUMAN GO:0005737; GO:0007243; GO:0046872; GO:0004222; GO:0042277; GO:0006518; GO:0006508 P62161 cytoplasm; intracellular protein kinase cascade; metal ion binding; metalloendopeptidase activity; peptide binding; peptide metabolic process; proteolysis reviewed IPR024079; IPR024077; IPR024080; IPR001567; Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78) THOP1 Homo sapiens (Human) 689 P52888 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005814 GO:0005814 centriole cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007052 GO:0007052 mitotic spindle organization cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007052 GO:0007052 mitotic spindle organization cell organization and biogenesis P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007093 GO:0007093 mitotic cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007265 GO:0007265 Ras protein signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007613 GO:0007613 memory other biological processes P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0032486 GO:0032486 Rap protein signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0046599 GO:0046599 regulation of centriole replication cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0046599 GO:0046599 regulation of centriole replication cell organization and biogenesis P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0048167 GO:0048167 regulation of synaptic plasticity cell-cell signaling P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0060291 GO:0060291 long-term synaptic potentiation cell-cell signaling P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 65.55 418 116 5 3157 1988 1 418 2E-171 526 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0060292 GO:0060292 long term synaptic depression cell-cell signaling P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005814 GO:0005814 centriole cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007052 GO:0007052 mitotic spindle organization cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007052 GO:0007052 mitotic spindle organization cell organization and biogenesis P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007093 GO:0007093 mitotic cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007265 GO:0007265 Ras protein signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0007613 GO:0007613 memory other biological processes P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0032486 GO:0032486 Rap protein signal transduction signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0046599 GO:0046599 regulation of centriole replication cell cycle and proliferation P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0046599 GO:0046599 regulation of centriole replication cell organization and biogenesis P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0048167 GO:0048167 regulation of synaptic plasticity cell-cell signaling P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0060291 GO:0060291 long-term synaptic potentiation cell-cell signaling P ConsensusfromContig5625 sp P53351 PLK2_MOUSE 69.51 246 75 0 1785 1048 436 681 3E-114 375 P53351 PLK2_MOUSE GO:0005524; GO:0000082; GO:0032486; GO:0005814; GO:0030425; GO:0060292; GO:0060291; GO:0007613; GO:0007093; GO:0007052; GO:0043066; GO:0043123; GO:0004674; GO:0046599; GO:0004871 ATP binding; G1/S transition of mitotic cell cycle; Rap protein signal transduction; centriole; dendrite; long term synaptic depression; long-term synaptic potentiation; memory; mitotic cell cycle checkpoint; mitotic spindle organization; negative regulation of apoptotic process; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein serine/threonine kinase activity; regulation of centriole replication; signal transducer activity reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (Serine/threonine-protein kinase SNK) (Serum-inducible kinase) Plk2 Snk Mus musculus (Mouse) 682 P53351 GO:0060292 GO:0060292 long term synaptic depression cell-cell signaling P ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig6235 sp P53450 FOS_TAKRU 61.28 359 124 8 1238 195 22 376 1E-93 293 P53450 FOS_TAKRU GO:0005634; GO:0043565; GO:0003700 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR004827; IPR000837; Proto-oncogene c-Fos (Cellular oncogene fos) fos Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 376 P53450 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig5622 sp P53451 TCPD_TAKRU 87.5 536 63 1 1942 347 1 536 0 910 P53451 TCPD_TAKRU GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012717; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) cct4 cctd Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 536 P53451 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5746 sp P54864 JUN_SERCA 60.06 313 119 4 1301 372 5 314 6E-111 340 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig6334 sp P54864 JUN_SERCA 71.19 177 44 3 610 83 1 171 1E-79 251 P54864 JUN_SERCA GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR015558; IPR005643; IPR002112; IPR008917; Transcription factor AP-1 (Proto-oncogene c-Jun) JUN Serinus canaria (Island canary) (Fringilla canaria) 314 P54864 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005158 GO:0005158 insulin receptor binding signal transduction activity F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005200 GO:0005200 structural constituent of cytoskeleton cytoskeletal activity F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0007016 GO:0007016 cytoskeletal anchoring at plasma membrane cell organization and biogenesis P ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0032587 GO:0032587 ruffle membrane plasma membrane C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0032587 GO:0032587 ruffle membrane other membranes C ConsensusfromContig2042 sp P54939 TLN1_CHICK 86.03 136 19 0 2 409 718 853 3E-71 240 P54939 TLN1_CHICK GO:0015629; GO:0007155; GO:0009986; GO:0007016; GO:0005829; GO:0005925; GO:0001726; GO:0032587; GO:0005200 P05106 actin cytoskeleton; cell adhesion; cell surface; cytoskeletal anchoring at plasma membrane; cytosol; focal adhesion; ruffle; ruffle membrane; structural constituent of cytoskeleton reviewed IPR019749; IPR014352; IPR019748; IPR019747; IPR000299; IPR018979; IPR002558; IPR002404; IPR011993; IPR015710; IPR015224; IPR015009; IPR006077; Talin-1 TLN1 TLN Gallus gallus (Chicken) 2541 P54939 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0001965 GO:0001965 G-protein alpha-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002286 GO:0002286 T cell activation during immune response other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002690 GO:0002690 positive regulation of leukocyte chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002741 GO:0002741 positive regulation of cytokine secretion during immune response transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004930 GO:0004930 G-protein coupled receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0006954 GO:0006954 inflammatory response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007204 GO:0007204 elevation of cytosolic calcium ion concentration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0010804 GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0014068 GO:0014068 positive regulation of phosphoinositide 3-kinase cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0015057 GO:0015057 thrombin receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030193 GO:0030193 regulation of blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030335 GO:0030335 positive regulation of cell migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization protein metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031143 GO:0031143 pseudopodium other cellular component C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031274 GO:0031274 positive regulation of pseudopodium assembly cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031681 GO:0031681 G-protein beta-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0032930 GO:0032930 positive regulation of superoxide release other metabolic processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035025 GO:0035025 positive regulation of Rho protein signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035926 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0042119 GO:0042119 neutrophil activation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043122 GO:0043122 regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043311 GO:0043311 positive regulation of eosinophil degranulation transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045909 GO:0045909 positive regulation of vasodilation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050702 GO:0050702 interleukin-1 beta secretion transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050921 GO:0050921 positive regulation of chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050927 GO:0050927 positive regulation of positive chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0051607 GO:0051607 defense response to virus stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0061028 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070374 GO:0070374 positive regulation of ERK1 and ERK2 cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070493 GO:0070493 thrombin receptor signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070661 GO:0070661 leukocyte proliferation cell cycle and proliferation P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070963 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072608 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072643 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090195 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090198 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0097029 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000484 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 55.47 247 105 2 1113 373 79 320 4E-87 253 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000778 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0001965 GO:0001965 G-protein alpha-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002286 GO:0002286 T cell activation during immune response other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002690 GO:0002690 positive regulation of leukocyte chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002741 GO:0002741 positive regulation of cytokine secretion during immune response transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004930 GO:0004930 G-protein coupled receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0006954 GO:0006954 inflammatory response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007204 GO:0007204 elevation of cytosolic calcium ion concentration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0010804 GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0014068 GO:0014068 positive regulation of phosphoinositide 3-kinase cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0015057 GO:0015057 thrombin receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030193 GO:0030193 regulation of blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030335 GO:0030335 positive regulation of cell migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization protein metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031143 GO:0031143 pseudopodium other cellular component C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031274 GO:0031274 positive regulation of pseudopodium assembly cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031681 GO:0031681 G-protein beta-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0032930 GO:0032930 positive regulation of superoxide release other metabolic processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035025 GO:0035025 positive regulation of Rho protein signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035926 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0042119 GO:0042119 neutrophil activation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043122 GO:0043122 regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043311 GO:0043311 positive regulation of eosinophil degranulation transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045909 GO:0045909 positive regulation of vasodilation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050702 GO:0050702 interleukin-1 beta secretion transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050921 GO:0050921 positive regulation of chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050927 GO:0050927 positive regulation of positive chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0051607 GO:0051607 defense response to virus stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0061028 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070374 GO:0070374 positive regulation of ERK1 and ERK2 cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070493 GO:0070493 thrombin receptor signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070661 GO:0070661 leukocyte proliferation cell cycle and proliferation P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070963 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072608 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072643 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090195 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090198 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0097029 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000484 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 56.67 60 26 0 391 212 315 374 4E-87 88.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000778 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0001965 GO:0001965 G-protein alpha-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002286 GO:0002286 T cell activation during immune response other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002690 GO:0002690 positive regulation of leukocyte chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0002741 GO:0002741 positive regulation of cytokine secretion during immune response transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0004930 GO:0004930 G-protein coupled receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0006954 GO:0006954 inflammatory response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007204 GO:0007204 elevation of cytosolic calcium ion concentration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0010804 GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0014068 GO:0014068 positive regulation of phosphoinositide 3-kinase cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0015057 GO:0015057 thrombin receptor activity signal transduction activity F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030193 GO:0030193 regulation of blood coagulation stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030335 GO:0030335 positive regulation of cell migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization protein metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0030836 GO:0030836 positive regulation of actin filament depolymerization cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031143 GO:0031143 pseudopodium other cellular component C ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031274 GO:0031274 positive regulation of pseudopodium assembly cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0031681 GO:0031681 G-protein beta-subunit binding other molecular function F ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0032930 GO:0032930 positive regulation of superoxide release other metabolic processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034137 GO:0034137 positive regulation of toll-like receptor 2 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034140 GO:0034140 negative regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034141 GO:0034141 positive regulation of toll-like receptor 3 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0034145 GO:0034145 positive regulation of toll-like receptor 4 signaling pathway stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035025 GO:0035025 positive regulation of Rho protein signal transduction signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0035926 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0042119 GO:0042119 neutrophil activation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043122 GO:0043122 regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0043311 GO:0043311 positive regulation of eosinophil degranulation transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045909 GO:0045909 positive regulation of vasodilation other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046328 GO:0046328 regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046329 GO:0046329 negative regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0046330 GO:0046330 positive regulation of JNK cascade stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050702 GO:0050702 interleukin-1 beta secretion transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050900 GO:0050900 leukocyte migration other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050921 GO:0050921 positive regulation of chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0050927 GO:0050927 positive regulation of positive chemotaxis other biological processes P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0051607 GO:0051607 defense response to virus stress response P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" transport P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0060100 GO:0060100 "positive regulation of phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0061028 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070374 GO:0070374 positive regulation of ERK1 and ERK2 cascade signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070493 GO:0070493 thrombin receptor signaling pathway signal transduction P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070661 GO:0070661 leukocyte proliferation cell cycle and proliferation P ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0070963 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072608 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0072643 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090195 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0090198 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:0097029 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000484 ConsensusfromContig5571 sp P55085 PAR2_HUMAN 34.04 47 21 1 1220 1110 33 79 4E-87 24.6 P55085 PAR2_HUMAN GO:0001965; GO:0031681; GO:0004930; GO:0005794; GO:0002286; GO:0007596; GO:0035926; GO:0051607; GO:0007204; GO:0061028; GO:0006954; GO:0045087; GO:0005887; GO:0072643; GO:0050702; GO:0072608; GO:0050900; GO:0070661; GO:0097029; GO:0046329; GO:0090198; GO:0034140; GO:0010804; GO:0042119; GO:0070374; GO:0043123; GO:0046330; GO:0035025; GO:0030836; GO:0002741; GO:0043311; GO:0003104; GO:2000778; GO:2000484; GO:0002690; GO:0070963; GO:0060100; GO:0014068; GO:0050927; GO:0031274; GO:1900135; GO:0032930; GO:0034137; GO:0034141; GO:0034145; GO:0045944; GO:0045909; GO:0031143; GO:0005102; GO:0030193; GO:0015057 P22681; Q92905; Q14868; Q15363 G-protein alpha-subunit binding; G-protein beta-subunit binding; G-protein coupled receptor activity; Golgi apparatus; T cell activation involved in immune response; blood coagulation; chemokine (C-C motif) ligand 2 secretion; defense response to virus; elevation of cytosolic calcium ion concentration; establishment of endothelial barrier; inflammatory response; innate immune response; integral to plasma membrane; interferon-gamma secretion; interleukin-1 beta secretion; interleukin-10 secretion; leukocyte migration; leukocyte proliferation; mature dendritic cell differentiation; negative regulation of JNK cascade; negative regulation of chemokine secretion; negative regulation of toll-like receptor 3 signaling pathway; negative regulation of tumor necrosis factor-mediated signaling pathway; neutrophil activation; positive regulation of ERK1 and ERK2 cascade; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of JNK cascade; positive regulation of Rho protein signal transduction; positive regulation of actin filament depolymerization; positive regulation of cytokine secretion involved in immune response; positive regulation of eosinophil degranulation; positive regulation of glomerular filtration; positive regulation of interleukin-6 secretion; positive regulation of interleukin-8 secretion; positive regulation of leukocyte chemotaxis; positive regulation of neutrophil mediated killing of gram-negative bacterium; positive regulation of phagocytosis, engulfment; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of positive chemotaxis; positive regulation of pseudopodium assembly; positive regulation of renin secretion into blood stream; positive regulation of superoxide anion generation; positive regulation of toll-like receptor 2 signaling pathway; positive regulation of toll-like receptor 3 signaling pathway; positive regulation of toll-like receptor 4 signaling pathway; positive regulation of transcription from RNA polymerase II promoter; positive regulation of vasodilation; pseudopodium; receptor binding; regulation of blood coagulation; thrombin receptor activity reviewed IPR000276; IPR017452; IPR002281; IPR003912; Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] F2RL1 GPR11 PAR2 Homo sapiens (Human) 397 P55085 GO:2000778 ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0007611 GO:0007611 learning or memory other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0009749 GO:0009749 response to glucose stimulus other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0010033 GO:0010033 response to organic substance other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0010038 GO:0010038 response to metal ion other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0010165 GO:0010165 response to X-ray other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0016005 GO:0016005 phospholipase A2 activator activity enzyme regulator activity F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0021766 GO:0021766 hippocampus development developmental processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0032025 GO:0032025 response to cobalt ion other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0032355 GO:0032355 response to estradiol stimulus other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0032496 GO:0032496 response to lipopolysaccharide other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0034349 GO:0034349 glial cell apoptosis death P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0035094 GO:0035094 response to nicotine other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0035556 ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0042542 GO:0042542 response to hydrogen peroxide stress response P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0043200 GO:0043200 response to amino acid stimulus other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0043525 GO:0043525 positive regulation of neuron apoptosis death P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0046677 GO:0046677 response to antibiotic other biological processes P ConsensusfromContig6267 sp P55213 CASP3_RAT 62.76 239 87 1 1037 327 37 275 4E-105 318 P55213 CASP3_RAT GO:0071407; GO:0004197; GO:0008234; GO:0005829; GO:0034349; GO:0021766; GO:0035556; GO:0007611; GO:0030182; GO:0016005; GO:0043525; GO:0006508; GO:0010165; GO:0043200; GO:0046677; GO:0032025; GO:0042493; GO:0032355; GO:0051384; GO:0009749; GO:0042542; GO:0001666; GO:0032496; GO:0035094; GO:0042060 cellular response to organic cyclic compound; cysteine-type endopeptidase activity; cysteine-type peptidase activity; cytosol; glial cell apoptotic process; hippocampus development; intracellular signal transduction; learning or memory; neuron differentiation; phospholipase A2 activator activity; positive regulation of neuron apoptotic process; proteolysis; response to X-ray; response to amino acid stimulus; response to antibiotic; response to cobalt ion; response to drug; response to estradiol stimulus; response to glucocorticoid stimulus; response to glucose stimulus; response to hydrogen peroxide; response to hypoxia; response to lipopolysaccharide; response to nicotine; wound healing reviewed IPR011600; IPR001309; IPR016129; IPR002138; IPR015917; Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (IRP) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12] Casp3 Cpp32 Rattus norvegicus (Rat) 277 P55213 GO:0051384 GO:0051384 response to glucocorticoid stimulus other biological processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000176 GO:0000176 nuclear exosome (RNase complex) nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000460 GO:0000460 maturation of 5.8S rRNA RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000956 GO:0000956 nuclear-transcribed mRNA catabolic process RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0008408 GO:0008408 3'-5' exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0035327 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071028 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071034 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071035 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071044 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 51 500 204 10 1735 269 377 846 0 460 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071048 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000176 GO:0000176 nuclear exosome (RNase complex) nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000460 GO:0000460 maturation of 5.8S rRNA RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000956 GO:0000956 nuclear-transcribed mRNA catabolic process RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0008408 GO:0008408 3'-5' exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0035327 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071028 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071034 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071035 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071044 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 60 230 86 3 2839 2162 7 234 0 290 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071048 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000176 GO:0000176 nuclear exosome (RNase complex) nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000460 GO:0000460 maturation of 5.8S rRNA RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000956 GO:0000956 nuclear-transcribed mRNA catabolic process RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0008408 GO:0008408 3'-5' exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0035327 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071028 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071034 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071035 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071044 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 65.67 134 46 0 2162 1761 234 367 0 193 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071048 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000176 GO:0000176 nuclear exosome (RNase complex) nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000460 GO:0000460 maturation of 5.8S rRNA RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000956 GO:0000956 nuclear-transcribed mRNA catabolic process RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0008408 GO:0008408 3'-5' exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0035327 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071028 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071034 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071035 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071044 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 72 25 7 0 218 144 863 887 0 48.5 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071048 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000176 GO:0000176 nuclear exosome (RNase complex) nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000460 GO:0000460 maturation of 5.8S rRNA RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0000956 GO:0000956 nuclear-transcribed mRNA catabolic process RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0008408 GO:0008408 3'-5' exonuclease activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0035327 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071028 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071034 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071035 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071044 ConsensusfromContig6126 sp P56960 EXOSX_MOUSE 100 17 0 0 1782 1732 361 377 0 40.8 P56960 EXOSX_MOUSE GO:0008408; GO:0071034; GO:0003723; GO:0005737; GO:0009048; GO:0004532; GO:0000178; GO:0071044; GO:0000460; GO:0000176; GO:0071035; GO:0071048; GO:0000184; GO:0090305; GO:0005730; GO:0000166; GO:0035327 3'-5' exonuclease activity; CUT catabolic process; RNA binding; cytoplasm; dosage compensation by inactivation of X chromosome; exoribonuclease activity; exosome (RNase complex); histone mRNA catabolic process; maturation of 5.8S rRNA; nuclear exosome (RNase complex); nuclear polyadenylation-dependent rRNA catabolic process; nuclear retention of unspliced pre-mRNA at the site of transcription; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleic acid phosphodiester bond hydrolysis; nucleolus; nucleotide binding; transcriptionally active chromatin reviewed IPR002562; IPR012588; IPR010997; IPR002121; IPR012337; Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2 homolog) (Polymyositis/scleroderma autoantigen 2 homolog) Exosc10 Pmscl2 Mus musculus (Mouse) 887 P56960 GO:0071048 ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0015018 GO:0015018 galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity other molecular function F ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6052 sp P58158 B3GA3_MOUSE 57.94 340 129 3 1099 107 1 335 4E-130 385 P58158 B3GA3_MOUSE GO:0000139; GO:0050650; GO:0005801; GO:0050651; GO:0015018; GO:0015012; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; chondroitin sulfate proteoglycan biosynthetic process; cis-Golgi network; dermatan sulfate proteoglycan biosynthetic process; galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity; heparan sulfate proteoglycan biosynthetic process; integral to membrane; metal ion binding; protein glycosylation reviewed IPR005027; Protein modification; protein glycosylation. Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I) B3gat3 Mus musculus (Mouse) 335 P58158 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0004720 GO:0004720 protein-lysine 6-oxidase activity other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005044 GO:0005044 scavenger receptor activity signal transduction activity F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005507 GO:0005507 copper ion binding other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016641 GO:0016641 "oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor" other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 79.88 169 34 0 509 3 584 752 9E-112 306 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0004720 GO:0004720 protein-lysine 6-oxidase activity other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005044 GO:0005044 scavenger receptor activity signal transduction activity F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005507 GO:0005507 copper ion binding other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0016641 GO:0016641 "oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor" other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig809 sp P58215 LOXL3_HUMAN 67.11 76 25 0 745 518 505 580 9E-112 119 P58215 LOXL3_HUMAN GO:0005507; GO:0001837; GO:0005576; GO:0005615; GO:0016020; GO:0045892; GO:0005634; GO:0004720; GO:0005044 copper ion binding; epithelial to mesenchymal transition; extracellular region; extracellular space; membrane; negative regulation of transcription, DNA-dependent; nucleus; protein-lysine 6-oxidase activity; scavenger receptor activity reviewed IPR001695; IPR019828; IPR001190; IPR017448; Lysyl oxidase homolog 3 (EC 1.4.3.-) (Lysyl oxidase-like protein 3) LOXL3 LOXL Homo sapiens (Human) 753 P58215 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0006817 GO:0006817 phosphate transport transport P ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0015114 GO:0015114 phosphate transmembrane transporter activity transporter activity F ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6293 sp P58369 ANKH_TETNG 82.35 204 36 0 1018 407 27 230 3E-159 352 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0035435 ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0006817 GO:0006817 phosphate transport transport P ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0015114 GO:0015114 phosphate transmembrane transporter activity transporter activity F ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6293 sp P58369 ANKH_TETNG 75.74 136 33 0 410 3 230 365 3E-159 232 P58369 ANKH_TETNG GO:0016021; GO:0015114 integral to membrane; phosphate ion transmembrane transporter activity reviewed IPR009887; Progressive ankylosis protein homolog (ANK) ankh GSTENG00031805001 Tetraodon nigroviridis (Spotted green pufferfish) (Chelonodon nigroviridis) 487 P58369 GO:0035435 ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5737 sp P58797 NXF1_COTJA 68.5 454 140 1 1356 4 163 616 0 605 P58797 NXF1_COTJA GO:0003723; GO:0005737; GO:0006406; GO:0000166; GO:0005634 RNA binding; cytoplasm; mRNA export from nucleus; nucleotide binding; nucleus reviewed IPR001611; IPR002075; IPR018222; IPR012677; IPR005637; IPR015245; IPR003603; IPR009060; Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP) NXF1 Coturnix coturnix japonica (Japanese quail) (Coturnix japonica) 616 P58797 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0005689 GO:0005689 U12-dependent spliceosome nucleus C ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig690 sp P59708 PM14_MOUSE 99.2 125 1 0 149 523 1 125 7E-76 230 P59708 PM14_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0000166; GO:0005634 RNA binding; RNA splicing; mRNA processing; nucleotide binding; nucleus reviewed IPR012677; IPR000504; Pre-mRNA branch site protein p14 (SF3b 14 kDa subunit) Sf3b14 Mus musculus (Mouse) 125 P59708 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0005885 GO:0005885 Arp2/3 protein complex cytoskeleton C ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0030041 GO:0030041 actin filament polymerization cell organization and biogenesis P ConsensusfromContig5923 sp P59999 ARPC4_MOUSE 98.81 168 2 0 1028 525 1 168 1E-113 338 P59999 ARPC4_MOUSE GO:0034314; GO:0005885; GO:0030041; GO:0042995; GO:0005737 Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; actin filament polymerization; cell projection; cytoplasm reviewed IPR008384; Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC) Arpc4 Arc20 Mus musculus (Mouse) 168 P59999 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005787 GO:0005787 signal peptidase complex ER/Golgi C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005787 GO:0005787 signal peptidase complex other membranes C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0006112 GO:0006112 energy reserve metabolic process other metabolic processes P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0006465 GO:0006465 signal peptide processing protein metabolism P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0006614 GO:0006614 SRP-dependent cotranslational protein targeting to membrane transport P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0044281 ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0050796 GO:0050796 regulation of insulin secretion transport P ConsensusfromContig6226 sp P61009 SPCS3_HUMAN 83.89 180 29 0 144 683 1 180 3E-110 322 P61009 SPCS3_HUMAN GO:0006614; GO:0005789; GO:0016021; GO:0008233; GO:0006508; GO:0050796; GO:0005787; GO:0006465; GO:0006412 SRP-dependent cotranslational protein targeting to membrane; endoplasmic reticulum membrane; integral to membrane; peptidase activity; proteolysis; regulation of insulin secretion; signal peptidase complex; signal peptide processing; translation reviewed IPR007653; Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit) SPCS3 SPC22 UNQ1841/PRO3567 Homo sapiens (Human) 180 P61009 GO:0050796 GO:0050796 regulation of insulin secretion cell-cell signaling P ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0008118 GO:0008118 "N-acetyllactosaminide alpha-2,3-sialyltransferase activity" other molecular function F ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0008373 GO:0008373 sialyltransferase activity other molecular function F ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0030173 GO:0030173 integral to Golgi membrane ER/Golgi C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0030173 GO:0030173 integral to Golgi membrane other membranes C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig851 sp P61132 SIAT6_PANTR 71.59 176 50 0 3 530 200 375 8E-93 282 P61132 SIAT6_PANTR GO:0032580; GO:0008118; GO:0005576; GO:0030173; GO:0006486; GO:0097503 Golgi cisterna membrane; N-acetyllactosaminide alpha-2,3-sialyltransferase activity; extracellular region; integral to Golgi membrane; protein glycosylation; sialylation reviewed IPR001675; IPR012163; Protein modification; protein glycosylation. CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6) ST3GAL3 SIAT6 Pan troglodytes (Chimpanzee) 375 P61132 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0003714 GO:0003714 transcription corepressor activity transcription regulatory activity F ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig2114 sp P61203 CSN2_RAT 96.5 200 0 1 601 2 28 220 1E-131 385 P61203 CSN2_RAT GO:0008180; GO:0008283; GO:0005737; GO:0000122; GO:0030182; GO:0005634; GO:0035914; GO:0003714 COP9 signalosome; cell proliferation; cytoplasm; negative regulation of transcription from RNA polymerase II promoter; neuron differentiation; nucleus; skeletal muscle cell differentiation; transcription corepressor activity reviewed IPR013143; IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15) Cops2 Csn2 Trip15 Rattus norvegicus (Rat) 443 P61203 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5730 sp P61222 ABCE1_MOUSE 90.82 599 55 0 2491 695 1 599 0 1113 P61222 ABCE1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0051536; GO:0005739 ATP binding; ATP catabolic process; ATPase activity; iron-sulfur cluster binding; mitochondrion reviewed IPR001450; IPR017896; IPR017900; IPR003593; IPR013283; IPR003439; IPR017871; IPR027417; IPR007209; ATP-binding cassette sub-family E member 1 (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I) Abce1 Rli Mus musculus (Mouse) 599 P61222 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0070534 GO:0070534 protein K63-linked ubiquitination protein metabolism P ConsensusfromContig5636 sp P62255 UB2G1_RAT 90.68 118 11 0 319 672 53 170 1E-68 228 P62255 UB2G1_RAT GO:0005524; GO:0070936; GO:0070534; GO:0006511; GO:0004842 ATP binding; protein K48-linked ubiquitination; protein K63-linked ubiquitination; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 G1 (EC 6.3.2.19) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed] Ube2g1 Ubc7 Ube2g Rattus norvegicus (Rat) 170 P62255 GO:0070936 ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0070936 ConsensusfromContig5891 sp P62257 UBE2H_MOUSE 98.36 183 3 0 1606 1058 1 183 3E-99 306 P62257 UBE2H_MOUSE GO:0005524; GO:0070979; GO:0070936; GO:0004842 ATP binding; protein K11-linked ubiquitination; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR000608; IPR023313; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 H (EC 6.3.2.19) (UBCH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H) Ube2h Mus musculus (Mouse) 183 P62257 GO:0070979 ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5992 sp P62323 SMD3_XENLA 93.7 127 7 1 129 509 1 126 4E-72 229 P62323 SMD3_XENLA GO:0008380; GO:0071208; GO:0006397; GO:0005634; GO:0030529 RNA splicing; histone pre-mRNA DCP binding; mRNA processing; nucleus; ribonucleoprotein complex reviewed IPR027141; IPR010920; IPR001163; IPR006649; Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3) snrpd3 Xenopus laevis (African clawed frog) 126 P62323 GO:0071208 ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig6351 sp P62335 PRS10_SPETR 96.66 389 13 0 1278 112 1 389 0 741 P62335 PRS10_SPETR GO:0005524; GO:0005737; GO:0017111; GO:0005634; GO:0005886; GO:0022624; GO:0030163 ATP binding; cytoplasm; nucleoside-triphosphatase activity; nucleus; plasma membrane; proteasome accessory complex; protein catabolic process reviewed IPR005937; IPR003593; IPR003959; IPR003960; IPR027417; 26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Conserved ATPase domain protein 44) (CADp44) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) PSMC6 SUG2 Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 389 P62335 GO:0030163 GO:0030163 protein catabolic process protein metabolism P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0000302 GO:0000302 response to reactive oxygen species stress response P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0000381 GO:0000381 "regulation of alternative nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5876 sp P62997 TRA2B_RAT 89.72 107 11 0 404 84 107 213 6E-62 207 P62997 TRA2B_RAT GO:0003729; GO:0000398; GO:0000166; GO:0005634; GO:0048026; GO:0000381; GO:0000302 mRNA binding; mRNA splicing, via spliceosome; nucleotide binding; nucleus; positive regulation of mRNA splicing, via spliceosome; regulation of alternative mRNA splicing, via spliceosome; response to reactive oxygen species reviewed IPR012677; IPR000504; Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (RA301) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B) Tra2b Sfrs10 Rattus norvegicus (Rat) 288 P62997 GO:0048026 GO:0048026 "positive regulation of nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig6038 sp P63031 MPC1_RAT 82.52 103 18 0 151 459 1 103 4E-57 187 P63031 MPC1_RAT GO:0016021; GO:0005743; GO:0006850 integral to membrane; mitochondrial inner membrane; mitochondrial pyruvate transport reviewed IPR005336; Mitochondrial pyruvate carrier 1 (Apoptosis-regulating basic protein) (Brain protein 44-like protein) Mpc1 Arbp Brp44l Rattus norvegicus (Rat) 109 P63031 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1158 sp P69849 NOMO3_HUMAN 71.67 120 34 0 361 2 515 634 3E-55 190 P69849 NOMO3_HUMAN GO:0030246; GO:0016021 carbohydrate binding; integral to membrane reviewed IPR013784; IPR008969; IPR014766; IPR013783; Nodal modulator 3 (pM5 protein 3) NOMO3 Homo sapiens (Human) 1222 P69849 GO:0004180 GO:0004180 carboxypeptidase activity other molecular function F ConsensusfromContig1158 sp P69849 NOMO3_HUMAN 71.67 120 34 0 361 2 515 634 3E-55 190 P69849 NOMO3_HUMAN GO:0030246; GO:0016021 carbohydrate binding; integral to membrane reviewed IPR013784; IPR008969; IPR014766; IPR013783; Nodal modulator 3 (pM5 protein 3) NOMO3 Homo sapiens (Human) 1222 P69849 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1158 sp P69849 NOMO3_HUMAN 71.67 120 34 0 361 2 515 634 3E-55 190 P69849 NOMO3_HUMAN GO:0030246; GO:0016021 carbohydrate binding; integral to membrane reviewed IPR013784; IPR008969; IPR014766; IPR013783; Nodal modulator 3 (pM5 protein 3) NOMO3 Homo sapiens (Human) 1222 P69849 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1158 sp P69849 NOMO3_HUMAN 71.67 120 34 0 361 2 515 634 3E-55 190 P69849 NOMO3_HUMAN GO:0030246; GO:0016021 carbohydrate binding; integral to membrane reviewed IPR013784; IPR008969; IPR014766; IPR013783; Nodal modulator 3 (pM5 protein 3) NOMO3 Homo sapiens (Human) 1222 P69849 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0000086 GO:0000086 G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0001556 GO:0001556 oocyte maturation other biological processes P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0001578 GO:0001578 microtubule bundle formation cell organization and biogenesis P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007092 GO:0007092 activation of anaphase-promoting complex activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007092 GO:0007092 activation of anaphase-promoting complex activity during mitotic cell cycle protein metabolism P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0007092 GO:0007092 activation of anaphase-promoting complex activity during mitotic cell cycle cell organization and biogenesis P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint stress response P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0051233 GO:0051233 spindle midzone cytoskeleton C ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0051297 GO:0051297 centrosome organization cell organization and biogenesis P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5578 sp P70032 PLK1_XENLA 75.95 582 135 4 1839 103 14 593 0 894 P70032 PLK1_XENLA GO:0005524; GO:0031572; GO:0000086; GO:0007092; GO:0005813; GO:0051297; GO:0000910; GO:0005737; GO:0000776; GO:0008017; GO:0001578; GO:0030496; GO:0007067; GO:0043066; GO:0000122; GO:0005634; GO:0001556; GO:0071168; GO:0004674; GO:0051233 Q90Z80; Q91876 ATP binding; G2 DNA damage checkpoint; G2/M transition of mitotic cell cycle; activation of mitotic anaphase-promoting complex activity; centrosome; centrosome organization; cytokinesis; cytoplasm; kinetochore; microtubule binding; microtubule bundle formation; midbody; mitosis; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; oocyte maturation; protein localization to chromatin; protein serine/threonine kinase activity; spindle midzone reviewed IPR011009; IPR000959; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Plx1) (Polo-like kinase 1) (PLK-1) plk1 plx1 Xenopus laevis (African clawed frog) 598 P70032 GO:0071168 ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005216 GO:0005216 ion channel activity transporter activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005218 GO:0005218 intracellular ligand-gated calcium channel activity transporter activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005220 GO:0005220 "inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity" transporter activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005220 GO:0005220 "inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity" signal transduction activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005262 GO:0005262 calcium channel activity transporter activity F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0006810 GO:0006810 transport transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0048016 GO:0048016 inositol phosphate-mediated signaling signal transduction P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0050913 GO:0050913 sensory perception of bitter taste other biological processes P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0050916 GO:0050916 sensory perception of sweet taste other biological processes P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0050917 GO:0050917 sensory perception of umami taste other biological processes P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0051592 GO:0051592 response to calcium ion other biological processes P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0060402 GO:0060402 calcium ion transport into cytosol transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0070588 GO:0070588 transmembrane calcium ion transport transport P ConsensusfromContig281 sp P70227 ITPR3_MOUSE 84.03 119 19 0 2 358 690 808 7E-65 219 P70227 ITPR3_MOUSE GO:0060402; GO:0005789; GO:0070679; GO:0005220; GO:0005887; GO:0005218; GO:0060291; GO:0007613; GO:0005730; GO:0005654; GO:0035091; GO:0051592; GO:0050913; GO:0050916; GO:0050917 calcium ion transport into cytosol; endoplasmic reticulum membrane; inositol 1,4,5 trisphosphate binding; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to plasma membrane; intracellular ligand-gated calcium channel activity; long-term synaptic potentiation; memory; nucleolus; nucleoplasm; phosphatidylinositol binding; response to calcium ion; sensory perception of bitter taste; sensory perception of sweet taste; sensory perception of umami taste reviewed IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor) Itpr3 Mus musculus (Mouse) 2670 P70227 GO:0070679 GO:0070679 "inositol 1,4,5 trisphosphate binding" other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0030870 GO:0030870 Mre11 complex nucleus C ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0045120 GO:0045120 pronucleus nucleus C ConsensusfromContig6254 sp P70388 RAD50_MOUSE 67.04 713 233 1 18 2156 602 1312 0 988 P70388 RAD50_MOUSE GO:0005524; GO:0006281; GO:0030870; GO:0000781; GO:0007126; GO:0004518; GO:0090305; GO:0045120; GO:0006974; GO:0008270 ATP binding; DNA repair; Mre11 complex; chromosome, telomeric region; meiosis; nuclease activity; nucleic acid phosphodiester bond hydrolysis; pronucleus; response to DNA damage stimulus; zinc ion binding reviewed IPR027417; IPR004584; IPR007517; IPR013134; DNA repair protein RAD50 (mRad50) (EC 3.6.-.-) Rad50 Mus musculus (Mouse) 1312 P70388 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0015020 GO:0015020 glucuronosyltransferase activity other molecular function F ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1109 sp P70691 UD12_MOUSE 45.99 187 100 1 6 566 204 389 2E-55 189 P70691 UD12_MOUSE GO:0005789; GO:0015020; GO:0016021 endoplasmic reticulum membrane; glucuronosyltransferase activity; integral to membrane reviewed IPR002213; UDP-glucuronosyltransferase 1-2 (UDPGT 1-2) (UGT1*2) (UGT1-02) (UGT1.2) (EC 2.4.1.17) (Bilirubin-specific UDPGT) (UDP-glucuronosyltransferase 1A2) (UGT1A2) Ugt1a2 Ugt1 Mus musculus (Mouse) 533 P70691 GO:0016758 GO:0016758 "transferase activity, transferring hexosyl groups" other molecular function F ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005338 GO:0005338 nucleotide-sugar transmembrane transporter activity transporter activity F ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005351 GO:0005351 sugar:hydrogen symporter activity transporter activity F ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005456 GO:0005456 CMP-sialic acid transmembrane transporter activity transporter activity F ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0006810 GO:0006810 transport transport P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0008643 GO:0008643 carbohydrate transport transport P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0015780 GO:0015780 nucleotide-sugar transport transport P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0015782 GO:0015782 CMP-sialic acid transport transport P ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig200 sp P78382 S35A1_HUMAN 69.88 249 75 0 770 24 23 271 1E-125 367 P78382 S35A1_HUMAN GO:0005456; GO:0000139; GO:0005975; GO:0006464; GO:0005887; GO:0005351 CMP-N-acetylneuraminate transmembrane transporter activity; Golgi membrane; carbohydrate metabolic process; cellular protein modification process; integral to plasma membrane; sugar:hydrogen symporter activity reviewed IPR007271; IPR021189; IPR004689; CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1) SLC35A1 Homo sapiens (Human) 337 P78382 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5922 sp P79110 TXTP_BOVIN 78.5 307 64 1 1157 243 5 311 1E-150 438 P79110 TXTP_BOVIN GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein) SLC25A1 SLC20A3 Bos taurus (Bovine) 311 P79110 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0004748 GO:0004748 ribonucleoside-diphosphate reductase activity other molecular function F ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005971 GO:0005971 ribonucleoside-diphosphate reductase complex other cellular component C ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0009263 GO:0009263 deoxyribonucleotide biosynthetic process other metabolic processes P ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6148 sp P79732 RIR1_DANRE 84.5 329 47 1 1397 423 466 794 0 587 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0004748 GO:0004748 ribonucleoside-diphosphate reductase activity other molecular function F ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0005971 GO:0005971 ribonucleoside-diphosphate reductase complex other cellular component C ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0009263 GO:0009263 deoxyribonucleotide biosynthetic process other metabolic processes P ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5831 sp P79732 RIR1_DANRE 92.78 471 34 0 138 1550 1 471 0 901 P79732 RIR1_DANRE GO:0005524; GO:0006260; GO:0009263; GO:0004748; GO:0005971 ATP binding; DNA replication; deoxyribonucleotide biosynthetic process; ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor; ribonucleoside-diphosphate reductase complex reviewed IPR005144; IPR013346; IPR000788; IPR013509; IPR008926; Genetic information processing; DNA replication. Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit) (Ribonucleotide reductase protein R1 class I) rrm1 Danio rerio (Zebrafish) (Brachydanio rerio) 794 P79732 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6283 sp P79797 TF3A_ICTPU 64.73 275 97 0 1375 551 1 275 9E-127 379 P79797 TF3A_ICTPU GO:0003677; GO:0003723; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Transcription factor IIIA (TFIIIA) gtf3a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 322 P79797 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig1884 sp P79800 RASK_MELGA 94.74 95 5 0 3 287 69 163 3E-60 190 P79800 RASK_MELGA GO:0005525; GO:0003924; GO:0005886; GO:0007264 GTP binding; GTPase activity; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR020849; GTPase KRas (K-Ras 2) (Ki-Ras) (K-ras) KRAS Meleagris gallopavo (Common turkey) 188 P79800 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0001706 GO:0001706 endoderm formation developmental processes P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0001707 GO:0001707 mesoderm formation developmental processes P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0007369 GO:0007369 gastrulation developmental processes P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5973 sp P79944 EOMES_XENLA 58.9 691 221 19 41 1999 26 691 0 702 P79944 EOMES_XENLA GO:0003677; GO:0030154; GO:0001706; GO:0001707; GO:0005634; GO:0045893; GO:0003700; GO:0006351 DNA binding; cell differentiation; endoderm formation; mesoderm formation; nucleus; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR008967; IPR001699; IPR018186; Eomesodermin eomes Xenopus laevis (African clawed frog) 692 P79944 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0006826 GO:0006826 iron ion transport transport P ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0006879 GO:0006879 cellular iron ion homeostasis other biological processes P ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0008199 GO:0008199 ferric iron binding other molecular function F ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5520 sp P80429 TRFE2_SALSA 66.27 679 219 6 2489 477 14 690 0 882 P80429 TRFE2_SALSA GO:0006879; GO:0005576; GO:0008199; GO:0006826 cellular iron ion homeostasis; extracellular region; ferric iron binding; iron ion transport reviewed IPR016357; IPR001156; IPR018195; Serotransferrin-2 (Serotransferrin II) (STF II) (sTF2) (Siderophilin II) tf2 Salmo salar (Atlantic salmon) 691 P80429 GO:0055072 GO:0055072 iron ion homeostasis other biological processes P ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0006820 GO:0006820 anion transport transport P ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0008308 GO:0008308 voltage-gated anion channel activity transporter activity F ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0015288 GO:0015288 porin activity transporter activity F ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0044070 GO:0044070 regulation of anion transport transport P ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0046930 GO:0046930 pore complex other membranes C ConsensusfromContig6092 sp P81004 VDAC2_XENLA 88.1 269 32 0 1724 918 1 269 5E-169 489 P81004 VDAC2_XENLA GO:0005741; GO:0000166; GO:0046930; GO:0015288; GO:0008308 mitochondrial outer membrane; nucleotide binding; pore complex; porin activity; voltage-gated anion channel activity reviewed IPR023614; IPR001925; IPR027246; Voltage-dependent anion-selective channel protein 2 (VDAC-2) (Outer mitochondrial membrane protein porin) vdac2 Xenopus laevis (African clawed frog) 282 P81004 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005547 GO:0005547 "phosphatidylinositol-3,4,5-trisphosphate binding" other molecular function F ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1139 sp P81436 OGT1_RABIT 98.26 115 2 0 2 346 19 133 6E-73 239 P81436 OGT1_RABIT GO:0070688; GO:0006915; GO:0071300; GO:0005813; GO:0005829; GO:0008047; GO:0080182; GO:0043984; GO:0043981; GO:0043982; GO:0046972; GO:0043995; GO:0043996; GO:0000123; GO:0005547; GO:0048015; GO:0005886; GO:0030854; GO:0051571; GO:0045862; GO:0045944; GO:0016262; GO:0006493; GO:0035020; GO:0006110; GO:0046626; GO:0032868 MLL5-L complex; apoptotic process; cellular response to retinoic acid; centrosome; cytosol; enzyme activator activity; histone H3-K4 trimethylation; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase activity (H4-K16 specific); histone acetyltransferase activity (H4-K5 specific); histone acetyltransferase activity (H4-K8 specific); histone acetyltransferase complex; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-mediated signaling; plasma membrane; positive regulation of granulocyte differentiation; positive regulation of histone H3-K4 methylation; positive regulation of proteolysis; positive regulation of transcription from RNA polymerase II promoter; protein N-acetylglucosaminyltransferase activity; protein O-linked glycosylation; regulation of Rac protein signal transduction; regulation of glycolysis; regulation of insulin receptor signaling pathway; response to insulin stimulus reviewed IPR013026; IPR011990; IPR001440; IPR019734; Protein modification; protein glycosylation. UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT) OGT Oryctolagus cuniculus (Rabbit) 1046 P81436 GO:0048015 GO:0048015 phosphoinositide-mediated signaling signal transduction P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0003678 GO:0003678 DNA helicase activity other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0048565 GO:0048565 gut development developmental processes P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0060420 GO:0060420 regulation of heart growth developmental processes P ConsensusfromContig5576 sp P83571 RUVB2_DANRE 86.87 259 34 0 1123 347 205 463 3E-140 417 P83571 RUVB2_DANRE GO:0005524; GO:0043141; GO:0016887; GO:0003678; GO:0006310; GO:0006281; GO:0071339; GO:0070286; GO:0048565; GO:0003351; GO:0007507; GO:0044458; GO:0045892; GO:0060420; GO:0006351 ATP binding; ATP-dependent 5'-3' DNA helicase activity; ATPase activity; DNA helicase activity; DNA recombination; DNA repair; MLL1 complex; axonemal dynein complex assembly; digestive tract development; epithelial cilium movement; heart development; motile cilium assembly; negative regulation of transcription, DNA-dependent; regulation of heart growth; transcription, DNA-dependent reviewed IPR003593; IPR027417; IPR027238; IPR010339; RuvB-like 2 (EC 3.6.4.12) (Reptin) (zReptin) ruvbl2 Danio rerio (Zebrafish) (Brachydanio rerio) 463 P83571 GO:0071339 ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0004758 GO:0004758 serine C-palmitoyltransferase activity other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0006686 GO:0006686 sphingomyelin biosynthetic process other metabolic processes P ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0009058 GO:0009058 biosynthetic process other metabolic processes P ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0016769 GO:0016769 "transferase activity, transferring nitrogenous groups" other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0017059 GO:0017059 serine C-palmitoyltransferase complex ER/Golgi C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0017059 GO:0017059 serine C-palmitoyltransferase complex other membranes C ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0030170 GO:0030170 pyridoxal phosphate binding other molecular function F ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0046511 GO:0046511 sphinganine biosynthetic process other metabolic processes P ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0046512 GO:0046512 sphingosine biosynthetic process other metabolic processes P ConsensusfromContig3101 sp P97363 SPTC2_MOUSE 81 100 19 0 23 322 60 159 1E-54 184 P97363 SPTC2_MOUSE GO:0046513; GO:0016021; GO:0005739; GO:0030170; GO:0004758; GO:0017059; GO:0046511; GO:0006686; GO:0046512 ceramide biosynthetic process; integral to membrane; mitochondrion; pyridoxal phosphate binding; serine C-palmitoyltransferase activity; serine C-palmitoyltransferase complex; sphinganine biosynthetic process; sphingomyelin biosynthetic process; sphingosine biosynthetic process reviewed IPR001917; IPR004839; IPR015424; IPR015421; IPR015422; Lipid metabolism; sphingolipid metabolism. Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2) Sptlc2 Lcb2 Mus musculus (Mouse) 560 P97363 GO:0046513 GO:0046513 ceramide biosynthetic process other metabolic processes P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0001741 GO:0001741 XY body nucleus C ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0006323 GO:0006323 DNA packaging cell organization and biogenesis P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0006337 GO:0006337 nucleosome disassembly cell organization and biogenesis P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0016514 GO:0016514 SWI/SNF complex nucleus C ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0071564 ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0071565 ConsensusfromContig1401 sp P97496 SMRC1_MOUSE 77.94 136 30 0 2 409 366 501 2E-62 212 P97496 SMRC1_MOUSE GO:0003677; GO:0006323; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0006351 Q3TKT4; Q9Z0H3 DNA binding; DNA packaging; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) (SWI3-related protein) (BAF155) Smarcc1 Baf155 Srg3 Mus musculus (Mouse) 1104 P97496 GO:0071778 ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0006662 GO:0006662 glycerol ether metabolic process other metabolic processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0008113 GO:0008113 peptide-methionine-(S)-S-oxide reductase activity other molecular function F ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0009725 GO:0009725 response to hormone stimulus other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0009749 GO:0009749 response to glucose stimulus other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0015035 GO:0015035 protein disulfide oxidoreductase activity other molecular function F ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0031669 GO:0031669 cellular response to nutrient levels other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0033743 GO:0033743 peptide-methionine (R)-S-oxide reductase activity other molecular function F ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0043025 GO:0043025 cell soma other cellular component C ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig6245 sp P97615 THIOM_RAT 60.48 167 65 1 2 502 1 166 3E-54 186 P97615 THIOM_RAT GO:0045454; GO:0031669; GO:0030425; GO:0006662; GO:0005739; GO:0043025; GO:0005730; GO:0015035; GO:0048678; GO:0042493; GO:0009749; GO:0009725; GO:0001666; GO:0007584; GO:0014070; GO:0006979 cell redox homeostasis; cellular response to nutrient levels; dendrite; glycerol ether metabolic process; mitochondrion; neuronal cell body; nucleolus; protein disulfide oxidoreductase activity; response to axon injury; response to drug; response to glucose stimulus; response to hormone stimulus; response to hypoxia; response to nutrient; response to organic cyclic compound; response to oxidative stress reviewed IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2) Txn2 Trx2 Rattus norvegicus (Rat) 166 P97615 GO:0048678 GO:0048678 response to axon injury stress response P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0001921 GO:0001921 positive regulation of receptor recycling signal transduction P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0001921 GO:0001921 positive regulation of receptor recycling protein metabolism P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0004222 GO:0004222 metalloendopeptidase activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0008237 GO:0008237 metallopeptidase activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0009897 GO:0009897 external side of plasma membrane plasma membrane C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0009897 GO:0009897 external side of plasma membrane other membranes C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0010814 GO:0010814 substance P catabolic process other metabolic processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0010815 GO:0010815 bradykinin catabolic process other metabolic processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0010816 GO:0010816 calcitonin catabolic process other metabolic processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0016485 GO:0016485 protein processing protein metabolism P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0016486 GO:0016486 peptide hormone processing protein metabolism P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0033093 GO:0033093 Weibel-Palade body other cellular component C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0034959 GO:0034959 endothelin maturation protein metabolism P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0042447 GO:0042447 hormone catabolic process other metabolic processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0043583 GO:0043583 ear development developmental processes P ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2135 sp P97739 ECE1_CAVPO 79.7 133 27 0 435 37 560 692 1E-72 237 P97739 ECE1_CAVPO GO:0016021; GO:0046872; GO:0004222; GO:0005886; GO:0006508 integral to membrane; metal ion binding; metalloendopeptidase activity; plasma membrane; proteolysis reviewed IPR024079; IPR000718; IPR018497; IPR008753; Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71) ECE1 Cavia porcellus (Guinea pig) 754 P97739 GO:0060037 GO:0060037 pharyngeal system development developmental processes P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0004534 GO:0004534 5'-3' exoribonuclease activity other molecular function F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0007569 GO:0007569 cell aging other biological processes P ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0008409 GO:0008409 5'-3' exonuclease activity other molecular function F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1799 sp P97789 XRN1_MOUSE 88.68 106 12 0 323 6 1 106 1E-60 206 P97789 XRN1_MOUSE GO:0004534; GO:0003677; GO:0003723; GO:0006396; GO:0007569; GO:0000932; GO:0071044; GO:0007126; GO:0000723 5'-3' exoribonuclease activity; DNA binding; RNA binding; RNA processing; cell aging; cytoplasmic mRNA processing body; histone mRNA catabolic process; meiosis; telomere maintenance reviewed IPR027073; IPR016494; IPR004859; 5'-3' exoribonuclease 1 (mXRN1) (EC 3.1.13.-) (Protein Dhm2) (Strand-exchange protein 1 homolog) Xrn1 Dhm2 Exo Sep1 Mus musculus (Mouse) 1719 P97789 GO:0071044 ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig747 sp P98157 LRP1_CHICK 61.03 195 70 3 7 585 4353 4543 9E-61 213 P98157 LRP1_CHICK GO:0005509; GO:0005905; GO:0006897; GO:0016021 calcium ion binding; coated pit; endocytosis; integral to membrane reviewed IPR011042; IPR026823; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) LRP1 Gallus gallus (Chicken) 4543 P98157 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0006810 GO:0006810 transport transport P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0006869 GO:0006869 lipid transport transport P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0008202 GO:0008202 steroid metabolic process other metabolic processes P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0021517 GO:0021517 ventral spinal cord development developmental processes P ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0030228 GO:0030228 lipoprotein receptor activity signal transduction activity F ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0034185 GO:0034185 apolipoprotein binding other molecular function F ConsensusfromContig502 sp P98165 VLDLR_CHICK 75.33 227 55 1 1 678 196 422 1E-95 304 P98165 VLDLR_CHICK GO:0005509; GO:0008203; GO:0005905; GO:0016021; GO:0006869; GO:0030228; GO:0021517; GO:0034361 calcium ion binding; cholesterol metabolic process; coated pit; integral to membrane; lipid transport; lipoprotein particle receptor activity; ventral spinal cord development; very-low-density lipoprotein particle reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R) (Vitellogenin receptor) (VTG receptor) VLDLR VTGR Gallus gallus (Chicken) 863 P98165 GO:0034361 GO:0034361 very-low-density lipoprotein particle non-structural extracellular C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0043088 GO:0043088 regulation of Cdc42 GTPase activity signal transduction P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0046847 GO:0046847 filopodium assembly cell organization and biogenesis P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig4855 sp P98174 FGD1_HUMAN 74.05 131 32 2 1 390 733 862 2E-58 199 P98174 FGD1_HUMAN GO:0005794; GO:0005089; GO:0030036; GO:0097190; GO:0005856; GO:0005829; GO:0046847; GO:0005085; GO:0030027; GO:0046872; GO:0048011; GO:0005634; GO:0009887; GO:0005543; GO:0005886; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton organization; apoptotic signaling pathway; cytoskeleton; cytosol; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; metal ion binding; neurotrophin TRK receptor signaling pathway; nucleus; organ morphogenesis; phospholipid binding; plasma membrane; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3) FGD1 FGDY ZFYVE3 Homo sapiens (Human) 961 P98174 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig6296 sp Q00688 FKBP3_HUMAN 68.92 222 67 2 42 701 3 224 2E-105 314 Q00688 FKBP3_HUMAN GO:0005528; GO:0016020; GO:0005634; GO:0003755; GO:0006457; GO:0004872 Q00987; Q9UGN5 FK506 binding; membrane; nucleus; peptidyl-prolyl cis-trans isomerase activity; protein folding; receptor activity reviewed IPR023566; IPR001179; Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase) FKBP3 FKBP25 Homo sapiens (Human) 224 Q00688 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000022 GO:0000022 mitotic spindle elongation cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000022 GO:0000022 mitotic spindle elongation cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005871 GO:0005871 kinesin complex cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0071777 ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0072686 ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 84.69 98 15 0 2 295 361 458 1E-56 181 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0097149 ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000022 GO:0000022 mitotic spindle elongation cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000022 GO:0000022 mitotic spindle elongation cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005871 GO:0005871 kinesin complex cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0071777 ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0072686 ConsensusfromContig2565 sp Q02241 KIF23_HUMAN 70.27 37 11 0 376 486 473 509 1E-56 58.9 Q02241 KIF23_HUMAN GO:0005524; GO:0019886; GO:0007596; GO:0097149; GO:0005813; GO:0000910; GO:0005829; GO:0045171; GO:0005871; GO:0005874; GO:0008017; GO:0003777; GO:0007018; GO:0030496; GO:0000022; GO:0005654; GO:0032467; GO:0051256 P62330; P62331; Q9NR09; Q9H0H5; P63104 ATP binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; blood coagulation; centralspindlin complex; centrosome; cytokinesis; cytosol; intercellular bridge; kinesin complex; microtubule; microtubule binding; microtubule motor activity; microtubule-based movement; midbody; mitotic spindle elongation; nucleoplasm; positive regulation of cytokinesis; spindle midzone assembly involved in mitosis reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1) KIF23 KNSL5 MKLP1 Homo sapiens (Human) 960 Q02241 GO:0097149 ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0004311 GO:0004311 farnesyltranstransferase activity other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0004659 GO:0004659 prenyltransferase activity other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0004660 GO:0004660 protein farnesyltransferase activity other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0005875 GO:0005875 microtubule associated complex cytoskeleton C ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0010035 GO:0010035 response to inorganic substance other biological processes P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0018343 GO:0018343 protein farnesylation protein metabolism P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0019840 GO:0019840 isoprenoid binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0034097 GO:0034097 response to cytokine stimulus other biological processes P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0045787 GO:0045787 positive regulation of cell cycle cell cycle and proliferation P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0048146 GO:0048146 positive regulation of fibroblast proliferation cell cycle and proliferation P ConsensusfromContig6259 sp Q02293 FNTB_RAT 78.16 348 76 0 128 1171 30 377 0 562 Q02293 FNTB_RAT GO:0004311; GO:0046872; GO:0005875; GO:0008285; GO:0045787; GO:0008284; GO:0048146; GO:0051770; GO:0043234; GO:0018343; GO:0004660; GO:0005965; GO:0034097; GO:0010035; GO:0014070; GO:0042060 Q04631 farnesyltranstransferase activity; metal ion binding; microtubule associated complex; negative regulation of cell proliferation; positive regulation of cell cycle; positive regulation of cell proliferation; positive regulation of fibroblast proliferation; positive regulation of nitric-oxide synthase biosynthetic process; protein complex; protein farnesylation; protein farnesyltransferase activity; protein farnesyltransferase complex; response to cytokine stimulus; response to inorganic substance; response to organic cyclic compound; wound healing reviewed IPR026872; IPR001330; IPR008930; Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta) Fntb Rattus norvegicus (Rat) 437 Q02293 GO:0051770 GO:0051770 positive regulation of nitric-oxide synthase biosynthetic process other metabolic processes P ConsensusfromContig2685 sp Q02391 GSLG1_CHICK 78.86 123 25 1 369 1 871 992 2E-57 197 Q02391 GSLG1_CHICK GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR001893; IPR017873; Golgi apparatus protein 1 (Cysteine-rich fibroblast growth factor receptor) GLG1 CFR Gallus gallus (Chicken) 1142 Q02391 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2685 sp Q02391 GSLG1_CHICK 78.86 123 25 1 369 1 871 992 2E-57 197 Q02391 GSLG1_CHICK GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR001893; IPR017873; Golgi apparatus protein 1 (Cysteine-rich fibroblast growth factor receptor) GLG1 CFR Gallus gallus (Chicken) 1142 Q02391 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2685 sp Q02391 GSLG1_CHICK 78.86 123 25 1 369 1 871 992 2E-57 197 Q02391 GSLG1_CHICK GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR001893; IPR017873; Golgi apparatus protein 1 (Cysteine-rich fibroblast growth factor receptor) GLG1 CFR Gallus gallus (Chicken) 1142 Q02391 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2685 sp Q02391 GSLG1_CHICK 78.86 123 25 1 369 1 871 992 2E-57 197 Q02391 GSLG1_CHICK GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR001893; IPR017873; Golgi apparatus protein 1 (Cysteine-rich fibroblast growth factor receptor) GLG1 CFR Gallus gallus (Chicken) 1142 Q02391 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2685 sp Q02391 GSLG1_CHICK 78.86 123 25 1 369 1 871 992 2E-57 197 Q02391 GSLG1_CHICK GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR001893; IPR017873; Golgi apparatus protein 1 (Cysteine-rich fibroblast growth factor receptor) GLG1 CFR Gallus gallus (Chicken) 1142 Q02391 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0001890 GO:0001890 placenta development developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003707 GO:0003707 steroid hormone receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0004879 GO:0004879 ligand-dependent nuclear receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005504 GO:0005504 fatty acid binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006091 GO:0006091 generation of precursor metabolites and energy other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0007566 GO:0007566 embryo implantation developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008366 GO:0008366 axon ensheathment developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0009062 GO:0009062 fatty acid catabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0014068 GO:0014068 positive regulation of phosphoinositide 3-kinase cascade signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0015908 GO:0015908 fatty acid transport transport P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0030522 GO:0030522 intracellular receptor-mediated signaling pathway signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0031589 GO:0031589 cell-substrate adhesion cell adhesion P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042640 GO:0042640 anagen developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043401 GO:0043401 steroid hormone mediated signaling signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043616 GO:0043616 keratinocyte proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045598 GO:0045598 regulation of fat cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045600 GO:0045600 positive regulation of fat cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0046697 GO:0046697 decidualization developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0050680 GO:0050680 negative regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0051546 GO:0051546 keratinocyte migration other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0060612 GO:0060612 adipose tissue development developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 81.36 177 33 0 331 861 265 441 7E-114 274 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0070539 GO:0070539 linoleic acid binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0001890 GO:0001890 placenta development developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0003707 GO:0003707 steroid hormone receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0004879 GO:0004879 ligand-dependent nuclear receptor activity signal transduction activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005504 GO:0005504 fatty acid binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006091 GO:0006091 generation of precursor metabolites and energy other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0007566 GO:0007566 embryo implantation developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0008366 GO:0008366 axon ensheathment developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0009062 GO:0009062 fatty acid catabolic process other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0014068 GO:0014068 positive regulation of phosphoinositide 3-kinase cascade signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0015908 GO:0015908 fatty acid transport transport P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0030522 GO:0030522 intracellular receptor-mediated signaling pathway signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0031589 GO:0031589 cell-substrate adhesion cell adhesion P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0042640 GO:0042640 anagen developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043401 GO:0043401 steroid hormone mediated signaling signal transduction P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0043616 GO:0043616 keratinocyte proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045598 GO:0045598 regulation of fat cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045600 GO:0045600 positive regulation of fat cell differentiation other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0046697 GO:0046697 decidualization developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0050680 GO:0050680 negative regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0051546 GO:0051546 keratinocyte migration other biological processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0060612 GO:0060612 adipose tissue development developmental processes P ConsensusfromContig1962 sp Q03181 PPARD_HUMAN 69.91 113 30 2 2 337 157 266 7E-114 159 Q03181 PPARD_HUMAN GO:0003677; GO:0060612; GO:0042640; GO:0097190; GO:0008366; GO:0030154; GO:0008283; GO:0031589; GO:0008203; GO:0046697; GO:0008144; GO:0007566; GO:0006635; GO:0015908; GO:0006091; GO:0006006; GO:0015758; GO:0051546; GO:0043616; GO:0004879; GO:0070539; GO:0050680; GO:0000122; GO:0005654; GO:0008284; GO:0045600; GO:0014068; GO:0045893; GO:0043565; GO:0003707; GO:0006367; GO:0042060; GO:0008270 O60341 DNA binding; adipose tissue development; anagen; apoptotic signaling pathway; axon ensheathment; cell differentiation; cell proliferation; cell-substrate adhesion; cholesterol metabolic process; decidualization; drug binding; embryo implantation; fatty acid beta-oxidation; fatty acid transport; generation of precursor metabolites and energy; glucose metabolic process; glucose transport; keratinocyte migration; keratinocyte proliferation; ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity; linoleic acid binding; negative regulation of epithelial cell proliferation; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; positive regulation of cell proliferation; positive regulation of fat cell differentiation; positive regulation of phosphatidylinositol 3-kinase cascade; positive regulation of transcription, DNA-dependent; sequence-specific DNA binding; steroid hormone receptor activity; transcription initiation from RNA polymerase II promoter; wound healing; zinc ion binding reviewed IPR003074; IPR003075; IPR008946; IPR000536; IPR001723; IPR001628; IPR013088; Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta) PPARD NR1C2 PPARB Homo sapiens (Human) 441 Q03181 GO:0070539 GO:0070539 linoleic acid binding other molecular function F ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1383 sp Q03701 CEBPZ_HUMAN 73.72 137 34 2 406 2 489 625 5E-62 209 Q03701 CEBPZ_HUMAN GO:0003677; GO:0005634; GO:0006355; GO:0006366 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription from RNA polymerase II promoter reviewed IPR016024; IPR005612; CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) CEBPZ CBF2 Homo sapiens (Human) 1054 Q03701 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000288 GO:0000288 "nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay" RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000289 GO:0000289 nuclear-transcribed mRNA poly(A) tail shortening RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006446 GO:0006446 regulation of translational initiation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008135 GO:0008135 "translation factor activity, nucleic acid binding" nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008219 GO:0008219 cell death death P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016071 GO:0016071 mRNA metabolic process RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016281 GO:0016281 eukaryotic translation initiation factor 4F complex translational apparatus C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 71.03 145 41 1 432 1 756 900 4E-55 182 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000288 GO:0000288 "nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay" RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0000289 GO:0000289 nuclear-transcribed mRNA poly(A) tail shortening RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0006446 GO:0006446 regulation of translational initiation protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008135 GO:0008135 "translation factor activity, nucleic acid binding" nucleic acid binding activity F ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008219 GO:0008219 cell death death P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016071 GO:0016071 mRNA metabolic process RNA metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0016281 GO:0016281 eukaryotic translation initiation factor 4F complex translational apparatus C ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig3281 sp Q04637 IF4G1_HUMAN 56 50 19 2 631 482 700 746 4E-55 53.1 Q04637 IF4G1_HUMAN GO:0008219; GO:0019221; GO:0005829; GO:0016281; GO:0008286; GO:0019048; GO:0000184; GO:0000289; GO:0006446; GO:0003743 O00571; O75822; P60842; P06730; Q14103-4; P11940 cell death; cytokine-mediated signaling pathway; cytosol; eukaryotic translation initiation factor 4F complex; insulin receptor signaling pathway; modulation by virus of host morphology or physiology; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA poly(A) tail shortening; regulation of translational initiation; translation initiation factor activity reviewed IPR016024; IPR003891; IPR016021; IPR003890; IPR003307; Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220) EIF4G1 EIF4F EIF4G EIF4GI Homo sapiens (Human) 1599 Q04637 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2287 sp Q05437 PRRX1_CHICK 82.54 126 21 1 17 391 99 224 4E-55 179 Q05437 PRRX1_CHICK GO:0007275; GO:0005634; GO:0043565; GO:0003700 multicellular organismal development; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity reviewed IPR017970; IPR001356; IPR009057; IPR003654; Paired mesoderm homeobox protein 1 (GMHOX) (Homeobox protein MHOX) (Paired-related homeobox protein 1) (PRX-1) PRRX1 MHOX PMX1 PRX1 Gallus gallus (Chicken) 245 Q05437 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006369 GO:0006369 termination of RNA polymerase II transcription RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006369 GO:0006369 termination of RNA polymerase II transcription cell organization and biogenesis P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 75.3 166 39 1 2477 1986 32 197 2E-71 228 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0031124 GO:0031124 mRNA 3'-end processing RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006369 GO:0006369 termination of RNA polymerase II transcription RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006369 GO:0006369 termination of RNA polymerase II transcription cell organization and biogenesis P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig5866 sp Q05519 SRS11_HUMAN 70 50 13 2 1989 1840 197 244 2E-71 65.5 Q05519 SRS11_HUMAN GO:0003723; GO:0031124; GO:0006406; GO:0000398; GO:0005654; GO:0000166; GO:0006369 P14921 RNA binding; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding; termination of RNA polymerase II transcription reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11) SRSF11 SFRS11 Homo sapiens (Human) 484 Q05519 GO:0031124 GO:0031124 mRNA 3'-end processing RNA metabolism P ConsensusfromContig3840 sp Q05AL1 ARMC8_DANRE 91.38 116 9 1 6 350 2 117 8E-64 211 Q05AL1 ARMC8_DANRE reviewed IPR011989; IPR016024; IPR000225; Armadillo repeat-containing protein 8 armc8 zgc:153683 Danio rerio (Zebrafish) (Brachydanio rerio) 673 Q05AL1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6319 sp Q05AL1 ARMC8_DANRE 94.72 246 13 0 117 854 212 457 0 477 Q05AL1 ARMC8_DANRE reviewed IPR011989; IPR016024; IPR000225; Armadillo repeat-containing protein 8 armc8 zgc:153683 Danio rerio (Zebrafish) (Brachydanio rerio) 673 Q05AL1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6319 sp Q05AL1 ARMC8_DANRE 89.81 216 22 0 854 1501 458 673 0 408 Q05AL1 ARMC8_DANRE reviewed IPR011989; IPR016024; IPR000225; Armadillo repeat-containing protein 8 armc8 zgc:153683 Danio rerio (Zebrafish) (Brachydanio rerio) 673 Q05AL1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6319 sp Q05AL1 ARMC8_DANRE 77.14 35 8 0 16 120 178 212 0 62.8 Q05AL1 ARMC8_DANRE reviewed IPR011989; IPR016024; IPR000225; Armadillo repeat-containing protein 8 armc8 zgc:153683 Danio rerio (Zebrafish) (Brachydanio rerio) 673 Q05AL1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1012 sp Q05BQ5 MBTD1_HUMAN 85.4 226 33 0 679 2 272 497 4E-141 416 Q05BQ5 MBTD1_HUMAN GO:0016568; GO:0005634; GO:0006355; GO:0006351; GO:0008270 chromatin modification; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR004092; IPR012313; MBT domain-containing protein 1 MBTD1 Homo sapiens (Human) 628 Q05BQ5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0000276 GO:0000276 "mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)" mitochondrion C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0000276 GO:0000276 "mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)" other membranes C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0005496 GO:0005496 steroid binding other molecular function F ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0015986 GO:0015986 ATP synthesis coupled proton transport transport P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0015986 GO:0015986 ATP synthesis coupled proton transport other metabolic processes P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0032403 GO:0032403 protein complex binding other molecular function F ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0045263 GO:0045263 "proton-transporting ATP synthase complex, coupling factor F(o)" other membranes C ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig6216 sp Q06647 ATPO_RAT 61.58 203 76 1 1095 493 9 211 5E-82 257 Q06647 ATPO_RAT GO:0046034; GO:0015986; GO:0000276; GO:0032403; GO:0046933; GO:0005496 ATP metabolic process; ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex, coupling factor F(o); protein complex binding; proton-transporting ATP synthase activity, rotational mechanism; steroid binding reviewed IPR000711; IPR020781; IPR026015; ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP) (Sperm flagella protein 4) Atp5o Rattus norvegicus (Rat) 213 Q06647 GO:0046933 GO:0046933 "hydrogen ion transporting ATP synthase activity, rotational mechanism" transporter activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0004714 GO:0004714 transmembrane receptor protein tyrosine kinase activity signal transduction activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0004714 GO:0004714 transmembrane receptor protein tyrosine kinase activity kinase activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016525 GO:0016525 negative regulation of angiogenesis developmental processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0030336 GO:0030336 negative regulation of cell migration other biological processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0032526 GO:0032526 response to retinoic acid other biological processes P ConsensusfromContig1393 sp Q06806 TIE1_MOUSE 59.8 204 81 1 10 621 656 858 1E-60 209 Q06806 TIE1_MOUSE GO:0005524; GO:0001525; GO:0001701; GO:0016021; GO:0016525; GO:0030336; GO:0018108; GO:0005886; GO:0045026; GO:0032526; GO:0004714 ATP binding; angiogenesis; in utero embryonic development; integral to membrane; negative regulation of angiogenesis; negative regulation of cell migration; peptidyl-tyrosine phosphorylation; plasma membrane; plasma membrane fusion; response to retinoic acid; transmembrane receptor protein tyrosine kinase activity reviewed IPR000742; IPR013032; IPR003961; IPR007110; IPR013783; IPR003599; IPR013151; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1) Tie1 Tie Tie-1 Mus musculus (Mouse) 1134 Q06806 GO:0045026 GO:0045026 plasma membrane fusion cell organization and biogenesis P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005911 GO:0005911 cell-cell junction plasma membrane C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005911 GO:0005911 cell-cell junction other membranes C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0032147 GO:0032147 activation of protein kinase activity other metabolic processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0032321 GO:0032321 positive regulation of Rho GTPase activity signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0032862 GO:0032862 activation of Rho GTPase activity signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0032863 GO:0032863 activation of Rac GTPase activity signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0035556 ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0042307 GO:0042307 positive regulation of protein import into nucleus transport P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0043089 GO:0043089 positive regulation of Cdc42 GTPase activity signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0045666 GO:0045666 positive regulation of neuron differentiation developmental processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0045859 GO:0045859 regulation of protein kinase activity other metabolic processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0051988 GO:0051988 regulation of attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0070301 GO:0070301 cellular response to hydrogen peroxide stress response P ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0070830 GO:0070830 cell organization and biogenesis ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0071277 ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0071479 ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0071777 ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0072686 ConsensusfromContig4597 sp Q07139 ECT2_MOUSE 55.17 174 76 2 9 530 18 189 2E-54 189 Q07139 ECT2_MOUSE GO:0005096; GO:0005089; GO:0032863; GO:0032147; GO:0000902; GO:0071277; GO:0070301; GO:0071479; GO:0097149; GO:0032154; GO:0000910; GO:0005737; GO:0035556; GO:0030496; GO:0005634; GO:0043089; GO:0043123; GO:0043065; GO:0032467; GO:0045666; GO:0042307; GO:0042803; GO:0051260; GO:0015031; GO:0051988; GO:0004871; GO:0005923; GO:0070830 GTPase activator activity; Rho guanyl-nucleotide exchange factor activity; activation of Rac GTPase activity; activation of protein kinase activity; cell morphogenesis; cellular response to calcium ion; cellular response to hydrogen peroxide; cellular response to ionizing radiation; centralspindlin complex; cleavage furrow; cytokinesis; cytoplasm; intracellular signal transduction; midbody; nucleus; positive regulation of Cdc42 GTPase activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; positive regulation of cytokinesis; positive regulation of neuron differentiation; positive regulation of protein import into nucleus; protein homodimerization activity; protein homooligomerization; protein transport; regulation of attachment of spindle microtubules to kinetochore; signal transducer activity; tight junction; tight junction assembly reviewed IPR001357; IPR000219; IPR026817; IPR001331; IPR011993; Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene) Ect2 mKIAA4037 Mus musculus (Mouse) 913 Q07139 GO:0097149 ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0000979 ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0035035 GO:0035035 histone acetyltransferase binding other molecular function F ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0046686 GO:0046686 response to cadmium ion other biological processes P ConsensusfromContig4650 sp Q07243 MTF1_MOUSE 85.82 141 20 0 475 53 81 221 4E-82 261 Q07243 MTF1_MOUSE GO:0000979; GO:0046872; GO:0005634; GO:0045944; GO:0046686; GO:0006979; GO:0003700; GO:0006351 RNA polymerase II core promoter sequence-specific DNA binding; metal ion binding; nucleus; positive regulation of transcription from RNA polymerase II promoter; response to cadmium ion; response to oxidative stress; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1) Mtf1 Mtf-1 Mus musculus (Mouse) 675 Q07243 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0004016 GO:0004016 adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006112 GO:0006112 energy reserve metabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006171 GO:0006171 cAMP biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006833 GO:0006833 water transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007202 GO:0007202 activation of phospholipase C activity other biological processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008294 GO:0008294 calcium- and calmodulin-responsive adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008543 GO:0008543 fibroblast growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0009190 GO:0009190 cyclic nucleotide biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016849 GO:0016849 phosphorus-oxygen lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0034199 GO:0034199 activation of protein kinase A activity other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0035556 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0044281 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 88 125 14 1 460 89 874 998 2E-72 224 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0071377 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0004016 GO:0004016 adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006112 GO:0006112 energy reserve metabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006171 GO:0006171 cAMP biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006833 GO:0006833 water transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007202 GO:0007202 activation of phospholipase C activity other biological processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008294 GO:0008294 calcium- and calmodulin-responsive adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008543 GO:0008543 fibroblast growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0009190 GO:0009190 cyclic nucleotide biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016849 GO:0016849 phosphorus-oxygen lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0034199 GO:0034199 activation of protein kinase A activity other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0035556 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0044281 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 96.43 28 1 0 86 3 1001 1028 2E-72 65.1 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0071377 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0004016 GO:0004016 adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006112 GO:0006112 energy reserve metabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006171 GO:0006171 cAMP biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0006833 GO:0006833 water transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007193 GO:0007193 inhibition of adenylate cyclase activity by G-protein signaling other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007202 GO:0007202 activation of phospholipase C activity other biological processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008294 GO:0008294 calcium- and calmodulin-responsive adenylate cyclase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0008543 GO:0008543 fibroblast growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0009190 GO:0009190 cyclic nucleotide biosynthetic process other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0016849 GO:0016849 phosphorus-oxygen lyase activity other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0034199 GO:0034199 activation of protein kinase A activity other metabolic processes P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0035556 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0044281 ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig3256 sp Q08462 ADCY2_HUMAN 100 9 0 0 500 474 861 869 2E-72 25 Q08462 ADCY2_HUMAN GO:0005524; GO:0007202; GO:0034199; GO:0004016; GO:0008179; GO:0007189; GO:0007193; GO:0008294; GO:0071377; GO:0005737; GO:0030425; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0016021; GO:0035556; GO:0045121; GO:0046872; GO:0048011; GO:0005886; GO:0043234; GO:0046982; GO:0007268; GO:0055085; GO:0006833 ATP binding; activation of phospholipase C activity; activation of protein kinase A activity; adenylate cyclase activity; adenylate cyclase binding; adenylate cyclase-activating G-protein coupled receptor signaling pathway; adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; calcium- and calmodulin-responsive adenylate cyclase activity; cellular response to glucagon stimulus; cytoplasm; dendrite; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; integral to membrane; intracellular signal transduction; membrane raft; metal ion binding; neurotrophin TRK receptor signaling pathway; plasma membrane; protein complex; protein heterodimerization activity; synaptic transmission; transmembrane transport; water transport reviewed IPR001054; IPR018297; IPR009398; Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2) ADCY2 KIAA1060 Homo sapiens (Human) 1091 Q08462 GO:0071377 ConsensusfromContig5849 sp Q08BB5 CTL2A_DANRE 49.32 219 109 2 1247 594 252 469 1E-63 223 Q08BB5 CTL2A_DANRE GO:0016311; GO:0004721 dephosphorylation; phosphoprotein phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-) ctdspl2a zgc:154017 Danio rerio (Zebrafish) (Brachydanio rerio) 469 Q08BB5 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig5849 sp Q08BB5 CTL2A_DANRE 49.32 219 109 2 1247 594 252 469 1E-63 223 Q08BB5 CTL2A_DANRE GO:0016311; GO:0004721 dephosphorylation; phosphoprotein phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-) ctdspl2a zgc:154017 Danio rerio (Zebrafish) (Brachydanio rerio) 469 Q08BB5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5849 sp Q08BB5 CTL2A_DANRE 49.32 219 109 2 1247 594 252 469 1E-63 223 Q08BB5 CTL2A_DANRE GO:0016311; GO:0004721 dephosphorylation; phosphoprotein phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-) ctdspl2a zgc:154017 Danio rerio (Zebrafish) (Brachydanio rerio) 469 Q08BB5 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig5849 sp Q08BB5 CTL2A_DANRE 49.32 219 109 2 1247 594 252 469 1E-63 223 Q08BB5 CTL2A_DANRE GO:0016311; GO:0004721 dephosphorylation; phosphoprotein phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-) ctdspl2a zgc:154017 Danio rerio (Zebrafish) (Brachydanio rerio) 469 Q08BB5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5849 sp Q08BB5 CTL2A_DANRE 49.32 219 109 2 1247 594 252 469 1E-63 223 Q08BB5 CTL2A_DANRE GO:0016311; GO:0004721 dephosphorylation; phosphoprotein phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD small phosphatase-like protein 2-A (CTDSP-like 2-A) (EC 3.1.3.-) ctdspl2a zgc:154017 Danio rerio (Zebrafish) (Brachydanio rerio) 469 Q08BB5 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig3906 sp Q08BR4 STB1B_DANRE 85.48 124 18 0 3 374 694 817 7E-71 235 Q08BR4 STB1B_DANRE GO:0003677; GO:0005694; GO:0018024; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA binding; chromosome; histone-lysine N-methyltransferase activity; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR016177; IPR025796; IPR001739; IPR003616; IPR007728; IPR003606; IPR001214; IPR002999; Histone-lysine N-methyltransferase SETDB1-B (EC 2.1.1.43) (SET domain bifurcated 1B) setdb1b zgc:152899 Danio rerio (Zebrafish) (Brachydanio rerio) 1216 Q08BR4 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig3299 sp Q08C69 RUSD1_DANRE 67.36 144 37 2 2 424 155 291 5E-60 193 Q08C69 RUSD1_DANRE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006145; RNA pseudouridylate synthase domain-containing protein 1 rpusd1 zgc:153465 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q08C69 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig3299 sp Q08C69 RUSD1_DANRE 67.36 144 37 2 2 424 155 291 5E-60 193 Q08C69 RUSD1_DANRE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006145; RNA pseudouridylate synthase domain-containing protein 1 rpusd1 zgc:153465 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q08C69 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig3299 sp Q08C69 RUSD1_DANRE 67.36 144 37 2 2 424 155 291 5E-60 193 Q08C69 RUSD1_DANRE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006145; RNA pseudouridylate synthase domain-containing protein 1 rpusd1 zgc:153465 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q08C69 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig3299 sp Q08C69 RUSD1_DANRE 67.36 144 37 2 2 424 155 291 5E-60 193 Q08C69 RUSD1_DANRE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006145; RNA pseudouridylate synthase domain-containing protein 1 rpusd1 zgc:153465 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q08C69 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig3299 sp Q08C69 RUSD1_DANRE 67.36 144 37 2 2 424 155 291 5E-60 193 Q08C69 RUSD1_DANRE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006145; RNA pseudouridylate synthase domain-containing protein 1 rpusd1 zgc:153465 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q08C69 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig398 sp Q08C72 CWC22_DANRE 94.78 134 7 0 161 562 602 735 4E-103 276 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig398 sp Q08C72 CWC22_DANRE 98.15 54 1 0 1 162 549 602 4E-103 119 Q08C72 CWC22_DANRE GO:0003723; GO:0008380; GO:0006397; GO:0005681 RNA binding; RNA splicing; mRNA processing; spliceosomal complex reviewed IPR016024; IPR003891; IPR016021; IPR003890; Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) cwc22 ncm zgc:153452 Danio rerio (Zebrafish) (Brachydanio rerio) 985 Q08C72 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig297 sp Q08CG8 RNF44_DANRE 97 100 3 0 451 152 349 448 8E-64 208 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig297 sp Q08CG8 RNF44_DANRE 97 100 3 0 451 152 349 448 8E-64 208 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig297 sp Q08CG8 RNF44_DANRE 97 100 3 0 451 152 349 448 8E-64 208 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig882 sp Q08CG8 RNF44_DANRE 98.37 123 2 0 405 37 326 448 1E-82 257 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig882 sp Q08CG8 RNF44_DANRE 98.37 123 2 0 405 37 326 448 1E-82 257 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig882 sp Q08CG8 RNF44_DANRE 98.37 123 2 0 405 37 326 448 1E-82 257 Q08CG8 RNF44_DANRE GO:0008270 zinc ion binding reviewed IPR001841; IPR013083; RING finger protein 44 rnf44 zgc:153103 Danio rerio (Zebrafish) (Brachydanio rerio) 448 Q08CG8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4851 sp Q08CL3 KBTB8_DANRE 80.71 140 27 0 2 421 154 293 5E-66 216 Q08CL3 KBTB8_DANRE GO:0005794; GO:0005819 Golgi apparatus; spindle reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR017096; IPR015915; IPR006652; Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP) kbtbd8 takrp zgc:152950 Danio rerio (Zebrafish) (Brachydanio rerio) 601 Q08CL3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig4851 sp Q08CL3 KBTB8_DANRE 80.71 140 27 0 2 421 154 293 5E-66 216 Q08CL3 KBTB8_DANRE GO:0005794; GO:0005819 Golgi apparatus; spindle reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR017096; IPR015915; IPR006652; Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP) kbtbd8 takrp zgc:152950 Danio rerio (Zebrafish) (Brachydanio rerio) 601 Q08CL3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5549 sp Q08CL8 CNO10_DANRE 86.02 558 67 3 1654 11 68 624 0 988 Q08CL8 CNO10_DANRE GO:0030014; GO:0005737; GO:0031047; GO:0005634; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; cytoplasm; gene silencing by RNA; nucleus; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR011990; IPR001440; IPR013105; IPR019734; CCR4-NOT transcription complex subunit 10 cnot10 im:7139356 zgc:152939 Danio rerio (Zebrafish) (Brachydanio rerio) 624 Q08CL8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5549 sp Q08CL8 CNO10_DANRE 86.02 558 67 3 1654 11 68 624 0 988 Q08CL8 CNO10_DANRE GO:0030014; GO:0005737; GO:0031047; GO:0005634; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; cytoplasm; gene silencing by RNA; nucleus; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR011990; IPR001440; IPR013105; IPR019734; CCR4-NOT transcription complex subunit 10 cnot10 im:7139356 zgc:152939 Danio rerio (Zebrafish) (Brachydanio rerio) 624 Q08CL8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5549 sp Q08CL8 CNO10_DANRE 86.02 558 67 3 1654 11 68 624 0 988 Q08CL8 CNO10_DANRE GO:0030014; GO:0005737; GO:0031047; GO:0005634; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; cytoplasm; gene silencing by RNA; nucleus; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR011990; IPR001440; IPR013105; IPR019734; CCR4-NOT transcription complex subunit 10 cnot10 im:7139356 zgc:152939 Danio rerio (Zebrafish) (Brachydanio rerio) 624 Q08CL8 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0042626 GO:0042626 "ATPase activity, coupled to transmembrane movement of substances" transporter activity F ConsensusfromContig3435 sp Q08D64 ABCB6_XENTR 78.77 146 31 0 20 457 696 841 1E-64 217 Q08D64 ABCB6_XENTR GO:0005524; GO:0006200; GO:0042626; GO:0005794; GO:0005783; GO:0016021; GO:0005741; GO:0005886 ATP binding; ATP catabolic process; ATPase activity, coupled to transmembrane movement of substances; Golgi apparatus; endoplasmic reticulum; integral to membrane; mitochondrial outer membrane; plasma membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 6, mitochondrial abcb6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 849 Q08D64 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0007032 GO:0007032 endosome organization cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 83.33 132 22 0 397 2 523 654 2E-62 202 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006898 GO:0006898 receptor-mediated endocytosis transport P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0006898 GO:0006898 receptor-mediated endocytosis cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0007032 GO:0007032 endosome organization cell organization and biogenesis P ConsensusfromContig1101 sp Q08DF4 DYN1_BOVIN 65.96 47 11 2 524 393 480 524 2E-62 58.2 Q08DF4 DYN1_BOVIN GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0007032; GO:0005874; GO:0005543; GO:0006898 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; endosome organization; microtubule; phospholipid binding; receptor-mediated endocytosis reviewed IPR027741; IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; IPR011993; IPR001849; Dynamin-1 (EC 3.6.5.5) DNM1 Bos taurus (Bovine) 856 Q08DF4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0016428 GO:0016428 tRNA (cytosine-5-)-methyltransferase activity other molecular function F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0030488 GO:0030488 tRNA methylation RNA metabolism P ConsensusfromContig6072 sp Q08J23 NSUN2_HUMAN 58.36 353 136 2 74 1132 394 735 1E-133 414 Q08J23 NSUN2_HUMAN GO:0051301; GO:0005737; GO:0007067; GO:0005730; GO:0005819; GO:0016428; GO:0000049 cell division; cytoplasm; mitosis; nucleolus; spindle; tRNA (cytosine-5-)-methyltransferase activity; tRNA binding reviewed IPR001678; IPR023267; IPR023270; tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4) NSUN2 SAKI TRM4 Homo sapiens (Human) 767 Q08J23 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0003827 GO:0003827 "alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity" other molecular function F ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0006487 GO:0006487 protein amino acid N-linked glycosylation protein metabolism P ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1954 sp Q09325 MGAT1_RAT 71.71 152 43 0 3 458 218 369 5E-79 248 Q09325 MGAT1_RAT GO:0000139; GO:0003827; GO:0016021; GO:0046872; GO:0006486 Golgi membrane; alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity; integral to membrane; metal ion binding; protein glycosylation reviewed IPR004139; Protein modification; protein glycosylation. Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I) Mgat1 Gnt1 Rattus norvegicus (Rat) 447 Q09325 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2203 sp Q0GE19 NTCP7_HUMAN 75 200 50 0 1 600 122 321 2E-87 268 Q0GE19 NTCP7_HUMAN GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR016833; Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7) SLC10A7 C4orf13 P7 PSEC0051 Homo sapiens (Human) 358 Q0GE19 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5980 sp Q0IHV9 DDX6_XENTR 92.5 240 18 0 1 720 240 479 8E-160 465 Q0IHV9 DDX6_XENTR GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0030529 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; multicellular organismal development; nucleus; ribonucleoprotein complex reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase ddx6 (EC 3.6.4.13) (DEAD box protein 6) ddx6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 481 Q0IHV9 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0005097 GO:0005097 Rab GTPase activator activity enzyme regulator activity F ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0032313 GO:0032313 regulation of Rab GTPase activity signal transduction P ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0032851 GO:0032851 positive regulation of Rab GTPase activity signal transduction P ConsensusfromContig4039 sp Q0IHY4 TBC12_XENTR 88.19 127 15 0 3 383 501 627 6E-78 249 Q0IHY4 TBC12_XENTR GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 12 tbc1d12 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 684 Q0IHY4 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0030286 GO:0030286 dynein complex cytoskeleton C ConsensusfromContig1656 sp Q0III3 DC1I2_BOVIN 85.9 227 32 0 2 682 386 612 3E-143 423 Q0III3 DC1I2_BOVIN GO:0005868; GO:0005874; GO:0007018; GO:0003774; GO:0006810; GO:0031982 cytoplasmic dynein complex; microtubule; microtubule-based movement; motor activity; transport; vesicle reviewed IPR025956; IPR015943; IPR001680; IPR017986; Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2) DYNC1I2 Bos taurus (Bovine) 612 Q0III3 GO:0031982 GO:0031982 vesicle other cellular component C ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0005747 GO:0005747 mitochondrial respiratory chain complex I mitochondrion C ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0005747 GO:0005747 mitochondrial respiratory chain complex I other membranes C ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig6350 sp Q0MQB7 NDUAA_PANTR 53.8 355 163 1 54 1115 1 355 3E-138 407 Q0MQB7 NDUAA_PANTR GO:0005524; GO:0005759; GO:0005747; GO:0006139; GO:0055114; GO:0016773 ATP binding; mitochondrial matrix; mitochondrial respiratory chain complex I; nucleobase-containing compound metabolic process; oxidation-reduction process; phosphotransferase activity, alcohol group as acceptor reviewed IPR002624; IPR015828; IPR027417; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit) NDUFA10 Pan troglodytes (Chimpanzee) 355 Q0MQB7 GO:0070469 GO:0070469 respiratory chain other membranes C ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0009056 GO:0009056 catabolic process other metabolic processes P ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0016788 GO:0016788 "hydrolase activity, acting on ester bonds" other molecular function F ConsensusfromContig3358 sp Q0P3Z2 PTER_DANRE 78.42 139 30 0 433 17 39 177 1E-75 236 Q0P3Z2 PTER_DANRE GO:0009056; GO:0016787; GO:0008270 catabolic process; hydrolase activity; zinc ion binding reviewed IPR001559; Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) pter si:ch211-261f3.2 zgc:153666 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q0P3Z2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6065 sp Q0P424 ELP6_DANRE 60.79 227 75 2 285 965 1 213 5E-67 221 Q0P424 ELP6_DANRE GO:0033588; GO:0030335; GO:0006355; GO:0006351 Elongator holoenzyme complex; positive regulation of cell migration; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR018627; Elongator complex protein 6 (Protein TMEM103) elp6 tmem103 si:dkey-77n11.4 zgc:153530 Danio rerio (Zebrafish) (Brachydanio rerio) 264 Q0P424 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6065 sp Q0P424 ELP6_DANRE 60.79 227 75 2 285 965 1 213 5E-67 221 Q0P424 ELP6_DANRE GO:0033588; GO:0030335; GO:0006355; GO:0006351 Elongator holoenzyme complex; positive regulation of cell migration; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR018627; Elongator complex protein 6 (Protein TMEM103) elp6 tmem103 si:dkey-77n11.4 zgc:153530 Danio rerio (Zebrafish) (Brachydanio rerio) 264 Q0P424 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6065 sp Q0P424 ELP6_DANRE 60.79 227 75 2 285 965 1 213 5E-67 221 Q0P424 ELP6_DANRE GO:0033588; GO:0030335; GO:0006355; GO:0006351 Elongator holoenzyme complex; positive regulation of cell migration; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR018627; Elongator complex protein 6 (Protein TMEM103) elp6 tmem103 si:dkey-77n11.4 zgc:153530 Danio rerio (Zebrafish) (Brachydanio rerio) 264 Q0P424 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5810 sp Q0P457 KTI12_DANRE 86.4 228 31 0 840 157 48 275 1E-148 424 Q0P457 KTI12_DANRE GO:0005524 ATP binding reviewed IPR013641; IPR027417; Protein KTI12 homolog kti12 si:dkey-77f17.5 zgc:153393 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q0P457 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5810 sp Q0P457 KTI12_DANRE 86.4 228 31 0 840 157 48 275 1E-148 424 Q0P457 KTI12_DANRE GO:0005524 ATP binding reviewed IPR013641; IPR027417; Protein KTI12 homolog kti12 si:dkey-77f17.5 zgc:153393 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q0P457 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5810 sp Q0P457 KTI12_DANRE 86.4 228 31 0 840 157 48 275 1E-148 424 Q0P457 KTI12_DANRE GO:0005524 ATP binding reviewed IPR013641; IPR027417; Protein KTI12 homolog kti12 si:dkey-77f17.5 zgc:153393 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q0P457 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5810 sp Q0P457 KTI12_DANRE 86.4 228 31 0 840 157 48 275 1E-148 424 Q0P457 KTI12_DANRE GO:0005524 ATP binding reviewed IPR013641; IPR027417; Protein KTI12 homolog kti12 si:dkey-77f17.5 zgc:153393 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q0P457 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6132 sp Q0P4D1 AMN1_DANRE 57.49 247 104 1 89 829 4 249 1E-91 283 Q0P4D1 AMN1_DANRE reviewed IPR026738; IPR006553; Protein AMN1 homolog amn1 zgc:153121 Danio rerio (Zebrafish) (Brachydanio rerio) 249 Q0P4D1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6132 sp Q0P4D1 AMN1_DANRE 57.49 247 104 1 89 829 4 249 1E-91 283 Q0P4D1 AMN1_DANRE reviewed IPR026738; IPR006553; Protein AMN1 homolog amn1 zgc:153121 Danio rerio (Zebrafish) (Brachydanio rerio) 249 Q0P4D1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6132 sp Q0P4D1 AMN1_DANRE 57.49 247 104 1 89 829 4 249 1E-91 283 Q0P4D1 AMN1_DANRE reviewed IPR026738; IPR006553; Protein AMN1 homolog amn1 zgc:153121 Danio rerio (Zebrafish) (Brachydanio rerio) 249 Q0P4D1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0000165 GO:0000165 MAPKKK cascade signal transduction P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0000400 GO:0000400 four-way junction DNA binding nucleic acid binding activity F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0000403 GO:0000403 Y-form DNA binding nucleic acid binding activity F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0000785 GO:0000785 chromatin other cellular component C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0001503 GO:0001503 ossification developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0001776 GO:0001776 leukocyte homeostasis other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0001933 GO:0001933 negative regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0002051 GO:0002051 osteoblast fate commitment developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0002076 GO:0002076 osteoblast development developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0003690 GO:0003690 double-stranded DNA binding nucleic acid binding activity F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0007050 GO:0007050 cell cycle arrest cell cycle and proliferation P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0010332 GO:0010332 response to gamma radiation other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0016363 GO:0016363 nuclear matrix nucleus C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0016571 GO:0016571 histone methylation protein metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0016571 GO:0016571 histone methylation cell organization and biogenesis P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0030097 GO:0030097 hemopoiesis developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0030511 GO:0030511 positive regulation of transforming growth factor beta receptor signaling pathway signal transduction P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0030674 GO:0030674 "protein binding, bridging" other molecular function F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0031062 GO:0031062 positive regulation of histone methylation protein metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0031062 GO:0031062 positive regulation of histone methylation cell organization and biogenesis P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0032092 GO:0032092 positive regulation of protein binding other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0035097 GO:0035097 histone methyltransferase complex nucleus C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0043280 GO:0043280 positive regulation of caspase activity death P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0043433 GO:0043433 negative regulation of transcription factor activity RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0044212 ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045597 GO:0045597 positive regulation of cell differentiation other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045668 GO:0045668 negative regulation of osteoblast differentiation developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045669 GO:0045669 positive regulation of osteoblast differentiation developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045736 GO:0045736 negative regulation of cyclin-dependent protein kinase activity cell cycle and proliferation P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045736 GO:0045736 negative regulation of cyclin-dependent protein kinase activity other metabolic processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045786 GO:0045786 negative regulation of cell cycle cell cycle and proliferation P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0046329 GO:0046329 negative regulation of JNK cascade signal transduction P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0046329 GO:0046329 negative regulation of JNK cascade stress response P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0046621 GO:0046621 negative regulation of organ growth other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0048704 GO:0048704 embryonic skeletal system morphogenesis developmental processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0051781 GO:0051781 positive regulation of cell division other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0051974 GO:0051974 negative regulation of telomerase activity other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0060021 GO:0060021 palate development other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0060135 GO:0060135 maternal process involved in pregnancy other biological processes P ConsensusfromContig3343 sp Q0P5I0 MEN1_BOVIN 82.49 177 30 1 532 2 110 285 3E-90 282 Q0P5I0 MEN1_BOVIN GO:0000165; GO:0000403; GO:0007050; GO:0000785; GO:0003682; GO:0006338; GO:0032154; GO:0005829; GO:0003690; GO:0048704; GO:0000400; GO:0030097; GO:0035097; GO:0018024; GO:0001776; GO:0060135; GO:0046329; GO:0008285; GO:0045736; GO:0046621; GO:0045668; GO:0043433; GO:0051974; GO:0000122; GO:0016363; GO:0002076; GO:0002051; GO:0060021; GO:0043065; GO:0051781; GO:0043280; GO:0031062; GO:0045669; GO:0032092; GO:0045944; GO:0030511; GO:0006974; GO:0009411; GO:0010332; GO:0043565; GO:0044212; GO:0006351 MAPK cascade; Y-form DNA binding; cell cycle arrest; chromatin; chromatin binding; chromatin remodeling; cleavage furrow; cytosol; double-stranded DNA binding; embryonic skeletal system morphogenesis; four-way junction DNA binding; hemopoiesis; histone methyltransferase complex; histone-lysine N-methyltransferase activity; leukocyte homeostasis; maternal process involved in female pregnancy; negative regulation of JNK cascade; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein serine/threonine kinase activity; negative regulation of organ growth; negative regulation of osteoblast differentiation; negative regulation of sequence-specific DNA binding transcription factor activity; negative regulation of telomerase activity; negative regulation of transcription from RNA polymerase II promoter; nuclear matrix; osteoblast development; osteoblast fate commitment; palate development; positive regulation of apoptotic process; positive regulation of cell division; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of histone methylation; positive regulation of osteoblast differentiation; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; response to DNA damage stimulus; response to UV; response to gamma radiation; sequence-specific DNA binding; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR007747; Menin MEN1 Bos taurus (Bovine) 610 Q0P5I0 GO:0070412 GO:0070412 R-SMAD binding other molecular function F ConsensusfromContig1742 sp Q0V9Q6 MCM8_XENTR 58.23 158 61 3 464 3 22 178 6E-55 191 Q0V9Q6 MCM8_XENTR GO:0005524; GO:0003677; GO:0006260; GO:0097362; GO:0007049; GO:0000724; GO:0004386; GO:0005634 ATP binding; DNA binding; DNA replication; MCM8-MCM9 complex; cell cycle; double-strand break repair via homologous recombination; helicase activity; nucleus reviewed IPR003593; IPR001208; IPR027925; IPR012340; IPR027417; DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) mcm8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 843 Q0V9Q6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1742 sp Q0V9Q6 MCM8_XENTR 58.23 158 61 3 464 3 22 178 6E-55 191 Q0V9Q6 MCM8_XENTR GO:0005524; GO:0003677; GO:0006260; GO:0097362; GO:0007049; GO:0000724; GO:0004386; GO:0005634 ATP binding; DNA binding; DNA replication; MCM8-MCM9 complex; cell cycle; double-strand break repair via homologous recombination; helicase activity; nucleus reviewed IPR003593; IPR001208; IPR027925; IPR012340; IPR027417; DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) mcm8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 843 Q0V9Q6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1742 sp Q0V9Q6 MCM8_XENTR 58.23 158 61 3 464 3 22 178 6E-55 191 Q0V9Q6 MCM8_XENTR GO:0005524; GO:0003677; GO:0006260; GO:0097362; GO:0007049; GO:0000724; GO:0004386; GO:0005634 ATP binding; DNA binding; DNA replication; MCM8-MCM9 complex; cell cycle; double-strand break repair via homologous recombination; helicase activity; nucleus reviewed IPR003593; IPR001208; IPR027925; IPR012340; IPR027417; DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) mcm8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 843 Q0V9Q6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1742 sp Q0V9Q6 MCM8_XENTR 58.23 158 61 3 464 3 22 178 6E-55 191 Q0V9Q6 MCM8_XENTR GO:0005524; GO:0003677; GO:0006260; GO:0097362; GO:0007049; GO:0000724; GO:0004386; GO:0005634 ATP binding; DNA binding; DNA replication; MCM8-MCM9 complex; cell cycle; double-strand break repair via homologous recombination; helicase activity; nucleus reviewed IPR003593; IPR001208; IPR027925; IPR012340; IPR027417; DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) mcm8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 843 Q0V9Q6 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig1742 sp Q0V9Q6 MCM8_XENTR 58.23 158 61 3 464 3 22 178 6E-55 191 Q0V9Q6 MCM8_XENTR GO:0005524; GO:0003677; GO:0006260; GO:0097362; GO:0007049; GO:0000724; GO:0004386; GO:0005634 ATP binding; DNA binding; DNA replication; MCM8-MCM9 complex; cell cycle; double-strand break repair via homologous recombination; helicase activity; nucleus reviewed IPR003593; IPR001208; IPR027925; IPR012340; IPR027417; DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8) mcm8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 843 Q0V9Q6 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig6147 sp Q0VCJ8 METL9_BOVIN 63.86 166 58 2 1080 586 152 316 2E-82 197 Q0VCJ8 METL9_BOVIN reviewed IPR007884; Methyltransferase-like protein 9 METTL9 Bos taurus (Bovine) 318 ConsensusfromContig6147 sp Q0VCJ8 METL9_BOVIN 56.78 118 44 1 1429 1097 29 146 2E-82 131 Q0VCJ8 METL9_BOVIN reviewed IPR007884; Methyltransferase-like protein 9 METTL9 Bos taurus (Bovine) 318 ConsensusfromContig1919 sp Q0VCM2 TM187_BOVIN 47.14 210 106 1 45 659 1 210 4E-61 198 Q0VCM2 TM187_BOVIN GO:0016021; GO:0030133 integral to membrane; transport vesicle reviewed IPR028066; Transmembrane protein 187 TMEM187 Bos taurus (Bovine) 256 Q0VCM2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1919 sp Q0VCM2 TM187_BOVIN 47.14 210 106 1 45 659 1 210 4E-61 198 Q0VCM2 TM187_BOVIN GO:0016021; GO:0030133 integral to membrane; transport vesicle reviewed IPR028066; Transmembrane protein 187 TMEM187 Bos taurus (Bovine) 256 Q0VCM2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1919 sp Q0VCM2 TM187_BOVIN 47.14 210 106 1 45 659 1 210 4E-61 198 Q0VCM2 TM187_BOVIN GO:0016021; GO:0030133 integral to membrane; transport vesicle reviewed IPR028066; Transmembrane protein 187 TMEM187 Bos taurus (Bovine) 256 Q0VCM2 GO:0030133 GO:0030133 transport vesicle ER/Golgi C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0003830 GO:0003830 "beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity" other molecular function F ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0006487 GO:0006487 protein amino acid N-linked glycosylation protein metabolism P ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2061 sp Q10470 MGAT3_MOUSE 80 140 27 1 467 51 377 516 1E-77 246 Q10470 MGAT3_MOUSE GO:0000139; GO:0003830; GO:0016021; GO:0006487 Golgi membrane; beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; integral to membrane; protein N-linked glycosylation reviewed IPR006813; Protein modification; protein glycosylation. Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III) Mgat3 Mus musculus (Mouse) 538 Q10470 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0002378 GO:0002378 immunoglobulin biosynthetic process other metabolic processes P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0004653 GO:0004653 polypeptide N-acetylgalactosaminyltransferase activity other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0005795 GO:0005795 Golgi stack ER/Golgi C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0016266 GO:0016266 O-glycan processing protein metabolism P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0018242 GO:0018242 protein amino acid O-linked glycosylation via serine protein metabolism P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0018243 GO:0018243 protein amino acid O-linked glycosylation via threonine protein metabolism P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0030173 GO:0030173 integral to Golgi membrane ER/Golgi C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0030173 GO:0030173 integral to Golgi membrane other membranes C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig766 sp Q10471 GALT2_HUMAN 88.12 160 19 0 3 482 359 518 4E-103 313 Q10471 GALT2_HUMAN GO:0032580; GO:0005795; GO:0016266; GO:0005576; GO:0002378; GO:0030173; GO:0030145; GO:0048471; GO:0004653; GO:0043687; GO:0018242; GO:0018243 Golgi cisterna membrane; Golgi stack; O-glycan processing; extracellular region; immunoglobulin biosynthetic process; integral to Golgi membrane; manganese ion binding; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; post-translational protein modification; protein O-linked glycosylation via serine; protein O-linked glycosylation via threonine reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form] GALNT2 Homo sapiens (Human) 571 Q10471 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2222 sp Q12800 TFCP2_HUMAN 90.48 105 10 0 471 157 10 114 2E-59 198 Q12800 TFCP2_HUMAN GO:0003677; GO:0005634; GO:0006357; GO:0003700; GO:0006351 DNA binding; nucleus; regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR007604; IPR013761; Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF) TFCP2 LSF SEF Homo sapiens (Human) 502 Q12800 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0000149 GO:0000149 SNARE binding other molecular function F ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0001950 GO:0001950 plasma membrane enriched fraction other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005484 GO:0005484 SNAP receptor activity other molecular function F ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005773 GO:0005773 vacuole other cytoplasmic organelle C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006461 GO:0006461 protein complex assembly cell organization and biogenesis P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006836 GO:0006836 neurotransmitter transport transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006892 GO:0006892 post-Golgi vesicle-mediated transport transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0006944 GO:0006944 membrane fusion cell organization and biogenesis P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016044 GO:0016044 membrane organization cell organization and biogenesis P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016081 GO:0016081 synaptic vesicle docking during exocytosis transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016081 GO:0016081 synaptic vesicle docking during exocytosis cell-cell signaling P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0017137 GO:0017137 Rab GTPase binding enzyme regulator activity F ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0030507 GO:0030507 spectrin binding cytoskeletal activity F ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0031201 GO:0031201 SNARE complex other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0035749 ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0042383 GO:0042383 sarcolemma plasma membrane C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0042383 GO:0042383 sarcolemma other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0042581 GO:0042581 specific granule other cellular component C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0043219 GO:0043219 lateral loop plasma membrane C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0043219 GO:0043219 lateral loop other membranes C ConsensusfromContig6007 sp Q12846 STX4_HUMAN 53.14 175 81 1 1989 1468 81 255 1E-53 191 Q12846 STX4_HUMAN GO:0031201; GO:0016323; GO:0009986; GO:0005829; GO:0016021; GO:0006886; GO:0043219; GO:0035749; GO:0006836; GO:0048471; GO:0030168; GO:0006892; GO:0042581; GO:0005802; GO:0005773 P54920 SNARE complex; basolateral plasma membrane; cell surface; cytosol; integral to membrane; intracellular protein transport; lateral loop; myelin sheath adaxonal region; neurotransmitter transport; perinuclear region of cytoplasm; platelet activation; post-Golgi vesicle-mediated transport; specific granule; trans-Golgi network; vacuole reviewed IPR006012; IPR006011; IPR010989; IPR000727; Syntaxin-4 (Renal carcinoma antigen NY-REN-31) STX4 STX4A Homo sapiens (Human) 297 Q12846 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0001541 GO:0001541 ovarian follicle development developmental processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0005851 GO:0005851 eukaryotic translation initiation factor 2B complex translational apparatus C ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0009408 GO:0009408 response to heat stress response P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0009749 GO:0009749 response to glucose stimulus other biological processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0014002 GO:0014002 astrocyte development developmental processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0014003 GO:0014003 oligodendrocyte development developmental processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0031369 GO:0031369 translation initiation factor binding other molecular function F ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0032057 GO:0032057 negative regulation of translational initiation in response to stress stress response P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0032057 GO:0032057 negative regulation of translational initiation in response to stress protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0042552 GO:0042552 myelination developmental processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0043434 GO:0043434 response to peptide hormone stimulus other biological processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0045948 GO:0045948 positive regulation of translational initiation protein metabolism P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0048708 GO:0048708 astrocyte differentiation developmental processes P ConsensusfromContig2080 sp Q13144 EI2BE_HUMAN 78.46 130 28 0 396 7 234 363 1E-68 225 Q13144 EI2BE_HUMAN GO:0014002; GO:0035690; GO:0005829; GO:0005851; GO:0005085; GO:0042552; GO:0032057; GO:0005634; GO:0014003; GO:0001541; GO:0045948; GO:0034976; GO:0009749; GO:0009408; GO:0043434; GO:0003743; GO:0031369 astrocyte development; cellular response to drug; cytosol; eukaryotic translation initiation factor 2B complex; guanyl-nucleotide exchange factor activity; myelination; negative regulation of translational initiation in response to stress; nucleus; oligodendrocyte development; ovarian follicle development; positive regulation of translational initiation; response to endoplasmic reticulum stress; response to glucose stimulus; response to heat; response to peptide hormone stimulus; translation initiation factor activity; translation initiation factor binding reviewed IPR016024; IPR001451; IPR016021; IPR011004; IPR003307; Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon) EIF2B5 EIF2BE Homo sapiens (Human) 721 Q13144 GO:0051716 GO:0051716 cellular response to stimulus other biological processes P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0000165 GO:0000165 MAPKKK cascade signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0000186 GO:0000186 activation of MAPKK activity signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0000186 GO:0000186 activation of MAPKK activity protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0002224 GO:0002224 toll-like receptor signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0002224 GO:0002224 toll-like receptor signaling pathway stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004706 GO:0004706 JUN kinase kinase kinase activity signal transduction activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004706 GO:0004706 JUN kinase kinase kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004709 GO:0004709 MAP kinase kinase kinase activity signal transduction activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004709 GO:0004709 MAP kinase kinase kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004710 GO:0004710 MAP/ERK kinase kinase activity signal transduction activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004710 GO:0004710 MAP/ERK kinase kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0006970 GO:0006970 response to osmotic stress stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007179 GO:0007179 transforming growth factor beta receptor signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007254 GO:0007254 JNK cascade signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007254 GO:0007254 JNK cascade stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007256 GO:0007256 activation of JNKK activity signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007256 GO:0007256 activation of JNKK activity stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007256 GO:0007256 activation of JNKK activity protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007257 GO:0007257 activation of JUN kinase activity signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007257 GO:0007257 activation of JUN kinase activity stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0007257 GO:0007257 activation of JUN kinase activity protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008063 GO:0008063 Toll signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008432 GO:0008432 JUN kinase binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008545 GO:0008545 JUN kinase kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008637 GO:0008637 apoptotic mitochondrial changes cell organization and biogenesis P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0008637 GO:0008637 apoptotic mitochondrial changes death P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0030334 GO:0030334 regulation of cell migration other biological processes P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0031434 GO:0031434 mitogen-activated protein kinase kinase binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0032232 GO:0032232 negative regulation of actin filament bundle formation cell organization and biogenesis P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034130 GO:0034130 toll-like receptor 1 signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034130 GO:0034130 toll-like receptor 1 signaling pathway stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034134 GO:0034134 toll-like receptor 2 signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034134 GO:0034134 toll-like receptor 2 signaling pathway stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034142 GO:0034142 toll-like receptor 4 signaling pathway signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0034142 GO:0034142 toll-like receptor 4 signaling pathway stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0042060 GO:0042060 wound healing stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043010 GO:0043010 camera-type eye development developmental processes P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043406 GO:0043406 positive regulation of MAP kinase activity other metabolic processes P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043507 GO:0043507 positive regulation of JUN kinase activity signal transduction P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043507 GO:0043507 positive regulation of JUN kinase activity stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0043507 GO:0043507 positive regulation of JUN kinase activity protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0046625 GO:0046625 sphingolipid binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0050434 GO:0050434 positive regulation of viral transcription RNA metabolism P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0051019 GO:0051019 mitogen-activated protein kinase binding other molecular function F ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0051259 GO:0051259 protein oligomerization cell organization and biogenesis P ConsensusfromContig1121 sp Q13233 M3K1_HUMAN 93.37 196 13 0 3 590 1301 1496 4E-126 395 Q13233 M3K1_HUMAN GO:0005524; GO:0038095; GO:0008545; GO:0004709; GO:0002755; GO:0008637; GO:0043010; GO:0071260; GO:0005829; GO:0045087; GO:0030838; GO:0030334; GO:0034166; GO:0034134; GO:0034142; GO:0034146; GO:0034162; GO:0038123; GO:0038124; GO:0007179; GO:0042060; GO:0008270 P15056; P61962; O75369; P45985; Q12851 ATP binding; Fc-epsilon receptor signaling pathway; JUN kinase kinase activity; MAP kinase kinase kinase activity; MyD88-dependent toll-like receptor signaling pathway; apoptotic mitochondrial changes; camera-type eye development; cellular response to mechanical stimulus; cytosol; innate immune response; positive regulation of actin filament polymerization; regulation of cell migration; toll-like receptor 10 signaling pathway; toll-like receptor 2 signaling pathway; toll-like receptor 4 signaling pathway; toll-like receptor 5 signaling pathway; toll-like receptor 9 signaling pathway; toll-like receptor TLR1:TLR2 signaling pathway; toll-like receptor TLR6:TLR2 signaling pathway; transforming growth factor beta receptor signaling pathway; wound healing; zinc ion binding reviewed IPR016024; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR001841; IPR013083; IPR007527; Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) MAP3K1 MAPKKK1 MEKK MEKK1 Homo sapiens (Human) 1512 Q13233 GO:0071260 ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0000159 GO:0000159 protein phosphatase type 2A complex other cellular component C ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" cell cycle and proliferation P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" signal transduction P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0006977 GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" stress response P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0008601 GO:0008601 protein phosphatase type 2A regulator activity enzyme regulator activity F ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" signal transduction P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" stress response P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" death P ConsensusfromContig2668 sp Q13362 2A5G_HUMAN 94.57 92 5 0 1 276 39 130 8E-55 184 Q13362 2A5G_HUMAN GO:0006977; GO:0000775; GO:0042771; GO:0008285; GO:0005634; GO:0043161; GO:0000159; GO:0008601; GO:0007165 O96017; P46695; Q00987; P67775; P30153; P30154; P04637 DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; chromosome, centromeric region; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; negative regulation of cell proliferation; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29) PPP2R5C KIAA0044 Homo sapiens (Human) 524 Q13362 GO:0043161 GO:0043161 proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 53.9 141 59 1 1330 908 154 288 6E-65 166 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 53.9 141 59 1 1330 908 154 288 6E-65 166 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007601 GO:0007601 visual perception other biological processes P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 53.9 141 59 1 1330 908 154 288 6E-65 166 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0050896 GO:0050896 response to stimulus other biological processes P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 62.16 74 21 2 1787 1575 1 70 6E-65 67 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 62.16 74 21 2 1787 1575 1 70 6E-65 67 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007601 GO:0007601 visual perception other biological processes P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 62.16 74 21 2 1787 1575 1 70 6E-65 67 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0050896 GO:0050896 response to stimulus other biological processes P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 60.66 61 23 1 1527 1348 87 147 6E-65 58.9 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 60.66 61 23 1 1527 1348 87 147 6E-65 58.9 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0007601 GO:0007601 visual perception other biological processes P ConsensusfromContig5603 sp Q13371 PHLP_HUMAN 60.66 61 23 1 1527 1348 87 147 6E-65 58.9 Q13371 PHLP_HUMAN GO:0061084; GO:0006457; GO:0007165; GO:0007601 negative regulation of protein refolding; protein folding; signal transduction; visual perception reviewed IPR001200; IPR023196; IPR024253; IPR012336; Phosducin-like protein (PHLP) PDCL Homo sapiens (Human) 301 Q13371 GO:0050896 GO:0050896 response to stimulus other biological processes P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0004888 GO:0004888 transmembrane receptor activity signal transduction activity F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005901 GO:0005901 caveola plasma membrane C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0005901 GO:0005901 caveola other membranes C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0021766 GO:0021766 hippocampus development developmental processes P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0021819 GO:0021819 layer formation in the cerebral cortex developmental processes P ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0030229 GO:0030229 very-low-density lipoprotein receptor activity signal transduction activity F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0034187 GO:0034187 apolipoprotein E binding other molecular function F ConsensusfromContig1265 sp Q14114 LRP8_HUMAN 68.42 152 48 0 2 457 583 734 9E-72 238 Q14114 LRP8_HUMAN GO:0021541; GO:0034185; GO:0007596; GO:0005509; GO:0005901; GO:0019221; GO:0005576; GO:0016021; GO:0021819; GO:0000122; GO:0007603; GO:0032793; GO:1900006; GO:0061003; GO:0061098; GO:0006508; GO:0038025; GO:0050804; GO:0001523; GO:0030229 ammon gyrus development; apolipoprotein binding; blood coagulation; calcium ion binding; caveola; cytokine-mediated signaling pathway; extracellular region; integral to membrane; layer formation in cerebral cortex; negative regulation of transcription from RNA polymerase II promoter; phototransduction, visible light; positive regulation of CREB transcription factor activity; positive regulation of dendrite development; positive regulation of dendritic spine morphogenesis; positive regulation of protein tyrosine kinase activity; proteolysis; reelin receptor activity; regulation of synaptic transmission; retinoid metabolic process; very-low-density lipoprotein particle receptor activity reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2) LRP8 APOER2 Homo sapiens (Human) 963 Q14114 GO:0045860 GO:0045860 positive regulation of protein kinase activity other metabolic processes P ConsensusfromContig6338 sp Q14146 URB2_HUMAN 35.64 651 406 8 532 2472 883 1524 2E-102 353 Q14146 URB2_HUMAN GO:0005730 nucleolus reviewed IPR018849; Unhealthy ribosome biogenesis protein 2 homolog URB2 KIAA0133 Homo sapiens (Human) 1524 Q14146 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6338 sp Q14146 URB2_HUMAN 35.64 651 406 8 532 2472 883 1524 2E-102 353 Q14146 URB2_HUMAN GO:0005730 nucleolus reviewed IPR018849; Unhealthy ribosome biogenesis protein 2 homolog URB2 KIAA0133 Homo sapiens (Human) 1524 Q14146 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005740 GO:0005740 mitochondrial envelope mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0035556 ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 59.87 157 58 2 165 635 233 384 2E-70 189 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005740 GO:0005740 mitochondrial envelope mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0035556 ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 53.23 62 28 1 1 186 175 235 2E-70 68.9 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005528 GO:0005528 FK506 binding other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0005740 GO:0005740 mitochondrial envelope mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0018208 GO:0018208 peptidyl-proline modification protein metabolism P ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0035556 ConsensusfromContig5899 sp Q14318 FKBP8_HUMAN 85.71 28 4 0 635 718 385 412 2E-70 52.4 Q14318 FKBP8_HUMAN GO:0005528; GO:0006915; GO:0043010; GO:0001708; GO:0021904; GO:0030176; GO:0035556; GO:0046872; GO:0005740; GO:0031966; GO:0019048; GO:0035264; GO:0003755; GO:0030513; GO:0006457; GO:0010468; GO:0007224 Itself; P00533; P07900; O39474; Q5T4F4 FK506 binding; apoptotic process; camera-type eye development; cell fate specification; dorsal/ventral neural tube patterning; integral to endoplasmic reticulum membrane; intracellular signal transduction; metal ion binding; mitochondrial envelope; mitochondrial membrane; modulation by virus of host morphology or physiology; multicellular organism growth; peptidyl-prolyl cis-trans isomerase activity; positive regulation of BMP signaling pathway; protein folding; regulation of gene expression; smoothened signaling pathway reviewed IPR023114; IPR023566; IPR001179; IPR013026; IPR011990; IPR001440; IPR019734; Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase) FKBP8 FKBP38 Homo sapiens (Human) 412 Q14318 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0001569 GO:0001569 patterning of blood vessels developmental processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005834 GO:0005834 heterotrimeric G-protein complex plasma membrane C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005834 GO:0005834 heterotrimeric G-protein complex other membranes C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway signal transduction P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway other metabolic processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007266 GO:0007266 Rho protein signal transduction signal transduction P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0019001 GO:0019001 guanyl nucleotide binding other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0030334 GO:0030334 regulation of cell migration other biological processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane plasma membrane C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane other membranes C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031526 GO:0031526 brush border membrane plasma membrane C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031526 GO:0031526 brush border membrane other membranes C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031584 GO:0031584 activation of phospholipase D activity other biological processes P ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031702 GO:0031702 type 1 angiotensin receptor binding signal transduction activity F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0031752 GO:0031752 D5 dopamine receptor binding signal transduction activity F ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5938 sp Q14344 GNA13_HUMAN 85.13 269 40 0 1263 457 109 377 1E-165 478 Q14344 GNA13_HUMAN GO:0031752; GO:0031683; GO:0005525; GO:0003924; GO:0007266; GO:0031584; GO:0007189; GO:0031526; GO:0030154; GO:0006928; GO:0005834; GO:0001701; GO:0007243; GO:0042470; GO:0046872; GO:0001569; GO:0030168; GO:0030334; GO:0008360; GO:0004871; GO:0031702 Q92888 D5 dopamine receptor binding; G-protein beta/gamma-subunit complex binding; GTP binding; GTPase activity; Rho protein signal transduction; activation of phospholipase D activity; adenylate cyclase-activating G-protein coupled receptor signaling pathway; brush border membrane; cell differentiation; cellular component movement; heterotrimeric G-protein complex; in utero embryonic development; intracellular protein kinase cascade; melanosome; metal ion binding; patterning of blood vessels; platelet activation; regulation of cell migration; regulation of cell shape; signal transducer activity; type 1 angiotensin receptor binding reviewed IPR000469; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13) GNA13 Homo sapiens (Human) 377 Q14344 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005911 GO:0005911 cell-cell junction plasma membrane C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0005911 GO:0005911 cell-cell junction other membranes C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0007156 GO:0007156 homophilic cell adhesion cell adhesion P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0007163 GO:0007163 establishment or maintenance of cell polarity cell organization and biogenesis P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0007267 GO:0007267 cell-cell signaling cell-cell signaling P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0009653 GO:0009653 anatomical structure morphogenesis other biological processes P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0016337 GO:0016337 cell-cell adhesion cell adhesion P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig1009 sp Q14517 FAT1_HUMAN 69.29 140 43 0 420 1 2533 2672 1E-58 203 Q14517 FAT1_HUMAN GO:0007015; GO:0009653; GO:0005509; GO:0016477; GO:0016337; GO:0005911; GO:0007267; GO:0007163; GO:0030175; GO:0007156; GO:0005887; GO:0030027; GO:0005634; GO:0048471 Q8N8S7; Q9NSC5; Q99JP6 actin filament organization; anatomical structure morphogenesis; calcium ion binding; cell migration; cell-cell adhesion; cell-cell junction; cell-cell signaling; establishment or maintenance of cell polarity; filopodium; homophilic cell adhesion; integral to plasma membrane; lamellipodium; nucleus; perinuclear region of cytoplasm reviewed IPR002126; IPR015919; IPR020894; IPR008985; IPR013320; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR001791; Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form] FAT1 CDHF7 FAT Homo sapiens (Human) 4588 Q14517 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0003756 GO:0003756 protein disulfide isomerase activity other molecular function F ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006662 GO:0006662 glycerol ether metabolic process other metabolic processes P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response signal transduction P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response stress response P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response other metabolic processes P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0015035 GO:0015035 protein disulfide oxidoreductase activity other molecular function F ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response signal transduction P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response stress response P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig189 sp Q14554 PDIA5_HUMAN 64.46 121 43 0 607 245 399 519 2E-51 178 Q14554 PDIA5_HUMAN GO:0006987; GO:0045454; GO:0005788; GO:0005789; GO:0006662; GO:0016491; GO:0003756; GO:0015035 activation of signaling protein activity involved in unfolded protein response; cell redox homeostasis; endoplasmic reticulum lumen; endoplasmic reticulum membrane; glycerol ether metabolic process; oxidoreductase activity; protein disulfide isomerase activity; protein disulfide oxidoreductase activity reviewed IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein) PDIA5 PDIR Homo sapiens (Human) 519 Q14554 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0004749 GO:0004749 ribose phosphate diphosphokinase activity other molecular function F ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0004857 GO:0004857 enzyme inhibitor activity enzyme regulator activity F ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0009165 GO:0009165 nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0030234 GO:0030234 enzyme regulator activity enzyme regulator activity F ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0043086 GO:0043086 negative regulation of catalytic activity other biological processes P ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig5762 sp Q14558 KPRA_HUMAN 86.93 329 43 0 1075 89 28 356 0 566 Q14558 KPRA_HUMAN GO:0004857; GO:0000287; GO:0033673; GO:0006139; GO:0009165; GO:0004749; GO:0002189 enzyme inhibitor activity; magnesium ion binding; negative regulation of kinase activity; nucleobase-containing compound metabolic process; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity; ribose phosphate diphosphokinase complex reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39) PRPSAP1 Homo sapiens (Human) 356 Q14558 GO:0050790 GO:0050790 regulation of catalytic activity other biological processes P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0001950 GO:0001950 plasma membrane enriched fraction other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005216 GO:0005216 ion channel activity transporter activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005220 GO:0005220 "inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity" transporter activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005220 GO:0005220 "inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity" signal transduction activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005262 GO:0005262 calcium channel activity transporter activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0006112 GO:0006112 energy reserve metabolic process other metabolic processes P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0006816 GO:0006816 calcium ion transport transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0007202 GO:0007202 activation of phospholipase C activity other biological processes P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0008543 GO:0008543 fibroblast growth factor receptor signaling pathway signal transduction P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0015085 GO:0015085 calcium ion transmembrane transporter activity transporter activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0015278 GO:0015278 calcium-release channel activity transporter activity F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0016529 GO:0016529 sarcoplasmic reticulum ER/Golgi C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0031095 GO:0031095 platelet dense tubular network membrane other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0033017 GO:0033017 sarcoplasmic reticulum membrane other membranes C ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0044281 ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0048016 GO:0048016 inositol phosphate-mediated signaling signal transduction P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0050796 GO:0050796 regulation of insulin secretion transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0050796 GO:0050796 regulation of insulin secretion cell-cell signaling P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0070588 GO:0070588 transmembrane calcium ion transport transport P ConsensusfromContig1339 sp Q14571 ITPR2_HUMAN 82.58 132 19 2 419 30 2572 2701 1E-66 226 Q14571 ITPR2_HUMAN GO:0038095; GO:0038096; GO:0007202; GO:0005938; GO:0071320; GO:0071361; GO:0006112; GO:0007173; GO:0008543; GO:0045087; GO:0005220; GO:0016021; GO:0048011; GO:0035091; GO:0005886; GO:0030168; GO:0031095; GO:0050796; GO:0001666; GO:0033017; GO:0044281 Fc-epsilon receptor signaling pathway; Fc-gamma receptor signaling pathway involved in phagocytosis; activation of phospholipase C activity; cell cortex; cellular response to cAMP; cellular response to ethanol; energy reserve metabolic process; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; innate immune response; inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity; integral to membrane; neurotrophin TRK receptor signaling pathway; phosphatidylinositol binding; plasma membrane; platelet activation; platelet dense tubular network membrane; regulation of insulin secretion; response to hypoxia; sarcoplasmic reticulum membrane; small molecule metabolic process reviewed IPR016024; IPR000699; IPR014821; IPR000493; IPR005821; IPR016093; IPR013662; IPR015925; Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor) ITPR2 Homo sapiens (Human) 2701 Q14571 GO:0071320 ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig649 sp Q14690 RRP5_HUMAN 65.73 213 73 0 2 640 1656 1868 8E-94 306 Q14690 RRP5_HUMAN GO:0003723; GO:0005829; GO:0006397; GO:0005730; GO:0005634; GO:0006364 P19838 RNA binding; cytosol; mRNA processing; nucleolus; nucleus; rRNA processing reviewed IPR003107; IPR012340; IPR003029; IPR022967; IPR008847; IPR013026; IPR011990; Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11) PDCD11 KIAA0185 Homo sapiens (Human) 1871 Q14690 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016581 GO:0016581 NuRD complex nucleus C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig887 sp Q14839 CHD4_HUMAN 83.33 198 31 1 589 2 363 560 4E-92 301 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016581 GO:0016581 NuRD complex nucleus C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3085 sp Q14839 CHD4_HUMAN 84.5 129 19 1 388 2 677 804 1E-65 221 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016581 GO:0016581 NuRD complex nucleus C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig5903 sp Q14839 CHD4_HUMAN 85.28 360 45 5 40 1113 1176 1529 0 556 Q14839 CHD4_HUMAN GO:0005524; GO:0004003; GO:0003677; GO:0016581; GO:0005813; GO:0016568; GO:0005737; GO:0006357; GO:0006351; GO:0008270 Q13547; P01106 ATP binding; ATP-dependent DNA helicase activity; DNA binding; NuRD complex; centrosome; chromatin modification; cytoplasm; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR012957; IPR012958; IPR023780; IPR000953; IPR016197; IPR002464; IPR009462; IPR009463; IPR014001; IPR001650; IPR027417; IPR000330; IPR019786; IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta) CHD4 Homo sapiens (Human) 1912 Q14839 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig5673 sp Q149F1 RUSD2_MOUSE 57.68 423 151 5 177 1445 159 553 7E-167 493 Q149F1 RUSD2_MOUSE GO:0003723; GO:0009982; GO:0001522 RNA binding; pseudouridine synthase activity; pseudouridine synthesis reviewed IPR020103; IPR006225; IPR006224; IPR006145; RNA pseudouridylate synthase domain-containing protein 2 Rpusd2 Mus musculus (Mouse) 553 Q149F1 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig1526 sp Q15034 HERC3_HUMAN 84.55 123 19 0 396 28 700 822 3E-61 208 Q15034 HERC3_HUMAN GO:0005737; GO:0016023; GO:0005634; GO:0042787; GO:0004842 cytoplasm; cytoplasmic membrane-bounded vesicle; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC3 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 3) HERC3 KIAA0032 Homo sapiens (Human) 1050 Q15034 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005626 GO:0005626 insoluble fraction other cellular component C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0006921 GO:0006921 cell structure disassembly during apoptosis cell organization and biogenesis P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0006921 GO:0006921 cell structure disassembly during apoptosis death P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0008307 GO:0008307 structural constituent of muscle other molecular function F ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0030056 GO:0030056 hemidesmosome plasma membrane C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0030056 GO:0030056 hemidesmosome other membranes C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0031581 GO:0031581 hemidesmosome assembly cell organization and biogenesis P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0034329 GO:0034329 cell junction assembly cell organization and biogenesis P ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0042383 GO:0042383 sarcolemma plasma membrane C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0042383 GO:0042383 sarcolemma other membranes C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0043292 GO:0043292 contractile fiber other cellular component C ConsensusfromContig762 sp Q15149 PLEC_HUMAN 85.58 104 15 0 2 313 4450 4553 9E-56 192 Q15149 PLEC_HUMAN GO:0006921; GO:0043034; GO:0005829; GO:0030198; GO:0005925; GO:0030056; GO:0031581; GO:0045111; GO:0042383; GO:0016528; GO:0008307 P35637; P16144 cellular component disassembly involved in execution phase of apoptosis; costamere; cytosol; extracellular matrix organization; focal adhesion; hemidesmosome; hemidesmosome assembly; intermediate filament cytoskeleton; sarcolemma; sarcoplasm; structural constituent of muscle reviewed IPR001589; IPR001715; IPR001101; IPR005326; IPR018159; Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) PLEC PLEC1 Homo sapiens (Human) 4684 Q15149 GO:0045111 GO:0045111 intermediate filament cytoskeleton cytoskeleton C ConsensusfromContig2431 sp Q15269 PWP2_HUMAN 82.19 146 26 0 440 3 302 447 1E-75 248 Q15269 PWP2_HUMAN GO:0005737; GO:0005730; GO:0004871 cytoplasm; nucleolus; signal transducer activity reviewed IPR020472; IPR027145; IPR011047; IPR007148; IPR015943; IPR001680; IPR019775; IPR017986; Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) 919 Q15269 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig2431 sp Q15269 PWP2_HUMAN 82.19 146 26 0 440 3 302 447 1E-75 248 Q15269 PWP2_HUMAN GO:0005737; GO:0005730; GO:0004871 cytoplasm; nucleolus; signal transducer activity reviewed IPR020472; IPR027145; IPR011047; IPR007148; IPR015943; IPR001680; IPR019775; IPR017986; Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) 919 Q15269 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2431 sp Q15269 PWP2_HUMAN 82.19 146 26 0 440 3 302 447 1E-75 248 Q15269 PWP2_HUMAN GO:0005737; GO:0005730; GO:0004871 cytoplasm; nucleolus; signal transducer activity reviewed IPR020472; IPR027145; IPR011047; IPR007148; IPR015943; IPR001680; IPR019775; IPR017986; Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) 919 Q15269 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2431 sp Q15269 PWP2_HUMAN 82.19 146 26 0 440 3 302 447 1E-75 248 Q15269 PWP2_HUMAN GO:0005737; GO:0005730; GO:0004871 cytoplasm; nucleolus; signal transducer activity reviewed IPR020472; IPR027145; IPR011047; IPR007148; IPR015943; IPR001680; IPR019775; IPR017986; Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) 919 Q15269 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2431 sp Q15269 PWP2_HUMAN 82.19 146 26 0 440 3 302 447 1E-75 248 Q15269 PWP2_HUMAN GO:0005737; GO:0005730; GO:0004871 cytoplasm; nucleolus; signal transducer activity reviewed IPR020472; IPR027145; IPR011047; IPR007148; IPR015943; IPR001680; IPR019775; IPR017986; Periodic tryptophan protein 2 homolog PWP2 PWP2H Homo sapiens (Human) 919 Q15269 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0006461 GO:0006461 protein complex assembly cell organization and biogenesis P ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0006887 GO:0006887 exocytosis transport P ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0030864 GO:0030864 cortical actin cytoskeleton cytoskeleton C ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0030866 GO:0030866 cortical actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0035090 GO:0035090 maintenance of apical/basal cell polarity cell organization and biogenesis P ConsensusfromContig874 sp Q15334 L2GL1_HUMAN 58.59 227 68 3 635 6 834 1051 4E-75 250 Q15334 L2GL1_HUMAN GO:0000137; GO:0000139; GO:0006893; GO:0005097; GO:0030424; GO:0007409; GO:0030864; GO:0030866; GO:0031901; GO:0006887; GO:0035090; GO:0035748; GO:0006461; GO:0019901; GO:0005198; GO:0032588 Golgi cis cisterna; Golgi membrane; Golgi to plasma membrane transport; Rab GTPase activator activity; axon; axonogenesis; cortical actin cytoskeleton; cortical actin cytoskeleton organization; early endosome membrane; exocytosis; maintenance of apical/basal cell polarity; myelin sheath abaxonal region; protein complex assembly; protein kinase binding; structural molecule activity; trans-Golgi network membrane reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein) LLGL1 DLG4 HUGL HUGL1 Homo sapiens (Human) 1064 Q15334 GO:0035748 ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0000375 GO:0000375 "RNA splicing, via transesterification reactions" RNA metabolism P ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0005689 GO:0005689 U12-dependent spliceosome nucleus C ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5696 sp Q15427 SF3B4_HUMAN 100 211 0 0 1343 711 1 211 1E-148 439 Q15427 SF3B4_HUMAN GO:0003723; GO:0005689; GO:0000398; GO:0005654; GO:0000166 O75934; Q15029; P62993; Q6P2Q9; P98175; Q13435; Q9BRX9 RNA binding; U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm; nucleotide binding reviewed IPR012677; IPR000504; Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49) SF3B4 SAP49 Homo sapiens (Human) 424 Q15427 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0016922 GO:0016922 ligand-dependent nuclear receptor binding signal transduction activity F ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6081 sp Q15650 TRIP4_HUMAN 55.1 245 109 1 1396 662 268 511 7E-78 259 Q15650 TRIP4_HUMAN GO:0005737; GO:0016922; GO:0005815; GO:0005634; GO:0045893; GO:0003713; GO:0006366; GO:0008270 cytoplasm; ligand-dependent nuclear receptor binding; microtubule organizing center; nucleus; positive regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter; zinc ion binding reviewed IPR007374; IPR015947; IPR009349; Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4) TRIP4 Homo sapiens (Human) 581 Q15650 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005086 GO:0005086 ARF guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3056 sp Q15751 HERC1_HUMAN 77.48 151 34 0 1 453 4472 4622 7E-75 250 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005086 GO:0005086 ARF guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 66.67 108 35 1 515 195 4277 4384 2E-54 144 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005086 GO:0005086 ARF guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2765 sp Q15751 HERC1_HUMAN 61.43 70 27 0 211 2 4379 4448 2E-54 89.7 Q15751 HERC1_HUMAN GO:0005086; GO:0005794; GO:0021702; GO:0005829; GO:0016020; GO:0010507; GO:0050885; GO:0031175; GO:0006810; GO:0004842 ARF guanyl-nucleotide exchange factor activity; Golgi apparatus; cerebellar Purkinje cell differentiation; cytosol; membrane; negative regulation of autophagy; neuromuscular process controlling balance; neuron projection development; transport; ubiquitin-protein ligase activity reviewed IPR001870; IPR008985; IPR000569; IPR009091; IPR000408; IPR018355; IPR003877; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC1 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 1) (p532) (p619) HERC1 Homo sapiens (Human) 4861 Q15751 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0008643 GO:0008643 carbohydrate transport transport P ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2939 sp Q15B89 S35D2_PIG 71.9 121 33 1 1 363 11 130 1E-54 180 Q15B89 S35D2_PIG GO:0000139; GO:0008643; GO:0016021 Golgi membrane; carbohydrate transport; integral to membrane reviewed IPR004853; UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Solute carrier family 35 member D2) (Fragment) SLC35D2 Sus scrofa (Pig) 343 Q15B89 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0016486 GO:0016486 peptide hormone processing protein metabolism P ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0030173 GO:0030173 integral to Golgi membrane ER/Golgi C ConsensusfromContig5916 sp Q16549 PCSK7_HUMAN 57.44 195 82 1 1448 867 455 649 1E-65 231 Q16549 PCSK7_HUMAN GO:0030173; GO:0016486; GO:0006508; GO:0004252 integral to Golgi membrane; peptide hormone processing; proteolysis; serine-type endopeptidase activity reviewed IPR008979; IPR000209; IPR022398; IPR023828; IPR015500; IPR009020; IPR002884; Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7) PCSK7 LPC PC7 PC8 SPC7 Homo sapiens (Human) 785 Q16549 GO:0030173 GO:0030173 integral to Golgi membrane other membranes C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0008144 GO:0008144 drug binding other molecular function F ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0030175 GO:0030175 filopodium other cellular component C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0030674 GO:0030674 "protein binding, bridging" other molecular function F ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0048870 GO:0048870 cell motility other biological processes P ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0051017 GO:0051017 actin filament bundle formation cell organization and biogenesis P ConsensusfromContig5657 sp Q16658 FSCN1_HUMAN 75.91 411 96 2 24 1253 85 493 0 662 Q16658 FSCN1_HUMAN GO:0051015; GO:0051017; GO:0030054; GO:0016477; GO:0008283; GO:0005829; GO:0008144; GO:0030175; GO:0071437; GO:0001725 Q9BXW9; P40692; Q9ULL4; P63104 actin filament binding; actin filament bundle assembly; cell junction; cell migration; cell proliferation; cytosol; drug binding; filopodium; invadopodium; stress fiber reviewed IPR008999; IPR010431; IPR022768; IPR024703; Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55) FSCN1 FAN1 HSN SNL Homo sapiens (Human) 493 Q16658 GO:0071437 ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0031305 GO:0031305 integral to mitochondrial inner membrane mitochondrion C ConsensusfromContig5777 sp Q16891 IMMT_HUMAN 66.58 380 122 1 23 1147 375 754 2E-165 498 Q16891 IMMT_HUMAN GO:0016021; GO:0051560; GO:0005743; GO:0009409 O60341 integral to membrane; mitochondrial calcium ion homeostasis; mitochondrial inner membrane; response to cold reviewed IPR019133; Mitochondrial inner membrane protein (Cell proliferation-inducing gene 4/52 protein) (Mitofilin) (p87/89) IMMT HMP MINOS2 PIG4 PIG52 Homo sapiens (Human) 758 Q16891 GO:0031305 GO:0031305 integral to mitochondrial inner membrane other membranes C ConsensusfromContig6136 sp Q17QH8 D39U1_BOVIN 61.61 224 78 2 218 889 5 220 1E-88 275 Q17QH8 D39U1_BOVIN GO:0016491 oxidoreductase activity reviewed IPR013549; IPR016040; IPR010099; Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1) SDR39U1 Bos taurus (Bovine) 294 Q17QH8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6136 sp Q17QH8 D39U1_BOVIN 44.44 72 40 0 889 1104 222 293 1E-88 74.7 Q17QH8 D39U1_BOVIN GO:0016491 oxidoreductase activity reviewed IPR013549; IPR016040; IPR010099; Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1) SDR39U1 Bos taurus (Bovine) 294 Q17QH8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0008060 GO:0008060 ARF GTPase activator activity enzyme regulator activity F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0008093 GO:0008093 cytoskeletal adaptor activity cytoskeletal activity F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0030030 GO:0030030 cell projection organization cell organization and biogenesis P ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0032312 GO:0032312 regulation of ARF GTPase activity signal transduction P ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0046847 GO:0046847 filopodium assembly cell organization and biogenesis P ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3277 sp Q1AAU6 ASAP1_RAT 76.92 117 25 1 2 346 366 482 5E-57 195 Q1AAU6 ASAP1_RAT GO:0008060; GO:0060271; GO:0005737; GO:0016020; GO:0005543; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; cilium morphogenesis; cytoplasm; membrane; phospholipid binding; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) Asap1 Ddef1 Rattus norvegicus (Rat) 1144 Q1AAU6 GO:0060271 GO:0060271 cilium morphogenesis cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0004835 GO:0004835 tubulin-tyrosine ligase activity other molecular function F ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0015630 GO:0015630 microtubule cytoskeleton cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0018094 GO:0018094 protein polyglycylation protein metabolism P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035082 GO:0035082 axoneme assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035083 GO:0035083 cilium axoneme assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035085 GO:0035085 cilium axoneme other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0042384 GO:0042384 cilium assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070735 GO:0070735 other molecular function ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070736 GO:0070736 other molecular function ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 73.27 101 27 0 3 305 371 471 1E-81 171 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070738 GO:0070738 other molecular function ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0004835 GO:0004835 tubulin-tyrosine ligase activity other molecular function F ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0015630 GO:0015630 microtubule cytoskeleton cytoskeleton C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0018094 GO:0018094 protein polyglycylation protein metabolism P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035082 GO:0035082 axoneme assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035083 GO:0035083 cilium axoneme assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0035085 GO:0035085 cilium axoneme other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0042384 GO:0042384 cilium assembly cell organization and biogenesis P ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070735 GO:0070735 other molecular function ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070736 GO:0070736 other molecular function ConsensusfromContig2300 sp Q1ECV4 TTLL3_DANRE 77.42 93 21 0 299 577 470 562 1E-81 153 Q1ECV4 TTLL3_DANRE GO:0035082; GO:0042384; GO:0035085; GO:0005874; GO:0015630; GO:0018094; GO:0070736 axoneme assembly; cilium assembly; cilium axoneme; microtubule; microtubule cytoskeleton; protein polyglycylation; protein-glycine ligase activity, initiating reviewed IPR004344; IPR027753; Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 3) ttll3 zgc:136840 Danio rerio (Zebrafish) (Brachydanio rerio) 771 Q1ECV4 GO:0070738 GO:0070738 other molecular function ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0004826 GO:0004826 phenylalanine-tRNA ligase activity other molecular function F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation protein metabolism P ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5921 sp Q1JPX3 SYFA_DANRE 86.92 497 65 0 1703 213 1 497 0 895 Q1JPX3 SYFA_DANRE GO:0005524; GO:0005737; GO:0004826; GO:0006432; GO:0000049 ATP binding; cytoplasm; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA binding reviewed IPR006195; IPR004529; IPR002319; IPR011991; Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS) farsa farsla zgc:136506 zgc:158185 Danio rerio (Zebrafish) (Brachydanio rerio) 497 Q1JPX3 GO:0043039 GO:0043039 tRNA aminoacylation RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 84.65 228 35 0 3 686 405 632 3E-134 394 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6246 sp Q1JPZ7 PRP39_DANRE 73.61 72 17 1 698 907 637 708 3E-134 108 Q1JPZ7 PRP39_DANRE GO:0008380; GO:0006397; GO:0005634 RNA splicing; mRNA processing; nucleus reviewed IPR003107; IPR011990; Pre-mRNA-processing factor 39 (PRP39 homolog) prpf39 si:dz261o22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 752 Q1JPZ7 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig3448 sp Q1JQ66 S35E3_DANRE 78.07 114 25 0 380 39 27 140 1E-56 184 Q1JQ66 S35E3_DANRE GO:0016021 integral to membrane reviewed IPR004853; Solute carrier family 35 member E3 slc35e3 Danio rerio (Zebrafish) (Brachydanio rerio) 313 Q1JQ66 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3448 sp Q1JQ66 S35E3_DANRE 78.07 114 25 0 380 39 27 140 1E-56 184 Q1JQ66 S35E3_DANRE GO:0016021 integral to membrane reviewed IPR004853; Solute carrier family 35 member E3 slc35e3 Danio rerio (Zebrafish) (Brachydanio rerio) 313 Q1JQ66 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig5720 sp Q1JQA3 AP3S2_BOVIN 91.15 192 17 0 987 412 1 192 3E-127 370 Q1JQA3 AP3S2_BOVIN GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adapter-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b) AP3S2 Bos taurus (Bovine) 193 Q1JQA3 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0005637 GO:0005637 nuclear inner membrane nucleus C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0005637 GO:0005637 nuclear inner membrane other membranes C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2167 sp Q1L911 NRM_DANRE 71.52 158 45 0 475 2 33 190 4E-74 231 Q1L911 NRM_DANRE GO:0016021; GO:0005635; GO:0005637 integral to membrane; nuclear envelope; nuclear inner membrane reviewed Nurim (Nuclear envelope membrane protein) (Nuclear rim protein) nrm si:dkey-263h23.2 Danio rerio (Zebrafish) (Brachydanio rerio) 275 Q1L911 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6017 sp Q1LU86 F92A1_DANRE 64.55 268 82 4 898 113 1 261 6E-111 333 Q1LU86 F92A1_DANRE reviewed IPR009602; Protein FAM92A1 fam92a1 si:dkey-98l21.1 zgc:100998 Danio rerio (Zebrafish) (Brachydanio rerio) 295 Q1LU86 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6017 sp Q1LU86 F92A1_DANRE 64.55 268 82 4 898 113 1 261 6E-111 333 Q1LU86 F92A1_DANRE reviewed IPR009602; Protein FAM92A1 fam92a1 si:dkey-98l21.1 zgc:100998 Danio rerio (Zebrafish) (Brachydanio rerio) 295 Q1LU86 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6017 sp Q1LU86 F92A1_DANRE 64.55 268 82 4 898 113 1 261 6E-111 333 Q1LU86 F92A1_DANRE reviewed IPR009602; Protein FAM92A1 fam92a1 si:dkey-98l21.1 zgc:100998 Danio rerio (Zebrafish) (Brachydanio rerio) 295 Q1LU86 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0007634 GO:0007634 optokinetic behavior other biological processes P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0031290 GO:0031290 retinal ganglion cell axon guidance developmental processes P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0031290 GO:0031290 retinal ganglion cell axon guidance cell organization and biogenesis P ConsensusfromContig2834 sp Q1LVF0 LAMC1_DANRE 74.71 174 44 0 522 1 1009 1182 7E-79 261 Q1LVF0 LAMC1_DANRE GO:0005604; GO:0007155; GO:0050908; GO:0048570; GO:0007634; GO:0031290; GO:0007519 basement membrane; cell adhesion; detection of light stimulus involved in visual perception; notochord morphogenesis; optokinetic behavior; retinal ganglion cell axon guidance; skeletal muscle tissue development reviewed IPR002049; IPR018031; IPR000034; IPR008211; Laminin subunit gamma-1 lamc1 Danio rerio (Zebrafish) (Brachydanio rerio) 1593 Q1LVF0 GO:0050908 GO:0050908 detection of light stimulus involved in visual perception other biological processes P ConsensusfromContig2664 sp Q1LVN8 SELO_DANRE 91.3 115 10 0 56 400 112 226 5E-68 223 Q1LVN8 SELO_DANRE reviewed IPR003846; Selenoprotein O (SelO) selo si:ch211-15i6.2 Danio rerio (Zebrafish) (Brachydanio rerio) 692 ConsensusfromContig192 sp Q1LVN8 SELO_DANRE 75.35 142 35 0 433 8 160 301 3E-73 229 Q1LVN8 SELO_DANRE reviewed IPR003846; Selenoprotein O (SelO) selo si:ch211-15i6.2 Danio rerio (Zebrafish) (Brachydanio rerio) 692 ConsensusfromContig192 sp Q1LVN8 SELO_DANRE 86.67 30 4 0 522 433 125 154 3E-73 67.4 Q1LVN8 SELO_DANRE reviewed IPR003846; Selenoprotein O (SelO) selo si:ch211-15i6.2 Danio rerio (Zebrafish) (Brachydanio rerio) 692 ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0008654 GO:0008654 phospholipid biosynthetic process other metabolic processes P ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0047184 GO:0047184 1-acylglycerophosphocholine O-acyltransferase activity other molecular function F ConsensusfromContig3290 sp Q1LWG4 PCAT1_DANRE 93.4 106 7 0 1 318 98 203 2E-63 206 Q1LWG4 PCAT1_DANRE GO:0047184; GO:0047192; GO:0005794; GO:0000139; GO:0005509; GO:0005783; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi apparatus; Golgi membrane; calcium ion binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) lpcat1 aytl2 si:dkey-261i16.4 zgc:158232 Danio rerio (Zebrafish) (Brachydanio rerio) 517 Q1LWG4 GO:0047192 GO:0047192 1-alkylglycerophosphocholine O-acetyltransferase activity other molecular function F ConsensusfromContig379 sp Q1LWL6 GSE1_DANRE 87.88 99 12 0 339 43 1105 1203 4E-54 187 Q1LWL6 GSE1_DANRE reviewed IPR022207; Genetic suppressor element 1 gse1 si:dkey-265o13.4 Danio rerio (Zebrafish) (Brachydanio rerio) 1203 ConsensusfromContig989 sp Q1LX49 LCHN_DANRE 67.31 156 41 3 23 478 332 481 3E-58 194 Q1LX49 LCHN_DANRE reviewed IPR018626; Protein LCHN lchn si:ch211-238n5.4 Danio rerio (Zebrafish) (Brachydanio rerio) 490 ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 84.59 318 38 4 2 952 48 355 0 555 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 83.4 235 34 4 907 1605 340 571 6E-129 393 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5880 sp Q1LYE3 ZN143_DANRE 93.48 46 3 0 1620 1757 578 623 6E-129 91.7 Q1LYE3 ZN143_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0045893; GO:0006351 DNA binding; metal ion binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 143 (Selenocysteine tRNA gene transcription-activating factor) znf143 staf si:dkey-8l13.2 zgc:66276 Danio rerio (Zebrafish) (Brachydanio rerio) 623 Q1LYE3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:0000785 GO:0000785 chromatin other cellular component C ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig6104 sp Q1RMA6 PARI_DANRE 56.03 514 198 4 226 1761 1 488 3E-173 520 Q1RMA6 PARI_DANRE GO:0003677; GO:0006281; GO:0000785; GO:0005737; GO:2000042; GO:0005634 DNA binding; DNA repair; chromatin; cytoplasm; negative regulation of double-strand break repair via homologous recombination; nucleus reviewed PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP) parpbp pari zgc:136263 Danio rerio (Zebrafish) (Brachydanio rerio) 568 Q1RMA6 GO:2000042 ConsensusfromContig5607 sp Q1RMX9 DCNL5_BOVIN 84.43 212 33 0 196 831 24 235 5E-133 388 Q1RMX9 DCNL5_BOVIN reviewed IPR014764; IPR005176; DCN1-like protein 5 (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5) DCUN1D5 Bos taurus (Bovine) 236 ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0004177 GO:0004177 aminopeptidase activity other molecular function F ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0008235 GO:0008235 metalloexopeptidase activity other molecular function F ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0019538 GO:0019538 protein metabolic process protein metabolism P ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig5550 sp Q27245 YH24_CAEEL 48.28 435 222 3 249 1550 87 519 2E-126 390 Q27245 YH24_CAEEL GO:0004177; GO:0005737; GO:0030145; GO:0008235; GO:0006508 aminopeptidase activity; cytoplasm; manganese ion binding; metalloexopeptidase activity; proteolysis reviewed IPR011356; IPR000819; Putative aminopeptidase W07G4.4 (EC 3.4.11.-) W07G4.4 Caenorhabditis elegans 522 Q27245 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0005216 GO:0005216 ion channel activity transporter activity F ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0005244 GO:0005244 voltage-gated ion channel activity transporter activity F ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0005249 GO:0005249 voltage-gated potassium channel activity transporter activity F ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0006810 GO:0006810 transport transport P ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0006813 GO:0006813 potassium ion transport transport P ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0034765 GO:0034765 regulation of transmembrane ion transport transport P ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0044224 ConsensusfromContig39 sp Q27955 KCAB2_BOVIN 88.53 218 24 1 3 656 51 267 1E-134 390 Q27955 KCAB2_BOVIN GO:0005737; GO:0016021; GO:0044224; GO:0005249 cytoplasm; integral to membrane; juxtaparanode region of axon; voltage-gated potassium channel activity reviewed IPR001395; IPR005983; IPR005399; IPR005401; IPR023210; Voltage-gated potassium channel subunit beta-2 (K(+) channel subunit beta-2) (Kv-beta-2) KCNAB2 KVB2 Bos taurus (Bovine) 367 Q27955 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 85.83 247 35 0 10 750 1 247 0 456 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 85.83 247 35 0 10 750 1 247 0 456 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 85.83 247 35 0 10 750 1 247 0 456 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005811 GO:0005811 lipid particle other cellular component C ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 80.6 201 39 0 743 1345 245 445 0 265 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 80.6 201 39 0 743 1345 245 445 0 265 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5611 sp Q28BP9 FAF2_XENTR 80.6 201 39 0 743 1345 245 445 0 265 Q28BP9 FAF2_XENTR GO:0005783; GO:0005811 endoplasmic reticulum; lipid particle reviewed IPR012336; IPR006577; IPR009060; IPR001012; FAS-associated factor 2 (UBX domain-containing protein 8) faf2 ubxd8 TNeu075m11.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 445 Q28BP9 GO:0005811 GO:0005811 lipid particle other cellular component C ConsensusfromContig687 sp Q28CH3 UAP1L_XENTR 85.58 104 15 0 313 2 218 321 8E-59 194 Q28CH3 UAP1L_XENTR GO:0016779 nucleotidyltransferase activity reviewed IPR002618; UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-) uap1l1 TGas075i06.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 511 Q28CH3 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig687 sp Q28CH3 UAP1L_XENTR 85.58 104 15 0 313 2 218 321 8E-59 194 Q28CH3 UAP1L_XENTR GO:0016779 nucleotidyltransferase activity reviewed IPR002618; UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-) uap1l1 TGas075i06.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 511 Q28CH3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig687 sp Q28CH3 UAP1L_XENTR 85.58 104 15 0 313 2 218 321 8E-59 194 Q28CH3 UAP1L_XENTR GO:0016779 nucleotidyltransferase activity reviewed IPR002618; UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-) uap1l1 TGas075i06.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 511 Q28CH3 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0006479 GO:0006479 protein amino acid methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0007552 GO:0007552 metamorphosis other biological processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0008170 GO:0008170 N-methyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0008469 GO:0008469 histone-arginine N-methyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0016274 GO:0016274 protein-arginine N-methyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0016571 GO:0016571 histone methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0016571 GO:0016571 histone methylation cell organization and biogenesis P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0018216 GO:0018216 peptidyl-arginine methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0022008 GO:0022008 neurogenesis developmental processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0031056 GO:0031056 regulation of histone modification protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0031056 GO:0031056 regulation of histone modification cell organization and biogenesis P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0034969 GO:0034969 histone arginine methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0034969 GO:0034969 histone arginine methylation cell organization and biogenesis P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0035246 GO:0035246 peptidyl-arginine N-methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0042054 GO:0042054 histone methyltransferase activity other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0043985 GO:0043985 histone H4-R3 methylation protein metabolism P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0043985 GO:0043985 histone H4-R3 methylation cell organization and biogenesis P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0044020 GO:0044020 histone methyltransferase activity (H4-R3 specific) other molecular function F ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0045653 GO:0045653 negative regulation of megakaryocyte differentiation developmental processes P ConsensusfromContig6210 sp Q28F07 ANM1_XENTR 90.31 351 31 2 1572 529 1 351 0 661 Q28F07 ANM1_XENTR GO:0005829; GO:0044020; GO:0007552; GO:0045653; GO:0022008; GO:0005634; GO:0045893; GO:0031056; GO:0003713; GO:0006351 cytosol; histone methyltransferase activity (H4-R3 specific); metamorphosis; negative regulation of megakaryocyte differentiation; neurogenesis; nucleus; positive regulation of transcription, DNA-dependent; regulation of histone modification; transcription coactivator activity; transcription, DNA-dependent reviewed IPR025799; IPR025714; Protein arginine N-methyltransferase 1 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 2) (Histone-arginine N-methyltransferase PRMT1) (EC 2.1.1.125) prmt1 hrmt1l2 TGas059i20.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 351 Q28F07 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0015991 GO:0015991 ATP hydrolysis coupled proton transport transport P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0016469 GO:0016469 proton-transporting two-sector ATPase complex other membranes C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0033178 GO:0033178 "proton-transporting two-sector ATPase complex, catalytic domain" other membranes C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0033180 GO:0033180 "proton-transporting V-type ATPase, V1 domain" other membranes C ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0046933 GO:0046933 "hydrogen ion transporting ATP synthase activity, rotational mechanism" transporter activity F ConsensusfromContig2888 sp Q29048 VATA_PIG 89.04 146 16 0 3 440 15 160 5E-74 240 Q29048 VATA_PIG GO:0005524; GO:0015991; GO:0005829; GO:0005886; GO:0046961; GO:0033180 ATP binding; ATP hydrolysis coupled proton transport; cytosol; plasma membrane; proton-transporting ATPase activity, rotational mechanism; proton-transporting V-type ATPase, V1 domain reviewed IPR020003; IPR000793; IPR000194; IPR004100; IPR024034; IPR005725; IPR027417; IPR022878; V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar proton pump subunit alpha) ATP6V1A ATP6A1 ATP6V1A1 Sus scrofa (Pig) 617 Q29048 GO:0046961 GO:0046961 "proton-transporting ATPase activity, rotational mechanism" transporter activity F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0007605 GO:0007605 sensory perception of sound other biological processes P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0016591 GO:0016591 "DNA-directed RNA polymerase II, holoenzyme" nucleus C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0030048 GO:0030048 actin filament-based movement transport P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0030330 GO:0030330 "DNA damage response, signal transduction by p53 class mediator" signal transduction P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0030330 GO:0030330 "DNA damage response, signal transduction by p53 class mediator" stress response P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0031941 GO:0031941 filamentous actin cytoskeleton C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0043531 GO:0043531 ADP binding other molecular function F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0045334 GO:0045334 clathrin-coated endocytic vesicle other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig2466 sp Q29122 MYO6_PIG 87.43 167 21 0 162 662 1034 1200 6E-98 315 Q29122 MYO6_PIG GO:0043531; GO:0005524; GO:0030330; GO:0016591; GO:0005794; GO:0051015; GO:0030048; GO:0005516; GO:0005938; GO:0016023; GO:0006897; GO:0031941; GO:0006886; GO:0003774; GO:0016459; GO:0031965; GO:0048471; GO:0045944; GO:0051046; GO:0001726; GO:0007605 ADP binding; ATP binding; DNA damage response, signal transduction by p53 class mediator; DNA-directed RNA polymerase II, holoenzyme; Golgi apparatus; actin filament binding; actin filament-based movement; calmodulin binding; cell cortex; cytoplasmic membrane-bounded vesicle; endocytosis; filamentous actin; intracellular protein transport; motor activity; myosin complex; nuclear membrane; perinuclear region of cytoplasm; positive regulation of transcription from RNA polymerase II promoter; regulation of secretion; ruffle; sensory perception of sound reviewed IPR000048; IPR001609; IPR027417; Unconventional myosin-VI (Unconventional myosin-6) MYO6 Sus scrofa (Pig) 1254 Q29122 GO:0051046 GO:0051046 regulation of secretion transport P ConsensusfromContig6174 sp Q29460 PA1B3_BOVIN 66.67 204 68 0 1397 786 2 205 2E-97 300 Q29460 PA1B3_BOVIN GO:0003847; GO:0005737; GO:0016042; GO:0007283 1-alkyl-2-acetylglycerophosphocholine esterase activity; cytoplasm; lipid catabolic process; spermatogenesis reviewed IPR013831; Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) PAFAH1B3 PAFAHG Bos taurus (Bovine) 232 Q29460 GO:0003847 GO:0003847 1-alkyl-2-acetylglycerophosphocholine esterase activity other molecular function F ConsensusfromContig6174 sp Q29460 PA1B3_BOVIN 66.67 204 68 0 1397 786 2 205 2E-97 300 Q29460 PA1B3_BOVIN GO:0003847; GO:0005737; GO:0016042; GO:0007283 1-alkyl-2-acetylglycerophosphocholine esterase activity; cytoplasm; lipid catabolic process; spermatogenesis reviewed IPR013831; Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) PAFAH1B3 PAFAHG Bos taurus (Bovine) 232 Q29460 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6174 sp Q29460 PA1B3_BOVIN 66.67 204 68 0 1397 786 2 205 2E-97 300 Q29460 PA1B3_BOVIN GO:0003847; GO:0005737; GO:0016042; GO:0007283 1-alkyl-2-acetylglycerophosphocholine esterase activity; cytoplasm; lipid catabolic process; spermatogenesis reviewed IPR013831; Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) PAFAH1B3 PAFAHG Bos taurus (Bovine) 232 Q29460 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6174 sp Q29460 PA1B3_BOVIN 66.67 204 68 0 1397 786 2 205 2E-97 300 Q29460 PA1B3_BOVIN GO:0003847; GO:0005737; GO:0016042; GO:0007283 1-alkyl-2-acetylglycerophosphocholine esterase activity; cytoplasm; lipid catabolic process; spermatogenesis reviewed IPR013831; Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) PAFAH1B3 PAFAHG Bos taurus (Bovine) 232 Q29460 GO:0016042 GO:0016042 lipid catabolic process other metabolic processes P ConsensusfromContig6174 sp Q29460 PA1B3_BOVIN 66.67 204 68 0 1397 786 2 205 2E-97 300 Q29460 PA1B3_BOVIN GO:0003847; GO:0005737; GO:0016042; GO:0007283 1-alkyl-2-acetylglycerophosphocholine esterase activity; cytoplasm; lipid catabolic process; spermatogenesis reviewed IPR013831; Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma) PAFAH1B3 PAFAHG Bos taurus (Bovine) 232 Q29460 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0004075 GO:0004075 biotin carboxylase activity other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0004736 GO:0004736 pyruvate carboxylase activity other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0006094 GO:0006094 gluconeogenesis other metabolic processes P ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2825 sp Q29RK2 PYC_BOVIN 89.6 125 13 0 376 2 395 519 5E-71 235 Q29RK2 PYC_BOVIN GO:0005524; GO:0003677; GO:0004075; GO:0006094; GO:0006629; GO:0046872; GO:0005743; GO:0005759; GO:0004736 ATP binding; DNA binding; biotin carboxylase activity; gluconeogenesis; lipid metabolic process; metal ion binding; mitochondrial inner membrane; mitochondrial matrix; pyruvate carboxylase activity reviewed IPR013785; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR003379; IPR005479; IPR009057; IPR016185; IPR000891; IPR005930; IPR011054; IPR011053; Carbohydrate biosynthesis; gluconeogenesis. Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB) PC Bos taurus (Bovine) 1178 Q29RK2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig705 sp Q2HJ19 AB17A_BOVIN 95.15 103 4 1 3 308 199 301 9E-62 201 Q2HJ19 AB17A_BOVIN GO:0005576; GO:0016787 extracellular region; hydrolase activity reviewed Alpha/beta hydrolase domain-containing protein 17A (EC 3.-.-.-) ABHD17A Bos taurus (Bovine) 310 Q2HJ19 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig705 sp Q2HJ19 AB17A_BOVIN 95.15 103 4 1 3 308 199 301 9E-62 201 Q2HJ19 AB17A_BOVIN GO:0005576; GO:0016787 extracellular region; hydrolase activity reviewed Alpha/beta hydrolase domain-containing protein 17A (EC 3.-.-.-) ABHD17A Bos taurus (Bovine) 310 Q2HJ19 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6336 sp Q2HJI0 RM19_BOVIN 62.5 264 91 1 160 927 28 291 6E-112 346 Q2HJI0 RM19_BOVIN GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR001857; IPR008991; 39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) MRPL19 Bos taurus (Bovine) 292 Q2HJI0 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0030479 GO:0030479 actin cortical patch cytoskeleton C ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0030509 GO:0030509 BMP signaling pathway signal transduction P ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0040037 GO:0040037 negative regulation of fibroblast growth factor receptor signaling pathway signal transduction P ConsensusfromContig2463 sp Q2I6J1 SHP2A_DANRE 93.81 194 11 1 584 3 707 899 3E-121 378 Q2I6J1 SHP2A_DANRE GO:0030509; GO:0007155; GO:0005856; GO:0005829; GO:0030175; GO:0016787; GO:0030027; GO:0016020; GO:0040037; GO:0090024; GO:0046856 BMP signaling pathway; cell adhesion; cytoskeleton; cytosol; filopodium; hydrolase activity; lamellipodium; membrane; negative regulation of fibroblast growth factor receptor signaling pathway; negative regulation of neutrophil chemotaxis; phosphatidylinositol dephosphorylation reviewed IPR005135; IPR000300; IPR001660; IPR013761; IPR021129; IPR000980; Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2A (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1A) (INPPL1-A) (SH2 domain-containing inositol 5'-phosphatase 2A) (SH2 domain-containing inositol phosphatase 2A) (SHIP-2A) inppl1a ship2a wu:fc58a04 zgc:198309 Danio rerio (Zebrafish) (Brachydanio rerio) 1266 Q2I6J1 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0000172 GO:0000172 ribonuclease MRP complex other cellular component C ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0004526 GO:0004526 ribonuclease P activity other molecular function F ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0004540 GO:0004540 ribonuclease activity other molecular function F ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0005655 GO:0005655 nucleolar ribonuclease P complex nucleus C ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0006379 GO:0006379 mRNA cleavage RNA metabolism P ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5641 sp Q2KIB9 RPP29_BOVIN 67.65 204 56 1 993 412 17 220 6E-87 269 Q2KIB9 RPP29_BOVIN GO:0003723; GO:0006379; GO:0005655; GO:0006364; GO:0000172; GO:0004526; GO:0008033 RNA binding; mRNA cleavage; nucleolar ribonuclease P complex; rRNA processing; ribonuclease MRP complex; ribonuclease P activity; tRNA processing reviewed IPR002730; IPR016848; IPR023534; Ribonuclease P protein subunit p29 (EC 3.1.26.5) POP4 RPP29 Bos taurus (Bovine) 220 Q2KIB9 GO:0030677 GO:0030677 ribonuclease P complex other cellular component C ConsensusfromContig920 sp Q2KIK0 SUGT1_BOVIN 51.09 184 89 1 69 620 17 199 3E-54 182 Q2KIK0 SUGT1_BOVIN GO:0005737; GO:0005634 cytoplasm; nucleus reviewed IPR007052; IPR008978; IPR007699; IPR013026; IPR011990; IPR001440; IPR019734; Suppressor of G2 allele of SKP1 homolog SUGT1 Bos taurus (Bovine) 338 Q2KIK0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0004478 GO:0004478 methionine adenosyltransferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006556 GO:0006556 S-adenosylmethionine biosynthetic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 80.47 128 25 0 89 472 145 272 1E-124 224 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0004478 GO:0004478 methionine adenosyltransferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006556 GO:0006556 S-adenosylmethionine biosynthetic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 87.39 111 14 0 513 845 286 396 1E-124 209 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0004478 GO:0004478 methionine adenosyltransferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006556 GO:0006556 S-adenosylmethionine biosynthetic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0006730 GO:0006730 one-carbon compound metabolic process other metabolic processes P ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5709 sp Q2KJC6 METK1_BOVIN 86.21 29 4 0 1 87 116 144 1E-124 58.2 Q2KJC6 METK1_BOVIN GO:0005524; GO:0006556; GO:0046872; GO:0004478; GO:0006730 ATP binding; S-adenosylmethionine biosynthetic process; metal ion binding; methionine adenosyltransferase activity; one-carbon metabolic process reviewed IPR022631; IPR022630; IPR022629; IPR022628; IPR002133; IPR022636; Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) MAT1A Bos taurus (Bovine) 396 Q2KJC6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0001558 GO:0001558 regulation of cell growth other biological processes P ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1882 sp Q2LD37 K1109_HUMAN 81.92 177 30 2 2 529 4664 4839 7E-84 277 Q2LD37 K1109_HUMAN GO:0016021; GO:0016020; GO:0005634; GO:0001558; GO:0030856 P35222 integral to membrane; membrane; nucleus; regulation of cell growth; regulation of epithelial cell differentiation reviewed IPR018863; Uncharacterized protein KIAA1109 (Fragile site-associated protein) KIAA1109 FSA KIAA1371 Homo sapiens (Human) 5005 Q2LD37 GO:0030856 GO:0030856 regulation of epithelial cell differentiation developmental processes P ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6074 sp Q2M2S8 ALKB7_BOVIN 59.41 170 64 1 287 781 38 207 6E-65 211 Q2M2S8 ALKB7_BOVIN GO:0051213; GO:0006631; GO:0046872; GO:0005759; GO:0070265; GO:0010883; GO:0006974 dioxygenase activity; fatty acid metabolic process; metal ion binding; mitochondrial matrix; necrotic cell death; regulation of lipid storage; response to DNA damage stimulus reviewed IPR027450; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) ALKBH7 Bos taurus (Bovine) 221 Q2M2S8 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3207 sp Q2M389 WASH7_HUMAN 82.07 145 26 0 438 4 281 425 2E-80 262 Q2M389 WASH7_HUMAN GO:0071203; GO:0016197; GO:0005768 WASH complex; endosomal transport; endosome reviewed IPR028283; IPR028282; IPR028191; IPR027307; WASH complex subunit 7 KIAA1033 Homo sapiens (Human) 1173 Q2M389 GO:0016197 GO:0016197 endosome transport transport P ConsensusfromContig3207 sp Q2M389 WASH7_HUMAN 82.07 145 26 0 438 4 281 425 2E-80 262 Q2M389 WASH7_HUMAN GO:0071203; GO:0016197; GO:0005768 WASH complex; endosomal transport; endosome reviewed IPR028283; IPR028282; IPR028191; IPR027307; WASH complex subunit 7 KIAA1033 Homo sapiens (Human) 1173 Q2M389 GO:0071203 ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0001501 GO:0001501 skeletal system development developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0001508 GO:0001508 regulation of action potential other biological processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0006469 GO:0006469 negative regulation of protein kinase activity other metabolic processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0006471 GO:0006471 protein amino acid ADP-ribosylation protein metabolism P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway signal transduction P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007189 GO:0007189 activation of adenylate cyclase activity by G-protein signaling pathway other metabolic processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007215 GO:0007215 glutamate signaling pathway signal transduction P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0007610 GO:0007610 behavior other biological processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0009791 GO:0009791 post-embryonic development developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0016322 GO:0016322 neuron remodeling developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0019001 GO:0019001 guanyl nucleotide binding other molecular function F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0021884 GO:0021884 forebrain neuron development developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0035412 ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0045634 GO:0045634 regulation of melanocyte differentiation other biological processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0048066 GO:0048066 pigmentation during development other biological processes P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig1606 sp Q2PKF4 GNAQ_PIG 84.81 158 24 0 535 62 15 172 7E-97 291 Q2PKF4 GNAQ_PIG GO:0007186; GO:0005525; GO:0003924; GO:0046872; GO:0031965; GO:0004871 G-protein coupled receptor signaling pathway; GTP binding; GTPase activity; metal ion binding; nuclear membrane; signal transducer activity reviewed IPR000654; IPR001019; IPR011025; IPR027417; Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q) GNAQ Sus scrofa (Pig) 359 Q2PKF4 GO:0060158 GO:0060158 activation of phospholipase C activity by dopamine receptor signaling pathway signal transduction P ConsensusfromContig1812 sp Q2PZI1 D19L1_HUMAN 59.39 165 57 1 2 496 425 579 1E-54 187 Q2PZI1 D19L1_HUMAN GO:0016021; GO:0016757 integral to membrane; transferase activity, transferring glycosyl groups reviewed IPR018732; Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1) DPY19L1 GA0500 KIAA0877 Homo sapiens (Human) 675 Q2PZI1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1812 sp Q2PZI1 D19L1_HUMAN 59.39 165 57 1 2 496 425 579 1E-54 187 Q2PZI1 D19L1_HUMAN GO:0016021; GO:0016757 integral to membrane; transferase activity, transferring glycosyl groups reviewed IPR018732; Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1) DPY19L1 GA0500 KIAA0877 Homo sapiens (Human) 675 Q2PZI1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 50.93 324 121 3 2 868 269 589 5E-92 291 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 38.83 309 169 3 2 868 101 409 2E-58 202 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 35.61 278 143 2 29 862 82 323 2E-52 186 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1316 sp Q2TA17 ZN668_BOVIN 36 275 152 3 5 805 158 416 3E-51 182 Q2TA17 ZN668_BOVIN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 668 ZNF668 Bos taurus (Bovine) 619 Q2TA17 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4270 sp Q2TAF3 EMAL4_XENLA 89.68 126 13 0 379 2 451 576 3E-80 259 Q2TAF3 EMAL4_XENLA GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus laevis (African clawed frog) 927 Q2TAF3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4270 sp Q2TAF3 EMAL4_XENLA 89.68 126 13 0 379 2 451 576 3E-80 259 Q2TAF3 EMAL4_XENLA GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus laevis (African clawed frog) 927 Q2TAF3 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4270 sp Q2TAF3 EMAL4_XENLA 89.68 126 13 0 379 2 451 576 3E-80 259 Q2TAF3 EMAL4_XENLA GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus laevis (African clawed frog) 927 Q2TAF3 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2976 sp Q2TL32 UBR4_RAT 90.97 144 13 0 432 1 4559 4702 4E-82 270 Q2TL32 UBR4_RAT GO:0005737; GO:0005856; GO:0016021; GO:0005634; GO:0042787; GO:0004842; GO:0008270 cytoplasm; cytoskeleton; integral to membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR016024; IPR025704; IPR017986; IPR003126; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase UBR4 (EC 6.3.2.-) (N-recognin-4) (Zinc finger UBR1-type protein 1) Ubr4 Rbaf600 Zubr1 Rattus norvegicus (Rat) 5194 Q2TL32 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5774 sp Q2YDK1 I20L2_BOVIN 42.74 365 164 8 1305 289 1 346 5E-78 256 Q2YDK1 I20L2_BOVIN GO:0004527; GO:0003676; GO:0090305; GO:0005730; GO:0042254 exonuclease activity; nucleic acid binding; nucleic acid phosphodiester bond hydrolysis; nucleolus; ribosome biogenesis reviewed IPR006055; IPR013520; IPR012337; Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-) ISG20L2 Bos taurus (Bovine) 349 Q2YDK1 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0008934 GO:0008934 inositol-1(or 4)-monophosphatase activity other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052832 ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052833 ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 81.65 109 20 0 469 795 1 109 7E-72 189 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052834 ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0008934 GO:0008934 inositol-1(or 4)-monophosphatase activity other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052832 ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052833 ConsensusfromContig6023 sp Q2YDR3 IMPA3_DANRE 66.67 69 23 0 803 1009 112 180 7E-72 103 Q2YDR3 IMPA3_DANRE GO:0006021; GO:0008934; GO:0052832; GO:0052833; GO:0016021; GO:0046872; GO:0046854 inositol biosynthetic process; inositol monophosphate 1-phosphatase activity; inositol monophosphate 3-phosphatase activity; inositol monophosphate 4-phosphatase activity; integral to membrane; metal ion binding; phosphatidylinositol phosphorylation reviewed IPR000760; IPR020550; Polyol metabolism; myo-inositol biosynthesis; myo-inositol from D-glucose 6-phosphate: step 2/2. Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3) impad1 impa3 zgc:123256 Danio rerio (Zebrafish) (Brachydanio rerio) 341 Q2YDR3 GO:0052834 ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 84.49 187 24 1 950 390 120 301 9E-133 323 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0070936 ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 65.82 79 17 1 1177 971 1 79 9E-133 104 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0070936 ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig6327 sp Q32L27 UB2Q2_BOVIN 90.91 44 4 0 397 266 299 342 9E-133 90.5 Q32L27 UB2Q2_BOVIN GO:0005524; GO:0005737; GO:0070936; GO:0004842 ATP binding; cytoplasm; protein K48-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR006575; IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Q2 (EC 6.3.2.19) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2) UBE2Q2 Bos taurus (Bovine) 342 Q32L27 GO:0070936 ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3329 sp Q32L63 VTA1_BOVIN 63.1 168 53 2 494 6 68 231 6E-68 215 Q32L63 VTA1_BOVIN GO:0010008; GO:0015031 endosome membrane; protein transport reviewed IPR023175 Vacuolar protein sorting-associated protein VTA1 homolog VTA1 Bos taurus (Bovine) 307 Q32L63 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0031683 GO:0031683 G-protein beta/gamma-subunit binding other molecular function F ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0032391 GO:0032391 photoreceptor connecting cilium other cellular component C ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0034605 GO:0034605 cellular response to heat stress response P ConsensusfromContig6224 sp Q32LE3 CETN1_BOVIN 80.23 172 34 0 1601 1086 1 172 2E-92 289 Q32LE3 CETN1_BOVIN GO:0005524; GO:0008026; GO:0005509; GO:0051301; GO:0034605; GO:0005813; GO:0005737; GO:0007067; GO:0003676; GO:0032391; GO:0000922 ATP binding; ATP-dependent helicase activity; calcium ion binding; cell division; cellular response to heat; centrosome; cytoplasm; mitosis; nucleic acid binding; photoreceptor connecting cilium; spindle pole reviewed IPR011992; IPR018247; IPR002048; IPR000629; Centrin-1 CETN1 Bos taurus (Bovine) 172 Q32LE3 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig1355 sp Q32LU7 PTCD3_DANRE 64.38 160 56 1 479 3 115 274 6E-56 192 Q32LU7 PTCD3_DANRE GO:0032543; GO:0005739; GO:0019843; GO:0006417; GO:0043024 mitochondrial translation; mitochondrion; rRNA binding; regulation of translation; ribosomal small subunit binding reviewed Pentatricopeptide repeat domain-containing protein 3, mitochondrial ptcd3 zgc:123014 Danio rerio (Zebrafish) (Brachydanio rerio) 667 Q32LU7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig4411 sp Q32PL1 PP1R7_DANRE 87.29 118 14 1 1 351 6 123 3E-62 200 Q32PL1 PP1R7_DANRE GO:0005634 nucleus reviewed IPR001611; IPR027733; IPR003603; Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22) ppp1r7 sds22 zgc:123325 Danio rerio (Zebrafish) (Brachydanio rerio) 345 Q32PL1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4411 sp Q32PL1 PP1R7_DANRE 87.29 118 14 1 1 351 6 123 3E-62 200 Q32PL1 PP1R7_DANRE GO:0005634 nucleus reviewed IPR001611; IPR027733; IPR003603; Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22) ppp1r7 sds22 zgc:123325 Danio rerio (Zebrafish) (Brachydanio rerio) 345 Q32PL1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0017137 GO:0017137 Rab GTPase binding enzyme regulator activity F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0030306 GO:0030306 ADP-ribosylation factor binding other molecular function F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0048592 GO:0048592 eye morphogenesis developmental processes P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0051726 GO:0051726 regulation of cell cycle cell cycle and proliferation P ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0055038 GO:0055038 recycling endosome membrane other cytoplasmic organelle C ConsensusfromContig5577 sp Q3LGD4 RFP4A_DANRE 78.49 344 71 2 1027 2 198 540 5E-164 481 Q3LGD4 RFP4A_DANRE GO:0030306; GO:0017137; GO:0005509; GO:0032154; GO:0000910; GO:0030139; GO:0048592; GO:0030496; GO:0042803; GO:0055038; GO:0051726; GO:0043565; GO:0003700; GO:0006810 ADP-ribosylation factor binding; Rab GTPase binding; calcium ion binding; cleavage furrow; cytokinesis; endocytic vesicle; eye morphogenesis; midbody; protein homodimerization activity; recycling endosome membrane; regulation of cell cycle; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transport reviewed IPR004827; IPR011992; IPR002048; IPR019018; Rab11 family-interacting protein 4A (FIP4-Rab11) (Rab11-FIP4-A) (zRab11-FIP4-A) rab11fip4a rab11fip4 Danio rerio (Zebrafish) (Brachydanio rerio) 621 Q3LGD4 GO:0055038 GO:0055038 recycling endosome membrane other membranes C ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0030833 GO:0030833 regulation of actin filament polymerization protein metabolism P ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0030833 GO:0030833 regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig143 sp Q3MHR7 ARPC2_BOVIN 84.03 144 23 0 432 1 16 159 8E-86 262 Q3MHR7 ARPC2_BOVIN GO:0042995; GO:0005856; GO:0005829; GO:0030833 cell projection; cytoskeleton; cytosol; regulation of actin filament polymerization reviewed IPR007188; Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC) ARPC2 Bos taurus (Bovine) 300 Q3MHR7 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig4097 sp Q3MI00 DNJB1_BOVIN 70.07 147 44 0 10 450 193 339 2E-74 233 Q3MI00 DNJB1_BOVIN GO:0005737; GO:0005730; GO:0006457; GO:0006950 cytoplasm; nucleolus; protein folding; response to stress reviewed IPR002939; IPR001623; IPR018253; IPR008971; DnaJ homolog subfamily B member 1 DNAJB1 Bos taurus (Bovine) 340 Q3MI00 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0009966 GO:0009966 regulation of signal transduction signal transduction P ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1136 sp Q3SWY2 ILK_BOVIN 85.93 199 28 0 663 67 1 199 8E-125 370 Q3SWY2 ILK_BOVIN GO:0005524; GO:0005925; GO:0030027; GO:0005886; GO:0004674; GO:0009966; GO:0030017 ATP binding; focal adhesion; lamellipodium; plasma membrane; protein serine/threonine kinase activity; regulation of signal transduction; sarcomere reviewed IPR002110; IPR020683; IPR016253; IPR011009; IPR000719; IPR001245; Integrin-linked protein kinase (EC 2.7.11.1) ILK Bos taurus (Bovine) 452 Q3SWY2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig6133 sp Q3SWY8 ZUFSP_BOVIN 55.24 315 135 3 875 1819 265 573 6E-123 382 Q3SWY8 ZUFSP_BOVIN GO:0046872 metal ion binding reviewed IPR012462; IPR007087; IPR015880; Zinc finger with UFM1-specific peptidase domain protein ZUFSP Bos taurus (Bovine) 579 Q3SWY8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6133 sp Q3SWY8 ZUFSP_BOVIN 55.24 315 135 3 875 1819 265 573 6E-123 382 Q3SWY8 ZUFSP_BOVIN GO:0046872 metal ion binding reviewed IPR012462; IPR007087; IPR015880; Zinc finger with UFM1-specific peptidase domain protein ZUFSP Bos taurus (Bovine) 579 Q3SWY8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6133 sp Q3SWY8 ZUFSP_BOVIN 55.24 315 135 3 875 1819 265 573 6E-123 382 Q3SWY8 ZUFSP_BOVIN GO:0046872 metal ion binding reviewed IPR012462; IPR007087; IPR015880; Zinc finger with UFM1-specific peptidase domain protein ZUFSP Bos taurus (Bovine) 579 Q3SWY8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0000125 GO:0000125 PCAF complex nucleus C ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0004402 GO:0004402 histone acetyltransferase activity other molecular function F ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0043966 GO:0043966 histone H3 acetylation protein metabolism P ConsensusfromContig6313 sp Q3SZP8 TAD2A_BOVIN 82.47 445 76 1 1801 467 1 443 0 722 Q3SZP8 TAD2A_BOVIN GO:0005671; GO:0003677; GO:0000125; GO:0003682; GO:0005694; GO:0043966; GO:0004402; GO:0007067; GO:0072686; GO:0031063; GO:0001932; GO:0031647; GO:0006355; GO:0090043; GO:0006351; GO:0008270 Ada2/Gcn5/Ada3 transcription activator complex; DNA binding; PCAF complex; chromatin binding; chromosome; histone H3 acetylation; histone acetyltransferase activity; mitosis; mitotic spindle; regulation of histone deacetylation; regulation of protein phosphorylation; regulation of protein stability; regulation of transcription, DNA-dependent; regulation of tubulin deacetylation; transcription, DNA-dependent; zinc ion binding reviewed IPR009057; IPR001005; IPR017884; IPR007526; IPR016827; IPR000433; Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein) TADA2A TADA2L Bos taurus (Bovine) 443 Q3SZP8 GO:0043966 GO:0043966 histone H3 acetylation cell organization and biogenesis P ConsensusfromContig494 sp Q3SZY7 ZFAN6_BOVIN 60.85 212 78 5 23 655 1 208 6E-80 246 Q3SZY7 ZFAN6_BOVIN GO:0003677; GO:0071356; GO:0006625; GO:0043122; GO:0042981; GO:0008270 DNA binding; cellular response to tumor necrosis factor; protein targeting to peroxisome; regulation of I-kappaB kinase/NF-kappaB cascade; regulation of apoptotic process; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3) ZFAND6 ZA20D3 Bos taurus (Bovine) 208 Q3SZY7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig494 sp Q3SZY7 ZFAN6_BOVIN 60.85 212 78 5 23 655 1 208 6E-80 246 Q3SZY7 ZFAN6_BOVIN GO:0003677; GO:0071356; GO:0006625; GO:0043122; GO:0042981; GO:0008270 DNA binding; cellular response to tumor necrosis factor; protein targeting to peroxisome; regulation of I-kappaB kinase/NF-kappaB cascade; regulation of apoptotic process; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3) ZFAND6 ZA20D3 Bos taurus (Bovine) 208 Q3SZY7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig494 sp Q3SZY7 ZFAN6_BOVIN 60.85 212 78 5 23 655 1 208 6E-80 246 Q3SZY7 ZFAN6_BOVIN GO:0003677; GO:0071356; GO:0006625; GO:0043122; GO:0042981; GO:0008270 DNA binding; cellular response to tumor necrosis factor; protein targeting to peroxisome; regulation of I-kappaB kinase/NF-kappaB cascade; regulation of apoptotic process; zinc ion binding reviewed IPR002653; IPR000058; AN1-type zinc finger protein 6 (Zinc finger A20 domain-containing protein 3) ZFAND6 ZA20D3 Bos taurus (Bovine) 208 Q3SZY7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0001570 GO:0001570 vasculogenesis developmental processes P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0004830 GO:0004830 tryptophan-tRNA ligase activity other molecular function F ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0006436 GO:0006436 tryptophanyl-tRNA aminoacylation protein metabolism P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0006436 GO:0006436 tryptophanyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig496 sp Q3T099 SYWM_BOVIN 72.19 169 46 1 1 504 73 241 4E-86 263 Q3T099 SYWM_BOVIN GO:0005524; GO:0005759; GO:0004830; GO:0006436; GO:0001570 ATP binding; mitochondrial matrix; tryptophan-tRNA ligase activity; tryptophanyl-tRNA aminoacylation; vasculogenesis reviewed IPR001412; IPR002305; IPR014729; IPR002306; IPR024109; Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) WARS2 Bos taurus (Bovine) 360 Q3T099 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0004139 GO:0004139 deoxyribose-phosphate aldolase activity other molecular function F ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0009264 GO:0009264 deoxyribonucleotide catabolic process other metabolic processes P ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig1093 sp Q3T0V9 DEOC_BOVIN 71.52 158 45 0 86 559 1 158 1E-71 226 Q3T0V9 DEOC_BOVIN GO:0005737; GO:0046121; GO:0009264; GO:0046386; GO:0004139 cytoplasm; deoxyribonucleoside catabolic process; deoxyribonucleotide catabolic process; deoxyribose phosphate catabolic process; deoxyribose-phosphate aldolase activity reviewed IPR013785; IPR011343; IPR002915; Carbohydrate degradation; 2-deoxy-D-ribose 1-phosphate degradation; D-glyceraldehyde 3-phosphate and acetaldehyde from 2-deoxy-alpha-D-ribose 1-phosphate: step 2/2. Putative deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase) DERA Bos taurus (Bovine) 318 Q3T0V9 GO:0046121 GO:0046121 deoxyribonucleoside catabolic process other metabolic processes P ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2239 sp Q3T114 UK114_BOVIN 73.6 125 31 1 18 392 14 136 8E-60 189 Q3T114 UK114_BOVIN GO:0019239; GO:0004519; GO:0005739; GO:0090305; GO:0005634 deaminase activity; endonuclease activity; mitochondrion; nucleic acid phosphodiester bond hydrolysis; nucleus reviewed IPR013813; IPR006056; IPR019897; IPR006175; Ribonuclease UK114 (EC 3.1.-.-) HRSP12 Bos taurus (Bovine) 137 Q3T114 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0032432 GO:0032432 actin filament bundle cytoskeleton C ConsensusfromContig5660 sp Q3TN34 MILK2_MOUSE 56.06 198 85 1 1235 642 58 253 4E-60 214 Q3TN34 MILK2_MOUSE GO:0031532; GO:0051015; GO:0030041; GO:0005856; GO:0005829; GO:0032456; GO:0031005; GO:0043005; GO:0031175; GO:0005886; GO:0055037; GO:0034446; GO:0005923; GO:0070830; GO:0008270 P57780; P51153 actin cytoskeleton reorganization; actin filament binding; actin filament polymerization; cytoskeleton; cytosol; endocytic recycling; filamin binding; neuron projection; neuron projection development; plasma membrane; recycling endosome; substrate adhesion-dependent cell spreading; tight junction; tight junction assembly; zinc ion binding reviewed IPR001715; IPR022735; IPR001781; MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) Micall2 Jrab Mus musculus (Mouse) 1009 Q3TN34 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0002446 GO:0002446 neutrophil mediated immunity other biological processes P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0006306 GO:0006306 DNA methylation DNA metabolism P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0007050 GO:0007050 cell cycle arrest cell cycle and proliferation P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0030218 GO:0030218 erythrocyte differentiation developmental processes P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0030854 GO:0030854 positive regulation of granulocyte differentiation developmental processes P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0042119 GO:0042119 neutrophil activation other biological processes P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0042800 GO:0042800 histone methyltransferase activity (H3-K4 specific) other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0048384 GO:0048384 retinoic acid receptor signaling pathway signal transduction P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0051568 GO:0051568 histone H3-K4 methylation protein metabolism P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0051568 GO:0051568 histone H3-K4 methylation cell organization and biogenesis P ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0070688 GO:0070688 MLL5-L complex nucleus C ConsensusfromContig1015 sp Q3UG20 KMT2E_MOUSE 70.25 158 46 1 3 473 335 492 5E-79 261 Q3UG20 KMT2E_MOUSE GO:0006306; GO:0070688; GO:0007050; GO:0071300; GO:0030218; GO:0042800; GO:0042119; GO:0002446; GO:0016607; GO:0030854; GO:0045893; GO:0048384; GO:0003713; GO:0006351; GO:0008270 DNA methylation; MLL5-L complex; cell cycle arrest; cellular response to retinoic acid; erythrocyte differentiation; histone methyltransferase activity (H3-K4 specific); neutrophil activation; neutrophil mediated immunity; nuclear speck; positive regulation of granulocyte differentiation; positive regulation of transcription, DNA-dependent; retinoic acid receptor signaling pathway; transcription coactivator activity; transcription, DNA-dependent; zinc ion binding reviewed IPR001214; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5 homolog) Kmt2e Mll5 Mus musculus (Mouse) 1868 Q3UG20 GO:0071300 ConsensusfromContig6355 sp Q3UHI4 TMED8_MOUSE 55.62 169 71 1 780 286 156 324 4E-56 190 Q3UHI4 TMED8_MOUSE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009038; Protein TMED8 Tmed8 Mus musculus (Mouse) 326 Q3UHI4 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6355 sp Q3UHI4 TMED8_MOUSE 55.62 169 71 1 780 286 156 324 4E-56 190 Q3UHI4 TMED8_MOUSE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009038; Protein TMED8 Tmed8 Mus musculus (Mouse) 326 Q3UHI4 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6355 sp Q3UHI4 TMED8_MOUSE 55.62 169 71 1 780 286 156 324 4E-56 190 Q3UHI4 TMED8_MOUSE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009038; Protein TMED8 Tmed8 Mus musculus (Mouse) 326 Q3UHI4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6355 sp Q3UHI4 TMED8_MOUSE 55.62 169 71 1 780 286 156 324 4E-56 190 Q3UHI4 TMED8_MOUSE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009038; Protein TMED8 Tmed8 Mus musculus (Mouse) 326 Q3UHI4 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6355 sp Q3UHI4 TMED8_MOUSE 55.62 169 71 1 780 286 156 324 4E-56 190 Q3UHI4 TMED8_MOUSE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009038; Protein TMED8 Tmed8 Mus musculus (Mouse) 326 Q3UHI4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5695 sp Q3V1V3 ESF1_MOUSE 52.33 451 190 6 130 1482 419 844 7E-96 315 Q3V1V3 ESF1_MOUSE GO:0005730; GO:0005654; GO:0006355; GO:0006351 nucleolus; nucleoplasm; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012580; ESF1 homolog (ABT1-associated protein) Esf1 Abtap Mus musculus (Mouse) 845 Q3V1V3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig865 sp Q3Y4E2 SELN_DANRE 76.52 132 31 0 398 3 86 217 3E-59 197 Q3Y4E2 SELN_DANRE GO:0016021; GO:0048741 integral to membrane; skeletal muscle fiber development reviewed Selenoprotein N (SePN) (SelN) sepn1 sepn Danio rerio (Zebrafish) (Brachydanio rerio) 557 Q3Y4E2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig865 sp Q3Y4E2 SELN_DANRE 76.52 132 31 0 398 3 86 217 3E-59 197 Q3Y4E2 SELN_DANRE GO:0016021; GO:0048741 integral to membrane; skeletal muscle fiber development reviewed Selenoprotein N (SePN) (SelN) sepn1 sepn Danio rerio (Zebrafish) (Brachydanio rerio) 557 Q3Y4E2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig865 sp Q3Y4E2 SELN_DANRE 76.52 132 31 0 398 3 86 217 3E-59 197 Q3Y4E2 SELN_DANRE GO:0016021; GO:0048741 integral to membrane; skeletal muscle fiber development reviewed Selenoprotein N (SePN) (SelN) sepn1 sepn Danio rerio (Zebrafish) (Brachydanio rerio) 557 Q3Y4E2 GO:0048741 GO:0048741 skeletal muscle fiber development developmental processes P ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0005832 GO:0005832 chaperonin-containing T-complex cytosol C ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6101 sp Q3ZBH0 TCPB_BOVIN 90.85 328 30 0 1215 232 208 535 0 577 Q3ZBH0 TCPB_BOVIN GO:0005524; GO:0007339; GO:0051131; GO:0005832; GO:0005874; GO:0005634; GO:0006457; GO:0002199 ATP binding; binding of sperm to zona pellucida; chaperone-mediated protein complex assembly; chaperonin-containing T-complex; microtubule; nucleus; protein folding; zona pellucida receptor complex reviewed IPR012716; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta) CCT2 Bos taurus (Bovine) 535 Q3ZBH0 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0004767 GO:0004767 sphingomyelin phosphodiesterase activity other molecular function F ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0006685 GO:0006685 sphingomyelin catabolic process other metabolic processes P ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig824 sp Q3ZC91 ASM3A_BOVIN 61.45 262 99 1 1 780 143 404 2E-112 340 Q3ZC91 ASM3A_BOVIN GO:0005615; GO:0016798; GO:0006685; GO:0004767 extracellular space; hydrolase activity, acting on glycosyl bonds; sphingomyelin catabolic process; sphingomyelin phosphodiesterase activity reviewed IPR017064; IPR004843; Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-) SMPDL3A Bos taurus (Bovine) 450 Q3ZC91 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig5820 sp Q499W2 SLD5_RAT 68.95 219 66 1 21 671 1 219 5E-105 312 Q499W2 SLD5_RAT GO:0006260; GO:0005737; GO:0005634 DNA replication; cytoplasm; nucleus reviewed IPR021151; IPR008591; DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed] Gins4 Sld5 Rattus norvegicus (Rat) 223 Q499W2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5820 sp Q499W2 SLD5_RAT 68.95 219 66 1 21 671 1 219 5E-105 312 Q499W2 SLD5_RAT GO:0006260; GO:0005737; GO:0005634 DNA replication; cytoplasm; nucleus reviewed IPR021151; IPR008591; DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed] Gins4 Sld5 Rattus norvegicus (Rat) 223 Q499W2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5820 sp Q499W2 SLD5_RAT 68.95 219 66 1 21 671 1 219 5E-105 312 Q499W2 SLD5_RAT GO:0006260; GO:0005737; GO:0005634 DNA replication; cytoplasm; nucleus reviewed IPR021151; IPR008591; DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed] Gins4 Sld5 Rattus norvegicus (Rat) 223 Q499W2 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0004601 GO:0004601 peroxidase activity other molecular function F ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0004602 GO:0004602 glutathione peroxidase activity other molecular function F ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig91 sp Q4AEI2 GPX1_HYLLA 65.12 129 44 1 112 495 12 140 2E-54 177 Q4AEI2 GPX1_HYLLA GO:0005737; GO:0004602; GO:0006979 cytoplasm; glutathione peroxidase activity; response to oxidative stress reviewed IPR000889; IPR012336; Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase) GPX1 Hylobates lar (Common gibbon) (White-handed gibbon) 201 Q4AEI2 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0001757 GO:0001757 somite specification developmental processes P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007249 GO:0007249 I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation signal transduction P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation protein metabolism P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0008384 GO:0008384 IkappaB kinase activity kinase activity F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043124 GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2353 sp Q4G3H4 IKKA_DANRE 89.45 218 22 1 3 656 432 648 1E-134 403 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0055113 GO:0055113 epiboly involved in gastrulation with mouth forming second developmental processes P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0001757 GO:0001757 somite specification developmental processes P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007249 GO:0007249 I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation signal transduction P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation protein metabolism P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0008384 GO:0008384 IkappaB kinase activity kinase activity F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043124 GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2354 sp Q4G3H4 IKKA_DANRE 92.76 152 11 0 4 459 497 648 3E-93 292 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0055113 GO:0055113 epiboly involved in gastrulation with mouth forming second developmental processes P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0001757 GO:0001757 somite specification developmental processes P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007249 GO:0007249 I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation signal transduction P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007252 GO:0007252 I-kappaB phosphorylation protein metabolism P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0008384 GO:0008384 IkappaB kinase activity kinase activity F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0043124 GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2865 sp Q4G3H4 IKKA_DANRE 83.08 130 22 0 419 30 224 353 4E-57 194 Q4G3H4 IKKA_DANRE GO:0005524; GO:0007249; GO:0071356; GO:0007417; GO:0005737; GO:0055113; GO:0043124; GO:0043066; GO:0005634; GO:0045944; GO:0046982; GO:0042803; GO:0004674; GO:0001757 ATP binding; I-kappaB kinase/NF-kappaB cascade; cellular response to tumor necrosis factor; central nervous system development; cytoplasm; epiboly involved in gastrulation with mouth forming second; negative regulation of I-kappaB kinase/NF-kappaB cascade; negative regulation of apoptotic process; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein heterodimerization activity; protein homodimerization activity; protein serine/threonine kinase activity; somite specification reviewed IPR022007; IPR011009; IPR000719; IPR017441; IPR008271; Inhibitor of nuclear factor kappa-B kinase subunit alpha (I kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) chuk ikk1 zgc:56539 Danio rerio (Zebrafish) (Brachydanio rerio) 758 Q4G3H4 GO:0055113 GO:0055113 epiboly involved in gastrulation with mouth forming second developmental processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008705 GO:0008705 methionine synthase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008898 GO:0008898 homocysteine S-methyltransferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0009086 GO:0009086 methionine biosynthetic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0031419 GO:0031419 cobalamin binding other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0042558 GO:0042558 pteridine and derivative metabolic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 75.41 122 30 0 55 420 871 992 7E-55 184 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008705 GO:0008705 methionine synthase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0008898 GO:0008898 homocysteine S-methyltransferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0009086 GO:0009086 methionine biosynthetic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0031419 GO:0031419 cobalamin binding other molecular function F ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0042558 GO:0042558 pteridine and derivative metabolic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0044237 GO:0044237 cellular metabolic process other metabolic processes P ConsensusfromContig3964 sp Q4JIJ3 METH_BOVIN 91.67 24 2 0 8 79 855 878 7E-55 49.7 Q4JIJ3 METH_BOVIN GO:0031419; GO:0005737; GO:0008898; GO:0008705; GO:0042558; GO:0008270 cobalamin binding; cytoplasm; homocysteine S-methyltransferase activity; methionine synthase activity; pteridine-containing compound metabolic process; zinc ion binding reviewed IPR003759; IPR006158; IPR011005; IPR011822; IPR000489; IPR003726; IPR004223; Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1. Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS) MTR Bos taurus (Bovine) 1265 Q4JIJ3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0004715 GO:0004715 non-membrane spanning protein tyrosine kinase activity kinase activity F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0018108 GO:0018108 peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig2950 sp Q4JIM5 ABL2_MOUSE 75.84 178 43 0 2 535 321 498 2E-81 266 Q4JIM5 ABL2_MOUSE GO:0005524; GO:0015629; GO:0051017; GO:0007155; GO:0016023; GO:0000287; GO:0030145; GO:0004715; GO:0004713 ATP binding; actin cytoskeleton; actin filament bundle assembly; cell adhesion; cytoplasmic membrane-bounded vesicle; magnesium ion binding; manganese ion binding; non-membrane spanning protein tyrosine kinase activity; protein tyrosine kinase activity reviewed IPR015015; IPR011009; IPR000719; IPR017441; IPR001245; IPR000980; IPR001452; IPR008266; IPR020635; Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG) Abl2 Arg Mus musculus (Mouse) 1182 Q4JIM5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1589 sp Q4KLG9 ZFN2B_RAT 68.97 145 45 0 148 582 1 145 3E-76 236 Q4KLG9 ZFN2B_RAT GO:0005783; GO:0008270 endoplasmic reticulum; zinc ion binding reviewed IPR003903; IPR000058; AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Zfand2b Airapl Rattus norvegicus (Rat) 257 Q4KLG9 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1589 sp Q4KLG9 ZFN2B_RAT 68.97 145 45 0 148 582 1 145 3E-76 236 Q4KLG9 ZFN2B_RAT GO:0005783; GO:0008270 endoplasmic reticulum; zinc ion binding reviewed IPR003903; IPR000058; AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Zfand2b Airapl Rattus norvegicus (Rat) 257 Q4KLG9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1589 sp Q4KLG9 ZFN2B_RAT 68.97 145 45 0 148 582 1 145 3E-76 236 Q4KLG9 ZFN2B_RAT GO:0005783; GO:0008270 endoplasmic reticulum; zinc ion binding reviewed IPR003903; IPR000058; AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein) Zfand2b Airapl Rattus norvegicus (Rat) 257 Q4KLG9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0016705 GO:0016705 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen" other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0016706 GO:0016706 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors" other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0019511 GO:0019511 peptidyl-proline hydroxylation protein metabolism P ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0019797 GO:0019797 procollagen-proline 3-dioxygenase activity other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0031418 GO:0031418 L-ascorbic acid binding other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0032963 GO:0032963 collagen metabolic process other metabolic processes P ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2926 sp Q4KLM6 P3H2_RAT 84.85 132 20 0 404 9 559 690 2E-78 251 Q4KLM6 P3H2_RAT GO:0005794; GO:0031418; GO:0005604; GO:0032963; GO:0005783; GO:0005506; GO:0008285; GO:0019511; GO:0019797 Golgi apparatus; L-ascorbic acid binding; basement membrane; collagen metabolic process; endoplasmic reticulum; iron ion binding; negative regulation of cell proliferation; peptidyl-proline hydroxylation; procollagen-proline 3-dioxygenase activity reviewed IPR005123; IPR006620; IPR011990; IPR013105; Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) Leprel1 P3h2 Rattus norvegicus (Rat) 703 Q4KLM6 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2698 sp Q4KLT3 TRM44_XENLA 75 140 35 0 5 424 267 406 4E-75 242 Q4KLT3 TRM44_XENLA GO:0005737; GO:0046872; GO:0008168; GO:0008033 cytoplasm; metal ion binding; methyltransferase activity; tRNA processing reviewed IPR011671; IPR000571; Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19) trmt44 mettl19 Xenopus laevis (African clawed frog) 668 Q4KLT3 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig162 sp Q4KMD3 U1SBP_DANRE 76.81 138 32 0 27 440 2 139 5E-72 222 Q4KMD3 U1SBP_DANRE GO:0003723; GO:0000166; GO:0005634 RNA binding; nucleotide binding; nucleus reviewed IPR012677; IPR000504; U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog) snrnp35 u1snrnpbp zgc:112337 Danio rerio (Zebrafish) (Brachydanio rerio) 208 Q4KMD3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig162 sp Q4KMD3 U1SBP_DANRE 76.81 138 32 0 27 440 2 139 5E-72 222 Q4KMD3 U1SBP_DANRE GO:0003723; GO:0000166; GO:0005634 RNA binding; nucleotide binding; nucleus reviewed IPR012677; IPR000504; U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog) snrnp35 u1snrnpbp zgc:112337 Danio rerio (Zebrafish) (Brachydanio rerio) 208 Q4KMD3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig162 sp Q4KMD3 U1SBP_DANRE 76.81 138 32 0 27 440 2 139 5E-72 222 Q4KMD3 U1SBP_DANRE GO:0003723; GO:0000166; GO:0005634 RNA binding; nucleotide binding; nucleus reviewed IPR012677; IPR000504; U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog) snrnp35 u1snrnpbp zgc:112337 Danio rerio (Zebrafish) (Brachydanio rerio) 208 Q4KMD3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig162 sp Q4KMD3 U1SBP_DANRE 76.81 138 32 0 27 440 2 139 5E-72 222 Q4KMD3 U1SBP_DANRE GO:0003723; GO:0000166; GO:0005634 RNA binding; nucleotide binding; nucleus reviewed IPR012677; IPR000504; U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog) snrnp35 u1snrnpbp zgc:112337 Danio rerio (Zebrafish) (Brachydanio rerio) 208 Q4KMD3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig162 sp Q4KMD3 U1SBP_DANRE 76.81 138 32 0 27 440 2 139 5E-72 222 Q4KMD3 U1SBP_DANRE GO:0003723; GO:0000166; GO:0005634 RNA binding; nucleotide binding; nucleus reviewed IPR012677; IPR000504; U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U1 snRNP-binding protein homolog) snrnp35 u1snrnpbp zgc:112337 Danio rerio (Zebrafish) (Brachydanio rerio) 208 Q4KMD3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0000719 GO:0000719 photoreactive repair stress response P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0000719 GO:0000719 photoreactive repair DNA metabolism P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0003684 GO:0003684 damaged DNA binding nucleic acid binding activity F ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0003904 GO:0003904 deoxyribodipyrimidine photo-lyase activity other molecular function F ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0003913 GO:0003913 DNA photolyase activity other molecular function F ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0018298 GO:0018298 protein-chromophore linkage protein metabolism P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1662 sp Q4KML2 CRYD_DANRE 94.38 160 9 0 482 3 282 441 2E-108 325 Q4KML2 CRYD_DANRE GO:0003913; GO:0006281; GO:0018298 DNA photolyase activity; DNA repair; protein-chromophore linkage reviewed IPR002081; IPR014133; IPR006050; IPR005101; IPR014729; Cryptochrome DASH (Protein CRY-DASH) (zCRY-DASH) cry-dash Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q4KML2 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0002206 GO:0002206 gene conversion of immunoglobulin genes developmental processes P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0002206 GO:0002206 gene conversion of immunoglobulin genes DNA metabolism P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0003684 GO:0003684 damaged DNA binding nucleic acid binding activity F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0003887 GO:0003887 DNA-directed DNA polymerase activity other molecular function F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0019985 GO:0019985 bypass DNA synthesis stress response P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0019985 GO:0019985 bypass DNA synthesis DNA metabolism P ConsensusfromContig4239 sp Q4KWZ7 REV1_CHICK 74.36 117 30 0 351 1 600 716 5E-53 184 Q4KWZ7 REV1_CHICK GO:0006260; GO:0003887; GO:0003684; GO:0006302; GO:0002206; GO:0000287; GO:0005654; GO:0019985 DNA replication; DNA-directed DNA polymerase activity; damaged DNA binding; double-strand break repair; gene conversion of immunoglobulin genes; magnesium ion binding; nucleoplasm; translesion synthesis reviewed IPR001357; IPR017961; IPR001126; IPR017963; IPR012112; DNA repair protein REV1 (EC 2.7.7.-) (Rev1-like terminal deoxycytidyl transferase) REV1 Gallus gallus (Chicken) 1255 Q4KWZ7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1089 sp Q4QQW8 PLBL2_RAT 57.89 152 64 0 3 458 131 282 4E-60 201 Q4QQW8 PLBL2_RAT GO:0016787; GO:0016042; GO:0043202 hydrolase activity; lipid catabolic process; lysosomal lumen reviewed IPR007000; Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) Plbd2 RDCR-0918-3 Rattus norvegicus (Rat) 585 Q4QQW8 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig1089 sp Q4QQW8 PLBL2_RAT 57.89 152 64 0 3 458 131 282 4E-60 201 Q4QQW8 PLBL2_RAT GO:0016787; GO:0016042; GO:0043202 hydrolase activity; lipid catabolic process; lysosomal lumen reviewed IPR007000; Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) Plbd2 RDCR-0918-3 Rattus norvegicus (Rat) 585 Q4QQW8 GO:0016042 GO:0016042 lipid catabolic process other metabolic processes P ConsensusfromContig1089 sp Q4QQW8 PLBL2_RAT 57.89 152 64 0 3 458 131 282 4E-60 201 Q4QQW8 PLBL2_RAT GO:0016787; GO:0016042; GO:0043202 hydrolase activity; lipid catabolic process; lysosomal lumen reviewed IPR007000; Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) Plbd2 RDCR-0918-3 Rattus norvegicus (Rat) 585 Q4QQW8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1089 sp Q4QQW8 PLBL2_RAT 57.89 152 64 0 3 458 131 282 4E-60 201 Q4QQW8 PLBL2_RAT GO:0016787; GO:0016042; GO:0043202 hydrolase activity; lipid catabolic process; lysosomal lumen reviewed IPR007000; Putative phospholipase B-like 2 (EC 3.1.1.-) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) Plbd2 RDCR-0918-3 Rattus norvegicus (Rat) 585 Q4QQW8 GO:0043202 GO:0043202 lysosomal lumen other cytoplasmic organelle C ConsensusfromContig5773 sp Q4QRJ7 EIF2A_DANRE 79.91 433 83 2 1544 252 136 566 0 657 Q4QRJ7 EIF2A_DANRE GO:0006417; GO:0003743 regulation of translation; translation initiation factor activity reviewed IPR011387; IPR013979; IPR015943; Eukaryotic translation initiation factor 2A (eIF-2A) eif2a zgc:110460 Danio rerio (Zebrafish) (Brachydanio rerio) 580 Q4QRJ7 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig5773 sp Q4QRJ7 EIF2A_DANRE 79.91 433 83 2 1544 252 136 566 0 657 Q4QRJ7 EIF2A_DANRE GO:0006417; GO:0003743 regulation of translation; translation initiation factor activity reviewed IPR011387; IPR013979; IPR015943; Eukaryotic translation initiation factor 2A (eIF-2A) eif2a zgc:110460 Danio rerio (Zebrafish) (Brachydanio rerio) 580 Q4QRJ7 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5773 sp Q4QRJ7 EIF2A_DANRE 79.91 433 83 2 1544 252 136 566 0 657 Q4QRJ7 EIF2A_DANRE GO:0006417; GO:0003743 regulation of translation; translation initiation factor activity reviewed IPR011387; IPR013979; IPR015943; Eukaryotic translation initiation factor 2A (eIF-2A) eif2a zgc:110460 Danio rerio (Zebrafish) (Brachydanio rerio) 580 Q4QRJ7 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig5773 sp Q4QRJ7 EIF2A_DANRE 79.91 433 83 2 1544 252 136 566 0 657 Q4QRJ7 EIF2A_DANRE GO:0006417; GO:0003743 regulation of translation; translation initiation factor activity reviewed IPR011387; IPR013979; IPR015943; Eukaryotic translation initiation factor 2A (eIF-2A) eif2a zgc:110460 Danio rerio (Zebrafish) (Brachydanio rerio) 580 Q4QRJ7 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 69.59 194 55 1 820 1389 282 475 1E-135 270 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 60.76 158 55 3 374 829 128 284 1E-135 154 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6212 sp Q4R4I6 CAP1_MACFA 48.03 127 64 1 1 375 2 128 1E-135 105 Q4R4I6 CAP1_MACFA GO:0000902; GO:0007010; GO:0005886 cell morphogenesis; cytoskeleton organization; plasma membrane reviewed IPR001837; IPR013912; IPR013992; IPR017901; IPR016098; IPR018106; IPR006599; Adenylyl cyclase-associated protein 1 (CAP 1) CAP1 QtrA-13003 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 475 Q4R4I6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0033919 GO:0033919 "glucan 1,3-alpha-glucosidase activity" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 63.04 349 128 1 1139 96 592 940 0 484 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0033919 GO:0033919 "glucan 1,3-alpha-glucosidase activity" other molecular function F ConsensusfromContig6234 sp Q4R4N7 GANAB_MACFA 75.73 103 24 1 1440 1135 491 593 0 172 Q4R4N7 GANAB_MACFA GO:0005794; GO:0030246; GO:0005975; GO:0005783; GO:0033919; GO:0042470 Golgi apparatus; carbohydrate binding; carbohydrate metabolic process; endoplasmic reticulum; glucan 1,3-alpha-glucosidase activity; melanosome reviewed IPR011013; IPR000322; IPR025887; IPR017853; Glycan metabolism; N-glycan metabolism. Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha) GANAB QccE-15075 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 944 Q4R4N7 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0004450 GO:0004450 isocitrate dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0006097 GO:0006097 glyoxylate cycle other metabolic processes P ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0006102 GO:0006102 isocitrate metabolic process other metabolic processes P ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0006103 GO:0006103 2-oxoglutarate metabolic process other metabolic processes P ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig5735 sp Q4R502 IDHP_MACFA 86.51 415 55 1 1247 3 23 436 0 752 Q4R502 IDHP_MACFA GO:0006103; GO:0051287; GO:0006097; GO:0004450; GO:0006102; GO:0000287; GO:0005739; GO:0006099 2-oxoglutarate metabolic process; NAD binding; glyoxylate cycle; isocitrate dehydrogenase (NADP+) activity; isocitrate metabolic process; magnesium ion binding; mitochondrion; tricarboxylic acid cycle reviewed IPR019818; IPR004790; IPR024084; Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase) IDH2 QnpA-13564 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 452 Q4R502 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0015986 GO:0015986 ATP synthesis coupled proton transport transport P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0015986 GO:0015986 ATP synthesis coupled proton transport other metabolic processes P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0045261 GO:0045261 "proton-transporting ATP synthase complex, catalytic core F(1)" other membranes C ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0046933 GO:0046933 "hydrogen ion transporting ATP synthase activity, rotational mechanism" transporter activity F ConsensusfromContig6329 sp Q4R5B0 ATPG_MACFA 74.07 297 72 1 1022 147 1 297 4E-152 437 Q4R5B0 ATPG_MACFA GO:0015986; GO:0005753; GO:0046933; GO:0045261; GO:0046961 ATP synthesis coupled proton transport; mitochondrial proton-transporting ATP synthase complex; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1); proton-transporting ATPase activity, rotational mechanism reviewed IPR000131; IPR023632; IPR023633; ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit) ATP5C1 QtrA-13429 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 298 Q4R5B0 GO:0046961 GO:0046961 "proton-transporting ATPase activity, rotational mechanism" transporter activity F ConsensusfromContig5563 sp Q4R5D9 YTHD2_MACFA 66.05 377 114 5 2697 1573 214 578 0 430 Q4R5D9 YTHD2_MACFA reviewed IPR007275; YTH domain family protein 2 YTHDF2 QnpA-16856 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 579 ConsensusfromContig5563 sp Q4R5D9 YTHD2_MACFA 84.69 196 29 1 3332 2745 1 195 0 242 Q4R5D9 YTHD2_MACFA reviewed IPR007275; YTH domain family protein 2 YTHDF2 QnpA-16856 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 579 ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig5598 sp Q4R6V2 TCPE_MACFA 86.14 541 75 0 278 1900 1 541 0 979 Q4R6V2 TCPE_MACFA GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012718; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon) CCT5 QtsA-17059 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 541 Q4R6V2 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0020037 GO:0020037 heme binding other molecular function F ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2489 sp Q4U2R1 HERC2_MOUSE 91.88 160 13 0 3 482 3517 3676 5E-92 300 Q4U2R1 HERC2_MOUSE GO:0006281; GO:0032183; GO:0005814; GO:0020037; GO:0005743; GO:0005634; GO:0042787; GO:0007283; GO:0004842; GO:0008270 DNA repair; SUMO binding; centriole; heme binding; mitochondrial inner membrane; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR004939; IPR006624; IPR021097; IPR001199; IPR008979; IPR000569; IPR010606; IPR009091; IPR000408; IPR014722; IPR000433; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HERC2 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 2) Herc2 Jdf2 Kiaa0393 Rjs Mus musculus (Mouse) 4836 Q4U2R1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2629 sp Q4V8S3 TM242_DANRE 74.29 105 27 0 34 348 12 116 9E-52 167 Q4V8S3 TM242_DANRE GO:0016021 integral to membrane reviewed IPR009792; Transmembrane protein 242 tmem242 si:dkey-60a16.5 Danio rerio (Zebrafish) (Brachydanio rerio) 142 Q4V8S3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2629 sp Q4V8S3 TM242_DANRE 74.29 105 27 0 34 348 12 116 9E-52 167 Q4V8S3 TM242_DANRE GO:0016021 integral to membrane reviewed IPR009792; Transmembrane protein 242 tmem242 si:dkey-60a16.5 Danio rerio (Zebrafish) (Brachydanio rerio) 142 Q4V8S3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 50 418 189 4 1591 341 310 708 0 408 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 50 418 189 4 1591 341 310 708 0 408 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 59.41 202 80 1 2408 1809 35 236 0 249 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 59.41 202 80 1 2408 1809 35 236 0 249 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 75 52 13 0 1740 1585 260 311 0 87.8 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6238 sp Q4V9P9 NOL11_DANRE 75 52 13 0 1740 1585 260 311 0 87.8 Q4V9P9 NOL11_DANRE GO:0030490; GO:0005730; GO:1901838; GO:0006351 maturation of SSU-rRNA; nucleolus; positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter; transcription, DNA-dependent reviewed IPR017986; Nucleolar protein 11-like nol11 wu:fb30e03 zgc:109901 Danio rerio (Zebrafish) (Brachydanio rerio) 708 Q4V9P9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 76.18 319 75 1 628 1581 207 525 0 519 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6150 sp Q4VBT2 NOC4L_DANRE 61.26 191 74 0 77 649 23 213 0 243 Q4VBT2 NOC4L_DANRE GO:0016021; GO:0031965; GO:0005730; GO:0042254 integral to membrane; nuclear membrane; nucleolus; ribosome biogenesis reviewed IPR005612; IPR027193; Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein) noc4l zgc:110429 Danio rerio (Zebrafish) (Brachydanio rerio) 525 Q4VBT2 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0005762 GO:0005762 mitochondrial large ribosomal subunit mitochondrion C ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0005762 GO:0005762 mitochondrial large ribosomal subunit translational apparatus C ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5875 sp Q502B0 RM41_DANRE 66.67 135 45 0 710 306 1 135 1E-60 196 Q502B0 RM41_DANRE GO:0006915; GO:0007049; GO:0005762; GO:0003735; GO:0006412 apoptotic process; cell cycle; mitochondrial large ribosomal subunit; structural constituent of ribosome; translation reviewed IPR019189; 39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) mrpl41 zgc:112362 Danio rerio (Zebrafish) (Brachydanio rerio) 135 Q502B0 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0008654 GO:0008654 phospholipid biosynthetic process other metabolic processes P ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0047184 GO:0047184 1-acylglycerophosphocholine O-acyltransferase activity other molecular function F ConsensusfromContig5748 sp Q502J0 PCAT2_DANRE 75.5 200 46 2 1108 518 330 529 1E-99 311 Q502J0 PCAT2_DANRE GO:0003841; GO:0047184; GO:0047192; GO:0000139; GO:0005509; GO:0005789; GO:0016021; GO:0005811; GO:0008654 1-acylglycerol-3-phosphate O-acyltransferase activity; 1-acylglycerophosphocholine O-acyltransferase activity; 1-alkylglycerophosphocholine O-acetyltransferase activity; Golgi membrane; calcium ion binding; endoplasmic reticulum membrane; integral to membrane; lipid particle; phospholipid biosynthetic process reviewed IPR011992; IPR018247; IPR002048; IPR002123; Lipid metabolism; phospholipid metabolism. Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 1) lpcat2 aytl1 zgc:112165 Danio rerio (Zebrafish) (Brachydanio rerio) 529 Q502J0 GO:0047192 GO:0047192 1-alkylglycerophosphocholine O-acetyltransferase activity other molecular function F ConsensusfromContig5970 sp Q503D6 FA58A_DANRE 73.19 138 37 0 1232 819 109 246 1E-61 206 Q503D6 FA58A_DANRE GO:0000079; GO:0006355 regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-related protein FAM58A fam58a zgc:110684 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q503D6 GO:0000079 GO:0000079 regulation of cyclin-dependent protein kinase activity cell cycle and proliferation P ConsensusfromContig5970 sp Q503D6 FA58A_DANRE 73.19 138 37 0 1232 819 109 246 1E-61 206 Q503D6 FA58A_DANRE GO:0000079; GO:0006355 regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-related protein FAM58A fam58a zgc:110684 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q503D6 GO:0000079 GO:0000079 regulation of cyclin-dependent protein kinase activity other metabolic processes P ConsensusfromContig5970 sp Q503D6 FA58A_DANRE 73.19 138 37 0 1232 819 109 246 1E-61 206 Q503D6 FA58A_DANRE GO:0000079; GO:0006355 regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-related protein FAM58A fam58a zgc:110684 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q503D6 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5970 sp Q503D6 FA58A_DANRE 73.19 138 37 0 1232 819 109 246 1E-61 206 Q503D6 FA58A_DANRE GO:0000079; GO:0006355 regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-related protein FAM58A fam58a zgc:110684 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q503D6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5970 sp Q503D6 FA58A_DANRE 73.19 138 37 0 1232 819 109 246 1E-61 206 Q503D6 FA58A_DANRE GO:0000079; GO:0006355 regulation of cyclin-dependent protein serine/threonine kinase activity; regulation of transcription, DNA-dependent reviewed IPR013763; IPR015429; IPR006671; Cyclin-related protein FAM58A fam58a zgc:110684 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q503D6 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 64.17 321 111 2 237 1187 324 644 1E-146 405 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0000224 GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 64.17 321 111 2 237 1187 324 644 1E-146 405 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 64.17 321 111 2 237 1187 324 644 1E-146 405 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0006516 GO:0006516 glycoprotein catabolic process other metabolic processes P ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 64.17 321 111 2 237 1187 324 644 1E-146 405 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 64.17 321 111 2 237 1187 324 644 1E-146 405 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 92.86 42 3 0 110 235 282 323 1E-146 91.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0000224 GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 92.86 42 3 0 110 235 282 323 1E-146 91.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 92.86 42 3 0 110 235 282 323 1E-146 91.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0006516 GO:0006516 glycoprotein catabolic process other metabolic processes P ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 92.86 42 3 0 110 235 282 323 1E-146 91.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 92.86 42 3 0 110 235 282 323 1E-146 91.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 76.32 38 9 0 1 114 246 283 1E-146 69.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0000224 GO:0000224 peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 76.32 38 9 0 1 114 246 283 1E-146 69.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 76.32 38 9 0 1 114 246 283 1E-146 69.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0006516 GO:0006516 glycoprotein catabolic process other metabolic processes P ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 76.32 38 9 0 1 114 246 283 1E-146 69.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5751 sp Q503I8 NGLY1_DANRE 76.32 38 9 0 1 114 246 283 1E-146 69.3 Q503I8 NGLY1_DANRE GO:0005737; GO:0006516; GO:0046872; GO:0000224 cytoplasm; glycoprotein catabolic process; metal ion binding; peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity reviewed IPR008979; IPR006588; IPR018997; IPR006567; IPR002931; Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase) ngly1 zgc:110561 Danio rerio (Zebrafish) (Brachydanio rerio) 644 Q503I8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5814 sp Q503P2 NIP7_DANRE 91.11 180 16 0 957 418 1 180 4E-120 352 Q503P2 NIP7_DANRE GO:0003723; GO:0005730; GO:0042255 RNA binding; nucleolus; ribosome assembly reviewed IPR002478; IPR015947; IPR005155; IPR016686; 60S ribosome subunit biogenesis protein NIP7 homolog nip7 zgc:110384 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q503P2 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5814 sp Q503P2 NIP7_DANRE 91.11 180 16 0 957 418 1 180 4E-120 352 Q503P2 NIP7_DANRE GO:0003723; GO:0005730; GO:0042255 RNA binding; nucleolus; ribosome assembly reviewed IPR002478; IPR015947; IPR005155; IPR016686; 60S ribosome subunit biogenesis protein NIP7 homolog nip7 zgc:110384 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q503P2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5814 sp Q503P2 NIP7_DANRE 91.11 180 16 0 957 418 1 180 4E-120 352 Q503P2 NIP7_DANRE GO:0003723; GO:0005730; GO:0042255 RNA binding; nucleolus; ribosome assembly reviewed IPR002478; IPR015947; IPR005155; IPR016686; 60S ribosome subunit biogenesis protein NIP7 homolog nip7 zgc:110384 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q503P2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5814 sp Q503P2 NIP7_DANRE 91.11 180 16 0 957 418 1 180 4E-120 352 Q503P2 NIP7_DANRE GO:0003723; GO:0005730; GO:0042255 RNA binding; nucleolus; ribosome assembly reviewed IPR002478; IPR015947; IPR005155; IPR016686; 60S ribosome subunit biogenesis protein NIP7 homolog nip7 zgc:110384 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q503P2 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5814 sp Q503P2 NIP7_DANRE 91.11 180 16 0 957 418 1 180 4E-120 352 Q503P2 NIP7_DANRE GO:0003723; GO:0005730; GO:0042255 RNA binding; nucleolus; ribosome assembly reviewed IPR002478; IPR015947; IPR005155; IPR016686; 60S ribosome subunit biogenesis protein NIP7 homolog nip7 zgc:110384 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q503P2 GO:0042255 GO:0042255 ribosome assembly cell organization and biogenesis P ConsensusfromContig720 sp Q504E7 SZRD1_DANRE 88.14 118 14 0 44 397 1 118 2E-62 195 Q504E7 SZRD1_DANRE reviewed IPR024771; IPR024642; SUZ domain-containing protein 1 szrd1 zgc:109926 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q504E7 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig720 sp Q504E7 SZRD1_DANRE 88.14 118 14 0 44 397 1 118 2E-62 195 Q504E7 SZRD1_DANRE reviewed IPR024771; IPR024642; SUZ domain-containing protein 1 szrd1 zgc:109926 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q504E7 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig720 sp Q504E7 SZRD1_DANRE 88.14 118 14 0 44 397 1 118 2E-62 195 Q504E7 SZRD1_DANRE reviewed IPR024771; IPR024642; SUZ domain-containing protein 1 szrd1 zgc:109926 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q504E7 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig278 sp Q504G0 TM127_DANRE 88.35 103 12 0 3 311 135 237 4E-51 168 Q504G0 TM127_DANRE GO:0016021; GO:0005886 integral to membrane; plasma membrane reviewed Transmembrane protein 127 tmem127 si:dkey-49h9.5 zgc:109899 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q504G0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig278 sp Q504G0 TM127_DANRE 88.35 103 12 0 3 311 135 237 4E-51 168 Q504G0 TM127_DANRE GO:0016021; GO:0005886 integral to membrane; plasma membrane reviewed Transmembrane protein 127 tmem127 si:dkey-49h9.5 zgc:109899 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q504G0 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig278 sp Q504G0 TM127_DANRE 88.35 103 12 0 3 311 135 237 4E-51 168 Q504G0 TM127_DANRE GO:0016021; GO:0005886 integral to membrane; plasma membrane reviewed Transmembrane protein 127 tmem127 si:dkey-49h9.5 zgc:109899 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q504G0 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig278 sp Q504G0 TM127_DANRE 88.35 103 12 0 3 311 135 237 4E-51 168 Q504G0 TM127_DANRE GO:0016021; GO:0005886 integral to membrane; plasma membrane reviewed Transmembrane protein 127 tmem127 si:dkey-49h9.5 zgc:109899 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q504G0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig278 sp Q504G0 TM127_DANRE 88.35 103 12 0 3 311 135 237 4E-51 168 Q504G0 TM127_DANRE GO:0016021; GO:0005886 integral to membrane; plasma membrane reviewed Transmembrane protein 127 tmem127 si:dkey-49h9.5 zgc:109899 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q504G0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0005732 GO:0005732 small nucleolar ribonucleoprotein complex other cellular component C ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0030515 GO:0030515 snoRNA binding nucleic acid binding activity F ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0031120 GO:0031120 snRNA pseudouridine synthesis RNA metabolism P ConsensusfromContig6162 sp Q52KK4 NAF1_RAT 57.36 197 80 1 704 1282 112 308 5E-69 235 Q52KK4 NAF1_RAT GO:0003723; GO:0030054; GO:0005813; GO:0005737; GO:0005634; GO:0001522; GO:0006364; GO:0042254; GO:0005732 RNA binding; cell junction; centrosome; cytoplasm; nucleus; pseudouridine synthesis; rRNA processing; ribosome biogenesis; small nucleolar ribonucleoprotein complex reviewed IPR007504; IPR009000; H/ACA ribonucleoprotein complex non-core subunit NAF1 Naf1 Rattus norvegicus (Rat) 457 Q52KK4 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0006672 GO:0006672 ceramide metabolic process other metabolic processes P ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4493 sp Q53FV1 ORML2_HUMAN 88.66 97 11 0 2 292 19 115 8E-58 181 Q53FV1 ORML2_HUMAN GO:0006672; GO:0005783; GO:0005789; GO:0016021 ceramide metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane reviewed IPR007203; ORM1-like protein 2 (Adoplin-2) ORMDL2 HSPC160 MSTP095 Homo sapiens (Human) 153 Q53FV1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2886 sp Q566H4 MED16_XENLA 82.5 160 28 0 480 1 520 679 4E-87 275 Q566H4 MED16_XENLA GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021665; IPR015943; IPR001680; IPR017986; Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) med16 Xenopus laevis (African clawed frog) 697 Q566H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2886 sp Q566H4 MED16_XENLA 82.5 160 28 0 480 1 520 679 4E-87 275 Q566H4 MED16_XENLA GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021665; IPR015943; IPR001680; IPR017986; Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) med16 Xenopus laevis (African clawed frog) 697 Q566H4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2886 sp Q566H4 MED16_XENLA 82.5 160 28 0 480 1 520 679 4E-87 275 Q566H4 MED16_XENLA GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021665; IPR015943; IPR001680; IPR017986; Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) med16 Xenopus laevis (African clawed frog) 697 Q566H4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0008023 GO:0008023 transcription elongation factor complex nucleus C ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0008607 GO:0008607 phosphorylase kinase regulator activity enzyme regulator activity F ConsensusfromContig2648 sp Q566Y1 ELP4_DANRE 81.82 110 19 1 3 332 3 111 1E-57 188 Q566Y1 ELP4_DANRE GO:0033588; GO:0005737; GO:0008607; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR008728; Elongator complex protein 4 (ELP4) elp4 si:dkey-157g7.1 zgc:112389 Danio rerio (Zebrafish) (Brachydanio rerio) 397 Q566Y1 GO:0033588 GO:0033588 Elongator holoenzyme complex other cellular component C ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0006446 GO:0006446 regulation of translational initiation protein metabolism P ConsensusfromContig5803 sp Q567V6 EIF3K_DANRE 92.27 220 16 1 107 766 1 219 4E-151 429 Q567V6 EIF3K_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0005634; GO:0006446; GO:0043022; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleus; regulation of translational initiation; ribosome binding; translation initiation factor activity; translational initiation reviewed IPR016024; IPR009374; IPR016020; IPR011991; Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (eIF-3 p25) eif3k eif3s12 zgc:110726 Danio rerio (Zebrafish) (Brachydanio rerio) 219 Q567V6 GO:0043022 GO:0043022 ribosome binding translation activity F ConsensusfromContig6121 sp Q568A0 PKRI1_DANRE 80.83 120 22 1 711 355 6 125 2E-62 199 Q568A0 PKRI1_DANRE GO:0005730 nucleolus reviewed IPR009548; PRKR-interacting protein 1 homolog prkrip1 si:dkey-93f15.1 zgc:110608 Danio rerio (Zebrafish) (Brachydanio rerio) 182 Q568A0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6121 sp Q568A0 PKRI1_DANRE 80.83 120 22 1 711 355 6 125 2E-62 199 Q568A0 PKRI1_DANRE GO:0005730 nucleolus reviewed IPR009548; PRKR-interacting protein 1 homolog prkrip1 si:dkey-93f15.1 zgc:110608 Danio rerio (Zebrafish) (Brachydanio rerio) 182 Q568A0 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0010212 GO:0010212 response to ionizing radiation other biological processes P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint stress response P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0031593 GO:0031593 polyubiquitin binding other molecular function F ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0045739 GO:0045739 positive regulation of DNA repair stress response P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0045739 GO:0045739 positive regulation of DNA repair DNA metabolism P ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0070531 GO:0070531 BRCA1-A complex nucleus C ConsensusfromContig374 sp Q568D5 BRE_DANRE 85.39 219 32 0 58 714 1 219 4E-136 395 Q568D5 BRE_DANRE GO:0070531; GO:0070552; GO:0031572; GO:0006915; GO:0016568; GO:0005737; GO:0006302; GO:0031593; GO:0045739; GO:0010212 BRCA1-A complex; BRISC complex; G2 DNA damage checkpoint; apoptotic process; chromatin modification; cytoplasm; double-strand break repair; polyubiquitin binding; positive regulation of DNA repair; response to ionizing radiation reviewed IPR010358; BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein) bre zgc:110368 Danio rerio (Zebrafish) (Brachydanio rerio) 386 Q568D5 GO:0070552 GO:0070552 BRISC complex nucleus C ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0008893 GO:0008893 "guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity" other molecular function F ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0015969 GO:0015969 guanosine tetraphosphate metabolic process other metabolic processes P ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1548 sp Q568P1 MESH1_DANRE 83.01 153 25 1 226 681 1 153 2E-76 235 Q568P1 MESH1_DANRE GO:0008893; GO:0008152; GO:0046872 guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity; metabolic process; metal ion binding reviewed IPR003607; Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase) hddc3 Mesh1 zgc:110184 Danio rerio (Zebrafish) (Brachydanio rerio) 180 Q568P1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0042626 GO:0042626 "ATPase activity, coupled to transmembrane movement of substances" transporter activity F ConsensusfromContig6085 sp Q56A55 ABCB8_DANRE 90.38 208 20 0 934 311 507 714 3E-127 386 Q56A55 ABCB8_DANRE GO:0005524; GO:0042626; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 8, mitochondrial abcb8 zgc:113037 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q56A55 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig4807 sp Q58DN7 ACSF3_BOVIN 72.27 119 33 0 2 358 219 337 1E-55 188 Q58DN7 ACSF3_BOVIN GO:0005524; GO:0006633; GO:0090410; GO:0090409; GO:0005739 ATP binding; fatty acid biosynthetic process; malonate catabolic process; malonyl-CoA synthetase activity; mitochondrion reviewed IPR025110; IPR020845; IPR000873; Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-) ACSF3 Bos taurus (Bovine) 586 Q58DN7 GO:0016878 GO:0016878 acid-thiol ligase activity other molecular function F ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig6325 sp Q58DT3 ZDHC4_BOVIN 48.98 294 149 1 1017 136 40 332 1E-79 255 Q58DT3 ZDHC4_BOVIN GO:0016021; GO:0016746; GO:0008270 integral to membrane; transferase activity, transferring acyl groups; zinc ion binding reviewed IPR001594; Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) ZDHHC4 Bos taurus (Bovine) 343 Q58DT3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3616 sp Q58WW2 DCAF6_HUMAN 81.03 116 22 0 349 2 28 143 6E-62 207 Q58WW2 DCAF6_HUMAN GO:0080008; GO:0030374; GO:0005634; GO:0045944; GO:0016567 Cul4-RING ubiquitin ligase complex; ligand-dependent nuclear receptor transcription coactivator activity; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein ubiquitination reviewed IPR000048; IPR015943; IPR001680; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) DCAF6 IQWD1 MSTP055 Homo sapiens (Human) 860 Q58WW2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3616 sp Q58WW2 DCAF6_HUMAN 81.03 116 22 0 349 2 28 143 6E-62 207 Q58WW2 DCAF6_HUMAN GO:0080008; GO:0030374; GO:0005634; GO:0045944; GO:0016567 Cul4-RING ubiquitin ligase complex; ligand-dependent nuclear receptor transcription coactivator activity; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein ubiquitination reviewed IPR000048; IPR015943; IPR001680; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) DCAF6 IQWD1 MSTP055 Homo sapiens (Human) 860 Q58WW2 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3616 sp Q58WW2 DCAF6_HUMAN 81.03 116 22 0 349 2 28 143 6E-62 207 Q58WW2 DCAF6_HUMAN GO:0080008; GO:0030374; GO:0005634; GO:0045944; GO:0016567 Cul4-RING ubiquitin ligase complex; ligand-dependent nuclear receptor transcription coactivator activity; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein ubiquitination reviewed IPR000048; IPR015943; IPR001680; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) DCAF6 IQWD1 MSTP055 Homo sapiens (Human) 860 Q58WW2 GO:0030374 GO:0030374 ligand-dependent nuclear receptor transcription coactivator activity transcription regulatory activity F ConsensusfromContig3616 sp Q58WW2 DCAF6_HUMAN 81.03 116 22 0 349 2 28 143 6E-62 207 Q58WW2 DCAF6_HUMAN GO:0080008; GO:0030374; GO:0005634; GO:0045944; GO:0016567 Cul4-RING ubiquitin ligase complex; ligand-dependent nuclear receptor transcription coactivator activity; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein ubiquitination reviewed IPR000048; IPR015943; IPR001680; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) DCAF6 IQWD1 MSTP055 Homo sapiens (Human) 860 Q58WW2 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3616 sp Q58WW2 DCAF6_HUMAN 81.03 116 22 0 349 2 28 143 6E-62 207 Q58WW2 DCAF6_HUMAN GO:0080008; GO:0030374; GO:0005634; GO:0045944; GO:0016567 Cul4-RING ubiquitin ligase complex; ligand-dependent nuclear receptor transcription coactivator activity; nucleus; positive regulation of transcription from RNA polymerase II promoter; protein ubiquitination reviewed IPR000048; IPR015943; IPR001680; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP) DCAF6 IQWD1 MSTP055 Homo sapiens (Human) 860 Q58WW2 GO:0080008 GO:0080008 CUL4 RING ubiquitin ligase complex other cellular component C ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6278 sp Q5BJ41 CNOT6_XENLA 82.23 287 50 1 1361 501 267 552 2E-161 474 Q5BJ41 CNOT6_XENLA GO:0030014; GO:0003723; GO:0005737; GO:0043928; GO:0031047; GO:0046872; GO:0070966; GO:0005634; GO:0004535; GO:2000327; GO:0006355; GO:0006417; GO:0006351 CCR4-NOT complex; RNA binding; cytoplasm; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; gene silencing by RNA; metal ion binding; nuclear-transcribed mRNA catabolic process, no-go decay; nucleus; poly(A)-specific ribonuclease activity; positive regulation of ligand-dependent nuclear receptor transcription coactivator activity; regulation of transcription, DNA-dependent; regulation of translation; transcription, DNA-dependent reviewed IPR005135; IPR001611; IPR003591; CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (Cytoplasmic deadenylase) cnot6 Xenopus laevis (African clawed frog) 552 Q5BJ41 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0006488 GO:0006488 dolichol-linked oligosaccharide biosynthetic process protein metabolism P ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0016758 GO:0016758 "transferase activity, transferring hexosyl groups" other molecular function F ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0018279 GO:0018279 protein amino acid N-linked glycosylation via asparagine protein metabolism P ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig6250 sp Q5BKT4 AG10A_HUMAN 51.41 319 150 2 1375 419 160 473 2E-96 305 Q5BKT4 AG10A_HUMAN GO:0006488; GO:0005789; GO:0016021; GO:0043687; GO:0018279; GO:0016758 dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; post-translational protein modification; protein N-linked glycosylation via asparagine; transferase activity, transferring hexosyl groups reviewed IPR016900; Protein modification; protein glycosylation. Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A) ALG10 ALG10A Homo sapiens (Human) 473 Q5BKT4 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig936 sp Q5BKX6 S45A4_HUMAN 80.62 160 29 1 1 480 570 727 8E-72 237 Q5BKX6 S45A4_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR016196; Solute carrier family 45 member 4 SLC45A4 KIAA1126 Homo sapiens (Human) 768 Q5BKX6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig936 sp Q5BKX6 S45A4_HUMAN 80.62 160 29 1 1 480 570 727 8E-72 237 Q5BKX6 S45A4_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR016196; Solute carrier family 45 member 4 SLC45A4 KIAA1126 Homo sapiens (Human) 768 Q5BKX6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig936 sp Q5BKX6 S45A4_HUMAN 80.62 160 29 1 1 480 570 727 8E-72 237 Q5BKX6 S45A4_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR016196; Solute carrier family 45 member 4 SLC45A4 KIAA1126 Homo sapiens (Human) 768 Q5BKX6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0006810 GO:0006810 transport transport P ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0006829 GO:0006829 zinc ion transport transport P ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0030001 GO:0030001 metal ion transport transport P ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0046873 GO:0046873 metal ion transmembrane transporter activity transporter activity F ConsensusfromContig312 sp Q5BL29 S39A9_DANRE 89.87 158 16 0 25 498 137 294 2E-57 187 Q5BL29 S39A9_DANRE GO:0016021; GO:0005385 integral to membrane; zinc ion transmembrane transporter activity reviewed IPR003689; Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9) slc39a9 zip9 zgc:101628 Danio rerio (Zebrafish) (Brachydanio rerio) 309 Q5BL29 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig261 sp Q5BL35 SPOLA_DANRE 96.59 88 3 0 265 2 132 219 2E-54 179 Q5BL35 SPOLA_DANRE GO:0031463; GO:0031397; GO:0005634; GO:0043161; GO:0016567 Cul3-RING ubiquitin ligase complex; negative regulation of protein ubiquitination; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR000210; IPR011333; IPR013069; IPR002083; IPR008974; Protein modification; protein ubiquitination. Speckle-type POZ protein-like A (HIB homolog 2) spopla spopl zgc:101524 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q5BL35 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5568 sp Q5BL35 SPOLA_DANRE 97.75 178 4 0 2 535 215 392 1E-116 360 Q5BL35 SPOLA_DANRE GO:0031463; GO:0031397; GO:0005634; GO:0043161; GO:0016567 Cul3-RING ubiquitin ligase complex; negative regulation of protein ubiquitination; nucleus; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR000210; IPR011333; IPR013069; IPR002083; IPR008974; Protein modification; protein ubiquitination. Speckle-type POZ protein-like A (HIB homolog 2) spopla spopl zgc:101524 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q5BL35 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6211 sp Q5C9Z4 NOM1_HUMAN 69.23 416 128 0 1725 478 440 855 0 574 Q5C9Z4 NOM1_HUMAN GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR016024; IPR003891; IPR016021; IPR003890; Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) NOM1 C7orf3 Homo sapiens (Human) 860 Q5C9Z4 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0004675 GO:0004675 transmembrane receptor protein serine/threonine kinase activity signal transduction activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0004675 GO:0004675 transmembrane receptor protein serine/threonine kinase activity kinase activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005024 GO:0005024 transforming growth factor beta receptor activity signal transduction activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005024 GO:0005024 transforming growth factor beta receptor activity kinase activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0040008 GO:0040008 regulation of growth other biological processes P ConsensusfromContig202 sp Q5CD18 TGFR1_PIG 96.74 92 3 0 4 279 176 267 2E-59 195 Q5CD18 TGFR1_PIG GO:0005524; GO:0006915; GO:0030154; GO:0016021; GO:0046872; GO:0005886; GO:0040008; GO:0005923; GO:0005024; GO:0007178 ATP binding; apoptotic process; cell differentiation; integral to membrane; metal ion binding; plasma membrane; regulation of growth; tight junction; transforming growth factor beta-activated receptor activity; transmembrane receptor protein serine/threonine kinase signaling pathway reviewed IPR000472; IPR011009; IPR000719; IPR017441; IPR008271; IPR003605; TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I) TGFBR1 Sus scrofa (Pig) 503 Q5CD18 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 97.2 143 4 0 570 142 239 381 5E-106 297 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig429 sp Q5DU09 ZN652_MOUSE 100 47 0 0 142 2 382 428 5E-106 108 Q5DU09 ZN652_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 652 Znf652 Kiaa0924 Zfp652 Mus musculus (Mouse) 608 Q5DU09 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5651 sp Q5E9A0 OSER1_BOVIN 47.68 323 132 8 1573 620 1 291 2E-61 213 Q5E9A0 OSER1_BOVIN reviewed IPR008494; Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein) OSER1 Bos taurus (Bovine) 291 ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0001569 GO:0001569 patterning of blood vessels developmental processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0001841 GO:0001841 neural tube formation developmental processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0003157 ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0030216 GO:0030216 keratinocyte differentiation other biological processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0035329 ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0043539 GO:0043539 protein serine/threonine kinase activator activity enzyme regulator activity F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0046621 GO:0046621 negative regulation of organ growth other biological processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0046983 GO:0046983 protein dimerization activity other molecular function F ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0060215 GO:0060215 primitive hemopoiesis developmental processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0060706 GO:0060706 cell differentiation involved in embryonic placenta development developmental processes P ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0071902 ConsensusfromContig1007 sp Q5E9L6 STK4_BOVIN 94.31 123 7 0 370 2 50 172 7E-79 246 Q5E9L6 STK4_BOVIN GO:0005524; GO:0006915; GO:0060706; GO:0000902; GO:0007417; GO:0005737; GO:0003157; GO:0035329; GO:0007243; GO:0030216; GO:0000287; GO:0090090; GO:0008285; GO:0046621; GO:0001841; GO:0005634; GO:0001569; GO:0018105; GO:0043065; GO:0060215; GO:0046777; GO:0043539; GO:0004674 ATP binding; apoptotic process; cell differentiation involved in embryonic placenta development; cell morphogenesis; central nervous system development; cytoplasm; endocardium development; hippo signaling cascade; intracellular protein kinase cascade; keratinocyte differentiation; magnesium ion binding; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of cell proliferation; negative regulation of organ growth; neural tube formation; nucleus; patterning of blood vessels; peptidyl-serine phosphorylation; positive regulation of apoptotic process; primitive hemopoiesis; protein autophosphorylation; protein serine/threonine kinase activator activity; protein serine/threonine kinase activity reviewed IPR011009; IPR024205; IPR000719; IPR017441; IPR011524; IPR002290; Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)] STK4 MST1 Bos taurus (Bovine) 487 Q5E9L6 GO:0090090 ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0005666 GO:0005666 DNA-directed RNA polymerase III complex nucleus C ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0006383 GO:0006383 transcription from RNA polymerase III promoter RNA metabolism P ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0009615 GO:0009615 response to virus other biological processes P ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0032728 GO:0032728 positive regulation of interferon-beta production other biological processes P ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig5929 sp Q5E9Z7 RPC4_BOVIN 52 350 152 7 1060 38 54 396 4E-77 252 Q5E9Z7 RPC4_BOVIN GO:0003677; GO:0005666; GO:0003899; GO:0051607; GO:0045087; GO:0045089; GO:0032728; GO:0006383 DNA binding; DNA-directed RNA polymerase III complex; DNA-directed RNA polymerase activity; defense response to virus; innate immune response; positive regulation of innate immune response; positive regulation of interferon-beta production; transcription from RNA polymerase III promoter reviewed IPR007811; DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) POLR3D Bos taurus (Bovine) 398 Q5E9Z7 GO:0045089 GO:0045089 positive regulation of innate immune response stress response P ConsensusfromContig6307 sp Q5EAQ1 M4GDB_DANRE 69.43 157 48 0 1801 1331 8 164 2E-64 217 Q5EAQ1 M4GDB_DANRE GO:0003723; GO:0005737; GO:0005634; GO:0006417 RNA binding; cytoplasm; nucleus; regulation of translation reviewed IPR016024; IPR016021; IPR003890; MIF4G domain-containing protein B mif4gdb zgc:110826 Danio rerio (Zebrafish) (Brachydanio rerio) 222 Q5EAQ1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6307 sp Q5EAQ1 M4GDB_DANRE 69.43 157 48 0 1801 1331 8 164 2E-64 217 Q5EAQ1 M4GDB_DANRE GO:0003723; GO:0005737; GO:0005634; GO:0006417 RNA binding; cytoplasm; nucleus; regulation of translation reviewed IPR016024; IPR016021; IPR003890; MIF4G domain-containing protein B mif4gdb zgc:110826 Danio rerio (Zebrafish) (Brachydanio rerio) 222 Q5EAQ1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6307 sp Q5EAQ1 M4GDB_DANRE 69.43 157 48 0 1801 1331 8 164 2E-64 217 Q5EAQ1 M4GDB_DANRE GO:0003723; GO:0005737; GO:0005634; GO:0006417 RNA binding; cytoplasm; nucleus; regulation of translation reviewed IPR016024; IPR016021; IPR003890; MIF4G domain-containing protein B mif4gdb zgc:110826 Danio rerio (Zebrafish) (Brachydanio rerio) 222 Q5EAQ1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6307 sp Q5EAQ1 M4GDB_DANRE 69.43 157 48 0 1801 1331 8 164 2E-64 217 Q5EAQ1 M4GDB_DANRE GO:0003723; GO:0005737; GO:0005634; GO:0006417 RNA binding; cytoplasm; nucleus; regulation of translation reviewed IPR016024; IPR016021; IPR003890; MIF4G domain-containing protein B mif4gdb zgc:110826 Danio rerio (Zebrafish) (Brachydanio rerio) 222 Q5EAQ1 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig6307 sp Q5EAQ1 M4GDB_DANRE 69.43 157 48 0 1801 1331 8 164 2E-64 217 Q5EAQ1 M4GDB_DANRE GO:0003723; GO:0005737; GO:0005634; GO:0006417 RNA binding; cytoplasm; nucleus; regulation of translation reviewed IPR016024; IPR016021; IPR003890; MIF4G domain-containing protein B mif4gdb zgc:110826 Danio rerio (Zebrafish) (Brachydanio rerio) 222 Q5EAQ1 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0004679 GO:0004679 AMP-activated protein kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006694 GO:0006694 steroid biosynthetic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006695 GO:0006695 cholesterol biosynthetic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006914 GO:0006914 autophagy other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0010508 GO:0010508 positive regulation of autophagy other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0014823 GO:0014823 response to activity other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016126 GO:0016126 sterol biosynthetic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0019395 GO:0019395 fatty acid oxidation other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0031000 GO:0031000 response to caffeine other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0031588 GO:0031588 AMP-activated protein kinase complex other cellular component C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0031669 GO:0031669 cellular response to nutrient levels other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0032007 GO:0032007 negative regulation of TOR signaling pathway signal transduction P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0035174 GO:0035174 histone serine kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0035404 ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0042149 GO:0042149 cellular response to glucose starvation stress response P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0042593 GO:0042593 glucose homeostasis other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0042752 GO:0042752 regulation of circadian rhythm other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0045821 GO:0045821 positive regulation of glycolysis other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0048511 GO:0048511 rhythmic process other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0050321 GO:0050321 tau-protein kinase activity kinase activity F ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0050995 GO:0050995 negative regulation of lipid catabolic process other metabolic processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0051291 GO:0051291 protein heterooligomerization cell organization and biogenesis P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0055089 GO:0055089 fatty acid homeostasis other biological processes P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0060627 GO:0060627 regulation of vesicle-mediated transport transport P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0070301 GO:0070301 cellular response to hydrogen peroxide stress response P ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0071361 ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0071417 ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:0071456 ConsensusfromContig3761 sp Q5EG47 AAPK1_MOUSE 93.75 96 6 0 1 288 25 120 5E-57 190 Q5EG47 AAPK1_MOUSE GO:0004679; GO:0031588; GO:0005524; GO:0016055; GO:0050405; GO:0047322; GO:0016324; GO:0006914; GO:0071361; GO:0042149; GO:0070301; GO:0071456; GO:0071417; GO:0006695; GO:0003682; GO:0009631; GO:0005737; GO:0006633; GO:0055089; GO:0019395; GO:0042593; GO:0006006; GO:0035174; GO:0008610; GO:0046872; GO:0032007; GO:0043066; GO:2001274; GO:0050995; GO:0005634; GO:0010508; GO:0008284; GO:0045821; GO:0051291; GO:0042752; GO:2000505; GO:0006355; GO:0060627; GO:0014823; GO:0031000; GO:0048511; GO:0050321; GO:0006351 AMP-activated protein kinase activity; AMP-activated protein kinase complex; ATP binding; Wnt receptor signaling pathway; [acetyl-CoA carboxylase] kinase activity; [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; apical plasma membrane; autophagy; cellular response to ethanol; cellular response to glucose starvation; cellular response to hydrogen peroxide; cellular response to hypoxia; cellular response to organonitrogen compound; cholesterol biosynthetic process; chromatin binding; cold acclimation; cytoplasm; fatty acid biosynthetic process; fatty acid homeostasis; fatty acid oxidation; glucose homeostasis; glucose metabolic process; histone serine kinase activity; lipid biosynthetic process; metal ion binding; negative regulation of TOR signaling cascade; negative regulation of apoptotic process; negative regulation of glucose import in response to insulin stimulus; negative regulation of lipid catabolic process; nucleus; positive regulation of autophagy; positive regulation of cell proliferation; positive regulation of glycolysis; protein heterooligomerization; regulation of circadian rhythm; regulation of energy homeostasis; regulation of transcription, DNA-dependent; regulation of vesicle-mediated transport; response to activity; response to caffeine; rhythmic process; tau-protein kinase activity; transcription, DNA-dependent reviewed IPR028375; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; 5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26) Prkaa1 Mus musculus (Mouse) 559 Q5EG47 GO:2000505 ConsensusfromContig5677 sp Q5F362 CC50A_CHICK 79.35 339 66 4 2005 989 38 372 4E-179 525 Q5F362 CC50A_CHICK GO:0016021 integral to membrane reviewed IPR005045; Cell cycle control protein 50A (Transmembrane protein 30A) TMEM30A CDC50A RCJMB04_32j24 Gallus gallus (Chicken) 372 Q5F362 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5677 sp Q5F362 CC50A_CHICK 79.35 339 66 4 2005 989 38 372 4E-179 525 Q5F362 CC50A_CHICK GO:0016021 integral to membrane reviewed IPR005045; Cell cycle control protein 50A (Transmembrane protein 30A) TMEM30A CDC50A RCJMB04_32j24 Gallus gallus (Chicken) 372 Q5F362 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0004190 GO:0004190 aspartic-type endopeptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 89.93 149 15 0 471 25 307 455 3E-105 248 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0004190 GO:0004190 aspartic-type endopeptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 76.39 72 17 0 680 465 238 309 3E-105 120 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0004190 GO:0004190 aspartic-type endopeptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2363 sp Q5F383 SPP2B_CHICK 86.67 30 4 0 766 677 209 238 3E-105 57.4 Q5F383 SPP2B_CHICK GO:0030660; GO:0042500; GO:0010008; GO:0071458; GO:0071556; GO:0005765; GO:0006509; GO:0031293; GO:0005886; GO:0042803; GO:0050776 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; endosome membrane; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; lysosomal membrane; membrane protein ectodomain proteolysis; membrane protein intracellular domain proteolysis; plasma membrane; protein homodimerization activity; regulation of immune response reviewed IPR007369; IPR006639; IPR003137; Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) SPPL2B RCJMB04_29c5 Gallus gallus (Chicken) 596 Q5F383 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007064 GO:0007064 mitotic sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007064 GO:0007064 mitotic sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 66.33 300 55 5 1958 1140 1009 1289 2E-104 348 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007064 GO:0007064 mitotic sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007064 GO:0007064 mitotic sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6266 sp Q5F3U9 PDS5B_CHICK 88.46 26 3 0 2037 1960 983 1008 2E-104 54.7 Q5F3U9 PDS5B_CHICK GO:0051301; GO:0007064; GO:0008285; GO:0005634 cell division; mitotic sister chromatid cohesion; negative regulation of cell proliferation; nucleus reviewed IPR011989; IPR016024; Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) PDS5B APRIN RCJMB04_6g19 Gallus gallus (Chicken) 1412 Q5F3U9 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0004707 GO:0004707 MAP kinase activity signal transduction activity F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0004707 GO:0004707 MAP kinase activity kinase activity F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig868 sp Q5F3W3 MK06_CHICK 78.57 182 31 2 1 525 324 504 7E-87 276 Q5F3W3 MK06_CHICK GO:0005524; GO:0004707; GO:0000165; GO:0007049 ATP binding; MAP kinase activity; MAPK cascade; cell cycle reviewed IPR011009; IPR008350; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) MAPK6 RCJMB04_5i17 Gallus gallus (Chicken) 721 Q5F3W3 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5995 sp Q5F418 PSMD1_CHICK 93.12 509 35 0 1 1527 328 836 0 897 Q5F418 PSMD1_CHICK GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR016642; IPR011989; IPR016024; IPR002015; 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) PSMD1 RCJMB04_3m24 Gallus gallus (Chicken) 955 Q5F418 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig5995 sp Q5F418 PSMD1_CHICK 93.12 509 35 0 1 1527 328 836 0 897 Q5F418 PSMD1_CHICK GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR016642; IPR011989; IPR016024; IPR002015; 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) PSMD1 RCJMB04_3m24 Gallus gallus (Chicken) 955 Q5F418 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5995 sp Q5F418 PSMD1_CHICK 93.12 509 35 0 1 1527 328 836 0 897 Q5F418 PSMD1_CHICK GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR016642; IPR011989; IPR016024; IPR002015; 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) PSMD1 RCJMB04_3m24 Gallus gallus (Chicken) 955 Q5F418 GO:0030234 GO:0030234 enzyme regulator activity enzyme regulator activity F ConsensusfromContig5995 sp Q5F418 PSMD1_CHICK 93.12 509 35 0 1 1527 328 836 0 897 Q5F418 PSMD1_CHICK GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR016642; IPR011989; IPR016024; IPR002015; 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) PSMD1 RCJMB04_3m24 Gallus gallus (Chicken) 955 Q5F418 GO:0042176 GO:0042176 regulation of protein catabolic process protein metabolism P ConsensusfromContig5995 sp Q5F418 PSMD1_CHICK 93.12 509 35 0 1 1527 328 836 0 897 Q5F418 PSMD1_CHICK GO:0030234; GO:0022624; GO:0050790; GO:0042176 enzyme regulator activity; proteasome accessory complex; regulation of catalytic activity; regulation of protein catabolic process reviewed IPR016642; IPR011989; IPR016024; IPR002015; 26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) PSMD1 RCJMB04_3m24 Gallus gallus (Chicken) 955 Q5F418 GO:0050790 GO:0050790 regulation of catalytic activity other biological processes P ConsensusfromContig2299 sp Q5H9R7 PP6R3_HUMAN 70.69 116 34 0 349 2 421 536 2E-53 184 Q5H9R7 PP6R3_HUMAN GO:0005737; GO:0005634; GO:0043666 O15084; O00743 cytoplasm; nucleus; regulation of phosphoprotein phosphatase activity reviewed IPR016024; IPR007587; Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) 873 Q5H9R7 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2299 sp Q5H9R7 PP6R3_HUMAN 70.69 116 34 0 349 2 421 536 2E-53 184 Q5H9R7 PP6R3_HUMAN GO:0005737; GO:0005634; GO:0043666 O15084; O00743 cytoplasm; nucleus; regulation of phosphoprotein phosphatase activity reviewed IPR016024; IPR007587; Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) 873 Q5H9R7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2299 sp Q5H9R7 PP6R3_HUMAN 70.69 116 34 0 349 2 421 536 2E-53 184 Q5H9R7 PP6R3_HUMAN GO:0005737; GO:0005634; GO:0043666 O15084; O00743 cytoplasm; nucleus; regulation of phosphoprotein phosphatase activity reviewed IPR016024; IPR007587; Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) 873 Q5H9R7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2299 sp Q5H9R7 PP6R3_HUMAN 70.69 116 34 0 349 2 421 536 2E-53 184 Q5H9R7 PP6R3_HUMAN GO:0005737; GO:0005634; GO:0043666 O15084; O00743 cytoplasm; nucleus; regulation of phosphoprotein phosphatase activity reviewed IPR016024; IPR007587; Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) 873 Q5H9R7 GO:0019903 GO:0019903 protein phosphatase binding other molecular function F ConsensusfromContig2299 sp Q5H9R7 PP6R3_HUMAN 70.69 116 34 0 349 2 421 536 2E-53 184 Q5H9R7 PP6R3_HUMAN GO:0005737; GO:0005634; GO:0043666 O15084; O00743 cytoplasm; nucleus; regulation of phosphoprotein phosphatase activity reviewed IPR016024; IPR007587; Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL) PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 Homo sapiens (Human) 873 Q5H9R7 GO:0043666 GO:0043666 regulation of phosphoprotein phosphatase activity other metabolic processes P ConsensusfromContig5666 sp Q5I0D1 GLOD4_RAT 72.92 288 78 0 60 923 1 288 5E-159 456 Q5I0D1 GLOD4_RAT GO:0005739 mitochondrion reviewed IPR025870; Glyoxalase domain-containing protein 4 Glod4 Rattus norvegicus (Rat) 298 Q5I0D1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6015 sp Q5I0H4 TMCO1_RAT 96.28 188 7 0 188 751 1 188 2E-102 310 Q5I0H4 TMCO1_RAT GO:0000139; GO:0005789; GO:0016021 Golgi membrane; endoplasmic reticulum membrane; integral to membrane reviewed IPR002809; IPR008559; Transmembrane and coiled-coil domains protein 1 (Meg-2-like protein) Tmco1 Rattus norvegicus (Rat) 188 Q5I0H4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0006725 GO:0006725 cellular aromatic compound metabolic process other metabolic processes P ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0008815 GO:0008815 citrate (pro-3S)-lyase activity other molecular function F ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0009346 GO:0009346 citrate lyase complex other cellular component C ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0016830 GO:0016830 carbon-carbon lyase activity other molecular function F ConsensusfromContig1049 sp Q5I0K3 CLYBL_RAT 69.23 208 64 0 20 643 131 338 1E-103 311 Q5I0K3 CLYBL_RAT GO:0006725; GO:0008815; GO:0009346; GO:0046872; GO:0005739 cellular aromatic compound metabolic process; citrate (pro-3S)-lyase activity; citrate lyase complex; metal ion binding; mitochondrion reviewed IPR005000; IPR011206; IPR015813; Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (EC 4.1.-.-) Clybl Rattus norvegicus (Rat) 338 Q5I0K3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0004577 GO:0004577 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0016758 GO:0016758 "transferase activity, transferring hexosyl groups" other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig5913 sp Q5I0K7 ALG13_RAT 54.6 163 74 0 120 608 1 163 2E-60 197 Q5I0K7 ALG13_RAT GO:0004577; GO:0030246; GO:0005783; GO:0030259 N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity; carbohydrate binding; endoplasmic reticulum; lipid glycosylation reviewed IPR007235; UDP-N-acetylglucosamine transferase subunit ALG13 homolog (EC 2.4.1.141) (Glycosyltransferase 28 domain-containing protein 1) Alg13 Glt28d1 Rattus norvegicus (Rat) 165 Q5I0K7 GO:0030259 GO:0030259 lipid glycosylation other metabolic processes P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 90.54 74 7 0 144 365 2210 2283 4E-65 114 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 90.54 74 7 0 144 365 2210 2283 4E-65 114 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 79.63 54 11 0 1 162 2162 2215 4E-65 91.3 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 79.63 54 11 0 1 162 2162 2215 4E-65 91.3 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 97.06 34 1 0 358 459 2281 2314 4E-65 75.9 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 97.06 34 1 0 358 459 2281 2314 4E-65 75.9 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 90 10 1 0 473 502 2319 2328 4E-65 29.6 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2772 sp Q5JWR5 DOP1_HUMAN 90 10 1 0 473 502 2319 2328 4E-65 29.6 Q5JWR5 DOP1_HUMAN GO:0015031 protein transport reviewed IPR007249; Protein dopey-1 DOPEY1 KIAA1117 Homo sapiens (Human) 2465 Q5JWR5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6205 sp Q5M7P5 NOL6_XENTR 56.35 252 108 2 25 774 894 1145 9E-89 291 Q5M7P5 NOL6_XENTR GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR005554; Nucleolar protein 6 nol6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1145 Q5M7P5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6205 sp Q5M7P5 NOL6_XENTR 56.35 252 108 2 25 774 894 1145 9E-89 291 Q5M7P5 NOL6_XENTR GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR005554; Nucleolar protein 6 nol6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1145 Q5M7P5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6205 sp Q5M7P5 NOL6_XENTR 56.35 252 108 2 25 774 894 1145 9E-89 291 Q5M7P5 NOL6_XENTR GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR005554; Nucleolar protein 6 nol6 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 1145 Q5M7P5 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0000724 GO:0000724 double-strand break repair via homologous recombination stress response P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0000724 GO:0000724 double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0016575 GO:0016575 histone deacetylation protein metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0016575 GO:0016575 histone deacetylation cell organization and biogenesis P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0016580 GO:0016580 Sin3 complex nucleus C ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0035267 GO:0035267 NuA4 histone acetyltransferase complex nucleus C ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0040008 GO:0040008 regulation of growth other biological processes P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0043967 GO:0043967 histone H4 acetylation protein metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0043967 GO:0043967 histone H4 acetylation cell organization and biogenesis P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0043968 GO:0043968 histone H2A acetylation protein metabolism P ConsensusfromContig5951 sp Q5NVP9 MO4L1_PONAB 81.25 256 39 1 325 1092 77 323 6E-147 429 Q5NVP9 MO4L1_PONAB GO:0035267; GO:0016580; GO:0000724; GO:0043968; GO:0043967; GO:0016575; GO:0040008; GO:0006355; GO:0006351 NuA4 histone acetyltransferase complex; Sin3 complex; double-strand break repair via homologous recombination; histone H2A acetylation; histone H4 acetylation; histone deacetylation; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000953; IPR016197; IPR017398; IPR008676; IPR026541; IPR025995; Mortality factor 4-like protein 1 MORF4L1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 323 Q5NVP9 GO:0043968 GO:0043968 histone H2A acetylation cell organization and biogenesis P ConsensusfromContig6315 sp Q5PQR3 BTBD9_RAT 73.38 278 68 3 870 49 313 588 0 446 Q5PQR3 BTBD9_RAT GO:0008344; GO:0007155; GO:0042748; GO:0007616; GO:0060586; GO:1900242; GO:0050951; GO:0042428 adult locomotory behavior; cell adhesion; circadian sleep/wake cycle, non-REM sleep; long-term memory; multicellular organismal iron ion homeostasis; regulation of synaptic vesicle endocytosis; sensory perception of temperature stimulus; serotonin metabolic process reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR000421; IPR008979; BTB/POZ domain-containing protein 9 Btbd9 Rattus norvegicus (Rat) 612 Q5PQR3 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig6315 sp Q5PQR3 BTBD9_RAT 73.4 188 49 1 1435 872 126 312 0 255 Q5PQR3 BTBD9_RAT GO:0008344; GO:0007155; GO:0042748; GO:0007616; GO:0060586; GO:1900242; GO:0050951; GO:0042428 adult locomotory behavior; cell adhesion; circadian sleep/wake cycle, non-REM sleep; long-term memory; multicellular organismal iron ion homeostasis; regulation of synaptic vesicle endocytosis; sensory perception of temperature stimulus; serotonin metabolic process reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR000421; IPR008979; BTB/POZ domain-containing protein 9 Btbd9 Rattus norvegicus (Rat) 612 Q5PQR3 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig6315 sp Q5PQR3 BTBD9_RAT 72.13 122 34 0 1809 1444 1 122 0 192 Q5PQR3 BTBD9_RAT GO:0008344; GO:0007155; GO:0042748; GO:0007616; GO:0060586; GO:1900242; GO:0050951; GO:0042428 adult locomotory behavior; cell adhesion; circadian sleep/wake cycle, non-REM sleep; long-term memory; multicellular organismal iron ion homeostasis; regulation of synaptic vesicle endocytosis; sensory perception of temperature stimulus; serotonin metabolic process reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR000421; IPR008979; BTB/POZ domain-containing protein 9 Btbd9 Rattus norvegicus (Rat) 612 Q5PQR3 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0006829 GO:0006829 zinc ion transport transport P ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0008324 GO:0008324 cation transmembrane transporter activity transporter activity F ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2320 sp Q5PQZ3 ZNT9_DANRE 79.24 236 49 0 2 709 118 353 6E-123 369 Q5PQZ3 ZNT9_DANRE GO:0016021; GO:0000166; GO:0005634; GO:0006355; GO:0006351; GO:0005385 integral to membrane; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion transmembrane transporter activity reviewed IPR002524; IPR027469; IPR009061; IPR022656; Zinc transporter 9 (ZnT-9) (Solute carrier family 30 member 9) slc30a9 Danio rerio (Zebrafish) (Brachydanio rerio) 573 Q5PQZ3 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0004591 GO:0004591 oxoglutarate dehydrogenase (succinyl-transferring) activity other molecular function F ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0016624 GO:0016624 "oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor" other molecular function F ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0030976 GO:0030976 thiamin pyrophosphate binding other molecular function F ConsensusfromContig5731 sp Q5PRA2 DHTK1_DANRE 84.55 330 51 0 1727 738 591 920 0 602 Q5PRA2 DHTK1_DANRE GO:0006096; GO:0005739; GO:0004591; GO:0030976; GO:0006099 glycolysis; mitochondrion; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1) dhtkd1 zgc:101818 Danio rerio (Zebrafish) (Brachydanio rerio) 920 Q5PRA2 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5618 sp Q5PRD0 143BA_DANRE 92.21 244 19 0 1175 444 1 244 2E-163 467 Q5PRD0 143BA_DANRE GO:0005737; GO:0006911 cytoplasm; phagocytosis, engulfment reviewed IPR000308; IPR023409; IPR023410; 14-3-3 protein beta/alpha-A ywhaba ywhab1 wu:fb80c08 Danio rerio (Zebrafish) (Brachydanio rerio) 244 Q5PRD0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5618 sp Q5PRD0 143BA_DANRE 92.21 244 19 0 1175 444 1 244 2E-163 467 Q5PRD0 143BA_DANRE GO:0005737; GO:0006911 cytoplasm; phagocytosis, engulfment reviewed IPR000308; IPR023409; IPR023410; 14-3-3 protein beta/alpha-A ywhaba ywhab1 wu:fb80c08 Danio rerio (Zebrafish) (Brachydanio rerio) 244 Q5PRD0 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0000715 GO:0000715 "nucleotide-excision repair, DNA damage recognition" stress response P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0000715 GO:0000715 "nucleotide-excision repair, DNA damage recognition" DNA metabolism P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0000715 GO:0000715 "nucleotide-excision repair, DNA damage recognition" cell organization and biogenesis P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig846 sp Q5QJC4 DCR1A_CHICK 70.56 214 63 0 659 18 641 854 5E-104 328 Q5QJC4 DCR1A_CHICK GO:0016787; GO:0005654; GO:0000715 hydrolase activity; nucleoplasm; nucleotide-excision repair, DNA damage recognition reviewed IPR001279; IPR011084; DNA cross-link repair 1A protein (SNM1 homolog A) (chSNM1A) DCLRE1A SNM1A Gallus gallus (Chicken) 972 Q5QJC4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2058 sp Q5R212 PRS35_RAT 75.91 137 33 0 447 37 267 403 3E-75 236 Q5R212 PRS35_RAT GO:0003824; GO:0005576; GO:0008152 catalytic activity; extracellular region; metabolic process reviewed IPR001254; IPR018114; IPR009003; Inactive serine protease 35 Prss35 Rattus norvegicus (Rat) 406 Q5R212 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2058 sp Q5R212 PRS35_RAT 75.91 137 33 0 447 37 267 403 3E-75 236 Q5R212 PRS35_RAT GO:0003824; GO:0005576; GO:0008152 catalytic activity; extracellular region; metabolic process reviewed IPR001254; IPR018114; IPR009003; Inactive serine protease 35 Prss35 Rattus norvegicus (Rat) 406 Q5R212 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig2058 sp Q5R212 PRS35_RAT 75.91 137 33 0 447 37 267 403 3E-75 236 Q5R212 PRS35_RAT GO:0003824; GO:0005576; GO:0008152 catalytic activity; extracellular region; metabolic process reviewed IPR001254; IPR018114; IPR009003; Inactive serine protease 35 Prss35 Rattus norvegicus (Rat) 406 Q5R212 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2058 sp Q5R212 PRS35_RAT 75.91 137 33 0 447 37 267 403 3E-75 236 Q5R212 PRS35_RAT GO:0003824; GO:0005576; GO:0008152 catalytic activity; extracellular region; metabolic process reviewed IPR001254; IPR018114; IPR009003; Inactive serine protease 35 Prss35 Rattus norvegicus (Rat) 406 Q5R212 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2058 sp Q5R212 PRS35_RAT 75.91 137 33 0 447 37 267 403 3E-75 236 Q5R212 PRS35_RAT GO:0003824; GO:0005576; GO:0008152 catalytic activity; extracellular region; metabolic process reviewed IPR001254; IPR018114; IPR009003; Inactive serine protease 35 Prss35 Rattus norvegicus (Rat) 406 Q5R212 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5645 sp Q5R469 PUF60_PONAB 67.35 196 43 2 1154 570 383 558 1E-72 243 Q5R469 PUF60_PONAB GO:0003677; GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0000166; GO:0005634; GO:0006355; GO:0030529; GO:0006351 DNA binding; RNA binding; RNA splicing; apoptotic process; mRNA processing; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; ribonucleoprotein complex; transcription, DNA-dependent reviewed IPR012677; IPR006532; IPR000504; IPR003954; Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) PUF60 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 558 Q5R469 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0006891 GO:0006891 intra-Golgi vesicle-mediated transport transport P ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0030126 GO:0030126 COPI vesicle coat ER/Golgi C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0030126 GO:0030126 COPI vesicle coat other membranes C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0030663 GO:0030663 COPI coated vesicle membrane ER/Golgi C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0030663 GO:0030663 COPI coated vesicle membrane other membranes C ConsensusfromContig5960 sp Q5R5F2 COPZ1_PONAB 79.1 177 16 1 16 483 1 177 3E-95 283 Q5R5F2 COPZ1_PONAB GO:0030126; GO:0006891; GO:0006886 COPI vesicle coat; intra-Golgi vesicle-mediated transport; intracellular protein transport reviewed IPR022775; IPR000804; IPR011012; Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP) COPZ1 COPZ Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 177 Q5R5F2 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 57.94 252 81 5 1766 1065 1 245 3E-134 284 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6321 sp Q5R5H4 PARL_PONAB 80.31 127 25 0 1075 695 242 368 3E-134 217 Q5R5H4 PARL_PONAB GO:0016021; GO:0005743; GO:0005634; GO:0006508; GO:0004252 integral to membrane; mitochondrial inner membrane; nucleus; proteolysis; serine-type endopeptidase activity reviewed IPR002610; IPR022764; Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane-cleaving protease PARL) [Cleaved into: P-beta (Pbeta)] PARL PSARL Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 379 Q5R5H4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0004823 GO:0004823 leucine-tRNA ligase activity other molecular function F ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation protein metabolism P ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig3097 sp Q5R614 SYLC_PONAB 85.09 114 17 0 343 2 697 810 3E-63 213 Q5R614 SYLC_PONAB GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) LARS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1176 Q5R614 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0004467 GO:0004467 long-chain-fatty-acid-CoA ligase activity other molecular function F ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005778 GO:0005778 peroxisomal membrane other cytoplasmic organelle C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005778 GO:0005778 peroxisomal membrane other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4318 sp Q5R668 ACSL3_PONAB 69.42 121 37 0 3 365 131 251 9E-54 184 Q5R668 ACSL3_PONAB GO:0005524; GO:0005789; GO:0016021; GO:0001676; GO:0004467; GO:0005741; GO:0005778 ATP binding; endoplasmic reticulum membrane; integral to membrane; long-chain fatty acid metabolic process; long-chain fatty acid-CoA ligase activity; mitochondrial outer membrane; peroxisomal membrane reviewed IPR020845; IPR000873; Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3) ACSL3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 720 Q5R668 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5819 sp Q5R673 MINA_PONAB 60.26 458 164 3 150 1517 23 464 0 564 Q5R673 MINA_PONAB GO:0051213; GO:0046872; GO:0005730; GO:0006355; GO:0042254; GO:0006351 dioxygenase activity; metal ion binding; nucleolus; regulation of transcription, DNA-dependent; ribosome biogenesis; transcription, DNA-dependent reviewed IPR003347; IPR013109; Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA (EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) MINA Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 465 Q5R673 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5819 sp Q5R673 MINA_PONAB 60.26 458 164 3 150 1517 23 464 0 564 Q5R673 MINA_PONAB GO:0051213; GO:0046872; GO:0005730; GO:0006355; GO:0042254; GO:0006351 dioxygenase activity; metal ion binding; nucleolus; regulation of transcription, DNA-dependent; ribosome biogenesis; transcription, DNA-dependent reviewed IPR003347; IPR013109; Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA (EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) MINA Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 465 Q5R673 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5819 sp Q5R673 MINA_PONAB 60.26 458 164 3 150 1517 23 464 0 564 Q5R673 MINA_PONAB GO:0051213; GO:0046872; GO:0005730; GO:0006355; GO:0042254; GO:0006351 dioxygenase activity; metal ion binding; nucleolus; regulation of transcription, DNA-dependent; ribosome biogenesis; transcription, DNA-dependent reviewed IPR003347; IPR013109; Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA (EC 1.14.11.-) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) MINA Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 465 Q5R673 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig4023 sp Q5R6L5 CAND1_PONAB 94.67 150 8 0 2 451 1081 1230 5E-92 295 Q5R6L5 CAND1_PONAB GO:0010265; GO:0031461; GO:0005737; GO:0005634; GO:0016567 SCF complex assembly; cullin-RING ubiquitin ligase complex; cytoplasm; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR013932; Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1) CAND1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1230 Q5R6L5 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4023 sp Q5R6L5 CAND1_PONAB 94.67 150 8 0 2 451 1081 1230 5E-92 295 Q5R6L5 CAND1_PONAB GO:0010265; GO:0031461; GO:0005737; GO:0005634; GO:0016567 SCF complex assembly; cullin-RING ubiquitin ligase complex; cytoplasm; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR013932; Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1) CAND1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1230 Q5R6L5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4023 sp Q5R6L5 CAND1_PONAB 94.67 150 8 0 2 451 1081 1230 5E-92 295 Q5R6L5 CAND1_PONAB GO:0010265; GO:0031461; GO:0005737; GO:0005634; GO:0016567 SCF complex assembly; cullin-RING ubiquitin ligase complex; cytoplasm; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR013932; Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1) CAND1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1230 Q5R6L5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4023 sp Q5R6L5 CAND1_PONAB 94.67 150 8 0 2 451 1081 1230 5E-92 295 Q5R6L5 CAND1_PONAB GO:0010265; GO:0031461; GO:0005737; GO:0005634; GO:0016567 SCF complex assembly; cullin-RING ubiquitin ligase complex; cytoplasm; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR013932; Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (p120 CAND1) CAND1 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1230 Q5R6L5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5526 sp Q5R802 KANL2_PONAB 65.93 364 114 3 152 1213 13 376 7E-142 421 Q5R802 KANL2_PONAB GO:0043984; GO:0043981; GO:0043982; GO:0000123 histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex reviewed IPR026316; IPR025927; KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog) KANSL2 NSL2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 492 ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0004749 GO:0004749 ribose phosphate diphosphokinase activity other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0009116 GO:0009116 nucleoside metabolic process other metabolic processes P ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0009156 GO:0009156 ribonucleoside monophosphate biosynthetic process other metabolic processes P ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0009165 GO:0009165 nucleotide biosynthetic process other metabolic processes P ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0044249 GO:0044249 cellular biosynthetic process other metabolic processes P ConsensusfromContig6076 sp Q5R8F8 PRPS2_PONAB 95.91 318 13 0 1048 95 1 318 0 629 Q5R8F8 PRPS2_PONAB GO:0006015; GO:0005524; GO:0016301; GO:0000287; GO:0009165; GO:0042803; GO:0009156; GO:0004749 5-phosphoribose 1-diphosphate biosynthetic process; ATP binding; kinase activity; magnesium ion binding; nucleotide biosynthetic process; protein homodimerization activity; ribonucleoside monophosphate biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR000842; IPR005946; Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from D-ribose 5-phosphate (route I): step 1/1. Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase II) (PRS-II) PRPS2 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 318 Q5R8F8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig107 sp Q5R8W6 LC7L3_PONAB 86.67 135 17 1 406 2 1 134 7E-75 237 Q5R8W6 LC7L3_PONAB GO:0003677; GO:0008380; GO:0005685; GO:0003729; GO:0006376; GO:0016607; GO:0005634 DNA binding; RNA splicing; U1 snRNP; mRNA binding; mRNA splice site selection; nuclear speck; nucleus reviewed IPR004882; Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) LUC7L3 CROP Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 432 Q5R8W6 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig829 sp Q5R9I3 PI3R4_PONAB 84.71 157 20 1 473 3 1181 1333 4E-86 280 Q5R9I3 PI3R4_PONAB GO:0005524; GO:0005770; GO:0004674 ATP binding; late endosome; protein serine/threonine kinase activity reviewed IPR011989; IPR016024; IPR021133; IPR011009; IPR000719; IPR008271; IPR015943; IPR001680; IPR019775; IPR017986; Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) PIK3R4 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1358 Q5R9I3 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0005669 GO:0005669 transcription factor TFIID complex nucleus C ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5701 sp Q5R9W6 TAF13_PONAB 100 98 0 0 80 373 27 124 7E-64 202 Q5R9W6 TAF13_PONAB GO:0003677; GO:0005730; GO:0006355; GO:0005669; GO:0006366 DNA binding; nucleolus; regulation of transcription, DNA-dependent; transcription factor TFIID complex; transcription from RNA polymerase II promoter reviewed IPR009072; IPR003195; Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18) TAF13 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 124 Q5R9W6 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6039 sp Q5RC82 NMD3_PONAB 77.1 441 98 3 298 1617 65 503 0 721 Q5RC82 NMD3_PONAB GO:0005737; GO:0005730; GO:0005654; GO:0015031 cytoplasm; nucleolus; nucleoplasm; protein transport reviewed IPR007064; 60S ribosomal export protein NMD3 NMD3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 503 Q5RC82 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0004622 GO:0004622 lysophospholipase activity other molecular function F ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0016042 GO:0016042 lipid catabolic process other metabolic processes P ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2446 sp Q5RDS0 PLPL6_PONAB 88.36 146 17 0 2 439 564 709 3E-83 271 Q5RDS0 PLPL6_PONAB GO:0005789; GO:0016021; GO:0016042; GO:0004622; GO:0046470 endoplasmic reticulum membrane; integral to membrane; lipid catabolic process; lysophospholipase activity; phosphatidylcholine metabolic process reviewed IPR016035; IPR018490; IPR000595; IPR001423; IPR002641; IPR014710; Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6) PNPLA6 NTE Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 1365 Q5RDS0 GO:0046470 GO:0046470 phosphatidylcholine metabolic process other metabolic processes P ConsensusfromContig1602 sp Q5REG4 DTX3_PONAB 60.11 188 73 2 783 226 158 345 9E-70 229 Q5REG4 DTX3_PONAB GO:0007219; GO:0005737; GO:0016874; GO:0016567; GO:0008270 Notch signaling pathway; cytoplasm; ligase activity; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase DTX3 (EC 6.3.2.-) (Protein deltex-3) (Deltex3) DTX3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 347 Q5REG4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1602 sp Q5REG4 DTX3_PONAB 60.11 188 73 2 783 226 158 345 9E-70 229 Q5REG4 DTX3_PONAB GO:0007219; GO:0005737; GO:0016874; GO:0016567; GO:0008270 Notch signaling pathway; cytoplasm; ligase activity; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase DTX3 (EC 6.3.2.-) (Protein deltex-3) (Deltex3) DTX3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 347 Q5REG4 GO:0007219 GO:0007219 Notch signaling pathway signal transduction P ConsensusfromContig1602 sp Q5REG4 DTX3_PONAB 60.11 188 73 2 783 226 158 345 9E-70 229 Q5REG4 DTX3_PONAB GO:0007219; GO:0005737; GO:0016874; GO:0016567; GO:0008270 Notch signaling pathway; cytoplasm; ligase activity; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase DTX3 (EC 6.3.2.-) (Protein deltex-3) (Deltex3) DTX3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 347 Q5REG4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1602 sp Q5REG4 DTX3_PONAB 60.11 188 73 2 783 226 158 345 9E-70 229 Q5REG4 DTX3_PONAB GO:0007219; GO:0005737; GO:0016874; GO:0016567; GO:0008270 Notch signaling pathway; cytoplasm; ligase activity; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase DTX3 (EC 6.3.2.-) (Protein deltex-3) (Deltex3) DTX3 Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii) 347 Q5REG4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4355 sp Q5RFW2 TAB2_DANRE 78.44 167 30 3 2 502 449 609 3E-69 229 Q5RFW2 TAB2_DANRE GO:0060027; GO:0007507; GO:0008270 convergent extension involved in gastrulation; heart development; zinc ion binding reviewed IPR003892; IPR001876; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TGF-beta-activated kinase 1-binding protein 2) tab2 map3k7ip2 zgc:77446 Danio rerio (Zebrafish) (Brachydanio rerio) 711 Q5RFW2 GO:0060027 GO:0060027 convergent extension involved in gastrulation developmental processes P ConsensusfromContig6131 sp Q5RGE6 HSP7E_DANRE 84.35 492 77 0 1663 188 1 492 0 854 Q5RGE6 HSP7E_DANRE GO:0005524; GO:0005829 ATP binding; cytosol reviewed IPR013126; Heat shock 70 kDa protein 14 hspa14 si:dkey-153k10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 504 Q5RGE6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6131 sp Q5RGE6 HSP7E_DANRE 84.35 492 77 0 1663 188 1 492 0 854 Q5RGE6 HSP7E_DANRE GO:0005524; GO:0005829 ATP binding; cytosol reviewed IPR013126; Heat shock 70 kDa protein 14 hspa14 si:dkey-153k10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 504 Q5RGE6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6131 sp Q5RGE6 HSP7E_DANRE 84.35 492 77 0 1663 188 1 492 0 854 Q5RGE6 HSP7E_DANRE GO:0005524; GO:0005829 ATP binding; cytosol reviewed IPR013126; Heat shock 70 kDa protein 14 hspa14 si:dkey-153k10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 504 Q5RGE6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6131 sp Q5RGE6 HSP7E_DANRE 84.35 492 77 0 1663 188 1 492 0 854 Q5RGE6 HSP7E_DANRE GO:0005524; GO:0005829 ATP binding; cytosol reviewed IPR013126; Heat shock 70 kDa protein 14 hspa14 si:dkey-153k10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 504 Q5RGE6 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6131 sp Q5RGE6 HSP7E_DANRE 84.35 492 77 0 1663 188 1 492 0 854 Q5RGE6 HSP7E_DANRE GO:0005524; GO:0005829 ATP binding; cytosol reviewed IPR013126; Heat shock 70 kDa protein 14 hspa14 si:dkey-153k10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 504 Q5RGE6 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0030166 GO:0030166 proteoglycan biosynthetic process other metabolic processes P ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 96.09 128 5 0 1672 1289 138 265 1E-142 272 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0030166 GO:0030166 proteoglycan biosynthetic process other metabolic processes P ConsensusfromContig5665 sp Q5RH51 XYLK_DANRE 84.83 145 22 0 1292 858 265 409 1E-142 258 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0030166 GO:0030166 proteoglycan biosynthetic process other metabolic processes P ConsensusfromContig341 sp Q5RH51 XYLK_DANRE 92.73 110 8 0 332 3 26 135 2E-64 207 Q5RH51 XYLK_DANRE GO:0005524; GO:0000139; GO:0048701; GO:0016021; GO:0016301; GO:0030166 ATP binding; Golgi membrane; embryonic cranial skeleton morphogenesis; integral to membrane; kinase activity; proteoglycan biosynthetic process reviewed IPR009581; IPR024869; Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase) fam20b si:ch211-195o19.3 Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q5RH51 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0006513 GO:0006513 protein monoubiquitination protein metabolism P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0007095 GO:0007095 mitotic cell cycle G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0007095 GO:0007095 mitotic cell cycle G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0007095 GO:0007095 mitotic cell cycle G2/M transition DNA damage checkpoint stress response P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0019985 GO:0019985 bypass DNA synthesis stress response P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0019985 GO:0019985 bypass DNA synthesis DNA metabolism P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0031464 GO:0031464 Cul4A-RING ubiquitin ligase complex other cellular component C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0031465 GO:0031465 Cul4B-RING ubiquitin ligase complex other cellular component C ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint stress response P ConsensusfromContig5776 sp Q5RHI5 DTL_DANRE 66.73 505 159 5 2633 1119 3 498 0 659 Q5RHI5 DTL_DANRE GO:0031464; GO:0031465; GO:0006260; GO:0005813; GO:0005694; GO:0005737; GO:0007095; GO:0005634; GO:0006513; GO:0000209; GO:0009411; GO:0019985; GO:0006511 Cul4A-RING ubiquitin ligase complex; Cul4B-RING ubiquitin ligase complex; DNA replication; centrosome; chromosome; cytoplasm; mitotic G2 DNA damage checkpoint; nucleus; protein monoubiquitination; protein polyubiquitination; response to UV; translesion synthesis; ubiquitin-dependent protein catabolic process reviewed IPR020472; IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Denticleless protein homolog dtl cdt2 si:dkey-18c8.4 Danio rerio (Zebrafish) (Brachydanio rerio) 647 Q5RHI5 GO:0051726 GO:0051726 regulation of cell cycle cell cycle and proliferation P ConsensusfromContig6301 sp Q5RKN3 MED28_DANRE 85 180 26 1 4 543 1 179 5E-90 272 Q5RKN3 MED28_DANRE GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021640; Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28) med28 zgc:103633 Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q5RKN3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6301 sp Q5RKN3 MED28_DANRE 85 180 26 1 4 543 1 179 5E-90 272 Q5RKN3 MED28_DANRE GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021640; Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28) med28 zgc:103633 Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q5RKN3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6301 sp Q5RKN3 MED28_DANRE 85 180 26 1 4 543 1 179 5E-90 272 Q5RKN3 MED28_DANRE GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021640; Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28) med28 zgc:103633 Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q5RKN3 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6301 sp Q5RKN3 MED28_DANRE 85 180 26 1 4 543 1 179 5E-90 272 Q5RKN3 MED28_DANRE GO:0005634; GO:0006355; GO:0006351 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021640; Mediator of RNA polymerase II transcription subunit 28 (Mediator complex subunit 28) med28 zgc:103633 Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q5RKN3 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0004336 GO:0004336 galactosylceramidase activity other molecular function F ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0006683 GO:0006683 galactosylceramide catabolic process other metabolic processes P ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig3018 sp Q5SNX7 GALC_DANRE 77.52 129 29 0 414 28 201 329 2E-66 219 Q5SNX7 GALC_DANRE GO:0005975; GO:0004336; GO:0006683; GO:0005764 carbohydrate metabolic process; galactosylceramidase activity; galactosylceramide catabolic process; lysosome reviewed IPR001286; IPR013781; IPR017853; Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactosylceramidase) galc galca si:ch211-199l3.4 zgc:92561 Danio rerio (Zebrafish) (Brachydanio rerio) 660 Q5SNX7 GO:0043169 GO:0043169 cation binding other molecular function F ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig813 sp Q5SPJ8 XPOT_DANRE 85.33 150 22 0 4 453 639 788 4E-84 271 Q5SPJ8 XPOT_DANRE GO:0005737; GO:0005634; GO:0000049; GO:0006810 cytoplasm; nucleus; tRNA binding; transport reviewed IPR011989; IPR016024; IPR013598; Exportin-T (Exportin(tRNA)) (tRNA exportin) xpot si:ch211-286m4.4 Danio rerio (Zebrafish) (Brachydanio rerio) 961 Q5SPJ8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5881 sp Q5SSI6 UTP18_MOUSE 54.6 478 204 4 1423 5 77 546 4E-173 508 Q5SSI6 UTP18_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR015943; IPR001680; IPR017986; U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) Utp18 Wdr50 Mus musculus (Mouse) 552 Q5SSI6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5881 sp Q5SSI6 UTP18_MOUSE 54.6 478 204 4 1423 5 77 546 4E-173 508 Q5SSI6 UTP18_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR015943; IPR001680; IPR017986; U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) Utp18 Wdr50 Mus musculus (Mouse) 552 Q5SSI6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5881 sp Q5SSI6 UTP18_MOUSE 54.6 478 204 4 1423 5 77 546 4E-173 508 Q5SSI6 UTP18_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR015943; IPR001680; IPR017986; U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) Utp18 Wdr50 Mus musculus (Mouse) 552 Q5SSI6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5881 sp Q5SSI6 UTP18_MOUSE 54.6 478 204 4 1423 5 77 546 4E-173 508 Q5SSI6 UTP18_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR015943; IPR001680; IPR017986; U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) Utp18 Wdr50 Mus musculus (Mouse) 552 Q5SSI6 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5881 sp Q5SSI6 UTP18_MOUSE 54.6 478 204 4 1423 5 77 546 4E-173 508 Q5SSI6 UTP18_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR015943; IPR001680; IPR017986; U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50) Utp18 Wdr50 Mus musculus (Mouse) 552 Q5SSI6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0001816 GO:0001816 cytokine production other biological processes P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0010586 GO:0010586 miRNA metabolic process RNA metabolism P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0010587 GO:0010587 miRNA catabolic process RNA metabolism P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0019827 GO:0019827 stem cell maintenance other biological processes P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0031054 GO:0031054 pre-microRNA processing RNA metabolism P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0031123 GO:0031123 RNA 3'-end processing RNA metabolism P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0031664 GO:0031664 regulation of lipopolysaccharide-mediated signaling pathway signal transduction P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0032088 GO:0032088 negative regulation of NF-kappaB transcription factor activity RNA metabolism P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0032755 GO:0032755 positive regulation of interleukin-6 production other biological processes P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0050265 GO:0050265 RNA uridylyltransferase activity other molecular function F ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0070102 GO:0070102 interleukin-6-mediated signaling pathway signal transduction P ConsensusfromContig673 sp Q5TAX3 TUT4_HUMAN 93.04 115 8 0 1 345 1034 1148 2E-69 231 Q5TAX3 TUT4_HUMAN GO:0031123; GO:0050265; GO:0001816; GO:0005737; GO:0070102; GO:0010587; GO:0032088; GO:0003676; GO:0005730; GO:0032755; GO:0031054; GO:0031664; GO:0019827; GO:0008270 Q96CG3 RNA 3'-end processing; RNA uridylyltransferase activity; cytokine production; cytoplasm; interleukin-6-mediated signaling pathway; miRNA catabolic process; negative regulation of NF-kappaB transcription factor activity; nucleic acid binding; nucleolus; positive regulation of interleukin-6 production; pre-miRNA processing; regulation of lipopolysaccharide-mediated signaling pathway; stem cell maintenance; zinc ion binding reviewed IPR002934; IPR002058; IPR001878; Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11) ZCCHC11 KIAA0191 TUT4 Homo sapiens (Human) 1644 Q5TAX3 GO:0071044 ConsensusfromContig5907 sp Q5TYV0 EMC7_DANRE 82.64 144 25 0 1 432 58 201 2E-62 208 Q5TYV0 EMC7_DANRE GO:0072546; GO:0030246 ER membrane protein complex; carbohydrate binding reviewed IPR013784; IPR019008; ER membrane protein complex subunit 7 emc7 si:ch211-150c22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q5TYV0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5907 sp Q5TYV0 EMC7_DANRE 82.64 144 25 0 1 432 58 201 2E-62 208 Q5TYV0 EMC7_DANRE GO:0072546; GO:0030246 ER membrane protein complex; carbohydrate binding reviewed IPR013784; IPR019008; ER membrane protein complex subunit 7 emc7 si:ch211-150c22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q5TYV0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5907 sp Q5TYV0 EMC7_DANRE 82.64 144 25 0 1 432 58 201 2E-62 208 Q5TYV0 EMC7_DANRE GO:0072546; GO:0030246 ER membrane protein complex; carbohydrate binding reviewed IPR013784; IPR019008; ER membrane protein complex subunit 7 emc7 si:ch211-150c22.3 Danio rerio (Zebrafish) (Brachydanio rerio) 237 Q5TYV0 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6215 sp Q5TZ51 MPV17_DANRE 86.44 177 24 0 629 99 1 177 5E-102 300 Q5TZ51 MPV17_DANRE GO:0016021; GO:0005743 integral to membrane; mitochondrial inner membrane reviewed IPR007248; Protein Mpv17 mpv17 zgc:63573 Danio rerio (Zebrafish) (Brachydanio rerio) 177 Q5TZ51 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3802 sp Q5U374 KLH12_DANRE 89.32 103 11 0 309 1 195 297 1E-61 202 Q5U374 KLH12_DANRE GO:0048208; GO:0031463; GO:0030134; GO:0016055; GO:0009952; GO:0060028; GO:0006513 COPII vesicle coating; Cul3-RING ubiquitin ligase complex; ER to Golgi transport vesicle; Wnt receptor signaling pathway; anterior/posterior pattern specification; convergent extension involved in axis elongation; protein monoubiquitination reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 12 klhl12 si:dkeyp-53e12.5 zgc:92570 Danio rerio (Zebrafish) (Brachydanio rerio) 564 Q5U374 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig3802 sp Q5U374 KLH12_DANRE 89.32 103 11 0 309 1 195 297 1E-61 202 Q5U374 KLH12_DANRE GO:0048208; GO:0031463; GO:0030134; GO:0016055; GO:0009952; GO:0060028; GO:0006513 COPII vesicle coating; Cul3-RING ubiquitin ligase complex; ER to Golgi transport vesicle; Wnt receptor signaling pathway; anterior/posterior pattern specification; convergent extension involved in axis elongation; protein monoubiquitination reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 12 klhl12 si:dkeyp-53e12.5 zgc:92570 Danio rerio (Zebrafish) (Brachydanio rerio) 564 Q5U374 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig3802 sp Q5U374 KLH12_DANRE 89.32 103 11 0 309 1 195 297 1E-61 202 Q5U374 KLH12_DANRE GO:0048208; GO:0031463; GO:0030134; GO:0016055; GO:0009952; GO:0060028; GO:0006513 COPII vesicle coating; Cul3-RING ubiquitin ligase complex; ER to Golgi transport vesicle; Wnt receptor signaling pathway; anterior/posterior pattern specification; convergent extension involved in axis elongation; protein monoubiquitination reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 12 klhl12 si:dkeyp-53e12.5 zgc:92570 Danio rerio (Zebrafish) (Brachydanio rerio) 564 Q5U374 GO:0009952 GO:0009952 anterior/posterior pattern formation developmental processes P ConsensusfromContig3802 sp Q5U374 KLH12_DANRE 89.32 103 11 0 309 1 195 297 1E-61 202 Q5U374 KLH12_DANRE GO:0048208; GO:0031463; GO:0030134; GO:0016055; GO:0009952; GO:0060028; GO:0006513 COPII vesicle coating; Cul3-RING ubiquitin ligase complex; ER to Golgi transport vesicle; Wnt receptor signaling pathway; anterior/posterior pattern specification; convergent extension involved in axis elongation; protein monoubiquitination reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 12 klhl12 si:dkeyp-53e12.5 zgc:92570 Danio rerio (Zebrafish) (Brachydanio rerio) 564 Q5U374 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig3802 sp Q5U374 KLH12_DANRE 89.32 103 11 0 309 1 195 297 1E-61 202 Q5U374 KLH12_DANRE GO:0048208; GO:0031463; GO:0030134; GO:0016055; GO:0009952; GO:0060028; GO:0006513 COPII vesicle coating; Cul3-RING ubiquitin ligase complex; ER to Golgi transport vesicle; Wnt receptor signaling pathway; anterior/posterior pattern specification; convergent extension involved in axis elongation; protein monoubiquitination reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 12 klhl12 si:dkeyp-53e12.5 zgc:92570 Danio rerio (Zebrafish) (Brachydanio rerio) 564 Q5U374 GO:0060028 GO:0060028 convergent extension involved in axis elongation developmental processes P ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0004722 GO:0004722 protein serine/threonine phosphatase activity other molecular function F ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0006998 GO:0006998 nuclear envelope organization cell organization and biogenesis P ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0010867 GO:0010867 positive regulation of triglyceride biosynthetic process other metabolic processes P ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5771 sp Q5U395 CNEPA_DANRE 95.92 245 10 0 1146 412 1 245 3E-157 457 Q5U395 CNEPA_DANRE GO:0071595; GO:0005789; GO:0016021; GO:0006998; GO:0031965; GO:0010867; GO:0006470; GO:0004722 Nem1-Spo7 phosphatase complex; endoplasmic reticulum membrane; integral to membrane; nuclear envelope organization; nuclear membrane; positive regulation of triglyceride biosynthetic process; protein dephosphorylation; protein serine/threonine phosphatase activity reviewed IPR011948; IPR023214; IPR004274; CTD nuclear envelope phosphatase 1A (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard-A) ctdnep1a dullard Danio rerio (Zebrafish) (Brachydanio rerio) 245 Q5U395 GO:0071595 ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0005758 GO:0005758 mitochondrial intermembrane space mitochondrion C ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4678 sp Q5U3A7 OPA1_DANRE 89.87 158 16 0 101 574 745 902 2E-98 312 Q5U3A7 OPA1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0006915; GO:0009790; GO:0016021; GO:0008053; GO:0005743; GO:0005758; GO:0070584 GTP binding; GTP catabolic process; GTPase activity; apoptotic process; embryo development; integral to membrane; mitochondrial fusion; mitochondrial inner membrane; mitochondrial intermembrane space; mitochondrion morphogenesis reviewed IPR001401; IPR022812; IPR027740; IPR027417; Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1 homolog) [Cleaved into: Dynamin-like 120 kDa protein, form S1] opa1 zgc:92092 Danio rerio (Zebrafish) (Brachydanio rerio) 966 Q5U3A7 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5802 sp Q5U3P0 PCID2_DANRE 89.97 399 40 0 94 1290 1 399 0 742 Q5U3P0 PCID2_DANRE reviewed IPR013143; IPR000717; PCI domain-containing protein 2 (CSN12-like protein) pcid2 zgc:101845 Danio rerio (Zebrafish) (Brachydanio rerio) 399 Q5U3P0 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0008568 GO:0008568 microtubule-severing ATPase activity other molecular function F ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2547 sp Q5U3S1 KATL1_DANRE 67.86 168 53 1 565 65 3 170 2E-68 224 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0008568 GO:0008568 microtubule-severing ATPase activity other molecular function F ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2066 sp Q5U3S1 KATL1_DANRE 93.1 145 10 0 70 504 202 346 8E-93 285 Q5U3S1 KATL1_DANRE GO:0005524; GO:0005737; GO:0005874; GO:0008568 ATP binding; cytoplasm; microtubule; microtubule-severing ATPase activity reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1) katnal1 zgc:101696 Danio rerio (Zebrafish) (Brachydanio rerio) 488 Q5U3S1 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig2440 sp Q5U458 DJC11_MOUSE 71.76 170 48 0 1 510 308 477 3E-82 259 Q5U458 DJC11_MOUSE GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 Dnajc11 Mus musculus (Mouse) 559 Q5U458 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0022604 GO:0022604 regulation of cell morphogenesis cell organization and biogenesis P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0030177 GO:0030177 positive regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6294 sp Q5U595 ZRN1A_XENLA 94.18 395 23 0 1 1185 295 689 0 788 Q5U595 ZRN1A_XENLA GO:0016055; GO:0016477; GO:0005737; GO:0007010; GO:0005634; GO:0030177; GO:0035523; GO:1990168; GO:0070536; GO:0006508; GO:0022604; GO:0004221; GO:0004843; GO:0008270 Wnt receptor signaling pathway; cell migration; cytoplasm; cytoskeleton organization; nucleus; positive regulation of Wnt receptor signaling pathway; protein K29-linked deubiquitination; protein K33-linked deubiquitination; protein K63-linked deubiquitination; proteolysis; regulation of cell morphogenesis; ubiquitin thiolesterase activity; ubiquitin-specific protease activity; zinc ion binding reviewed IPR003323; IPR001876; Ubiquitin thioesterase zranb1-A (EC 3.4.19.12) (Zinc finger Ran-binding domain-containing protein 1A) zranb1-a Xenopus laevis (African clawed frog) 701 Q5U595 GO:0070536 GO:0070536 protein K63-linked deubiquitination protein metabolism P ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5713 sp Q5UIP0 RIF1_HUMAN 49.84 313 135 7 230 1135 2158 2459 2E-74 261 Q5UIP0 RIF1_HUMAN GO:0007049; GO:0000781; GO:0005737; GO:0001939; GO:0001940; GO:0006974; GO:0005819; GO:0019827; GO:0000723 cell cycle; chromosome, telomeric region; cytoplasm; female pronucleus; male pronucleus; response to DNA damage stimulus; spindle; stem cell maintenance; telomere maintenance reviewed IPR011989; IPR016024; IPR022031; Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) RIF1 Homo sapiens (Human) 2472 Q5UIP0 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0043412 GO:0043412 biopolymer modification other metabolic processes P ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig1932 sp Q5VV42 CDKAL_HUMAN 86.6 97 13 0 291 1 346 442 3E-54 182 Q5VV42 CDKAL_HUMAN GO:0051539; GO:0009451; GO:0005789; GO:0016021; GO:0046872; GO:0008033; GO:0016740 4 iron, 4 sulfur cluster binding; RNA modification; endoplasmic reticulum membrane; integral to membrane; metal ion binding; tRNA processing; transferase activity reviewed IPR006638; IPR023970; IPR005839; IPR020612; IPR013848; IPR006466; IPR007197; IPR023404; IPR002792; Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.-.-.-) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase) CDKAL1 Homo sapiens (Human) 579 Q5VV42 GO:0051539 GO:0051539 "4 iron, 4 sulfur cluster binding" other molecular function F ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig5832 sp Q5XGG2 TRUB2_XENTR 53.59 306 139 2 1299 385 8 311 1E-107 330 Q5XGG2 TRUB2_XENTR GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-) trub2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 325 Q5XGG2 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5804 sp Q5XGY1 TSR1_XENLA 70.98 348 101 0 1135 92 468 815 1E-178 526 Q5XGY1 TSR1_XENLA GO:0005730; GO:0042255 nucleolus; ribosome assembly reviewed IPR012948; IPR007034; Pre-rRNA-processing protein TSR1 homolog tsr1 Xenopus laevis (African clawed frog) 815 Q5XGY1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5804 sp Q5XGY1 TSR1_XENLA 70.98 348 101 0 1135 92 468 815 1E-178 526 Q5XGY1 TSR1_XENLA GO:0005730; GO:0042255 nucleolus; ribosome assembly reviewed IPR012948; IPR007034; Pre-rRNA-processing protein TSR1 homolog tsr1 Xenopus laevis (African clawed frog) 815 Q5XGY1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5804 sp Q5XGY1 TSR1_XENLA 70.98 348 101 0 1135 92 468 815 1E-178 526 Q5XGY1 TSR1_XENLA GO:0005730; GO:0042255 nucleolus; ribosome assembly reviewed IPR012948; IPR007034; Pre-rRNA-processing protein TSR1 homolog tsr1 Xenopus laevis (African clawed frog) 815 Q5XGY1 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5804 sp Q5XGY1 TSR1_XENLA 70.98 348 101 0 1135 92 468 815 1E-178 526 Q5XGY1 TSR1_XENLA GO:0005730; GO:0042255 nucleolus; ribosome assembly reviewed IPR012948; IPR007034; Pre-rRNA-processing protein TSR1 homolog tsr1 Xenopus laevis (African clawed frog) 815 Q5XGY1 GO:0042255 GO:0042255 ribosome assembly cell organization and biogenesis P ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0005671 GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex nucleus C ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0017025 GO:0017025 TATA-binding protein binding other molecular function F ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0043966 GO:0043966 histone H3 acetylation protein metabolism P ConsensusfromContig5824 sp Q5XI68 NC2B_RAT 97.37 114 3 0 1811 1470 1 114 8E-68 228 Q5XI68 NC2B_RAT GO:0005634; GO:0006355; GO:0043565; GO:0006351 nucleus; regulation of transcription, DNA-dependent; sequence-specific DNA binding; transcription, DNA-dependent reviewed IPR003958; IPR009072; IPR003957; Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein) Dr1 Rattus norvegicus (Rat) 176 Q5XI68 GO:0043966 GO:0043966 histone H3 acetylation cell organization and biogenesis P ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 75.29 344 79 3 1052 36 464 806 8E-127 408 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 75.29 344 79 3 1052 36 464 806 8E-127 408 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 75.29 344 79 3 1052 36 464 806 8E-127 408 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 75.29 344 79 3 1052 36 464 806 8E-127 408 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 65.6 282 97 0 2104 1259 118 399 4E-106 353 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 65.6 282 97 0 2104 1259 118 399 4E-106 353 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 65.6 282 97 0 2104 1259 118 399 4E-106 353 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6241 sp Q5XIW8 SNUT1_RAT 65.6 282 97 0 2104 1259 118 399 4E-106 353 Q5XIW8 SNUT1_RAT GO:0015030; GO:0005794; GO:0008380; GO:0071013; GO:0006397; GO:0045585 Cajal body; Golgi apparatus; RNA splicing; catalytic step 2 spliceosome; mRNA processing; positive regulation of cytotoxic T cell differentiation reviewed IPR005011; U4/U6.U5 tri-snRNP-associated protein 1 (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (rSART-1) Sart1 Rattus norvegicus (Rat) 806 Q5XIW8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5939 sp Q5XJS5 THOC6_DANRE 77.82 248 55 0 3 746 76 323 3E-148 426 Q5XJS5 THOC6_DANRE GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0051028; GO:0007275; GO:0005634 RNA binding; RNA splicing; apoptotic process; mRNA processing; mRNA transport; multicellular organismal development; nucleus reviewed IPR015943; IPR001680; IPR019775; IPR017986; THO complex subunit 6 homolog (WD repeat-containing protein 58) thoc6 wdr58 zgc:101618 Danio rerio (Zebrafish) (Brachydanio rerio) 323 Q5XJS5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5939 sp Q5XJS5 THOC6_DANRE 77.82 248 55 0 3 746 76 323 3E-148 426 Q5XJS5 THOC6_DANRE GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0051028; GO:0007275; GO:0005634 RNA binding; RNA splicing; apoptotic process; mRNA processing; mRNA transport; multicellular organismal development; nucleus reviewed IPR015943; IPR001680; IPR019775; IPR017986; THO complex subunit 6 homolog (WD repeat-containing protein 58) thoc6 wdr58 zgc:101618 Danio rerio (Zebrafish) (Brachydanio rerio) 323 Q5XJS5 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5939 sp Q5XJS5 THOC6_DANRE 77.82 248 55 0 3 746 76 323 3E-148 426 Q5XJS5 THOC6_DANRE GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0051028; GO:0007275; GO:0005634 RNA binding; RNA splicing; apoptotic process; mRNA processing; mRNA transport; multicellular organismal development; nucleus reviewed IPR015943; IPR001680; IPR019775; IPR017986; THO complex subunit 6 homolog (WD repeat-containing protein 58) thoc6 wdr58 zgc:101618 Danio rerio (Zebrafish) (Brachydanio rerio) 323 Q5XJS5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5939 sp Q5XJS5 THOC6_DANRE 77.82 248 55 0 3 746 76 323 3E-148 426 Q5XJS5 THOC6_DANRE GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0051028; GO:0007275; GO:0005634 RNA binding; RNA splicing; apoptotic process; mRNA processing; mRNA transport; multicellular organismal development; nucleus reviewed IPR015943; IPR001680; IPR019775; IPR017986; THO complex subunit 6 homolog (WD repeat-containing protein 58) thoc6 wdr58 zgc:101618 Danio rerio (Zebrafish) (Brachydanio rerio) 323 Q5XJS5 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5939 sp Q5XJS5 THOC6_DANRE 77.82 248 55 0 3 746 76 323 3E-148 426 Q5XJS5 THOC6_DANRE GO:0003723; GO:0008380; GO:0006915; GO:0006397; GO:0051028; GO:0007275; GO:0005634 RNA binding; RNA splicing; apoptotic process; mRNA processing; mRNA transport; multicellular organismal development; nucleus reviewed IPR015943; IPR001680; IPR019775; IPR017986; THO complex subunit 6 homolog (WD repeat-containing protein 58) thoc6 wdr58 zgc:101618 Danio rerio (Zebrafish) (Brachydanio rerio) 323 Q5XJS5 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig351 sp Q5XK67 RPAC2_XENLA 72.9 107 29 0 1 321 8 114 8E-55 175 Q5XK67 RPAC2_XENLA GO:0003677; GO:0003899; GO:0005634; GO:0006351 DNA binding; DNA-directed RNA polymerase activity; nucleus; transcription, DNA-dependent reviewed IPR009025; IPR008193; DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) polr1d Xenopus laevis (African clawed frog) 114 Q5XK67 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig351 sp Q5XK67 RPAC2_XENLA 72.9 107 29 0 1 321 8 114 8E-55 175 Q5XK67 RPAC2_XENLA GO:0003677; GO:0003899; GO:0005634; GO:0006351 DNA binding; DNA-directed RNA polymerase activity; nucleus; transcription, DNA-dependent reviewed IPR009025; IPR008193; DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) polr1d Xenopus laevis (African clawed frog) 114 Q5XK67 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig351 sp Q5XK67 RPAC2_XENLA 72.9 107 29 0 1 321 8 114 8E-55 175 Q5XK67 RPAC2_XENLA GO:0003677; GO:0003899; GO:0005634; GO:0006351 DNA binding; DNA-directed RNA polymerase activity; nucleus; transcription, DNA-dependent reviewed IPR009025; IPR008193; DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) polr1d Xenopus laevis (African clawed frog) 114 Q5XK67 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig351 sp Q5XK67 RPAC2_XENLA 72.9 107 29 0 1 321 8 114 8E-55 175 Q5XK67 RPAC2_XENLA GO:0003677; GO:0003899; GO:0005634; GO:0006351 DNA binding; DNA-directed RNA polymerase activity; nucleus; transcription, DNA-dependent reviewed IPR009025; IPR008193; DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) polr1d Xenopus laevis (African clawed frog) 114 Q5XK67 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5857 sp Q5ZHP7 EAF2_CHICK 80.19 106 21 0 89 406 1 106 6E-56 186 Q5ZHP7 EAF2_CHICK GO:0032783; GO:0005654; GO:0045893; GO:0006351 ELL-EAF complex; nucleoplasm; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027093; IPR019194; ELL-associated factor 2 EAF2 RCJMB04_34m12 Gallus gallus (Chicken) 264 Q5ZHP7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5857 sp Q5ZHP7 EAF2_CHICK 80.19 106 21 0 89 406 1 106 6E-56 186 Q5ZHP7 EAF2_CHICK GO:0032783; GO:0005654; GO:0045893; GO:0006351 ELL-EAF complex; nucleoplasm; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027093; IPR019194; ELL-associated factor 2 EAF2 RCJMB04_34m12 Gallus gallus (Chicken) 264 Q5ZHP7 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5857 sp Q5ZHP7 EAF2_CHICK 80.19 106 21 0 89 406 1 106 6E-56 186 Q5ZHP7 EAF2_CHICK GO:0032783; GO:0005654; GO:0045893; GO:0006351 ELL-EAF complex; nucleoplasm; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027093; IPR019194; ELL-associated factor 2 EAF2 RCJMB04_34m12 Gallus gallus (Chicken) 264 Q5ZHP7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5857 sp Q5ZHP7 EAF2_CHICK 80.19 106 21 0 89 406 1 106 6E-56 186 Q5ZHP7 EAF2_CHICK GO:0032783; GO:0005654; GO:0045893; GO:0006351 ELL-EAF complex; nucleoplasm; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027093; IPR019194; ELL-associated factor 2 EAF2 RCJMB04_34m12 Gallus gallus (Chicken) 264 Q5ZHP7 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5857 sp Q5ZHP7 EAF2_CHICK 80.19 106 21 0 89 406 1 106 6E-56 186 Q5ZHP7 EAF2_CHICK GO:0032783; GO:0005654; GO:0045893; GO:0006351 ELL-EAF complex; nucleoplasm; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR027093; IPR019194; ELL-associated factor 2 EAF2 RCJMB04_34m12 Gallus gallus (Chicken) 264 Q5ZHP7 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5858 sp Q5ZHV1 RB33B_CHICK 57.21 222 85 3 49 699 5 221 4E-82 259 Q5ZHV1 RB33B_CHICK GO:0005525; GO:0005796; GO:0000139; GO:0006914; GO:0015031; GO:2000785; GO:2000156; GO:0007264 GTP binding; Golgi lumen; Golgi membrane; autophagy; protein transport; regulation of autophagic vacuole assembly; regulation of retrograde vesicle-mediated transport, Golgi to ER; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-33B RAB33B RCJMB04_32p6 Gallus gallus (Chicken) 228 Q5ZHV1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5661 sp Q5ZI69 RM37_CHICK 54.12 340 151 1 1046 42 90 429 7E-139 413 Q5ZI69 RM37_CHICK GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR010793; 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) MRPL37 RCJMB04_29m8 Gallus gallus (Chicken) 429 Q5ZI69 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig5661 sp Q5ZI69 RM37_CHICK 54.12 340 151 1 1046 42 90 429 7E-139 413 Q5ZI69 RM37_CHICK GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR010793; 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) MRPL37 RCJMB04_29m8 Gallus gallus (Chicken) 429 Q5ZI69 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5661 sp Q5ZI69 RM37_CHICK 54.12 340 151 1 1046 42 90 429 7E-139 413 Q5ZI69 RM37_CHICK GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR010793; 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) MRPL37 RCJMB04_29m8 Gallus gallus (Chicken) 429 Q5ZI69 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5661 sp Q5ZI69 RM37_CHICK 54.12 340 151 1 1046 42 90 429 7E-139 413 Q5ZI69 RM37_CHICK GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR010793; 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) MRPL37 RCJMB04_29m8 Gallus gallus (Chicken) 429 Q5ZI69 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5661 sp Q5ZI69 RM37_CHICK 54.12 340 151 1 1046 42 90 429 7E-139 413 Q5ZI69 RM37_CHICK GO:0005739; GO:0005840; GO:0003735; GO:0006412 mitochondrion; ribosome; structural constituent of ribosome; translation reviewed IPR010793; 39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) MRPL37 RCJMB04_29m8 Gallus gallus (Chicken) 429 Q5ZI69 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0000738 GO:0000738 "DNA catabolic process, exonucleolytic" DNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0004534 GO:0004534 5'-3' exoribonuclease activity other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006353 GO:0006353 transcription termination RNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006353 GO:0006353 transcription termination cell organization and biogenesis P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0008409 GO:0008409 5'-3' exonuclease activity other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0016049 GO:0016049 cell growth other biological processes P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6213 sp Q5ZIP4 XRN2_CHICK 71.47 617 155 6 14 1846 223 824 0 868 Q5ZIP4 XRN2_CHICK GO:0008409; GO:0004534; GO:0000738; GO:0006353; GO:0016049; GO:0006397; GO:0003676; GO:0005730; GO:0006355; GO:0007283; GO:0008270 5'-3' exonuclease activity; 5'-3' exoribonuclease activity; DNA catabolic process, exonucleolytic; DNA-dependent transcription, termination; cell growth; mRNA processing; nucleic acid binding; nucleolus; regulation of transcription, DNA-dependent; spermatogenesis; zinc ion binding reviewed IPR027073; IPR017151; IPR004859; IPR001878; 5'-3' exoribonuclease 2 (EC 3.1.13.-) XRN2 RCJMB04_24h23 Gallus gallus (Chicken) 949 Q5ZIP4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig4475 sp Q5ZIQ3 HNRPK_CHICK 92.52 107 8 0 321 1 107 213 5E-56 186 Q5ZIQ3 HNRPK_CHICK GO:0003677; GO:0003723; GO:0008380; GO:0005737; GO:0006397; GO:0005654; GO:0006355; GO:0005681; GO:0006351 DNA binding; RNA binding; RNA splicing; cytoplasm; mRNA processing; nucleoplasm; regulation of transcription, DNA-dependent; spliceosomal complex; transcription, DNA-dependent reviewed IPR004087; IPR004088; IPR012987; Heterogeneous nuclear ribonucleoprotein K (hnRNP K) HNRNPK HNRPK RCJMB04_24e23 Gallus gallus (Chicken) 427 Q5ZIQ3 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6122 sp Q5ZIT5 RAB10_CHICK 98.5 200 3 0 764 165 1 200 3E-141 409 Q5ZIT5 RAB10_CHICK GO:0019003; GO:0005525; GO:0005794; GO:0043001; GO:0007409; GO:0061467; GO:0032869; GO:0005789; GO:0071782; GO:0071786; GO:0016197; GO:0045200; GO:0097051; GO:0032593; GO:0030670; GO:0030859; GO:0072372; GO:0055037; GO:0055038; GO:0007264; GO:0005802 GDP binding; GTP binding; Golgi apparatus; Golgi to plasma membrane protein transport; axonogenesis; basolateral protein localization; cellular response to insulin stimulus; endoplasmic reticulum membrane; endoplasmic reticulum tubular network; endoplasmic reticulum tubular network organization; endosomal transport; establishment of neuroblast polarity; establishment of protein localization to endoplasmic reticulum membrane; insulin-responsive compartment; phagocytic vesicle membrane; polarized epithelial cell differentiation; primary cilium; recycling endosome; recycling endosome membrane; small GTPase mediated signal transduction; trans-Golgi network reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-10 RAB10 RCJMB04_23k10 Gallus gallus (Chicken) 200 Q5ZIT5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0004712 GO:0004712 protein serine/threonine/tyrosine kinase activity kinase activity F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0007224 GO:0007224 smoothened signaling pathway signal transduction P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" signal transduction P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" stress response P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" death P ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig6317 sp Q5ZIU3 DYRK2_CHICK 73.49 249 60 5 2 742 282 526 7E-127 380 Q5ZIU3 DYRK2_CHICK GO:0005524; GO:0005737; GO:0042771; GO:0000287; GO:0030145; GO:0051534; GO:0005634; GO:0045725; GO:0004674; GO:0004712; GO:0004713; GO:0030529; GO:0007224; GO:0000151 ATP binding; cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; magnesium ion binding; manganese ion binding; negative regulation of NFAT protein import into nucleus; nucleus; positive regulation of glycogen biosynthetic process; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; ribonucleoprotein complex; smoothened signaling pathway; ubiquitin ligase complex reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1) DYRK2 RCJMB04_23i19 Gallus gallus (Chicken) 526 Q5ZIU3 GO:0045725 GO:0045725 positive regulation of glycogen biosynthetic process other metabolic processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0001833 GO:0001833 inner cell mass cell proliferation cell cycle and proliferation P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0001833 GO:0001833 inner cell mass cell proliferation developmental processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0019843 GO:0019843 rRNA binding nucleic acid binding activity F ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0030282 GO:0030282 bone mineralization developmental processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0030595 GO:0030595 leukocyte chemotaxis other biological processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0042256 GO:0042256 mature ribosome assembly cell organization and biogenesis P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0042273 GO:0042273 ribosomal large subunit biogenesis other biological processes P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0043022 GO:0043022 ribosome binding translation activity F ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0043148 GO:0043148 mitotic spindle stabilization cell cycle and proliferation P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0043148 GO:0043148 mitotic spindle stabilization protein metabolism P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0043148 GO:0043148 mitotic spindle stabilization cell organization and biogenesis P ConsensusfromContig5895 sp Q5ZIY4 SBDS_CHICK 86.4 250 34 0 1309 560 1 250 3E-143 417 Q5ZIY4 SBDS_CHICK GO:0003723; GO:0008283; GO:0005737; GO:0042256; GO:0005730; GO:0005654; GO:0005634; GO:0006364; GO:0042273; GO:0043022; GO:0000922 RNA binding; cell proliferation; cytoplasm; mature ribosome assembly; nucleolus; nucleoplasm; nucleus; rRNA processing; ribosomal large subunit biogenesis; ribosome binding; spindle pole reviewed IPR018978; IPR018023; IPR019783; IPR002140; Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein homolog) SBDS RCJMB04_22m12 Gallus gallus (Chicken) 250 Q5ZIY4 GO:0048539 GO:0048539 bone marrow development developmental processes P ConsensusfromContig4177 sp Q5ZIZ2 SMYD5_CHICK 69.64 112 34 0 2 337 42 153 9E-51 172 Q5ZIZ2 SMYD5_CHICK GO:0046872; GO:0008168 metal ion binding; methyltransferase activity reviewed IPR001214; IPR002893; SET and MYND domain-containing protein 5 (EC 2.1.1.-) SMYD5 RCJMB04_22j23 Gallus gallus (Chicken) 420 Q5ZIZ2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4177 sp Q5ZIZ2 SMYD5_CHICK 69.64 112 34 0 2 337 42 153 9E-51 172 Q5ZIZ2 SMYD5_CHICK GO:0046872; GO:0008168 metal ion binding; methyltransferase activity reviewed IPR001214; IPR002893; SET and MYND domain-containing protein 5 (EC 2.1.1.-) SMYD5 RCJMB04_22j23 Gallus gallus (Chicken) 420 Q5ZIZ2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0051020 GO:0051020 GTPase binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0051865 GO:0051865 protein autoubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0070585 GO:0070585 protein localization in mitochondrion other biological processes P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090140 ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090141 ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 90.07 151 14 1 876 424 129 278 3E-86 274 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090344 ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0051020 GO:0051020 GTPase binding other molecular function F ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0051865 GO:0051865 protein autoubiquitination protein metabolism P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0070585 GO:0070585 protein localization in mitochondrion other biological processes P ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090140 ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090141 ConsensusfromContig5924 sp Q5ZJ41 MARH5_CHICK 80.12 161 31 1 1261 779 1 160 5E-81 261 Q5ZJ41 MARH5_CHICK GO:0005783; GO:0005789; GO:0016021; GO:0005741; GO:0090344; GO:0090141; GO:0051865; GO:0070585; GO:0000209; GO:0090140; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; mitochondrial outer membrane; negative regulation of cell aging; positive regulation of mitochondrial fission; protein autoubiquitination; protein localization to mitochondrion; protein polyubiquitination; regulation of mitochondrial fission; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR011016; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase MARCH5 (EC 6.3.2.-) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) MARCH5 RCJMB04_20o22 Gallus gallus (Chicken) 281 Q5ZJ41 GO:0090344 ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0042273 GO:0042273 ribosomal large subunit biogenesis other biological processes P ConsensusfromContig5534 sp Q5ZJ56 RL7_CHICK 78.86 246 52 0 29 766 1 246 3E-130 376 Q5ZJ56 RL7_CHICK GO:0003723; GO:0005840 RNA binding; ribosome reviewed IPR018038; IPR016082; IPR012988; IPR005998; 60S ribosomal protein L7 RPL7 RCJMB04_20k1 Gallus gallus (Chicken) 246 Q5ZJ56 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0007004 GO:0007004 telomere maintenance via telomerase DNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0007004 GO:0007004 telomere maintenance via telomerase cell organization and biogenesis P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5715 sp Q5ZJH9 DKC1_CHICK 87.43 382 47 1 93 1235 22 403 0 690 Q5ZJH9 DKC1_CHICK GO:0003723; GO:0005730; GO:0005654; GO:0009982; GO:0001522; GO:0006364; GO:0030529; GO:0007004 RNA binding; nucleolus; nucleoplasm; pseudouridine synthase activity; pseudouridine synthesis; rRNA processing; ribonucleoprotein complex; telomere maintenance via telomerase reviewed IPR012960; IPR002501; IPR020103; IPR002478; IPR015947; IPR004802; IPR004521; H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (Dyskerin) DKC1 RCJMB04_17p9 Gallus gallus (Chicken) 516 Q5ZJH9 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig3452 sp Q5ZJQ8 UBAC2_CHICK 69.49 118 36 0 3 356 44 161 7E-53 176 Q5ZJQ8 UBAC2_CHICK GO:0016021 integral to membrane reviewed IPR009060; IPR015940; IPR000449; Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1) UBAC2 PHGDHL1 RCJMB04_16f18 Gallus gallus (Chicken) 344 Q5ZJQ8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3452 sp Q5ZJQ8 UBAC2_CHICK 69.49 118 36 0 3 356 44 161 7E-53 176 Q5ZJQ8 UBAC2_CHICK GO:0016021 integral to membrane reviewed IPR009060; IPR015940; IPR000449; Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1) UBAC2 PHGDHL1 RCJMB04_16f18 Gallus gallus (Chicken) 344 Q5ZJQ8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0005795 GO:0005795 Golgi stack ER/Golgi C ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0006944 GO:0006944 membrane fusion cell organization and biogenesis P ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0007030 GO:0007030 Golgi organization cell organization and biogenesis P ConsensusfromContig6078 sp Q5ZK10 NSF1C_CHICK 73.26 374 94 3 13 1134 1 368 0 529 Q5ZK10 NSF1C_CHICK GO:0007030; GO:0005795; GO:0008289; GO:0061025; GO:0005634 Golgi organization; Golgi stack; lipid binding; membrane fusion; nucleus reviewed IPR012989; IPR009060; IPR001012; NSFL1 cofactor p47 (p97 cofactor p47) NSFL1C RCJMB04_13o20 Gallus gallus (Chicken) 369 Q5ZK10 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0019964 GO:0019964 interferon-gamma binding other molecular function F ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0031463 GO:0031463 Cul3-RING ubiquitin ligase complex other cellular component C ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0043161 GO:0043161 proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0044444 GO:0044444 cytoplasmic part other cellular component C ConsensusfromContig2092 sp Q5ZKD9 KLH20_CHICK 95.09 163 8 0 88 576 1 163 1E-106 325 Q5ZKD9 KLH20_CHICK GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 KLHL20 RCJMB04_11i2 Gallus gallus (Chicken) 610 Q5ZKD9 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6349 sp Q5ZKI4 CCD93_CHICK 61.96 397 143 4 213 1388 26 419 0 489 Q5ZKI4 CCD93_CHICK reviewed IPR019159; Coiled-coil domain-containing protein 93 CCDC93 RCJMB04_10i21 Gallus gallus (Chicken) 617 ConsensusfromContig6349 sp Q5ZKI4 CCD93_CHICK 83.43 181 30 0 1444 1986 437 617 0 314 Q5ZKI4 CCD93_CHICK reviewed IPR019159; Coiled-coil domain-containing protein 93 CCDC93 RCJMB04_10i21 Gallus gallus (Chicken) 617 ConsensusfromContig6349 sp Q5ZKI4 CCD93_CHICK 76.92 13 3 0 176 214 14 26 0 25.4 Q5ZKI4 CCD93_CHICK reviewed IPR019159; Coiled-coil domain-containing protein 93 CCDC93 RCJMB04_10i21 Gallus gallus (Chicken) 617 ConsensusfromContig3979 sp Q5ZKJ5 TM180_CHICK 80.85 141 26 1 421 2 8 148 3E-74 237 Q5ZKJ5 TM180_CHICK GO:0016021 integral to membrane reviewed IPR016196; Transmembrane protein 180 TMEM180 RCJMB04_10g6 Gallus gallus (Chicken) 509 Q5ZKJ5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3979 sp Q5ZKJ5 TM180_CHICK 80.85 141 26 1 421 2 8 148 3E-74 237 Q5ZKJ5 TM180_CHICK GO:0016021 integral to membrane reviewed IPR016196; Transmembrane protein 180 TMEM180 RCJMB04_10g6 Gallus gallus (Chicken) 509 Q5ZKJ5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0001510 GO:0001510 RNA methylation RNA metabolism P ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2289 sp Q5ZKM1 SPB1_CHICK 61.14 229 74 5 666 1 63 283 2E-69 232 Q5ZKM1 SPB1_CHICK GO:0001510; GO:0008168; GO:0005730; GO:0006364 RNA methylation; methyltransferase activity; nucleolus; rRNA processing reviewed IPR015507; IPR012920; IPR024576; IPR002877; pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3) FTSJ3 RCJMB04_10b6 Gallus gallus (Chicken) 832 Q5ZKM1 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0004693 GO:0004693 cyclin-dependent protein kinase activity kinase activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0006282 GO:0006282 regulation of DNA repair stress response P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0006282 GO:0006282 regulation of DNA repair DNA metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0017069 GO:0017069 snRNA binding nucleic acid binding activity F ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0031056 GO:0031056 regulation of histone modification protein metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0031056 GO:0031056 regulation of histone modification cell organization and biogenesis P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0043111 GO:0043111 replication fork arrest DNA metabolism P ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0044212 ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0071157 ConsensusfromContig5654 sp Q5ZKN1 CDK9_CHICK 91.76 376 26 3 1139 15 1 372 0 710 Q5ZKN1 CDK9_CHICK GO:0005524; GO:0016605; GO:0008353; GO:0071345; GO:0004693; GO:0071157; GO:0008024; GO:0006282; GO:0031056; GO:0006355; GO:0043111; GO:0044212; GO:0006351 ATP binding; PML body; RNA polymerase II carboxy-terminal domain kinase activity; cellular response to cytokine stimulus; cyclin-dependent protein serine/threonine kinase activity; negative regulation of cell cycle arrest; positive transcription elongation factor complex b; regulation of DNA repair; regulation of histone modification; regulation of transcription, DNA-dependent; replication fork arrest; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 9) CDK9 RCJMB04_9p8 Gallus gallus (Chicken) 372 Q5ZKN1 GO:0071345 ConsensusfromContig3762 sp Q5ZL26 KPRB_CHICK 98.85 87 1 0 261 1 133 219 6E-56 182 Q5ZL26 KPRB_CHICK GO:0000287; GO:0009165; GO:0004749 magnesium ion binding; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) PRPSAP2 RCJMB04_8b17 Gallus gallus (Chicken) 369 Q5ZL26 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig3762 sp Q5ZL26 KPRB_CHICK 98.85 87 1 0 261 1 133 219 6E-56 182 Q5ZL26 KPRB_CHICK GO:0000287; GO:0009165; GO:0004749 magnesium ion binding; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) PRPSAP2 RCJMB04_8b17 Gallus gallus (Chicken) 369 Q5ZL26 GO:0004749 GO:0004749 ribose phosphate diphosphokinase activity other molecular function F ConsensusfromContig3762 sp Q5ZL26 KPRB_CHICK 98.85 87 1 0 261 1 133 219 6E-56 182 Q5ZL26 KPRB_CHICK GO:0000287; GO:0009165; GO:0004749 magnesium ion binding; nucleotide biosynthetic process; ribose phosphate diphosphokinase activity reviewed IPR005946; Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) PRPSAP2 RCJMB04_8b17 Gallus gallus (Chicken) 369 Q5ZL26 GO:0009165 GO:0009165 nucleotide biosynthetic process other metabolic processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0001530 GO:0001530 lipopolysaccharide binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002368 GO:0002368 B cell cytokine production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway signal transduction P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway stress response P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002842 GO:0002842 positive regulation of T cell mediated immune response to tumor cell other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006919 GO:0006919 activation of caspase activity death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006986 GO:0006986 response to unfolded protein stress response P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0019907 GO:0019907 cyclin-dependent protein kinase activating kinase holoenzyme complex nucleus C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0030135 GO:0030135 coated vesicle other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0030141 GO:0030141 secretory granule other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032727 GO:0032727 positive regulation of interferon-alpha production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032729 GO:0032729 positive regulation of interferon-gamma production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032733 GO:0032733 positive regulation of interleukin-10 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032735 GO:0032735 positive regulation of interleukin-12 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032755 GO:0032755 positive regulation of interleukin-6 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042026 GO:0042026 protein refolding protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042100 GO:0042100 B cell proliferation cell cycle and proliferation P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042113 GO:0042113 B cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043032 GO:0043032 positive regulation of macrophage activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043498 GO:0043498 cell surface binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044459 GO:0044459 plasma membrane part plasma membrane C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044459 GO:0044459 plasma membrane part other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0046696 GO:0046696 lipopolysaccharide receptor complex other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0048291 GO:0048291 isotype switching to IgG isotypes developmental processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0048291 GO:0048291 isotype switching to IgG isotypes DNA metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0050870 GO:0050870 positive regulation of T cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 87.73 163 20 0 627 139 99 261 1E-97 296 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0001530 GO:0001530 lipopolysaccharide binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002368 GO:0002368 B cell cytokine production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway signal transduction P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002755 GO:0002755 MyD88-dependent toll-like receptor signaling pathway stress response P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0002842 GO:0002842 positive regulation of T cell mediated immune response to tumor cell other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0005905 GO:0005905 coated pit other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006919 GO:0006919 activation of caspase activity death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0006986 GO:0006986 response to unfolded protein stress response P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0019907 GO:0019907 cyclin-dependent protein kinase activating kinase holoenzyme complex nucleus C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0030135 GO:0030135 coated vesicle other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0030141 GO:0030141 secretory granule other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032727 GO:0032727 positive regulation of interferon-alpha production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032729 GO:0032729 positive regulation of interferon-gamma production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032733 GO:0032733 positive regulation of interleukin-10 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032735 GO:0032735 positive regulation of interleukin-12 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0032755 GO:0032755 positive regulation of interleukin-6 production other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042026 GO:0042026 protein refolding protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042100 GO:0042100 B cell proliferation cell cycle and proliferation P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0042113 GO:0042113 B cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043032 GO:0043032 positive regulation of macrophage activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0043498 GO:0043498 cell surface binding other molecular function F ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044459 GO:0044459 plasma membrane part plasma membrane C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0044459 GO:0044459 plasma membrane part other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0046696 GO:0046696 lipopolysaccharide receptor complex other membranes C ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0048291 GO:0048291 isotype switching to IgG isotypes developmental processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0048291 GO:0048291 isotype switching to IgG isotypes DNA metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0050870 GO:0050870 positive regulation of T cell activation other biological processes P ConsensusfromContig2655 sp Q5ZL72 CH60_CHICK 86.36 44 6 0 133 2 263 306 1E-97 81.6 Q5ZL72 CH60_CHICK GO:0005524; GO:0002368; GO:0042100; GO:0002755; GO:0006919; GO:0009986; GO:0005905; GO:0030135; GO:0019907; GO:0005829; GO:0005769; GO:0005615; GO:0048291; GO:0046696; GO:0005759; GO:0043066; GO:0050870; GO:0002842; GO:0043065; GO:0032733; GO:0032735; GO:0032755; GO:0043032; GO:0042026; GO:0006986 Q8AYS8 ATP binding; B cell cytokine production; B cell proliferation; MyD88-dependent toll-like receptor signaling pathway; activation of cysteine-type endopeptidase activity involved in apoptotic process; cell surface; coated pit; coated vesicle; cyclin-dependent protein kinase activating kinase holoenzyme complex; cytosol; early endosome; extracellular space; isotype switching to IgG isotypes; lipopolysaccharide receptor complex; mitochondrial matrix; negative regulation of apoptotic process; positive regulation of T cell activation; positive regulation of T cell mediated immune response to tumor cell; positive regulation of apoptotic process; positive regulation of interleukin-10 production; positive regulation of interleukin-12 production; positive regulation of interleukin-6 production; positive regulation of macrophage activation; protein refolding; response to unfolded protein reviewed IPR018370; IPR001844; IPR002423; IPR027409; IPR027413; 60 kDa heat shock protein, mitochondrial (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) HSPD1 HSP60 RCJMB04_7g5 Gallus gallus (Chicken) 573 Q5ZL72 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0016459 GO:0016459 myosin complex cytoskeleton C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0060171 GO:0060171 stereocilium membrane plasma membrane C ConsensusfromContig5226 sp Q5ZLA6 MYO1C_CHICK 80.17 116 22 1 350 3 140 254 9E-59 199 Q5ZLA6 MYO1C_CHICK GO:0005524; GO:0005737; GO:0003774; GO:0016459; GO:0060171 ATP binding; cytoplasm; motor activity; myosin complex; stereocilium membrane reviewed IPR000048; IPR001609; IPR010926; IPR027417; Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb) MYO1C RCJMB04_6o17 Gallus gallus (Chicken) 1028 Q5ZLA6 GO:0060171 GO:0060171 stereocilium membrane other membranes C ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5100 sp Q5ZLD7 VPS53_CHICK 91.38 116 10 0 1 348 677 792 2E-66 220 Q5ZLD7 VPS53_CHICK GO:0005794; GO:0010008; GO:0015031 Golgi apparatus; endosome membrane; protein transport reviewed IPR007234; Vacuolar protein sorting-associated protein 53 homolog VPS53 RCJMB04_6k3 Gallus gallus (Chicken) 831 Q5ZLD7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig1200 sp Q5ZLT0 XPO7_CHICK 94.97 179 9 0 539 3 55 233 2E-114 355 Q5ZLT0 XPO7_CHICK GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR016024; IPR001494; Exportin-7 XPO7 RCJMB04_4p4 Gallus gallus (Chicken) 1087 Q5ZLT0 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0008093 GO:0008093 cytoskeletal adaptor activity cytoskeletal activity F ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0009617 GO:0009617 response to bacterium other biological processes P ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0030175 GO:0030175 filopodium other cellular component C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0032956 GO:0032956 regulation of actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0046847 GO:0046847 filopodium assembly cell organization and biogenesis P ConsensusfromContig576 sp Q60437 BAIP2_CRIGR 63.87 155 51 4 20 472 362 515 4E-57 192 Q60437 BAIP2_CRIGR GO:0051764; GO:0051017; GO:0005856; GO:0005829; GO:0030175; GO:0046847; GO:0016020; GO:0070064; GO:0032956; GO:0008360; GO:0009617; GO:0001726; GO:0007165 Q9NZQ3 actin crosslink formation; actin filament bundle assembly; cytoskeleton; cytosol; filopodium; filopodium assembly; membrane; proline-rich region binding; regulation of actin cytoskeleton organization; regulation of cell shape; response to bacterium; ruffle; signal transduction reviewed IPR027681; IPR013606; IPR001452; Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53) (Insulin receptor tyrosine kinase 53 kDa substrate) (p58/p53) BAIAP2 Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 521 Q60437 GO:0070064 GO:0070064 proline-rich region binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0004003 GO:0004003 ATP-dependent DNA helicase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005675 GO:0005675 holo TFIIH complex nucleus C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0008094 GO:0008094 DNA-dependent ATPase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0016817 GO:0016817 "hydrolase activity, acting on acid anhydrides" other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0019907 GO:0019907 cyclin-dependent protein kinase activating kinase holoenzyme complex nucleus C ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0035315 GO:0035315 hair cell differentiation developmental processes P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0043139 GO:0043139 5'-3' DNA helicase activity other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig322 sp Q60452 ERCC2_CRIGR 77.53 178 40 0 535 2 122 299 6E-88 279 Q60452 ERCC2_CRIGR GO:0051539; GO:0043139; GO:0005524; GO:0004003; GO:0003677; GO:0071817; GO:0006915; GO:0007059; GO:0005737; GO:0035315; GO:0005675; GO:0046872; GO:0033683; GO:0045944; GO:0008022; GO:0047485; GO:0006468; GO:1901990; GO:0006979; GO:0006366; GO:0006283 4 iron, 4 sulfur cluster binding; 5'-3' DNA helicase activity; ATP binding; ATP-dependent DNA helicase activity; DNA binding; MMXD complex; apoptotic process; chromosome segregation; cytoplasm; hair cell differentiation; holo TFIIH complex; metal ion binding; nucleotide-excision repair, DNA incision; positive regulation of transcription from RNA polymerase II promoter; protein C-terminus binding; protein N-terminus binding; protein phosphorylation; regulation of mitotic cell cycle phase transition; response to oxidative stress; transcription from RNA polymerase II promoter; transcription-coupled nucleotide-excision repair reviewed IPR006555; IPR010614; IPR002464; IPR013020; IPR010643; IPR014013; IPR006554; IPR027417; IPR001945; TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (Xeroderma pigmentosum group D-complementing protein) ERCC2 XPD Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus) 760 Q60452 GO:0071817 ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0004591 GO:0004591 oxoglutarate dehydrogenase (succinyl-transferring) activity other molecular function F ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0006091 GO:0006091 generation of precursor metabolites and energy other metabolic processes P ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0016624 GO:0016624 "oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor" other molecular function F ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0030976 GO:0030976 thiamin pyrophosphate binding other molecular function F ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0031966 GO:0031966 mitochondrial membrane mitochondrion C ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0031966 GO:0031966 mitochondrial membrane other membranes C ConsensusfromContig3179 sp Q60HE2 ODO1_MACFA 95.42 131 6 0 1 393 409 539 3E-84 272 Q60HE2 ODO1_MACFA GO:0006091; GO:0006096; GO:0005759; GO:0031966; GO:0004591; GO:0030976; GO:0006099 generation of precursor metabolites and energy; glycolysis; mitochondrial matrix; mitochondrial membrane; oxoglutarate dehydrogenase (succinyl-transferring) activity; thiamine pyrophosphate binding; tricarboxylic acid cycle reviewed IPR011603; IPR001017; IPR005475; 2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase) OGDH QccE-15394 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 1023 Q60HE2 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0003887 GO:0003887 DNA-directed DNA polymerase activity other molecular function F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0016035 GO:0016035 zeta DNA polymerase complex other cellular component C ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0019985 GO:0019985 bypass DNA synthesis stress response P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0019985 GO:0019985 bypass DNA synthesis DNA metabolism P ConsensusfromContig2716 sp Q61493 DPOLZ_MOUSE 71.18 170 44 1 3 512 2951 3115 4E-80 266 Q61493 DPOLZ_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0003887; GO:0005694; GO:0046872; GO:0000166; GO:0005634; GO:0019985; GO:0016035 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA-directed DNA polymerase activity; chromosome; metal ion binding; nucleotide binding; nucleus; translesion synthesis; zeta DNA polymerase complex reviewed IPR006172; IPR017964; IPR006133; IPR006134; IPR023211; IPR012337; IPR025687; DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (Seizure-related protein 4) Rev3l Polz Sez4 Mus musculus (Mouse) 3122 Q61493 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0002151 ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003730 GO:0003730 mRNA 3'-UTR binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005844 GO:0005844 polysome other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0017148 GO:0017148 negative regulation of translation protein metabolism P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 81.33 166 31 0 76 573 1 166 1E-145 303 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0043034 GO:0043034 costamere other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0002151 ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003730 GO:0003730 mRNA 3'-UTR binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005844 GO:0005844 polysome other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0017148 GO:0017148 negative regulation of translation protein metabolism P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 84.96 133 20 0 573 971 167 299 1E-145 236 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0043034 GO:0043034 costamere other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0002151 ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0003730 GO:0003730 mRNA 3'-UTR binding nucleic acid binding activity F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0005844 GO:0005844 polysome other cellular component C ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0017148 GO:0017148 negative regulation of translation protein metabolism P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5830 sp Q61584 FXR1_MOUSE 61.07 375 102 8 889 1923 272 632 7E-88 294 Q61584 FXR1_MOUSE GO:0002151; GO:0003723; GO:0030154; GO:0043034; GO:0005737; GO:0003730; GO:0007517; GO:0017148; GO:0005634; GO:0005844 G-quadruplex RNA binding; RNA binding; cell differentiation; costamere; cytoplasm; mRNA 3'-UTR binding; muscle organ development; negative regulation of translation; nucleus; polysome reviewed IPR008395; IPR022034; IPR004087; IPR004088; Fragile X mental retardation syndrome-related protein 1 (mFxr1p) Fxr1 Fxr1h Mus musculus (Mouse) 677 Q61584 GO:0043034 GO:0043034 costamere other cellular component C ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0000381 GO:0000381 "regulation of alternative nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0003712 GO:0003712 transcription cofactor activity transcription regulatory activity F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0003724 GO:0003724 RNA helicase activity other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0016818 GO:0016818 "hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides" other molecular function F ConsensusfromContig6168 sp Q61656 DDX5_MOUSE 89.37 301 32 0 466 1368 111 411 1E-178 521 Q61656 DDX5_MOUSE GO:0005524; GO:0008026; GO:0003723; GO:0003724; GO:0008380; GO:0050681; GO:0007623; GO:0030331; GO:0001701; GO:0072332; GO:0006397; GO:0000122; GO:0005730; GO:0043517; GO:0045944; GO:0000381; GO:0060765; GO:0045667; GO:2001014; GO:0030529; GO:0005681; GO:0003713; GO:0006351 ATP binding; ATP-dependent helicase activity; RNA binding; RNA helicase activity; RNA splicing; androgen receptor binding; circadian rhythm; estrogen receptor binding; in utero embryonic development; intrinsic apoptotic signaling pathway by p53 class mediator; mRNA processing; negative regulation of transcription from RNA polymerase II promoter; nucleolus; positive regulation of DNA damage response, signal transduction by p53 class mediator; positive regulation of transcription from RNA polymerase II promoter; regulation of alternative mRNA splicing, via spliceosome; regulation of androgen receptor signaling pathway; regulation of osteoblast differentiation; regulation of skeletal muscle cell differentiation; ribonucleoprotein complex; spliceosomal complex; transcription coactivator activity; transcription, DNA-dependent reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR012587; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box RNA helicase DEAD1) (mDEAD1) (DEAD box protein 5) (RNA helicase p68) Ddx5 Tnz2 Mus musculus (Mouse) 614 Q61656 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0005088 GO:0005088 Ras guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig2808 sp Q62245 SOS1_MOUSE 87.85 214 25 1 1 642 493 705 4E-129 400 Q62245 SOS1_MOUSE GO:0003677; GO:0005088; GO:0005089; GO:0005829; GO:0005543; GO:0035023; GO:0007264 P26663; P62993; Q60631; P29355 DNA binding; Ras guanyl-nucleotide exchange factor activity; Rho guanyl-nucleotide exchange factor activity; cytosol; phospholipid binding; regulation of Rho protein signal transduction; small GTPase mediated signal transduction reviewed IPR000219; IPR009072; IPR007125; IPR011993; IPR001849; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Son of sevenless homolog 1 (SOS-1) (mSOS-1) Sos1 Mus musculus (Mouse) 1319 Q62245 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig5932 sp Q640F2 SHCBB_XENLA 57.96 333 136 2 473 1462 99 430 1E-116 365 Q640F2 SHCBB_XENLA GO:0008543; GO:2000177 fibroblast growth factor receptor signaling pathway; regulation of neural precursor cell proliferation reviewed IPR006626; IPR012334; IPR011050; SHC SH2 domain-binding protein 1 homolog B shcbp1-b Xenopus laevis (African clawed frog) 698 ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0047115 GO:0047115 "trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity" other molecular function F ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0047837 GO:0047837 D-xylose 1-dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig2027 sp Q642M9 DHDH_DANRE 84.26 108 17 0 325 2 1 108 9E-56 182 Q642M9 DHDH_DANRE GO:0047837; GO:0047115 D-xylose 1-dehydrogenase (NADP+) activity; trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity reviewed IPR016040; IPR000683; IPR004104; Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) dhdh ch211-203b17.3 zgc:101723 Danio rerio (Zebrafish) (Brachydanio rerio) 334 Q642M9 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0030296 GO:0030296 protein tyrosine kinase activator activity enzyme regulator activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0050731 GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 96.65 209 7 0 982 356 316 524 3E-151 428 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0061098 ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0030296 GO:0030296 protein tyrosine kinase activator activity enzyme regulator activity F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0050731 GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig5537 sp Q64303 PAK2_RAT 84.72 72 11 0 1191 976 246 317 3E-151 130 Q64303 PAK2_RAT GO:0005524; GO:0016020; GO:0005634; GO:0048471; GO:0004674 ATP binding; membrane; nucleus; perinuclear region of cytoplasm; protein serine/threonine kinase activity reviewed IPR000095; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (p21-activated kinase 2) (PAK-2) [Cleaved into: PAK-2p27; PAK-2p34] Pak2 Rattus norvegicus (Rat) 524 Q64303 GO:0061098 ConsensusfromContig984 sp Q64674 SPEE_MOUSE 80.42 286 56 0 61 918 15 300 3E-166 474 Q64674 SPEE_MOUSE GO:0008295; GO:0004766 spermidine biosynthetic process; spermidine synthase activity reviewed IPR001045; Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1. Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase) Srm Mus musculus (Mouse) 302 Q64674 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig984 sp Q64674 SPEE_MOUSE 80.42 286 56 0 61 918 15 300 3E-166 474 Q64674 SPEE_MOUSE GO:0008295; GO:0004766 spermidine biosynthetic process; spermidine synthase activity reviewed IPR001045; Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1. Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase) Srm Mus musculus (Mouse) 302 Q64674 GO:0004766 GO:0004766 spermidine synthase activity other molecular function F ConsensusfromContig984 sp Q64674 SPEE_MOUSE 80.42 286 56 0 61 918 15 300 3E-166 474 Q64674 SPEE_MOUSE GO:0008295; GO:0004766 spermidine biosynthetic process; spermidine synthase activity reviewed IPR001045; Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1. Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase) Srm Mus musculus (Mouse) 302 Q64674 GO:0008295 GO:0008295 spermidine biosynthetic process other metabolic processes P ConsensusfromContig984 sp Q64674 SPEE_MOUSE 80.42 286 56 0 61 918 15 300 3E-166 474 Q64674 SPEE_MOUSE GO:0008295; GO:0004766 spermidine biosynthetic process; spermidine synthase activity reviewed IPR001045; Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1. Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase) Srm Mus musculus (Mouse) 302 Q64674 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig984 sp Q64674 SPEE_MOUSE 80.42 286 56 0 61 918 15 300 3E-166 474 Q64674 SPEE_MOUSE GO:0008295; GO:0004766 spermidine biosynthetic process; spermidine synthase activity reviewed IPR001045; Amine and polyamine biosynthesis; spermidine biosynthesis; spermidine from putrescine: step 1/1. Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase) Srm Mus musculus (Mouse) 302 Q64674 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1562 sp Q66HT8 ARHL2_DANRE 77.44 195 41 2 20 601 14 206 8E-91 278 Q66HT8 ARHL2_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0004649 cytoplasm; metal ion binding; nucleus; poly(ADP-ribose) glycohydrolase activity reviewed IPR005502; Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) adprhl2 arh3 zgc:92867 Danio rerio (Zebrafish) (Brachydanio rerio) 370 Q66HT8 GO:0004649 GO:0004649 poly(ADP-ribose) glycohydrolase activity other molecular function F ConsensusfromContig1562 sp Q66HT8 ARHL2_DANRE 77.44 195 41 2 20 601 14 206 8E-91 278 Q66HT8 ARHL2_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0004649 cytoplasm; metal ion binding; nucleus; poly(ADP-ribose) glycohydrolase activity reviewed IPR005502; Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) adprhl2 arh3 zgc:92867 Danio rerio (Zebrafish) (Brachydanio rerio) 370 Q66HT8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1562 sp Q66HT8 ARHL2_DANRE 77.44 195 41 2 20 601 14 206 8E-91 278 Q66HT8 ARHL2_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0004649 cytoplasm; metal ion binding; nucleus; poly(ADP-ribose) glycohydrolase activity reviewed IPR005502; Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) adprhl2 arh3 zgc:92867 Danio rerio (Zebrafish) (Brachydanio rerio) 370 Q66HT8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1562 sp Q66HT8 ARHL2_DANRE 77.44 195 41 2 20 601 14 206 8E-91 278 Q66HT8 ARHL2_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0004649 cytoplasm; metal ion binding; nucleus; poly(ADP-ribose) glycohydrolase activity reviewed IPR005502; Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) adprhl2 arh3 zgc:92867 Danio rerio (Zebrafish) (Brachydanio rerio) 370 Q66HT8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1562 sp Q66HT8 ARHL2_DANRE 77.44 195 41 2 20 601 14 206 8E-91 278 Q66HT8 ARHL2_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0004649 cytoplasm; metal ion binding; nucleus; poly(ADP-ribose) glycohydrolase activity reviewed IPR005502; Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2) adprhl2 arh3 zgc:92867 Danio rerio (Zebrafish) (Brachydanio rerio) 370 Q66HT8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030126 GO:0030126 COPI vesicle coat ER/Golgi C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030126 GO:0030126 COPI vesicle coat other membranes C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030663 GO:0030663 COPI coated vesicle membrane ER/Golgi C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030663 GO:0030663 COPI coated vesicle membrane other membranes C ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0030903 GO:0030903 notochord development developmental processes P ConsensusfromContig375 sp Q66HV4 COPB_DANRE 98.02 202 4 0 98 703 1 202 7E-137 414 Q66HV4 COPB_DANRE GO:0030126; GO:0006886; GO:0030903; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; notochord development; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR011710; IPR016460; Coatomer subunit beta (Beta-coat protein) (Beta-COP) copb1 hap happy Danio rerio (Zebrafish) (Brachydanio rerio) 953 Q66HV4 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 69.61 181 53 1 258 800 148 326 5E-99 243 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5736 sp Q66I08 OSTA_DANRE 78.49 93 20 0 1 279 62 154 5E-99 140 Q66I08 OSTA_DANRE GO:0015721; GO:0005789; GO:0016021; GO:0005886; GO:0043234; GO:0046982; GO:0042803; GO:0005215 bile acid and bile salt transport; endoplasmic reticulum membrane; integral to membrane; plasma membrane; protein complex; protein heterodimerization activity; protein homodimerization activity; transporter activity reviewed IPR005178; Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha) slc51a osta zgc:92111 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q66I08 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6083 sp Q66I12 CCD47_DANRE 88.01 267 31 1 1335 538 200 466 2E-146 433 Q66I12 CCD47_DANRE GO:0016021 integral to membrane reviewed IPR012879; Coiled-coil domain-containing protein 47 ccdc47 zgc:92099 Danio rerio (Zebrafish) (Brachydanio rerio) 486 Q66I12 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6083 sp Q66I12 CCD47_DANRE 88.01 267 31 1 1335 538 200 466 2E-146 433 Q66I12 CCD47_DANRE GO:0016021 integral to membrane reviewed IPR012879; Coiled-coil domain-containing protein 47 ccdc47 zgc:92099 Danio rerio (Zebrafish) (Brachydanio rerio) 486 Q66I12 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6083 sp Q66I12 CCD47_DANRE 88.01 267 31 1 1335 538 200 466 2E-146 433 Q66I12 CCD47_DANRE GO:0016021 integral to membrane reviewed IPR012879; Coiled-coil domain-containing protein 47 ccdc47 zgc:92099 Danio rerio (Zebrafish) (Brachydanio rerio) 486 Q66I12 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0000785 GO:0000785 chromatin other cellular component C ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0006275 GO:0006275 regulation of DNA replication DNA metabolism P ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0034088 GO:0034088 maintenance of mitotic sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig5684 sp Q66I84 DCC1_DANRE 79.28 391 80 1 1235 66 1 391 0 640 Q66I84 DCC1_DANRE GO:0003677; GO:0006260; GO:0000785; GO:0034088; GO:0005634; GO:0006275 DNA binding; DNA replication; chromatin; maintenance of mitotic sister chromatid cohesion; nucleus; regulation of DNA replication reviewed IPR019128; Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog) dscc1 dcc1 zgc:103507 Danio rerio (Zebrafish) (Brachydanio rerio) 391 Q66I84 GO:0034088 GO:0034088 maintenance of mitotic sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6001 sp Q66KD6 PHOP2_XENTR 50.41 242 115 1 1131 406 1 237 3E-92 283 Q66KD6 PHOP2_XENTR GO:0016311; GO:0046872; GO:0016791 dephosphorylation; metal ion binding; phosphatase activity reviewed IPR023214; IPR006383; IPR016965; IPR006384; Probable phosphatase phospho2 (EC 3.1.3.-) phospho2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 238 Q66KD6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6001 sp Q66KD6 PHOP2_XENTR 50.41 242 115 1 1131 406 1 237 3E-92 283 Q66KD6 PHOP2_XENTR GO:0016311; GO:0046872; GO:0016791 dephosphorylation; metal ion binding; phosphatase activity reviewed IPR023214; IPR006383; IPR016965; IPR006384; Probable phosphatase phospho2 (EC 3.1.3.-) phospho2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 238 Q66KD6 GO:0016311 GO:0016311 dephosphorylation other metabolic processes P ConsensusfromContig6001 sp Q66KD6 PHOP2_XENTR 50.41 242 115 1 1131 406 1 237 3E-92 283 Q66KD6 PHOP2_XENTR GO:0016311; GO:0046872; GO:0016791 dephosphorylation; metal ion binding; phosphatase activity reviewed IPR023214; IPR006383; IPR016965; IPR006384; Probable phosphatase phospho2 (EC 3.1.3.-) phospho2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 238 Q66KD6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6001 sp Q66KD6 PHOP2_XENTR 50.41 242 115 1 1131 406 1 237 3E-92 283 Q66KD6 PHOP2_XENTR GO:0016311; GO:0046872; GO:0016791 dephosphorylation; metal ion binding; phosphatase activity reviewed IPR023214; IPR006383; IPR016965; IPR006384; Probable phosphatase phospho2 (EC 3.1.3.-) phospho2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 238 Q66KD6 GO:0016791 GO:0016791 phosphatase activity other molecular function F ConsensusfromContig6001 sp Q66KD6 PHOP2_XENTR 50.41 242 115 1 1131 406 1 237 3E-92 283 Q66KD6 PHOP2_XENTR GO:0016311; GO:0046872; GO:0016791 dephosphorylation; metal ion binding; phosphatase activity reviewed IPR023214; IPR006383; IPR016965; IPR006384; Probable phosphatase phospho2 (EC 3.1.3.-) phospho2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 238 Q66KD6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0006810 GO:0006810 transport transport P ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig742 sp Q66L49 SCMC1_DANRE 83.8 321 52 0 1303 341 157 477 0 566 Q66L49 SCMC1_DANRE GO:0005509; GO:0016021; GO:0005743; GO:0055085 calcium ion binding; integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR011992; IPR018247; IPR002048; IPR002167; IPR002067; IPR018108; IPR023395; Calcium-binding mitochondrial carrier protein SCaMC-1 (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24) slc25a24 scamc1 si:ch211-63o20.9 zgc:92470 Danio rerio (Zebrafish) (Brachydanio rerio) 477 Q66L49 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6194 sp Q68DE3 K2018_HUMAN 56.53 329 125 11 1511 534 1932 2245 2E-83 289 Q68DE3 K2018_HUMAN GO:0003677; GO:0005509; GO:0004571; GO:0016020; GO:0005634 DNA binding; calcium ion binding; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; membrane; nucleus reviewed IPR011598; IPR001382; Basic helix-loop-helix domain-containing protein KIAA2018 KIAA2018 Homo sapiens (Human) 2245 Q68DE3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6194 sp Q68DE3 K2018_HUMAN 56.53 329 125 11 1511 534 1932 2245 2E-83 289 Q68DE3 K2018_HUMAN GO:0003677; GO:0005509; GO:0004571; GO:0016020; GO:0005634 DNA binding; calcium ion binding; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; membrane; nucleus reviewed IPR011598; IPR001382; Basic helix-loop-helix domain-containing protein KIAA2018 KIAA2018 Homo sapiens (Human) 2245 Q68DE3 GO:0004571 GO:0004571 "mannosyl-oligosaccharide 1,2-alpha-mannosidase activity" other molecular function F ConsensusfromContig6194 sp Q68DE3 K2018_HUMAN 56.53 329 125 11 1511 534 1932 2245 2E-83 289 Q68DE3 K2018_HUMAN GO:0003677; GO:0005509; GO:0004571; GO:0016020; GO:0005634 DNA binding; calcium ion binding; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; membrane; nucleus reviewed IPR011598; IPR001382; Basic helix-loop-helix domain-containing protein KIAA2018 KIAA2018 Homo sapiens (Human) 2245 Q68DE3 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6194 sp Q68DE3 K2018_HUMAN 56.53 329 125 11 1511 534 1932 2245 2E-83 289 Q68DE3 K2018_HUMAN GO:0003677; GO:0005509; GO:0004571; GO:0016020; GO:0005634 DNA binding; calcium ion binding; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; membrane; nucleus reviewed IPR011598; IPR001382; Basic helix-loop-helix domain-containing protein KIAA2018 KIAA2018 Homo sapiens (Human) 2245 Q68DE3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6194 sp Q68DE3 K2018_HUMAN 56.53 329 125 11 1511 534 1932 2245 2E-83 289 Q68DE3 K2018_HUMAN GO:0003677; GO:0005509; GO:0004571; GO:0016020; GO:0005634 DNA binding; calcium ion binding; mannosyl-oligosaccharide 1,2-alpha-mannosidase activity; membrane; nucleus reviewed IPR011598; IPR001382; Basic helix-loop-helix domain-containing protein KIAA2018 KIAA2018 Homo sapiens (Human) 2245 Q68DE3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0004176 GO:0004176 ATP-dependent peptidase activity other molecular function F ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0031464 GO:0031464 Cul4A-RING ubiquitin ligase complex other cellular component C ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0033333 GO:0033333 fin development developmental processes P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0035118 GO:0035118 embryonic pectoral fin morphogenesis developmental processes P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0043161 GO:0043161 proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0060173 GO:0060173 limb development developmental processes P ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0071599 ConsensusfromContig6159 sp Q68EH9 CRBN_DANRE 85.49 317 34 3 1801 887 115 431 0 558 Q68EH9 CRBN_DANRE GO:0004176; GO:0031464; GO:0005737; GO:0033333; GO:0060173; GO:0005634; GO:0071599; GO:0043161; GO:0016567 ATP-dependent peptidase activity; Cul4A-RING ubiquitin ligase complex; cytoplasm; fin development; limb development; nucleus; otic vesicle development; proteasomal ubiquitin-dependent protein catabolic process; protein ubiquitination reviewed IPR003111; IPR015947; Protein modification; protein ubiquitination. Protein cereblon (zcrbn) crbn zgc:92404 Danio rerio (Zebrafish) (Brachydanio rerio) 431 Q68EH9 GO:0071600 ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3668 sp Q68EK7 RAB4B_DANRE 99 100 1 0 236 535 20 119 1E-66 209 Q68EK7 RAB4B_DANRE GO:0005525; GO:0005886; GO:0015031; GO:0007264 GTP binding; plasma membrane; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-4B rab4b zgc:101015 Danio rerio (Zebrafish) (Brachydanio rerio) 213 Q68EK7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005626 GO:0005626 insoluble fraction other cellular component C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0017156 GO:0017156 calcium ion-dependent exocytosis transport P ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig3636 sp Q68EM7 RHG17_HUMAN 73.41 173 44 2 5 520 308 479 5E-81 263 Q68EM7 RHG17_HUMAN GO:0005096; GO:0005829; GO:0016020; GO:0043547; GO:0051056; GO:0007264; GO:0005923 Q4VCS5; Q4VCS5-2 GTPase activator activity; cytosol; membrane; positive regulation of GTPase activity; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; tight junction reviewed IPR027267; IPR004148; IPR008936; IPR000198; Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1) ARHGAP17 RICH1 MSTP066 MSTP110 Homo sapiens (Human) 881 Q68EM7 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig5974 sp Q68FD7 FNIP1_MOUSE 86.62 157 21 0 1656 1186 1009 1165 4E-73 257 Q68FD7 FNIP1_MOUSE GO:0031929; GO:0009267; GO:0005737; GO:0005085; GO:0002327; GO:0032007; GO:0043154; GO:0000122; GO:0002904; GO:0033138; GO:0001934; GO:2000973 Q8QZS3 TOR signaling cascade; cellular response to starvation; cytoplasm; guanyl-nucleotide exchange factor activity; immature B cell differentiation; negative regulation of TOR signaling cascade; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription from RNA polymerase II promoter; positive regulation of B cell apoptotic process; positive regulation of peptidyl-serine phosphorylation; positive regulation of protein phosphorylation; regulation of pro-B cell differentiation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 1 Fnip1 Kiaa1961 Mus musculus (Mouse) 1165 Q68FD7 GO:0001932 GO:0001932 regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig5974 sp Q68FD7 FNIP1_MOUSE 86.62 157 21 0 1656 1186 1009 1165 4E-73 257 Q68FD7 FNIP1_MOUSE GO:0031929; GO:0009267; GO:0005737; GO:0005085; GO:0002327; GO:0032007; GO:0043154; GO:0000122; GO:0002904; GO:0033138; GO:0001934; GO:2000973 Q8QZS3 TOR signaling cascade; cellular response to starvation; cytoplasm; guanyl-nucleotide exchange factor activity; immature B cell differentiation; negative regulation of TOR signaling cascade; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription from RNA polymerase II promoter; positive regulation of B cell apoptotic process; positive regulation of peptidyl-serine phosphorylation; positive regulation of protein phosphorylation; regulation of pro-B cell differentiation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 1 Fnip1 Kiaa1961 Mus musculus (Mouse) 1165 Q68FD7 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5974 sp Q68FD7 FNIP1_MOUSE 86.62 157 21 0 1656 1186 1009 1165 4E-73 257 Q68FD7 FNIP1_MOUSE GO:0031929; GO:0009267; GO:0005737; GO:0005085; GO:0002327; GO:0032007; GO:0043154; GO:0000122; GO:0002904; GO:0033138; GO:0001934; GO:2000973 Q8QZS3 TOR signaling cascade; cellular response to starvation; cytoplasm; guanyl-nucleotide exchange factor activity; immature B cell differentiation; negative regulation of TOR signaling cascade; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription from RNA polymerase II promoter; positive regulation of B cell apoptotic process; positive regulation of peptidyl-serine phosphorylation; positive regulation of protein phosphorylation; regulation of pro-B cell differentiation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 1 Fnip1 Kiaa1961 Mus musculus (Mouse) 1165 Q68FD7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 76.44 225 53 0 19 693 1 225 0 376 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0003746 GO:0003746 translation elongation factor activity nucleic acid binding activity F ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 76.44 225 53 0 19 693 1 225 0 376 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0005853 GO:0005853 eukaryotic translation elongation factor 1 complex other cellular component C ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 76.44 225 53 0 19 693 1 225 0 376 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 76.44 225 53 0 19 693 1 225 0 376 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0006414 GO:0006414 translational elongation protein metabolism P ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 77.72 184 40 1 783 1331 254 437 0 315 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0003746 GO:0003746 translation elongation factor activity nucleic acid binding activity F ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 77.72 184 40 1 783 1331 254 437 0 315 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0005853 GO:0005853 eukaryotic translation elongation factor 1 complex other cellular component C ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 77.72 184 40 1 783 1331 254 437 0 315 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6157 sp Q68FR6 EF1G_RAT 77.72 184 40 1 783 1331 254 437 0 315 Q68FR6 EF1G_RAT GO:0005853; GO:0009615; GO:0003746 eukaryotic translation elongation factor 1 complex; response to virus; translation elongation factor activity reviewed IPR010987; IPR004045; IPR004046; IPR012336; IPR001662; Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma) Eef1g Rattus norvegicus (Rat) 437 Q68FR6 GO:0006414 GO:0006414 translational elongation protein metabolism P ConsensusfromContig1959 sp Q68VK5 TSN5_RAT 91.04 134 12 0 53 454 43 176 3E-80 244 Q68VK5 TSN5_RAT GO:0007155; GO:0008283; GO:0016021 cell adhesion; cell proliferation; integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-5 (Tspan-5) (Transmembrane 4 superfamily member 9) Tspan5 Tm4sf9 Rattus norvegicus (Rat) 268 Q68VK5 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig1959 sp Q68VK5 TSN5_RAT 91.04 134 12 0 53 454 43 176 3E-80 244 Q68VK5 TSN5_RAT GO:0007155; GO:0008283; GO:0016021 cell adhesion; cell proliferation; integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-5 (Tspan-5) (Transmembrane 4 superfamily member 9) Tspan5 Tm4sf9 Rattus norvegicus (Rat) 268 Q68VK5 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig1959 sp Q68VK5 TSN5_RAT 91.04 134 12 0 53 454 43 176 3E-80 244 Q68VK5 TSN5_RAT GO:0007155; GO:0008283; GO:0016021 cell adhesion; cell proliferation; integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-5 (Tspan-5) (Transmembrane 4 superfamily member 9) Tspan5 Tm4sf9 Rattus norvegicus (Rat) 268 Q68VK5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1959 sp Q68VK5 TSN5_RAT 91.04 134 12 0 53 454 43 176 3E-80 244 Q68VK5 TSN5_RAT GO:0007155; GO:0008283; GO:0016021 cell adhesion; cell proliferation; integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-5 (Tspan-5) (Transmembrane 4 superfamily member 9) Tspan5 Tm4sf9 Rattus norvegicus (Rat) 268 Q68VK5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0043568 GO:0043568 positive regulation of insulin-like growth factor receptor signaling pathway signal transduction P ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0048741 GO:0048741 skeletal muscle fiber development developmental processes P ConsensusfromContig4047 sp Q69ZQ1 K1161_MOUSE 65.85 164 56 0 2 493 333 496 2E-72 237 Q69ZQ1 K1161_MOUSE GO:0005975; GO:0004553; GO:0016021; GO:0031965; GO:0043568; GO:0051897; GO:0048741 carbohydrate metabolic process; hydrolase activity, hydrolyzing O-glycosyl compounds; integral to membrane; nuclear membrane; positive regulation of insulin-like growth factor receptor signaling pathway; positive regulation of protein kinase B signaling cascade; skeletal muscle fiber development reviewed IPR013785; IPR000322; IPR017853; Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-) Kiaa1161 Mus musculus (Mouse) 716 Q69ZQ1 GO:0051897 GO:0051897 positive regulation of protein kinase B signaling cascade signal transduction P ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6337 sp Q69ZQ2 ISY1_MOUSE 84.82 257 37 2 1119 349 1 255 5E-120 357 Q69ZQ2 ISY1_MOUSE GO:0008380; GO:0006397; GO:0005681 RNA splicing; mRNA processing; spliceosomal complex reviewed IPR009360; Pre-mRNA-splicing factor ISY1 homolog Isy1 Kiaa1160 Mus musculus (Mouse) 285 Q69ZQ2 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0016444 GO:0016444 somatic cell DNA recombination DNA metabolism P ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0045190 GO:0045190 isotype switching developmental processes P ConsensusfromContig407 sp Q6A028 SWP70_MOUSE 81.38 145 27 0 88 522 3 147 7E-86 270 Q6A028 SWP70_MOUSE GO:0005524; GO:0003677; GO:0005737; GO:0045190; GO:0030027; GO:0005634; GO:0005543; GO:0005886 Q61738-6 ATP binding; DNA binding; cytoplasm; isotype switching; lamellipodium; nucleus; phospholipid binding; plasma membrane reviewed IPR011993; IPR001849; Switch-associated protein 70 (SWAP-70) Swap70 Kiaa0640 Mus musculus (Mouse) 585 Q6A028 GO:0045190 GO:0045190 isotype switching DNA metabolism P ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2284 sp Q6DBW0 IKZF5_DANRE 80.47 128 23 1 107 484 1 128 3E-66 214 Q6DBW0 IKZF5_DANRE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein Pegasus (Ikaros family zinc finger protein 5) ikzf5 zgc:92405 Danio rerio (Zebrafish) (Brachydanio rerio) 419 Q6DBW0 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1732 sp Q6DBW1 RG1BB_DANRE 86 150 21 0 2 451 240 389 6E-88 271 Q6DBW1 RG1BB_DANRE GO:0005088; GO:0005622; GO:0051056; GO:0007264 Ras guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ras-GEF domain-containing family member 1B-B rasgef1bb rasgef zgc:91814 Danio rerio (Zebrafish) (Brachydanio rerio) 475 Q6DBW1 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig1732 sp Q6DBW1 RG1BB_DANRE 86 150 21 0 2 451 240 389 6E-88 271 Q6DBW1 RG1BB_DANRE GO:0005088; GO:0005622; GO:0051056; GO:0007264 Ras guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ras-GEF domain-containing family member 1B-B rasgef1bb rasgef zgc:91814 Danio rerio (Zebrafish) (Brachydanio rerio) 475 Q6DBW1 GO:0005088 GO:0005088 Ras guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig1732 sp Q6DBW1 RG1BB_DANRE 86 150 21 0 2 451 240 389 6E-88 271 Q6DBW1 RG1BB_DANRE GO:0005088; GO:0005622; GO:0051056; GO:0007264 Ras guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ras-GEF domain-containing family member 1B-B rasgef1bb rasgef zgc:91814 Danio rerio (Zebrafish) (Brachydanio rerio) 475 Q6DBW1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1732 sp Q6DBW1 RG1BB_DANRE 86 150 21 0 2 451 240 389 6E-88 271 Q6DBW1 RG1BB_DANRE GO:0005088; GO:0005622; GO:0051056; GO:0007264 Ras guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ras-GEF domain-containing family member 1B-B rasgef1bb rasgef zgc:91814 Danio rerio (Zebrafish) (Brachydanio rerio) 475 Q6DBW1 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig1732 sp Q6DBW1 RG1BB_DANRE 86 150 21 0 2 451 240 389 6E-88 271 Q6DBW1 RG1BB_DANRE GO:0005088; GO:0005622; GO:0051056; GO:0007264 Ras guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ras-GEF domain-containing family member 1B-B rasgef1bb rasgef zgc:91814 Danio rerio (Zebrafish) (Brachydanio rerio) 475 Q6DBW1 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0031080 GO:0031080 Nup107-160 complex nucleus C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0031080 GO:0031080 Nup107-160 complex other membranes C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig1686 sp Q6DBY0 NUP85_DANRE 72.63 179 49 0 1 537 60 238 1E-76 247 Q6DBY0 NUP85_DANRE GO:0051028; GO:0031965; GO:0031080; GO:0015031 mRNA transport; nuclear membrane; nuclear pore outer ring; protein transport reviewed IPR011502; Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (Nucleoporin Nup85) (Pericentrin-1) nup85 pcnt1 zgc:100943 Danio rerio (Zebrafish) (Brachydanio rerio) 649 Q6DBY0 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0044262 GO:0044262 cellular carbohydrate metabolic process other metabolic processes P ConsensusfromContig976 sp Q6DBY5 UEVLD_DANRE 75.82 244 59 0 48 779 164 407 2E-128 379 Q6DBY5 UEVLD_DANRE GO:0044262; GO:0006464; GO:0016616; GO:0015031 cellular carbohydrate metabolic process; cellular protein modification process; oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; protein transport reviewed IPR001557; IPR022383; IPR001236; IPR015955; IPR016040; IPR016135; IPR008883; Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein) uevld uev3 zgc:100959 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DBY5 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6331 sp Q6DC58 TM223_DANRE 75.94 187 44 1 491 1051 63 248 2E-96 299 Q6DC58 TM223_DANRE GO:0016021 integral to membrane reviewed IPR026100; Transmembrane protein 223 tmem223 zgc:101024 Danio rerio (Zebrafish) (Brachydanio rerio) 248 Q6DC58 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6331 sp Q6DC58 TM223_DANRE 75.94 187 44 1 491 1051 63 248 2E-96 299 Q6DC58 TM223_DANRE GO:0016021 integral to membrane reviewed IPR026100; Transmembrane protein 223 tmem223 zgc:101024 Danio rerio (Zebrafish) (Brachydanio rerio) 248 Q6DC58 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6331 sp Q6DC58 TM223_DANRE 75.94 187 44 1 491 1051 63 248 2E-96 299 Q6DC58 TM223_DANRE GO:0016021 integral to membrane reviewed IPR026100; Transmembrane protein 223 tmem223 zgc:101024 Danio rerio (Zebrafish) (Brachydanio rerio) 248 Q6DC58 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6331 sp Q6DC58 TM223_DANRE 75.94 187 44 1 491 1051 63 248 2E-96 299 Q6DC58 TM223_DANRE GO:0016021 integral to membrane reviewed IPR026100; Transmembrane protein 223 tmem223 zgc:101024 Danio rerio (Zebrafish) (Brachydanio rerio) 248 Q6DC58 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 86.06 208 23 3 1807 1184 1 202 9E-179 370 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 86.06 208 23 3 1807 1184 1 202 9E-179 370 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 86.06 208 23 3 1807 1184 1 202 9E-179 370 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 86.06 208 23 3 1807 1184 1 202 9E-179 370 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 71.73 191 37 1 1173 601 209 382 9E-179 280 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 71.73 191 37 1 1173 601 209 382 9E-179 280 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 71.73 191 37 1 1173 601 209 382 9E-179 280 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6362 sp Q6DC64 MET16_DANRE 71.73 191 37 1 1173 601 209 382 9E-179 280 Q6DC64 MET16_DANRE GO:0008168 methyltransferase activity reviewed IPR010286; IPR017182; Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein) mettl16 mett10d zgc:100981 Danio rerio (Zebrafish) (Brachydanio rerio) 471 Q6DC64 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig489 sp Q6DC66 BOKA_DANRE 87.18 117 12 1 384 734 1 114 1E-65 209 Q6DC66 BOKA_DANRE GO:0006915; GO:0042981 apoptotic process; regulation of apoptotic process reviewed IPR002475; IPR026298; IPR026309; Bcl-2-related ovarian killer protein homolog A (zBok1) boka bok zgc:100979 Danio rerio (Zebrafish) (Brachydanio rerio) 221 Q6DC66 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig489 sp Q6DC66 BOKA_DANRE 87.18 117 12 1 384 734 1 114 1E-65 209 Q6DC66 BOKA_DANRE GO:0006915; GO:0042981 apoptotic process; regulation of apoptotic process reviewed IPR002475; IPR026298; IPR026309; Bcl-2-related ovarian killer protein homolog A (zBok1) boka bok zgc:100979 Danio rerio (Zebrafish) (Brachydanio rerio) 221 Q6DC66 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig489 sp Q6DC66 BOKA_DANRE 87.18 117 12 1 384 734 1 114 1E-65 209 Q6DC66 BOKA_DANRE GO:0006915; GO:0042981 apoptotic process; regulation of apoptotic process reviewed IPR002475; IPR026298; IPR026309; Bcl-2-related ovarian killer protein homolog A (zBok1) boka bok zgc:100979 Danio rerio (Zebrafish) (Brachydanio rerio) 221 Q6DC66 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig4609 sp Q6DCZ7 FBP1L_XENLA 60 170 68 0 510 1 169 338 2E-63 210 Q6DCZ7 FBP1L_XENLA GO:0006914; GO:0005938; GO:0016023; GO:0005856; GO:0006897; GO:0008289; GO:0005886 autophagy; cell cortex; cytoplasmic membrane-bounded vesicle; cytoskeleton; endocytosis; lipid binding; plasma membrane reviewed IPR001060; IPR001452; Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1) fnbp1l toca1 Xenopus laevis (African clawed frog) 543 Q6DCZ7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6179 sp Q6DFC2 CCD77_XENLA 52.31 260 105 3 742 2 131 384 5E-109 251 Q6DFC2 CCD77_XENLA reviewed Coiled-coil domain-containing protein 77 ccdc77 Xenopus laevis (African clawed frog) 496 ConsensusfromContig6179 sp Q6DFC2 CCD77_XENLA 72.73 110 29 1 1064 738 23 132 5E-109 165 Q6DFC2 CCD77_XENLA reviewed Coiled-coil domain-containing protein 77 ccdc77 Xenopus laevis (African clawed frog) 496 ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0016605 GO:0016605 PML body nucleus C ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0019964 GO:0019964 interferon-gamma binding other molecular function F ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0031463 GO:0031463 Cul3-RING ubiquitin ligase complex other cellular component C ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0043161 GO:0043161 proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0044444 GO:0044444 cytoplasmic part other cellular component C ConsensusfromContig5915 sp Q6DFF6 KLH20_XENLA 100 160 0 0 723 244 161 320 1E-108 332 Q6DFF6 KLH20_XENLA GO:0031463; GO:0016605; GO:0005737; GO:0019964; GO:0043066; GO:0048471; GO:0043161; GO:0004842 Cul3-RING ubiquitin ligase complex; PML body; cytoplasm; interferon-gamma binding; negative regulation of apoptotic process; perinuclear region of cytoplasm; proteasomal ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR011705; IPR000210; IPR011333; IPR013069; IPR011043; IPR015916; IPR017096; IPR006652; Protein modification; protein ubiquitination. Kelch-like protein 20 klhl20 Xenopus laevis (African clawed frog) 604 Q6DFF6 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig411 sp Q6DG19 MFSD5_DANRE 83.51 188 31 0 566 3 1 188 1E-96 298 Q6DG19 MFSD5_DANRE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR008509; IPR016196; Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) mfsd5 zgc:91807 Danio rerio (Zebrafish) (Brachydanio rerio) 481 Q6DG19 GO:0006810 GO:0006810 transport transport P ConsensusfromContig411 sp Q6DG19 MFSD5_DANRE 83.51 188 31 0 566 3 1 188 1E-96 298 Q6DG19 MFSD5_DANRE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR008509; IPR016196; Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) mfsd5 zgc:91807 Danio rerio (Zebrafish) (Brachydanio rerio) 481 Q6DG19 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig411 sp Q6DG19 MFSD5_DANRE 83.51 188 31 0 566 3 1 188 1E-96 298 Q6DG19 MFSD5_DANRE GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR008509; IPR016196; Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) mfsd5 zgc:91807 Danio rerio (Zebrafish) (Brachydanio rerio) 481 Q6DG19 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3202 sp Q6DG60 UBE2Z_DANRE 78.46 130 19 4 390 1 8 128 2E-58 189 Q6DG60 UBE2Z_DANRE GO:0005524; GO:0006915; GO:0005737; GO:0005634; GO:0004842 ATP binding; apoptotic process; cytoplasm; nucleus; ubiquitin-protein ligase activity reviewed IPR000608; IPR016135; Protein modification; protein ubiquitination. Ubiquitin-conjugating enzyme E2 Z (EC 6.3.2.19) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z) ube2z zgc:92419 Danio rerio (Zebrafish) (Brachydanio rerio) 328 Q6DG60 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0006916 GO:0006916 anti-apoptosis death P ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0006979 GO:0006979 response to oxidative stress stress response P ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0042277 GO:0042277 peptide binding other molecular function F ConsensusfromContig5644 sp Q6DGG0 PPID_RAT 69.97 353 103 1 141 1190 18 370 4E-178 513 Q6DGG0 PPID_RAT GO:0030544; GO:0051879; GO:0006915; GO:0071492; GO:0061077; GO:0016018; GO:0030331; GO:0034389; GO:0005739; GO:0043066; GO:0000122; GO:0005730; GO:0005654; GO:0003755; GO:0043065; GO:0006461; GO:0015031; GO:0051881; GO:0006979; GO:0008134 Hsp70 protein binding; Hsp90 protein binding; apoptotic process; cellular response to UV-A; chaperone-mediated protein folding; cyclosporin A binding; estrogen receptor binding; lipid particle organization; mitochondrion; negative regulation of apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleolus; nucleoplasm; peptidyl-prolyl cis-trans isomerase activity; positive regulation of apoptotic process; protein complex assembly; protein transport; regulation of mitochondrial membrane potential; response to oxidative stress; transcription factor binding reviewed IPR002130; IPR020892; IPR013026; IPR011990; IPR019734; Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Rotamase D) Ppid Rattus norvegicus (Rat) 370 Q6DGG0 GO:0051881 GO:0051881 regulation of mitochondrial membrane potential other biological processes P ConsensusfromContig1414 sp Q6DGK9 CK049_DANRE 76.28 156 37 0 3 470 63 218 4E-86 262 Q6DGK9 CK049_DANRE reviewed UPF0705 protein C11orf49 homolog zgc:92873 Danio rerio (Zebrafish) (Brachydanio rerio) 331 Q6DGK9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1414 sp Q6DGK9 CK049_DANRE 76.28 156 37 0 3 470 63 218 4E-86 262 Q6DGK9 CK049_DANRE reviewed UPF0705 protein C11orf49 homolog zgc:92873 Danio rerio (Zebrafish) (Brachydanio rerio) 331 Q6DGK9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1414 sp Q6DGK9 CK049_DANRE 76.28 156 37 0 3 470 63 218 4E-86 262 Q6DGK9 CK049_DANRE reviewed UPF0705 protein C11orf49 homolog zgc:92873 Danio rerio (Zebrafish) (Brachydanio rerio) 331 Q6DGK9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig163 sp Q6DGR4 F203A_DANRE 80.57 283 55 0 53 901 1 283 1E-138 406 Q6DGR4 F203A_DANRE reviewed IPR011989; IPR016024; IPR007206; IPR007205; Protein FAM203A (Brain protein 16) fam203a brp16 zgc:92803 Danio rerio (Zebrafish) (Brachydanio rerio) 377 Q6DGR4 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig163 sp Q6DGR4 F203A_DANRE 80.57 283 55 0 53 901 1 283 1E-138 406 Q6DGR4 F203A_DANRE reviewed IPR011989; IPR016024; IPR007206; IPR007205; Protein FAM203A (Brain protein 16) fam203a brp16 zgc:92803 Danio rerio (Zebrafish) (Brachydanio rerio) 377 Q6DGR4 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig163 sp Q6DGR4 F203A_DANRE 80.57 283 55 0 53 901 1 283 1E-138 406 Q6DGR4 F203A_DANRE reviewed IPR011989; IPR016024; IPR007206; IPR007205; Protein FAM203A (Brain protein 16) fam203a brp16 zgc:92803 Danio rerio (Zebrafish) (Brachydanio rerio) 377 Q6DGR4 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3483 sp Q6DGU5 S2546_DANRE 83.02 106 13 1 320 3 59 159 1E-55 183 Q6DGU5 S2546_DANRE GO:0016021; GO:0005743; GO:0006810 integral to membrane; mitochondrial inner membrane; transport reviewed IPR018108; IPR023395; Solute carrier family 25 member 46 slc25a46 si:ch211-220b11.2 zgc:92767 Danio rerio (Zebrafish) (Brachydanio rerio) 405 Q6DGU5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1470 sp Q6DGX3 ANR54_DANRE 85.21 142 20 1 1 426 145 285 3E-78 241 Q6DGX3 ANR54_DANRE GO:0005737; GO:0030496; GO:0005634 cytoplasm; midbody; nucleus reviewed IPR002110; IPR020683; Ankyrin repeat domain-containing protein 54 ankrd54 zgc:110569 zgc:92735 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q6DGX3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1470 sp Q6DGX3 ANR54_DANRE 85.21 142 20 1 1 426 145 285 3E-78 241 Q6DGX3 ANR54_DANRE GO:0005737; GO:0030496; GO:0005634 cytoplasm; midbody; nucleus reviewed IPR002110; IPR020683; Ankyrin repeat domain-containing protein 54 ankrd54 zgc:110569 zgc:92735 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q6DGX3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1470 sp Q6DGX3 ANR54_DANRE 85.21 142 20 1 1 426 145 285 3E-78 241 Q6DGX3 ANR54_DANRE GO:0005737; GO:0030496; GO:0005634 cytoplasm; midbody; nucleus reviewed IPR002110; IPR020683; Ankyrin repeat domain-containing protein 54 ankrd54 zgc:110569 zgc:92735 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q6DGX3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5522 sp Q6DGZ3 THOC7_DANRE 85.71 196 28 0 1 588 7 202 1E-110 324 Q6DGZ3 THOC7_DANRE GO:0003723; GO:0008380; GO:0000445; GO:0005737; GO:0006397; GO:0051028 RNA binding; RNA splicing; THO complex part of transcription export complex; cytoplasm; mRNA processing; mRNA transport reviewed IPR008501; THO complex subunit 7 homolog thoc7 zgc:92711 Danio rerio (Zebrafish) (Brachydanio rerio) 202 Q6DGZ3 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5840 sp Q6DH26 MED31_DANRE 92.73 110 8 0 179 508 2 111 2E-69 215 Q6DH26 MED31_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR008831; Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1) med31 soh1 Danio rerio (Zebrafish) (Brachydanio rerio) 136 Q6DH26 GO:0001104 ConsensusfromContig5840 sp Q6DH26 MED31_DANRE 92.73 110 8 0 179 508 2 111 2E-69 215 Q6DH26 MED31_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR008831; Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1) med31 soh1 Danio rerio (Zebrafish) (Brachydanio rerio) 136 Q6DH26 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5840 sp Q6DH26 MED31_DANRE 92.73 110 8 0 179 508 2 111 2E-69 215 Q6DH26 MED31_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR008831; Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1) med31 soh1 Danio rerio (Zebrafish) (Brachydanio rerio) 136 Q6DH26 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5840 sp Q6DH26 MED31_DANRE 92.73 110 8 0 179 508 2 111 2E-69 215 Q6DH26 MED31_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR008831; Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1) med31 soh1 Danio rerio (Zebrafish) (Brachydanio rerio) 136 Q6DH26 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5840 sp Q6DH26 MED31_DANRE 92.73 110 8 0 179 508 2 111 2E-69 215 Q6DH26 MED31_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR008831; Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit soh1) med31 soh1 Danio rerio (Zebrafish) (Brachydanio rerio) 136 Q6DH26 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0001654 GO:0001654 eye development developmental processes P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig5908 sp Q6DHC1 RB18B_DANRE 89.86 148 15 0 21 464 45 192 1E-89 278 Q6DHC1 RB18B_DANRE GO:0005525; GO:0007420; GO:0009790; GO:0001654; GO:0015031; GO:0007264 GTP binding; brain development; embryo development; eye development; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR025662; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-18-B rab18b rab18 zgc:92523 Danio rerio (Zebrafish) (Brachydanio rerio) 205 Q6DHC1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5663 sp Q6DHU8 TOPK_DANRE 80 340 61 4 1356 346 4 339 0 522 Q6DHU8 TOPK_DANRE GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR008271; Lymphokine-activated killer T-cell-originated protein kinase homolog (EC 2.7.12.2) (PDZ-binding kinase) pbk topk zgc:92050 Danio rerio (Zebrafish) (Brachydanio rerio) 339 Q6DHU8 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig254 sp Q6DI35 TFP11_DANRE 83.44 157 26 0 471 1 131 287 7E-77 250 Q6DI35 TFP11_DANRE GO:0003677; GO:0008380; GO:0006397; GO:0006355; GO:0005681 DNA binding; RNA splicing; mRNA processing; regulation of transcription, DNA-dependent; spliceosomal complex reviewed IPR000467; IPR022783; IPR024933; IPR022159; Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1) tfip11 stip zgc:86644 Danio rerio (Zebrafish) (Brachydanio rerio) 832 Q6DI35 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig713 sp Q6DIP5 EMAL4_XENTR 68.42 133 27 3 3 386 722 844 9E-52 182 Q6DIP5 EMAL4_XENTR GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 928 Q6DIP5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig713 sp Q6DIP5 EMAL4_XENTR 68.42 133 27 3 3 386 722 844 9E-52 182 Q6DIP5 EMAL4_XENTR GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 928 Q6DIP5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig713 sp Q6DIP5 EMAL4_XENTR 68.42 133 27 3 3 386 722 844 9E-52 182 Q6DIP5 EMAL4_XENTR GO:0005737; GO:0005874 cytoplasm; microtubule reviewed IPR005108; IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Echinoderm microtubule-associated protein-like 4 (EMAP-4) eml4 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 928 Q6DIP5 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0001755 GO:0001755 neural crest cell migration developmental processes P ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig5914 sp Q6DIR5 TES_XENTR 72.73 187 51 0 754 194 234 420 1E-96 296 Q6DIR5 TES_XENTR GO:0005938; GO:0005925; GO:0001755; GO:0042127; GO:0008270 cell cortex; focal adhesion; neural crest cell migration; regulation of cell proliferation; zinc ion binding reviewed IPR010442; IPR027683; IPR001781; Testin tes TNeu019j18.1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 422 Q6DIR5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2177 sp Q6DJB3 DEFI8_XENTR 84.75 118 18 0 355 2 204 321 9E-69 219 Q6DJB3 DEFI8_XENTR GO:0035556; GO:0008270 intracellular signal transduction; zinc ion binding reviewed IPR025258; IPR002219; IPR001841; Differentially expressed in FDCP 8 homolog (DEF-8) def8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 443 Q6DJB3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2177 sp Q6DJB3 DEFI8_XENTR 84.75 118 18 0 355 2 204 321 9E-69 219 Q6DJB3 DEFI8_XENTR GO:0035556; GO:0008270 intracellular signal transduction; zinc ion binding reviewed IPR025258; IPR002219; IPR001841; Differentially expressed in FDCP 8 homolog (DEF-8) def8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 443 Q6DJB3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2177 sp Q6DJB3 DEFI8_XENTR 84.75 118 18 0 355 2 204 321 9E-69 219 Q6DJB3 DEFI8_XENTR GO:0035556; GO:0008270 intracellular signal transduction; zinc ion binding reviewed IPR025258; IPR002219; IPR001841; Differentially expressed in FDCP 8 homolog (DEF-8) def8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 443 Q6DJB3 GO:0035556 ConsensusfromContig2177 sp Q6DJB3 DEFI8_XENTR 84.75 118 18 0 355 2 204 321 9E-69 219 Q6DJB3 DEFI8_XENTR GO:0035556; GO:0008270 intracellular signal transduction; zinc ion binding reviewed IPR025258; IPR002219; IPR001841; Differentially expressed in FDCP 8 homolog (DEF-8) def8 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) 443 Q6DJB3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0016973 GO:0016973 poly(A)+ mRNA export from nucleus transport P ConsensusfromContig5799 sp Q6DRB1 GLE1_DANRE 69.29 547 163 2 471 2096 129 675 0 672 Q6DRB1 GLE1_DANRE GO:0005737; GO:0005643; GO:0016973; GO:0015031 cytoplasm; nuclear pore; poly(A)+ mRNA export from nucleus; protein transport reviewed IPR012476; Nucleoporin GLE1 (GLE1-like protein) gle1 gle1l Danio rerio (Zebrafish) (Brachydanio rerio) 695 Q6DRB1 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5648 sp Q6DRC4 EIF3G_DANRE 93.48 276 17 1 830 3 1 275 0 536 Q6DRC4 EIF3G_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0000166; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; nucleotide binding; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR017334; IPR024675; IPR012677; IPR000504; Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) eif3g eif3s4 Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q6DRC4 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0001654 GO:0001654 eye development developmental processes P ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0048538 GO:0048538 thymus development developmental processes P ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0048794 GO:0048794 swim bladder development developmental processes P ConsensusfromContig6343 sp Q6DRF9 WDR55_DANRE 75.14 346 86 0 13 1050 21 366 6E-173 505 Q6DRF9 WDR55_DANRE GO:0001654; GO:0005730; GO:0060465; GO:0006364; GO:0048794; GO:0048538 eye development; nucleolus; pharynx development; rRNA processing; swim bladder development; thymus development reviewed IPR015943; IPR001680; IPR019775; IPR017986; IPR017422; WD repeat-containing protein 55 wdr55 Danio rerio (Zebrafish) (Brachydanio rerio) 387 Q6DRF9 GO:0060465 GO:0060465 pharynx development developmental processes P ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5745 sp Q6DRM0 WRB_DANRE 85.12 168 25 0 966 463 3 170 8E-101 300 Q6DRM0 WRB_DANRE GO:0005789; GO:0007507; GO:0016021; GO:0060041 endoplasmic reticulum membrane; heart development; integral to membrane; retina development in camera-type eye reviewed Tail-anchored protein insertion receptor WRB (Tryptophan-rich basic protein) (WRB) wrb Danio rerio (Zebrafish) (Brachydanio rerio) 170 Q6DRM0 GO:0060041 GO:0060041 retina development in camera-type eye developmental processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 75.98 358 86 0 1489 416 329 686 0 580 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 75.98 358 86 0 1489 416 329 686 0 580 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 75.98 358 86 0 1489 416 329 686 0 580 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 75.98 358 86 0 1489 416 329 686 0 580 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 75.98 358 86 0 1489 416 329 686 0 580 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0019216 GO:0019216 regulation of lipid metabolic process other metabolic processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 82.5 80 14 0 1725 1486 250 329 0 137 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 82.5 80 14 0 1725 1486 250 329 0 137 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 82.5 80 14 0 1725 1486 250 329 0 137 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 82.5 80 14 0 1725 1486 250 329 0 137 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 82.5 80 14 0 1725 1486 250 329 0 137 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0019216 GO:0019216 regulation of lipid metabolic process other metabolic processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 43.86 114 52 2 422 99 685 792 0 87 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 43.86 114 52 2 422 99 685 792 0 87 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 43.86 114 52 2 422 99 685 792 0 87 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 43.86 114 52 2 422 99 685 792 0 87 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0007517 GO:0007517 muscle organ development developmental processes P ConsensusfromContig6138 sp Q6DRN3 NOC3L_DANRE 43.86 114 52 2 422 99 685 792 0 87 Q6DRN3 NOC3L_DANRE GO:0007517; GO:0005730; GO:0005634; GO:0019216 muscle organ development; nucleolus; nucleus; regulation of lipid metabolic process reviewed IPR016024; IPR005612; IPR011501; IPR016903; Nucleolar complex protein 3 homolog (NOC3 protein homolog) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein) noc3l Danio rerio (Zebrafish) (Brachydanio rerio) 800 Q6DRN3 GO:0019216 GO:0019216 regulation of lipid metabolic process other metabolic processes P ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0003407 ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0007096 GO:0007096 regulation of exit from mitosis cell cycle and proliferation P ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0007096 GO:0007096 regulation of exit from mitosis cell organization and biogenesis P ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0042127 GO:0042127 regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6342 sp Q6DRP2 GNL3_DANRE 68.25 274 85 2 458 1273 126 399 2E-129 395 Q6DRP2 GNL3_DANRE GO:0005525; GO:0003924; GO:0003407; GO:0005730; GO:0042127; GO:0007096; GO:0045664; GO:0042254 GTP binding; GTPase activity; neural retina development; nucleolus; regulation of cell proliferation; regulation of exit from mitosis; regulation of neuron differentiation; ribosome biogenesis reviewed IPR014813; IPR023179; IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3 (Nucleostemin-like protein) gnl3 Danio rerio (Zebrafish) (Brachydanio rerio) 561 Q6DRP2 GO:0045664 GO:0045664 regulation of neuron differentiation developmental processes P ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0009615 GO:0009615 response to virus other biological processes P ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5770 sp Q6EE23 RSAD2_SINCH 70.2 255 72 1 39 803 1 251 3E-130 380 Q6EE23 RSAD2_SINCH GO:0051539; GO:0003824; GO:0051607; GO:0005789; GO:0045087; GO:0005811; GO:0008152; GO:0046872 4 iron, 4 sulfur cluster binding; catalytic activity; defense response to virus; endoplasmic reticulum membrane; innate immune response; lipid particle; metabolic process; metal ion binding reviewed IPR013785; IPR006638; IPR007197; IPR026372; Radical S-adenosyl methionine domain-containing protein 2 (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible) rsad2 Siniperca chuatsi (Chinese perch) 354 Q6EE23 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6263 sp Q6EE31 TCPQ_CHICK 80.71 539 104 0 93 1709 1 539 0 890 Q6EE31 TCPQ_CHICK GO:0005524; GO:0005737; GO:0005815; GO:0006457 ATP binding; cytoplasm; microtubule organizing center; protein folding reviewed IPR012721; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) CCT8 Gallus gallus (Chicken) 548 Q6EE31 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0007417 GO:0007417 central nervous system development developmental processes P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0007422 GO:0007422 peripheral nervous system development developmental processes P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0043049 GO:0043049 otic placode formation developmental processes P ConsensusfromContig6198 sp Q6EJB7 SOX3_DANRE 92.67 300 19 3 1574 681 1 299 0 520 Q6EJB7 SOX3_DANRE GO:0003677; GO:0007417; GO:0030182; GO:0005634; GO:0043049; GO:0007422; GO:0051091; GO:0006351 DNA binding; central nervous system development; neuron differentiation; nucleus; otic placode formation; peripheral nervous system development; positive regulation of sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR009071; IPR022097; Transcription factor Sox-3 sox3 zgc:110279 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6EJB7 GO:0051091 GO:0051091 positive regulation of transcription factor activity RNA metabolism P ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0004161 GO:0004161 dimethylallyltranstransferase activity other molecular function F ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0004311 GO:0004311 farnesyltranstransferase activity other molecular function F ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0004337 GO:0004337 geranyltranstransferase activity other molecular function F ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0006720 GO:0006720 isoprenoid metabolic process other metabolic processes P ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0008299 GO:0008299 isoprenoid biosynthetic process other metabolic processes P ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2276 sp Q6F596 GGPPS_RAT 90.68 118 11 0 355 2 8 125 9E-62 198 Q6F596 GGPPS_RAT GO:0005737; GO:0004161; GO:0045337; GO:0004311; GO:0033384; GO:0033386; GO:0004337; GO:0006720; GO:0046872 cytoplasm; dimethylallyltranstransferase activity; farnesyl diphosphate biosynthetic process; farnesyltranstransferase activity; geranyl diphosphate biosynthetic process; geranylgeranyl diphosphate biosynthetic process; geranyltranstransferase activity; isoprenoid metabolic process; metal ion binding reviewed IPR000092; IPR017446; IPR008949; Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1. Isoprenoid biosynthesis; geranylgeranyl diphosphate biosynthesis; geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate: step 1/1. Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10) Ggps1 Rattus norvegicus (Rat) 300 Q6F596 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint stress response P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0032874 GO:0032874 positive regulation of stress-activated MAPK cascade signal transduction P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0032874 GO:0032874 positive regulation of stress-activated MAPK cascade stress response P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0051403 GO:0051403 stress-activated MAPK cascade signal transduction P ConsensusfromContig2232 sp Q6GPK9 TAOK2_XENLA 80.87 115 22 0 346 2 432 546 2E-54 187 Q6GPK9 TAOK2_XENLA GO:0005524; GO:0031572; GO:0032874; GO:0004674; GO:0051403 ATP binding; G2 DNA damage checkpoint; positive regulation of stress-activated MAPK cascade; protein serine/threonine kinase activity; stress-activated MAPK cascade reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Thousand and one amino acid protein 2) taok2 Xenopus laevis (African clawed frog) 1025 Q6GPK9 GO:0051403 GO:0051403 stress-activated MAPK cascade stress response P ConsensusfromContig6310 sp Q6GQN0 CEP41_DANRE 56.42 335 117 7 1786 848 47 374 1E-108 340 Q6GQN0 CEP41_DANRE GO:0005814; GO:0035083; GO:0036064; GO:0072372; GO:0018095; GO:0015031; GO:0070740 centriole; cilium axoneme assembly; cilium basal body; primary cilium; protein polyglutamylation; protein transport; tubulin-glutamic acid ligase activity reviewed IPR001763; Centrosomal protein of 41 kDa (Cep41) (Testis-specific gene A14 protein) cep41 tsga14 zgc:91859 Danio rerio (Zebrafish) (Brachydanio rerio) 374 Q6GQN0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0006666 GO:0006666 3-keto-sphinganine metabolic process other metabolic processes P ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0030148 GO:0030148 sphingolipid biosynthetic process other metabolic processes P ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0047560 GO:0047560 3-dehydrosphinganine reductase activity other molecular function F ConsensusfromContig1624 sp Q6GV12 KDSR_MOUSE 83.1 142 24 0 426 1 17 158 4E-80 249 Q6GV12 KDSR_MOUSE GO:0047560; GO:0006666; GO:0005783; GO:0005789; GO:0016021; GO:0030148 3-dehydrosphinganine reductase activity; 3-keto-sphinganine metabolic process; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; sphingolipid biosynthetic process reviewed IPR002198; IPR002347; IPR016040; IPR020904; Lipid metabolism; sphingolipid metabolism. 3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1 homolog) (FVT-1) Kdsr Fvt1 Mus musculus (Mouse) 332 Q6GV12 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0001104 ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5756 sp Q6IQ63 MED6_DANRE 87.89 223 26 1 1449 2114 1 223 6E-115 357 Q6IQ63 MED6_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR007018; IPR016820; Mediator of RNA polymerase II transcription subunit 6 (Mediator complex subunit 6) med6 zgc:86933 Danio rerio (Zebrafish) (Brachydanio rerio) 254 Q6IQ63 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016706 GO:0016706 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors" other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 73.39 124 33 0 234 605 27 150 1E-60 194 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0016706 GO:0016706 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors" other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6288 sp Q6IQE9 ALKB6_DANRE 54.84 62 27 1 674 859 174 234 1E-60 62 Q6IQE9 ALKB6_DANRE GO:0005737; GO:0046872; GO:0005634; GO:0016706 cytoplasm; metal ion binding; nucleus; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors reviewed IPR027450; IPR005123; Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6) alkbh6 si:ch211-222c22.5 Danio rerio (Zebrafish) (Brachydanio rerio) 234 Q6IQE9 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5739 sp Q6IQU7 INT12_DANRE 61.23 472 167 11 1 1392 5 468 1E-114 355 Q6IQU7 INT12_DANRE GO:0005634; GO:0008270 nucleus; zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Integrator complex subunit 12 (Int12) ints12 zgc:86602 Danio rerio (Zebrafish) (Brachydanio rerio) 479 Q6IQU7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5739 sp Q6IQU7 INT12_DANRE 61.23 472 167 11 1 1392 5 468 1E-114 355 Q6IQU7 INT12_DANRE GO:0005634; GO:0008270 nucleus; zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Integrator complex subunit 12 (Int12) ints12 zgc:86602 Danio rerio (Zebrafish) (Brachydanio rerio) 479 Q6IQU7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5739 sp Q6IQU7 INT12_DANRE 61.23 472 167 11 1 1392 5 468 1E-114 355 Q6IQU7 INT12_DANRE GO:0005634; GO:0008270 nucleus; zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Integrator complex subunit 12 (Int12) ints12 zgc:86602 Danio rerio (Zebrafish) (Brachydanio rerio) 479 Q6IQU7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0008060 GO:0008060 ARF GTPase activator activity enzyme regulator activity F ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0032312 GO:0032312 regulation of ARF GTPase activity signal transduction P ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig5127 sp Q6IVG4 ACAP2_RABIT 88.99 109 12 0 327 1 293 401 1E-53 184 Q6IVG4 ACAP2_RABIT GO:0008060; GO:1990090; GO:0010008; GO:0005543; GO:0043547; GO:0036010; GO:0032312; GO:0008270 ARF GTPase activator activity; cellular response to nerve growth factor stimulus; endosome membrane; phospholipid binding; positive regulation of GTPase activity; protein localization to endosome; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2) ACAP2 CENTB2 Oryctolagus cuniculus (Rabbit) 778 Q6IVG4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1839 sp Q6N043 Z280D_HUMAN 79.46 112 23 0 345 10 346 457 6E-60 202 Q6N043 Z280D_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR025243; IPR007087; IPR015880; Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634) ZNF280D KIAA1584 SUHW4 ZNF634 Homo sapiens (Human) 979 Q6N043 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2405 sp Q6NUC6 RC3H1_XENLA 99.1 111 1 0 3 335 142 252 3E-58 198 Q6NUC6 RC3H1_XENLA GO:0003723; GO:0000932; GO:0008270 RNA binding; cytoplasmic mRNA processing body; zinc ion binding reviewed IPR000571; IPR001841; IPR013083; IPR017907; Roquin-1 (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) rc3h1 Xenopus laevis (African clawed frog) 1114 Q6NUC6 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2405 sp Q6NUC6 RC3H1_XENLA 99.1 111 1 0 3 335 142 252 3E-58 198 Q6NUC6 RC3H1_XENLA GO:0003723; GO:0000932; GO:0008270 RNA binding; cytoplasmic mRNA processing body; zinc ion binding reviewed IPR000571; IPR001841; IPR013083; IPR017907; Roquin-1 (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) rc3h1 Xenopus laevis (African clawed frog) 1114 Q6NUC6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2405 sp Q6NUC6 RC3H1_XENLA 99.1 111 1 0 3 335 142 252 3E-58 198 Q6NUC6 RC3H1_XENLA GO:0003723; GO:0000932; GO:0008270 RNA binding; cytoplasmic mRNA processing body; zinc ion binding reviewed IPR000571; IPR001841; IPR013083; IPR017907; Roquin-1 (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) rc3h1 Xenopus laevis (African clawed frog) 1114 Q6NUC6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2405 sp Q6NUC6 RC3H1_XENLA 99.1 111 1 0 3 335 142 252 3E-58 198 Q6NUC6 RC3H1_XENLA GO:0003723; GO:0000932; GO:0008270 RNA binding; cytoplasmic mRNA processing body; zinc ion binding reviewed IPR000571; IPR001841; IPR013083; IPR017907; Roquin-1 (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) rc3h1 Xenopus laevis (African clawed frog) 1114 Q6NUC6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5968 sp Q6NUD0 MEP50_XENLA 61.42 127 49 0 2169 1789 72 198 5E-76 174 Q6NUD0 MEP50_XENLA GO:0005737; GO:0035097 cytoplasm; histone methyltransferase complex reviewed IPR015943; IPR001680; IPR019775; IPR017986; Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77) wdr77 mep50 Xenopus laevis (African clawed frog) 333 ConsensusfromContig5968 sp Q6NUD0 MEP50_XENLA 41.28 109 56 2 1751 1437 211 315 5E-76 82 Q6NUD0 MEP50_XENLA GO:0005737; GO:0035097 cytoplasm; histone methyltransferase complex reviewed IPR015943; IPR001680; IPR019775; IPR017986; Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77) wdr77 mep50 Xenopus laevis (African clawed frog) 333 ConsensusfromContig5968 sp Q6NUD0 MEP50_XENLA 63.64 66 24 0 2363 2166 7 72 5E-76 73.9 Q6NUD0 MEP50_XENLA GO:0005737; GO:0035097 cytoplasm; histone methyltransferase complex reviewed IPR015943; IPR001680; IPR019775; IPR017986; Methylosome protein 50 (MEP-50) (WD repeat-containing protein 77) wdr77 mep50 Xenopus laevis (African clawed frog) 333 ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig1755 sp Q6NUD7 ZN521_XENLA 91.74 121 9 1 534 175 1190 1310 1E-70 237 Q6NUD7 ZN521_XENLA GO:0003677; GO:0030154; GO:0046872; GO:0007275; GO:0005634; GO:0006355; GO:0006351 DNA binding; cell differentiation; metal ion binding; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; IPR013083; Zinc finger protein 521 znf521 Xenopus laevis (African clawed frog) 1310 Q6NUD7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2860 sp Q6NUW9 FGGY_DANRE 69.39 147 45 0 443 3 290 436 8E-54 183 Q6NUW9 FGGY_DANRE GO:0005975; GO:0016301; GO:0016773 carbohydrate metabolic process; kinase activity; phosphotransferase activity, alcohol group as acceptor reviewed IPR006003; IPR018485; IPR018484; FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-) fggy zgc:85818 Danio rerio (Zebrafish) (Brachydanio rerio) 545 Q6NUW9 GO:0016773 GO:0016773 "phosphotransferase activity, alcohol group as acceptor" other molecular function F ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6099 sp Q6NV26 SDA1_DANRE 61 259 62 6 723 1 373 610 8E-80 259 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6043 sp Q6NV26 SDA1_DANRE 87.53 361 45 0 110 1192 1 361 0 542 Q6NV26 SDA1_DANRE GO:0030036; GO:0005730; GO:0015031; GO:0042273; GO:0000055 actin cytoskeleton organization; nucleolus; protein transport; ribosomal large subunit biogenesis; ribosomal large subunit export from nucleus reviewed IPR016024; IPR027312; IPR007949; IPR012977; Protein SDA1 homolog (SDA1 domain-containing protein 1) sdad1 Danio rerio (Zebrafish) (Brachydanio rerio) 682 Q6NV26 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0008670 GO:0008670 "2,4-dienoyl-CoA reductase (NADPH) activity" other molecular function F ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig342 sp Q6NV34 DECR2_DANRE 86.41 184 25 0 601 50 90 273 8E-116 338 Q6NV34 DECR2_DANRE GO:0008670; GO:0006631; GO:0005777 2,4-dienoyl-CoA reductase (NADPH) activity; fatty acid metabolic process; peroxisome reviewed IPR002198; IPR002347; IPR016040; Peroxisomal 2,4-dienoyl-CoA reductase (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) decr2 si:ch211-153c20.5 zgc:85626 Danio rerio (Zebrafish) (Brachydanio rerio) 300 Q6NV34 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0019725 GO:0019725 cellular homeostasis other biological processes P ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0031307 GO:0031307 integral to mitochondrial outer membrane mitochondrion C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0031307 GO:0031307 integral to mitochondrial outer membrane other membranes C ConsensusfromContig2610 sp Q6NVC5 MIRO1_DANRE 84.25 127 20 0 5 385 374 500 2E-71 230 Q6NVC5 MIRO1_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0019725; GO:0031307; GO:0097345; GO:0047497; GO:0007264 GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular homeostasis; integral to mitochondrial outer membrane; mitochondrial outer membrane permeabilization; mitochondrion transport along microtubule; small GTPase mediated signal transduction reviewed IPR011992; IPR018247; IPR013566; IPR013567; IPR002048; IPR020860; IPR013684; IPR027417; IPR021181; IPR005225; IPR001806; Mitochondrial Rho GTPase 1-A (MIRO-1-A) (EC 3.6.5.-) (Ras homolog gene family member T1-A) rhot1a zgc:55581 Danio rerio (Zebrafish) (Brachydanio rerio) 619 Q6NVC5 GO:0047497 GO:0047497 mitochondrion transport along microtubule transport P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0005793 GO:0005793 ER-Golgi intermediate compartment ER/Golgi C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0007411 GO:0007411 axon guidance developmental processes P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0007411 GO:0007411 axon guidance cell organization and biogenesis P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0030509 GO:0030509 BMP signaling pathway signal transduction P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0031225 GO:0031225 anchored to membrane other membranes C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0042802 GO:0042802 identical protein binding other molecular function F ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0045121 GO:0045121 membrane raft other membranes C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0046658 GO:0046658 anchored to plasma membrane plasma membrane C ConsensusfromContig480 sp Q6NW40 RGMB_HUMAN 56.9 174 55 4 503 3 53 213 2E-53 184 Q6NW40 RGMB_HUMAN GO:0030509; GO:0046658; GO:0007411; GO:0007155; GO:0005793; GO:0042802; GO:0045121; GO:0045893 BMP signaling pathway; anchored to plasma membrane; axon guidance; cell adhesion; endoplasmic reticulum-Golgi intermediate compartment; identical protein binding; membrane raft; positive regulation of transcription, DNA-dependent reviewed IPR009496; IPR010536; RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON) RGMB Homo sapiens (Human) 437 Q6NW40 GO:0046658 GO:0046658 anchored to plasma membrane other membranes C ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0000226 GO:0000226 microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0034501 GO:0034501 protein localization to kinetochore other biological processes P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig5542 sp Q6NW76 AURKB_DANRE 80.53 226 34 4 111 779 1 219 4E-115 340 Q6NW76 AURKB_DANRE GO:0005524; GO:0034644; GO:0005694; GO:0007059; GO:0036089; GO:0046872; GO:0007275; GO:0002903; GO:0000122; GO:0005634; GO:0032467; GO:0034501; GO:0004674; GO:0051256 ATP binding; cellular response to UV; chromosome; chromosome segregation; cleavage furrow formation; metal ion binding; multicellular organismal development; negative regulation of B cell apoptotic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of cytokinesis; protein localization to kinetochore; protein serine/threonine kinase activity; spindle midzone assembly involved in mitosis reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase B (EC 2.7.11.1) (Serine/threonine kinase A) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase aurora-B) aurkb stka Danio rerio (Zebrafish) (Brachydanio rerio) 320 Q6NW76 GO:0071777 ConsensusfromContig6299 sp Q6NWE0 CK054_DANRE 79.87 298 60 0 1306 413 22 319 0 520 Q6NWE0 CK054_DANRE GO:0016787; GO:0046872; GO:0005634 hydrolase activity; metal ion binding; nucleus reviewed IPR015021; Ester hydrolase C11orf54 homolog (EC 3.1.-.-) zgc:85789 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6NWE0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6299 sp Q6NWE0 CK054_DANRE 79.87 298 60 0 1306 413 22 319 0 520 Q6NWE0 CK054_DANRE GO:0016787; GO:0046872; GO:0005634 hydrolase activity; metal ion binding; nucleus reviewed IPR015021; Ester hydrolase C11orf54 homolog (EC 3.1.-.-) zgc:85789 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6NWE0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6299 sp Q6NWE0 CK054_DANRE 79.87 298 60 0 1306 413 22 319 0 520 Q6NWE0 CK054_DANRE GO:0016787; GO:0046872; GO:0005634 hydrolase activity; metal ion binding; nucleus reviewed IPR015021; Ester hydrolase C11orf54 homolog (EC 3.1.-.-) zgc:85789 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6NWE0 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 68.47 314 71 4 489 1382 174 475 5E-163 313 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5710 sp Q6NWE1 PHF10_DANRE 93.45 168 9 1 2 505 10 175 5E-163 284 Q6NWE1 PHF10_DANRE GO:0007399; GO:0005634; GO:0006355; GO:0006351; GO:0008270 nervous system development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR011011; IPR001965; IPR019787; IPR001841; IPR013083; PHD finger protein 10 phf10 si:dkey-66m17.1 Danio rerio (Zebrafish) (Brachydanio rerio) 490 Q6NWE1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0005882 GO:0005882 intermediate filament cytoskeleton C ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0016363 GO:0016363 nuclear matrix nucleus C ConsensusfromContig5733 sp Q6NWF6 K2C8_DANRE 93.7 365 23 0 2616 1522 84 448 0 702 Q6NWF6 K2C8_DANRE GO:0005737; GO:0045095; GO:0016363; GO:0005654; GO:0005198 cytoplasm; keratin filament; nuclear matrix; nucleoplasm; structural molecule activity reviewed IPR001664; IPR018039; IPR003054; Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) krt8 krt2-8 Danio rerio (Zebrafish) (Brachydanio rerio) 520 Q6NWF6 GO:0045095 GO:0045095 keratin filament cytoskeleton C ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0008469 GO:0008469 histone-arginine N-methyltransferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0019919 GO:0019919 "peptidyl-arginine methylation, to asymmetrical-dimethyl arginine" protein metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0034969 GO:0034969 histone arginine methylation protein metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0034969 GO:0034969 histone arginine methylation cell organization and biogenesis P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0034970 GO:0034970 histone H3-R2 methylation protein metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0034970 GO:0034970 histone H3-R2 methylation cell organization and biogenesis P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0035241 GO:0035241 protein-arginine omega-N monomethyltransferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0035242 GO:0035242 protein-arginine omega-N asymmetric methyltransferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0042054 GO:0042054 histone methyltransferase activity other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0043985 GO:0043985 histone H4-R3 methylation protein metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0043985 GO:0043985 histone H4-R3 methylation cell organization and biogenesis P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0044020 GO:0044020 histone methyltransferase activity (H4-R3 specific) other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0070611 GO:0070611 histone methyltransferase activity (H3-R2 specific) other molecular function F ConsensusfromContig5668 sp Q6NWG4 ANM6_DANRE 80.29 345 68 0 1193 159 1 345 0 583 Q6NWG4 ANM6_DANRE GO:0006281; GO:0042393; GO:0070612; GO:0070611; GO:0044020; GO:0045892; GO:0005634; GO:0035242; GO:0035241; GO:0006351 DNA repair; histone binding; histone methyltransferase activity (H2A-R3 specific); histone methyltransferase activity (H3-R2 specific); histone methyltransferase activity (H4-R3 specific); negative regulation of transcription, DNA-dependent; nucleus; protein-arginine omega-N asymmetric methyltransferase activity; protein-arginine omega-N monomethyltransferase activity; transcription, DNA-dependent reviewed IPR025799; IPR026132; Protein arginine N-methyltransferase 6 (EC 2.1.1.-) (Histone-arginine N-methyltransferase PRMT6) (EC 2.1.1.125) prmt6 Danio rerio (Zebrafish) (Brachydanio rerio) 349 Q6NWG4 GO:0070612 GO:0070612 histone methyltransferase activity (H2A-R3 specific) other molecular function F ConsensusfromContig501 sp Q6NWH1 DCA10_DANRE 91.03 234 21 0 32 733 75 308 4E-156 451 Q6NWH1 DCA10_DANRE GO:0080008; GO:0016567 Cul4-RING ubiquitin ligase complex; protein ubiquitination reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) dcaf10 wdr32 zgc:85718 Danio rerio (Zebrafish) (Brachydanio rerio) 508 Q6NWH1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig501 sp Q6NWH1 DCA10_DANRE 91.03 234 21 0 32 733 75 308 4E-156 451 Q6NWH1 DCA10_DANRE GO:0080008; GO:0016567 Cul4-RING ubiquitin ligase complex; protein ubiquitination reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32) dcaf10 wdr32 zgc:85718 Danio rerio (Zebrafish) (Brachydanio rerio) 508 Q6NWH1 GO:0080008 GO:0080008 CUL4 RING ubiquitin ligase complex other cellular component C ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0043130 GO:0043130 ubiquitin binding other molecular function F ConsensusfromContig5825 sp Q6NWJ4 DNJC2_DANRE 85.46 282 41 0 118 963 1 282 2E-149 443 Q6NWJ4 DNJC2_DANRE GO:0003677; GO:0003682; GO:0016568; GO:0005829; GO:0042393; GO:0005634; GO:0045893; GO:0006351; GO:0043130 DNA binding; chromatin binding; chromatin modification; cytosol; histone binding; nucleus; positive regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin binding reviewed IPR001623; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 2 dnajc2 zgc:85671 Danio rerio (Zebrafish) (Brachydanio rerio) 618 Q6NWJ4 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0000463 GO:0000463 "maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" RNA metabolism P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0000466 GO:0000466 "maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" RNA metabolism P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0030687 GO:0030687 "preribosome, large subunit precursor" other cellular component C ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5650 sp Q6NX08 WDR12_DANRE 87.04 409 53 0 225 1451 1 409 0 711 Q6NX08 WDR12_DANRE GO:0070545; GO:0008283; GO:0000466; GO:0000463; GO:0005654; GO:0030687 PeBoW complex; cell proliferation; maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); nucleoplasm; preribosome, large subunit precursor reviewed IPR020472; IPR012972; IPR015943; IPR001680; IPR019775; IPR017986; Ribosome biogenesis protein wdr12 (WD repeat-containing protein 12) wdr12 Danio rerio (Zebrafish) (Brachydanio rerio) 422 Q6NX08 GO:0070545 GO:0070545 PeBoW complex nucleus C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0043406 GO:0043406 positive regulation of MAP kinase activity other metabolic processes P ConsensusfromContig5896 sp Q6NX65 PDC10_RAT 96.91 162 5 0 1 486 49 210 1E-107 319 Q6NX65 PDC10_RAT GO:0000139; GO:0001525; GO:0006915; GO:0005829; GO:0043066; GO:0005886; GO:0043406; GO:0008284 Golgi membrane; angiogenesis; apoptotic process; cytosol; negative regulation of apoptotic process; plasma membrane; positive regulation of MAP kinase activity; positive regulation of cell proliferation reviewed IPR009652; Programmed cell death protein 10 Pdcd10 Rattus norvegicus (Rat) 210 Q6NX65 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0003725 GO:0003725 double-stranded RNA binding nucleic acid binding activity F ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3465 sp Q6NXA4 ILF3_DANRE 86.21 116 16 0 11 358 143 258 3E-65 216 Q6NXA4 ILF3_DANRE GO:0003677; GO:0003723; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR014720; IPR006561; Interleukin enhancer-binding factor 3 homolog ilf3 zgc:77030 Danio rerio (Zebrafish) (Brachydanio rerio) 833 Q6NXA4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5639 sp Q6NY52 THOC5_DANRE 79.4 636 130 1 256 2160 48 683 0 1006 Q6NY52 THOC5_DANRE GO:0003723; GO:0008380; GO:0030154; GO:0005737; GO:0006397; GO:0051028; GO:0005634 RNA binding; RNA splicing; cell differentiation; cytoplasm; mRNA processing; mRNA transport; nucleus reviewed IPR019163; THO complex subunit 5 homolog thoc5 zgc:76912 Danio rerio (Zebrafish) (Brachydanio rerio) 684 Q6NY52 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0015030 GO:0015030 Cajal body nucleus C ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5855 sp Q6NY89 LSG1_DANRE 77.87 244 46 2 1 711 398 640 3E-120 365 Q6NY89 LSG1_DANRE GO:0015030; GO:0005525; GO:0003924; GO:0005829; GO:0005783; GO:0051168; GO:0015031; GO:0042254 Cajal body; GTP binding; GTPase activity; cytosol; endoplasmic reticulum; nuclear export; protein transport; ribosome biogenesis reviewed IPR006073; IPR027417; Large subunit GTPase 1 homolog (EC 3.6.1.-) lsg1 zgc:76988 Danio rerio (Zebrafish) (Brachydanio rerio) 640 Q6NY89 GO:0051168 GO:0051168 nuclear export transport P ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig5861 sp Q6NYE2 RCC2_DANRE 89.09 495 54 0 388 1872 1 495 0 862 Q6NYE2 RCC2_DANRE GO:0051301; GO:0007067; GO:0005730 cell division; mitosis; nucleolus reviewed IPR009091; IPR000408; Protein RCC2 homolog rcc2 zgc:77115 Danio rerio (Zebrafish) (Brachydanio rerio) 495 Q6NYE2 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0004152 GO:0004152 dihydroorotate dehydrogenase activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0004158 GO:0004158 dihydroorotate oxidase activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0006212 GO:0006212 uracil catabolic process other metabolic processes P ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0006214 GO:0006214 thymidine catabolic process other metabolic processes P ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0006222 GO:0006222 UMP biosynthetic process other metabolic processes P ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0017113 GO:0017113 dihydropyrimidine dehydrogenase (NADP+) activity other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0051539 GO:0051539 "4 iron, 4 sulfur cluster binding" other molecular function F ConsensusfromContig1149 sp Q6NYG8 DPYD_DANRE 83.5 103 17 0 325 17 12 114 2E-53 184 Q6NYG8 DPYD_DANRE GO:0051539; GO:0006222; GO:0019483; GO:0005737; GO:0004158; GO:0017113; GO:0046872; GO:0000166; GO:0006214; GO:0006212 4 iron, 4 sulfur cluster binding; UMP biosynthetic process; beta-alanine biosynthetic process; cytoplasm; dihydroorotate oxidase activity; dihydropyrimidine dehydrogenase (NADP+) activity; metal ion binding; nucleotide binding; thymidine catabolic process; uracil catabolic process reviewed IPR017896; IPR017900; IPR013785; IPR005720; IPR012135; IPR028261; IPR009051; IPR023753; Amino-acid biosynthesis; beta-alanine biosynthesis. Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase) dpyd zgc:77205 Danio rerio (Zebrafish) (Brachydanio rerio) 1022 Q6NYG8 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0004021 GO:0004021 L-alanine:2-oxoglutarate aminotransferase activity other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0006103 GO:0006103 2-oxoglutarate metabolic process other metabolic processes P ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0008483 GO:0008483 transaminase activity other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0009058 GO:0009058 biosynthetic process other metabolic processes P ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0016769 GO:0016769 "transferase activity, transferring nitrogenous groups" other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0030170 GO:0030170 pyridoxal phosphate binding other molecular function F ConsensusfromContig2242 sp Q6NYL5 ALAT2_DANRE 77.99 209 45 1 624 1 76 284 5E-116 348 Q6NYL5 ALAT2_DANRE GO:0006103; GO:0042853; GO:0042851; GO:0004021; GO:0009058; GO:0030170 2-oxoglutarate metabolic process; L-alanine catabolic process; L-alanine metabolic process; L-alanine:2-oxoglutarate aminotransferase activity; biosynthetic process; pyridoxal phosphate binding reviewed IPR004839; IPR015424; IPR015421; IPR015422; Amino-acid degradation; L-alanine degradation via transaminase pathway; pyruvate from L-alanine: step 1/1. Alanine aminotransferase 2-like (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2) gpt2l gpt2 im:6791811 si:ch211-261f3.4 Danio rerio (Zebrafish) (Brachydanio rerio) 549 Q6NYL5 GO:0042851 GO:0042851 L-alanine metabolic process other metabolic processes P ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig4095 sp Q6NYU2 HELZ_DANRE 82.17 129 22 1 2 388 689 816 9E-55 190 Q6NYU2 HELZ_DANRE GO:0005524; GO:0004386; GO:0046872; GO:0005634; GO:0003700 ATP binding; helicase activity; metal ion binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR027417; IPR011539; IPR000571; Probable helicase with zinc finger domain (EC 3.6.4.-) helz zgc:77407 Danio rerio (Zebrafish) (Brachydanio rerio) 1860 Q6NYU2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0031023 GO:0031023 microtubule organizing center organization cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0034453 GO:0034453 microtubule anchoring cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 87.25 102 13 0 3 308 812 913 6E-56 191 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0031023 GO:0031023 microtubule organizing center organization cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0034453 GO:0034453 microtubule anchoring cell organization and biogenesis P ConsensusfromContig4136 sp Q6NYW6 CLAP2_DANRE 92.31 26 1 1 326 400 920 945 6E-56 46.2 Q6NYW6 CLAP2_DANRE GO:0005794; GO:0051301; GO:0000777; GO:0005874; GO:0034453; GO:0007020; GO:0005815; GO:0031023; GO:0007067; GO:0005819; GO:0005802 Golgi apparatus; cell division; condensed chromosome kinetochore; microtubule; microtubule anchoring; microtubule nucleation; microtubule organizing center; microtubule organizing center organization; mitosis; spindle; trans-Golgi network reviewed IPR011989; IPR016024; IPR024395; CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) clasp2 Danio rerio (Zebrafish) (Brachydanio rerio) 1288 Q6NYW6 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5700 sp Q6NYX8 PITH1_DANRE 90 190 19 0 221 790 21 210 1E-124 365 Q6NYX8 PITH1_DANRE reviewed IPR008979; IPR010400; PITH domain-containing protein 1 pithd1 zgc:77241 Danio rerio (Zebrafish) (Brachydanio rerio) 210 Q6NYX8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5700 sp Q6NYX8 PITH1_DANRE 90 190 19 0 221 790 21 210 1E-124 365 Q6NYX8 PITH1_DANRE reviewed IPR008979; IPR010400; PITH domain-containing protein 1 pithd1 zgc:77241 Danio rerio (Zebrafish) (Brachydanio rerio) 210 Q6NYX8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5700 sp Q6NYX8 PITH1_DANRE 90 190 19 0 221 790 21 210 1E-124 365 Q6NYX8 PITH1_DANRE reviewed IPR008979; IPR010400; PITH domain-containing protein 1 pithd1 zgc:77241 Danio rerio (Zebrafish) (Brachydanio rerio) 210 Q6NYX8 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 83.87 217 35 0 2274 1624 356 572 0 396 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 51.22 287 122 4 1637 822 568 851 0 262 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 86.67 60 8 0 562 383 936 995 0 117 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane ER/Golgi C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0012507 GO:0012507 ER to Golgi transport vesicle membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6027 sp Q6NZC7 S23IP_MOUSE 68.97 87 23 1 834 574 848 930 0 103 Q6NZC7 S23IP_MOUSE GO:0012507; GO:0005783; GO:0046872 ER to Golgi transport vesicle membrane; endoplasmic reticulum; metal ion binding reviewed IPR004177; IPR001660; IPR013761; IPR021129; SEC23-interacting protein Sec23ip Mus musculus (Mouse) 998 Q6NZC7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5602 sp Q6NZI6 ORAI2_XENLA 79.73 148 24 1 921 496 110 257 2E-111 240 Q6NZI6 ORAI2_XENLA GO:0016021 integral to membrane reviewed IPR012446; Protein orai-2 (Transmembrane protein 142B) orai2 tmem142b Xenopus laevis (African clawed frog) 257 Q6NZI6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5602 sp Q6NZI6 ORAI2_XENLA 79.73 148 24 1 921 496 110 257 2E-111 240 Q6NZI6 ORAI2_XENLA GO:0016021 integral to membrane reviewed IPR012446; Protein orai-2 (Transmembrane protein 142B) orai2 tmem142b Xenopus laevis (African clawed frog) 257 Q6NZI6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5602 sp Q6NZI6 ORAI2_XENLA 83.78 111 16 1 1253 921 1 109 2E-111 184 Q6NZI6 ORAI2_XENLA GO:0016021 integral to membrane reviewed IPR012446; Protein orai-2 (Transmembrane protein 142B) orai2 tmem142b Xenopus laevis (African clawed frog) 257 Q6NZI6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5602 sp Q6NZI6 ORAI2_XENLA 83.78 111 16 1 1253 921 1 109 2E-111 184 Q6NZI6 ORAI2_XENLA GO:0016021 integral to membrane reviewed IPR012446; Protein orai-2 (Transmembrane protein 142B) orai2 tmem142b Xenopus laevis (African clawed frog) 257 Q6NZI6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig6248 sp Q6NZZ9 RBM22_DANRE 88.22 416 48 1 2024 777 1 415 0 671 Q6NZZ9 RBM22_DANRE GO:0005737; GO:0009790; GO:0045292; GO:0046872; GO:0000166; GO:0005634; GO:0033120; GO:0036002; GO:0017069; GO:0005681 cytoplasm; embryo development; mRNA cis splicing, via spliceosome; metal ion binding; nucleotide binding; nucleus; positive regulation of RNA splicing; pre-mRNA binding; snRNA binding; spliceosomal complex reviewed IPR012677; IPR000504; IPR000571; Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) rbm22 zgc:77910 Danio rerio (Zebrafish) (Brachydanio rerio) 425 Q6NZZ9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6196 sp Q6P036 S2533_DANRE 89.07 311 34 0 110 1042 1 311 0 576 Q6P036 S2533_DANRE GO:0016021; GO:0005743; GO:0055085 integral to membrane; mitochondrial inner membrane; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 33 slc25a33 zgc:65787 Danio rerio (Zebrafish) (Brachydanio rerio) 314 Q6P036 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig4062 sp Q6P0H6 CSN4_DANRE 88.29 111 13 0 3 335 15 125 1E-65 209 Q6P0H6 CSN4_DANRE GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 4 (Signalosome subunit 4) cops4 csn4 zgc:77137 Danio rerio (Zebrafish) (Brachydanio rerio) 406 Q6P0H6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4062 sp Q6P0H6 CSN4_DANRE 88.29 111 13 0 3 335 15 125 1E-65 209 Q6P0H6 CSN4_DANRE GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 4 (Signalosome subunit 4) cops4 csn4 zgc:77137 Danio rerio (Zebrafish) (Brachydanio rerio) 406 Q6P0H6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4062 sp Q6P0H6 CSN4_DANRE 88.29 111 13 0 3 335 15 125 1E-65 209 Q6P0H6 CSN4_DANRE GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 4 (Signalosome subunit 4) cops4 csn4 zgc:77137 Danio rerio (Zebrafish) (Brachydanio rerio) 406 Q6P0H6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4062 sp Q6P0H6 CSN4_DANRE 88.29 111 13 0 3 335 15 125 1E-65 209 Q6P0H6 CSN4_DANRE GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 4 (Signalosome subunit 4) cops4 csn4 zgc:77137 Danio rerio (Zebrafish) (Brachydanio rerio) 406 Q6P0H6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig4062 sp Q6P0H6 CSN4_DANRE 88.29 111 13 0 3 335 15 125 1E-65 209 Q6P0H6 CSN4_DANRE GO:0008180; GO:0005737 COP9 signalosome; cytoplasm reviewed IPR000717; IPR011990; IPR011991; COP9 signalosome complex subunit 4 (Signalosome subunit 4) cops4 csn4 zgc:77137 Danio rerio (Zebrafish) (Brachydanio rerio) 406 Q6P0H6 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5965 sp Q6P0T2 TAF8_DANRE 81.76 296 54 0 247 1134 1 296 5E-167 480 Q6P0T2 TAF8_DANRE GO:0030154; GO:0005737; GO:0007275; GO:0005634; GO:0006355; GO:0006351 cell differentiation; cytoplasm; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006565; IPR009072; IPR019473; Transcription initiation factor TFIID subunit 8 (Protein taube nuss-like) (TBP-associated factor 8) taf8 tbnl Danio rerio (Zebrafish) (Brachydanio rerio) 308 Q6P0T2 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6232 sp Q6P0U9 NUPL2_DANRE 52.78 216 75 8 148 771 1 197 7E-52 185 Q6P0U9 NUPL2_DANRE GO:0051028; GO:0046872; GO:0031965; GO:0005643; GO:0015031 mRNA transport; metal ion binding; nuclear membrane; nuclear pore; protein transport reviewed IPR000571; Nucleoporin-like protein 2 nupl2 zgc:77724 Danio rerio (Zebrafish) (Brachydanio rerio) 414 Q6P0U9 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig3362 sp Q6P112 RGL1_DANRE 86.67 105 14 0 146 460 446 550 4E-56 192 Q6P112 RGL1_DANRE GO:0005085; GO:0005622; GO:0051056; GO:0007264 guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000159; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1) rgl1 zgc:77299 Danio rerio (Zebrafish) (Brachydanio rerio) 804 Q6P112 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig3362 sp Q6P112 RGL1_DANRE 86.67 105 14 0 146 460 446 550 4E-56 192 Q6P112 RGL1_DANRE GO:0005085; GO:0005622; GO:0051056; GO:0007264 guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000159; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1) rgl1 zgc:77299 Danio rerio (Zebrafish) (Brachydanio rerio) 804 Q6P112 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3362 sp Q6P112 RGL1_DANRE 86.67 105 14 0 146 460 446 550 4E-56 192 Q6P112 RGL1_DANRE GO:0005085; GO:0005622; GO:0051056; GO:0007264 guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000159; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1) rgl1 zgc:77299 Danio rerio (Zebrafish) (Brachydanio rerio) 804 Q6P112 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3362 sp Q6P112 RGL1_DANRE 86.67 105 14 0 146 460 446 550 4E-56 192 Q6P112 RGL1_DANRE GO:0005085; GO:0005622; GO:0051056; GO:0007264 guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000159; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1) rgl1 zgc:77299 Danio rerio (Zebrafish) (Brachydanio rerio) 804 Q6P112 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig3362 sp Q6P112 RGL1_DANRE 86.67 105 14 0 146 460 446 550 4E-56 192 Q6P112 RGL1_DANRE GO:0005085; GO:0005622; GO:0051056; GO:0007264 guanyl-nucleotide exchange factor activity; intracellular; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction reviewed IPR000159; IPR000651; IPR019804; IPR008937; IPR023578; IPR001895; Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1) rgl1 zgc:77299 Danio rerio (Zebrafish) (Brachydanio rerio) 804 Q6P112 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig2221 sp Q6P132 TXB1B_DANRE 78.79 132 28 0 1 396 245 376 3E-62 209 Q6P132 TXB1B_DANRE GO:0006915 apoptotic process reviewed IPR012852; Tax1-binding protein 1 homolog B tax1bp1b tax1bp1 zgc:77129 Danio rerio (Zebrafish) (Brachydanio rerio) 823 Q6P132 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2994 sp Q6P2B1 TNPO3_MOUSE 84.38 128 20 0 386 3 265 392 9E-73 238 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0035048 GO:0035048 splicing factor protein import into nucleus transport P ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3662 sp Q6P2B1 TNPO3_MOUSE 84.03 144 23 0 1 432 79 222 1E-67 224 Q6P2B1 TNPO3_MOUSE GO:0005737; GO:0005634; GO:0035048 cytoplasm; nucleus; splicing factor protein import into nucleus reviewed IPR011989; IPR016024; IPR013598; Transportin-3 Tnpo3 Mus musculus (Mouse) 923 Q6P2B1 GO:0035048 GO:0035048 splicing factor protein import into nucleus transport P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 98.27 231 4 0 349 1041 1 231 1E-160 472 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 88.78 98 11 0 1010 1303 222 319 1E-65 160 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5614 sp Q6P3K7 KC1DB_DANRE 94.64 56 3 0 1402 1569 353 408 1E-65 113 Q6P3K7 KC1DB_DANRE GO:0005524; GO:0016055; GO:0005737; GO:0005634; GO:0004674 ATP binding; Wnt receptor signaling pathway; cytoplasm; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Casein kinase I isoform delta-B (CKI-delta-B) (CKId-B) (EC 2.7.11.1) csnk1db Danio rerio (Zebrafish) (Brachydanio rerio) 409 Q6P3K7 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0004303 GO:0004303 estradiol 17-beta-dehydrogenase activity other molecular function F ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0006694 GO:0006694 steroid biosynthetic process other metabolic processes P ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5561 sp Q6P3L6 DH12A_DANRE 79.22 308 64 0 102 1025 1 308 2E-158 469 Q6P3L6 DH12A_DANRE GO:0005789; GO:0004303; GO:0006703; GO:0016021 endoplasmic reticulum membrane; estradiol 17-beta-dehydrogenase activity; estrogen biosynthetic process; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Steroid biosynthesis; estrogen biosynthesis. Estradiol 17-beta-dehydrogenase 12-A (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 12-A) (17-beta-HSD 12-A) (zf3.1) (zfHSD17B12A) hsd17b12a zgc:55589 Danio rerio (Zebrafish) (Brachydanio rerio) 319 Q6P3L6 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0001832 GO:0001832 blastocyst growth developmental processes P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0001833 GO:0001833 inner cell mass cell proliferation cell cycle and proliferation P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0001833 GO:0001833 inner cell mass cell proliferation developmental processes P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0016180 GO:0016180 snRNA processing RNA metabolism P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0032039 GO:0032039 integrator complex nucleus C ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0034474 GO:0034474 U2 snRNA 3'-end processing RNA metabolism P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig6041 sp Q6P4S8 INT1_MOUSE 63.01 365 133 2 1427 336 1830 2193 2E-143 459 Q6P4S8 INT1_MOUSE GO:0034474; GO:0001833; GO:0016021; GO:0032039; GO:0043066; GO:0043154; GO:0031965; GO:0005634 U2 snRNA 3'-end processing; inner cell mass cell proliferation; integral to membrane; integrator complex; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; nuclear membrane; nucleus reviewed IPR016024; IPR022145; Integrator complex subunit 1 (Int1) Ints1 Mus musculus (Mouse) 2195 Q6P4S8 GO:0043154 GO:0043154 negative regulation of caspase activity death P ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0001740 GO:0001740 Barr body nucleus C ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0009048 GO:0009048 "dosage compensation, by inactivation of X chromosome" other metabolic processes P ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0051276 GO:0051276 chromosome organization cell organization and biogenesis P ConsensusfromContig6000 sp Q6P5D8 SMHD1_MOUSE 52.19 525 235 6 85 1626 1447 1966 2E-148 481 Q6P5D8 SMHD1_MOUSE GO:0005524; GO:0001740; GO:0051276; GO:0060821 ATP binding; Barr body; chromosome organization; inactivation of X chromosome by DNA methylation reviewed IPR003594; IPR010935; Structural maintenance of chromosomes flexible hinge domain-containing protein 1 Smchd1 Kiaa0650 Mus musculus (Mouse) 2007 Q6P5D8 GO:0060821 ConsensusfromContig4863 sp Q6P950 PR3CB_DANRE 70.25 158 44 1 598 134 39 196 1E-72 229 Q6P950 PR3CB_DANRE GO:0005977 glycogen metabolic process reviewed IPR005036; IPR017434; Protein phosphatase 1 regulatory subunit 3C-B ppp1r3cb zgc:73259 Danio rerio (Zebrafish) (Brachydanio rerio) 317 Q6P950 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig4863 sp Q6P950 PR3CB_DANRE 70.25 158 44 1 598 134 39 196 1E-72 229 Q6P950 PR3CB_DANRE GO:0005977 glycogen metabolic process reviewed IPR005036; IPR017434; Protein phosphatase 1 regulatory subunit 3C-B ppp1r3cb zgc:73259 Danio rerio (Zebrafish) (Brachydanio rerio) 317 Q6P950 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig4863 sp Q6P950 PR3CB_DANRE 70.25 158 44 1 598 134 39 196 1E-72 229 Q6P950 PR3CB_DANRE GO:0005977 glycogen metabolic process reviewed IPR005036; IPR017434; Protein phosphatase 1 regulatory subunit 3C-B ppp1r3cb zgc:73259 Danio rerio (Zebrafish) (Brachydanio rerio) 317 Q6P950 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig4863 sp Q6P950 PR3CB_DANRE 70.25 158 44 1 598 134 39 196 1E-72 229 Q6P950 PR3CB_DANRE GO:0005977 glycogen metabolic process reviewed IPR005036; IPR017434; Protein phosphatase 1 regulatory subunit 3C-B ppp1r3cb zgc:73259 Danio rerio (Zebrafish) (Brachydanio rerio) 317 Q6P950 GO:0005977 GO:0005977 glycogen metabolic process other metabolic processes P ConsensusfromContig3676 sp Q6P9Z4 FEM1A_DANRE 75.16 157 38 1 12 479 384 540 1E-60 203 Q6P9Z4 FEM1A_DANRE GO:0005737; GO:0051438; GO:0004842 cytoplasm; regulation of ubiquitin-protein ligase activity; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; Protein modification; protein ubiquitination. Protein fem-1 homolog A (FEM1a) (FEM1-alpha) fem1a zgc:63483 Danio rerio (Zebrafish) (Brachydanio rerio) 617 Q6P9Z4 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3676 sp Q6P9Z4 FEM1A_DANRE 75.16 157 38 1 12 479 384 540 1E-60 203 Q6P9Z4 FEM1A_DANRE GO:0005737; GO:0051438; GO:0004842 cytoplasm; regulation of ubiquitin-protein ligase activity; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; Protein modification; protein ubiquitination. Protein fem-1 homolog A (FEM1a) (FEM1-alpha) fem1a zgc:63483 Danio rerio (Zebrafish) (Brachydanio rerio) 617 Q6P9Z4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3676 sp Q6P9Z4 FEM1A_DANRE 75.16 157 38 1 12 479 384 540 1E-60 203 Q6P9Z4 FEM1A_DANRE GO:0005737; GO:0051438; GO:0004842 cytoplasm; regulation of ubiquitin-protein ligase activity; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; Protein modification; protein ubiquitination. Protein fem-1 homolog A (FEM1a) (FEM1-alpha) fem1a zgc:63483 Danio rerio (Zebrafish) (Brachydanio rerio) 617 Q6P9Z4 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3676 sp Q6P9Z4 FEM1A_DANRE 75.16 157 38 1 12 479 384 540 1E-60 203 Q6P9Z4 FEM1A_DANRE GO:0005737; GO:0051438; GO:0004842 cytoplasm; regulation of ubiquitin-protein ligase activity; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; Protein modification; protein ubiquitination. Protein fem-1 homolog A (FEM1a) (FEM1-alpha) fem1a zgc:63483 Danio rerio (Zebrafish) (Brachydanio rerio) 617 Q6P9Z4 GO:0051438 GO:0051438 regulation of ubiquitin-protein ligase activity other biological processes P ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig3693 sp Q6PAV2 HERC4_MOUSE 86.29 124 17 0 1 372 883 1006 3E-59 201 Q6PAV2 HERC4_MOUSE GO:0030154; GO:0005737; GO:0005829; GO:0005634; GO:0042787; GO:0007283; GO:0004842 cell differentiation; cytoplasm; cytosol; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; spermatogenesis; ubiquitin-protein ligase activity reviewed IPR000569; IPR009091; IPR000408; Protein modification; protein ubiquitination. Probable E3 ubiquitin-protein ligase HERC4 (EC 6.3.2.-) (HECT domain and RCC1-like domain-containing protein 4) Herc4 Mus musculus (Mouse) 1057 Q6PAV2 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0015035 GO:0015035 protein disulfide oxidoreductase activity other molecular function F ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0016226 GO:0016226 iron-sulfur cluster assembly other metabolic processes P ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0030097 GO:0030097 hemopoiesis developmental processes P ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig5926 sp Q6PBM1 GLRX5_DANRE 74.84 155 38 1 298 759 1 155 1E-68 219 Q6PBM1 GLRX5_DANRE GO:0051537; GO:0045454; GO:0009055; GO:0030097; GO:0016226; GO:0046872; GO:0005739; GO:0015035 2 iron, 2 sulfur cluster binding; cell redox homeostasis; electron carrier activity; hemopoiesis; iron-sulfur cluster assembly; metal ion binding; mitochondrion; protein disulfide oxidoreductase activity reviewed IPR002109; IPR004480; IPR012336; Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5) glrx5 grx5 shiraz si:ch211-121d13.1 Danio rerio (Zebrafish) (Brachydanio rerio) 155 Q6PBM1 GO:0051537 GO:0051537 "2 iron, 2 sulfur cluster binding" other molecular function F ConsensusfromContig5741 sp Q6PBP3 F213A_DANRE 77.36 212 48 0 175 810 1 212 2E-113 340 Q6PBP3 F213A_DANRE GO:0016209; GO:0005737 antioxidant activity; cytoplasm reviewed IPR012336; Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) fam213a pamm zgc:73311 Danio rerio (Zebrafish) (Brachydanio rerio) 212 Q6PBP3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5741 sp Q6PBP3 F213A_DANRE 77.36 212 48 0 175 810 1 212 2E-113 340 Q6PBP3 F213A_DANRE GO:0016209; GO:0005737 antioxidant activity; cytoplasm reviewed IPR012336; Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM) fam213a pamm zgc:73311 Danio rerio (Zebrafish) (Brachydanio rerio) 212 Q6PBP3 GO:0016209 GO:0016209 antioxidant activity other molecular function F ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0005732 GO:0005732 small nucleolar ribonucleoprotein complex other cellular component C ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0030515 GO:0030515 snoRNA binding nucleic acid binding activity F ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0031118 GO:0031118 rRNA pseudouridine synthesis RNA metabolism P ConsensusfromContig6363 sp Q6PBV6 NHP2_DANRE 89.25 93 10 0 772 494 56 148 3E-54 181 Q6PBV6 NHP2_DANRE GO:0005730; GO:0031118; GO:0005732; GO:0030515 nucleolus; rRNA pseudouridine synthesis; small nucleolar ribonucleoprotein complex; snoRNA binding reviewed IPR002415; IPR004038; IPR018492; H/ACA ribonucleoprotein complex subunit 2-like protein (Nucleolar protein family A member 2-like protein) (snoRNP protein NHP2) nhp2 nola2 zgc:73227 Danio rerio (Zebrafish) (Brachydanio rerio) 150 Q6PBV6 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig6014 sp Q6PC19 SSU72_DANRE 94.33 194 11 0 137 718 1 194 4E-132 386 Q6PC19 SSU72_DANRE GO:0005737; GO:0006397; GO:0005634; GO:0004721 cytoplasm; mRNA processing; nucleus; phosphoprotein phosphatase activity reviewed IPR006811; RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) ssu72 zgc:73143 Danio rerio (Zebrafish) (Brachydanio rerio) 194 Q6PC19 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig6014 sp Q6PC19 SSU72_DANRE 94.33 194 11 0 137 718 1 194 4E-132 386 Q6PC19 SSU72_DANRE GO:0005737; GO:0006397; GO:0005634; GO:0004721 cytoplasm; mRNA processing; nucleus; phosphoprotein phosphatase activity reviewed IPR006811; RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) ssu72 zgc:73143 Danio rerio (Zebrafish) (Brachydanio rerio) 194 Q6PC19 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6014 sp Q6PC19 SSU72_DANRE 94.33 194 11 0 137 718 1 194 4E-132 386 Q6PC19 SSU72_DANRE GO:0005737; GO:0006397; GO:0005634; GO:0004721 cytoplasm; mRNA processing; nucleus; phosphoprotein phosphatase activity reviewed IPR006811; RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) ssu72 zgc:73143 Danio rerio (Zebrafish) (Brachydanio rerio) 194 Q6PC19 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6014 sp Q6PC19 SSU72_DANRE 94.33 194 11 0 137 718 1 194 4E-132 386 Q6PC19 SSU72_DANRE GO:0005737; GO:0006397; GO:0005634; GO:0004721 cytoplasm; mRNA processing; nucleus; phosphoprotein phosphatase activity reviewed IPR006811; RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) ssu72 zgc:73143 Danio rerio (Zebrafish) (Brachydanio rerio) 194 Q6PC19 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6014 sp Q6PC19 SSU72_DANRE 94.33 194 11 0 137 718 1 194 4E-132 386 Q6PC19 SSU72_DANRE GO:0005737; GO:0006397; GO:0005634; GO:0004721 cytoplasm; mRNA processing; nucleus; phosphoprotein phosphatase activity reviewed IPR006811; RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16) ssu72 zgc:73143 Danio rerio (Zebrafish) (Brachydanio rerio) 194 Q6PC19 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3683 sp Q6PCJ1 DCTN1_XENLA 90.48 105 10 0 315 1 372 476 2E-52 183 Q6PCJ1 DCTN1_XENLA GO:0005737; GO:0005869; GO:0030286; GO:0005874; GO:0010970; GO:0003774 cytoplasm; dynactin complex; dynein complex; microtubule; microtubule-based transport; motor activity reviewed IPR000938; IPR027663; IPR022157; Dynactin subunit 1 dctn1 Xenopus laevis (African clawed frog) 1232 Q6PCJ1 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig3683 sp Q6PCJ1 DCTN1_XENLA 90.48 105 10 0 315 1 372 476 2E-52 183 Q6PCJ1 DCTN1_XENLA GO:0005737; GO:0005869; GO:0030286; GO:0005874; GO:0010970; GO:0003774 cytoplasm; dynactin complex; dynein complex; microtubule; microtubule-based transport; motor activity reviewed IPR000938; IPR027663; IPR022157; Dynactin subunit 1 dctn1 Xenopus laevis (African clawed frog) 1232 Q6PCJ1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3683 sp Q6PCJ1 DCTN1_XENLA 90.48 105 10 0 315 1 372 476 2E-52 183 Q6PCJ1 DCTN1_XENLA GO:0005737; GO:0005869; GO:0030286; GO:0005874; GO:0010970; GO:0003774 cytoplasm; dynactin complex; dynein complex; microtubule; microtubule-based transport; motor activity reviewed IPR000938; IPR027663; IPR022157; Dynactin subunit 1 dctn1 Xenopus laevis (African clawed frog) 1232 Q6PCJ1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig3683 sp Q6PCJ1 DCTN1_XENLA 90.48 105 10 0 315 1 372 476 2E-52 183 Q6PCJ1 DCTN1_XENLA GO:0005737; GO:0005869; GO:0030286; GO:0005874; GO:0010970; GO:0003774 cytoplasm; dynactin complex; dynein complex; microtubule; microtubule-based transport; motor activity reviewed IPR000938; IPR027663; IPR022157; Dynactin subunit 1 dctn1 Xenopus laevis (African clawed frog) 1232 Q6PCJ1 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig3683 sp Q6PCJ1 DCTN1_XENLA 90.48 105 10 0 315 1 372 476 2E-52 183 Q6PCJ1 DCTN1_XENLA GO:0005737; GO:0005869; GO:0030286; GO:0005874; GO:0010970; GO:0003774 cytoplasm; dynactin complex; dynein complex; microtubule; microtubule-based transport; motor activity reviewed IPR000938; IPR027663; IPR022157; Dynactin subunit 1 dctn1 Xenopus laevis (African clawed frog) 1232 Q6PCJ1 GO:0030286 GO:0030286 dynein complex cytoskeleton C ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2213 sp Q6PCR6 ZFR_DANRE 96.74 92 3 0 277 2 878 969 3E-56 191 Q6PCR6 ZFR_DANRE GO:0003677; GO:0003723; GO:0005737; GO:0007275; GO:0005634; GO:0008270 DNA binding; RNA binding; cytoplasm; multicellular organismal development; nucleus; zinc ion binding reviewed IPR006561; IPR007087; IPR015880; IPR003604; Zinc finger RNA-binding protein zfr Danio rerio (Zebrafish) (Brachydanio rerio) 1074 Q6PCR6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0000159 GO:0000159 protein phosphatase type 2A complex other cellular component C ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5779 sp Q6PD03 2A5A_MOUSE 87.65 413 50 1 2650 1415 54 466 0 671 Q6PD03 2A5A_MOUSE GO:0031430; GO:0030018; GO:0000775; GO:0016020; GO:0090005; GO:0090219; GO:0005634; GO:0035307; GO:0000159; GO:0008601; GO:0007165 M band; Z disc; chromosome, centromeric region; membrane; negative regulation of establishment of protein localization to plasma membrane; negative regulation of lipid kinase activity; nucleus; positive regulation of protein dephosphorylation; protein phosphatase type 2A complex; protein phosphatase type 2A regulator activity; signal transduction reviewed IPR016024; IPR002554; Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha) Ppp2r5a Mus musculus (Mouse) 486 Q6PD03 GO:0008601 GO:0008601 protein phosphatase type 2A regulator activity enzyme regulator activity F ConsensusfromContig2687 sp Q6PEH8 MED25_DANRE 94.74 171 9 0 9 521 1 171 7E-112 340 Q6PEH8 MED25_DANRE GO:0005634; GO:0060021; GO:0006355; GO:0006351 nucleus; palate development; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021394; IPR021397; IPR021419; IPR002035; Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) med25 Danio rerio (Zebrafish) (Brachydanio rerio) 701 Q6PEH8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2687 sp Q6PEH8 MED25_DANRE 94.74 171 9 0 9 521 1 171 7E-112 340 Q6PEH8 MED25_DANRE GO:0005634; GO:0060021; GO:0006355; GO:0006351 nucleus; palate development; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021394; IPR021397; IPR021419; IPR002035; Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) med25 Danio rerio (Zebrafish) (Brachydanio rerio) 701 Q6PEH8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2687 sp Q6PEH8 MED25_DANRE 94.74 171 9 0 9 521 1 171 7E-112 340 Q6PEH8 MED25_DANRE GO:0005634; GO:0060021; GO:0006355; GO:0006351 nucleus; palate development; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021394; IPR021397; IPR021419; IPR002035; Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) med25 Danio rerio (Zebrafish) (Brachydanio rerio) 701 Q6PEH8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2687 sp Q6PEH8 MED25_DANRE 94.74 171 9 0 9 521 1 171 7E-112 340 Q6PEH8 MED25_DANRE GO:0005634; GO:0060021; GO:0006355; GO:0006351 nucleus; palate development; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021394; IPR021397; IPR021419; IPR002035; Mediator of RNA polymerase II transcription subunit 25 (Mediator complex subunit 25) med25 Danio rerio (Zebrafish) (Brachydanio rerio) 701 Q6PEH8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6306 sp Q6PFD9 NUP98_MOUSE 56.39 649 265 8 115 2034 1172 1811 0 718 Q6PFD9 NUP98_MOUSE GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Mus musculus (Mouse) 1816 Q6PFD9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6306 sp Q6PFD9 NUP98_MOUSE 56.39 649 265 8 115 2034 1172 1811 0 718 Q6PFD9 NUP98_MOUSE GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Mus musculus (Mouse) 1816 Q6PFD9 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6306 sp Q6PFD9 NUP98_MOUSE 56.39 649 265 8 115 2034 1172 1811 0 718 Q6PFD9 NUP98_MOUSE GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Mus musculus (Mouse) 1816 Q6PFD9 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6306 sp Q6PFD9 NUP98_MOUSE 56.39 649 265 8 115 2034 1172 1811 0 718 Q6PFD9 NUP98_MOUSE GO:0006260; GO:0000776; GO:0051028; GO:0042405; GO:0031965; GO:0034399; GO:0051292; GO:0044615; GO:0005654; GO:0042277; GO:0000059; GO:0017056 DNA replication; kinetochore; mRNA transport; nuclear inclusion body; nuclear membrane; nuclear periphery; nuclear pore complex assembly; nuclear pore nuclear basket; nucleoplasm; peptide binding; protein import into nucleus, docking; structural constituent of nuclear pore reviewed IPR021967; IPR007230; Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)] Nup98 Mus musculus (Mouse) 1816 Q6PFD9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig500 sp Q6PFJ9 ARI1_DANRE 91.33 196 12 3 648 73 164 358 1E-125 372 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6140 sp Q6PFJ9 ARI1_DANRE 92.59 108 8 0 202 525 84 191 2E-65 216 Q6PFJ9 ARI1_DANRE GO:0005737; GO:0004842; GO:0008270 cytoplasm; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR002867; IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase arih1 (EC 6.3.2.-) (Protein ariadne-1 homolog) (ARI-1) arih1 si:dkey-151p17.4 si:dkey-73n10.2 Danio rerio (Zebrafish) (Brachydanio rerio) 527 Q6PFJ9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6063 sp Q6PFQ2 EIF3C_DANRE 86.83 896 107 4 125 2806 1 887 0 1338 Q6PFQ2 EIF3C_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR016024; IPR027516; IPR008905; IPR000717; IPR011991; Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) eif3c eif3s8 Danio rerio (Zebrafish) (Brachydanio rerio) 926 Q6PFQ2 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig6063 sp Q6PFQ2 EIF3C_DANRE 86.83 896 107 4 125 2806 1 887 0 1338 Q6PFQ2 EIF3C_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR016024; IPR027516; IPR008905; IPR000717; IPR011991; Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) eif3c eif3s8 Danio rerio (Zebrafish) (Brachydanio rerio) 926 Q6PFQ2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6063 sp Q6PFQ2 EIF3C_DANRE 86.83 896 107 4 125 2806 1 887 0 1338 Q6PFQ2 EIF3C_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR016024; IPR027516; IPR008905; IPR000717; IPR011991; Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) eif3c eif3s8 Danio rerio (Zebrafish) (Brachydanio rerio) 926 Q6PFQ2 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig6063 sp Q6PFQ2 EIF3C_DANRE 86.83 896 107 4 125 2806 1 887 0 1338 Q6PFQ2 EIF3C_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR016024; IPR027516; IPR008905; IPR000717; IPR011991; Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) eif3c eif3s8 Danio rerio (Zebrafish) (Brachydanio rerio) 926 Q6PFQ2 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6063 sp Q6PFQ2 EIF3C_DANRE 86.83 896 107 4 125 2806 1 887 0 1338 Q6PFQ2 EIF3C_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR016024; IPR027516; IPR008905; IPR000717; IPR011991; Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) eif3c eif3s8 Danio rerio (Zebrafish) (Brachydanio rerio) 926 Q6PFQ2 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig292 sp Q6PFT6 TMM47_DANRE 90.24 164 16 0 85 576 1 164 1E-89 267 Q6PFT6 TMM47_DANRE GO:0016021 integral to membrane reviewed IPR015664; IPR004031; Transmembrane protein 47 (Transmembrane 4 superfamily member 10) tmem47 tm4sf10 zgc:63990 Danio rerio (Zebrafish) (Brachydanio rerio) 181 Q6PFT6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig292 sp Q6PFT6 TMM47_DANRE 90.24 164 16 0 85 576 1 164 1E-89 267 Q6PFT6 TMM47_DANRE GO:0016021 integral to membrane reviewed IPR015664; IPR004031; Transmembrane protein 47 (Transmembrane 4 superfamily member 10) tmem47 tm4sf10 zgc:63990 Danio rerio (Zebrafish) (Brachydanio rerio) 181 Q6PFT6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig292 sp Q6PFT6 TMM47_DANRE 90.24 164 16 0 85 576 1 164 1E-89 267 Q6PFT6 TMM47_DANRE GO:0016021 integral to membrane reviewed IPR015664; IPR004031; Transmembrane protein 47 (Transmembrane 4 superfamily member 10) tmem47 tm4sf10 zgc:63990 Danio rerio (Zebrafish) (Brachydanio rerio) 181 Q6PFT6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig292 sp Q6PFT6 TMM47_DANRE 90.24 164 16 0 85 576 1 164 1E-89 267 Q6PFT6 TMM47_DANRE GO:0016021 integral to membrane reviewed IPR015664; IPR004031; Transmembrane protein 47 (Transmembrane 4 superfamily member 10) tmem47 tm4sf10 zgc:63990 Danio rerio (Zebrafish) (Brachydanio rerio) 181 Q6PFT6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 77.19 320 73 0 3 962 832 1151 0 498 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6118 sp Q6PGC1 DHX29_MOUSE 64.76 227 72 4 937 1608 1143 1364 0 298 Q6PGC1 DHX29_MOUSE GO:0005524; GO:0008026; GO:0016282; GO:0005739; GO:0043024; GO:0003743 ATP binding; ATP-dependent helicase activity; eukaryotic 43S preinitiation complex; mitochondrion; ribosomal small subunit binding; translation initiation factor activity reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; ATP-dependent RNA helicase Dhx29 (EC 3.6.4.13) (DEAH box protein 29) Dhx29 Mus musculus (Mouse) 1365 Q6PGC1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2793 sp Q6PHG2 HEMO_DANRE 67.74 124 38 1 372 1 21 142 7E-51 172 Q6PHG2 HEMO_DANRE GO:0071391; GO:0005576; GO:0046872; GO:0006810 cellular response to estrogen stimulus; extracellular region; metal ion binding; transport reviewed IPR000585; IPR018487; IPR016358; Hemopexin hpx Danio rerio (Zebrafish) (Brachydanio rerio) 447 Q6PHG2 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2793 sp Q6PHG2 HEMO_DANRE 67.74 124 38 1 372 1 21 142 7E-51 172 Q6PHG2 HEMO_DANRE GO:0071391; GO:0005576; GO:0046872; GO:0006810 cellular response to estrogen stimulus; extracellular region; metal ion binding; transport reviewed IPR000585; IPR018487; IPR016358; Hemopexin hpx Danio rerio (Zebrafish) (Brachydanio rerio) 447 Q6PHG2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2793 sp Q6PHG2 HEMO_DANRE 67.74 124 38 1 372 1 21 142 7E-51 172 Q6PHG2 HEMO_DANRE GO:0071391; GO:0005576; GO:0046872; GO:0006810 cellular response to estrogen stimulus; extracellular region; metal ion binding; transport reviewed IPR000585; IPR018487; IPR016358; Hemopexin hpx Danio rerio (Zebrafish) (Brachydanio rerio) 447 Q6PHG2 GO:0042221 GO:0042221 response to chemical stimulus other biological processes P ConsensusfromContig2793 sp Q6PHG2 HEMO_DANRE 67.74 124 38 1 372 1 21 142 7E-51 172 Q6PHG2 HEMO_DANRE GO:0071391; GO:0005576; GO:0046872; GO:0006810 cellular response to estrogen stimulus; extracellular region; metal ion binding; transport reviewed IPR000585; IPR018487; IPR016358; Hemopexin hpx Danio rerio (Zebrafish) (Brachydanio rerio) 447 Q6PHG2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2764 sp Q6PHK6 PURB_DANRE 98.44 128 2 0 559 176 21 148 3E-83 255 Q6PHK6 PURB_DANRE GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006628; Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B) purb Danio rerio (Zebrafish) (Brachydanio rerio) 297 Q6PHK6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2764 sp Q6PHK6 PURB_DANRE 98.44 128 2 0 559 176 21 148 3E-83 255 Q6PHK6 PURB_DANRE GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006628; Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B) purb Danio rerio (Zebrafish) (Brachydanio rerio) 297 Q6PHK6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2764 sp Q6PHK6 PURB_DANRE 98.44 128 2 0 559 176 21 148 3E-83 255 Q6PHK6 PURB_DANRE GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006628; Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B) purb Danio rerio (Zebrafish) (Brachydanio rerio) 297 Q6PHK6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2764 sp Q6PHK6 PURB_DANRE 98.44 128 2 0 559 176 21 148 3E-83 255 Q6PHK6 PURB_DANRE GO:0003677; GO:0005634; GO:0006355; GO:0006351 DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR006628; Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B) purb Danio rerio (Zebrafish) (Brachydanio rerio) 297 Q6PHK6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0009968 GO:0009968 negative regulation of signal transduction signal transduction P ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig2174 sp Q6PHS6 SNX13_MOUSE 88.15 135 16 0 3 407 729 863 1E-77 252 Q6PHS6 SNX13_MOUSE GO:0007154; GO:0031901; GO:0006886; GO:0035091; GO:0043547; GO:0038032 cell communication; early endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of GTPase activity; termination of G-protein coupled receptor signaling pathway reviewed IPR001683; IPR003114; IPR013996; IPR016137; IPR000342; IPR013937; Sorting nexin-13 Snx13 Mus musculus (Mouse) 957 Q6PHS6 GO:0038032 ConsensusfromContig5815 sp Q6PJI9 WDR59_HUMAN 70.22 225 64 2 2 673 752 974 4E-100 324 Q6PJI9 WDR59_HUMAN reviewed IPR006575; IPR016135; IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 59 WDR59 KIAA1923 FP977 Homo sapiens (Human) 974 Q6PJI9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5815 sp Q6PJI9 WDR59_HUMAN 70.22 225 64 2 2 673 752 974 4E-100 324 Q6PJI9 WDR59_HUMAN reviewed IPR006575; IPR016135; IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 59 WDR59 KIAA1923 FP977 Homo sapiens (Human) 974 Q6PJI9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5815 sp Q6PJI9 WDR59_HUMAN 70.22 225 64 2 2 673 752 974 4E-100 324 Q6PJI9 WDR59_HUMAN reviewed IPR006575; IPR016135; IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 59 WDR59 KIAA1923 FP977 Homo sapiens (Human) 974 Q6PJI9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0000170 GO:0000170 sphingosine hydroxylase activity other molecular function F ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0006665 GO:0006665 sphingolipid metabolic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0006667 GO:0006667 sphinganine metabolic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0016705 GO:0016705 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen" other molecular function F ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0030148 GO:0030148 sphingolipid biosynthetic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0042284 GO:0042284 sphingolipid delta-4 desaturase activity other molecular function F ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0044281 ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0046513 GO:0046513 ceramide biosynthetic process other metabolic processes P ConsensusfromContig6309 sp Q6QHC5 DEGS2_HUMAN 74.07 216 56 0 1553 906 106 321 4E-116 352 Q6QHC5 DEGS2_HUMAN GO:0046513; GO:0005789; GO:0006633; GO:0016021; GO:0044281; GO:0006667; GO:0030148; GO:0042284; GO:0000170 ceramide biosynthetic process; endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; small molecule metabolic process; sphinganine metabolic process; sphingolipid biosynthetic process; sphingolipid delta-4 desaturase activity; sphingosine hydroxylase activity reviewed IPR005804; IPR011388; IPR013866; Membrane lipid metabolism; sphingolipid biosynthesis. Sphingolipid delta(4)-desaturase/C4-hydroxylase DES2 (EC 1.-.-.-) (EC 1.14.-.-) (Degenerative spermatocyte homolog 2) DEGS2 C14orf66 Homo sapiens (Human) 323 Q6QHC5 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0007224 GO:0007224 smoothened signaling pathway signal transduction P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0007519 GO:0007519 skeletal muscle tissue development developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0008015 GO:0008015 blood circulation other biological processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0008158 GO:0008158 hedgehog receptor activity signal transduction activity F ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0009952 GO:0009952 anterior/posterior pattern formation developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0021984 GO:0021984 adenohypophysis development developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0031290 GO:0031290 retinal ganglion cell axon guidance developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0031290 GO:0031290 retinal ganglion cell axon guidance cell organization and biogenesis P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0042694 GO:0042694 muscle cell fate specification other biological processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0048701 GO:0048701 embryonic cranial skeleton morphogenesis developmental processes P ConsensusfromContig2428 sp Q6R5J2 DISP1_DANRE 94.47 217 12 0 2 652 904 1120 2E-125 392 Q6R5J2 DISP1_DANRE GO:0021984; GO:0009952; GO:0008015; GO:0048701; GO:0008158; GO:0048839; GO:0016021; GO:0042694; GO:0031290; GO:0007519; GO:0007224 adenohypophysis development; anterior/posterior pattern specification; blood circulation; embryonic cranial skeleton morphogenesis; hedgehog receptor activity; inner ear development; integral to membrane; muscle cell fate specification; retinal ganglion cell axon guidance; skeletal muscle tissue development; smoothened signaling pathway reviewed IPR003392; IPR000731; Protein dispatched homolog 1 (Protein chameleon) disp1 con Danio rerio (Zebrafish) (Brachydanio rerio) 1464 Q6R5J2 GO:0048839 GO:0048839 inner ear development developmental processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0002551 GO:0002551 mast cell chemotaxis other biological processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0006935 GO:0006935 chemotaxis other biological processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0016601 GO:0016601 Rac protein signal transduction signal transduction P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0017137 GO:0017137 Rab GTPase binding enzyme regulator activity F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0030334 GO:0030334 regulation of cell migration other biological processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0045453 GO:0045453 bone resorption other biological processes P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0045740 GO:0045740 positive regulation of DNA replication DNA metabolism P ConsensusfromContig5958 sp Q6RUV5 RAC1_RAT 99.39 165 1 0 21 515 28 192 1E-103 327 Q6RUV5 RAC1_RAT GO:0005525; GO:0003924; GO:0000139; GO:0016601; GO:0060071; GO:0007015; GO:0048532; GO:0002093; GO:0007411; GO:0045453; GO:0008283; GO:0045216; GO:0021799; GO:0090103; GO:0031410; GO:0048813; GO:0071542; GO:0021831; GO:0043652; GO:0003382; GO:0019897; GO:0006972; GO:0030027; GO:0030032; GO:0002551; GO:0042470; GO:0001891; GO:0045740; GO:0030838; GO:0043552; GO:0001934; GO:0030334; GO:0097178; GO:0032587; GO:0034446 GTP binding; GTPase activity; Golgi membrane; Rac protein signal transduction; Wnt receptor signaling pathway, planar cell polarity pathway; actin filament organization; anatomical structure arrangement; auditory receptor cell morphogenesis; axon guidance; bone resorption; cell proliferation; cell-cell junction organization; cerebral cortex radially oriented cell migration; cochlea morphogenesis; cytoplasmic vesicle; dendrite morphogenesis; dopaminergic neuron differentiation; embryonic olfactory bulb interneuron precursor migration; engulfment of apoptotic cell; epithelial cell morphogenesis; extrinsic to plasma membrane; hyperosmotic response; lamellipodium; lamellipodium assembly; mast cell chemotaxis; melanosome; phagocytic cup; positive regulation of DNA replication; positive regulation of actin filament polymerization; positive regulation of phosphatidylinositol 3-kinase activity; positive regulation of protein phosphorylation; regulation of cell migration; ruffle assembly; ruffle membrane; substrate adhesion-dependent cell spreading reviewed IPR027417; IPR005225; IPR001806; IPR003578; Ras-related C3 botulinum toxin substrate 1 (p21-Rac1) Rac1 Rattus norvegicus (Rat) 192 Q6RUV5 GO:0048870 GO:0048870 cell motility other biological processes P ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2143 sp Q6TCH7 PAQR3_HUMAN 62.25 151 57 0 460 8 159 309 4E-69 218 Q6TCH7 PAQR3_HUMAN GO:0000139; GO:0016021 Golgi membrane; integral to membrane reviewed IPR004254; Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG) PAQR3 Homo sapiens (Human) 311 Q6TCH7 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig842 sp Q6TH01 C10_DANRE 100 98 0 0 721 428 1 98 4E-62 199 Q6TH01 C10_DANRE GO:0005737 cytoplasm reviewed IPR026317; Protein C10 si:dkey-29f10.1 zgc:86838 Danio rerio (Zebrafish) (Brachydanio rerio) 122 Q6TH01 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig842 sp Q6TH01 C10_DANRE 100 98 0 0 721 428 1 98 4E-62 199 Q6TH01 C10_DANRE GO:0005737 cytoplasm reviewed IPR026317; Protein C10 si:dkey-29f10.1 zgc:86838 Danio rerio (Zebrafish) (Brachydanio rerio) 122 Q6TH01 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig842 sp Q6TH01 C10_DANRE 100 98 0 0 721 428 1 98 4E-62 199 Q6TH01 C10_DANRE GO:0005737 cytoplasm reviewed IPR026317; Protein C10 si:dkey-29f10.1 zgc:86838 Danio rerio (Zebrafish) (Brachydanio rerio) 122 Q6TH01 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5681 sp Q6TH15 EIF3D_DANRE 94.55 532 27 1 78 1667 1 532 0 1065 Q6TH15 EIF3D_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR007783; Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) eif3d eif3s7 si:dkey-165I8.6 Danio rerio (Zebrafish) (Brachydanio rerio) 552 Q6TH15 GO:0003743 GO:0003743 translation initiation factor activity nucleic acid binding activity F ConsensusfromContig5681 sp Q6TH15 EIF3D_DANRE 94.55 532 27 1 78 1667 1 532 0 1065 Q6TH15 EIF3D_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR007783; Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) eif3d eif3s7 si:dkey-165I8.6 Danio rerio (Zebrafish) (Brachydanio rerio) 552 Q6TH15 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5681 sp Q6TH15 EIF3D_DANRE 94.55 532 27 1 78 1667 1 532 0 1065 Q6TH15 EIF3D_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR007783; Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) eif3d eif3s7 si:dkey-165I8.6 Danio rerio (Zebrafish) (Brachydanio rerio) 552 Q6TH15 GO:0005852 GO:0005852 eukaryotic translation initiation factor 3 complex other cellular component C ConsensusfromContig5681 sp Q6TH15 EIF3D_DANRE 94.55 532 27 1 78 1667 1 532 0 1065 Q6TH15 EIF3D_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR007783; Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) eif3d eif3s7 si:dkey-165I8.6 Danio rerio (Zebrafish) (Brachydanio rerio) 552 Q6TH15 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5681 sp Q6TH15 EIF3D_DANRE 94.55 532 27 1 78 1667 1 532 0 1065 Q6TH15 EIF3D_DANRE GO:0016282; GO:0033290; GO:0005852; GO:0001731; GO:0006446; GO:0003743; GO:0006413 eukaryotic 43S preinitiation complex; eukaryotic 48S preinitiation complex; eukaryotic translation initiation factor 3 complex; formation of translation preinitiation complex; regulation of translational initiation; translation initiation factor activity; translational initiation reviewed IPR007783; Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) eif3d eif3s7 si:dkey-165I8.6 Danio rerio (Zebrafish) (Brachydanio rerio) 552 Q6TH15 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0007034 GO:0007034 vacuolar transport transport P ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0030904 GO:0030904 retromer complex other membranes C ConsensusfromContig5963 sp Q6TNP8 VP26A_DANRE 96.33 327 12 0 2181 1201 1 327 0 652 Q6TNP8 VP26A_DANRE GO:0005768; GO:0010008; GO:0015031; GO:0030904; GO:0007034; GO:0031982 endosome; endosome membrane; protein transport; retromer complex; vacuolar transport; vesicle reviewed IPR005377; Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) vps26a zgc:56673 Danio rerio (Zebrafish) (Brachydanio rerio) 327 Q6TNP8 GO:0031982 GO:0031982 vesicle other cellular component C ConsensusfromContig5559 sp Q6TNS2 PK1IP_DANRE 67.58 256 78 3 1505 747 97 350 9E-119 360 Q6TNS2 PK1IP_DANRE GO:0009968; GO:0005730 negative regulation of signal transduction; nucleolus reviewed IPR015943; IPR001680; IPR019775; IPR017986; p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like) pak1ip1 zgc:56683 Danio rerio (Zebrafish) (Brachydanio rerio) 368 Q6TNS2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5559 sp Q6TNS2 PK1IP_DANRE 67.58 256 78 3 1505 747 97 350 9E-119 360 Q6TNS2 PK1IP_DANRE GO:0009968; GO:0005730 negative regulation of signal transduction; nucleolus reviewed IPR015943; IPR001680; IPR019775; IPR017986; p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like) pak1ip1 zgc:56683 Danio rerio (Zebrafish) (Brachydanio rerio) 368 Q6TNS2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5559 sp Q6TNS2 PK1IP_DANRE 67.58 256 78 3 1505 747 97 350 9E-119 360 Q6TNS2 PK1IP_DANRE GO:0009968; GO:0005730 negative regulation of signal transduction; nucleolus reviewed IPR015943; IPR001680; IPR019775; IPR017986; p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like) pak1ip1 zgc:56683 Danio rerio (Zebrafish) (Brachydanio rerio) 368 Q6TNS2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5559 sp Q6TNS2 PK1IP_DANRE 67.58 256 78 3 1505 747 97 350 9E-119 360 Q6TNS2 PK1IP_DANRE GO:0009968; GO:0005730 negative regulation of signal transduction; nucleolus reviewed IPR015943; IPR001680; IPR019775; IPR017986; p21-activated protein kinase-interacting protein 1-like (PAK1-interacting protein 1-like) pak1ip1 zgc:56683 Danio rerio (Zebrafish) (Brachydanio rerio) 368 Q6TNS2 GO:0009968 GO:0009968 negative regulation of signal transduction signal transduction P ConsensusfromContig1407 sp Q6TNS7 RABL3_DANRE 91.6 131 11 0 406 14 103 233 1E-84 254 Q6TNS7 RABL3_DANRE GO:0005525; GO:0007264 GTP binding; small GTPase mediated signal transduction reviewed IPR027417; IPR001806; Rab-like protein 3 rabl3 zgc:100876 Danio rerio (Zebrafish) (Brachydanio rerio) 233 Q6TNS7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1407 sp Q6TNS7 RABL3_DANRE 91.6 131 11 0 406 14 103 233 1E-84 254 Q6TNS7 RABL3_DANRE GO:0005525; GO:0007264 GTP binding; small GTPase mediated signal transduction reviewed IPR027417; IPR001806; Rab-like protein 3 rabl3 zgc:100876 Danio rerio (Zebrafish) (Brachydanio rerio) 233 Q6TNS7 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1407 sp Q6TNS7 RABL3_DANRE 91.6 131 11 0 406 14 103 233 1E-84 254 Q6TNS7 RABL3_DANRE GO:0005525; GO:0007264 GTP binding; small GTPase mediated signal transduction reviewed IPR027417; IPR001806; Rab-like protein 3 rabl3 zgc:100876 Danio rerio (Zebrafish) (Brachydanio rerio) 233 Q6TNS7 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5544 sp Q6TNT2 ANR46_DANRE 85.9 227 31 1 22 699 1 227 1E-129 379 Q6TNT2 ANR46_DANRE GO:0016021 integral to membrane reviewed IPR002110; IPR020683; Ankyrin repeat domain-containing protein 46 ankrd46 zgc:109722 Danio rerio (Zebrafish) (Brachydanio rerio) 228 Q6TNT2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5544 sp Q6TNT2 ANR46_DANRE 85.9 227 31 1 22 699 1 227 1E-129 379 Q6TNT2 ANR46_DANRE GO:0016021 integral to membrane reviewed IPR002110; IPR020683; Ankyrin repeat domain-containing protein 46 ankrd46 zgc:109722 Danio rerio (Zebrafish) (Brachydanio rerio) 228 Q6TNT2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5795 sp Q6UFZ9 143B1_ONCMY 94.78 230 12 0 2469 1780 1 230 1E-150 450 Q6UFZ9 143B1_ONCMY GO:0005737 cytoplasm reviewed IPR000308; IPR023409; IPR023410; 14-3-3 protein beta/alpha-1 (Protein 14-3-3B1) Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 244 Q6UFZ9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5795 sp Q6UFZ9 143B1_ONCMY 94.78 230 12 0 2469 1780 1 230 1E-150 450 Q6UFZ9 143B1_ONCMY GO:0005737 cytoplasm reviewed IPR000308; IPR023409; IPR023410; 14-3-3 protein beta/alpha-1 (Protein 14-3-3B1) Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 244 Q6UFZ9 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig6057 sp Q6VEU3 PNO1_DANRE 67.12 219 67 2 1070 429 1 219 8E-97 298 Q6VEU3 PNO1_DANRE GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR004087; IPR004088; RNA-binding protein PNO1 pno1 zgc:65782 Danio rerio (Zebrafish) (Brachydanio rerio) 252 Q6VEU3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6057 sp Q6VEU3 PNO1_DANRE 67.12 219 67 2 1070 429 1 219 8E-97 298 Q6VEU3 PNO1_DANRE GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR004087; IPR004088; RNA-binding protein PNO1 pno1 zgc:65782 Danio rerio (Zebrafish) (Brachydanio rerio) 252 Q6VEU3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6057 sp Q6VEU3 PNO1_DANRE 67.12 219 67 2 1070 429 1 219 8E-97 298 Q6VEU3 PNO1_DANRE GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR004087; IPR004088; RNA-binding protein PNO1 pno1 zgc:65782 Danio rerio (Zebrafish) (Brachydanio rerio) 252 Q6VEU3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6057 sp Q6VEU3 PNO1_DANRE 67.12 219 67 2 1070 429 1 219 8E-97 298 Q6VEU3 PNO1_DANRE GO:0003723; GO:0005730 RNA binding; nucleolus reviewed IPR004087; IPR004088; RNA-binding protein PNO1 pno1 zgc:65782 Danio rerio (Zebrafish) (Brachydanio rerio) 252 Q6VEU3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0008083 GO:0008083 growth factor activity signal transduction activity F ConsensusfromContig6146 sp Q6ZN28 MACC1_HUMAN 45.05 555 302 2 2138 483 293 847 2E-163 499 Q6ZN28 MACC1_HUMAN GO:0005737; GO:0005634; GO:0051781; GO:0006355; GO:0006351 cytoplasm; nucleus; positive regulation of cell division; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011511; IPR001452; Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5) MACC1 Homo sapiens (Human) 852 Q6ZN28 GO:0051781 GO:0051781 positive regulation of cell division other biological processes P ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 72.73 143 38 1 2 427 577 719 9E-76 222 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 72.73 143 38 1 2 427 577 719 9E-76 222 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 72.73 143 38 1 2 427 577 719 9E-76 222 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 78.26 46 10 0 429 566 720 765 9E-76 82.4 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 78.26 46 10 0 429 566 720 765 9E-76 82.4 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2142 sp Q6ZXV5 TMTC3_HUMAN 78.26 46 10 0 429 566 720 765 9E-76 82.4 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4009 sp Q6ZXV5 TMTC3_HUMAN 76.6 141 33 0 1 423 373 513 3E-73 240 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4009 sp Q6ZXV5 TMTC3_HUMAN 76.6 141 33 0 1 423 373 513 3E-73 240 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4009 sp Q6ZXV5 TMTC3_HUMAN 76.6 141 33 0 1 423 373 513 3E-73 240 Q6ZXV5 TMTC3_HUMAN GO:0060447; GO:0016021; GO:0048286; GO:0048747; GO:0009791; GO:0010468 bud outgrowth involved in lung branching; integral to membrane; lung alveolus development; muscle fiber development; post-embryonic development; regulation of gene expression reviewed IPR013618; IPR013026; IPR011990; IPR013105; IPR019734; Transmembrane and TPR repeat-containing protein 3 (Protein SMILE) TMTC3 Homo sapiens (Human) 915 Q6ZXV5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0006879 GO:0006879 cellular iron ion homeostasis other biological processes P ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0042626 GO:0042626 "ATPase activity, coupled to transmembrane movement of substances" transporter activity F ConsensusfromContig2069 sp Q704E8 ABCB7_RAT 80.65 155 30 0 467 3 91 245 1E-84 270 Q704E8 ABCB7_RAT GO:0005524; GO:0042626; GO:0006879; GO:0016021; GO:0005743 ATP binding; ATPase activity, coupled to transmembrane movement of substances; cellular iron ion homeostasis; integral to membrane; mitochondrial inner membrane reviewed IPR003593; IPR011527; IPR003439; IPR017871; IPR001140; IPR027417; ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein) Abcb7 Rattus norvegicus (Rat) 752 Q704E8 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5985 sp Q70CQ1 UBP49_HUMAN 76.85 324 75 0 162 1133 346 669 0 537 Q70CQ1 UBP49_HUMAN GO:0004197; GO:0005737; GO:0035616; GO:0042393; GO:0000398; GO:0005634; GO:0004221; GO:0006511; GO:0004843; GO:0008270 cysteine-type endopeptidase activity; cytoplasm; histone H2B conserved C-terminal lysine deubiquitination; histone binding; mRNA splicing, via spliceosome; nucleus; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49) USP49 Homo sapiens (Human) 688 Q70CQ1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1723 sp Q70EL1 UBP54_HUMAN 88.15 135 16 0 415 11 220 354 4E-85 278 Q70EL1 UBP54_HUMAN GO:0004221; GO:0006511 P54253 ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54) USP54 C10orf29 Homo sapiens (Human) 1684 Q70EL1 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig1723 sp Q70EL1 UBP54_HUMAN 88.15 135 16 0 415 11 220 354 4E-85 278 Q70EL1 UBP54_HUMAN GO:0004221; GO:0006511 P54253 ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54) USP54 C10orf29 Homo sapiens (Human) 1684 Q70EL1 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1723 sp Q70EL1 UBP54_HUMAN 88.15 135 16 0 415 11 220 354 4E-85 278 Q70EL1 UBP54_HUMAN GO:0004221; GO:0006511 P54253 ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process reviewed IPR001394; Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54) USP54 C10orf29 Homo sapiens (Human) 1684 Q70EL1 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig6180 sp Q70Z53 F10C1_HUMAN 72.25 227 63 0 792 112 1 227 1E-110 332 Q70Z53 F10C1_HUMAN GO:0005634 Q8IWX8; Q96DF8; Q13123; Q12852; Q13435 nucleus reviewed IPR019129; Protein FRA10AC1 FRA10AC1 C10orf4 PRO2972 Homo sapiens (Human) 315 Q70Z53 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6180 sp Q70Z53 F10C1_HUMAN 72.25 227 63 0 792 112 1 227 1E-110 332 Q70Z53 F10C1_HUMAN GO:0005634 Q8IWX8; Q96DF8; Q13123; Q12852; Q13435 nucleus reviewed IPR019129; Protein FRA10AC1 FRA10AC1 C10orf4 PRO2972 Homo sapiens (Human) 315 Q70Z53 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2423 sp Q71R50 DHR11_CHICK 84.8 125 19 0 375 1 1 125 2E-72 224 Q71R50 DHR11_CHICK GO:0005576; GO:0016491 extracellular region; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; IPR020904; Dehydrogenase/reductase SDR family member 11 (EC 1.-.-.-) DHRS11 Gallus gallus (Chicken) 255 Q71R50 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2423 sp Q71R50 DHR11_CHICK 84.8 125 19 0 375 1 1 125 2E-72 224 Q71R50 DHR11_CHICK GO:0005576; GO:0016491 extracellular region; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; IPR020904; Dehydrogenase/reductase SDR family member 11 (EC 1.-.-.-) DHRS11 Gallus gallus (Chicken) 255 Q71R50 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig2423 sp Q71R50 DHR11_CHICK 84.8 125 19 0 375 1 1 125 2E-72 224 Q71R50 DHR11_CHICK GO:0005576; GO:0016491 extracellular region; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; IPR020904; Dehydrogenase/reductase SDR family member 11 (EC 1.-.-.-) DHRS11 Gallus gallus (Chicken) 255 Q71R50 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig2423 sp Q71R50 DHR11_CHICK 84.8 125 19 0 375 1 1 125 2E-72 224 Q71R50 DHR11_CHICK GO:0005576; GO:0016491 extracellular region; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; IPR020904; Dehydrogenase/reductase SDR family member 11 (EC 1.-.-.-) DHRS11 Gallus gallus (Chicken) 255 Q71R50 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2423 sp Q71R50 DHR11_CHICK 84.8 125 19 0 375 1 1 125 2E-72 224 Q71R50 DHR11_CHICK GO:0005576; GO:0016491 extracellular region; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; IPR020904; Dehydrogenase/reductase SDR family member 11 (EC 1.-.-.-) DHRS11 Gallus gallus (Chicken) 255 Q71R50 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5744 sp Q767K6 DHX16_PIG 82.23 349 62 0 1272 226 697 1045 0 610 Q767K6 DHX16_PIG GO:0005524; GO:0008026; GO:0008380; GO:0006397; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; RNA splicing; mRNA processing; nucleic acid binding; nucleus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (DEAH-box protein 16) DHX16 DDX16 Sus scrofa (Pig) 1045 Q767K6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0006413 GO:0006413 translational initiation protein metabolism P ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0008494 GO:0008494 translation activator activity nucleic acid binding activity F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0042788 GO:0042788 polysomal ribosome translational apparatus C ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0043022 GO:0043022 ribosome binding translation activity F ConsensusfromContig5823 sp Q767L0 ABCF1_PIG 83.52 273 45 0 1 819 532 804 4E-136 413 Q767L0 ABCF1_PIG GO:0005524; GO:0006200; GO:0016887; GO:0005635; GO:0005654; GO:0042788; GO:0043022; GO:0008494; GO:0006413 ATP binding; ATP catabolic process; ATPase activity; nuclear envelope; nucleoplasm; polysomal ribosome; ribosome binding; translation activator activity; translational initiation reviewed IPR003593; IPR003439; IPR017871; IPR027417; ATP-binding cassette sub-family F member 1 ABCF1 Sus scrofa (Pig) 807 Q767L0 GO:0045727 GO:0045727 positive regulation of translation protein metabolism P ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0004394 GO:0004394 heparan sulfate 2-O-sulfotransferase activity other molecular function F ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0008146 GO:0008146 sulfotransferase activity other molecular function F ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0015014 GO:0015014 "heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process" other metabolic processes P ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0030202 GO:0030202 heparin metabolic process other metabolic processes P ConsensusfromContig1378 sp Q76KB1 HS2ST_CHICK 85.59 111 16 0 3 335 246 356 5E-60 196 Q76KB1 HS2ST_CHICK GO:0000139; GO:0016021; GO:0008146 Golgi membrane; integral to membrane; sulfotransferase activity reviewed IPR007734; IPR027417; IPR005331; Heparan sulfate 2-O-sulfotransferase 1 (cHS2ST) (EC 2.8.2.-) HS2ST1 HS2ST Gallus gallus (Chicken) 356 Q76KB1 GO:0060676 GO:0060676 ureteric bud formation developmental processes P ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0008060 GO:0008060 ARF GTPase activator activity enzyme regulator activity F ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0032312 GO:0032312 regulation of ARF GTPase activity signal transduction P ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig313 sp Q7SIG6 ASAP2_MOUSE 84.11 107 11 1 28 330 254 360 6E-55 188 Q7SIG6 ASAP2_MOUSE GO:0008060; GO:0032580; GO:0005543; GO:0005886; GO:0043547; GO:0032312; GO:0008270 ARF GTPase activator activity; Golgi cisterna membrane; phospholipid binding; plasma membrane; positive regulation of GTPase activity; regulation of ARF GTPase activity; zinc ion binding reviewed IPR027267; IPR002110; IPR020683; IPR001164; IPR011993; IPR001849; IPR001452; Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP) Asap2 Ddef2 Gm1523 Gm592 Mus musculus (Mouse) 958 Q7SIG6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3300 sp Q7SX85 SESD1_DANRE 92.97 128 9 0 385 2 295 422 8E-63 209 Q7SX85 SESD1_DANRE GO:0048514 blood vessel morphogenesis reviewed IPR001251; IPR018159; SEC14 domain and spectrin repeat-containing protein 1 (Protein Solo) sestd1 sol solo si:dz106a20.1 si:dz42h5.2 Danio rerio (Zebrafish) (Brachydanio rerio) 714 Q7SX85 GO:0048514 GO:0048514 blood vessel morphogenesis developmental processes P ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0004333 GO:0004333 fumarate hydratase activity other molecular function F ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0006106 GO:0006106 fumarate metabolic process other metabolic processes P ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig6037 sp Q7SX99 FUMH_DANRE 86.64 509 64 1 109 1623 1 509 0 860 Q7SX99 FUMH_DANRE GO:0004333; GO:0006106; GO:0005739; GO:0006099; GO:0045239 fumarate hydratase activity; fumarate metabolic process; mitochondrion; tricarboxylic acid cycle; tricarboxylic acid cycle enzyme complex reviewed IPR005677; IPR024083; IPR018951; IPR020557; IPR000362; IPR022761; IPR008948; Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2) fh zgc:66253 Danio rerio (Zebrafish) (Brachydanio rerio) 509 Q7SX99 GO:0045239 GO:0045239 tricarboxylic acid cycle enzyme complex other cellular component C ConsensusfromContig5562 sp Q7SXB5 PF23B_DANRE 46.18 314 126 6 1709 870 1 305 3E-68 233 Q7SXB5 PF23B_DANRE GO:0008270 zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR013083; PHD finger protein 23B phf23b zgc:110484 zgc:66469 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q7SXB5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5562 sp Q7SXB5 PF23B_DANRE 46.18 314 126 6 1709 870 1 305 3E-68 233 Q7SXB5 PF23B_DANRE GO:0008270 zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR013083; PHD finger protein 23B phf23b zgc:110484 zgc:66469 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q7SXB5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5562 sp Q7SXB5 PF23B_DANRE 46.18 314 126 6 1709 870 1 305 3E-68 233 Q7SXB5 PF23B_DANRE GO:0008270 zinc ion binding reviewed IPR019786; IPR011011; IPR001965; IPR013083; PHD finger protein 23B phf23b zgc:110484 zgc:66469 Danio rerio (Zebrafish) (Brachydanio rerio) 315 Q7SXB5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0008641 GO:0008641 small protein activating enzyme activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0016925 GO:0016925 protein sumoylation protein metabolism P ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0019948 GO:0019948 SUMO activating enzyme activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 78.41 477 84 6 2045 648 168 636 0 671 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0008641 GO:0008641 small protein activating enzyme activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0016925 GO:0016925 protein sumoylation protein metabolism P ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0019948 GO:0019948 SUMO activating enzyme activity other molecular function F ConsensusfromContig6221 sp Q7SXG4 SAE2_DANRE 87.43 183 23 0 2545 1997 1 183 2E-101 335 Q7SXG4 SAE2_DANRE GO:0005524; GO:0019948; GO:0005737; GO:0016874; GO:0046872; GO:0005634; GO:0016925 ATP binding; SUMO activating enzyme activity; cytoplasm; ligase activity; metal ion binding; nucleus; protein sumoylation reviewed IPR009036; IPR016040; IPR000594; IPR028077; IPR023280; IPR000127; IPR019572; IPR018074; Protein modification; protein sumoylation. SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2) uba2 sae2 sae2b uble1b si:ch211-149o7.1 zgc:66354 Danio rerio (Zebrafish) (Brachydanio rerio) 650 Q7SXG4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 95.54 224 10 0 3 674 13 236 3E-156 405 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 95.54 224 10 0 3 674 13 236 3E-156 405 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 95.54 224 10 0 3 674 13 236 3E-156 405 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 95.54 224 10 0 3 674 13 236 3E-156 405 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 95.54 224 10 0 3 674 13 236 3E-156 405 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 69.72 142 36 3 791 1216 270 404 3E-156 169 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 69.72 142 36 3 791 1216 270 404 3E-156 169 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 69.72 142 36 3 791 1216 270 404 3E-156 169 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 69.72 142 36 3 791 1216 270 404 3E-156 169 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6009 sp Q7SXL7 FL2D_DANRE 69.72 142 36 3 791 1216 270 404 3E-156 169 Q7SXL7 FL2D_DANRE GO:0008380; GO:0007049; GO:0006397; GO:0005730 RNA splicing; cell cycle; mRNA processing; nucleolus reviewed Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (WT1-associated protein) (Wilms tumor 1-associating protein) wtap ch211-195e3.2 zgc:66202 Danio rerio (Zebrafish) (Brachydanio rerio) 423 Q7SXL7 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6171 sp Q7SXN5 DNM1L_DANRE 91.74 327 27 0 1932 952 362 688 0 607 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1629 sp Q7SXN5 DNM1L_DANRE 93.88 147 8 1 438 1 165 311 4E-87 274 Q7SXN5 DNM1L_DANRE GO:0005525; GO:0003924; GO:0005829; GO:0003374; GO:0016020; GO:0000266; GO:0005739; GO:0005777; GO:0042803 GTP binding; GTPase activity; cytosol; dynamin polymerization involved in mitochondrial fission; membrane; mitochondrial fission; mitochondrion; peroxisome; protein homodimerization activity reviewed IPR000375; IPR001401; IPR019762; IPR022812; IPR003130; IPR020850; IPR027417; Dynamin-1-like protein (EC 3.6.5.5) dnm1l zgc:66163 Danio rerio (Zebrafish) (Brachydanio rerio) 691 Q7SXN5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6166 sp Q7SXR1 TRBP2_DANRE 87.91 215 23 2 1824 1189 132 346 5E-117 358 Q7SXR1 TRBP2_DANRE GO:0003723; GO:0005737; GO:0031047; GO:0006417 RNA binding; cytoplasm; gene silencing by RNA; regulation of translation reviewed IPR014720; RISC-loading complex subunit tarbp2 tarbp2 Danio rerio (Zebrafish) (Brachydanio rerio) 346 Q7SXR1 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6166 sp Q7SXR1 TRBP2_DANRE 87.91 215 23 2 1824 1189 132 346 5E-117 358 Q7SXR1 TRBP2_DANRE GO:0003723; GO:0005737; GO:0031047; GO:0006417 RNA binding; cytoplasm; gene silencing by RNA; regulation of translation reviewed IPR014720; RISC-loading complex subunit tarbp2 tarbp2 Danio rerio (Zebrafish) (Brachydanio rerio) 346 Q7SXR1 GO:0003725 GO:0003725 double-stranded RNA binding nucleic acid binding activity F ConsensusfromContig6166 sp Q7SXR1 TRBP2_DANRE 87.91 215 23 2 1824 1189 132 346 5E-117 358 Q7SXR1 TRBP2_DANRE GO:0003723; GO:0005737; GO:0031047; GO:0006417 RNA binding; cytoplasm; gene silencing by RNA; regulation of translation reviewed IPR014720; RISC-loading complex subunit tarbp2 tarbp2 Danio rerio (Zebrafish) (Brachydanio rerio) 346 Q7SXR1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6166 sp Q7SXR1 TRBP2_DANRE 87.91 215 23 2 1824 1189 132 346 5E-117 358 Q7SXR1 TRBP2_DANRE GO:0003723; GO:0005737; GO:0031047; GO:0006417 RNA binding; cytoplasm; gene silencing by RNA; regulation of translation reviewed IPR014720; RISC-loading complex subunit tarbp2 tarbp2 Danio rerio (Zebrafish) (Brachydanio rerio) 346 Q7SXR1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6166 sp Q7SXR1 TRBP2_DANRE 87.91 215 23 2 1824 1189 132 346 5E-117 358 Q7SXR1 TRBP2_DANRE GO:0003723; GO:0005737; GO:0031047; GO:0006417 RNA binding; cytoplasm; gene silencing by RNA; regulation of translation reviewed IPR014720; RISC-loading complex subunit tarbp2 tarbp2 Danio rerio (Zebrafish) (Brachydanio rerio) 346 Q7SXR1 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0006783 GO:0006783 heme biosynthetic process other metabolic processes P ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1461 sp Q7SXW0 S2539_DANRE 83.67 98 16 0 7 300 61 158 1E-54 179 Q7SXW0 S2539_DANRE GO:0006783; GO:0016021; GO:0006828; GO:0016530; GO:0005743; GO:0005739; GO:0055085 heme biosynthetic process; integral to membrane; manganese ion transport; metallochaperone activity; mitochondrial inner membrane; mitochondrion; transmembrane transport reviewed IPR002067; IPR018108; IPR023395; Solute carrier family 25 member 39 slc25a39 zgc:63736 Danio rerio (Zebrafish) (Brachydanio rerio) 359 Q7SXW0 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2031 sp Q7SXW6 ARP2A_DANRE 79.43 141 29 0 1 423 5 145 2E-76 238 Q7SXW6 ARP2A_DANRE GO:0005524; GO:0034314; GO:0005885; GO:0042995; GO:0005737 ATP binding; Arp2/3 complex-mediated actin nucleation; Arp2/3 protein complex; cell projection; cytoplasm reviewed IPR004000; IPR020902; IPR027306; Actin-related protein 2-A (Actin-like protein 2-A) actr2a actr2 arp2a Danio rerio (Zebrafish) (Brachydanio rerio) 394 Q7SXW6 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0004697 GO:0004697 protein kinase C activity kinase activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0030374 GO:0030374 ligand-dependent nuclear receptor transcription coactivator activity transcription regulatory activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0035162 GO:0035162 embryonic hemopoiesis developmental processes P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0035403 ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0035408 ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0035556 ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0042113 GO:0042113 B cell activation other biological processes P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0050681 GO:0050681 androgen receptor binding signal transduction activity F ConsensusfromContig2225 sp Q7SY24 KPCB_DANRE 93.71 175 11 0 1 525 11 185 5E-118 355 Q7SY24 KPCB_DANRE GO:0005524; GO:0042113; GO:0050853; GO:0050681; GO:0006915; GO:0003682; GO:0005737; GO:0035162; GO:0042393; GO:0035403; GO:0035556; GO:0030374; GO:0016020; GO:0005634; GO:0043123; GO:0004697; GO:0006357; GO:0006351; GO:0008270 ATP binding; B cell activation; B cell receptor signaling pathway; androgen receptor binding; apoptotic process; chromatin binding; cytoplasm; embryonic hemopoiesis; histone binding; histone kinase activity (H3-T6 specific); intracellular signal transduction; ligand-dependent nuclear receptor transcription coactivator activity; membrane; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein kinase C activity; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent; zinc ion binding reviewed IPR000961; IPR000008; IPR020454; IPR011009; IPR017892; IPR002219; IPR000719; IPR017441; IPR014375; IPR002290; IPR008271; Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13) prkcbb prkcb1 Danio rerio (Zebrafish) (Brachydanio rerio) 670 Q7SY24 GO:0050853 GO:0050853 B cell receptor signaling pathway signal transduction P ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0004833 GO:0004833 "tryptophan 2,3-dioxygenase activity" other molecular function F ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0006569 GO:0006569 tryptophan catabolic process other metabolic processes P ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0019441 GO:0019441 tryptophan catabolic process to kynurenine other metabolic processes P ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2641 sp Q7SY53 T23OB_DANRE 79.25 106 22 0 319 2 127 232 7E-57 187 Q7SY53 T23OB_DANRE GO:0020037; GO:0046872; GO:0004833; GO:0019442; GO:0019441 heme binding; metal ion binding; tryptophan 2,3-dioxygenase activity; tryptophan catabolic process to acetyl-CoA; tryptophan catabolic process to kynurenine reviewed IPR004981; Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2. Tryptophan 2,3-dioxygenase B (TDO-B) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase B) (Tryptophan oxygenase B) (TO-B) (TRPO-B) (Tryptophan pyrrolase B) (Tryptophanase B) tdo2b tdo2 tdo2l zgc:63488 Danio rerio (Zebrafish) (Brachydanio rerio) 407 Q7SY53 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig4257 sp Q7SYD9 INT6_DANRE 85.03 147 10 1 497 93 494 640 5E-77 252 Q7SYD9 INT6_DANRE GO:0005634 nucleus reviewed IPR002035; Integrator complex subunit 6 (Int6) (Protein DDX26B) ints6 ddx26b zgc:63527 Danio rerio (Zebrafish) (Brachydanio rerio) 892 Q7SYD9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4257 sp Q7SYD9 INT6_DANRE 85.03 147 10 1 497 93 494 640 5E-77 252 Q7SYD9 INT6_DANRE GO:0005634 nucleus reviewed IPR002035; Integrator complex subunit 6 (Int6) (Protein DDX26B) ints6 ddx26b zgc:63527 Danio rerio (Zebrafish) (Brachydanio rerio) 892 Q7SYD9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0006887 GO:0006887 exocytosis transport P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0008544 GO:0008544 epidermis development developmental processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0010719 GO:0010719 negative regulation of epithelial to mesenchymal transition developmental processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0010719 GO:0010719 negative regulation of epithelial to mesenchymal transition cell organization and biogenesis P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0030336 GO:0030336 negative regulation of cell migration other biological processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0031581 GO:0031581 hemidesmosome assembly cell organization and biogenesis P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0043588 GO:0043588 skin development developmental processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0048919 GO:0048919 posterior lateral line neuromast development developmental processes P ConsensusfromContig656 sp Q7SZE3 L2GL2_DANRE 68.46 149 35 3 1 423 863 1007 2E-53 189 Q7SZE3 L2GL2_DANRE GO:0007049; GO:0005737; GO:0005856; GO:0007010; GO:0008544; GO:0006887; GO:0031581; GO:0030336; GO:0050680; GO:0010719; GO:0048919; GO:0045682 cell cycle; cytoplasm; cytoskeleton; cytoskeleton organization; epidermis development; exocytosis; hemidesmosome assembly; negative regulation of cell migration; negative regulation of epithelial cell proliferation; negative regulation of epithelial to mesenchymal transition; posterior lateral line neuromast development; regulation of epidermis development reviewed IPR000664; IPR013577; IPR015943; IPR001680; IPR019775; IPR017986; Lethal(2) giant larvae protein homolog 2 (Protein penner) llgl2 pen Danio rerio (Zebrafish) (Brachydanio rerio) 1020 Q7SZE3 GO:0050680 GO:0050680 negative regulation of epithelial cell proliferation cell cycle and proliferation P ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5594 sp Q7T292 MFRN2_DANRE 75.2 125 31 0 375 1 21 145 2E-61 202 Q7T292 MFRN2_DANRE GO:0016021; GO:0006811; GO:0055072; GO:0005743 integral to membrane; ion transport; iron ion homeostasis; mitochondrial inner membrane reviewed IPR018108; IPR023395; Mitoferrin-2 (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28) slc25a28 mfrn2 zgc:64212 Danio rerio (Zebrafish) (Brachydanio rerio) 376 Q7T292 GO:0055072 GO:0055072 iron ion homeostasis other biological processes P ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0052650 ConsensusfromContig6031 sp Q7T2D1 RD10B_DANRE 80.3 335 65 1 1195 194 1 335 0 575 Q7T2D1 RD10B_DANRE GO:0052650; GO:0005789; GO:0016021 NADP-retinol dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002198; IPR002347; IPR016040; IPR020904; Cofactor metabolism; retinol metabolism. Retinol dehydrogenase 10-B (EC 1.1.1.300) rdh10b rdh10 si:ch211-193n21.3 Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q7T2D1 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6359 sp Q7T339 CHMP5_DANRE 88.18 220 26 0 1015 356 1 220 2E-120 357 Q7T339 CHMP5_DANRE GO:0005829; GO:0010008; GO:0015031 cytosol; endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 5 (Chromatin-modifying protein 5) chmp5 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7T339 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0015991 GO:0015991 ATP hydrolysis coupled proton transport transport P ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig1168 sp Q7T385 VTC1A_DANRE 94.19 172 10 0 162 677 1 172 2E-113 337 Q7T385 VTC1A_DANRE GO:0015991; GO:0015078; GO:0033180 ATP hydrolysis coupled proton transport; hydrogen ion transmembrane transporter activity; proton-transporting V-type ATPase, V1 domain reviewed IPR004907; V-type proton ATPase subunit C 1-A (V-ATPase subunit C 1-A) (Vacuolar proton pump subunit C 1-A) atp6v1c1a atp6v1c1 zgc:64034 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q7T385 GO:0033180 GO:0033180 "proton-transporting V-type ATPase, V1 domain" other membranes C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0008378 GO:0008378 galactosyltransferase activity other molecular function F ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5884 sp Q7T3S5 B3G5A_DANRE 73.61 379 100 0 385 1521 1 379 0 591 Q7T3S5 B3G5A_DANRE GO:0000139; GO:0008378; GO:0016021; GO:0047256; GO:0006486 Golgi membrane; galactosyltransferase activity; integral to membrane; lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity; protein glycosylation reviewed IPR002659; Protein modification; protein glycosylation. Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase A (EC 2.4.1.206) (Lactotriaosylceramide synthase A) (Lc(3)Cer synthase A) (Lc3 synthase A) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5A) (BGnT-5A) (Beta-1,3-Gn-T5A) (Beta-1,3-N-acetylglucosaminyltransferase 5A) (Beta3Gn-T5A) b3gnt5a b3gnt5 Danio rerio (Zebrafish) (Brachydanio rerio) 379 Q7T3S5 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig6089 sp Q7T3T8 ZAR1_DANRE 61.38 334 117 7 1145 165 1 329 5E-121 360 Q7T3T8 ZAR1_DANRE GO:0005737; GO:0007275 cytoplasm; multicellular organismal development reviewed IPR026775; IPR027377; Zygote arrest protein 1 (Oocyte-specific maternal effect factor) zar1 Danio rerio (Zebrafish) (Brachydanio rerio) 329 Q7T3T8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6089 sp Q7T3T8 ZAR1_DANRE 61.38 334 117 7 1145 165 1 329 5E-121 360 Q7T3T8 ZAR1_DANRE GO:0005737; GO:0007275 cytoplasm; multicellular organismal development reviewed IPR026775; IPR027377; Zygote arrest protein 1 (Oocyte-specific maternal effect factor) zar1 Danio rerio (Zebrafish) (Brachydanio rerio) 329 Q7T3T8 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig6089 sp Q7T3T8 ZAR1_DANRE 61.38 334 117 7 1145 165 1 329 5E-121 360 Q7T3T8 ZAR1_DANRE GO:0005737; GO:0007275 cytoplasm; multicellular organismal development reviewed IPR026775; IPR027377; Zygote arrest protein 1 (Oocyte-specific maternal effect factor) zar1 Danio rerio (Zebrafish) (Brachydanio rerio) 329 Q7T3T8 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6089 sp Q7T3T8 ZAR1_DANRE 61.38 334 117 7 1145 165 1 329 5E-121 360 Q7T3T8 ZAR1_DANRE GO:0005737; GO:0007275 cytoplasm; multicellular organismal development reviewed IPR026775; IPR027377; Zygote arrest protein 1 (Oocyte-specific maternal effect factor) zar1 Danio rerio (Zebrafish) (Brachydanio rerio) 329 Q7T3T8 GO:0008508 GO:0008508 bile acid:sodium symporter activity transporter activity F ConsensusfromContig6089 sp Q7T3T8 ZAR1_DANRE 61.38 334 117 7 1145 165 1 329 5E-121 360 Q7T3T8 ZAR1_DANRE GO:0005737; GO:0007275 cytoplasm; multicellular organismal development reviewed IPR026775; IPR027377; Zygote arrest protein 1 (Oocyte-specific maternal effect factor) zar1 Danio rerio (Zebrafish) (Brachydanio rerio) 329 Q7T3T8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0008143 GO:0008143 poly(A) RNA binding nucleic acid binding activity F ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0070934 ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0070937 ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0071013 GO:0071013 nucleus ConsensusfromContig5983 sp Q7TMK9 HNRPQ_MOUSE 91.23 308 27 0 297 1220 120 427 0 590 Q7TMK9 HNRPQ_MOUSE GO:0070937; GO:0070934; GO:0008380; GO:0071013; GO:0071346; GO:0071204; GO:0006397; GO:0017148; GO:0000166; GO:0008143 CRD-mediated mRNA stability complex; CRD-mediated mRNA stabilization; RNA splicing; catalytic step 2 spliceosome; cellular response to interferon-gamma; histone pre-mRNA 3'end processing complex; mRNA processing; negative regulation of translation; nucleotide binding; poly(A) RNA binding reviewed IPR006535; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) (pp68) Syncrip Hnrpq Nsap1 Nsap1l Mus musculus (Mouse) 623 Q7TMK9 GO:0071204 ConsensusfromContig1198 sp Q7Z429 LFG1_HUMAN 75.94 212 51 0 3 638 143 354 5E-99 298 Q7Z429 LFG1_HUMAN GO:0016021 integral to membrane reviewed IPR006214; Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) GRINA LFG1 NMDARA1 TMBIM3 Homo sapiens (Human) 371 Q7Z429 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1198 sp Q7Z429 LFG1_HUMAN 75.94 212 51 0 3 638 143 354 5E-99 298 Q7Z429 LFG1_HUMAN GO:0016021 integral to membrane reviewed IPR006214; Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3) GRINA LFG1 NMDARA1 TMBIM3 Homo sapiens (Human) 371 Q7Z429 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6324 sp Q7Z5U6 WDR53_HUMAN 50.84 238 107 4 1663 968 1 234 3E-74 250 Q7Z5U6 WDR53_HUMAN reviewed IPR015943; IPR001680; IPR019775; IPR017986; WD repeat-containing protein 53 WDR53 Homo sapiens (Human) 358 ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0006626 GO:0006626 protein targeting to mitochondrion transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0006626 GO:0006626 protein targeting to mitochondrion cell organization and biogenesis P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0006820 GO:0006820 anion transport transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0008308 GO:0008308 voltage-gated anion channel activity transporter activity F ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0015288 GO:0015288 porin activity transporter activity F ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0044070 GO:0044070 regulation of anion transport transport P ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0046930 GO:0046930 pore complex other membranes C ConsensusfromContig2676 sp Q7ZTM6 TOM40_XENLA 74.17 120 31 0 46 405 53 172 6E-67 212 Q7ZTM6 TOM40_XENLA GO:0006811; GO:0005741; GO:0046930; GO:0015288; GO:0006626 ion transport; mitochondrial outer membrane; pore complex; porin activity; protein targeting to mitochondrion reviewed IPR023614; IPR027246; Mitochondrial import receptor subunit TOM40 homolog (Translocase of outer membrane 40 kDa subunit homolog) tomm40 Xenopus laevis (African clawed frog) 336 Q7ZTM6 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5541 sp Q7ZTZ2 RLP24_DANRE 79.05 148 31 0 103 546 1 148 1E-57 190 Q7ZTZ2 RLP24_DANRE GO:0005730; GO:0042254 nucleolus; ribosome biogenesis reviewed IPR023442; IPR023441; IPR000988; IPR024546; IPR011017; Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) rsl24d1 zgc:56202 Danio rerio (Zebrafish) (Brachydanio rerio) 161 Q7ZTZ2 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0006869 GO:0006869 lipid transport transport P ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5632 sp Q7ZU13 SPNS1_DANRE 76.39 466 88 2 1866 505 6 461 0 709 Q7ZU13 SPNS1_DANRE GO:0016021; GO:0006869; GO:0005743; GO:0055085 integral to membrane; lipid transport; mitochondrial inner membrane; transmembrane transport reviewed IPR011701; IPR020846; IPR016196; Protein spinster homolog 1 (Protein not really started) (Spinster-like protein) spns1 nrs spinl Danio rerio (Zebrafish) (Brachydanio rerio) 506 Q7ZU13 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig2714 sp Q7ZUA6 LMBR1_CHICK 81.92 177 30 1 557 27 314 488 1E-84 264 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig2714 sp Q7ZUA6 LMBR1_CHICK 81.92 177 30 1 557 27 314 488 1E-84 264 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2714 sp Q7ZUA6 LMBR1_CHICK 81.92 177 30 1 557 27 314 488 1E-84 264 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3721 sp Q7ZUA6 LMBR1_CHICK 87.29 118 15 0 354 1 134 251 2E-52 177 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig3721 sp Q7ZUA6 LMBR1_CHICK 87.29 118 15 0 354 1 134 251 2E-52 177 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3721 sp Q7ZUA6 LMBR1_CHICK 87.29 118 15 0 354 1 134 251 2E-52 177 Q7ZUA6 LMBR1_CHICK GO:0016021 integral to membrane reviewed IPR008075; IPR006876; Limb region 1 protein homolog LMBR1 SAPH1 Gallus gallus (Chicken) 488 Q7ZUA6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig550 sp Q7ZUF2 BRD9_DANRE 75.11 221 32 4 1 660 236 434 5E-97 302 Q7ZUF2 BRD9_DANRE GO:0016568; GO:0070577; GO:0006355; GO:0006351 chromatin modification; histone acetyl-lysine binding; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001487; IPR021900; Bromodomain-containing protein 9 brd9 Danio rerio (Zebrafish) (Brachydanio rerio) 631 ConsensusfromContig679 sp Q7ZUV1 PKHF2_DANRE 91.95 87 7 0 266 6 54 140 2E-52 171 Q7ZUV1 PKHF2_DANRE GO:0031901; GO:0005783; GO:0046872; GO:0005543; GO:0015031 early endosome membrane; endoplasmic reticulum; metal ion binding; phospholipid binding; protein transport reviewed IPR011993; IPR001849; IPR000306; IPR017455; IPR011011; IPR013083; Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2) plekhf2 zgc:56073 Danio rerio (Zebrafish) (Brachydanio rerio) 247 Q7ZUV1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6316 sp Q7ZUW2 HYOU1_DANRE 79.81 213 43 0 860 222 676 888 4E-103 331 Q7ZUW2 HYOU1_DANRE GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; Hypoxia up-regulated protein 1 hyou1 Danio rerio (Zebrafish) (Brachydanio rerio) 980 Q7ZUW2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6316 sp Q7ZUW2 HYOU1_DANRE 79.81 213 43 0 860 222 676 888 4E-103 331 Q7ZUW2 HYOU1_DANRE GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; Hypoxia up-regulated protein 1 hyou1 Danio rerio (Zebrafish) (Brachydanio rerio) 980 Q7ZUW2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6316 sp Q7ZUW2 HYOU1_DANRE 79.81 213 43 0 860 222 676 888 4E-103 331 Q7ZUW2 HYOU1_DANRE GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; Hypoxia up-regulated protein 1 hyou1 Danio rerio (Zebrafish) (Brachydanio rerio) 980 Q7ZUW2 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6316 sp Q7ZUW2 HYOU1_DANRE 79.81 213 43 0 860 222 676 888 4E-103 331 Q7ZUW2 HYOU1_DANRE GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; Hypoxia up-regulated protein 1 hyou1 Danio rerio (Zebrafish) (Brachydanio rerio) 980 Q7ZUW2 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0004497 GO:0004497 monooxygenase activity other molecular function F ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0008612 GO:0008612 peptidyl-lysine modification to hypusine protein metabolism P ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0019135 GO:0019135 deoxyhypusine monooxygenase activity other molecular function F ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig184 sp Q7ZUX6 DOHH_DANRE 83.77 302 47 1 75 974 1 302 0 516 Q7ZUX6 DOHH_DANRE GO:0019135; GO:0046872; GO:0008612 deoxyhypusine monooxygenase activity; metal ion binding; peptidyl-lysine modification to hypusine reviewed IPR011989; IPR016024; IPR027517; IPR004155; Protein modification; eIF5A hypusination. Deoxyhypusine hydroxylase (DOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) dohh zgc:56338 Danio rerio (Zebrafish) (Brachydanio rerio) 305 Q7ZUX6 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0001104 ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6053 sp Q7ZV35 MED7_DANRE 81.67 251 35 3 1159 410 1 241 1E-122 362 Q7ZV35 MED7_DANRE GO:0001104; GO:0016592 RNA polymerase II transcription cofactor activity; mediator complex reviewed IPR009244; Mediator of RNA polymerase II transcription subunit 7 (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) med7 crsp9 Danio rerio (Zebrafish) (Brachydanio rerio) 241 Q7ZV35 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig5679 sp Q7ZV46 METRL_DANRE 77.22 158 36 0 211 684 1 158 9E-83 255 Q7ZV46 METRL_DANRE GO:0005576 extracellular region reviewed IPR008993; Meteorin-like protein metrnl zgc:56225 Danio rerio (Zebrafish) (Brachydanio rerio) 286 Q7ZV46 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5679 sp Q7ZV46 METRL_DANRE 77.22 158 36 0 211 684 1 158 9E-83 255 Q7ZV46 METRL_DANRE GO:0005576 extracellular region reviewed IPR008993; Meteorin-like protein metrnl zgc:56225 Danio rerio (Zebrafish) (Brachydanio rerio) 286 Q7ZV46 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6142 sp Q7ZV90 PIF1_DANRE 55.36 224 94 2 662 3 1 222 9E-76 250 Q7ZV90 PIF1_DANRE GO:0005524; GO:0003677; GO:0032508; GO:0003678; GO:0006310; GO:0006281; GO:0005739; GO:0005634; GO:0000723 ATP binding; DNA binding; DNA duplex unwinding; DNA helicase activity; DNA recombination; DNA repair; mitochondrion; nucleus; telomere maintenance reviewed IPR003593; IPR010285; IPR027417; ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) pif1 zgc:56161 Danio rerio (Zebrafish) (Brachydanio rerio) 639 Q7ZV90 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0000104 GO:0000104 succinate dehydrogenase activity other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0006105 GO:0006105 succinate metabolic process other metabolic processes P ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0008177 GO:0008177 succinate dehydrogenase (ubiquinone) activity other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0016627 GO:0016627 "oxidoreductase activity, acting on the CH-CH group of donors" other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0022904 GO:0022904 respiratory electron transport chain other metabolic processes P ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig1635 sp Q7ZVF3 DHSA_DANRE 97.71 131 3 0 393 1 266 396 9E-74 238 Q7ZVF3 DHSA_DANRE GO:0050660; GO:0005743; GO:0022904; GO:0008177; GO:0006105; GO:0006099 flavin adenine dinucleotide binding; mitochondrial inner membrane; respiratory electron transport chain; succinate dehydrogenase (ubiquinone) activity; succinate metabolic process; tricarboxylic acid cycle reviewed IPR003953; IPR003952; IPR015939; IPR027477; IPR011281; IPR014006; Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp) sdha si:dkeyp-84f11.2 Danio rerio (Zebrafish) (Brachydanio rerio) 661 Q7ZVF3 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig1293 sp Q7ZVK4 VPS36_DANRE 86.21 145 20 0 439 5 1 145 3E-91 277 Q7ZVK4 VPS36_DANRE GO:0005768; GO:0032266; GO:0015031 endosome; phosphatidylinositol-3-phosphate binding; protein transport reviewed IPR007286; IPR021648; IPR011991; Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36) vps36 zgc:55965 Danio rerio (Zebrafish) (Brachydanio rerio) 382 Q7ZVK4 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1293 sp Q7ZVK4 VPS36_DANRE 86.21 145 20 0 439 5 1 145 3E-91 277 Q7ZVK4 VPS36_DANRE GO:0005768; GO:0032266; GO:0015031 endosome; phosphatidylinositol-3-phosphate binding; protein transport reviewed IPR007286; IPR021648; IPR011991; Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36) vps36 zgc:55965 Danio rerio (Zebrafish) (Brachydanio rerio) 382 Q7ZVK4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1293 sp Q7ZVK4 VPS36_DANRE 86.21 145 20 0 439 5 1 145 3E-91 277 Q7ZVK4 VPS36_DANRE GO:0005768; GO:0032266; GO:0015031 endosome; phosphatidylinositol-3-phosphate binding; protein transport reviewed IPR007286; IPR021648; IPR011991; Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36) vps36 zgc:55965 Danio rerio (Zebrafish) (Brachydanio rerio) 382 Q7ZVK4 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig1293 sp Q7ZVK4 VPS36_DANRE 86.21 145 20 0 439 5 1 145 3E-91 277 Q7ZVK4 VPS36_DANRE GO:0005768; GO:0032266; GO:0015031 endosome; phosphatidylinositol-3-phosphate binding; protein transport reviewed IPR007286; IPR021648; IPR011991; Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36) vps36 zgc:55965 Danio rerio (Zebrafish) (Brachydanio rerio) 382 Q7ZVK4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1293 sp Q7ZVK4 VPS36_DANRE 86.21 145 20 0 439 5 1 145 3E-91 277 Q7ZVK4 VPS36_DANRE GO:0005768; GO:0032266; GO:0015031 endosome; phosphatidylinositol-3-phosphate binding; protein transport reviewed IPR007286; IPR021648; IPR011991; Vacuolar protein-sorting-associated protein 36 (ESCRT-II complex subunit VPS36) vps36 zgc:55965 Danio rerio (Zebrafish) (Brachydanio rerio) 382 Q7ZVK4 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5794 sp Q7ZVP1 JADE3_DANRE 63.8 558 187 9 799 2463 225 770 0 562 Q7ZVP1 JADE3_DANRE GO:0008270 zinc ion binding reviewed IPR019542; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Protein Jade-3 (PHD finger protein 16) phf16 jade3 Danio rerio (Zebrafish) (Brachydanio rerio) 795 Q7ZVP1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5794 sp Q7ZVP1 JADE3_DANRE 63.8 558 187 9 799 2463 225 770 0 562 Q7ZVP1 JADE3_DANRE GO:0008270 zinc ion binding reviewed IPR019542; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Protein Jade-3 (PHD finger protein 16) phf16 jade3 Danio rerio (Zebrafish) (Brachydanio rerio) 795 Q7ZVP1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5794 sp Q7ZVP1 JADE3_DANRE 78.17 339 71 2 123 1136 1 337 1E-162 505 Q7ZVP1 JADE3_DANRE GO:0008270 zinc ion binding reviewed IPR019542; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Protein Jade-3 (PHD finger protein 16) phf16 jade3 Danio rerio (Zebrafish) (Brachydanio rerio) 795 Q7ZVP1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5794 sp Q7ZVP1 JADE3_DANRE 78.17 339 71 2 123 1136 1 337 1E-162 505 Q7ZVP1 JADE3_DANRE GO:0008270 zinc ion binding reviewed IPR019542; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; Protein Jade-3 (PHD finger protein 16) phf16 jade3 Danio rerio (Zebrafish) (Brachydanio rerio) 795 Q7ZVP1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 82.41 216 36 1 643 2 261 476 4E-103 329 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0043484 GO:0043484 regulation of RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 77.86 140 31 0 1028 609 133 272 7E-92 235 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0043484 GO:0043484 regulation of RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 80.23 86 17 0 1305 1048 40 125 7E-92 121 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0043484 GO:0043484 regulation of RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5947 sp Q7ZVR8 ESRP2_DANRE 90 10 1 0 1054 1025 124 133 7E-92 25.4 Q7ZVR8 ESRP2_DANRE GO:0008380; GO:0003729; GO:0006397; GO:0000166; GO:0005634; GO:0043484 RNA splicing; mRNA binding; mRNA processing; nucleotide binding; nucleus; regulation of RNA splicing reviewed IPR012677; IPR012337; IPR000504; Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B) esrp2 rbm35b zgc:77254 Danio rerio (Zebrafish) (Brachydanio rerio) 736 Q7ZVR8 GO:0043484 GO:0043484 regulation of RNA splicing RNA metabolism P ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5623 sp Q7ZVS9 MYCB_DANRE 72.77 382 79 8 289 1419 35 396 4E-155 456 Q7ZVS9 MYCB_DANRE GO:0003677; GO:0005634; GO:0003700; GO:0006351 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR011598; IPR003327; IPR002418; IPR012682; Transcriptional regulator Myc-B (c-Myc-B) mycb zgc:55680 Danio rerio (Zebrafish) (Brachydanio rerio) 396 Q7ZVS9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0030318 GO:0030318 melanocyte differentiation other biological processes P ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0031386 GO:0031386 protein tag other molecular function F ConsensusfromContig5906 sp Q7ZW16 RNF41_DANRE 96.23 318 12 0 2054 1101 1 318 0 640 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0030318 GO:0030318 melanocyte differentiation other biological processes P ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0031386 GO:0031386 protein tag other molecular function F ConsensusfromContig3152 sp Q7ZW16 RNF41_DANRE 74.78 115 29 0 345 1 69 183 4E-58 187 Q7ZW16 RNF41_DANRE GO:0097191; GO:0030318; GO:0000209; GO:0031386; GO:0004842; GO:0008270 extrinsic apoptotic signaling pathway; melanocyte differentiation; protein polyubiquitination; protein tag; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR013323; IPR008974; IPR015036; IPR018957; IPR001841; IPR013083; IPR017907; IPR013010; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase NRDP1 (EC 6.3.2.-) (RING finger protein 41) rnf41 nrdp1 zgc:55389 Danio rerio (Zebrafish) (Brachydanio rerio) 318 Q7ZW16 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0031902 GO:0031902 late endosome membrane other cytoplasmic organelle C ConsensusfromContig6318 sp Q7ZW25 CHM2A_DANRE 93.79 161 10 0 36 518 60 220 2E-77 243 Q7ZW25 CHM2A_DANRE GO:0031902; GO:0015031 late endosome membrane; protein transport reviewed IPR005024; Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) chmp2a bc2 Danio rerio (Zebrafish) (Brachydanio rerio) 220 Q7ZW25 GO:0031902 GO:0031902 late endosome membrane other membranes C ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0004756 GO:0004756 "selenide, water dikinase activity" kinase activity F ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig4221 sp Q7ZW38 SPS1_DANRE 100 96 0 0 364 77 1 96 4E-63 204 Q7ZW38 SPS1_DANRE GO:0005524; GO:0031965; GO:0005886; GO:0046982; GO:0042803; GO:0004756 ATP binding; nuclear membrane; plasma membrane; protein heterodimerization activity; protein homodimerization activity; selenide, water dikinase activity reviewed IPR010918; IPR000728; IPR016188; IPR004536; Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1) sephs1 si:ch211-220f12.5 Danio rerio (Zebrafish) (Brachydanio rerio) 392 Q7ZW38 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 87.18 78 10 0 220 453 447 524 2E-62 147 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 87.18 78 10 0 220 453 447 524 2E-62 147 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 87.18 78 10 0 220 453 447 524 2E-62 147 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 87.18 78 10 0 220 453 447 524 2E-62 147 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 94.44 72 4 0 2 217 375 446 2E-62 112 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 94.44 72 4 0 2 217 375 446 2E-62 112 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 94.44 72 4 0 2 217 375 446 2E-62 112 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig997 sp Q7ZWF4 RN145_DANRE 94.44 72 4 0 2 217 375 446 2E-62 112 Q7ZWF4 RN145_DANRE GO:0016021; GO:0008270 integral to membrane; zinc ion binding reviewed IPR025754; IPR001841; IPR013083; RING finger protein 145 rnf145 zgc:56435 Danio rerio (Zebrafish) (Brachydanio rerio) 685 Q7ZWF4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6277 sp Q7ZWJ7 RL34_DANRE 96.58 117 4 0 77 427 1 117 1E-76 230 Q7ZWJ7 RL34_DANRE GO:0005840; GO:0003735; GO:0006412 ribosome; structural constituent of ribosome; translation reviewed IPR008195; IPR018065; 60S ribosomal protein L34 rpl34 Danio rerio (Zebrafish) (Brachydanio rerio) 117 Q7ZWJ7 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig6277 sp Q7ZWJ7 RL34_DANRE 96.58 117 4 0 77 427 1 117 1E-76 230 Q7ZWJ7 RL34_DANRE GO:0005840; GO:0003735; GO:0006412 ribosome; structural constituent of ribosome; translation reviewed IPR008195; IPR018065; 60S ribosomal protein L34 rpl34 Danio rerio (Zebrafish) (Brachydanio rerio) 117 Q7ZWJ7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6277 sp Q7ZWJ7 RL34_DANRE 96.58 117 4 0 77 427 1 117 1E-76 230 Q7ZWJ7 RL34_DANRE GO:0005840; GO:0003735; GO:0006412 ribosome; structural constituent of ribosome; translation reviewed IPR008195; IPR018065; 60S ribosomal protein L34 rpl34 Danio rerio (Zebrafish) (Brachydanio rerio) 117 Q7ZWJ7 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig6277 sp Q7ZWJ7 RL34_DANRE 96.58 117 4 0 77 427 1 117 1E-76 230 Q7ZWJ7 RL34_DANRE GO:0005840; GO:0003735; GO:0006412 ribosome; structural constituent of ribosome; translation reviewed IPR008195; IPR018065; 60S ribosomal protein L34 rpl34 Danio rerio (Zebrafish) (Brachydanio rerio) 117 Q7ZWJ7 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6277 sp Q7ZWJ7 RL34_DANRE 96.58 117 4 0 77 427 1 117 1E-76 230 Q7ZWJ7 RL34_DANRE GO:0005840; GO:0003735; GO:0006412 ribosome; structural constituent of ribosome; translation reviewed IPR008195; IPR018065; 60S ribosomal protein L34 rpl34 Danio rerio (Zebrafish) (Brachydanio rerio) 117 Q7ZWJ7 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 80.92 393 64 5 1945 782 1 387 0 603 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 57.14 182 64 4 792 268 384 558 0 126 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5870 sp Q7ZX03 FOXK2_XENLA 62.71 59 11 3 278 123 568 622 0 60.1 Q7ZX03 FOXK2_XENLA GO:0000287; GO:0005634; GO:0043565; GO:0003700; GO:0006351 magnesium ion binding; nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR000253; IPR008984; IPR001766; IPR018122; IPR011991; Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1) foxk2 foxk1 ilf1 Xenopus laevis (African clawed frog) 642 Q7ZX03 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0007032 GO:0007032 endosome organization cell organization and biogenesis P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0007040 GO:0007040 lysosome organization cell organization and biogenesis P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0008333 GO:0008333 endosome to lysosome transport transport P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0045022 GO:0045022 early endosome to late endosome transport transport P ConsensusfromContig6048 sp Q7ZYX1 AKTIP_DANRE 91.47 293 25 0 1028 150 1 293 0 565 Q7ZYX1 AKTIP_DANRE GO:0070695; GO:0016881; GO:0006915; GO:0045022; GO:0007032; GO:0008333; GO:0007040; GO:0005886; GO:0015031 FHF complex; acid-amino acid ligase activity; apoptotic process; early endosome to late endosome transport; endosome organization; endosome to lysosome transport; lysosome organization; plasma membrane; protein transport reviewed IPR000608; IPR016135; AKT-interacting protein (Fused toes protein homolog) aktip fts Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q7ZYX1 GO:0070695 GO:0070695 FHF complex other cellular component C ConsensusfromContig6249 sp Q802F2 SELTA_DANRE 81.25 192 35 1 79 651 2 193 2E-111 333 Q802F2 SELTA_DANRE GO:0045454; GO:0008430 cell redox homeostasis; selenium binding reviewed IPR011893; IPR019389; IPR012336; Selenoprotein T1a selt1a sept1a Danio rerio (Zebrafish) (Brachydanio rerio) 193 Q802F2 GO:0008430 GO:0008430 selenium binding other molecular function F ConsensusfromContig6249 sp Q802F2 SELTA_DANRE 81.25 192 35 1 79 651 2 193 2E-111 333 Q802F2 SELTA_DANRE GO:0045454; GO:0008430 cell redox homeostasis; selenium binding reviewed IPR011893; IPR019389; IPR012336; Selenoprotein T1a selt1a sept1a Danio rerio (Zebrafish) (Brachydanio rerio) 193 Q802F2 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig3719 sp Q802U2 MIO_DANRE 82.79 122 21 0 366 1 391 512 1E-66 221 Q802U2 MIO_DANRE reviewed IPR015943; IPR001680; IPR017986; WD repeat-containing protein mio mios zgc:55958 Danio rerio (Zebrafish) (Brachydanio rerio) 876 Q802U2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3719 sp Q802U2 MIO_DANRE 82.79 122 21 0 366 1 391 512 1E-66 221 Q802U2 MIO_DANRE reviewed IPR015943; IPR001680; IPR017986; WD repeat-containing protein mio mios zgc:55958 Danio rerio (Zebrafish) (Brachydanio rerio) 876 Q802U2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig47 sp Q802W4 NOL10_DANRE 82.95 176 30 0 3 530 204 379 5E-104 321 Q802W4 NOL10_DANRE GO:0005730 nucleolus reviewed IPR012580; IPR011047; IPR015943; IPR001680; Nucleolar protein 10 nol10 zgc:55626 Danio rerio (Zebrafish) (Brachydanio rerio) 722 Q802W4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig47 sp Q802W4 NOL10_DANRE 82.95 176 30 0 3 530 204 379 5E-104 321 Q802W4 NOL10_DANRE GO:0005730 nucleolus reviewed IPR012580; IPR011047; IPR015943; IPR001680; Nucleolar protein 10 nol10 zgc:55626 Danio rerio (Zebrafish) (Brachydanio rerio) 722 Q802W4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0006261 GO:0006261 DNA-dependent DNA replication DNA metabolism P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007062 GO:0007062 sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007062 GO:0007062 sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0042555 GO:0042555 MCM complex nucleus C ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 76.03 413 99 0 752 1990 218 630 0 645 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0000084 GO:0000084 S phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0006261 GO:0006261 DNA-dependent DNA replication DNA metabolism P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007062 GO:0007062 sister chromatid cohesion cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007062 GO:0007062 sister chromatid cohesion cell organization and biogenesis P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0042555 GO:0042555 MCM complex nucleus C ConsensusfromContig6158 sp Q803A6 MCMBP_DANRE 73.56 208 55 0 97 720 1 208 0 340 Q803A6 MCMBP_DANRE GO:0006261; GO:0051301; GO:0003682; GO:0007067; GO:0000084; GO:0005634; GO:0007062 DNA-dependent DNA replication; cell division; chromatin binding; mitosis; mitotic S phase; nucleus; sister chromatid cohesion reviewed IPR019140; Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein) mcmbp si:dkey-192p21.2 Danio rerio (Zebrafish) (Brachydanio rerio) 631 Q803A6 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0010212 GO:0010212 response to ionizing radiation other biological processes P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0033522 GO:0033522 histone H2A ubiquitination protein metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0033522 GO:0033522 histone H2A ubiquitination cell organization and biogenesis P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0033523 GO:0033523 histone H2B ubiquitination protein metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0033523 GO:0033523 histone H2B ubiquitination cell organization and biogenesis P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0045739 GO:0045739 positive regulation of DNA repair stress response P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0045739 GO:0045739 positive regulation of DNA repair DNA metabolism P ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5612 sp Q803C1 RNF8_DANRE 54.74 464 186 6 192 1556 23 471 3E-143 439 Q803C1 RNF8_DANRE GO:0051301; GO:0003682; GO:0000781; GO:0006303; GO:0070535; GO:0033523; GO:0042393; GO:0043486; GO:0045190; GO:0045900; GO:0005634; GO:0045739; GO:0070936; GO:0042803; GO:0010212; GO:0035861; GO:0007286; GO:0000151; GO:0006511; GO:0004842; GO:0008270 cell division; chromatin binding; chromosome, telomeric region; double-strand break repair via nonhomologous end joining; histone H2A K63-linked ubiquitination; histone H2B ubiquitination; histone binding; histone exchange; isotype switching; negative regulation of translational elongation; nucleus; positive regulation of DNA repair; protein K48-linked ubiquitination; protein homodimerization activity; response to ionizing radiation; site of double-strand break; spermatid development; ubiquitin ligase complex; ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR017335; IPR000253; IPR008984; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF8 (EC 6.3.2.-) (RING finger protein 8) rnf8 zgc:55936 Danio rerio (Zebrafish) (Brachydanio rerio) 485 Q803C1 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5851 sp Q803H0 CG025_DANRE 87.88 198 24 0 1723 1130 1 198 2E-118 365 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5851 sp Q803H0 CG025_DANRE 87.88 198 24 0 1723 1130 1 198 2E-118 365 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5851 sp Q803H0 CG025_DANRE 87.88 198 24 0 1723 1130 1 198 2E-118 365 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5851 sp Q803H0 CG025_DANRE 85.94 192 27 0 986 411 236 427 4E-114 354 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5851 sp Q803H0 CG025_DANRE 85.94 192 27 0 986 411 236 427 4E-114 354 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5851 sp Q803H0 CG025_DANRE 85.94 192 27 0 986 411 236 427 4E-114 354 Q803H0 CG025_DANRE reviewed IPR010733; UPF0415 protein C7orf25 homolog zgc:55781 Danio rerio (Zebrafish) (Brachydanio rerio) 427 Q803H0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0033116 GO:0033116 ER-Golgi intermediate compartment membrane ER/Golgi C ConsensusfromContig1056 sp Q803I2 ERGI3_DANRE 90.44 136 11 1 410 3 108 241 5E-86 263 Q803I2 ERGI3_DANRE GO:0005794; GO:0005789; GO:0033116; GO:0016021; GO:0016192 Golgi apparatus; endoplasmic reticulum membrane; endoplasmic reticulum-Golgi intermediate compartment membrane; integral to membrane; vesicle-mediated transport reviewed IPR012936; Endoplasmic reticulum-Golgi intermediate compartment protein 3 ergic3 zgc:113959 zgc:55762 Danio rerio (Zebrafish) (Brachydanio rerio) 383 Q803I2 GO:0033116 GO:0033116 ER-Golgi intermediate compartment membrane other membranes C ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0031519 GO:0031519 PcG protein complex nucleus C ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0035102 GO:0035102 PRC1 complex nucleus C ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5516 sp Q803I4 RING2_DANRE 98.45 193 3 0 144 722 1 193 4E-139 403 Q803I4 RING2_DANRE GO:0071339; GO:0035102; GO:0016874; GO:0033339; GO:0016567; GO:0006355; GO:0006351; GO:0008270 MLL1 complex; PRC1 complex; ligase activity; pectoral fin development; protein ubiquitination; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR018957; IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RING2 (EC 6.3.2.-) (RING finger protein 1B) (RING1b) (RING finger protein 2) rnf2 ring1b Danio rerio (Zebrafish) (Brachydanio rerio) 336 Q803I4 GO:0071339 ConsensusfromContig659 sp Q803R2 CCZ1_DANRE 94.18 189 11 0 1 567 281 469 2E-126 371 Q803R2 CCZ1_DANRE GO:0005765 lysosomal membrane reviewed IPR013176; Vacuolar fusion protein CCZ1 homolog ccz1 zgc:55344 Danio rerio (Zebrafish) (Brachydanio rerio) 480 Q803R2 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig659 sp Q803R2 CCZ1_DANRE 94.18 189 11 0 1 567 281 469 2E-126 371 Q803R2 CCZ1_DANRE GO:0005765 lysosomal membrane reviewed IPR013176; Vacuolar fusion protein CCZ1 homolog ccz1 zgc:55344 Danio rerio (Zebrafish) (Brachydanio rerio) 480 Q803R2 GO:0005765 GO:0005765 lysosomal membrane other cytoplasmic organelle C ConsensusfromContig659 sp Q803R2 CCZ1_DANRE 94.18 189 11 0 1 567 281 469 2E-126 371 Q803R2 CCZ1_DANRE GO:0005765 lysosomal membrane reviewed IPR013176; Vacuolar fusion protein CCZ1 homolog ccz1 zgc:55344 Danio rerio (Zebrafish) (Brachydanio rerio) 480 Q803R2 GO:0005765 GO:0005765 lysosomal membrane other membranes C ConsensusfromContig659 sp Q803R2 CCZ1_DANRE 94.18 189 11 0 1 567 281 469 2E-126 371 Q803R2 CCZ1_DANRE GO:0005765 lysosomal membrane reviewed IPR013176; Vacuolar fusion protein CCZ1 homolog ccz1 zgc:55344 Danio rerio (Zebrafish) (Brachydanio rerio) 480 Q803R2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6229 sp Q803V5 LST8_DANRE 99.08 326 3 0 174 1151 1 326 0 680 Q803V5 LST8_DANRE GO:0005737 cytoplasm reviewed IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog) mlst8 gbl lst8 zgc:55455 zgc:85668 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q803V5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6229 sp Q803V5 LST8_DANRE 99.08 326 3 0 174 1151 1 326 0 680 Q803V5 LST8_DANRE GO:0005737 cytoplasm reviewed IPR011047; IPR015943; IPR001680; IPR019775; IPR017986; Target of rapamycin complex subunit lst8 (TORC subunit lst8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (MTOR associated protein, LST8 homolog) mlst8 gbl lst8 zgc:55455 zgc:85668 Danio rerio (Zebrafish) (Brachydanio rerio) 326 Q803V5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0002009 GO:0002009 morphogenesis of an epithelium developmental processes P ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0005604 GO:0005604 basement membrane extracellular matrix C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0043588 GO:0043588 skin development developmental processes P ConsensusfromContig293 sp Q80T14 FRAS1_MOUSE 58.75 160 66 0 481 2 2097 2256 4E-57 199 Q80T14 FRAS1_MOUSE GO:0005604; GO:0007154; GO:0016021; GO:0046872; GO:0002009; GO:0005886; GO:0015031; GO:0043588 basement membrane; cell communication; integral to membrane; metal ion binding; morphogenesis of an epithelium; plasma membrane; protein transport; skin development reviewed IPR003644; IPR006212; IPR009030; IPR001007; Extracellular matrix protein FRAS1 Fras1 Kiaa1500 Mus musculus (Mouse) 4010 Q80T14 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0015095 GO:0015095 magnesium ion transmembrane transporter activity transporter activity F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0015693 GO:0015693 magnesium ion transport transport P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0016409 GO:0016409 palmitoyltransferase activity other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0018345 GO:0018345 protein palmitoylation protein metabolism P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0019706 GO:0019706 protein-cysteine S-palmitoleyltransferase activity other molecular function F ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0030660 GO:0030660 Golgi-associated vesicle membrane ER/Golgi C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0030660 GO:0030660 Golgi-associated vesicle membrane other membranes C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0042953 GO:0042953 lipoprotein transport transport P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig3185 sp Q80TN5 ZDH17_MOUSE 87.33 150 19 0 2 451 318 467 4E-91 283 Q80TN5 ZDH17_MOUSE GO:0030660; GO:0016021; GO:0042953; GO:0015095; GO:0043123; GO:0018345; GO:0019706; GO:0004871; GO:0008270 Golgi-associated vesicle membrane; integral to membrane; lipoprotein transport; magnesium ion transmembrane transporter activity; positive regulation of I-kappaB kinase/NF-kappaB cascade; protein palmitoylation; protein-cysteine S-palmitoyltransferase activity; signal transducer activity; zinc ion binding reviewed IPR002110; IPR020683; IPR001594; Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin-interacting protein 14) (Zinc finger DHHC domain-containing protein 17) (DHHC-17) Zdhhc17 Hip14 Kiaa0946 Mus musculus (Mouse) 632 Q80TN5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0002329 GO:0002329 pre-B cell differentiation developmental processes P ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2807 sp Q80WG5 LRC8A_MOUSE 92.86 126 9 0 3 380 482 607 8E-63 209 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0002329 GO:0002329 pre-B cell differentiation developmental processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 83.04 171 29 0 635 123 196 366 4E-95 295 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0002329 GO:0002329 pre-B cell differentiation developmental processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 100 24 0 0 72 1 383 406 4E-95 52.4 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0002329 GO:0002329 pre-B cell differentiation developmental processes P ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig357 sp Q80WG5 LRC8A_MOUSE 85 20 3 0 127 68 365 384 4E-95 43.9 Q80WG5 LRC8A_MOUSE GO:0016021; GO:0002329 integral to membrane; pre-B cell differentiation reviewed IPR001611; IPR025875; IPR003591; IPR021040; Leucine-rich repeat-containing protein 8A Lrrc8a Lrrc8 Mus musculus (Mouse) 810 Q80WG5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5917 sp Q80YG3 KLDC1_MOUSE 47.67 386 181 6 371 1513 13 382 2E-121 372 Q80YG3 KLDC1_MOUSE GO:0005737 cytoplasm reviewed IPR011043; IPR015915; Kelch domain-containing protein 1 Klhdc1 Mus musculus (Mouse) 406 Q80YG3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5917 sp Q80YG3 KLDC1_MOUSE 47.67 386 181 6 371 1513 13 382 2E-121 372 Q80YG3 KLDC1_MOUSE GO:0005737 cytoplasm reviewed IPR011043; IPR015915; Kelch domain-containing protein 1 Klhdc1 Mus musculus (Mouse) 406 Q80YG3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5917 sp Q80YG3 KLDC1_MOUSE 47.67 386 181 6 371 1513 13 382 2E-121 372 Q80YG3 KLDC1_MOUSE GO:0005737 cytoplasm reviewed IPR011043; IPR015915; Kelch domain-containing protein 1 Klhdc1 Mus musculus (Mouse) 406 Q80YG3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig1107 sp Q810B6 ANFY1_MOUSE 96.64 119 4 0 362 6 863 981 1E-69 231 Q810B6 ANFY1_MOUSE GO:0006897; GO:0010008; GO:0046872 endocytosis; endosome membrane; metal ion binding reviewed IPR002110; IPR020683; IPR000210; IPR011333; IPR013069; IPR000306; IPR017455; IPR011011; IPR013083; Ankyrin repeat and FYVE domain-containing protein 1 (Ankyrin repeats hooked to a zinc finger motif) Ankfy1 Ankhzn Kiaa1255 Mus musculus (Mouse) 1169 Q810B6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0008475 GO:0008475 procollagen-lysine 5-dioxygenase activity other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0016702 GO:0016702 "oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen" other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0016705 GO:0016705 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen" other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0016706 GO:0016706 "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors" other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0030867 GO:0030867 rough endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0030867 GO:0030867 rough endoplasmic reticulum membrane other membranes C ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0031418 GO:0031418 L-ascorbic acid binding other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0032870 GO:0032870 cellular response to hormone stimulus other biological processes P ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2566 sp Q811A3 PLOD2_RAT 64.57 223 79 0 2 670 211 433 3E-101 316 Q811A3 PLOD2_RAT GO:0031418; GO:0032870; GO:0005506; GO:0008475; GO:0001666; GO:0030867 L-ascorbic acid binding; cellular response to hormone stimulus; iron ion binding; procollagen-lysine 5-dioxygenase activity; response to hypoxia; rough endoplasmic reticulum membrane reviewed IPR005123; IPR006620; IPR001006; Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2) Plod2 Rattus norvegicus (Rat) 737 Q811A3 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig354 sp Q863I2 OXSR1_PIG 94.66 131 7 0 393 1 115 245 6E-87 270 Q863I2 OXSR1_PIG GO:0005524; GO:0005737; GO:0007243; GO:0000287; GO:0004674 ATP binding; cytoplasm; intracellular protein kinase cascade; magnesium ion binding; protein serine/threonine kinase activity reviewed IPR011009; IPR024678; IPR000719; IPR017441; IPR002290; Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein) OXSR1 OSR1 Sus scrofa (Pig) 529 Q863I2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig172 sp Q864Z2 RGS5_PIG 67.03 182 59 1 43 588 1 181 1E-83 257 Q864Z2 RGS5_PIG GO:0005737; GO:0016020; GO:0038032 cytoplasm; membrane; termination of G-protein coupled receptor signaling pathway reviewed IPR024066; IPR016137; IPR000342; Regulator of G-protein signaling 5 (RGS5) RGS5 Sus scrofa (Pig) 181 Q864Z2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig172 sp Q864Z2 RGS5_PIG 67.03 182 59 1 43 588 1 181 1E-83 257 Q864Z2 RGS5_PIG GO:0005737; GO:0016020; GO:0038032 cytoplasm; membrane; termination of G-protein coupled receptor signaling pathway reviewed IPR024066; IPR016137; IPR000342; Regulator of G-protein signaling 5 (RGS5) RGS5 Sus scrofa (Pig) 181 Q864Z2 GO:0009968 GO:0009968 negative regulation of signal transduction signal transduction P ConsensusfromContig172 sp Q864Z2 RGS5_PIG 67.03 182 59 1 43 588 1 181 1E-83 257 Q864Z2 RGS5_PIG GO:0005737; GO:0016020; GO:0038032 cytoplasm; membrane; termination of G-protein coupled receptor signaling pathway reviewed IPR024066; IPR016137; IPR000342; Regulator of G-protein signaling 5 (RGS5) RGS5 Sus scrofa (Pig) 181 Q864Z2 GO:0038032 ConsensusfromContig6261 sp Q86SZ2 TPC6B_HUMAN 89.17 157 17 0 569 99 1 157 4E-100 298 Q86SZ2 TPC6B_HUMAN GO:0005794; GO:0005783; GO:0016192 O43617 Golgi apparatus; endoplasmic reticulum; vesicle-mediated transport reviewed IPR024096; IPR007194; Trafficking protein particle complex subunit 6B TRAPPC6B Homo sapiens (Human) 158 Q86SZ2 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6261 sp Q86SZ2 TPC6B_HUMAN 89.17 157 17 0 569 99 1 157 4E-100 298 Q86SZ2 TPC6B_HUMAN GO:0005794; GO:0005783; GO:0016192 O43617 Golgi apparatus; endoplasmic reticulum; vesicle-mediated transport reviewed IPR024096; IPR007194; Trafficking protein particle complex subunit 6B TRAPPC6B Homo sapiens (Human) 158 Q86SZ2 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6261 sp Q86SZ2 TPC6B_HUMAN 89.17 157 17 0 569 99 1 157 4E-100 298 Q86SZ2 TPC6B_HUMAN GO:0005794; GO:0005783; GO:0016192 O43617 Golgi apparatus; endoplasmic reticulum; vesicle-mediated transport reviewed IPR024096; IPR007194; Trafficking protein particle complex subunit 6B TRAPPC6B Homo sapiens (Human) 158 Q86SZ2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6261 sp Q86SZ2 TPC6B_HUMAN 89.17 157 17 0 569 99 1 157 4E-100 298 Q86SZ2 TPC6B_HUMAN GO:0005794; GO:0005783; GO:0016192 O43617 Golgi apparatus; endoplasmic reticulum; vesicle-mediated transport reviewed IPR024096; IPR007194; Trafficking protein particle complex subunit 6B TRAPPC6B Homo sapiens (Human) 158 Q86SZ2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6261 sp Q86SZ2 TPC6B_HUMAN 89.17 157 17 0 569 99 1 157 4E-100 298 Q86SZ2 TPC6B_HUMAN GO:0005794; GO:0005783; GO:0016192 O43617 Golgi apparatus; endoplasmic reticulum; vesicle-mediated transport reviewed IPR024096; IPR007194; Trafficking protein particle complex subunit 6B TRAPPC6B Homo sapiens (Human) 158 Q86SZ2 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0004177 GO:0004177 aminopeptidase activity other molecular function F ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1530 sp Q86TI2 DPP9_HUMAN 88.15 135 16 0 406 2 27 161 2E-69 229 Q86TI2 DPP9_HUMAN GO:0004177; GO:0005737; GO:0005829; GO:0016020; GO:0006508; GO:0008236 Itself aminopeptidase activity; cytoplasm; cytosol; membrane; proteolysis; serine-type peptidase activity reviewed IPR001375; IPR002469; Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9) DPP9 DPRP2 Homo sapiens (Human) 863 Q86TI2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1406 sp Q86TL2 TM110_HUMAN 61.58 177 66 1 448 978 27 201 7E-70 226 Q86TL2 TM110_HUMAN GO:0016021 integral to membrane reviewed IPR022127; Transmembrane protein 110 TMEM110 Homo sapiens (Human) 294 Q86TL2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1406 sp Q86TL2 TM110_HUMAN 61.58 177 66 1 448 978 27 201 7E-70 226 Q86TL2 TM110_HUMAN GO:0016021 integral to membrane reviewed IPR022127; Transmembrane protein 110 TMEM110 Homo sapiens (Human) 294 Q86TL2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1406 sp Q86TL2 TM110_HUMAN 61.58 177 66 1 448 978 27 201 7E-70 226 Q86TL2 TM110_HUMAN GO:0016021 integral to membrane reviewed IPR022127; Transmembrane protein 110 TMEM110 Homo sapiens (Human) 294 Q86TL2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1406 sp Q86TL2 TM110_HUMAN 61.58 177 66 1 448 978 27 201 7E-70 226 Q86TL2 TM110_HUMAN GO:0016021 integral to membrane reviewed IPR022127; Transmembrane protein 110 TMEM110 Homo sapiens (Human) 294 Q86TL2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1406 sp Q86TL2 TM110_HUMAN 61.58 177 66 1 448 978 27 201 7E-70 226 Q86TL2 TM110_HUMAN GO:0016021 integral to membrane reviewed IPR022127; Transmembrane protein 110 TMEM110 Homo sapiens (Human) 294 Q86TL2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0016758 GO:0016758 "transferase activity, transferring hexosyl groups" other molecular function F ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0030206 GO:0030206 chondroitin sulfate biosynthetic process other metabolic processes P ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0030279 GO:0030279 negative regulation of ossification developmental processes P ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0031667 GO:0031667 response to nutrient levels other biological processes P ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0047238 GO:0047238 glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity other molecular function F ConsensusfromContig658 sp Q86X52 CHSS1_HUMAN 82.68 127 22 0 396 16 378 504 4E-69 227 Q86X52 CHSS1_HUMAN GO:0032580; GO:0000139; GO:0050510; GO:0005975; GO:0030206; GO:0005576; GO:0047238; GO:0016021; GO:0046872; GO:0030279; GO:0031667 Golgi cisterna membrane; Golgi membrane; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; carbohydrate metabolic process; chondroitin sulfate biosynthetic process; extracellular region; glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity; integral to membrane; metal ion binding; negative regulation of ossification; response to nutrient levels reviewed IPR008428; Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1) CHSY1 CHSY CSS1 KIAA0990 UNQ756/PRO1487 Homo sapiens (Human) 802 Q86X52 GO:0050510 GO:0050510 N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity other molecular function F ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig6005 sp Q8AY73 XPO2_ORENI 93.33 300 20 0 16 915 672 971 0 592 Q8AY73 XPO2_ORENI GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR005043; IPR013713; IPR001494; Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) cse1l cas xpo2 Oreochromis niloticus (Nile tilapia) (Tilapia nilotica) 971 Q8AY73 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0004712 GO:0004712 protein serine/threonine/tyrosine kinase activity kinase activity F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0007060 GO:0007060 male meiosis chromosome segregation cell cycle and proliferation P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0007093 GO:0007093 mitotic cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0016321 GO:0016321 female meiosis chromosome segregation cell cycle and proliferation P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0031101 GO:0031101 fin regeneration stress response P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0031101 GO:0031101 fin regeneration developmental processes P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0042246 GO:0042246 tissue regeneration stress response P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0042246 GO:0042246 tissue regeneration developmental processes P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig1527 sp Q8AYG3 TTK_DANRE 79.65 113 22 1 349 14 699 811 2E-54 187 Q8AYG3 TTK_DANRE GO:0005524; GO:0051301; GO:0009790; GO:0046872; GO:0007093; GO:0018108; GO:0004674; GO:0004712; GO:0004713; GO:0042246 ATP binding; cell division; embryo development; metal ion binding; mitotic cell cycle checkpoint; peptidyl-tyrosine phosphorylation; protein serine/threonine kinase activity; protein serine/threonine/tyrosine kinase activity; protein tyrosine kinase activity; tissue regeneration reviewed IPR027084; IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; IPR011990; Dual specificity protein kinase Ttk (EC 2.7.12.1) (Mitotic checkpoint serine/threonine-protein kinase Mps1) (Monopolar spindle protein 1) (Protein nightcap) ttk mps1 ncp Danio rerio (Zebrafish) (Brachydanio rerio) 982 Q8AYG3 GO:0060249 GO:0060249 anatomical structure homeostasis other biological processes P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0000155 GO:0000155 two-component sensor activity signal transduction activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0000155 GO:0000155 two-component sensor activity kinase activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0000160 GO:0000160 two-component signal transduction system (phosphorelay) signal transduction P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0004673 GO:0004673 protein histidine kinase activity kinase activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0004740 GO:0004740 pyruvate dehydrogenase (acetyl-transferring) kinase activity kinase activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0006006 GO:0006006 glucose metabolic process other metabolic processes P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0007166 GO:0007166 cell surface receptor linked signal transduction signal transduction P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0018106 GO:0018106 peptidyl-histidine phosphorylation protein metabolism P ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0032403 GO:0032403 protein complex binding other molecular function F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0045254 GO:0045254 pyruvate dehydrogenase complex other cellular component C ConsensusfromContig2910 sp Q8BFP9 PDK1_MOUSE 71.2 125 36 0 455 81 308 432 2E-59 196 Q8BFP9 PDK1_MOUSE GO:0005524; GO:0008283; GO:0006006; GO:0097411; GO:0008631; GO:0005967; GO:0005886; GO:0004674; GO:0004740; GO:0010510; GO:0010906 ATP binding; cell proliferation; glucose metabolic process; hypoxia-inducible factor-1alpha signaling pathway; intrinsic apoptotic signaling pathway in response to oxidative stress; mitochondrial pyruvate dehydrogenase complex; plasma membrane; protein serine/threonine kinase activity; pyruvate dehydrogenase (acetyl-transferring) kinase activity; regulation of acetyl-CoA biosynthetic process from pyruvate; regulation of glucose metabolic process reviewed IPR018955; IPR003594; IPR005467; [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) Pdk1 Mus musculus (Mouse) 434 Q8BFP9 GO:0046982 GO:0046982 protein heterodimerization activity other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0005539 GO:0005539 glycosaminoglycan binding other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0008449 GO:0008449 N-acetylglucosamine-6-sulfatase activity other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0008484 GO:0008484 sulfuric ester hydrolase activity other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0030203 GO:0030203 glycosaminoglycan metabolic process other metabolic processes P ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0042340 GO:0042340 keratan sulfate catabolic process other metabolic processes P ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0043199 GO:0043199 sulfate binding other molecular function F ConsensusfromContig6034 sp Q8BFR4 GNS_MOUSE 63.94 477 168 4 232 1653 36 511 0 639 Q8BFR4 GNS_MOUSE GO:0008449; GO:0030203; GO:0005764; GO:0046872; GO:0008484 N-acetylglucosamine-6-sulfatase activity; glycosaminoglycan metabolic process; lysosome; metal ion binding; sulfuric ester hydrolase activity reviewed IPR017849; IPR017850; IPR012251; IPR015981; IPR000917; IPR024607; N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S) Gns Mus musculus (Mouse) 544 Q8BFR4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0035145 GO:0035145 exon-exon junction complex nucleus C ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig6178 sp Q8BG81 PDIP3_MOUSE 52.04 319 115 8 428 1327 112 411 1E-81 265 Q8BG81 PDIP3_MOUSE GO:0003723; GO:0005737; GO:0035145; GO:0016607; GO:0000166; GO:0045727 RNA binding; cytoplasm; exon-exon junction complex; nuclear speck; nucleotide binding; positive regulation of translation reviewed IPR012677; IPR000504; Polymerase delta-interacting protein 3 (S6K1 Aly/REF-like target) (SKAR) Poldip3 Mus musculus (Mouse) 420 Q8BG81 GO:0045727 GO:0045727 positive regulation of translation protein metabolism P ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 58.6 157 63 1 1738 1268 48 202 7E-113 187 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 58.6 157 63 1 1738 1268 48 202 7E-113 187 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 58.6 157 63 1 1738 1268 48 202 7E-113 187 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 54.6 163 71 1 1260 781 204 366 7E-113 152 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 54.6 163 71 1 1260 781 204 366 7E-113 152 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 54.6 163 71 1 1260 781 204 366 7E-113 152 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 52.05 73 35 0 781 563 367 439 7E-113 81.6 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 52.05 73 35 0 781 563 367 439 7E-113 81.6 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 52.05 73 35 0 781 563 367 439 7E-113 81.6 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 62.86 35 13 0 1859 1755 8 42 7E-113 53.1 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 62.86 35 13 0 1859 1755 8 42 7E-113 53.1 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6323 sp Q8BGC1 CE022_MOUSE 62.86 35 13 0 1859 1755 8 42 7E-113 53.1 Q8BGC1 CE022_MOUSE reviewed IPR024131; UPF0489 protein C5orf22 homolog Mus musculus (Mouse) 442 Q8BGC1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0004816 GO:0004816 asparagine-tRNA ligase activity other molecular function F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0006421 GO:0006421 asparaginyl-tRNA aminoacylation protein metabolism P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0006421 GO:0006421 asparaginyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5659 sp Q8BGV0 SYNM_MOUSE 73.33 180 45 1 558 19 121 297 8E-88 279 Q8BGV0 SYNM_MOUSE GO:0005524; GO:0004816; GO:0006421; GO:0005759; GO:0005739; GO:0003676 ATP binding; asparagine-tRNA ligase activity; asparaginyl-tRNA aminoacylation; mitochondrial matrix; mitochondrion; nucleic acid binding reviewed IPR004364; IPR018150; IPR006195; IPR004522; IPR002312; IPR012340; IPR004365; Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS) Nars2 Mus musculus (Mouse) 477 Q8BGV0 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5579 sp Q8BHG3 CC50B_MOUSE 57.61 335 130 4 1540 563 11 342 5E-129 390 Q8BHG3 CC50B_MOUSE GO:0016021; GO:0070863 integral to membrane; positive regulation of protein exit from endoplasmic reticulum reviewed IPR005045; Cell cycle control protein 50B (Transmembrane protein 30B) Tmem30b Cdc50b Mus musculus (Mouse) 353 Q8BHG3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5579 sp Q8BHG3 CC50B_MOUSE 57.61 335 130 4 1540 563 11 342 5E-129 390 Q8BHG3 CC50B_MOUSE GO:0016021; GO:0070863 integral to membrane; positive regulation of protein exit from endoplasmic reticulum reviewed IPR005045; Cell cycle control protein 50B (Transmembrane protein 30B) Tmem30b Cdc50b Mus musculus (Mouse) 353 Q8BHG3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5579 sp Q8BHG3 CC50B_MOUSE 57.61 335 130 4 1540 563 11 342 5E-129 390 Q8BHG3 CC50B_MOUSE GO:0016021; GO:0070863 integral to membrane; positive regulation of protein exit from endoplasmic reticulum reviewed IPR005045; Cell cycle control protein 50B (Transmembrane protein 30B) Tmem30b Cdc50b Mus musculus (Mouse) 353 Q8BHG3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5579 sp Q8BHG3 CC50B_MOUSE 57.61 335 130 4 1540 563 11 342 5E-129 390 Q8BHG3 CC50B_MOUSE GO:0016021; GO:0070863 integral to membrane; positive regulation of protein exit from endoplasmic reticulum reviewed IPR005045; Cell cycle control protein 50B (Transmembrane protein 30B) Tmem30b Cdc50b Mus musculus (Mouse) 353 Q8BHG3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0005770 GO:0005770 late endosome other cytoplasmic organelle C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0030100 GO:0030100 regulation of endocytosis transport P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0030100 GO:0030100 regulation of endocytosis cell organization and biogenesis P ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig3073 sp Q8BIJ7 RUFY1_MOUSE 51.01 198 97 0 612 19 294 491 6E-54 188 Q8BIJ7 RUFY1_MOUSE GO:0005737; GO:0031901; GO:0006897; GO:0008289; GO:0046872; GO:0008565; GO:0030100 cytoplasm; early endosome membrane; endocytosis; lipid binding; metal ion binding; protein transporter activity; regulation of endocytosis reviewed IPR004012; IPR000306; IPR017455; IPR011011; IPR013083; RUN and FYVE domain-containing protein 1 (Rab4-interacting protein) Rufy1 Rabip4 Mus musculus (Mouse) 712 Q8BIJ7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3403 sp Q8BKE9 IFT74_MOUSE 83.78 148 24 0 226 669 55 202 3E-80 257 Q8BKE9 IFT74_MOUSE GO:0005813; GO:0003682; GO:0016023; GO:0005634; GO:0033630; GO:0045944 centrosome; chromatin binding; cytoplasmic membrane-bounded vesicle; nucleus; positive regulation of cell adhesion mediated by integrin; positive regulation of transcription from RNA polymerase II promoter reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Ift74 Ccdc2 Cmg1 Mus musculus (Mouse) 600 Q8BKE9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3403 sp Q8BKE9 IFT74_MOUSE 83.78 148 24 0 226 669 55 202 3E-80 257 Q8BKE9 IFT74_MOUSE GO:0005813; GO:0003682; GO:0016023; GO:0005634; GO:0033630; GO:0045944 centrosome; chromatin binding; cytoplasmic membrane-bounded vesicle; nucleus; positive regulation of cell adhesion mediated by integrin; positive regulation of transcription from RNA polymerase II promoter reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Ift74 Ccdc2 Cmg1 Mus musculus (Mouse) 600 Q8BKE9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3403 sp Q8BKE9 IFT74_MOUSE 83.78 148 24 0 226 669 55 202 3E-80 257 Q8BKE9 IFT74_MOUSE GO:0005813; GO:0003682; GO:0016023; GO:0005634; GO:0033630; GO:0045944 centrosome; chromatin binding; cytoplasmic membrane-bounded vesicle; nucleus; positive regulation of cell adhesion mediated by integrin; positive regulation of transcription from RNA polymerase II promoter reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Ift74 Ccdc2 Cmg1 Mus musculus (Mouse) 600 Q8BKE9 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig3403 sp Q8BKE9 IFT74_MOUSE 83.78 148 24 0 226 669 55 202 3E-80 257 Q8BKE9 IFT74_MOUSE GO:0005813; GO:0003682; GO:0016023; GO:0005634; GO:0033630; GO:0045944 centrosome; chromatin binding; cytoplasmic membrane-bounded vesicle; nucleus; positive regulation of cell adhesion mediated by integrin; positive regulation of transcription from RNA polymerase II promoter reviewed Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2) Ift74 Ccdc2 Cmg1 Mus musculus (Mouse) 600 Q8BKE9 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5725 sp Q8BKX7 ZN410_MOUSE 55.95 370 127 9 1193 171 98 460 1E-118 367 Q8BKX7 ZN410_MOUSE GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007087; IPR015880; IPR013087; Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1) Znf410 Apa1 D12Ertd748e Zfp410 Mus musculus (Mouse) 478 Q8BKX7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0008643 GO:0008643 carbohydrate transport transport P ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 73.02 189 51 0 475 1041 158 346 4E-113 262 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0030259 GO:0030259 lipid glycosylation other metabolic processes P ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0008643 GO:0008643 carbohydrate transport transport P ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5586 sp Q8BLX4 FUCT1_MOUSE 60 155 59 2 18 473 3 157 4E-113 169 Q8BLX4 FUCT1_MOUSE GO:0000139; GO:0008643; GO:0016021; GO:0030259; GO:0045746; GO:0055085 Golgi membrane; carbohydrate transport; integral to membrane; lipid glycosylation; negative regulation of Notch signaling pathway; transmembrane transport reviewed IPR013657; GDP-fucose transporter 1 (Solute carrier family 35 member C1) Slc35c1 Fuct1 Mus musculus (Mouse) 363 Q8BLX4 GO:0030259 GO:0030259 lipid glycosylation other metabolic processes P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0004823 GO:0004823 leucine-tRNA ligase activity other molecular function F ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation protein metabolism P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig4038 sp Q8BMJ2 SYLC_MOUSE 79.76 168 34 0 3 506 490 657 5E-91 293 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0004823 GO:0004823 leucine-tRNA ligase activity other molecular function F ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation protein metabolism P ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0006429 GO:0006429 leucyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig1994 sp Q8BMJ2 SYLC_MOUSE 80.36 168 33 0 3 506 194 361 3E-94 302 Q8BMJ2 SYLC_MOUSE GO:0005524; GO:0002161; GO:0005737; GO:0004823; GO:0006429; GO:0006450 ATP binding; aminoacyl-tRNA editing activity; cytoplasm; leucine-tRNA ligase activity; leucyl-tRNA aminoacylation; regulation of translational fidelity reviewed IPR001412; IPR002300; IPR004493; IPR014729; IPR009080; IPR013155; IPR009008; Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) Lars Mus musculus (Mouse) 1178 Q8BMJ2 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5848 sp Q8BN59 LARP6_MOUSE 55.6 455 161 12 2344 1022 55 482 1E-96 321 Q8BN59 LARP6_MOUSE GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) Larp6 Mus musculus (Mouse) 492 Q8BN59 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0001649 GO:0001649 osteoblast differentiation developmental processes P ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0033687 GO:0033687 osteoblast proliferation cell cycle and proliferation P ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6305 sp Q8BPY9 FIGL1_MOUSE 54.36 677 258 11 1977 22 33 683 0 655 Q8BPY9 FIGL1_MOUSE GO:0005524; GO:0046034; GO:0071479; GO:0005737; GO:0016787; GO:0000287; GO:0043066; GO:2001243; GO:0000228; GO:0017111; GO:0001649; GO:0033687; GO:0051726; GO:0010569 ATP binding; ATP metabolic process; cellular response to ionizing radiation; cytoplasm; hydrolase activity; magnesium ion binding; negative regulation of apoptotic process; negative regulation of intrinsic apoptotic signaling pathway; nuclear chromosome; nucleoside-triphosphatase activity; osteoblast differentiation; osteoblast proliferation; regulation of cell cycle; regulation of double-strand break repair via homologous recombination reviewed IPR003593; IPR003959; IPR003960; IPR027417; IPR015415; Fidgetin-like protein 1 (EC 3.6.4.-) Fignl1 Mus musculus (Mouse) 683 Q8BPY9 GO:0051726 GO:0051726 regulation of cell cycle cell cycle and proliferation P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0005932 GO:0005932 microtubule basal body cytoskeleton C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0010826 GO:0010826 negative regulation of centrosome duplication cell cycle and proliferation P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0010826 GO:0010826 negative regulation of centrosome duplication cell organization and biogenesis P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0030030 GO:0030030 cell projection organization cell organization and biogenesis P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0042384 GO:0042384 cilium assembly cell organization and biogenesis P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0048754 GO:0048754 branching morphogenesis of a tube developmental processes P ConsensusfromContig75 sp Q8BR76 MKS3_MOUSE 72.2 205 57 0 616 2 720 924 2E-107 337 Q8BR76 MKS3_MOUSE GO:0036038; GO:0048754; GO:0042384; GO:0030659; GO:0005789; GO:0016021; GO:0005932; GO:0010826; GO:0005886 TCTN-B9D complex; branching morphogenesis of an epithelial tube; cilium assembly; cytoplasmic vesicle membrane; endoplasmic reticulum membrane; integral to membrane; microtubule basal body; negative regulation of centrosome duplication; plasma membrane reviewed IPR009030; IPR019170; Meckelin (Meckel syndrome type 3 protein homolog) (Transmembrane protein 67) Tmem67 Mks3 Mus musculus (Mouse) 992 Q8BR76 GO:0060271 GO:0060271 cilium morphogenesis cell organization and biogenesis P ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0004553 GO:0004553 "hydrolase activity, hydrolyzing O-glycosyl compounds" other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0004559 GO:0004559 alpha-mannosidase activity other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0004572 GO:0004572 "mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity" other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0006013 GO:0006013 mannose metabolic process other metabolic processes P ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0015923 GO:0015923 mannosidase activity other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0016799 GO:0016799 "hydrolase activity, hydrolyzing N-glycosyl compounds" other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0030246 GO:0030246 carbohydrate binding other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0043169 GO:0043169 cation binding other molecular function F ConsensusfromContig4970 sp Q8BRK9 MA2A2_MOUSE 79.63 108 22 0 397 74 494 601 8E-54 187 Q8BRK9 MA2A2_MOUSE GO:0000139; GO:0030246; GO:0016799; GO:0016021; GO:0006013; GO:0015923; GO:0004572; GO:0006486; GO:0008270 Golgi membrane; carbohydrate binding; hydrolase activity, hydrolyzing N-glycosyl compounds; integral to membrane; mannose metabolic process; mannosidase activity; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity; protein glycosylation; zinc ion binding reviewed IPR011013; IPR011330; IPR013780; IPR027291; IPR011682; IPR015341; IPR000602; Protein modification; protein glycosylation. Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase) Man2a2 Mana2x Mus musculus (Mouse) 1152 Q8BRK9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0004579 GO:0004579 dolichyl-diphosphooligosaccharide-protein glycotransferase activity other molecular function F ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0006810 GO:0006810 transport transport P ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0008250 GO:0008250 oligosaccharyltransferase complex ER/Golgi C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0008250 GO:0008250 oligosaccharyltransferase complex other membranes C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0018279 GO:0018279 protein amino acid N-linked glycosylation via asparagine protein metabolism P ConsensusfromContig204 sp Q8BTV1 TUSC3_MOUSE 91.54 201 17 0 609 7 65 265 3E-127 369 Q8BTV1 TUSC3_MOUSE GO:0045454; GO:0050890; GO:0016021; GO:0015095; GO:0005739; GO:0008250; GO:0018279 cell redox homeostasis; cognition; integral to membrane; magnesium ion transmembrane transporter activity; mitochondrion; oligosaccharyltransferase complex; protein N-linked glycosylation via asparagine reviewed IPR006844; IPR021149; IPR012336; IPR013766; Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33) Tusc3 N33 Mus musculus (Mouse) 347 Q8BTV1 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5539 sp Q8BVH9 METL6_MOUSE 75.38 260 63 1 352 1128 11 270 2E-142 418 Q8BVH9 METL6_MOUSE GO:0008168 methyltransferase activity reviewed IPR013217; IPR026113; Methyltransferase-like protein 6 (EC 2.1.1.-) Mettl6 Mus musculus (Mouse) 282 Q8BVH9 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0004091 GO:0004091 carboxylesterase activity other molecular function F ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0006482 GO:0006482 protein amino acid demethylation protein metabolism P ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0019903 GO:0019903 protein phosphatase binding other molecular function F ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0051721 GO:0051721 protein phosphatase 2A binding other molecular function F ConsensusfromContig308 sp Q8BVQ5 PPME1_MOUSE 81.71 246 42 2 771 40 4 248 3E-136 397 Q8BVQ5 PPME1_MOUSE GO:0004091; GO:0051722; GO:0006482; GO:0051721 carboxylesterase activity; protein C-terminal methylesterase activity; protein demethylation; protein phosphatase 2A binding reviewed IPR000073; IPR000639; IPR016812; Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89) Ppme1 Pme1 Mus musculus (Mouse) 386 Q8BVQ5 GO:0051722 GO:0051722 protein C-terminal methylesterase activity other molecular function F ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 73.95 311 81 0 1164 2096 378 688 0 413 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6257 sp Q8BY89 CTL2_MOUSE 53.1 371 154 6 43 1125 4 364 0 329 Q8BY89 CTL2_MOUSE GO:0016021; GO:0043123; GO:0004871; GO:0006810 integral to membrane; positive regulation of I-kappaB kinase/NF-kappaB cascade; signal transducer activity; transport reviewed IPR007603; Choline transporter-like protein 2 (Solute carrier family 44 member 2) Slc44a2 Ctl2 Mus musculus (Mouse) 706 Q8BY89 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig394 sp Q8C0L8 COG5_MOUSE 70 150 45 0 1 450 488 637 4E-59 200 Q8C0L8 COG5_MOUSE GO:0000139; GO:0017119; GO:0005829; GO:0006891; GO:0015031 Golgi membrane; Golgi transport complex; cytosol; intra-Golgi vesicle-mediated transport; protein transport reviewed IPR019465; Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (Component of oligomeric Golgi complex 5) Cog5 Mus musculus (Mouse) 829 Q8C0L8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0004653 GO:0004653 polypeptide N-acetylgalactosaminyltransferase activity other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 80.08 236 47 0 1947 1240 161 396 0 407 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0004653 GO:0004653 polypeptide N-acetylgalactosaminyltransferase activity other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig6088 sp Q8C7U7 GALT6_MOUSE 64.32 227 81 0 1246 566 395 621 0 324 Q8C7U7 GALT6_MOUSE GO:0000139; GO:0016021; GO:0048471; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; perinuclear region of cytoplasm; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6) Galnt6 Mus musculus (Mouse) 622 Q8C7U7 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5889 sp Q8C854 MYEF2_MOUSE 77.32 269 59 2 1787 987 41 309 5E-124 387 Q8C854 MYEF2_MOUSE GO:0003677; GO:0003723; GO:0000166; GO:0005634; GO:0006351 DNA binding; RNA binding; nucleotide binding; nucleus; transcription, DNA-dependent reviewed IPR012677; IPR000504; Myelin expression factor 2 (MEF-2) (MyEF-2) Myef2 Kiaa1341 Mef2 Mus musculus (Mouse) 591 Q8C854 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0002669 GO:0002669 positive regulation of T cell anergy other biological processes P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0009615 GO:0009615 response to virus other biological processes P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0032088 GO:0032088 negative regulation of NF-kappaB transcription factor activity RNA metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0035519 ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0045732 GO:0045732 positive regulation of protein catabolic process protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0046329 GO:0046329 negative regulation of JNK cascade signal transduction P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0046329 GO:0046329 negative regulation of JNK cascade stress response P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0046642 GO:0046642 negative regulation of alpha-beta T cell proliferation cell cycle and proliferation P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0050687 GO:0050687 negative regulation of defense response to virus stress response P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0070534 GO:0070534 protein K63-linked ubiquitination protein metabolism P ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0070936 ConsensusfromContig2280 sp Q8C863 ITCH_MOUSE 86.15 130 18 0 1 390 387 516 3E-75 245 Q8C863 ITCH_MOUSE GO:0006915; GO:0005938; GO:0031410; GO:0005829; GO:0051607; GO:0045087; GO:0016020; GO:0046329; GO:0032088; GO:0046642; GO:0043066; GO:0050687; GO:0005634; GO:0005886; GO:0002669; GO:0045732; GO:0035519; GO:0070936; GO:0070534; GO:0042787; GO:0090085; GO:0043021; GO:0000151; GO:0004842 Q80TQ2 apoptotic process; cell cortex; cytoplasmic vesicle; cytosol; defense response to virus; innate immune response; membrane; negative regulation of JNK cascade; negative regulation of NF-kappaB transcription factor activity; negative regulation of alpha-beta T cell proliferation; negative regulation of apoptotic process; negative regulation of defense response to virus; nucleus; plasma membrane; positive regulation of T cell anergy; positive regulation of protein catabolic process; protein K29-linked ubiquitination; protein K48-linked ubiquitination; protein K63-linked ubiquitination; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; regulation of protein deubiquitination; ribonucleoprotein complex binding; ubiquitin ligase complex; ubiquitin-protein ligase activity reviewed IPR000008; IPR024928; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase Itchy (EC 6.3.2.-) Itch Mus musculus (Mouse) 864 Q8C863 GO:0090085 ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0006662 GO:0006662 glycerol ether metabolic process other metabolic processes P ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0015035 GO:0015035 protein disulfide oxidoreductase activity other molecular function F ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0015036 GO:0015036 disulfide oxidoreductase activity other molecular function F ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig5617 sp Q8CDN6 TXNL1_MOUSE 71.49 249 70 1 968 225 41 289 3E-125 371 Q8CDN6 TXNL1_MOUSE GO:0045454; GO:0005737; GO:0006662; GO:0005634; GO:0000502; GO:0015035 cell redox homeostasis; cytoplasm; glycerol ether metabolic process; nucleus; proteasome complex; protein disulfide oxidoreductase activity reviewed IPR008979; IPR010400; IPR005746; IPR012336; IPR017937; IPR013766; Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein) Txnl1 Trp32 Txnl Mus musculus (Mouse) 289 Q8CDN6 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0005765 GO:0005765 lysosomal membrane other cytoplasmic organelle C ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0005765 GO:0005765 lysosomal membrane other membranes C ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3319 sp Q8CIF6 SIDT2_MOUSE 86.4 125 17 0 376 2 408 532 2E-60 203 Q8CIF6 SIDT2_MOUSE GO:0051033; GO:0033227; GO:0016021; GO:0005765 RNA transmembrane transporter activity; dsRNA transport; integral to membrane; lysosomal membrane reviewed IPR025958; SID1 transmembrane family member 2 Sidt2 Mus musculus (Mouse) 832 Q8CIF6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0001315 GO:0001315 age-dependent response to reactive oxygen species stress response P ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0004784 GO:0004784 superoxide dismutase activity other molecular function F ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0006801 GO:0006801 superoxide metabolic process other metabolic processes P ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0030145 GO:0030145 manganese ion binding other molecular function F ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5702 sp Q8HXP3 SODM_MACFA 82.38 210 37 0 121 750 13 222 3E-132 380 Q8HXP3 SODM_MACFA GO:0001315; GO:0030145; GO:0005759; GO:0006357; GO:0004784; GO:0006801 age-dependent response to reactive oxygen species; manganese ion binding; mitochondrial matrix; regulation of transcription from RNA polymerase II promoter; superoxide dismutase activity; superoxide metabolic process reviewed IPR001189; IPR019833; IPR019832; IPR019831; Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1) SOD2 QnpA-14761 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 222 Q8HXP3 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3512 sp Q8HY87 RNZ2_MACFA 76.15 109 26 0 332 6 77 185 6E-53 182 Q8HY87 RNZ2_MACFA GO:0004519; GO:0046872; GO:0072684; GO:0005739; GO:0005634 endonuclease activity; metal ion binding; mitochondrial tRNA 3'-trailer cleavage, endonucleolytic; mitochondrion; nucleus reviewed IPR001279; IPR027794; Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2) ELAC2 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 826 Q8HY87 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0004351 GO:0004351 glutamate decarboxylase activity other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0004356 GO:0004356 glutamate-ammonia ligase activity other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0006542 GO:0006542 glutamine biosynthetic process other metabolic processes P ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0006807 GO:0006807 nitrogen compound metabolic process other metabolic processes P ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0009749 GO:0009749 response to glucose stimulus other biological processes P ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig5890 sp Q8HZM5 GLNA_CANFA 85.75 372 53 0 118 1233 1 372 0 700 Q8HZM5 GLNA_CANFA GO:0005524; GO:0004351; GO:0004356; GO:0006542; GO:0005739 ATP binding; glutamate decarboxylase activity; glutamate-ammonia ligase activity; glutamine biosynthetic process; mitochondrion reviewed IPR008147; IPR014746; IPR008146; IPR027303; IPR027302; Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase) GLUL Canis familiaris (Dog) (Canis lupus familiaris) 373 Q8HZM5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3939 sp Q8IUR6 CRERF_HUMAN 89.84 128 13 0 2 385 447 574 2E-75 241 Q8IUR6 CRERF_HUMAN GO:0005737; GO:1900102; GO:0000122; GO:0016604; GO:0005634; GO:0032388; GO:0045732; GO:0051222; GO:0034976; GO:0006986; GO:0043565; GO:0003700; GO:0006351; GO:0006810 O43889-2 cytoplasm; negative regulation of endoplasmic reticulum unfolded protein response; negative regulation of transcription from RNA polymerase II promoter; nuclear body; nucleus; positive regulation of intracellular transport; positive regulation of protein catabolic process; positive regulation of protein transport; response to endoplasmic reticulum stress; response to unfolded protein; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; transport reviewed IPR004827; CREB3 regulatory factor (Luman recruitment factor) (LRF) CREBRF C5orf41 Homo sapiens (Human) 639 Q8IUR6 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3939 sp Q8IUR6 CRERF_HUMAN 89.84 128 13 0 2 385 447 574 2E-75 241 Q8IUR6 CRERF_HUMAN GO:0005737; GO:1900102; GO:0000122; GO:0016604; GO:0005634; GO:0032388; GO:0045732; GO:0051222; GO:0034976; GO:0006986; GO:0043565; GO:0003700; GO:0006351; GO:0006810 O43889-2 cytoplasm; negative regulation of endoplasmic reticulum unfolded protein response; negative regulation of transcription from RNA polymerase II promoter; nuclear body; nucleus; positive regulation of intracellular transport; positive regulation of protein catabolic process; positive regulation of protein transport; response to endoplasmic reticulum stress; response to unfolded protein; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; transport reviewed IPR004827; CREB3 regulatory factor (Luman recruitment factor) (LRF) CREBRF C5orf41 Homo sapiens (Human) 639 Q8IUR6 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3939 sp Q8IUR6 CRERF_HUMAN 89.84 128 13 0 2 385 447 574 2E-75 241 Q8IUR6 CRERF_HUMAN GO:0005737; GO:1900102; GO:0000122; GO:0016604; GO:0005634; GO:0032388; GO:0045732; GO:0051222; GO:0034976; GO:0006986; GO:0043565; GO:0003700; GO:0006351; GO:0006810 O43889-2 cytoplasm; negative regulation of endoplasmic reticulum unfolded protein response; negative regulation of transcription from RNA polymerase II promoter; nuclear body; nucleus; positive regulation of intracellular transport; positive regulation of protein catabolic process; positive regulation of protein transport; response to endoplasmic reticulum stress; response to unfolded protein; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; transport reviewed IPR004827; CREB3 regulatory factor (Luman recruitment factor) (LRF) CREBRF C5orf41 Homo sapiens (Human) 639 Q8IUR6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3939 sp Q8IUR6 CRERF_HUMAN 89.84 128 13 0 2 385 447 574 2E-75 241 Q8IUR6 CRERF_HUMAN GO:0005737; GO:1900102; GO:0000122; GO:0016604; GO:0005634; GO:0032388; GO:0045732; GO:0051222; GO:0034976; GO:0006986; GO:0043565; GO:0003700; GO:0006351; GO:0006810 O43889-2 cytoplasm; negative regulation of endoplasmic reticulum unfolded protein response; negative regulation of transcription from RNA polymerase II promoter; nuclear body; nucleus; positive regulation of intracellular transport; positive regulation of protein catabolic process; positive regulation of protein transport; response to endoplasmic reticulum stress; response to unfolded protein; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; transport reviewed IPR004827; CREB3 regulatory factor (Luman recruitment factor) (LRF) CREBRF C5orf41 Homo sapiens (Human) 639 Q8IUR6 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig4195 sp Q8IUS5 EPHX4_HUMAN 69.17 120 36 1 637 278 242 360 1E-51 176 Q8IUS5 EPHX4_HUMAN GO:0016787; GO:0016021; GO:0008152 hydrolase activity; integral to membrane; metabolic process reviewed IPR000073; IPR000639; Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein) EPHX4 ABHD7 EPHXRP Homo sapiens (Human) 362 Q8IUS5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig4195 sp Q8IUS5 EPHX4_HUMAN 69.17 120 36 1 637 278 242 360 1E-51 176 Q8IUS5 EPHX4_HUMAN GO:0016787; GO:0016021; GO:0008152 hydrolase activity; integral to membrane; metabolic process reviewed IPR000073; IPR000639; Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein) EPHX4 ABHD7 EPHXRP Homo sapiens (Human) 362 Q8IUS5 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig4195 sp Q8IUS5 EPHX4_HUMAN 69.17 120 36 1 637 278 242 360 1E-51 176 Q8IUS5 EPHX4_HUMAN GO:0016787; GO:0016021; GO:0008152 hydrolase activity; integral to membrane; metabolic process reviewed IPR000073; IPR000639; Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein) EPHX4 ABHD7 EPHXRP Homo sapiens (Human) 362 Q8IUS5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4195 sp Q8IUS5 EPHX4_HUMAN 69.17 120 36 1 637 278 242 360 1E-51 176 Q8IUS5 EPHX4_HUMAN GO:0016787; GO:0016021; GO:0008152 hydrolase activity; integral to membrane; metabolic process reviewed IPR000073; IPR000639; Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein) EPHX4 ABHD7 EPHXRP Homo sapiens (Human) 362 Q8IUS5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4195 sp Q8IUS5 EPHX4_HUMAN 69.17 120 36 1 637 278 242 360 1E-51 176 Q8IUS5 EPHX4_HUMAN GO:0016787; GO:0016021; GO:0008152 hydrolase activity; integral to membrane; metabolic process reviewed IPR000073; IPR000639; Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein) EPHX4 ABHD7 EPHXRP Homo sapiens (Human) 362 Q8IUS5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1861 sp Q8IWZ3 ANKH1_HUMAN 69.13 149 31 2 525 100 151 291 7E-54 191 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig1861 sp Q8IWZ3 ANKH1_HUMAN 69.13 149 31 2 525 100 151 291 7E-54 191 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1861 sp Q8IWZ3 ANKH1_HUMAN 69.13 149 31 2 525 100 151 291 7E-54 191 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1861 sp Q8IWZ3 ANKH1_HUMAN 69.13 149 31 2 525 100 151 291 7E-54 191 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig1861 sp Q8IWZ3 ANKH1_HUMAN 69.13 149 31 2 525 100 151 291 7E-54 191 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5528 sp Q8IWZ3 ANKH1_HUMAN 50 298 129 5 1588 698 2264 2542 4E-75 266 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5528 sp Q8IWZ3 ANKH1_HUMAN 50 298 129 5 1588 698 2264 2542 4E-75 266 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5528 sp Q8IWZ3 ANKH1_HUMAN 50 298 129 5 1588 698 2264 2542 4E-75 266 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5528 sp Q8IWZ3 ANKH1_HUMAN 50 298 129 5 1588 698 2264 2542 4E-75 266 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5528 sp Q8IWZ3 ANKH1_HUMAN 50 298 129 5 1588 698 2264 2542 4E-75 266 Q8IWZ3 ANKH1_HUMAN GO:0003723; GO:0005737; GO:0005634 Q9NRI5 RNA binding; cytoplasm; nucleus reviewed IPR002110; IPR020683; IPR004087; IPR004088; Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK) ANKHD1 KIAA1085 MASK VBARP PP2500 Homo sapiens (Human) 2542 Q8IWZ3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6025 sp Q8IXU6 S35F2_HUMAN 60.65 338 130 1 1331 327 2 339 2E-129 386 Q8IXU6 S35F2_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR009262; Solute carrier family 35 member F2 SLC35F2 Homo sapiens (Human) 374 Q8IXU6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5898 sp Q8IY37 DHX37_HUMAN 70.82 922 261 4 2768 27 232 1153 0 1301 Q8IY37 DHX37_HUMAN GO:0005524; GO:0008026; GO:0003676 ATP binding; ATP-dependent helicase activity; nucleic acid binding reviewed IPR011545; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37) DHX37 DDX37 KIAA1517 Homo sapiens (Human) 1157 Q8IY37 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6230 sp Q8JFW1 ASND1_DANRE 71.88 352 96 2 1173 124 258 608 2E-141 423 Q8JFW1 ASND1_DANRE GO:0006529; GO:0004066; GO:0006541 asparagine biosynthetic process; asparagine synthase (glutamine-hydrolyzing) activity; glutamine metabolic process reviewed IPR001962; IPR017932; IPR000583; IPR014729; Asparagine synthetase domain-containing protein 1 asnsd1 si:dz211o13.6 Danio rerio (Zebrafish) (Brachydanio rerio) 612 Q8JFW1 GO:0004066 GO:0004066 asparagine synthase (glutamine-hydrolyzing) activity other molecular function F ConsensusfromContig6230 sp Q8JFW1 ASND1_DANRE 71.88 352 96 2 1173 124 258 608 2E-141 423 Q8JFW1 ASND1_DANRE GO:0006529; GO:0004066; GO:0006541 asparagine biosynthetic process; asparagine synthase (glutamine-hydrolyzing) activity; glutamine metabolic process reviewed IPR001962; IPR017932; IPR000583; IPR014729; Asparagine synthetase domain-containing protein 1 asnsd1 si:dz211o13.6 Danio rerio (Zebrafish) (Brachydanio rerio) 612 Q8JFW1 GO:0006529 GO:0006529 asparagine biosynthetic process other metabolic processes P ConsensusfromContig6230 sp Q8JFW1 ASND1_DANRE 71.88 352 96 2 1173 124 258 608 2E-141 423 Q8JFW1 ASND1_DANRE GO:0006529; GO:0004066; GO:0006541 asparagine biosynthetic process; asparagine synthase (glutamine-hydrolyzing) activity; glutamine metabolic process reviewed IPR001962; IPR017932; IPR000583; IPR014729; Asparagine synthetase domain-containing protein 1 asnsd1 si:dz211o13.6 Danio rerio (Zebrafish) (Brachydanio rerio) 612 Q8JFW1 GO:0006541 GO:0006541 glutamine metabolic process other metabolic processes P ConsensusfromContig6230 sp Q8JFW1 ASND1_DANRE 71.88 352 96 2 1173 124 258 608 2E-141 423 Q8JFW1 ASND1_DANRE GO:0006529; GO:0004066; GO:0006541 asparagine biosynthetic process; asparagine synthase (glutamine-hydrolyzing) activity; glutamine metabolic process reviewed IPR001962; IPR017932; IPR000583; IPR014729; Asparagine synthetase domain-containing protein 1 asnsd1 si:dz211o13.6 Danio rerio (Zebrafish) (Brachydanio rerio) 612 Q8JFW1 GO:0008652 GO:0008652 cellular amino acid biosynthetic process other metabolic processes P ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0003756 GO:0003756 protein disulfide isomerase activity other molecular function F ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0006662 GO:0006662 glycerol ether metabolic process other metabolic processes P ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0015035 GO:0015035 protein disulfide oxidoreductase activity other molecular function F ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig5867 sp Q8JG64 PDIA3_CHICK 76.34 448 105 1 1781 441 45 492 0 708 Q8JG64 PDIA3_CHICK GO:0045454; GO:0009986; GO:0005788; GO:0006662; GO:0043065; GO:0003756; GO:0015035; GO:0006457 cell redox homeostasis; cell surface; endoplasmic reticulum lumen; glycerol ether metabolic process; positive regulation of apoptotic process; protein disulfide isomerase activity; protein disulfide oxidoreductase activity; protein folding reviewed IPR005788; IPR005792; IPR005746; IPR012336; IPR017937; IPR013766; Protein disulfide-isomerase A3 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Glucose-regulated thiol oxidoreductase 58 kDa protein) PDIA3 ERP57 GRP58 Gallus gallus (Chicken) 505 Q8JG64 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig5599 sp Q8JH71 ALDOB_DANRE 85.71 364 52 0 1221 130 1 364 0 661 Q8JH71 ALDOB_DANRE GO:0005737; GO:0004332; GO:0006096; GO:0005815 cytoplasm; fructose-bisphosphate aldolase activity; glycolysis; microtubule organizing center reviewed IPR000741; IPR013785; Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) aldob Danio rerio (Zebrafish) (Brachydanio rerio) 364 Q8JH71 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5599 sp Q8JH71 ALDOB_DANRE 85.71 364 52 0 1221 130 1 364 0 661 Q8JH71 ALDOB_DANRE GO:0005737; GO:0004332; GO:0006096; GO:0005815 cytoplasm; fructose-bisphosphate aldolase activity; glycolysis; microtubule organizing center reviewed IPR000741; IPR013785; Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) aldob Danio rerio (Zebrafish) (Brachydanio rerio) 364 Q8JH71 GO:0004332 GO:0004332 fructose-bisphosphate aldolase activity other molecular function F ConsensusfromContig5599 sp Q8JH71 ALDOB_DANRE 85.71 364 52 0 1221 130 1 364 0 661 Q8JH71 ALDOB_DANRE GO:0005737; GO:0004332; GO:0006096; GO:0005815 cytoplasm; fructose-bisphosphate aldolase activity; glycolysis; microtubule organizing center reviewed IPR000741; IPR013785; Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) aldob Danio rerio (Zebrafish) (Brachydanio rerio) 364 Q8JH71 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5599 sp Q8JH71 ALDOB_DANRE 85.71 364 52 0 1221 130 1 364 0 661 Q8JH71 ALDOB_DANRE GO:0005737; GO:0004332; GO:0006096; GO:0005815 cytoplasm; fructose-bisphosphate aldolase activity; glycolysis; microtubule organizing center reviewed IPR000741; IPR013785; Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) aldob Danio rerio (Zebrafish) (Brachydanio rerio) 364 Q8JH71 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig5599 sp Q8JH71 ALDOB_DANRE 85.71 364 52 0 1221 130 1 364 0 661 Q8JH71 ALDOB_DANRE GO:0005737; GO:0004332; GO:0006096; GO:0005815 cytoplasm; fructose-bisphosphate aldolase activity; glycolysis; microtubule organizing center reviewed IPR000741; IPR013785; Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase) aldob Danio rerio (Zebrafish) (Brachydanio rerio) 364 Q8JH71 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig5545 sp Q8JHF0 PEN2_DANRE 83.84 99 16 0 112 408 1 99 7E-58 183 Q8JHF0 PEN2_DANRE GO:0007219; GO:0016021; GO:0043524 Notch signaling pathway; integral to membrane; negative regulation of neuron apoptotic process reviewed IPR019379; Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2 homolog) psenen pen2 zgc:109727 Danio rerio (Zebrafish) (Brachydanio rerio) 101 Q8JHF0 GO:0007219 GO:0007219 Notch signaling pathway signal transduction P ConsensusfromContig5545 sp Q8JHF0 PEN2_DANRE 83.84 99 16 0 112 408 1 99 7E-58 183 Q8JHF0 PEN2_DANRE GO:0007219; GO:0016021; GO:0043524 Notch signaling pathway; integral to membrane; negative regulation of neuron apoptotic process reviewed IPR019379; Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2 homolog) psenen pen2 zgc:109727 Danio rerio (Zebrafish) (Brachydanio rerio) 101 Q8JHF0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5545 sp Q8JHF0 PEN2_DANRE 83.84 99 16 0 112 408 1 99 7E-58 183 Q8JHF0 PEN2_DANRE GO:0007219; GO:0016021; GO:0043524 Notch signaling pathway; integral to membrane; negative regulation of neuron apoptotic process reviewed IPR019379; Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2 homolog) psenen pen2 zgc:109727 Danio rerio (Zebrafish) (Brachydanio rerio) 101 Q8JHF0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5545 sp Q8JHF0 PEN2_DANRE 83.84 99 16 0 112 408 1 99 7E-58 183 Q8JHF0 PEN2_DANRE GO:0007219; GO:0016021; GO:0043524 Notch signaling pathway; integral to membrane; negative regulation of neuron apoptotic process reviewed IPR019379; Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2 homolog) psenen pen2 zgc:109727 Danio rerio (Zebrafish) (Brachydanio rerio) 101 Q8JHF0 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5545 sp Q8JHF0 PEN2_DANRE 83.84 99 16 0 112 408 1 99 7E-58 183 Q8JHF0 PEN2_DANRE GO:0007219; GO:0016021; GO:0043524 Notch signaling pathway; integral to membrane; negative regulation of neuron apoptotic process reviewed IPR019379; Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2 homolog) psenen pen2 zgc:109727 Danio rerio (Zebrafish) (Brachydanio rerio) 101 Q8JHF0 GO:0043524 GO:0043524 negative regulation of neuron apoptosis death P ConsensusfromContig118 sp Q8JHI6 MED29_DANRE 90.14 142 10 1 455 42 34 175 7E-88 262 Q8JHI6 MED29_DANRE GO:0042462; GO:0016592; GO:0006355; GO:0006351 eye photoreceptor cell development; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021018; Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) med29 ixl Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q8JHI6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig118 sp Q8JHI6 MED29_DANRE 90.14 142 10 1 455 42 34 175 7E-88 262 Q8JHI6 MED29_DANRE GO:0042462; GO:0016592; GO:0006355; GO:0006351 eye photoreceptor cell development; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021018; Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) med29 ixl Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q8JHI6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig118 sp Q8JHI6 MED29_DANRE 90.14 142 10 1 455 42 34 175 7E-88 262 Q8JHI6 MED29_DANRE GO:0042462; GO:0016592; GO:0006355; GO:0006351 eye photoreceptor cell development; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021018; Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) med29 ixl Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q8JHI6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig118 sp Q8JHI6 MED29_DANRE 90.14 142 10 1 455 42 34 175 7E-88 262 Q8JHI6 MED29_DANRE GO:0042462; GO:0016592; GO:0006355; GO:0006351 eye photoreceptor cell development; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021018; Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) med29 ixl Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q8JHI6 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig118 sp Q8JHI6 MED29_DANRE 90.14 142 10 1 455 42 34 175 7E-88 262 Q8JHI6 MED29_DANRE GO:0042462; GO:0016592; GO:0006355; GO:0006351 eye photoreceptor cell development; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR021018; Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29) med29 ixl Danio rerio (Zebrafish) (Brachydanio rerio) 179 Q8JHI6 GO:0042462 GO:0042462 eye photoreceptor cell development developmental processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0003995 GO:0003995 acyl-CoA dehydrogenase activity other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0016627 GO:0016627 "oxidoreductase activity, acting on the CH-CH group of donors" other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 73.41 331 88 0 1627 635 293 623 0 504 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0003995 GO:0003995 acyl-CoA dehydrogenase activity other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0016627 GO:0016627 "oxidoreductase activity, acting on the CH-CH group of donors" other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig6193 sp Q8JZN5 ACAD9_MOUSE 71.92 260 73 0 2411 1632 31 290 0 402 Q8JZN5 ACAD9_MOUSE GO:0003995; GO:0030425; GO:0050660; GO:0005739; GO:0005634 acyl-CoA dehydrogenase activity; dendrite; flavin adenine dinucleotide binding; mitochondrion; nucleus reviewed IPR006089; IPR006091; IPR009075; IPR013786; IPR009100; Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-) Acad9 Mus musculus (Mouse) 625 Q8JZN5 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0004653 GO:0004653 polypeptide N-acetylgalactosaminyltransferase activity other molecular function F ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0005529 GO:0005529 sugar binding other molecular function F ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1673 sp Q8K1B9 GLT18_MOUSE 77.31 119 27 0 389 33 501 619 2E-65 216 Q8K1B9 GLT18_MOUSE GO:0000139; GO:0016021; GO:0004653; GO:0006486 Golgi membrane; integral to membrane; polypeptide N-acetylgalactosaminyltransferase activity; protein glycosylation reviewed IPR001173; IPR000772; Protein modification; protein glycosylation. Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4) Galnt18 Galntl4 Mus musculus (Mouse) 622 Q8K1B9 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0003690 GO:0003690 double-stranded DNA binding nucleic acid binding activity F ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0016363 GO:0016363 nuclear matrix nucleus C ConsensusfromContig5656 sp Q8K339 KIN17_MOUSE 67.7 291 88 3 1217 345 87 371 6E-114 345 Q8K339 KIN17_MOUSE GO:0006310; GO:0006281; GO:0006260; GO:0003723; GO:0005737; GO:0003690; GO:0006397; GO:0046872; GO:0016363; GO:0006974 DNA recombination; DNA repair; DNA replication; RNA binding; cytoplasm; double-stranded DNA binding; mRNA processing; metal ion binding; nuclear matrix; response to DNA damage stimulus reviewed IPR019447; IPR005824; IPR015880; DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein) Kin Btcd Kin17 Mus musculus (Mouse) 391 Q8K339 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig505 sp Q8K387 UBP45_MOUSE 66.15 130 40 1 1 378 684 813 2E-53 184 Q8K387 UBP45_MOUSE GO:0008234; GO:0004221; GO:0006511; GO:0008270 cysteine-type peptidase activity; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; zinc ion binding reviewed IPR018200; IPR001394; IPR013083; IPR001607; Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45) Usp45 Mus musculus (Mouse) 813 Q8K387 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0002102 GO:0002102 podosome cytoskeleton C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0007519 GO:0007519 skeletal muscle tissue development developmental processes P ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0043034 GO:0043034 costamere other cellular component C ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig1247 sp Q8K4L3 SVIL_MOUSE 60.11 188 75 0 565 2 1289 1476 6E-75 252 Q8K4L3 SVIL_MOUSE GO:0030054; GO:0043034; GO:0007010; GO:0071437; GO:0005634; GO:0005886; GO:0002102; GO:0007519 cell junction; costamere; cytoskeleton organization; invadopodium; nucleus; plasma membrane; podosome; skeletal muscle tissue development reviewed IPR007123; IPR015628; IPR007122; IPR003128; Supervillin (Archvillin) (p205/p250) Svil Mus musculus (Mouse) 2170 Q8K4L3 GO:0071437 ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 50.94 212 92 3 1249 626 1 204 1E-56 178 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 50.94 212 92 3 1249 626 1 204 1E-56 178 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 50.94 212 92 3 1249 626 1 204 1E-56 178 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0010923 GO:0010923 negative regulation of phosphatase activity other metabolic processes P ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 50.94 212 92 3 1249 626 1 204 1E-56 178 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 45.71 70 37 1 632 426 202 271 1E-56 64.7 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 45.71 70 37 1 632 426 202 271 1E-56 64.7 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 45.71 70 37 1 632 426 202 271 1E-56 64.7 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0010923 GO:0010923 negative regulation of phosphatase activity other metabolic processes P ConsensusfromContig6300 sp Q8N567 ZCHC9_HUMAN 45.71 70 37 1 632 426 202 271 1E-56 64.7 Q8N567 ZCHC9_HUMAN GO:0010923; GO:0003676; GO:0008270 negative regulation of phosphatase activity; nucleic acid binding; zinc ion binding reviewed IPR001878; Zinc finger CCHC domain-containing protein 9 ZCCHC9 Homo sapiens (Human) 271 Q8N567 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2365 sp Q8N5D0 WDTC1_HUMAN 87.97 133 16 0 401 3 154 286 4E-79 252 Q8N5D0 WDTC1_HUMAN GO:0055082; GO:0032869; GO:0005829; GO:0004857; GO:0006006; GO:0001701; GO:0043231; GO:0035264; GO:0045717; GO:0000122; GO:0005634; GO:0008361 cellular chemical homeostasis; cellular response to insulin stimulus; cytosol; enzyme inhibitor activity; glucose metabolic process; in utero embryonic development; intracellular membrane-bounded organelle; multicellular organism growth; negative regulation of fatty acid biosynthetic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; regulation of cell size reviewed IPR013026; IPR011990; IPR013105; IPR015943; IPR001680; IPR017986; WD and tetratricopeptide repeats protein 1 WDTC1 KIAA1037 Homo sapiens (Human) 677 Q8N5D0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2365 sp Q8N5D0 WDTC1_HUMAN 87.97 133 16 0 401 3 154 286 4E-79 252 Q8N5D0 WDTC1_HUMAN GO:0055082; GO:0032869; GO:0005829; GO:0004857; GO:0006006; GO:0001701; GO:0043231; GO:0035264; GO:0045717; GO:0000122; GO:0005634; GO:0008361 cellular chemical homeostasis; cellular response to insulin stimulus; cytosol; enzyme inhibitor activity; glucose metabolic process; in utero embryonic development; intracellular membrane-bounded organelle; multicellular organism growth; negative regulation of fatty acid biosynthetic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; regulation of cell size reviewed IPR013026; IPR011990; IPR013105; IPR015943; IPR001680; IPR017986; WD and tetratricopeptide repeats protein 1 WDTC1 KIAA1037 Homo sapiens (Human) 677 Q8N5D0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2365 sp Q8N5D0 WDTC1_HUMAN 87.97 133 16 0 401 3 154 286 4E-79 252 Q8N5D0 WDTC1_HUMAN GO:0055082; GO:0032869; GO:0005829; GO:0004857; GO:0006006; GO:0001701; GO:0043231; GO:0035264; GO:0045717; GO:0000122; GO:0005634; GO:0008361 cellular chemical homeostasis; cellular response to insulin stimulus; cytosol; enzyme inhibitor activity; glucose metabolic process; in utero embryonic development; intracellular membrane-bounded organelle; multicellular organism growth; negative regulation of fatty acid biosynthetic process; negative regulation of transcription from RNA polymerase II promoter; nucleus; regulation of cell size reviewed IPR013026; IPR011990; IPR013105; IPR015943; IPR001680; IPR017986; WD and tetratricopeptide repeats protein 1 WDTC1 KIAA1037 Homo sapiens (Human) 677 Q8N5D0 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig5635 sp Q8N5I2 ARRD1_HUMAN 48.03 456 198 6 2 1354 2 423 3E-135 411 Q8N5I2 ARRD1_HUMAN GO:0031410; GO:0005886 cytoplasmic vesicle; plasma membrane reviewed IPR011021; IPR011022; IPR014756; Arrestin domain-containing protein 1 ARRDC1 Homo sapiens (Human) 433 ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig453 sp Q8N680 ZBTB2_HUMAN 75.18 141 31 1 447 37 1 141 3E-69 226 Q8N680 ZBTB2_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 2 ZBTB2 KIAA1483 ZNF437 Homo sapiens (Human) 514 Q8N680 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0001657 GO:0001657 ureteric bud development developmental processes P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0002043 GO:0002043 blood vessel endothelial cell proliferation during sprouting angiogenesis cell cycle and proliferation P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0002043 GO:0002043 blood vessel endothelial cell proliferation during sprouting angiogenesis developmental processes P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0005615 GO:0005615 extracellular space non-structural extracellular C ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0010594 GO:0010594 regulation of endothelial cell migration other biological processes P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0030514 GO:0030514 negative regulation of BMP signaling pathway signal transduction P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0042118 GO:0042118 endothelial cell activation other biological processes P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0060393 GO:0060393 regulation of pathway-restricted SMAD protein phosphorylation signal transduction P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0060393 GO:0060393 regulation of pathway-restricted SMAD protein phosphorylation protein metabolism P ConsensusfromContig701 sp Q8N8U9 BMPER_HUMAN 73.55 121 32 0 3 365 503 623 2E-60 201 Q8N8U9 BMPER_HUMAN GO:0002043; GO:0042118; GO:0005615; GO:0048839; GO:0030514; GO:0070374; GO:0010594; GO:0060393; GO:0001657 blood vessel endothelial cell proliferation involved in sprouting angiogenesis; endothelial cell activation; extracellular space; inner ear development; negative regulation of BMP signaling pathway; positive regulation of ERK1 and ERK2 cascade; regulation of endothelial cell migration; regulation of pathway-restricted SMAD protein phosphorylation; ureteric bud development reviewed IPR002919; IPR014853; IPR001007; IPR001846; BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2) BMPER KIAA1965 Homo sapiens (Human) 685 Q8N8U9 GO:0070374 GO:0070374 positive regulation of ERK1 and ERK2 cascade signal transduction P ConsensusfromContig5950 sp Q8N8V4 ANS4B_HUMAN 45.01 431 188 9 1537 302 17 417 8E-87 281 Q8N8V4 ANS4B_HUMAN GO:0005886 plasma membrane reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR021129; Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein) (Harp) ANKS4B HARP Homo sapiens (Human) 417 Q8N8V4 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5950 sp Q8N8V4 ANS4B_HUMAN 45.01 431 188 9 1537 302 17 417 8E-87 281 Q8N8V4 ANS4B_HUMAN GO:0005886 plasma membrane reviewed IPR002110; IPR020683; IPR001660; IPR013761; IPR021129; Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein) (Harp) ANKS4B HARP Homo sapiens (Human) 417 Q8N8V4 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1305 sp Q8NBL1 PGLT1_HUMAN 77.97 177 39 0 531 1 76 252 3E-91 278 Q8NBL1 PGLT1_HUMAN GO:0007219; GO:0035251; GO:0035252; GO:0072358; GO:0005788; GO:0006493; GO:0008593 Notch signaling pathway; UDP-glucosyltransferase activity; UDP-xylosyltransferase activity; cardiovascular system development; endoplasmic reticulum lumen; protein O-linked glycosylation; regulation of Notch signaling pathway reviewed IPR006598; Protein modification; protein glycosylation. Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) 392 Q8NBL1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1305 sp Q8NBL1 PGLT1_HUMAN 77.97 177 39 0 531 1 76 252 3E-91 278 Q8NBL1 PGLT1_HUMAN GO:0007219; GO:0035251; GO:0035252; GO:0072358; GO:0005788; GO:0006493; GO:0008593 Notch signaling pathway; UDP-glucosyltransferase activity; UDP-xylosyltransferase activity; cardiovascular system development; endoplasmic reticulum lumen; protein O-linked glycosylation; regulation of Notch signaling pathway reviewed IPR006598; Protein modification; protein glycosylation. Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) 392 Q8NBL1 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig1305 sp Q8NBL1 PGLT1_HUMAN 77.97 177 39 0 531 1 76 252 3E-91 278 Q8NBL1 PGLT1_HUMAN GO:0007219; GO:0035251; GO:0035252; GO:0072358; GO:0005788; GO:0006493; GO:0008593 Notch signaling pathway; UDP-glucosyltransferase activity; UDP-xylosyltransferase activity; cardiovascular system development; endoplasmic reticulum lumen; protein O-linked glycosylation; regulation of Notch signaling pathway reviewed IPR006598; Protein modification; protein glycosylation. Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) 392 Q8NBL1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1305 sp Q8NBL1 PGLT1_HUMAN 77.97 177 39 0 531 1 76 252 3E-91 278 Q8NBL1 PGLT1_HUMAN GO:0007219; GO:0035251; GO:0035252; GO:0072358; GO:0005788; GO:0006493; GO:0008593 Notch signaling pathway; UDP-glucosyltransferase activity; UDP-xylosyltransferase activity; cardiovascular system development; endoplasmic reticulum lumen; protein O-linked glycosylation; regulation of Notch signaling pathway reviewed IPR006598; Protein modification; protein glycosylation. Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) 392 Q8NBL1 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1305 sp Q8NBL1 PGLT1_HUMAN 77.97 177 39 0 531 1 76 252 3E-91 278 Q8NBL1 PGLT1_HUMAN GO:0007219; GO:0035251; GO:0035252; GO:0072358; GO:0005788; GO:0006493; GO:0008593 Notch signaling pathway; UDP-glucosyltransferase activity; UDP-xylosyltransferase activity; cardiovascular system development; endoplasmic reticulum lumen; protein O-linked glycosylation; regulation of Notch signaling pathway reviewed IPR006598; Protein modification; protein glycosylation. Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) POGLUT1 C3orf9 CLP46 KTELC1 MDSRP MDS010 UNQ490/PRO1006 Homo sapiens (Human) 392 Q8NBL1 GO:0035251 GO:0035251 UDP-glucosyltransferase activity other molecular function F ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2757 sp Q8NBP5 MFSD9_HUMAN 61.71 222 69 1 626 9 44 265 4E-76 243 Q8NBP5 MFSD9_HUMAN GO:0016021; GO:0005886; GO:0055085; GO:0005215 integral to membrane; plasma membrane; transmembrane transport; transporter activity reviewed IPR011701; IPR020846; IPR016196; IPR005829; IPR001958; Major facilitator superfamily domain-containing protein 9 MFSD9 PSEC0066 Homo sapiens (Human) 474 Q8NBP5 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0000932 GO:0000932 cytoplasmic mRNA processing body other cellular component C ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0009267 GO:0009267 cellular response to starvation stress response P ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0035068 GO:0035068 micro-ribonucleoprotein complex other cellular component C ConsensusfromContig5859 sp Q8NDV7 TNR6A_HUMAN 77.02 457 87 12 1374 34 1514 1962 3E-163 515 Q8NDV7 TNR6A_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0009267; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0035068; GO:0035278; GO:0048011; GO:0000166; GO:0048015 Q9UL18; Q9UKV8; Q9H9G7; Q9HCK5; A5YKK6; Q58A45 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cellular response to starvation; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; nucleotide binding; phosphatidylinositol-mediated signaling reviewed IPR019486; IPR026804; IPR012677; IPR000504; Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) TNRC6A CAGH26 KIAA1460 TNRC6 Homo sapiens (Human) 1962 Q8NDV7 GO:0035278 GO:0035278 "gene silencing by miRNA, negative regulation of translation" protein metabolism P ConsensusfromContig4540 sp Q8NE00 TM104_HUMAN 74.05 131 33 1 53 445 366 495 8E-59 196 Q8NE00 TM104_HUMAN GO:0016021 integral to membrane reviewed IPR013057; Transmembrane protein 104 TMEM104 Homo sapiens (Human) 496 Q8NE00 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig4540 sp Q8NE00 TM104_HUMAN 74.05 131 33 1 53 445 366 495 8E-59 196 Q8NE00 TM104_HUMAN GO:0016021 integral to membrane reviewed IPR013057; Transmembrane protein 104 TMEM104 Homo sapiens (Human) 496 Q8NE00 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig4540 sp Q8NE00 TM104_HUMAN 74.05 131 33 1 53 445 366 495 8E-59 196 Q8NE00 TM104_HUMAN GO:0016021 integral to membrane reviewed IPR013057; Transmembrane protein 104 TMEM104 Homo sapiens (Human) 496 Q8NE00 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig4540 sp Q8NE00 TM104_HUMAN 74.05 131 33 1 53 445 366 495 8E-59 196 Q8NE00 TM104_HUMAN GO:0016021 integral to membrane reviewed IPR013057; Transmembrane protein 104 TMEM104 Homo sapiens (Human) 496 Q8NE00 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4540 sp Q8NE00 TM104_HUMAN 74.05 131 33 1 53 445 366 495 8E-59 196 Q8NE00 TM104_HUMAN GO:0016021 integral to membrane reviewed IPR013057; Transmembrane protein 104 TMEM104 Homo sapiens (Human) 496 Q8NE00 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6297 sp Q8NE22 SETD9_HUMAN 56.4 211 74 4 919 341 20 230 3E-86 233 Q8NE22 SETD9_HUMAN GO:0008168 methyltransferase activity reviewed SET domain-containing protein 9 (EC 2.1.1.-) SETD9 C5orf35 Homo sapiens (Human) 299 ConsensusfromContig6297 sp Q8NE22 SETD9_HUMAN 65.79 76 26 0 365 138 223 298 3E-86 108 Q8NE22 SETD9_HUMAN GO:0008168 methyltransferase activity reviewed SET domain-containing protein 9 (EC 2.1.1.-) SETD9 C5orf35 Homo sapiens (Human) 299 ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0001895 GO:0001895 retina homeostasis other biological processes P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0007601 GO:0007601 visual perception other biological processes P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0034464 GO:0034464 BBSome other cellular component C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0035058 GO:0035058 sensory cilium assembly cell organization and biogenesis P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0042384 GO:0042384 cilium assembly cell organization and biogenesis P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0043001 GO:0043001 Golgi to plasma membrane protein transport transport P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0045494 GO:0045494 photoreceptor cell maintenance other biological processes P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0050896 GO:0050896 response to stimulus other biological processes P ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0060170 GO:0060170 cilium membrane plasma membrane C ConsensusfromContig3798 sp Q8NFJ9 BBS1_HUMAN 72.58 124 34 0 373 2 169 292 5E-59 197 Q8NFJ9 BBS1_HUMAN GO:0034464; GO:0043001; GO:0060170; GO:0005737; GO:0005815; GO:0035058; GO:0045494; GO:0050896; GO:0007601 P05062; Q9H0F7; Q9BXC9; Q96RK4; Q8IWZ6; Q3SYG4; P68104; P48356-1; Q15154; Q96QF0-1 BBSome; Golgi to plasma membrane protein transport; cilium membrane; cytoplasm; microtubule organizing center; nonmotile primary cilium assembly; photoreceptor cell maintenance; response to stimulus; visual perception reviewed IPR011047; Bardet-Biedl syndrome 1 protein (BBS2-like protein 2) BBS1 BBS2L2 Homo sapiens (Human) 593 Q8NFJ9 GO:0060170 GO:0060170 cilium membrane other membranes C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0008378 GO:0008378 galactosyltransferase activity other molecular function F ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0016266 GO:0016266 O-glycan processing protein metabolism P ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig5601 sp Q8NFL0 B3GN7_HUMAN 63.98 322 113 2 455 1411 80 401 2E-152 457 Q8NFL0 B3GN7_HUMAN GO:0000139; GO:0016266; GO:0008378; GO:0016021; GO:0018146; GO:0043687 Golgi membrane; O-glycan processing; galactosyltransferase activity; integral to membrane; keratan sulfate biosynthetic process; post-translational protein modification reviewed IPR002659; Protein modification; protein glycosylation. UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-) B3GNT7 Homo sapiens (Human) 401 Q8NFL0 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6207 sp Q8NG11 TSN14_HUMAN 67.33 150 48 1 257 706 30 178 4E-84 197 Q8NG11 TSN14_HUMAN GO:0016021 integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14) TSPAN14 TM4SF14 Homo sapiens (Human) 270 Q8NG11 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6207 sp Q8NG11 TSN14_HUMAN 67.33 150 48 1 257 706 30 178 4E-84 197 Q8NG11 TSN14_HUMAN GO:0016021 integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14) TSPAN14 TM4SF14 Homo sapiens (Human) 270 Q8NG11 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6207 sp Q8NG11 TSN14_HUMAN 69.47 95 28 1 690 974 172 265 4E-84 137 Q8NG11 TSN14_HUMAN GO:0016021 integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14) TSPAN14 TM4SF14 Homo sapiens (Human) 270 Q8NG11 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6207 sp Q8NG11 TSN14_HUMAN 69.47 95 28 1 690 974 172 265 4E-84 137 Q8NG11 TSN14_HUMAN GO:0016021 integral to membrane reviewed IPR000301; IPR018499; IPR018503; IPR008952; Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14) TSPAN14 TM4SF14 Homo sapiens (Human) 270 Q8NG11 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig4551 sp Q8QHJ8 XPO6_DANRE 85.03 167 21 1 511 11 428 590 1E-76 252 Q8QHJ8 XPO6_DANRE GO:0005737; GO:0006886; GO:0005634 cytoplasm; intracellular protein transport; nucleus reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-6 (Exp6) xpo6 Danio rerio (Zebrafish) (Brachydanio rerio) 1128 Q8QHJ8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6096 sp Q8QZR7 PDK1L_MOUSE 41.5 359 155 9 243 1274 8 326 2E-83 270 Q8QZR7 PDK1L_MOUSE GO:0005524; GO:0005634; GO:0004674 ATP binding; nucleus; protein serine/threonine kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR008271; Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like) Pdik1l Mus musculus (Mouse) 341 Q8QZR7 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0044212 ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.55 274 38 2 1410 643 57 319 1E-136 413 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0045120 GO:0045120 pronucleus nucleus C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0044212 ConsensusfromContig5759 sp Q8R081 HNRPL_MOUSE 75.16 161 35 1 510 28 371 526 5E-69 237 Q8R081 HNRPL_MOUSE GO:0003723; GO:0005737; GO:0006397; GO:0005654; GO:0000166; GO:0045120; GO:0030529; GO:0044212 RNA binding; cytoplasm; mRNA processing; nucleoplasm; nucleotide binding; pronucleus; ribonucleoprotein complex; transcription regulatory region DNA binding reviewed IPR006536; IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein L (hnRNP L) Hnrnpl Hnrpl Mus musculus (Mouse) 586 Q8R081 GO:0045120 GO:0045120 pronucleus nucleus C ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0031461 GO:0031461 cullin-RING ubiquitin ligase complex other cellular component C ConsensusfromContig5809 sp Q8R0X2 CACL1_MOUSE 64.97 197 68 1 324 914 126 321 1E-83 275 Q8R0X2 CACL1_MOUSE GO:0000082; GO:0031461; GO:0008284; GO:0045860; GO:0006511 G1/S transition of mitotic cell cycle; cullin-RING ubiquitin ligase complex; positive regulation of cell proliferation; positive regulation of protein kinase activity; ubiquitin-dependent protein catabolic process reviewed IPR001373; IPR016159; CDK2-associated and cullin domain-containing protein 1 Cacul1 Mus musculus (Mouse) 377 Q8R0X2 GO:0031625 GO:0031625 ubiquitin protein ligase binding other molecular function F ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0005487 GO:0005487 nucleocytoplasmic transporter activity transporter activity F ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6218 sp Q8R332 NUPL1_MOUSE 80.82 245 46 1 796 62 203 446 2E-118 370 Q8R332 NUPL1_MOUSE GO:0051028; GO:0031965; GO:0005643; GO:0006913; GO:0015031 P63085 mRNA transport; nuclear membrane; nuclear pore; nucleocytoplasmic transport; protein transport reviewed IPR024882; Nucleoporin p58/p45 (Nucleoporin-like protein 1) Nupl1 Mus musculus (Mouse) 587 Q8R332 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004693 GO:0004693 cyclin-dependent protein kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 95.31 128 6 0 1 384 95 222 4E-123 258 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0004693 GO:0004693 cyclin-dependent protein kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig697 sp Q8R3L8 CDK8_MOUSE 81.25 128 14 3 372 728 219 345 4E-123 205 Q8R3L8 CDK8_MOUSE GO:0005524; GO:0008353; GO:0004693; GO:0016592; GO:0006355; GO:0006351 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; cyclin-dependent protein serine/threonine kinase activity; mediator complex; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) Cdk8 Mus musculus (Mouse) 464 Q8R3L8 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0000346 GO:0000346 transcription export complex nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0000347 GO:0000347 THO complex nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0000445 GO:0000445 THO complex part of transcription export complex nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0016363 GO:0016363 nuclear matrix nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0032784 GO:0032784 regulation of RNA elongation RNA metabolism P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0046784 GO:0046784 intronless viral mRNA export from host nucleus transport P ConsensusfromContig5833 sp Q8R3N6 THOC1_MOUSE 74.26 571 142 4 3 1712 83 649 0 688 Q8R3N6 THOC1_MOUSE GO:0003677; GO:0003723; GO:0008380; GO:0000445; GO:0006915; GO:0005737; GO:0046784; GO:0006397; GO:0016363; GO:0016607; GO:0032784; GO:0007165; GO:0006351 DNA binding; RNA binding; RNA splicing; THO complex part of transcription export complex; apoptotic process; cytoplasm; intronless viral mRNA export from host nucleus; mRNA processing; nuclear matrix; nuclear speck; regulation of DNA-dependent transcription, elongation; signal transduction; transcription, DNA-dependent reviewed IPR011029; IPR000488; IPR021861; THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) Thoc1 Hpr1 Mus musculus (Mouse) 657 Q8R3N6 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0008967 GO:0008967 phosphoglycolate phosphatase activity other molecular function F ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0046380 GO:0046380 N-acetylneuraminate biosynthetic process other metabolic processes P ConsensusfromContig5912 sp Q8TBE9 NANP_HUMAN 50.41 242 118 2 1426 701 1 240 2E-73 239 Q8TBE9 NANP_HUMAN GO:0006045; GO:0046380; GO:0050124; GO:0005975 N-acetylglucosamine biosynthetic process; N-acetylneuraminate biosynthetic process; N-acylneuraminate-9-phosphatase activity; carbohydrate metabolic process reviewed IPR023214; IPR006439; IPR011950; Amino-sugar metabolism; N-acetylneuraminate biosynthesis. N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase) NANP C20orf147 HDHD4 Homo sapiens (Human) 248 Q8TBE9 GO:0050124 GO:0050124 N-acylneuraminate-9-phosphatase activity other molecular function F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig553 sp Q8TDG4 HELQ_HUMAN 64.77 193 66 1 28 606 877 1067 2E-84 276 Q8TDG4 HELQ_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005730 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleolus reviewed IPR011545; IPR014001; IPR001650; IPR027417; Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase) HELQ HEL308 Homo sapiens (Human) 1101 Q8TDG4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005913 GO:0005913 cell-cell adherens junction plasma membrane C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0005913 GO:0005913 cell-cell adherens junction other membranes C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0008013 GO:0008013 beta-catenin binding other molecular function F ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0008092 GO:0008092 cytoskeletal protein binding cytoskeletal activity F ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0016337 GO:0016337 cell-cell adhesion cell adhesion P ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0030159 GO:0030159 receptor signaling complex scaffold activity other molecular function F ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0035556 ConsensusfromContig953 sp Q8TDM6 DLG5_HUMAN 80.5 159 30 1 1 477 1649 1806 3E-65 222 Q8TDM6 DLG5_HUMAN GO:0008013; GO:0005913; GO:0016337; GO:0005737; GO:0008092; GO:0035556; GO:0008285; GO:0005886; GO:0030159; GO:0042981 Q64729; Q62312 beta-catenin binding; cell-cell adherens junction; cell-cell adhesion; cytoplasm; cytoskeletal protein binding; intracellular signal transduction; negative regulation of cell proliferation; plasma membrane; receptor signaling complex scaffold activity; regulation of apoptotic process reviewed IPR001315; IPR011029; IPR006907; IPR008145; IPR008144; IPR027417; IPR001478; IPR001452; Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG) DLG5 KIAA0583 PDLG Homo sapiens (Human) 1919 Q8TDM6 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:0046425 GO:0046425 regulation of JAK-STAT cascade signal transduction P ConsensusfromContig2347 sp Q8TEK3 DOT1L_HUMAN 86.81 144 19 0 434 3 81 224 3E-70 236 Q8TEK3 DOT1L_HUMAN GO:0003677; GO:0018024; GO:0005634; GO:0046425; GO:2000677 Q03111 DNA binding; histone-lysine N-methyltransferase activity; nucleus; regulation of JAK-STAT cascade; regulation of transcription regulatory region DNA binding reviewed IPR017956; IPR013110; IPR025789; IPR021169; Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4) DOT1L KIAA1814 KMT4 Homo sapiens (Human) 1739 Q8TEK3 GO:2000677 ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell cycle and proliferation P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell organization and biogenesis P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0000902 GO:0000902 cell morphogenesis cell organization and biogenesis P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001654 GO:0001654 eye development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001736 GO:0001736 establishment of planar polarity developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001756 GO:0001756 somitogenesis developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001764 GO:0001764 neuron migration developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001839 GO:0001839 neural plate morphogenesis developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0001841 GO:0001841 neural tube formation developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0007163 GO:0007163 establishment or maintenance of cell polarity cell organization and biogenesis P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0007369 GO:0007369 gastrulation developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0014812 GO:0014812 muscle cell migration other biological processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0021535 GO:0021535 cell migration in hindbrain developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0021915 GO:0021915 neural tube development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0030010 GO:0030010 establishment of cell polarity cell organization and biogenesis P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0030111 GO:0030111 regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0030903 GO:0030903 notochord development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0035121 GO:0035121 tail morphogenesis other biological processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0042074 GO:0042074 cell migration involved in gastrulation developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0045813 GO:0045813 "positive regulation of Wnt receptor signaling pathway, calcium modulating pathway" signal transduction P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0048048 GO:0048048 embryonic eye morphogenesis developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0055002 GO:0055002 striated muscle cell development developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0060026 GO:0060026 convergent extension developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0060027 GO:0060027 convergent extension involved in gastrulation developmental processes P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0060070 GO:0060070 Wnt receptor signaling pathway through beta-catenin signal transduction P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0060071 GO:0060071 "Wnt receptor signaling pathway, planar cell polarity pathway" signal transduction P ConsensusfromContig2848 sp Q8UVJ6 VANG2_DANRE 94.23 156 9 0 3 470 210 365 3E-82 258 Q8UVJ6 VANG2_DANRE GO:0060071; GO:0003401; GO:0060070; GO:0021535; GO:0042074; GO:0000902; GO:0044782; GO:0035844; GO:0060027; GO:0048048; GO:0000132; GO:0001736; GO:0016021; GO:0060972; GO:0014812; GO:0001839; GO:0001841; GO:0001764; GO:0030903; GO:0005886; GO:0045813; GO:0036342; GO:0001756; GO:0055002 Wnt receptor signaling pathway, planar cell polarity pathway; axis elongation; canonical Wnt receptor signaling pathway; cell migration in hindbrain; cell migration involved in gastrulation; cell morphogenesis; cilium organization; cloaca development; convergent extension involved in gastrulation; embryonic eye morphogenesis; establishment of mitotic spindle orientation; establishment of planar polarity; integral to membrane; left/right pattern formation; muscle cell migration; neural plate morphogenesis; neural tube formation; neuron migration; notochord development; plasma membrane; positive regulation of Wnt receptor signaling pathway, calcium modulating pathway; post-anal tail morphogenesis; somitogenesis; striated muscle cell development reviewed IPR009539; Vang-like protein 2 (Protein strabismus) (Protein trilobite) (Van Gogh-like protein 2) vangl2 stbm tri Danio rerio (Zebrafish) (Brachydanio rerio) 526 Q8UVJ6 GO:0060071 GO:0060071 "Wnt receptor signaling pathway, planar cell polarity pathway" developmental processes P ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig98 sp Q8VBV3 EXOS2_MOUSE 80.55 293 57 0 27 905 1 293 2E-176 500 Q8VBV3 EXOS2_MOUSE GO:0003723; GO:0005737; GO:0000178; GO:0005730; GO:0030307; GO:0006364 RNA binding; cytoplasm; exosome (RNase complex); nucleolus; positive regulation of cell growth; rRNA processing reviewed IPR025721; IPR026699; IPR012340; IPR022967; Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4) Exosc2 Rrp4 Mus musculus (Mouse) 293 Q8VBV3 GO:0030307 GO:0030307 positive regulation of cell growth other biological processes P ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 53.26 475 218 2 1961 549 123 597 1E-167 499 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig5688 sp Q8VCY6 UTP6_MOUSE 60.24 83 33 0 2208 1960 41 123 1E-167 115 Q8VCY6 UTP6_MOUSE GO:0005730; GO:0006364 nucleolus; rRNA processing reviewed IPR003107; IPR011990; IPR013949; U3 small nucleolar RNA-associated protein 6 homolog (Multiple hat domains protein) Utp6 Mhat Mus musculus (Mouse) 597 Q8VCY6 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig3149 sp Q8VDZ4 ZDHC5_MOUSE 84.68 111 17 0 334 2 142 252 1E-62 208 Q8VDZ4 ZDHC5_MOUSE GO:0030425; GO:0016021; GO:0016409; GO:0005886; GO:0018345; GO:0008270 dendrite; integral to membrane; palmitoyltransferase activity; plasma membrane; protein palmitoylation; zinc ion binding reviewed IPR001594; Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) Zdhhc5 Kiaa1748 Mus musculus (Mouse) 715 Q8VDZ4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig6058 sp Q8VE97 SRSF4_MOUSE 80.98 184 27 1 52 603 3 178 3E-89 286 Q8VE97 SRSF4_MOUSE GO:0003723; GO:0008380; GO:0006397; GO:0048025; GO:0016607; GO:0000166 RNA binding; RNA splicing; mRNA processing; negative regulation of mRNA splicing, via spliceosome; nuclear speck; nucleotide binding reviewed IPR012677; IPR000504; Serine/arginine-rich splicing factor 4 (Splicing factor, arginine/serine-rich 4) Srsf4 Sfrs4 MNCb-2616 Mus musculus (Mouse) 489 Q8VE97 GO:0048025 GO:0048025 "negative regulation of nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5581 sp Q8VEM8 MPCP_MOUSE 78.65 356 75 1 427 1494 3 357 0 531 Q8VEM8 MPCP_MOUSE GO:0016021; GO:0005743; GO:0015293 integral to membrane; mitochondrial inner membrane; symporter activity reviewed IPR018108; IPR023395; Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3) Slc25a3 Mus musculus (Mouse) 357 Q8VEM8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0000125 GO:0000125 PCAF complex nucleus C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0004402 GO:0004402 histone acetyltransferase activity other molecular function F ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0005669 GO:0005669 transcription factor TFIID complex nucleus C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0006352 GO:0006352 transcription initiation RNA metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0006352 GO:0006352 transcription initiation cell organization and biogenesis P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0030307 GO:0030307 positive regulation of cell growth other biological processes P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0030914 GO:0030914 STAGA complex nucleus C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0032435 GO:0032435 negative regulation of proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0033276 GO:0033276 transcription factor TFTC complex nucleus C ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0033613 GO:0033613 transcription activator binding other molecular function F ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0043966 GO:0043966 histone H3 acetylation protein metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0043966 GO:0043966 histone H3 acetylation cell organization and biogenesis P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0044212 ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0060760 GO:0060760 other biological processes ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0070555 GO:0070555 response to interleukin-1 other biological processes P ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0070742 GO:0070742 other molecular function ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0070761 GO:0070761 other cellular component ConsensusfromContig5791 sp Q8VI33 TAF9_MOUSE 80.82 245 45 1 1069 341 3 247 5E-138 401 Q8VI33 TAF9_MOUSE GO:0003677; GO:0006352; GO:0071339; GO:0000125; GO:0030914; GO:0043966; GO:0004402; GO:0043066; GO:0032435; GO:0030307; GO:0060760; GO:0045944; GO:0070761; GO:0050821; GO:0070555; GO:0003713; GO:0005669; GO:0033276; GO:0044212 DNA binding; DNA-dependent transcription, initiation; MLL1 complex; PCAF complex; STAGA complex; histone H3 acetylation; histone acetyltransferase activity; negative regulation of apoptotic process; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of cell growth; positive regulation of response to cytokine stimulus; positive regulation of transcription from RNA polymerase II promoter; pre-snoRNP complex; protein stabilization; response to interleukin-1; transcription coactivator activity; transcription factor TFIID complex; transcription factor TFTC complex; transcription regulatory region DNA binding reviewed IPR009072; IPR003162; Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32) Taf9 Taf2g Mus musculus (Mouse) 264 Q8VI33 GO:0071339 ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0008023 GO:0008023 transcription elongation factor complex nucleus C ConsensusfromContig544 sp Q8WND5 ELP1_RABIT 63.33 240 88 0 731 12 900 1139 4E-96 312 Q8WND5 ELP1_RABIT GO:0033588; GO:0005737; GO:0008607; GO:0030335; GO:0006357; GO:0008023; GO:0006351 Elongator holoenzyme complex; cytoplasm; phosphorylase kinase regulator activity; positive regulation of cell migration; regulation of transcription from RNA polymerase II promoter; transcription elongation factor complex; transcription, DNA-dependent reviewed IPR011042; IPR006849; Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) IKBKAP ELP1 IKAP Oryctolagus cuniculus (Rabbit) 1333 Q8WND5 GO:0008607 GO:0008607 phosphorylase kinase regulator activity enzyme regulator activity F ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000236 GO:0000236 mitotic prometaphase cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000236 GO:0000236 mitotic prometaphase cell organization and biogenesis P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000940 GO:0000940 outer kinetochore of condensed chromosome other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005487 GO:0005487 nucleocytoplasmic transporter activity transporter activity F ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006999 GO:0006999 nuclear pore organization cell organization and biogenesis P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0031080 GO:0031080 Nup107-160 complex nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0031080 GO:0031080 Nup107-160 complex other membranes C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0044281 ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0048339 GO:0048339 paraxial mesoderm development developmental processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 65.57 366 126 0 494 1591 791 1156 0 464 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000236 GO:0000236 mitotic prometaphase cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000236 GO:0000236 mitotic prometaphase cell organization and biogenesis P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0000940 GO:0000940 outer kinetochore of condensed chromosome other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005487 GO:0005487 nucleocytoplasmic transporter activity transporter activity F ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0006999 GO:0006999 nuclear pore organization cell organization and biogenesis P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0031080 GO:0031080 Nup107-160 complex nucleus C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0031080 GO:0031080 Nup107-160 complex other membranes C ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0044281 ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0048339 GO:0048339 paraxial mesoderm development developmental processes P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig6093 sp Q8WUM0 NU133_HUMAN 61.21 165 61 1 15 500 628 792 0 223 Q8WUM0 NU133_HUMAN GO:0005975; GO:0000777; GO:0019221; GO:0005829; GO:0015758; GO:0006406; GO:0007077; GO:0006999; GO:0031080; GO:0005487; GO:0048339; GO:0015031; GO:0010827; GO:0044281; GO:0055085; GO:0016032 P49454; P57740 carbohydrate metabolic process; condensed chromosome kinetochore; cytokine-mediated signaling pathway; cytosol; glucose transport; mRNA export from nucleus; mitotic nuclear envelope disassembly; nuclear pore organization; nuclear pore outer ring; nucleocytoplasmic transporter activity; paraxial mesoderm development; protein transport; regulation of glucose transport; small molecule metabolic process; transmembrane transport; viral process reviewed IPR007187; IPR014908; IPR015943; Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133) NUP133 Homo sapiens (Human) 1156 Q8WUM0 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 71.75 177 50 0 1695 1165 73 249 5E-89 265 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0001522 GO:0001522 pseudouridine synthesis RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0009451 GO:0009451 RNA modification RNA metabolism P ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0009982 GO:0009982 pseudouridine synthase activity other molecular function F ConsensusfromContig5597 sp Q8WWH5 TRUB1_HUMAN 64.91 57 20 0 1162 992 251 307 5E-89 86.7 Q8WWH5 TRUB1_HUMAN GO:0003723; GO:0009982; GO:0001522; GO:0008033 RNA binding; pseudouridine synthase activity; pseudouridine synthesis; tRNA processing reviewed IPR002501; IPR020103; IPR014780; Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-) TRUB1 PUS4 Homo sapiens (Human) 349 Q8WWH5 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0004149 GO:0004149 dihydrolipoyllysine-residue succinyltransferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 88.98 118 13 0 836 483 228 345 2E-114 219 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0045252 GO:0045252 oxoglutarate dehydrogenase complex other cellular component C ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0004149 GO:0004149 dihydrolipoyllysine-residue succinyltransferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 87.14 70 9 0 499 290 340 409 2E-114 131 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0045252 GO:0045252 oxoglutarate dehydrogenase complex other cellular component C ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0004149 GO:0004149 dihydrolipoyllysine-residue succinyltransferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5850 sp Q90512 ODO2_TAKRU 89.29 56 6 0 997 830 174 229 2E-114 107 Q90512 ODO2_TAKRU GO:0033512; GO:0004149; GO:0005739; GO:0045252; GO:0006099 L-lysine catabolic process to acetyl-CoA via saccharopine; dihydrolipoyllysine-residue succinyltransferase activity; mitochondrion; oxoglutarate dehydrogenase complex; tricarboxylic acid cycle reviewed IPR003016; IPR001078; IPR000089; IPR023213; IPR011053; IPR006255; Amino-acid degradation; L-lysine degradation via saccharopine pathway; glutaryl-CoA from L-lysine: step 6/6. Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K) (Fragment) dlst Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 409 Q90512 GO:0045252 GO:0045252 oxoglutarate dehydrogenase complex other cellular component C ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6258 sp Q90888 MAFB_CHICK 78.99 119 24 1 553 909 194 311 1E-55 197 Q90888 MAFB_CHICK GO:0005634; GO:0043565; GO:0003700; GO:0006351 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent reviewed IPR004827; IPR004826; IPR013592; IPR008917; IPR024874; Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B) MAFB Gallus gallus (Chicken) 311 Q90888 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell cycle and proliferation P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0001738 GO:0001738 morphogenesis of a polarized epithelium developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0001841 GO:0001841 neural tube formation developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004697 GO:0004697 protein kinase C activity kinase activity F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005543 GO:0005543 phospholipid binding other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005915 GO:0005915 zonula adherens plasma membrane C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005915 GO:0005915 zonula adherens other membranes C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007097 GO:0007097 nuclear migration other biological processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007502 GO:0007502 gut mesoderm development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0008078 GO:0008078 mesodermal cell migration developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016332 GO:0016332 establishment or maintenance of polarity of embryonic epithelium developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016332 GO:0016332 establishment or maintenance of polarity of embryonic epithelium cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0021744 GO:0021744 dorsal motor nucleus of vagus nerve development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0031226 GO:0031226 intrinsic to plasma membrane plasma membrane C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0031226 GO:0031226 intrinsic to plasma membrane other membranes C ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0034332 GO:0034332 adherens junction organization cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0034334 GO:0034334 adherens junction maintenance cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0035050 GO:0035050 embryonic heart tube development developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0035556 ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045199 GO:0045199 maintenance of epithelial cell apical/basal polarity cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045216 GO:0045216 cell-cell junction organization cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045217 GO:0045217 cell-cell junction maintenance cell organization and biogenesis P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0048546 GO:0048546 digestive tract morphogenesis developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0048699 GO:0048699 generation of neurons developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0060041 GO:0060041 retina development in camera-type eye developmental processes P ConsensusfromContig5900 sp Q90XF2 KPCI_DANRE 97.99 199 4 0 1 597 390 588 3E-139 411 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0060042 GO:0060042 retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell cycle and proliferation P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000132 GO:0000132 establishment of mitotic spindle orientation cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0001738 GO:0001738 morphogenesis of a polarized epithelium developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0001841 GO:0001841 neural tube formation developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0004697 GO:0004697 protein kinase C activity kinase activity F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005543 GO:0005543 phospholipid binding other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005915 GO:0005915 zonula adherens plasma membrane C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0005915 GO:0005915 zonula adherens other membranes C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007097 GO:0007097 nuclear migration other biological processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007502 GO:0007502 gut mesoderm development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0008078 GO:0008078 mesodermal cell migration developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016332 GO:0016332 establishment or maintenance of polarity of embryonic epithelium developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016332 GO:0016332 establishment or maintenance of polarity of embryonic epithelium cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0021744 GO:0021744 dorsal motor nucleus of vagus nerve development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0031226 GO:0031226 intrinsic to plasma membrane plasma membrane C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0031226 GO:0031226 intrinsic to plasma membrane other membranes C ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0034332 GO:0034332 adherens junction organization cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0034334 GO:0034334 adherens junction maintenance cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0035050 GO:0035050 embryonic heart tube development developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0035556 ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045199 GO:0045199 maintenance of epithelial cell apical/basal polarity cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045216 GO:0045216 cell-cell junction organization cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0045217 GO:0045217 cell-cell junction maintenance cell organization and biogenesis P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0048546 GO:0048546 digestive tract morphogenesis developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0048699 GO:0048699 generation of neurons developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0060041 GO:0060041 retina development in camera-type eye developmental processes P ConsensusfromContig3621 sp Q90XF2 KPCI_DANRE 89.62 106 10 1 3 317 217 322 2E-58 194 Q90XF2 KPCI_DANRE GO:0005524; GO:0034334; GO:0045217; GO:0005829; GO:0007502; GO:0048546; GO:0021744; GO:0035050; GO:0000132; GO:0016332; GO:0035556; GO:0031226; GO:0045199; GO:0008078; GO:0001738; GO:0001841; GO:0007405; GO:0007097; GO:0005634; GO:0042476; GO:0005543; GO:0004697; GO:0004674; GO:0060042; GO:0008270; GO:0005915 ATP binding; adherens junction maintenance; cell-cell junction maintenance; cytosol; digestive tract mesoderm development; digestive tract morphogenesis; dorsal motor nucleus of vagus nerve development; embryonic heart tube development; establishment of mitotic spindle orientation; establishment or maintenance of polarity of embryonic epithelium; intracellular signal transduction; intrinsic to plasma membrane; maintenance of epithelial cell apical/basal polarity; mesodermal cell migration; morphogenesis of a polarized epithelium; neural tube formation; neuroblast proliferation; nuclear migration; nucleus; odontogenesis; phospholipid binding; protein kinase C activity; protein serine/threonine kinase activity; retina morphogenesis in camera-type eye; zinc ion binding; zonula adherens reviewed IPR000961; IPR020454; IPR011009; IPR000270; IPR012233; IPR017892; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (aPKC-lambda/iota) (Heart and soul protein) (nPKC-iota) prkci hal Danio rerio (Zebrafish) (Brachydanio rerio) 588 Q90XF2 GO:0060042 GO:0060042 retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0004825 GO:0004825 methionine-tRNA ligase activity other molecular function F ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0006431 GO:0006431 methionyl-tRNA aminoacylation protein metabolism P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0006431 GO:0006431 methionyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig2856 sp Q90YI3 SYMM_TAKRU 65.22 138 48 0 1 414 430 567 1E-62 207 Q90YI3 SYMM_TAKRU GO:0005524; GO:0004825; GO:0006431; GO:0005759 ATP binding; methionine-tRNA ligase activity; methionyl-tRNA aminoacylation; mitochondrial matrix reviewed IPR014758; IPR015413; IPR014729; IPR009080; Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS) mars2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 590 Q90YI3 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig1019 sp Q90YT3 RL35A_ICTPU 90.91 110 10 0 379 50 1 110 1E-68 209 Q90YT3 RL35A_ICTPU GO:0005840; GO:0003735; GO:0000049; GO:0006412 ribosome; structural constituent of ribosome; tRNA binding; translation reviewed IPR001780; IPR018266; IPR009000; 60S ribosomal protein L35a rpl35a Ictalurus punctatus (Channel catfish) (Silurus punctatus) 110 Q90YT3 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig3195 sp Q90Z08 U119B_DANRE 74.22 128 32 1 393 13 1 128 3E-60 192 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3195 sp Q90Z08 U119B_DANRE 74.22 128 32 1 393 13 1 128 3E-60 192 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig3195 sp Q90Z08 U119B_DANRE 74.22 128 32 1 393 13 1 128 3E-60 192 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig719 sp Q90Z08 U119B_DANRE 77.08 192 41 1 2 568 22 213 4E-105 308 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig719 sp Q90Z08 U119B_DANRE 77.08 192 41 1 2 568 22 213 4E-105 308 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig719 sp Q90Z08 U119B_DANRE 77.08 192 41 1 2 568 22 213 4E-105 308 Q90Z08 U119B_DANRE GO:0070121; GO:0005929; GO:0060271; GO:0008289; GO:0007399; GO:0015031 Kupffer's vesicle development; cilium; cilium morphogenesis; lipid binding; nervous system development; protein transport reviewed IPR008015; IPR014756; Protein unc-119 homolog B (Protein unc-119 homolog 1) unc119b unc119 unc119.1 unc119c si:dkey-117k10 Danio rerio (Zebrafish) (Brachydanio rerio) 243 Q90Z08 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0006694 GO:0006694 steroid biosynthetic process other metabolic processes P ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0006869 GO:0006869 lipid transport transport P ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0015485 GO:0015485 cholesterol binding other molecular function F ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0017127 GO:0017127 cholesterol transporter activity transporter activity F ConsensusfromContig2740 sp Q90ZB9 STAR3_SALFO 90.91 99 9 0 3 299 195 293 1E-62 201 Q90ZB9 STAR3_SALFO GO:0015485; GO:0030301; GO:0017127; GO:0006694 cholesterol binding; cholesterol transport; cholesterol transporter activity; steroid biosynthetic process reviewed IPR019498; IPR000799; IPR023393; IPR002913; StAR-related lipid transfer protein 3 (MLN64-like protein) (START domain-containing protein 3) (StARD3) (Fragment) stard3 mln64 Salvelinus fontinalis (Brook trout) (Salmo fontinalis) 294 Q90ZB9 GO:0030301 GO:0030301 cholesterol transport transport P ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0007155 GO:0007155 cell adhesion cell adhesion P ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig216 sp Q91048 PTK7_CHICK 68.35 218 61 4 3 638 570 785 2E-86 281 Q91048 PTK7_CHICK GO:0005524; GO:0016055; GO:0007155; GO:0016021; GO:0018108; GO:0004713 ATP binding; Wnt receptor signaling pathway; cell adhesion; integral to membrane; peptidyl-tyrosine phosphorylation; protein tyrosine kinase activity reviewed IPR007110; IPR013783; IPR013098; IPR003599; IPR003598; IPR011009; IPR000719; IPR001245; IPR008266; IPR020635; Inactive tyrosine-protein kinase 7 (Kinase-like protein) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7) PTK7 KLG Gallus gallus (Chicken) 1051 Q91048 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5669 sp Q91195 CYT_ONCMY 65.35 127 44 0 41 421 3 129 6E-52 168 Q91195 CYT_ONCMY GO:0004869; GO:0005576 cysteine-type endopeptidase inhibitor activity; extracellular region reviewed IPR027214; IPR000010; IPR018073; Cystatin Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 130 Q91195 GO:0004869 GO:0004869 cysteine-type endopeptidase inhibitor activity enzyme regulator activity F ConsensusfromContig5669 sp Q91195 CYT_ONCMY 65.35 127 44 0 41 421 3 129 6E-52 168 Q91195 CYT_ONCMY GO:0004869; GO:0005576 cysteine-type endopeptidase inhibitor activity; extracellular region reviewed IPR027214; IPR000010; IPR018073; Cystatin Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 130 Q91195 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5669 sp Q91195 CYT_ONCMY 65.35 127 44 0 41 421 3 129 6E-52 168 Q91195 CYT_ONCMY GO:0004869; GO:0005576 cysteine-type endopeptidase inhibitor activity; extracellular region reviewed IPR027214; IPR000010; IPR018073; Cystatin Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 130 Q91195 GO:0010466 GO:0010466 negative regulation of peptidase activity other biological processes P ConsensusfromContig5669 sp Q91195 CYT_ONCMY 65.35 127 44 0 41 421 3 129 6E-52 168 Q91195 CYT_ONCMY GO:0004869; GO:0005576 cysteine-type endopeptidase inhibitor activity; extracellular region reviewed IPR027214; IPR000010; IPR018073; Cystatin Oncorhynchus mykiss (Rainbow trout) (Salmo gairdneri) 130 Q91195 GO:0030414 GO:0030414 peptidase inhibitor activity enzyme regulator activity F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0003873 GO:0003873 6-phosphofructo-2-kinase activity kinase activity F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0004331 GO:0004331 "fructose-2,6-bisphosphate 2-phosphatase activity" other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0006000 GO:0006000 fructose metabolic process other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0006003 GO:0006003 "fructose 2,6-bisphosphate metabolic process" other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 81.82 275 50 0 536 1360 196 470 0 474 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0003873 GO:0003873 6-phosphofructo-2-kinase activity kinase activity F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0004331 GO:0004331 "fructose-2,6-bisphosphate 2-phosphatase activity" other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0006000 GO:0006000 fructose metabolic process other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0006003 GO:0006003 "fructose 2,6-bisphosphate metabolic process" other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6308 sp Q91309 F26_LITCT 72.5 160 43 1 43 519 31 190 0 252 Q91309 F26_LITCT GO:0003873; GO:0005524; GO:0006003; GO:0006000; GO:0004331 6-phosphofructo-2-kinase activity; ATP binding; fructose 2,6-bisphosphate metabolic process; fructose metabolic process; fructose-2,6-bisphosphate 2-phosphatase activity reviewed IPR003094; IPR013079; IPR016260; IPR013078; IPR027417; IPR001345; 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PF-2-K/Fru-2,6-P2ase) (PFK/FBPase) (6PF-2-K/Fru-2,6-P2ase liver/muscle isozymes) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)] Lithobates catesbeiana (American bullfrog) (Rana catesbeiana) 470 Q91309 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0004070 GO:0004070 aspartate carbamoyltransferase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0004088 GO:0004088 carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0004151 GO:0004151 dihydroorotase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0006207 GO:0006207 'de novo' pyrimidine base biosynthetic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0006221 GO:0006221 pyrimidine nucleotide biosynthetic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0006520 GO:0006520 cellular amino acid metabolic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0006543 GO:0006543 glutamine catabolic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0006807 GO:0006807 nitrogen compound metabolic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016597 GO:0016597 amino acid binding other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016743 GO:0016743 carboxyl- or carbamoyltransferase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016810 GO:0016810 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds" other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016812 GO:0016812 "hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides" other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5782 sp Q91437 PYR1_SQUAC 75.57 741 167 6 3 2204 1508 2241 0 1113 Q91437 PYR1_SQUAC GO:0044205; GO:0006207; GO:0005524; GO:0016597; GO:0004070; GO:0070409; GO:0004088; GO:0005737; GO:0004151; GO:0006543; GO:0046872 'de novo' UMP biosynthetic process; 'de novo' pyrimidine nucleobase biosynthetic process; ATP binding; amino acid binding; aspartate carbamoyltransferase activity; carbamoyl phosphate biosynthetic process; carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity; cytoplasm; dihydroorotase activity; glutamine catabolic process; metal ion binding reviewed IPR006680; IPR006132; IPR006130; IPR002082; IPR006131; IPR011761; IPR013815; IPR013816; IPR006275; IPR005481; IPR005480; IPR006274; IPR002474; IPR005479; IPR005483; IPR002195; IPR017926; IPR011059; IPR011607; IPR016185; Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 1/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 2/3. Pyrimidine metabolism; UMP biosynthesis via de novo pathway; (S)-dihydroorotate from bicarbonate: step 3/3. CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)] CAD Squalus acanthias (Spiny dogfish) 2242 Q91437 GO:0070409 GO:0070409 carbamoyl phosphate biosynthetic process other metabolic processes P ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0003707 GO:0003707 steroid hormone receptor activity signal transduction activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0004879 GO:0004879 ligand-dependent nuclear receptor activity signal transduction activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0005496 GO:0005496 steroid binding other molecular function F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0030522 GO:0030522 intracellular receptor-mediated signaling pathway signal transduction P ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0043401 GO:0043401 steroid hormone mediated signaling signal transduction P ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig1586 sp Q91766 HNF4A_XENLA 76.92 117 27 0 13 363 230 346 3E-53 180 Q91766 HNF4A_XENLA GO:0005634; GO:0043565; GO:0003700; GO:0003707; GO:0006351; GO:0008270 nucleus; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; steroid hormone receptor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR008946; IPR000536; IPR000003; IPR001723; IPR001628; IPR013088; Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) hnf4a hnf4 nr2a1 Xenopus laevis (African clawed frog) 464 Q91766 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0005876 GO:0005876 spindle microtubule cytoskeleton C ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0018105 GO:0018105 peptidyl-serine phosphorylation protein metabolism P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0019894 GO:0019894 kinesin binding cytoskeletal activity F ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6091 sp Q91820 AURAA_XENLA 64.14 382 104 7 2096 960 53 404 8E-156 467 Q91820 AURAA_XENLA GO:0005524; GO:0051301; GO:0005813; GO:0005737; GO:0008017; GO:0018105; GO:0046777; GO:0004674; GO:0090307; GO:0005876; GO:0000922 ATP binding; cell division; centrosome; cytoplasm; microtubule binding; peptidyl-serine phosphorylation; protein autophosphorylation; protein serine/threonine kinase activity; spindle assembly involved in mitosis; spindle microtubule; spindle pole reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Aurora kinase A-A (EC 2.7.11.1) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (Serine/threonine-protein kinase 6-A) (Serine/threonine-protein kinase Eg2-A) (pEg2) (Serine/threonine-protein kinase aurora-A) (p46Eg265) aurka-a aurka eg2 stk6 Xenopus laevis (African clawed frog) 407 Q91820 GO:0090307 ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0007219 GO:0007219 Notch signaling pathway signal transduction P ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0007221 GO:0007221 positive regulation of transcription of Notch receptor target signal transduction P ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0007221 GO:0007221 positive regulation of transcription of Notch receptor target RNA metabolism P ConsensusfromContig3129 sp Q91880 SUH_XENLA 97.48 119 3 0 2 358 228 346 4E-80 251 Q91880 SUH_XENLA GO:0000978; GO:0000982; GO:0005737; GO:0007275; GO:0005634; GO:0007221 RNA polymerase II core promoter proximal region sequence-specific DNA binding; RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity; cytoplasm; multicellular organismal development; nucleus; positive regulation of transcription of Notch receptor target reviewed IPR015350; IPR013783; IPR014756; IPR002909; IPR015351; IPR008967; Suppressor of hairless protein homolog (X-Su(H)) rbpj rbpsuh suh Xenopus laevis (African clawed frog) 501 Q91880 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5662 sp Q91883 GRP78_XENLA 91.05 637 55 1 127 2031 3 639 0 1125 Q91883 GRP78_XENLA GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) hspa5 Xenopus laevis (African clawed frog) 658 Q91883 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5662 sp Q91883 GRP78_XENLA 91.05 637 55 1 127 2031 3 639 0 1125 Q91883 GRP78_XENLA GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) hspa5 Xenopus laevis (African clawed frog) 658 Q91883 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5662 sp Q91883 GRP78_XENLA 91.05 637 55 1 127 2031 3 639 0 1125 Q91883 GRP78_XENLA GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) hspa5 Xenopus laevis (African clawed frog) 658 Q91883 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5662 sp Q91883 GRP78_XENLA 91.05 637 55 1 127 2031 3 639 0 1125 Q91883 GRP78_XENLA GO:0005524; GO:0005788 ATP binding; endoplasmic reticulum lumen reviewed IPR018181; IPR013126; 78 kDa glucose-regulated protein (GRP-78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP) hspa5 Xenopus laevis (African clawed frog) 658 Q91883 GO:0005788 GO:0005788 endoplasmic reticulum lumen ER/Golgi C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0001702 GO:0001702 gastrulation with mouth forming second developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0001944 GO:0001944 vasculature development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0002076 GO:0002076 osteoblast development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0009952 GO:0009952 anterior/posterior pattern formation developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0015026 GO:0015026 coreceptor activity signal transduction activity F ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0017147 GO:0017147 Wnt-protein binding other molecular function F ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0030278 GO:0030278 regulation of ossification developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0033690 GO:0033690 positive regulation of osteoblast proliferation cell cycle and proliferation P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0035019 GO:0035019 somatic stem cell maintenance other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0035108 GO:0035108 limb morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0035426 ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0042074 GO:0042074 cell migration involved in gastrulation developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0042632 GO:0042632 cholesterol homeostasis other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0042813 GO:0042813 Wnt receptor activity signal transduction activity F ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0043235 GO:0043235 receptor complex other cellular component C ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0044332 ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0045598 GO:0045598 regulation of fat cell differentiation other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0046849 GO:0046849 bone remodeling other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0046850 GO:0046850 regulation of bone remodeling other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0048539 GO:0048539 bone marrow development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0048596 GO:0048596 embryonic camera-type eye morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0051091 GO:0051091 positive regulation of transcription factor activity RNA metabolism P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060033 GO:0060033 anatomical structure regression other biological processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060059 GO:0060059 embryonic retina morphogenesis in camera-type eye developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060070 GO:0060070 Wnt receptor signaling pathway through beta-catenin signal transduction P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060348 GO:0060348 bone development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060349 GO:0060349 bone morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060444 GO:0060444 branching involved in mammary gland duct morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060603 GO:0060603 mammary gland duct morphogenesis developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060612 GO:0060612 adipose tissue development developmental processes P ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060764 GO:0060764 developmental processes ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0060764 GO:0060764 cell-cell signaling ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0061178 ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0061299 ConsensusfromContig5838 sp Q91VN0 LRP5_MOUSE 29.15 494 320 12 2 1453 166 639 3E-55 210 Q91VN0 LRP5_MOUSE GO:0044332; GO:0042813; GO:0060612; GO:0060033; GO:0009952; GO:1902262; GO:0048539; GO:0060349; GO:0046849; GO:0060444; GO:0060070; GO:0042074; GO:0060764; GO:0042632; GO:0008203; GO:0015026; GO:0048596; GO:0042733; GO:0060059; GO:0006897; GO:0005783; GO:0035426; GO:0001702; GO:0016021; GO:0005739; GO:0002076; GO:0005886; GO:0033690; GO:0051091; GO:0045944; GO:0043235; GO:0042981; GO:0046850; GO:0045598; GO:0061178; GO:0030278; GO:0061304; GO:0035019 Wnt receptor signaling pathway involved in dorsal/ventral axis specification; Wnt-activated receptor activity; adipose tissue development; anatomical structure regression; anterior/posterior pattern specification; apoptotic process involved in patterning of blood vessels; bone marrow development; bone morphogenesis; bone remodeling; branching involved in mammary gland duct morphogenesis; canonical Wnt receptor signaling pathway; cell migration involved in gastrulation; cell-cell signaling involved in mammary gland development; cholesterol homeostasis; cholesterol metabolic process; coreceptor activity; embryonic camera-type eye morphogenesis; embryonic digit morphogenesis; embryonic retina morphogenesis in camera-type eye; endocytosis; endoplasmic reticulum; extracellular matrix-cell signaling; gastrulation with mouth forming second; integral to membrane; mitochondrion; osteoblast development; plasma membrane; positive regulation of osteoblast proliferation; positive regulation of sequence-specific DNA binding transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; receptor complex; regulation of apoptotic process; regulation of bone remodeling; regulation of fat cell differentiation; regulation of insulin secretion involved in cellular response to glucose stimulus; regulation of ossification; retinal blood vessel morphogenesis; somatic stem cell maintenance reviewed IPR011042; IPR000742; IPR023415; IPR000033; IPR002172; IPR017049; Low-density lipoprotein receptor-related protein 5 (LRP-5) (Low-density lipoprotein receptor-related protein 7) (LRP-7) (Lr3) Lrp5 Lrp7 Mus musculus (Mouse) 1614 Q91VN0 GO:0061304 ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005765 GO:0005765 lysosomal membrane other cytoplasmic organelle C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005765 GO:0005765 lysosomal membrane other membranes C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0005884 GO:0005884 actin filament cytoskeleton C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0031902 GO:0031902 late endosome membrane other cytoplasmic organelle C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0031902 GO:0031902 late endosome membrane other membranes C ConsensusfromContig2344 sp Q91W86 VPS11_MOUSE 83.89 149 24 0 447 1 317 465 9E-83 267 Q91W86 VPS11_MOUSE GO:0005884; GO:0005769; GO:0030139; GO:0006886; GO:0031902; GO:0005765; GO:0000166; GO:0016192; GO:0008270 Q9H9C1 actin filament; early endosome; endocytic vesicle; intracellular protein transport; late endosome membrane; lysosomal membrane; nucleotide binding; vesicle-mediated transport; zinc ion binding reviewed IPR016024; IPR000547; IPR016528; IPR024763; IPR015943; IPR017986; IPR001841; IPR013083; Vacuolar protein sorting-associated protein 11 homolog Vps11 Mus musculus (Mouse) 941 Q91W86 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1503 sp Q91WC7 NPAL2_MOUSE 62.07 232 87 1 21 716 50 280 9E-77 243 Q91WC7 NPAL2_MOUSE GO:0016021; GO:0015095 integral to membrane; magnesium ion transmembrane transporter activity reviewed IPR008521; NIPA-like protein 2 Nipal2 Npal2 Mus musculus (Mouse) 383 Q91WC7 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1503 sp Q91WC7 NPAL2_MOUSE 62.07 232 87 1 21 716 50 280 9E-77 243 Q91WC7 NPAL2_MOUSE GO:0016021; GO:0015095 integral to membrane; magnesium ion transmembrane transporter activity reviewed IPR008521; NIPA-like protein 2 Nipal2 Npal2 Mus musculus (Mouse) 383 Q91WC7 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1503 sp Q91WC7 NPAL2_MOUSE 62.07 232 87 1 21 716 50 280 9E-77 243 Q91WC7 NPAL2_MOUSE GO:0016021; GO:0015095 integral to membrane; magnesium ion transmembrane transporter activity reviewed IPR008521; NIPA-like protein 2 Nipal2 Npal2 Mus musculus (Mouse) 383 Q91WC7 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1503 sp Q91WC7 NPAL2_MOUSE 62.07 232 87 1 21 716 50 280 9E-77 243 Q91WC7 NPAL2_MOUSE GO:0016021; GO:0015095 integral to membrane; magnesium ion transmembrane transporter activity reviewed IPR008521; NIPA-like protein 2 Nipal2 Npal2 Mus musculus (Mouse) 383 Q91WC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1503 sp Q91WC7 NPAL2_MOUSE 62.07 232 87 1 21 716 50 280 9E-77 243 Q91WC7 NPAL2_MOUSE GO:0016021; GO:0015095 integral to membrane; magnesium ion transmembrane transporter activity reviewed IPR008521; NIPA-like protein 2 Nipal2 Npal2 Mus musculus (Mouse) 383 Q91WC7 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0000731 GO:0000731 DNA synthesis during DNA repair stress response P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0000731 GO:0000731 DNA synthesis during DNA repair DNA metabolism P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0030174 GO:0030174 regulation of DNA replication initiation DNA metabolism P ConsensusfromContig5540 sp Q91XU0 WRIP1_MOUSE 73.48 445 114 3 1614 286 213 655 0 656 Q91XU0 WRIP1_MOUSE GO:0005524; GO:0016887; GO:0003677; GO:0006260; GO:0000731; GO:0005739; GO:0005634; GO:0048471; GO:0030174 ATP binding; ATPase activity; DNA binding; DNA replication; DNA synthesis involved in DNA repair; mitochondrion; nucleus; perinuclear region of cytoplasm; regulation of DNA-dependent DNA replication initiation reviewed IPR003593; IPR003959; IPR008921; IPR021886; IPR027417; IPR006642; ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1) Wrnip1 Whip Mus musculus (Mouse) 660 Q91XU0 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig4697 sp Q91YE6 IPO9_MOUSE 86.87 99 13 0 297 1 521 619 6E-54 185 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig4229 sp Q91YE6 IPO9_MOUSE 85 140 21 0 473 54 661 800 2E-77 254 Q91YE6 IPO9_MOUSE GO:0008536; GO:0005737; GO:0042393; GO:0005634; GO:0050821; GO:0008565; GO:0006610; GO:0042254 Ran GTPase binding; cytoplasm; histone binding; nucleus; protein stabilization; protein transporter activity; ribosomal protein import into nucleus; ribosome biogenesis reviewed IPR011989; IPR016024; IPR001494; Importin-9 (Imp9) (Importin-9a) (Imp9a) (Importin-9b) (Imp9b) (Ran-binding protein 9) (RanBP9) Ipo9 Imp9 Ranbp9 Mus musculus (Mouse) 1041 Q91YE6 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0003954 GO:0003954 NADH dehydrogenase activity other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0005747 GO:0005747 mitochondrial respiratory chain complex I mitochondrion C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0005747 GO:0005747 mitochondrial respiratory chain complex I other membranes C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0008137 GO:0008137 NADH dehydrogenase (ubiquinone) activity other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0010181 GO:0010181 FMN binding other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0016651 GO:0016651 "oxidoreductase activity, acting on NADH or NADPH" other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0022900 GO:0022900 electron transport chain other metabolic processes P ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0051539 GO:0051539 "4 iron, 4 sulfur cluster binding" other molecular function F ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5536 sp Q91YT0 NDUV1_MOUSE 86.29 445 58 1 192 1526 18 459 0 780 Q91YT0 NDUV1_MOUSE GO:0051539; GO:0010181; GO:0051287; GO:0008137; GO:0046872; GO:0005743; GO:0005747 4 iron, 4 sulfur cluster binding; FMN binding; NAD binding; NADH dehydrogenase (ubiquinone) activity; metal ion binding; mitochondrial inner membrane; mitochondrial respiratory chain complex I reviewed IPR001949; IPR019575; IPR011537; IPR011538; IPR019554; NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH-ubiquinone oxidoreductase 51 kDa subunit) Ndufv1 Mus musculus (Mouse) 464 Q91YT0 GO:0070469 GO:0070469 respiratory chain other membranes C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0005741 GO:0005741 mitochondrial outer membrane mitochondrion C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0005741 GO:0005741 mitochondrial outer membrane other membranes C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0006914 GO:0006914 autophagy other metabolic processes P ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1325 sp Q91YT2 RN185_MOUSE 87.88 99 9 1 290 3 14 112 1E-56 182 Q91YT2 RN185_MOUSE GO:0006914; GO:0016021; GO:0016874; GO:0005741; GO:0016567; GO:0008270 autophagy; integral to membrane; ligase activity; mitochondrial outer membrane; protein ubiquitination; zinc ion binding reviewed IPR001841; IPR013083; IPR017907; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF185 (EC 6.3.2.-) (RING finger protein 185) Rnf185 Mus musculus (Mouse) 192 Q91YT2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0003746 GO:0003746 translation elongation factor activity nucleic acid binding activity F ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig6102 sp Q92005 EF1A_DANRE 92.87 449 32 0 1916 570 1 449 0 868 Q92005 EF1A_DANRE GO:0005525; GO:0006184; GO:0003924; GO:0005737; GO:0003746 GTP binding; GTP catabolic process; GTPase activity; cytoplasm; translation elongation factor activity reviewed IPR000795; IPR027417; IPR009000; IPR009001; IPR004539; IPR004161; IPR004160; Elongation factor 1-alpha (EF-1-alpha) eef1a ef1a Danio rerio (Zebrafish) (Brachydanio rerio) 462 Q92005 GO:0006414 GO:0006414 translational elongation protein metabolism P ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0004768 GO:0004768 stearoyl-CoA 9-desaturase activity other molecular function F ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0016717 GO:0016717 "oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water" other molecular function F ConsensusfromContig5638 sp Q92038 ACOD_CYPCA 79.31 232 47 1 67 759 96 327 1E-126 381 Q92038 ACOD_CYPCA GO:0005789; GO:0006633; GO:0016021; GO:0005506; GO:0006950; GO:0004768 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; iron ion binding; response to stress; stearoyl-CoA 9-desaturase activity reviewed IPR005804; IPR001522; IPR015876; Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) Cyprinus carpio (Common carp) 327 Q92038 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0003886 GO:0003886 DNA (cytosine-5-)-methyltransferase activity other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0006306 GO:0006306 DNA methylation DNA metabolism P ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0008134 GO:0008134 transcription factor binding other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5523 sp Q92072 DNMT1_CHICK 84.48 290 45 0 1 870 1244 1533 2E-173 529 Q92072 DNMT1_CHICK GO:0003886; GO:0003677; GO:0005634; GO:0006355; GO:0006351; GO:0008270 DNA (cytosine-5-)-methyltransferase activity; DNA binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR001025; IPR018117; IPR001525; IPR022702; IPR010506; IPR017198; IPR002857; DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (DNA methyltransferase GgaI) (DNA MTase GgaI) (M.GgaI) (MCMT) DNMT1 AIM DNMT Gallus gallus (Chicken) 1537 Q92072 GO:0090116 ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0000185 GO:0000185 activation of MAPKKK activity signal transduction P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0000185 GO:0000185 activation of MAPKKK activity other metabolic processes P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0042981 GO:0042981 regulation of apoptosis death P ConsensusfromContig3146 sp Q922B6 TRAF7_MOUSE 98.96 96 1 0 289 2 260 355 9E-62 203 Q922B6 TRAF7_MOUSE GO:0000185; GO:0016023; GO:0097194; GO:0005886; GO:0043410; GO:0006355; GO:0006351; GO:0000151; GO:0004842; GO:0008270 activation of MAPKKK activity; cytoplasmic membrane-bounded vesicle; execution phase of apoptosis; plasma membrane; positive regulation of MAPK cascade; regulation of transcription, DNA-dependent; transcription, DNA-dependent; ubiquitin ligase complex; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR020472; IPR013323; IPR008974; IPR015943; IPR001680; IPR019775; IPR017986; IPR001841; IPR013083; IPR017907; IPR001293; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase TRAF7 (EC 6.3.2.-) (TNF receptor-associated factor 7) Traf7 Mus musculus (Mouse) 594 Q922B6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0001666 GO:0001666 response to hypoxia stress response P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0003727 GO:0003727 single-stranded RNA binding nucleic acid binding activity F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0004176 GO:0004176 ATP-dependent peptidase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0006515 GO:0006515 misfolded or incompletely synthesized protein catabolic process protein metabolism P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0007005 GO:0007005 mitochondrion organization cell organization and biogenesis P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0007568 GO:0007568 aging other biological processes P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0009725 GO:0009725 response to hormone stimulus other biological processes P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0010044 GO:0010044 response to aluminum ion other biological processes P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0034599 GO:0034599 cellular response to oxidative stress stress response P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0042645 GO:0042645 mitochondrial nucleoid mitochondrion C ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0043623 GO:0043623 cellular protein complex assembly cell organization and biogenesis P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0070361 GO:0070361 mitochondrial light strand promoter anti-sense binding nucleic acid binding activity F ConsensusfromContig1599 sp Q924S5 LONM_RAT 79.48 307 62 1 1 921 633 938 5E-174 515 Q924S5 LONM_RAT GO:0043531; GO:0005524; GO:0004176; GO:0051880; GO:0007568; GO:0043623; GO:0034599; GO:0051131; GO:0006515; GO:0070362; GO:0070361; GO:0042645; GO:0007005; GO:0070407; GO:0051260; GO:0090296; GO:0010044; GO:0009725; GO:0001666; GO:0043565; GO:0004252; GO:0003697; GO:0003727 ADP binding; ATP binding; ATP-dependent peptidase activity; G-quadruplex DNA binding; aging; cellular protein complex assembly; cellular response to oxidative stress; chaperone-mediated protein complex assembly; misfolded or incompletely synthesized protein catabolic process; mitochondrial heavy strand promoter anti-sense binding; mitochondrial light strand promoter anti-sense binding; mitochondrial nucleoid; mitochondrion organization; oxidation-dependent protein catabolic process; protein homooligomerization; regulation of mitochondrial DNA replication; response to aluminum ion; response to hormone stimulus; response to hypoxia; sequence-specific DNA binding; serine-type endopeptidase activity; single-stranded DNA binding; single-stranded RNA binding reviewed IPR003593; IPR003959; IPR004815; IPR027065; IPR027503; IPR027417; IPR008269; IPR003111; IPR008268; IPR015947; IPR020568; IPR014721; Lon protease homolog, mitochondrial (EC 3.4.21.-) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15) Lonp1 Lon Prss15 Rattus norvegicus (Rat) 950 Q924S5 GO:0070407 GO:0070407 oxidation-dependent protein catabolic process protein metabolism P ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0000832 GO:0000832 inositol hexakisphosphate 5-kinase activity kinase activity F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0008440 GO:0008440 inositol trisphosphate 3-kinase activity kinase activity F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0046854 GO:0046854 phosphoinositide phosphorylation other metabolic processes P ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0052723 ConsensusfromContig3204 sp Q92551 IP6K1_HUMAN 84.16 101 16 0 23 325 247 347 2E-52 177 Q92551 IP6K1_HUMAN GO:0005524; GO:0005829; GO:0052723; GO:0052724; GO:0000832; GO:0043647; GO:0008440; GO:0005730; GO:0005654; GO:0046854 ATP binding; cytosol; inositol hexakisphosphate 1-kinase activity; inositol hexakisphosphate 3-kinase activity; inositol hexakisphosphate 5-kinase activity; inositol phosphate metabolic process; inositol-1,4,5-trisphosphate 3-kinase activity; nucleolus; nucleoplasm; phosphatidylinositol phosphorylation reviewed IPR005522; Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1) IP6K1 IHPK1 KIAA0263 Homo sapiens (Human) 441 Q92551 GO:0052724 ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006909 GO:0006909 phagocytosis transport P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006909 GO:0006909 phagocytosis cell organization and biogenesis P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006911 GO:0006911 "phagocytosis, engulfment" transport P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006911 GO:0006911 "phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016601 GO:0016601 Rac protein signal transduction signal transduction P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0030029 GO:0030029 actin filament-based process other biological processes P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig3763 sp Q92556 ELMO1_HUMAN 80.6 134 17 2 40 429 54 182 1E-61 207 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0050690 GO:0050690 regulation of defense response to virus by virus stress response P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006909 GO:0006909 phagocytosis transport P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006909 GO:0006909 phagocytosis cell organization and biogenesis P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006911 GO:0006911 "phagocytosis, engulfment" transport P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006911 GO:0006911 "phagocytosis, engulfment" cell organization and biogenesis P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0006928 GO:0006928 cell motion other biological processes P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0016601 GO:0016601 Rac protein signal transduction signal transduction P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0017124 GO:0017124 SH3 domain binding other molecular function F ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0030029 GO:0030029 actin filament-based process other biological processes P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig1563 sp Q92556 ELMO1_HUMAN 89.45 218 22 1 651 1 269 486 4E-140 416 Q92556 ELMO1_HUMAN GO:0038096; GO:0016601; GO:0030036; GO:0006915; GO:0006928; GO:0005856; GO:0005829; GO:0045087; GO:0006911; GO:0005543; GO:0005886; GO:0050690; GO:0016032 Q14185; P08631; P84095 Fc-gamma receptor signaling pathway involved in phagocytosis; Rac protein signal transduction; actin cytoskeleton organization; apoptotic process; cellular component movement; cytoskeleton; cytosol; innate immune response; phagocytosis, engulfment; phospholipid binding; plasma membrane; regulation of defense response to virus by virus; viral process reviewed IPR011989; IPR016024; IPR024574; IPR006816; IPR011993; IPR001849; Engulfment and cell motility protein 1 (Protein ced-12 homolog) ELMO1 KIAA0281 Homo sapiens (Human) 727 Q92556 GO:0050690 GO:0050690 regulation of defense response to virus by virus stress response P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0007033 GO:0007033 vacuole organization cell organization and biogenesis P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0007626 GO:0007626 locomotory behavior other biological processes P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0008219 GO:0008219 cell death death P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0010976 GO:0010976 positive regulation of neuron projection development developmental processes P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0010976 GO:0010976 positive regulation of neuron projection development cell organization and biogenesis P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0042578 GO:0042578 phosphoric ester hydrolase activity other molecular function F ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0043473 GO:0043473 pigmentation other biological processes P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0046488 GO:0046488 phosphatidylinositol metabolic process other metabolic processes P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0048666 GO:0048666 neuron development developmental processes P ConsensusfromContig4612 sp Q92562 FIG4_HUMAN 79.65 113 22 1 341 3 325 436 1E-53 184 Q92562 FIG4_HUMAN GO:0000139; GO:0008219; GO:0031901; GO:0031902; GO:0007626; GO:0032288; GO:0031642; GO:0048666; GO:0043813; GO:0004438; GO:0043812; GO:0043473; GO:0010976; GO:0044281; GO:0007033 Golgi membrane; cell death; early endosome membrane; late endosome membrane; locomotory behavior; myelin assembly; negative regulation of myelination; neuron development; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity; phosphatidylinositol-3-phosphatase activity; phosphatidylinositol-4-phosphate phosphatase activity; pigmentation; positive regulation of neuron projection development; small molecule metabolic process; vacuole organization reviewed IPR002013; Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) FIG4 KIAA0274 SAC3 Homo sapiens (Human) 907 Q92562 GO:0055037 GO:0055037 recycling endosome other cytoplasmic organelle C ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0005942 GO:0005942 phosphoinositide 3-kinase complex cytosol C ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0016303 GO:0016303 1-phosphatidylinositol-3-kinase activity kinase activity F ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0030168 GO:0030168 platelet activation stress response P ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0031295 GO:0031295 T cell costimulation other biological processes P ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0035014 GO:0035014 phosphoinositide 3-kinase regulator activity enzyme regulator activity F ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0042325 GO:0042325 regulation of phosphorylation other metabolic processes P ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0046935 GO:0046935 1-phosphatidylinositol-3-kinase regulator activity enzyme regulator activity F ConsensusfromContig3334 sp Q92569 P55G_HUMAN 88.39 112 12 1 337 2 214 324 3E-61 201 Q92569 P55G_HUMAN GO:0016303; GO:0005829; GO:0008286; GO:0005942; GO:0035014; GO:0043551; GO:0044281 Q8IZP0; P00533; P04626; P21860 1-phosphatidylinositol-3-kinase activity; cytosol; insulin receptor signaling pathway; phosphatidylinositol 3-kinase complex; phosphatidylinositol 3-kinase regulator activity; regulation of phosphatidylinositol 3-kinase activity; small molecule metabolic process reviewed IPR001720; IPR000980; Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK) PIK3R3 Homo sapiens (Human) 461 Q92569 GO:0050790 GO:0050790 regulation of catalytic activity other biological processes P ConsensusfromContig665 sp Q92615 LAR4B_HUMAN 77.07 157 36 0 112 582 151 307 2E-81 263 Q92615 LAR4B_HUMAN GO:0003723; GO:0010494; GO:0005829; GO:0042788; GO:0045727 RNA binding; cytoplasmic stress granule; cytosol; polysomal ribosome; positive regulation of translation reviewed IPR006630; IPR000504; IPR011991; La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5) LARP4B KIAA0217 LARP5 Homo sapiens (Human) 738 Q92615 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig665 sp Q92615 LAR4B_HUMAN 77.07 157 36 0 112 582 151 307 2E-81 263 Q92615 LAR4B_HUMAN GO:0003723; GO:0010494; GO:0005829; GO:0042788; GO:0045727 RNA binding; cytoplasmic stress granule; cytosol; polysomal ribosome; positive regulation of translation reviewed IPR006630; IPR000504; IPR011991; La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5) LARP4B KIAA0217 LARP5 Homo sapiens (Human) 738 Q92615 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig665 sp Q92615 LAR4B_HUMAN 77.07 157 36 0 112 582 151 307 2E-81 263 Q92615 LAR4B_HUMAN GO:0003723; GO:0010494; GO:0005829; GO:0042788; GO:0045727 RNA binding; cytoplasmic stress granule; cytosol; polysomal ribosome; positive regulation of translation reviewed IPR006630; IPR000504; IPR011991; La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5) LARP4B KIAA0217 LARP5 Homo sapiens (Human) 738 Q92615 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0006369 GO:0006369 termination of RNA polymerase II transcription RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0006369 GO:0006369 termination of RNA polymerase II transcription cell organization and biogenesis P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0006406 GO:0006406 mRNA export from nucleus transport P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0031124 GO:0031124 mRNA 3'-end processing RNA metabolism P ConsensusfromContig72 sp Q92620 PRP16_HUMAN 86.79 159 21 0 60 536 328 486 3E-91 294 Q92620 PRP16_HUMAN GO:0005524; GO:0008026; GO:0071013; GO:0031124; GO:0006406; GO:0000398; GO:0003676; GO:0005654; GO:0006369 O60231; Q92917; P98175 ATP binding; ATP-dependent helicase activity; catalytic step 2 spliceosome; mRNA 3'-end processing; mRNA export from nucleus; mRNA splicing, via spliceosome; nucleic acid binding; nucleoplasm; termination of RNA polymerase II transcription reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38) DHX38 DDX38 KIAA0224 PRP16 Homo sapiens (Human) 1227 Q92620 GO:0071013 GO:0071013 nucleus ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0044281 ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig2777 sp Q92621 NU205_HUMAN 74.58 118 30 0 356 3 1029 1146 2E-54 189 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0044281 ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig2481 sp Q92621 NU205_HUMAN 79.65 113 23 0 1 339 637 749 9E-55 191 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0044281 ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 58.72 390 156 4 571 1734 1539 1925 0 473 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0044281 ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 68.21 173 51 1 59 577 1372 1540 0 248 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0000059 GO:0000059 "protein import into nucleus, docking" cell organization and biogenesis P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005635 GO:0005635 nuclear envelope nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0006913 GO:0006913 nucleocytoplasmic transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0008645 GO:0008645 hexose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0010827 GO:0010827 regulation of glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0015758 GO:0015758 glucose transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0019221 GO:0019221 cytokine-mediated signaling pathway signal transduction P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0044281 ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig5752 sp Q92621 NU205_HUMAN 91.3 23 2 0 4 72 1330 1352 0 45.1 Q92621 NU205_HUMAN GO:0005975; GO:0019221; GO:0015758; GO:0051028; GO:0007077; GO:0031965; GO:0034399; GO:0005643; GO:0051292; GO:0000059; GO:0010827; GO:0044281; GO:0017056; GO:0055085; GO:0016032 carbohydrate metabolic process; cytokine-mediated signaling pathway; glucose transport; mRNA transport; mitotic nuclear envelope disassembly; nuclear membrane; nuclear periphery; nuclear pore; nuclear pore complex assembly; protein import into nucleus, docking; regulation of glucose transport; small molecule metabolic process; structural constituent of nuclear pore; transmembrane transport; viral process reviewed IPR021827; Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205) NUP205 C7orf14 KIAA0225 Homo sapiens (Human) 2012 Q92621 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0005070 GO:0005070 SH3/SH2 adaptor activity signal transduction activity F ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0007173 GO:0007173 epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0016044 GO:0016044 membrane organization cell organization and biogenesis P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0016197 GO:0016197 endosome transport transport P ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig1517 sp Q92783 STAM1_HUMAN 84.08 157 16 2 451 8 46 202 4E-88 273 Q92783 STAM1_HUMAN GO:0005070; GO:0005829; GO:0031901; GO:0016197; GO:0007173; GO:0006886; GO:0042059 Q13094; O95630; P0CG53; P0CG48 SH3/SH2 adaptor activity; cytosol; early endosome membrane; endosomal transport; epidermal growth factor receptor signaling pathway; intracellular protein transport; negative regulation of epidermal growth factor receptor signaling pathway reviewed IPR008942; IPR000108; IPR001452; IPR003903; IPR002014; IPR018205; Signal transducing adapter molecule 1 (STAM-1) STAM STAM1 Homo sapiens (Human) 540 Q92783 GO:0042059 GO:0042059 negative regulation of epidermal growth factor receptor signaling pathway signal transduction P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000014 GO:0000014 single-stranded DNA specific endodeoxyribonuclease activity other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000109 GO:0000109 nucleotide-excision repair complex nucleus C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000110 GO:0000110 nucleotide-excision repair factor 1 complex nucleus C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair cell cycle and proliferation P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants cell cycle and proliferation P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000784 GO:0000784 "nuclear chromosome, telomeric region" nucleus C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003684 GO:0003684 damaged DNA binding nucleic acid binding activity F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004520 GO:0004520 endodeoxyribonuclease activity other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006259 GO:0006259 DNA metabolic process DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009650 GO:0009650 UV protection other biological processes P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening cell organization and biogenesis P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance cell organization and biogenesis P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0043566 GO:0043566 structure-specific DNA binding nucleic acid binding activity F ConsensusfromContig2296 sp Q92889 XPF_HUMAN 87.5 104 13 0 313 2 546 649 3E-55 190 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000014 GO:0000014 single-stranded DNA specific endodeoxyribonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000109 GO:0000109 nucleotide-excision repair complex nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000110 GO:0000110 nucleotide-excision repair factor 1 complex nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair cell cycle and proliferation P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants cell cycle and proliferation P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000784 GO:0000784 "nuclear chromosome, telomeric region" nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003684 GO:0003684 damaged DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004520 GO:0004520 endodeoxyribonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006259 GO:0006259 DNA metabolic process DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009650 GO:0009650 UV protection other biological processes P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0043566 GO:0043566 structure-specific DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 61.93 176 65 2 165 689 742 916 5E-64 200 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000014 GO:0000014 single-stranded DNA specific endodeoxyribonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000109 GO:0000109 nucleotide-excision repair complex nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000110 GO:0000110 nucleotide-excision repair factor 1 complex nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair cell cycle and proliferation P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000710 GO:0000710 meiotic mismatch repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants cell cycle and proliferation P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000712 GO:0000712 resolution of meiotic joint molecules as recombinants DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000718 GO:0000718 "nucleotide-excision repair, DNA damage removal" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000723 GO:0000723 telomere maintenance cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000724 GO:0000724 double-strand break repair via homologous recombination DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000781 GO:0000781 "chromosome, telomeric region" other cellular component C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0000784 GO:0000784 "nuclear chromosome, telomeric region" nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003684 GO:0003684 damaged DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0004520 GO:0004520 endodeoxyribonuclease activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006259 GO:0006259 DNA metabolic process DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006283 GO:0006283 transcription-coupled nucleotide-excision repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006289 GO:0006289 nucleotide-excision repair DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006295 GO:0006295 "nucleotide-excision repair, DNA incision, 3'-to lesion" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006296 GO:0006296 "nucleotide-excision repair, DNA incision, 5'-to lesion" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0008022 GO:0008022 protein C-terminus binding other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0009650 GO:0009650 UV protection other biological processes P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0010834 GO:0010834 telomere maintenance via telomere shortening cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0032205 GO:0032205 negative regulation of telomere maintenance cell organization and biogenesis P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" stress response P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0033683 GO:0033683 "nucleotide-excision repair, DNA incision" DNA metabolism P ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0043566 GO:0043566 structure-specific DNA binding nucleic acid binding activity F ConsensusfromContig5707 sp Q92889 XPF_HUMAN 70.83 48 13 1 19 162 694 740 5E-64 67 Q92889 XPF_HUMAN GO:0009650; GO:0003684; GO:0000724; GO:0000710; GO:0032205; GO:0000784; GO:0005654; GO:0000110; GO:0000718; GO:0006295; GO:0006296; GO:0000712; GO:0009411; GO:0003697; GO:0000014; GO:0010834; GO:0005669; GO:0006283 Q8IY92 UV protection; damaged DNA binding; double-strand break repair via homologous recombination; meiotic mismatch repair; negative regulation of telomere maintenance; nuclear chromosome, telomeric region; nucleoplasm; nucleotide-excision repair factor 1 complex; nucleotide-excision repair, DNA damage removal; nucleotide-excision repair, DNA incision, 3'-to lesion; nucleotide-excision repair, DNA incision, 5'-to lesion; resolution of meiotic recombination intermediates; response to UV; single-stranded DNA binding; single-stranded DNA endodeoxyribonuclease activity; telomere maintenance via telomere shortening; transcription factor TFIID complex; transcription-coupled nucleotide-excision repair reviewed IPR020819; IPR006166; IPR006167; IPR011335; IPR010994; DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein) ERCC4 ERCC11 XPF Homo sapiens (Human) 916 Q92889 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0001741 GO:0001741 XY body nucleus C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0006337 GO:0006337 nucleosome disassembly cell organization and biogenesis P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0016514 GO:0016514 SWI/SNF complex nucleus C ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0047485 GO:0047485 protein N-terminus binding other molecular function F ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0071564 ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0071565 ConsensusfromContig1003 sp Q92922 SMRC1_HUMAN 82.02 178 29 2 648 124 572 749 2E-74 248 Q92922 SMRC1_HUMAN GO:0003677; GO:0016514; GO:0071778; GO:0001741; GO:0003682; GO:0006338; GO:0008286; GO:0071565; GO:0007399; GO:0071564; GO:0006337; GO:0009887; GO:0045944; GO:0045893; GO:0006357; GO:0003713; GO:0006351 P51532; Q96GM5 DNA binding; SWI/SNF complex; WINAC complex; XY body; chromatin binding; chromatin remodeling; insulin receptor signaling pathway; nBAF complex; nervous system development; npBAF complex; nucleosome disassembly; organ morphogenesis; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transcription, DNA-dependent; regulation of transcription from RNA polymerase II promoter; transcription coactivator activity; transcription, DNA-dependent reviewed IPR001357; IPR000953; IPR009057; IPR001005; IPR017884; IPR007526; IPR011991; SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1) SMARCC1 BAF155 Homo sapiens (Human) 1105 Q92922 GO:0071778 ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response signal transduction P ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response stress response P ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0006987 GO:0006987 activation of signaling protein activity involved in unfolded protein response other metabolic processes P ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0016888 GO:0016888 "endodeoxyribonuclease activity, producing 5'-phosphomonoesters" other molecular function F ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response signal transduction P ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0030968 GO:0030968 endoplasmic reticulum unfolded protein response stress response P ConsensusfromContig3224 sp Q93075 TATD2_HUMAN 59.86 147 56 2 439 2 560 704 5E-53 183 Q93075 TATD2_HUMAN GO:0006987; GO:0044267; GO:0016888; GO:0046872; GO:0090305; GO:0005654 activation of signaling protein activity involved in unfolded protein response; cellular protein metabolic process; endodeoxyribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleic acid phosphodiester bond hydrolysis; nucleoplasm reviewed IPR018228; IPR001130; Putative deoxyribonuclease TATDN2 (EC 3.1.21.-) TATDN2 KIAA0218 Homo sapiens (Human) 761 Q93075 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0000226 GO:0000226 microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig2783 sp Q95K09 GCP5_MACFA 87.59 137 17 0 628 218 588 724 1E-80 261 Q95K09 GCP5_MACFA GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 5 (GCP-5) (Fragment) TUBGCP5 GCP5 QtsA-11379 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 725 Q95K09 GO:0008274 GO:0008274 gamma-tubulin ring complex cytoskeleton C ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5910 sp Q95KK4 SSBP_RABIT 73.33 150 36 2 334 780 1 147 1E-67 223 Q95KK4 SSBP_RABIT GO:0006260; GO:0003682; GO:0042645; GO:0003697 DNA replication; chromatin binding; mitochondrial nucleoid; single-stranded DNA binding reviewed IPR012340; IPR000424; IPR011344; Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) SSBP1 SSB Oryctolagus cuniculus (Rabbit) 148 Q95KK4 GO:0042645 GO:0042645 mitochondrial nucleoid mitochondrion C ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig5671 sp Q95M12 LGMN_BOVIN 60.07 278 107 3 1664 831 157 430 8E-113 351 Q95M12 LGMN_BOVIN GO:0045177; GO:0004197; GO:0005770; GO:0005764; GO:1901185; GO:0040015; GO:0043524; GO:0051603; GO:0032801; GO:0003014; GO:0001101 apical part of cell; cysteine-type endopeptidase activity; late endosome; lysosome; negative regulation of ERBB signaling pathway; negative regulation of multicellular organism growth; negative regulation of neuron apoptotic process; proteolysis involved in cellular protein catabolic process; receptor catabolic process; renal system process; response to acid reviewed IPR001096; Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1) LGMN PRSC1 Bos taurus (Bovine) 433 Q95M12 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig630 sp Q96A49 SYAP1_HUMAN 81.65 158 29 0 5 478 55 212 6E-81 251 Q96A49 SYAP1_HUMAN GO:0005634 nucleus reviewed IPR005607; Synapse-associated protein 1 SYAP1 PRO3113 Homo sapiens (Human) 352 Q96A49 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0003697 GO:0003697 single-stranded DNA binding nucleic acid binding activity F ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig763 sp Q96AE4 FUBP1_HUMAN 75.94 266 50 6 797 39 1 265 2E-122 371 Q96AE4 FUBP1_HUMAN GO:0003723; GO:0005634; GO:0010628; GO:0003700; GO:0003697; GO:0006366 Q13155; Q9UPT9 RNA binding; nucleus; positive regulation of gene expression; sequence-specific DNA binding transcription factor activity; single-stranded DNA binding; transcription from RNA polymerase II promoter reviewed IPR015096; IPR004087; IPR004088; Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V) FUBP1 Homo sapiens (Human) 644 Q96AE4 GO:0010468 GO:0010468 regulation of gene expression other metabolic processes P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0007409 GO:0007409 axonogenesis developmental processes P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0007409 GO:0007409 axonogenesis cell organization and biogenesis P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0031225 GO:0031225 anchored to membrane other membranes C ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0046658 GO:0046658 anchored to plasma membrane plasma membrane C ConsensusfromContig409 sp Q96CW9 NTNG2_HUMAN 68.49 146 43 1 6 443 233 375 2E-60 201 Q96CW9 NTNG2_HUMAN GO:0046658; GO:0007409 Q9HBW1; Q9HCJ2 anchored to plasma membrane; axonogenesis reviewed IPR000742; IPR013032; IPR002049; IPR008211; Netrin-G2 (Laminet-2) NTNG2 KIAA1857 LMNT2 UNQ9381/PRO34206 Homo sapiens (Human) 530 Q96CW9 GO:0046658 GO:0046658 anchored to plasma membrane other membranes C ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig3089 sp Q96DR7 ARHGQ_HUMAN 82.17 129 23 0 1 387 540 668 1E-69 229 Q96DR7 ARHGQ_HUMAN GO:0005089; GO:0005543; GO:0035023; GO:0001726 Rho guanyl-nucleotide exchange factor activity; phospholipid binding; regulation of Rho protein signal transduction; ruffle reviewed IPR000219; IPR011993; IPR001849; IPR001452; Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) ARHGEF26 SGEF HMFN1864 Homo sapiens (Human) 871 Q96DR7 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0006665 GO:0006665 sphingolipid metabolic process other metabolic processes P ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0030148 GO:0030148 sphingolipid biosynthetic process other metabolic processes P ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0044281 ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0046513 GO:0046513 ceramide biosynthetic process other metabolic processes P ConsensusfromContig4667 sp Q96G23 CERS2_HUMAN 72.5 120 33 0 6 365 169 288 1E-60 196 Q96G23 CERS2_HUMAN GO:0046513; GO:0005789; GO:0016021; GO:0031965; GO:0043565; GO:0003700; GO:0044281; GO:0030148; GO:0050291 P07306; P07307; P27449; P07900; O15245 ceramide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; nuclear membrane; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; small molecule metabolic process; sphingolipid biosynthetic process; sphingosine N-acyltransferase activity reviewed IPR001356; IPR009057; IPR016439; IPR006634; Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein) CERS2 LASS2 TMSG1 Homo sapiens (Human) 380 Q96G23 GO:0050291 GO:0050291 sphingosine N-acyltransferase activity other molecular function F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5897 sp Q96GQ7 DDX27_HUMAN 79.74 538 104 2 1032 2630 237 774 0 788 Q96GQ7 DDX27_HUMAN GO:0005524; GO:0008026; GO:0003676; GO:0005634 ATP binding; ATP-dependent helicase activity; nucleic acid binding; nucleus reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27) DDX27 RHLP HSPC259 PP3241 Homo sapiens (Human) 796 Q96GQ7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000087 GO:0000087 M phase of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000236 GO:0000236 mitotic prometaphase cell cycle and proliferation P ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000236 GO:0000236 mitotic prometaphase cell organization and biogenesis P ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0006334 GO:0006334 nucleosome assembly cell organization and biogenesis P ConsensusfromContig6011 sp Q96H22 CENPN_HUMAN 33.92 339 218 4 1241 243 1 339 9E-53 186 Q96H22 CENPN_HUMAN GO:0034080; GO:0007059; GO:0000777; GO:0005829; GO:0007067; GO:0000278; GO:0005654 CENP-A containing nucleosome assembly at centromere; chromosome segregation; condensed chromosome kinetochore; cytosol; mitosis; mitotic cell cycle; nucleoplasm reviewed IPR027715; IPR007902; Centromere protein N (CENP-N) (Interphase centromere complex protein 32) CENPN C16orf60 ICEN32 BM-309 Homo sapiens (Human) 339 Q96H22 GO:0034080 GO:0034080 CenH3-containing nucleosome assembly at centromere cell organization and biogenesis P ConsensusfromContig2272 sp Q96HH6 TMM19_HUMAN 75.52 143 35 0 540 112 67 209 1E-53 180 Q96HH6 TMM19_HUMAN GO:0016021 integral to membrane reviewed IPR002794; Transmembrane protein 19 TMEM19 Homo sapiens (Human) 336 Q96HH6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2272 sp Q96HH6 TMM19_HUMAN 75.52 143 35 0 540 112 67 209 1E-53 180 Q96HH6 TMM19_HUMAN GO:0016021 integral to membrane reviewed IPR002794; Transmembrane protein 19 TMEM19 Homo sapiens (Human) 336 Q96HH6 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1278 sp Q96IP4 FA46A_HUMAN 87.23 94 12 0 401 120 349 442 1E-53 180 Q96IP4 FA46A_HUMAN reviewed IPR012937; Protein FAM46A (HBV X-transactivated gene 11 protein) (HBV XAg-transactivated protein 11) FAM46A C6orf37 XTP11 Homo sapiens (Human) 442 ConsensusfromContig5558 sp Q96J42 TXD15_HUMAN 56.25 288 113 2 357 1181 71 358 1E-104 322 Q96J42 TXD15_HUMAN GO:0045454; GO:0016021 cell redox homeostasis; integral to membrane reviewed IPR012336; IPR013766; Thioredoxin domain-containing protein 15 TXNDC15 C5orf14 UNQ335/PRO534 Homo sapiens (Human) 360 Q96J42 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5558 sp Q96J42 TXD15_HUMAN 56.25 288 113 2 357 1181 71 358 1E-104 322 Q96J42 TXD15_HUMAN GO:0045454; GO:0016021 cell redox homeostasis; integral to membrane reviewed IPR012336; IPR013766; Thioredoxin domain-containing protein 15 TXNDC15 C5orf14 UNQ335/PRO534 Homo sapiens (Human) 360 Q96J42 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5558 sp Q96J42 TXD15_HUMAN 56.25 288 113 2 357 1181 71 358 1E-104 322 Q96J42 TXD15_HUMAN GO:0045454; GO:0016021 cell redox homeostasis; integral to membrane reviewed IPR012336; IPR013766; Thioredoxin domain-containing protein 15 TXNDC15 C5orf14 UNQ335/PRO534 Homo sapiens (Human) 360 Q96J42 GO:0045454 GO:0045454 cell redox homeostasis other biological processes P ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0001539 GO:0001539 ciliary or flagellar motility other biological processes P ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005858 GO:0005858 axonemal dynein complex cytoskeleton C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0005929 GO:0005929 cilium other cellular component C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0009434 GO:0009434 microtubule-based flagellum cytoskeleton C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0030286 GO:0030286 dynein complex cytoskeleton C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0035085 GO:0035085 cilium axoneme other cellular component C ConsensusfromContig2705 sp Q96JB1 DYH8_HUMAN 77.48 111 25 0 335 3 4329 4439 6E-57 196 Q96JB1 DYH8_HUMAN GO:0005524; GO:0006200; GO:0016887; GO:0005858; GO:0001539; GO:0035085; GO:0005874; GO:0003777; GO:0007018 ATP binding; ATP catabolic process; ATPase activity; axonemal dynein complex; ciliary or bacterial-type flagellar motility; cilium axoneme; microtubule; microtubule motor activity; microtubule-based movement reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8) DNAH8 Homo sapiens (Human) 4490 Q96JB1 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005801 GO:0005801 cis-Golgi network ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006888 GO:0006888 ER to Golgi vesicle-mediated transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006890 GO:0006890 "retrograde vesicle-mediated transport, Golgi to ER" transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006891 GO:0006891 intra-Golgi vesicle-mediated transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0017119 GO:0017119 Golgi transport complex ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0033365 GO:0033365 protein localization in organelle other biological processes P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 67.16 134 41 2 406 11 447 579 2E-79 177 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005801 GO:0005801 cis-Golgi network ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006888 GO:0006888 ER to Golgi vesicle-mediated transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006890 GO:0006890 "retrograde vesicle-mediated transport, Golgi to ER" transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0006891 GO:0006891 intra-Golgi vesicle-mediated transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0017119 GO:0017119 Golgi transport complex ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0032580 GO:0032580 Golgi cisterna membrane ER/Golgi C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0032580 GO:0032580 Golgi cisterna membrane other membranes C ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0033365 GO:0033365 protein localization in organelle other biological processes P ConsensusfromContig3930 sp Q96JB2 COG3_HUMAN 85.87 92 13 0 678 403 356 447 2E-79 140 Q96JB2 COG3_HUMAN GO:0006888; GO:0032580; GO:0017119; GO:0005801; GO:0006891; GO:0006886; GO:0005634; GO:0005886; GO:0006486; GO:0033365; GO:0050821; GO:0008565; GO:0006890 ER to Golgi vesicle-mediated transport; Golgi cisterna membrane; Golgi transport complex; cis-Golgi network; intra-Golgi vesicle-mediated transport; intracellular protein transport; nucleus; plasma membrane; protein glycosylation; protein localization to organelle; protein stabilization; protein transporter activity; retrograde vesicle-mediated transport, Golgi to ER reviewed IPR007265; Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94) COG3 SEC34 Homo sapiens (Human) 828 Q96JB2 GO:0050821 GO:0050821 protein stabilization protein metabolism P ConsensusfromContig2946 sp Q96K37 S35E1_HUMAN 60.26 151 44 1 118 522 25 175 2E-51 176 Q96K37 S35E1_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR000620; IPR004853; Solute carrier family 35 member E1 SLC35E1 PSEC0038 Homo sapiens (Human) 410 Q96K37 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2946 sp Q96K37 S35E1_HUMAN 60.26 151 44 1 118 522 25 175 2E-51 176 Q96K37 S35E1_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR000620; IPR004853; Solute carrier family 35 member E1 SLC35E1 PSEC0038 Homo sapiens (Human) 410 Q96K37 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2946 sp Q96K37 S35E1_HUMAN 60.26 151 44 1 118 522 25 175 2E-51 176 Q96K37 S35E1_HUMAN GO:0016021; GO:0006810 integral to membrane; transport reviewed IPR000620; IPR004853; Solute carrier family 35 member E1 SLC35E1 PSEC0038 Homo sapiens (Human) 410 Q96K37 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006284 GO:0006284 base-excision repair stress response P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006284 GO:0006284 base-excision repair DNA metabolism P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0010972 GO:0010972 negative regulation of G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0019005 GO:0019005 SCF ubiquitin ligase complex other cellular component C ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0030307 GO:0030307 positive regulation of cell growth other biological processes P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0034644 GO:0034644 cellular response to UV other biological processes P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0035520 ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0043154 GO:0043154 negative regulation of caspase activity death P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1818 sp Q96K76 UBP47_HUMAN 96.19 105 3 1 1 315 194 297 6E-62 210 Q96K76 UBP47_HUMAN GO:0019005; GO:0006284; GO:0034644; GO:0005737; GO:0035520; GO:0010972; GO:0043066; GO:0043154; GO:0045892; GO:0030307; GO:0042493; GO:0004221; GO:0006511; GO:0004843 SCF ubiquitin ligase complex; base-excision repair; cellular response to UV; cytoplasm; monoubiquitinated protein deubiquitination; negative regulation of G2/M transition of mitotic cell cycle; negative regulation of apoptotic process; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; negative regulation of transcription, DNA-dependent; positive regulation of cell growth; response to drug; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity reviewed IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) USP47 Homo sapiens (Human) 1375 Q96K76 GO:0071987 ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0001671 GO:0001671 ATPase activator activity enzyme regulator activity F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0032781 GO:0032781 positive regulation of ATPase activity other biological processes P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0045861 GO:0045861 negative regulation of proteolysis protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0050708 GO:0050708 regulation of protein secretion transport P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 81.68 131 23 1 1915 1526 44 174 6E-114 229 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0001671 GO:0001671 ATPase activator activity enzyme regulator activity F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0032781 GO:0032781 positive regulation of ATPase activity other biological processes P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0045861 GO:0045861 negative regulation of proteolysis protein metabolism P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0050708 GO:0050708 regulation of protein secretion transport P ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6151 sp Q96KC8 DNJC1_HUMAN 54.15 229 100 3 1463 780 196 420 6E-114 205 Q96KC8 DNJC1_HUMAN GO:0001671; GO:0003677; GO:0003682; GO:0005783; GO:0005789; GO:0016021; GO:0045861; GO:0031965; GO:0006457; GO:0050708; GO:0006417 P01011 ATPase activator activity; DNA binding; chromatin binding; endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; negative regulation of proteolysis; nuclear membrane; protein folding; regulation of protein secretion; regulation of translation reviewed IPR001623; IPR018253; IPR009057; IPR001005; IPR017884; DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DNAJC1 HTJ1 Homo sapiens (Human) 554 Q96KC8 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0000096 GO:0000096 sulfur amino acid metabolic process other metabolic processes P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0004180 GO:0004180 carboxypeptidase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0006750 GO:0006750 glutathione biosynthetic process other metabolic processes P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0006805 GO:0006805 xenobiotic metabolic process other metabolic processes P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0008237 GO:0008237 metallopeptidase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0016805 GO:0016805 dipeptidase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0034701 GO:0034701 tripeptidase activity other molecular function F ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0044281 ConsensusfromContig5747 sp Q96KP4 CNDP2_HUMAN 80.18 449 89 0 1600 254 23 471 0 776 Q96KP4 CNDP2_HUMAN GO:0004180; GO:0005829; GO:0016805; GO:0006750; GO:1901687; GO:0046872; GO:0008237; GO:0006508; GO:0000096; GO:0034701; GO:0006805 Q92597 carboxypeptidase activity; cytosol; dipeptidase activity; glutathione biosynthetic process; glutathione derivative biosynthetic process; metal ion binding; metallopeptidase activity; proteolysis; sulfur amino acid metabolic process; tripeptidase activity; xenobiotic metabolic process reviewed IPR001261; IPR017153; IPR002933; IPR011650; Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Glutamate carboxypeptidase-like protein 1) (Peptidase A) CNDP2 CN2 CPGL PEPA Homo sapiens (Human) 475 Q96KP4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0000239 GO:0000239 pachytene cell cycle and proliferation P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0006306 GO:0006306 DNA methylation DNA metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0007130 GO:0007130 synaptonemal complex assembly cell cycle and proliferation P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0007130 GO:0007130 synaptonemal complex assembly cell organization and biogenesis P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0007281 GO:0007281 germ cell development other biological processes P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0007286 GO:0007286 spermatid development other biological processes P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0009566 GO:0009566 fertilization other biological processes P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0016279 GO:0016279 protein-lysine N-methyltransferase activity other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0018027 GO:0018027 peptidyl-lysine dimethylation protein metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0035265 GO:0035265 organ growth other biological processes P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0046974 GO:0046974 histone methyltransferase activity (H3-K9 specific) other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0046976 GO:0046976 histone methyltransferase activity (H3-K27 specific) other molecular function F ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0051567 GO:0051567 histone H3-K9 methylation protein metabolism P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0051567 GO:0051567 histone H3-K9 methylation cell organization and biogenesis P ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0070734 GO:0070734 protein metabolism ConsensusfromContig1402 sp Q96KQ7 EHMT2_HUMAN 70.33 182 54 0 3 548 788 969 3E-83 272 Q96KQ7 EHMT2_HUMAN GO:0006306; GO:0010424; GO:0005694; GO:0009566; GO:0046976; GO:0046974; GO:0000122; GO:0005634; GO:0035265; GO:0018027; GO:0006275; GO:0007286; GO:0007130; GO:0008270 Q99684; Q07120; Q13547; Q9NQX1; Q5JSZ5; Q9P2R6 DNA methylation; DNA methylation on cytosine within a CG sequence; chromosome; fertilization; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; nucleus; organ growth; peptidyl-lysine dimethylation; regulation of DNA replication; spermatid development; synaptonemal complex assembly; zinc ion binding reviewed IPR002110; IPR020683; IPR003616; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a) EHMT2 BAT8 C6orf30 G9A KMT1C NG36 Homo sapiens (Human) 1210 Q96KQ7 GO:0070734 GO:0070734 cell organization and biogenesis ConsensusfromContig1388 sp Q96LT7 CI072_HUMAN 64.29 154 35 1 2 403 101 254 5E-60 197 Q96LT7 CI072_HUMAN GO:0008219; GO:0005737; GO:0005634 cell death; cytoplasm; nucleus reviewed IPR027819; Protein C9orf72 C9orf72 Homo sapiens (Human) 481 Q96LT7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1388 sp Q96LT7 CI072_HUMAN 64.29 154 35 1 2 403 101 254 5E-60 197 Q96LT7 CI072_HUMAN GO:0008219; GO:0005737; GO:0005634 cell death; cytoplasm; nucleus reviewed IPR027819; Protein C9orf72 C9orf72 Homo sapiens (Human) 481 Q96LT7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1388 sp Q96LT7 CI072_HUMAN 64.29 154 35 1 2 403 101 254 5E-60 197 Q96LT7 CI072_HUMAN GO:0008219; GO:0005737; GO:0005634 cell death; cytoplasm; nucleus reviewed IPR027819; Protein C9orf72 C9orf72 Homo sapiens (Human) 481 Q96LT7 GO:0008219 GO:0008219 cell death death P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity stress response P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity protein metabolism P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030035 GO:0030035 microspike assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030175 GO:0030175 filopodium other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0043088 GO:0043088 regulation of Cdc42 GTPase activity signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0046847 GO:0046847 filopodium assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 68.81 218 63 2 175 813 410 627 2E-109 320 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0001726 GO:0001726 ruffle other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005085 GO:0005085 guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005089 GO:0005089 Rho guanyl-nucleotide exchange factor activity enzyme regulator activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity stress response P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007257 GO:0007257 activation of JUN kinase activity protein metabolism P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030027 GO:0030027 lamellipodium other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030035 GO:0030035 microspike assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0030175 GO:0030175 filopodium other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0031267 GO:0031267 small GTPase binding other molecular function F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0035023 GO:0035023 regulation of Rho protein signal transduction signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0043088 GO:0043088 regulation of Cdc42 GTPase activity signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0046847 GO:0046847 filopodium assembly cell organization and biogenesis P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0048011 GO:0048011 nerve growth factor receptor signaling pathway signal transduction P ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0051015 GO:0051015 actin filament binding cytoskeletal activity F ConsensusfromContig6100 sp Q96M96 FGD4_HUMAN 77.42 62 14 0 3 188 353 414 2E-109 98.2 Q96M96 FGD4_HUMAN GO:0005794; GO:0005089; GO:0015629; GO:0030036; GO:0097190; GO:0005829; GO:0030175; GO:0046847; GO:0005085; GO:0030027; GO:0030032; GO:0046872; GO:0030035; GO:0048011; GO:0005543; GO:0043065; GO:0043088; GO:0008360; GO:0001726; GO:0031267; GO:0007264 Golgi apparatus; Rho guanyl-nucleotide exchange factor activity; actin cytoskeleton; actin cytoskeleton organization; apoptotic signaling pathway; cytosol; filopodium; filopodium assembly; guanyl-nucleotide exchange factor activity; lamellipodium; lamellipodium assembly; metal ion binding; microspike assembly; neurotrophin TRK receptor signaling pathway; phospholipid binding; positive regulation of apoptotic process; regulation of Cdc42 GTPase activity; regulation of cell shape; ruffle; small GTPase binding; small GTPase mediated signal transduction reviewed IPR000219; IPR011993; IPR001849; IPR000306; IPR017455; IPR013083; FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6) FGD4 FRABP ZFYVE6 Homo sapiens (Human) 766 Q96M96 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0017053 GO:0017053 transcriptional repressor complex nucleus C ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5946 sp Q96QT6 PHF12_HUMAN 77.78 126 28 0 1468 1091 786 911 3E-57 210 Q96QT6 PHF12_HUMAN GO:0001106; GO:0016580; GO:0035091; GO:0017053; GO:0008270 RNA polymerase II transcription corepressor activity; Sin3 complex; phosphatidylinositol binding; transcriptional repressor complex; zinc ion binding reviewed IPR000253; IPR008984; IPR019786; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 12 (PHD factor 1) (Pf1) PHF12 KIAA1523 Homo sapiens (Human) 1004 Q96QT6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0001104 ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 81.82 176 32 0 557 30 613 788 5E-121 305 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0001104 ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig421 sp Q96RN5 MED15_HUMAN 89.02 82 9 0 838 593 519 600 5E-121 151 Q96RN5 MED15_HUMAN GO:0005794; GO:0001104; GO:0016592; GO:0005654; GO:0019827; GO:0006367 P36956-1; Q96F44 Golgi apparatus; RNA polymerase II transcription cofactor activity; mediator complex; nucleoplasm; stem cell maintenance; transcription initiation from RNA polymerase II promoter reviewed IPR019087; Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein) MED15 ARC105 CTG7A PCQAP TIG1 TNRC7 Homo sapiens (Human) 788 Q96RN5 GO:0016592 GO:0016592 Srb-mediator complex nucleus C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0000086 GO:0000086 G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0000226 GO:0000226 microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig1174 sp Q96RT7 GCP6_HUMAN 68.75 192 58 1 97 666 1593 1784 3E-85 282 Q96RT7 GCP6_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0008017; GO:0007020; GO:0000922 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule binding; microtubule nucleation; spindle pole reviewed IPR007259; Gamma-tubulin complex component 6 (GCP-6) TUBGCP6 GCP6 KIAA1669 Homo sapiens (Human) 1819 Q96RT7 GO:0008274 GO:0008274 gamma-tubulin ring complex cytoskeleton C ConsensusfromContig5842 sp Q96ST2 IWS1_HUMAN 75.35 353 80 3 1061 3 472 817 6E-149 466 Q96ST2 IWS1_HUMAN GO:0003677; GO:0008380; GO:0006397; GO:0051028; GO:0005634; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0006355; GO:0006351 DNA binding; RNA splicing; mRNA processing; mRNA transport; nucleus; regulation of histone H3-K36 trimethylation; regulation of histone H4 acetylation; regulation of mRNA export from nucleus; regulation of mRNA processing; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR017923; Protein IWS1 homolog (IWS1-like protein) IWS1 IWS1L Homo sapiens (Human) 819 Q96ST2 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5842 sp Q96ST2 IWS1_HUMAN 75.35 353 80 3 1061 3 472 817 6E-149 466 Q96ST2 IWS1_HUMAN GO:0003677; GO:0008380; GO:0006397; GO:0051028; GO:0005634; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0006355; GO:0006351 DNA binding; RNA splicing; mRNA processing; mRNA transport; nucleus; regulation of histone H3-K36 trimethylation; regulation of histone H4 acetylation; regulation of mRNA export from nucleus; regulation of mRNA processing; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR017923; Protein IWS1 homolog (IWS1-like protein) IWS1 IWS1L Homo sapiens (Human) 819 Q96ST2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5842 sp Q96ST2 IWS1_HUMAN 75.35 353 80 3 1061 3 472 817 6E-149 466 Q96ST2 IWS1_HUMAN GO:0003677; GO:0008380; GO:0006397; GO:0051028; GO:0005634; GO:2001253; GO:0090239; GO:0010793; GO:0050684; GO:0006355; GO:0006351 DNA binding; RNA splicing; mRNA processing; mRNA transport; nucleus; regulation of histone H3-K36 trimethylation; regulation of histone H4 acetylation; regulation of mRNA export from nucleus; regulation of mRNA processing; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR017923; Protein IWS1 homolog (IWS1-like protein) IWS1 IWS1L Homo sapiens (Human) 819 Q96ST2 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig350 sp Q98874 ERH_DANRE 99.04 104 1 0 319 8 1 104 7E-73 219 Q98874 ERH_DANRE GO:0007049 cell cycle reviewed IPR000781; Enhancer of rudimentary homolog erh e(r) zgc:86761 Danio rerio (Zebrafish) (Brachydanio rerio) 104 Q98874 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005811 GO:0005811 lipid particle other cellular component C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0015909 GO:0015909 long-chain fatty acid transport transport P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0019915 GO:0019915 lipid storage other biological processes P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig5964 sp Q99541 PLIN2_HUMAN 51.83 409 175 5 1692 532 1 409 2E-124 380 Q99541 PLIN2_HUMAN GO:0044255; GO:0005783; GO:0005576; GO:0005811; GO:0019915; GO:0015909; GO:0005634; GO:0005886; GO:0042493; GO:0014070; GO:0044281 cellular lipid metabolic process; endoplasmic reticulum; extracellular region; lipid particle; lipid storage; long-chain fatty acid transport; nucleus; plasma membrane; response to drug; response to organic cyclic compound; small molecule metabolic process reviewed IPR004279; Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP) PLIN2 ADFP Homo sapiens (Human) 437 Q99541 GO:0044281 ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig4732 sp Q99549 MPP8_HUMAN 78.62 159 32 1 479 3 627 783 3E-83 268 Q99549 MPP8_HUMAN GO:0007049; GO:0005737; GO:0035064; GO:0045892; GO:0005720; GO:0000788; GO:0005730; GO:0005886; GO:0044030; GO:0006351 Q9H9B1; P68431; Q15047 cell cycle; cytoplasm; methylated histone residue binding; negative regulation of transcription, DNA-dependent; nuclear heterochromatin; nuclear nucleosome; nucleolus; plasma membrane; regulation of DNA methylation; transcription, DNA-dependent reviewed IPR002110; IPR020683; IPR023780; IPR000953; IPR016197; IPR023779; M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3) MPHOSPH8 MPP8 Homo sapiens (Human) 860 Q99549 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5959 sp Q99614 TTC1_HUMAN 74.26 202 52 0 453 1058 91 292 4E-91 289 Q99614 TTC1_HUMAN GO:0005778; GO:0006457; GO:0051082 peroxisomal membrane; protein folding; unfolded protein binding reviewed IPR013026; IPR011990; IPR001440; IPR019734; Tetratricopeptide repeat protein 1 (TPR repeat protein 1) TTC1 TPR1 Homo sapiens (Human) 292 Q99614 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5959 sp Q99614 TTC1_HUMAN 74.26 202 52 0 453 1058 91 292 4E-91 289 Q99614 TTC1_HUMAN GO:0005778; GO:0006457; GO:0051082 peroxisomal membrane; protein folding; unfolded protein binding reviewed IPR013026; IPR011990; IPR001440; IPR019734; Tetratricopeptide repeat protein 1 (TPR repeat protein 1) TTC1 TPR1 Homo sapiens (Human) 292 Q99614 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5959 sp Q99614 TTC1_HUMAN 74.26 202 52 0 453 1058 91 292 4E-91 289 Q99614 TTC1_HUMAN GO:0005778; GO:0006457; GO:0051082 peroxisomal membrane; protein folding; unfolded protein binding reviewed IPR013026; IPR011990; IPR001440; IPR019734; Tetratricopeptide repeat protein 1 (TPR repeat protein 1) TTC1 TPR1 Homo sapiens (Human) 292 Q99614 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5959 sp Q99614 TTC1_HUMAN 74.26 202 52 0 453 1058 91 292 4E-91 289 Q99614 TTC1_HUMAN GO:0005778; GO:0006457; GO:0051082 peroxisomal membrane; protein folding; unfolded protein binding reviewed IPR013026; IPR011990; IPR001440; IPR019734; Tetratricopeptide repeat protein 1 (TPR repeat protein 1) TTC1 TPR1 Homo sapiens (Human) 292 Q99614 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6262 sp Q99733 NP1L4_HUMAN 81.87 193 34 1 4 579 145 337 3E-90 281 Q99733 NP1L4_HUMAN GO:0005737; GO:0006334; GO:0005634; GO:0051082 P04608 cytoplasm; nucleosome assembly; nucleus; unfolded protein binding reviewed IPR002164; Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) NAP1L4 NAP2 Homo sapiens (Human) 375 Q99733 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6262 sp Q99733 NP1L4_HUMAN 81.87 193 34 1 4 579 145 337 3E-90 281 Q99733 NP1L4_HUMAN GO:0005737; GO:0006334; GO:0005634; GO:0051082 P04608 cytoplasm; nucleosome assembly; nucleus; unfolded protein binding reviewed IPR002164; Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) NAP1L4 NAP2 Homo sapiens (Human) 375 Q99733 GO:0005678 GO:0005678 chromatin assembly complex nucleus C ConsensusfromContig6262 sp Q99733 NP1L4_HUMAN 81.87 193 34 1 4 579 145 337 3E-90 281 Q99733 NP1L4_HUMAN GO:0005737; GO:0006334; GO:0005634; GO:0051082 P04608 cytoplasm; nucleosome assembly; nucleus; unfolded protein binding reviewed IPR002164; Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) NAP1L4 NAP2 Homo sapiens (Human) 375 Q99733 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6262 sp Q99733 NP1L4_HUMAN 81.87 193 34 1 4 579 145 337 3E-90 281 Q99733 NP1L4_HUMAN GO:0005737; GO:0006334; GO:0005634; GO:0051082 P04608 cytoplasm; nucleosome assembly; nucleus; unfolded protein binding reviewed IPR002164; Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) NAP1L4 NAP2 Homo sapiens (Human) 375 Q99733 GO:0006334 GO:0006334 nucleosome assembly cell organization and biogenesis P ConsensusfromContig6262 sp Q99733 NP1L4_HUMAN 81.87 193 34 1 4 579 145 337 3E-90 281 Q99733 NP1L4_HUMAN GO:0005737; GO:0006334; GO:0005634; GO:0051082 P04608 cytoplasm; nucleosome assembly; nucleus; unfolded protein binding reviewed IPR002164; Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) NAP1L4 NAP2 Homo sapiens (Human) 375 Q99733 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2981 sp Q99805 TM9S2_HUMAN 92.41 224 17 0 1 672 403 626 2E-138 410 Q99805 TM9S2_HUMAN GO:0005768; GO:0010008; GO:0005887; GO:0006810 endosome; endosome membrane; integral to plasma membrane; transport reviewed IPR004240; Transmembrane 9 superfamily member 2 (p76) TM9SF2 Homo sapiens (Human) 663 Q99805 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005057 GO:0005057 receptor signaling protein activity signal transduction activity F ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0006916 GO:0006916 anti-apoptosis death P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0007166 GO:0007166 cell surface receptor linked signal transduction signal transduction P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0010226 GO:0010226 response to lithium ion other biological processes P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0014070 GO:0014070 response to organic cyclic substance other biological processes P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0035094 GO:0035094 response to nicotine other biological processes P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0043066 GO:0043066 negative regulation of apoptosis death P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0043525 GO:0043525 positive regulation of neuron apoptosis death P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0045111 GO:0045111 intermediate filament cytoskeleton cytoskeleton C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0051087 GO:0051087 chaperone binding other molecular function F ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0051219 GO:0051219 phosphoprotein binding other molecular function F ConsensusfromContig6357 sp Q99933 BAG1_HUMAN 54.59 207 93 1 1456 839 139 345 8E-70 234 Q99933 BAG1_HUMAN GO:0006915; GO:0007166; GO:0070389; GO:0005737; GO:0043066; GO:0005634; GO:0005057 P11142 apoptotic process; cell surface receptor signaling pathway; chaperone cofactor-dependent protein refolding; cytoplasm; negative regulation of apoptotic process; nucleus; receptor signaling protein activity reviewed IPR003103; IPR017093; IPR000626; BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1) BAG1 HAP Homo sapiens (Human) 345 Q99933 GO:0070389 GO:0070389 chaperone cofactor-dependent protein refolding protein metabolism P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0004435 GO:0004435 phosphoinositide phospholipase C activity other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0004629 GO:0004629 phospholipase C activity other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005516 GO:0005516 calmodulin binding other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005626 GO:0005626 insoluble fraction other cellular component C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0006892 GO:0006892 post-Golgi vesicle-mediated transport transport P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0008081 GO:0008081 phosphoric diester hydrolase activity other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0009395 GO:0009395 phospholipid catabolic process other metabolic processes P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0016042 GO:0016042 lipid catabolic process other metabolic processes P ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0035556 ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0042383 GO:0042383 sarcolemma plasma membrane C ConsensusfromContig2330 sp Q99JE6 PLCB3_RAT 83.02 106 18 0 318 1 660 765 3E-58 200 Q99JE6 PLCB3_RAT GO:0007186; GO:0005509; GO:0005829; GO:0035556; GO:0004435; GO:0009395; GO:0006892; GO:0042383; GO:0004871 G-protein coupled receptor signaling pathway; calcium ion binding; cytosol; intracellular signal transduction; phosphatidylinositol phospholipase C activity; phospholipid catabolic process; post-Golgi vesicle-mediated transport; sarcolemma; signal transducer activity reviewed IPR000008; IPR011992; IPR001192; IPR016280; IPR014815; IPR009535; IPR017946; IPR015359; IPR000909; IPR001711; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3) Plcb3 Rattus norvegicus (Rat) 1234 Q99JE6 GO:0042383 GO:0042383 sarcolemma other membranes C ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0005083 GO:0005083 small GTPase regulator activity enzyme regulator activity F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig4248 sp Q99JP0 M4K3_MOUSE 78.15 119 25 1 1 357 726 843 7E-57 194 Q99JP0 M4K3_MOUSE GO:0005524; GO:0007243; GO:0004674; GO:0009411; GO:0005083 Q13094; Q02111 ATP binding; intracellular protein kinase cascade; protein serine/threonine kinase activity; response to UV; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3) Map4k3 Mus musculus (Mouse) 894 Q99JP0 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0007160 GO:0007160 cell-matrix adhesion cell adhesion P ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0007163 GO:0007163 establishment or maintenance of cell polarity cell organization and biogenesis P ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0016337 GO:0016337 cell-cell adhesion cell adhesion P ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0043009 GO:0043009 chordate embryonic development developmental processes P ConsensusfromContig645 sp Q99JW4 LIMS1_MOUSE 92.8 125 9 0 1 375 78 202 2E-80 246 Q99JW4 LIMS1_MOUSE GO:0016337; GO:0045216; GO:0007160; GO:0043009; GO:0007163; GO:0005925; GO:0005886; GO:2001046; GO:0008270 cell-cell adhesion; cell-cell junction organization; cell-matrix adhesion; chordate embryonic development; establishment or maintenance of cell polarity; focal adhesion; plasma membrane; positive regulation of integrin-mediated signaling pathway; zinc ion binding reviewed IPR017351; IPR001781; LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) Lims1 Pinch1 Mus musculus (Mouse) 325 Q99JW4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0001657 GO:0001657 ureteric bud development developmental processes P ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0009986 GO:0009986 cell surface other cellular component C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016328 GO:0016328 lateral plasma membrane plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0016328 GO:0016328 lateral plasma membrane other membranes C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig6186 sp Q99JW5 EPCAM_MOUSE 41.84 294 146 9 124 972 27 306 1E-56 193 Q99JW5 EPCAM_MOUSE GO:0016324; GO:0016323; GO:0009986; GO:0016021; GO:0016328; GO:0008284; GO:0005923; GO:0001657 apical plasma membrane; basolateral plasma membrane; cell surface; integral to membrane; lateral plasma membrane; positive regulation of cell proliferation; tight junction; ureteric bud development reviewed IPR000716; Epithelial cell adhesion molecule (Ep-CAM) (Epithelial glycoprotein 314) (EGP314) (mEGP314) (Protein 289A) (Tumor-associated calcium signal transducer 1) (CD antigen CD326) Epcam Tacstd1 Mus musculus (Mouse) 315 Q99JW5 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0000062 GO:0000062 acyl-CoA binding other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0003857 GO:0003857 3-hydroxyacyl-CoA dehydrogenase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0003988 GO:0003988 acetyl-CoA C-acyltransferase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0004300 GO:0004300 enoyl-CoA hydratase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0006635 GO:0006635 fatty acid beta-oxidation other metabolic processes P ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016507 GO:0016507 fatty acid beta-oxidation multienzyme complex mitochondrion C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016508 GO:0016508 long-chain-enoyl-CoA hydratase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016509 GO:0016509 long-chain-3-hydroxyacyl-CoA dehydrogenase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0042645 GO:0042645 mitochondrial nucleoid mitochondrion C ConsensusfromContig5927 sp Q99JY0 ECHB_MOUSE 80.26 304 60 0 1639 728 151 454 0 530 Q99JY0 ECHB_MOUSE GO:0003857; GO:0051287; GO:0003988; GO:0005783; GO:0004300; GO:0006635; GO:0000062; GO:0016509; GO:0016508; GO:0016507; GO:0005743; GO:0042645; GO:0005741 3-hydroxyacyl-CoA dehydrogenase activity; NAD binding; acetyl-CoA C-acyltransferase activity; endoplasmic reticulum; enoyl-CoA hydratase activity; fatty acid beta-oxidation; fatty-acyl-CoA binding; long-chain-3-hydroxyacyl-CoA dehydrogenase activity; long-chain-enoyl-CoA hydratase activity; mitochondrial fatty acid beta-oxidation multienzyme complex; mitochondrial inner membrane; mitochondrial nucleoid; mitochondrial outer membrane reviewed IPR002155; IPR016039; IPR016038; IPR020615; IPR020610; IPR020617; IPR020613; IPR020616; Lipid metabolism; fatty acid beta-oxidation. Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)] Hadhb Mus musculus (Mouse) 475 Q99JY0 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0012506 GO:0012506 vesicle membrane other membranes C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042102 GO:0042102 positive regulation of T cell proliferation cell cycle and proliferation P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 71.03 321 75 4 1599 646 1 306 1E-161 463 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0012506 GO:0012506 vesicle membrane other membranes C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042102 GO:0042102 positive regulation of T cell proliferation cell cycle and proliferation P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 82.46 57 10 0 605 435 321 377 1E-161 103 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0007015 GO:0007015 actin filament organization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0012506 GO:0012506 vesicle membrane other membranes C ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0019904 GO:0019904 protein domain specific binding other molecular function F ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030032 GO:0030032 lamellipodium assembly cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042102 GO:0042102 positive regulation of T cell proliferation cell cycle and proliferation P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0042110 GO:0042110 T cell activation other biological processes P ConsensusfromContig5631 sp Q99M51 NCK1_MOUSE 84.62 26 4 0 664 587 301 326 1E-161 48.1 Q99M51 NCK1_MOUSE GO:0042110; GO:0007015; GO:0016477; GO:0005783; GO:0030032; GO:0060548; GO:0005634; GO:0042102; GO:0030838; GO:0045944; GO:0004860; GO:0006417; GO:0051707; GO:0012506 P00520; P97465 T cell activation; actin filament organization; cell migration; endoplasmic reticulum; lamellipodium assembly; negative regulation of cell death; nucleus; positive regulation of T cell proliferation; positive regulation of actin filament polymerization; positive regulation of transcription from RNA polymerase II promoter; protein kinase inhibitor activity; regulation of translation; response to other organism; vesicle membrane reviewed IPR017304; IPR000980; IPR001452; Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) Nck1 Mus musculus (Mouse) 377 Q99M51 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0005777 GO:0005777 peroxisome other cytoplasmic organelle C ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0019166 GO:0019166 trans-2-enoyl-CoA reductase (NADPH) activity other molecular function F ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig12 sp Q99MZ7 PECR_MOUSE 63.8 221 80 0 1082 420 61 281 9E-98 299 Q99MZ7 PECR_MOUSE GO:0030497; GO:0005739; GO:0005778; GO:0033306; GO:0019166 fatty acid elongation; mitochondrion; peroxisomal membrane; phytol metabolic process; trans-2-enoyl-CoA reductase (NADPH) activity reviewed IPR002347; IPR016040; Lipid metabolism; fatty acid biosynthesis. Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) Pecr Mus musculus (Mouse) 303 Q99MZ7 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005769 GO:0005769 early endosome other cytoplasmic organelle C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0016197 GO:0016197 endosome transport transport P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0034498 GO:0034498 early endosome to Golgi transport transport P ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig2554 sp Q99N27 SNX1_RAT 83.09 136 23 0 2 409 321 456 2E-74 237 Q99N27 SNX1_RAT GO:0005794; GO:0007154; GO:0005829; GO:0031901; GO:0016197; GO:0010008; GO:0006886; GO:0035091; GO:0045732; GO:0008565 Golgi apparatus; cell communication; cytosol; early endosome membrane; endosomal transport; endosome membrane; intracellular protein transport; phosphatidylinositol binding; positive regulation of protein catabolic process; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Rattus norvegicus (Rat) 522 Q99N27 GO:0045732 GO:0045732 positive regulation of protein catabolic process protein metabolism P ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6347 sp Q99PE9 ARL4D_MOUSE 67.89 190 58 2 1244 678 1 188 1E-85 268 Q99PE9 ARL4D_MOUSE GO:0005525; GO:0005737; GO:0005730; GO:0005634; GO:0005886; GO:0007264 GTP binding; cytoplasm; nucleolus; nucleus; plasma membrane; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR024156; IPR006689; ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) (ADP-ribosylation factor-like protein 5) Arl4d Arf4l Arl5 Mus musculus (Mouse) 201 Q99PE9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1218 sp Q9BQP7 MGME1_HUMAN 67.69 130 42 0 528 139 203 332 1E-63 206 Q9BQP7 MGME1_HUMAN GO:0043504; GO:0005739; GO:0008297 mitochondrial DNA repair; mitochondrion; single-stranded DNA exodeoxyribonuclease activity reviewed IPR026970; IPR011335; Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-) MGME1 C20orf72 DDK1 Homo sapiens (Human) 344 Q9BQP7 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig5892 sp Q9BQR3 PRS27_HUMAN 46.74 261 135 2 1239 466 22 281 5E-71 234 Q9BQR3 PRS27_HUMAN GO:0005576; GO:0005886; GO:0006508; GO:0004252 extracellular region; plasma membrane; proteolysis; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR009003; Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin) PRSS27 MPN UNQ1884/PRO4327 Homo sapiens (Human) 290 Q9BQR3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5864 sp Q9BRS8 LARP6_HUMAN 37.95 419 229 10 1385 159 85 482 3E-60 213 Q9BRS8 LARP6_HUMAN GO:0005794; GO:0003723; GO:0006396; GO:0000166; GO:0005634; GO:0006417; GO:0030529 Golgi apparatus; RNA binding; RNA processing; nucleotide binding; nucleus; regulation of translation; ribonucleoprotein complex reviewed IPR002344; IPR006630; IPR012677; IPR024642; IPR011991; La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6) LARP6 Homo sapiens (Human) 491 Q9BRS8 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0043231 GO:0043231 intracellular membrane-bounded organelle other cellular component C ConsensusfromContig5813 sp Q9BRV8 SIKE1_HUMAN 61.78 191 73 0 2 574 15 205 1E-71 233 Q9BRV8 SIKE1_HUMAN GO:0005829; GO:0005925; GO:0045087; GO:0043231 Q9Y228 cytosol; focal adhesion; innate immune response; intracellular membrane-bounded organelle reviewed IPR008555; Suppressor of IKBKE 1 (Suppressor of IKK-epsilon) SIKE1 SIKE Homo sapiens (Human) 207 Q9BRV8 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0000030 GO:0000030 mannosyltransferase activity other molecular function F ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0004578 GO:0004578 chitobiosyldiphosphodolichol beta-mannosyltransferase activity other molecular function F ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0006488 GO:0006488 dolichol-linked oligosaccharide biosynthetic process protein metabolism P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0009103 GO:0009103 lipopolysaccharide biosynthetic process other metabolic processes P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0018279 GO:0018279 protein amino acid N-linked glycosylation via asparagine protein metabolism P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0043687 GO:0043687 post-translational protein modification protein metabolism P ConsensusfromContig1775 sp Q9BT22 ALG1_HUMAN 65.32 222 77 0 1 666 240 461 2E-101 309 Q9BT22 ALG1_HUMAN GO:0004578; GO:0006488; GO:0005789; GO:0016021; GO:0009103; GO:0000030; GO:0043687; GO:0018279 chitobiosyldiphosphodolichol beta-mannosyltransferase activity; dolichol-linked oligosaccharide biosynthetic process; endoplasmic reticulum membrane; integral to membrane; lipopolysaccharide biosynthetic process; mannosyltransferase activity; post-translational protein modification; protein N-linked glycosylation via asparagine reviewed IPR026051; Protein modification; protein glycosylation. Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1) ALG1 HMAT1 HMT1 PSEC0061 UNQ861/PRO1870 Homo sapiens (Human) 464 Q9BT22 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig644 sp Q9BTE1 DCTN5_HUMAN 96.35 137 5 0 108 518 1 137 2E-92 273 Q9BTE1 DCTN5_HUMAN GO:0019886; GO:0005813; GO:0000777; GO:0005829 antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; condensed chromosome kinetochore; cytosol reviewed IPR001451; IPR011004; Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) 182 Q9BTE1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig644 sp Q9BTE1 DCTN5_HUMAN 96.35 137 5 0 108 518 1 137 2E-92 273 Q9BTE1 DCTN5_HUMAN GO:0019886; GO:0005813; GO:0000777; GO:0005829 antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; condensed chromosome kinetochore; cytosol reviewed IPR001451; IPR011004; Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) 182 Q9BTE1 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig644 sp Q9BTE1 DCTN5_HUMAN 96.35 137 5 0 108 518 1 137 2E-92 273 Q9BTE1 DCTN5_HUMAN GO:0019886; GO:0005813; GO:0000777; GO:0005829 antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; condensed chromosome kinetochore; cytosol reviewed IPR001451; IPR011004; Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) 182 Q9BTE1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig644 sp Q9BTE1 DCTN5_HUMAN 96.35 137 5 0 108 518 1 137 2E-92 273 Q9BTE1 DCTN5_HUMAN GO:0019886; GO:0005813; GO:0000777; GO:0005829 antigen processing and presentation of exogenous peptide antigen via MHC class II; centrosome; condensed chromosome kinetochore; cytosol reviewed IPR001451; IPR011004; Dynactin subunit 5 (Dynactin subunit p25) DCTN5 Homo sapiens (Human) 182 Q9BTE1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0004560 GO:0004560 alpha-L-fucosidase activity other molecular function F ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0006004 GO:0006004 fucose metabolic process other metabolic processes P ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0016798 GO:0016798 "hydrolase activity, acting on glycosyl bonds" other molecular function F ConsensusfromContig6303 sp Q9BTY2 FUCO2_HUMAN 57.46 409 173 1 2084 861 33 441 8E-164 490 Q9BTY2 FUCO2_HUMAN GO:0004560; GO:0005576; GO:0042806; GO:0006004; GO:0005764 alpha-L-fucosidase activity; extracellular region; fucose binding; fucose metabolic process; lysosome reviewed IPR013780; IPR000933; IPR018526; IPR016286; IPR013781; IPR017853; Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2) FUCA2 PSEC0151 UNQ227/PRO260 Homo sapiens (Human) 467 Q9BTY2 GO:0043169 GO:0043169 cation binding other molecular function F ConsensusfromContig6360 sp Q9BV90 SNR25_HUMAN 77.27 132 30 0 484 879 1 132 3E-70 223 Q9BV90 SNR25_HUMAN GO:0008380; GO:0005689; GO:0006397 RNA splicing; U12-type spliceosomal complex; mRNA processing reviewed IPR000626; U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) SNRNP25 C16orf33 Homo sapiens (Human) 132 Q9BV90 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6360 sp Q9BV90 SNR25_HUMAN 77.27 132 30 0 484 879 1 132 3E-70 223 Q9BV90 SNR25_HUMAN GO:0008380; GO:0005689; GO:0006397 RNA splicing; U12-type spliceosomal complex; mRNA processing reviewed IPR000626; U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) SNRNP25 C16orf33 Homo sapiens (Human) 132 Q9BV90 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6360 sp Q9BV90 SNR25_HUMAN 77.27 132 30 0 484 879 1 132 3E-70 223 Q9BV90 SNR25_HUMAN GO:0008380; GO:0005689; GO:0006397 RNA splicing; U12-type spliceosomal complex; mRNA processing reviewed IPR000626; U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) SNRNP25 C16orf33 Homo sapiens (Human) 132 Q9BV90 GO:0005689 GO:0005689 U12-dependent spliceosome nucleus C ConsensusfromContig6360 sp Q9BV90 SNR25_HUMAN 77.27 132 30 0 484 879 1 132 3E-70 223 Q9BV90 SNR25_HUMAN GO:0008380; GO:0005689; GO:0006397 RNA splicing; U12-type spliceosomal complex; mRNA processing reviewed IPR000626; U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) SNRNP25 C16orf33 Homo sapiens (Human) 132 Q9BV90 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6360 sp Q9BV90 SNR25_HUMAN 77.27 132 30 0 484 879 1 132 3E-70 223 Q9BV90 SNR25_HUMAN GO:0008380; GO:0005689; GO:0006397 RNA splicing; U12-type spliceosomal complex; mRNA processing reviewed IPR000626; U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein) SNRNP25 C16orf33 Homo sapiens (Human) 132 Q9BV90 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2502 sp Q9BVI0 PHF20_HUMAN 72.73 132 36 0 173 568 651 782 2E-67 228 Q9BVI0 PHF20_HUMAN GO:0003677; GO:0071339; GO:0043984; GO:0043981; GO:0043982; GO:0000123; GO:0031965; GO:0006355; GO:0006351; GO:0008270 P68431; P62805 DNA binding; MLL1 complex; histone H4-K16 acetylation; histone H4-K5 acetylation; histone H4-K8 acetylation; histone acetyltransferase complex; nuclear membrane; regulation of transcription, DNA-dependent; transcription, DNA-dependent; zinc ion binding reviewed IPR017956; IPR022255; IPR002999; IPR019786; IPR007087; IPR015880; IPR011011; IPR001965; IPR019787; IPR013083; PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP) PHF20 C20orf104 GLEA2 HCA58 NZF TZP Homo sapiens (Human) 1012 Q9BVI0 GO:0071339 ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6004 sp Q9BVS4 RIOK2_HUMAN 61.44 529 186 6 85 1647 1 519 0 640 Q9BVS4 RIOK2_HUMAN GO:0005524; GO:0004674 ATP binding; protein serine/threonine kinase activity reviewed IPR011009; IPR018934; IPR015285; IPR018935; IPR011991; Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2) RIOK2 Homo sapiens (Human) 552 Q9BVS4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0009922 GO:0009922 fatty acid elongase activity other molecular function F ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0019367 GO:0019367 "fatty acid elongation, saturated fatty acid" other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0019432 GO:0019432 triglyceride biosynthetic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030148 GO:0030148 sphingolipid biosynthetic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane other membranes C ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0034625 GO:0034625 "fatty acid elongation, monounsaturated fatty acid" other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0035338 ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0042761 GO:0042761 very-long-chain fatty acid biosynthetic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig5931 sp Q9BW60 ELOV1_HUMAN 64.93 268 91 2 1165 368 1 267 2E-115 348 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0044281 ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0009922 GO:0009922 fatty acid elongase activity other molecular function F ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0019367 GO:0019367 "fatty acid elongation, saturated fatty acid" other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0019432 GO:0019432 triglyceride biosynthetic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030148 GO:0030148 sphingolipid biosynthetic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0030176 GO:0030176 integral to endoplasmic reticulum membrane other membranes C ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0034625 GO:0034625 "fatty acid elongation, monounsaturated fatty acid" other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0035338 ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0042761 GO:0042761 very-long-chain fatty acid biosynthetic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0044255 GO:0044255 cellular lipid metabolic process other metabolic processes P ConsensusfromContig5885 sp Q9BW60 ELOV1_HUMAN 72.73 264 72 0 1506 715 4 267 2E-142 421 Q9BW60 ELOV1_HUMAN GO:0009922; GO:0034625; GO:0019367; GO:0030176; GO:0035338; GO:0030148; GO:0019432; GO:0042761 O75832; Q6IBS0 fatty acid elongase activity; fatty acid elongation, monounsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to endoplasmic reticulum membrane; long-chain fatty-acyl-CoA biosynthetic process; sphingolipid biosynthetic process; triglyceride biosynthetic process; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very-long-chain 3-oxoacyl-CoA synthase 1) ELOVL1 SSC1 CGI-88 Homo sapiens (Human) 279 Q9BW60 GO:0044281 ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0005689 GO:0005689 U12-dependent spliceosome nucleus C ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5769 sp Q9BWJ5 SF3B5_HUMAN 92.94 85 6 0 765 511 1 85 3E-54 178 Q9BWJ5 SF3B5_HUMAN GO:0005689; GO:0000398; GO:0005654 U12-type spliceosomal complex; mRNA splicing, via spliceosome; nucleoplasm reviewed IPR009846; IPR017089; Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit) SF3B5 SF3B10 Homo sapiens (Human) 86 Q9BWJ5 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0001525 GO:0001525 angiogenesis developmental processes P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0005667 GO:0005667 transcription factor complex nucleus C ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0006474 GO:0006474 N-terminal protein amino acid acetylation protein metabolism P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0016407 GO:0016407 acetyltransferase activity other molecular function F ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0043022 GO:0043022 ribosome binding translation activity F ConsensusfromContig4316 sp Q9BXJ9 NAA15_HUMAN 89.57 115 11 1 1 345 11 124 3E-63 211 Q9BXJ9 NAA15_HUMAN GO:0008080; GO:0006474; GO:0001525; GO:0030154; GO:0005737; GO:0005634; GO:0045893; GO:0005667; GO:0006351 N-acetyltransferase activity; N-terminal protein amino acid acetylation; angiogenesis; cell differentiation; cytoplasm; nucleus; positive regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR021183; IPR013026; IPR011990; IPR013105; IPR019734; N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100) NAA15 GA19 NARG1 NATH TBDN100 Homo sapiens (Human) 866 Q9BXJ9 GO:0045893 GO:0045893 "positive regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0000793 GO:0000793 condensed chromosome other cellular component C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell organization and biogenesis P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007276 GO:0007276 gamete generation other biological processes P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 64.39 132 47 0 581 186 1188 1319 7E-62 187 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0010332 GO:0010332 response to gamma radiation other biological processes P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0000793 GO:0000793 condensed chromosome other cellular component C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell organization and biogenesis P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007276 GO:0007276 gamete generation other biological processes P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 75.86 29 7 0 190 104 1318 1346 7E-62 52.4 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0010332 GO:0010332 response to gamma radiation other biological processes P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0000793 GO:0000793 condensed chromosome other cellular component C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell cycle and proliferation P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007129 GO:0007129 synapsis cell organization and biogenesis P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0007276 GO:0007276 gamete generation other biological processes P ConsensusfromContig3713 sp Q9BXW9 FACD2_HUMAN 65.62 32 11 0 105 10 1346 1377 7E-62 40 Q9BXW9 FACD2_HUMAN GO:0006281; GO:0000793; GO:0007276; GO:0005654; GO:0010332; GO:0007129 P51587; Q9NVI1; Q16658; O00255; P49959; O60934 DNA repair; condensed chromosome; gamete generation; nucleoplasm; response to gamma radiation; synapsis reviewed Fanconi anemia group D2 protein (Protein FACD2) FANCD2 FACD Homo sapiens (Human) 1471 Q9BXW9 GO:0010332 GO:0010332 response to gamma radiation other biological processes P ConsensusfromContig3422 sp Q9BY12 SCAPE_HUMAN 77.97 118 26 0 45 398 1205 1322 2E-57 198 Q9BY12 SCAPE_HUMAN GO:0005783; GO:0046872; GO:0005634 endoplasmic reticulum; metal ion binding; nucleus reviewed IPR015880; S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) 1400 Q9BY12 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3422 sp Q9BY12 SCAPE_HUMAN 77.97 118 26 0 45 398 1205 1322 2E-57 198 Q9BY12 SCAPE_HUMAN GO:0005783; GO:0046872; GO:0005634 endoplasmic reticulum; metal ion binding; nucleus reviewed IPR015880; S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) 1400 Q9BY12 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3422 sp Q9BY12 SCAPE_HUMAN 77.97 118 26 0 45 398 1205 1322 2E-57 198 Q9BY12 SCAPE_HUMAN GO:0005783; GO:0046872; GO:0005634 endoplasmic reticulum; metal ion binding; nucleus reviewed IPR015880; S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) 1400 Q9BY12 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig3422 sp Q9BY12 SCAPE_HUMAN 77.97 118 26 0 45 398 1205 1322 2E-57 198 Q9BY12 SCAPE_HUMAN GO:0005783; GO:0046872; GO:0005634 endoplasmic reticulum; metal ion binding; nucleus reviewed IPR015880; S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) 1400 Q9BY12 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3422 sp Q9BY12 SCAPE_HUMAN 77.97 118 26 0 45 398 1205 1322 2E-57 198 Q9BY12 SCAPE_HUMAN GO:0005783; GO:0046872; GO:0005634 endoplasmic reticulum; metal ion binding; nucleus reviewed IPR015880; S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291) SCAPER KIAA1454 ZNF291 MSTP063 Homo sapiens (Human) 1400 Q9BY12 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig1678 sp Q9C0E2 XPO4_HUMAN 95.24 126 6 0 2 379 117 242 2E-67 225 Q9C0E2 XPO4_HUMAN GO:0005737; GO:0005634; GO:0046827; GO:0015031 cytoplasm; nucleus; positive regulation of protein export from nucleus; protein transport reviewed IPR016024; IPR014877; Exportin-4 (Exp4) XPO4 KIAA1721 Homo sapiens (Human) 1151 Q9C0E2 GO:0046827 GO:0046827 positive regulation of protein export from nucleus transport P ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0004190 GO:0004190 aspartic-type endopeptidase activity other molecular function F ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig440 sp Q9CUS9 SPPL3_MOUSE 98.03 152 3 0 1 456 137 288 2E-80 249 Q9CUS9 SPPL3_MOUSE GO:0030660; GO:0042500; GO:0071458; GO:0071556; GO:0042803; GO:0006508; GO:0005791 Golgi-associated vesicle membrane; aspartic endopeptidase activity, intramembrane cleaving; integral to cytosolic side of endoplasmic reticulum membrane; integral to lumenal side of endoplasmic reticulum membrane; protein homodimerization activity; proteolysis; rough endoplasmic reticulum reviewed IPR007369; IPR006639; Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin-like protein 4) Sppl3 Imp2 Psl4 Usmg3 Mus musculus (Mouse) 384 Q9CUS9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0016445 GO:0016445 somatic diversification of immunoglobulins developmental processes P ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5573 sp Q9CWL8 CTBL1_MOUSE 75.71 564 131 3 1935 259 1 563 0 882 Q9CWL8 CTBL1_MOUSE GO:0000974; GO:0006915; GO:0043065; GO:0016445; GO:0005681 Prp19 complex; apoptotic process; positive regulation of apoptotic process; somatic diversification of immunoglobulins; spliceosomal complex reviewed IPR011989; IPR016024; IPR013180; Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) Ctnnbl1 Mus musculus (Mouse) 563 Q9CWL8 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0004527 GO:0004527 exonuclease activity other molecular function F ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0010212 GO:0010212 response to ionizing radiation other biological processes P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" signal transduction P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" stress response P ConsensusfromContig5821 sp Q9CZI9 AEN_MOUSE 52.36 212 95 2 987 364 107 316 8E-68 227 Q9CZI9 AEN_MOUSE GO:0004527; GO:0042771; GO:0003676; GO:0005730; GO:0005654; GO:0010212 exonuclease activity; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; nucleic acid binding; nucleolus; nucleoplasm; response to ionizing radiation reviewed IPR006055; IPR013520; IPR012337; Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Aen Isg20l1 Mus musculus (Mouse) 336 Q9CZI9 GO:0042771 GO:0042771 "DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis" death P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008260 GO:0008260 3-oxoacid CoA-transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008410 GO:0008410 CoA-transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0009725 GO:0009725 response to hormone stimulus other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0014823 GO:0014823 response to activity other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0032024 GO:0032024 positive regulation of insulin secretion transport P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0032024 GO:0032024 positive regulation of insulin secretion cell-cell signaling P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042594 GO:0042594 response to starvation stress response P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0045471 GO:0045471 response to ethanol other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0046950 GO:0046950 cellular ketone body metabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0046952 GO:0046952 ketone body catabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0060612 GO:0060612 adipose tissue development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0071229 ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 81.48 81 15 0 1 243 121 201 2E-57 146 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0071333 ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007507 GO:0007507 heart development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0007584 GO:0007584 response to nutrient other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008260 GO:0008260 3-oxoacid CoA-transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0008410 GO:0008410 CoA-transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0009725 GO:0009725 response to hormone stimulus other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0014823 GO:0014823 response to activity other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0032024 GO:0032024 positive regulation of insulin secretion transport P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0032024 GO:0032024 positive regulation of insulin secretion cell-cell signaling P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042493 GO:0042493 response to drug other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042594 GO:0042594 response to starvation stress response P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0045471 GO:0045471 response to ethanol other biological processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0046950 GO:0046950 cellular ketone body metabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0046952 GO:0046952 ketone body catabolic process other metabolic processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0060612 GO:0060612 adipose tissue development developmental processes P ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0071229 ConsensusfromContig57 sp Q9D0K2 SCOT1_MOUSE 73.91 69 18 0 240 446 201 269 2E-57 96.7 Q9D0K2 SCOT1_MOUSE GO:0008260; GO:0046952; GO:0042182; GO:0005759; GO:0005739 3-oxoacid CoA-transferase activity; ketone body catabolic process; ketone catabolic process; mitochondrial matrix; mitochondrion reviewed IPR012792; IPR012791; IPR014388; IPR004165; IPR004164; IPR004163; Ketone metabolism; succinyl-CoA degradation; acetoacetyl-CoA from succinyl-CoA: step 1/1. Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s) Oxct1 Oxct Scot Mus musculus (Mouse) 520 Q9D0K2 GO:0071333 ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0019367 GO:0019367 "fatty acid elongation, saturated fatty acid" other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0034626 GO:0034626 "fatty acid elongation, polyunsaturated fatty acid" other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 144 39 1 1304 873 138 280 2E-78 228 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0042761 GO:0042761 very-long-chain fatty acid biosynthetic process other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0016747 GO:0016747 "transferase activity, transferring acyl groups other than amino-acyl groups" other molecular function F ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0019367 GO:0019367 "fatty acid elongation, saturated fatty acid" other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0034626 GO:0034626 "fatty acid elongation, polyunsaturated fatty acid" other metabolic processes P ConsensusfromContig6050 sp Q9D2Y9 ELOV7_MOUSE 72.22 54 14 1 1456 1298 86 139 2E-78 87.4 Q9D2Y9 ELOV7_MOUSE GO:0005783; GO:0005789; GO:0034626; GO:0019367; GO:0016021; GO:0016740; GO:0042761 endoplasmic reticulum; endoplasmic reticulum membrane; fatty acid elongation, polyunsaturated fatty acid; fatty acid elongation, saturated fatty acid; integral to membrane; transferase activity; very long-chain fatty acid biosynthetic process reviewed IPR002076; Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase Elovl7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very-long-chain 3-oxoacyl-CoA synthase 7) Elovl7 Mus musculus (Mouse) 281 Q9D2Y9 GO:0042761 GO:0042761 very-long-chain fatty acid biosynthetic process other metabolic processes P ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1035 sp Q9D3B1 HACD2_MOUSE 88.5 113 13 0 341 3 111 223 2E-66 207 Q9D3B1 HACD2_MOUSE GO:0005789; GO:0006633; GO:0016021; GO:0016829 endoplasmic reticulum membrane; fatty acid biosynthetic process; integral to membrane; lyase activity reviewed IPR007482; Very-long-chain (3R)-3-hydroxyacyl-[acyl-carrier protein] dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B) Ptplb hacd2 Mus musculus (Mouse) 254 Q9D3B1 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 92.76 290 21 0 1218 349 212 501 0 519 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0071013 GO:0071013 nucleus ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6366 sp Q9D554 SF3A3_MOUSE 87.13 202 26 0 1849 1244 1 202 0 368 Q9D554 SF3A3_MOUSE GO:0008380; GO:0071013; GO:0006397; GO:0003676; GO:0008270 RNA splicing; catalytic step 2 spliceosome; mRNA processing; nucleic acid binding; zinc ion binding reviewed IPR024598; IPR021966; IPR015880; IPR000690; Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61) Sf3a3 Sap61 Mus musculus (Mouse) 501 Q9D554 GO:0071013 GO:0071013 nucleus ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0005506 GO:0005506 iron ion binding other molecular function F ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0016226 GO:0016226 iron-sulfur cluster assembly other metabolic processes P ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0032947 GO:0032947 protein complex scaffold other molecular function F ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5717 sp Q9D7P6 ISCU_MOUSE 79.62 157 31 1 1019 552 7 163 8E-82 253 Q9D7P6 ISCU_MOUSE GO:0005829; GO:0005506; GO:0016226; GO:0051536; GO:0005739 cytosol; iron ion binding; iron-sulfur cluster assembly; iron-sulfur cluster binding; mitochondrion reviewed IPR011339; IPR002871; Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein) Iscu Nifun Mus musculus (Mouse) 168 Q9D7P6 GO:0051536 GO:0051536 iron-sulfur cluster binding other molecular function F ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig708 sp Q9D844 DNJC4_MOUSE 48.37 184 91 2 62 604 21 203 8E-51 174 Q9D844 DNJC4_MOUSE GO:0016021; GO:0005739 integral to membrane; mitochondrion reviewed IPR001623; DnaJ homolog subfamily C member 4 (Multiple endocrine neoplasia type 1 candidate protein number 18 homolog) Dnajc4 Mcg18 Mus musculus (Mouse) 244 Q9D844 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig5722 sp Q9D8Z1 ASCC1_MOUSE 55.29 208 88 2 885 277 149 356 4E-74 238 Q9D8Z1 ASCC1_MOUSE GO:0003723; GO:0003824; GO:0005737; GO:0006355; GO:0005667; GO:0006351 RNA binding; catalytic activity; cytoplasm; regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR009210; IPR004087; IPR004088; IPR019510; IPR009097; Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Ascc1 Mus musculus (Mouse) 356 Q9D8Z1 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5722 sp Q9D8Z1 ASCC1_MOUSE 55.29 208 88 2 885 277 149 356 4E-74 238 Q9D8Z1 ASCC1_MOUSE GO:0003723; GO:0003824; GO:0005737; GO:0006355; GO:0005667; GO:0006351 RNA binding; catalytic activity; cytoplasm; regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR009210; IPR004087; IPR004088; IPR019510; IPR009097; Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Ascc1 Mus musculus (Mouse) 356 Q9D8Z1 GO:0005667 GO:0005667 transcription factor complex nucleus C ConsensusfromContig5722 sp Q9D8Z1 ASCC1_MOUSE 55.29 208 88 2 885 277 149 356 4E-74 238 Q9D8Z1 ASCC1_MOUSE GO:0003723; GO:0003824; GO:0005737; GO:0006355; GO:0005667; GO:0006351 RNA binding; catalytic activity; cytoplasm; regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR009210; IPR004087; IPR004088; IPR019510; IPR009097; Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Ascc1 Mus musculus (Mouse) 356 Q9D8Z1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5722 sp Q9D8Z1 ASCC1_MOUSE 55.29 208 88 2 885 277 149 356 4E-74 238 Q9D8Z1 ASCC1_MOUSE GO:0003723; GO:0003824; GO:0005737; GO:0006355; GO:0005667; GO:0006351 RNA binding; catalytic activity; cytoplasm; regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR009210; IPR004087; IPR004088; IPR019510; IPR009097; Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Ascc1 Mus musculus (Mouse) 356 Q9D8Z1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5722 sp Q9D8Z1 ASCC1_MOUSE 55.29 208 88 2 885 277 149 356 4E-74 238 Q9D8Z1 ASCC1_MOUSE GO:0003723; GO:0003824; GO:0005737; GO:0006355; GO:0005667; GO:0006351 RNA binding; catalytic activity; cytoplasm; regulation of transcription, DNA-dependent; transcription factor complex; transcription, DNA-dependent reviewed IPR009210; IPR004087; IPR004088; IPR019510; IPR009097; Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50) Ascc1 Mus musculus (Mouse) 356 Q9D8Z1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2044 sp Q9DAZ9 ZFY19_MOUSE 58.44 154 46 3 133 594 1 136 3E-52 181 Q9DAZ9 ZFY19_MOUSE GO:0008270 zinc ion binding reviewed IPR000306; IPR017455; IPR011011; IPR001841; IPR013083; Zinc finger FYVE domain-containing protein 19 Zfyve19 Mus musculus (Mouse) 389 Q9DAZ9 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2044 sp Q9DAZ9 ZFY19_MOUSE 58.44 154 46 3 133 594 1 136 3E-52 181 Q9DAZ9 ZFY19_MOUSE GO:0008270 zinc ion binding reviewed IPR000306; IPR017455; IPR011011; IPR001841; IPR013083; Zinc finger FYVE domain-containing protein 19 Zfyve19 Mus musculus (Mouse) 389 Q9DAZ9 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2044 sp Q9DAZ9 ZFY19_MOUSE 58.44 154 46 3 133 594 1 136 3E-52 181 Q9DAZ9 ZFY19_MOUSE GO:0008270 zinc ion binding reviewed IPR000306; IPR017455; IPR011011; IPR001841; IPR013083; Zinc finger FYVE domain-containing protein 19 Zfyve19 Mus musculus (Mouse) 389 Q9DAZ9 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2044 sp Q9DAZ9 ZFY19_MOUSE 58.44 154 46 3 133 594 1 136 3E-52 181 Q9DAZ9 ZFY19_MOUSE GO:0008270 zinc ion binding reviewed IPR000306; IPR017455; IPR011011; IPR001841; IPR013083; Zinc finger FYVE domain-containing protein 19 Zfyve19 Mus musculus (Mouse) 389 Q9DAZ9 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2044 sp Q9DAZ9 ZFY19_MOUSE 58.44 154 46 3 133 594 1 136 3E-52 181 Q9DAZ9 ZFY19_MOUSE GO:0008270 zinc ion binding reviewed IPR000306; IPR017455; IPR011011; IPR001841; IPR013083; Zinc finger FYVE domain-containing protein 19 Zfyve19 Mus musculus (Mouse) 389 Q9DAZ9 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0000149 GO:0000149 SNARE binding other molecular function F ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0007420 GO:0007420 brain development developmental processes P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0010807 GO:0010807 regulation of synaptic vesicle priming transport P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0010807 GO:0010807 regulation of synaptic vesicle priming cell organization and biogenesis P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0010807 GO:0010807 regulation of synaptic vesicle priming cell-cell signaling P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0019905 GO:0019905 syntaxin binding other molecular function F ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0030182 GO:0030182 neuron differentiation developmental processes P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0035249 GO:0035249 "synaptic transmission, glutamatergic" cell-cell signaling P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0035494 ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0045176 GO:0045176 apical protein localization other biological processes P ConsensusfromContig6080 sp Q9DB05 SNAA_MOUSE 86.96 253 33 0 924 166 43 295 9E-164 465 Q9DB05 SNAA_MOUSE GO:0035494; GO:0045176; GO:0007420; GO:0006886; GO:0030182; GO:0010807; GO:0035249; GO:0070044; GO:0019905 SNARE complex disassembly; apical protein localization; brain development; intracellular protein transport; neuron differentiation; regulation of synaptic vesicle priming; synaptic transmission, glutamatergic; synaptobrevin 2-SNAP-25-syntaxin-1a complex; syntaxin binding reviewed IPR000744; IPR011990; Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha) Napa Snapa Mus musculus (Mouse) 295 Q9DB05 GO:0070044 GO:0070044 synaptobrevin 2-SNAP-25-syntaxin-1a complex other membranes C ConsensusfromContig6032 sp Q9DBT3 CCD97_MOUSE 47.9 286 136 4 968 150 33 318 2E-51 182 Q9DBT3 CCD97_MOUSE reviewed IPR018613; Coiled-coil domain-containing protein 97 Ccdc97 D7Ertd462e Mus musculus (Mouse) 340 Q9DBT3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6032 sp Q9DBT3 CCD97_MOUSE 47.9 286 136 4 968 150 33 318 2E-51 182 Q9DBT3 CCD97_MOUSE reviewed IPR018613; Coiled-coil domain-containing protein 97 Ccdc97 D7Ertd462e Mus musculus (Mouse) 340 Q9DBT3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig6032 sp Q9DBT3 CCD97_MOUSE 47.9 286 136 4 968 150 33 318 2E-51 182 Q9DBT3 CCD97_MOUSE reviewed IPR018613; Coiled-coil domain-containing protein 97 Ccdc97 D7Ertd462e Mus musculus (Mouse) 340 Q9DBT3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 83.97 343 43 2 774 1784 243 579 0 607 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0071013 GO:0071013 nucleus ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5619 sp Q9DC48 PRP17_MOUSE 65.34 277 89 4 145 963 35 308 4E-108 345 Q9DC48 PRP17_MOUSE GO:0008380; GO:0071013; GO:0006397 RNA splicing; catalytic step 2 spliceosome; mRNA processing reviewed IPR015943; IPR001680; IPR019775; IPR017986; Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (PRP17 homolog) Cdc40 Prp17 Prpf17 Mus musculus (Mouse) 579 Q9DC48 GO:0071013 GO:0071013 nucleus ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0005802 GO:0005802 trans-Golgi network ER/Golgi C ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig6356 sp Q9DCR2 AP3S1_MOUSE 93.26 193 13 0 177 755 1 193 2E-130 380 Q9DCR2 AP3S1_MOUSE GO:0030123; GO:0005794; GO:0008089; GO:0048490; GO:0030659; GO:0006886; GO:0008565; GO:0005802 AP-3 adaptor complex; Golgi apparatus; anterograde axon cargo transport; anterograde synaptic vesicle transport; cytoplasmic vesicle membrane; intracellular protein transport; protein transporter activity; trans-Golgi network reviewed IPR016635; IPR022775; IPR000804; IPR011012; AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adapter-related protein complex 3 subunit sigma-1) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a) Ap3s1 Mus musculus (Mouse) 193 Q9DCR2 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5994 sp Q9DGE0 MP2K6_DANRE 78.82 340 68 1 42 1049 1 340 0 551 Q9DGE0 MP2K6_DANRE GO:0005524; GO:0005737; GO:0005856; GO:0005634; GO:0004674; GO:0006355; GO:0006950; GO:0006351 ATP binding; cytoplasm; cytoskeleton; nucleus; protein serine/threonine kinase activity; regulation of transcription, DNA-dependent; response to stress; transcription, DNA-dependent reviewed IPR011009; IPR000719; IPR002290; IPR008271; Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (Mitogen-activated protein kinase kinase 3) (zMKK3) map2k6 map2k3 Danio rerio (Zebrafish) (Brachydanio rerio) 361 Q9DGE0 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig1381 sp Q9DGN0 STAG2_XENLA 66.67 177 22 2 2 526 1053 1194 4E-57 204 Q9DGN0 STAG2_XENLA GO:0051301; GO:0007059; GO:0000775; GO:0007067; GO:0005634 O93309 cell division; chromosome segregation; chromosome, centromeric region; mitosis; nucleus reviewed IPR016024; IPR020839; IPR013721; Cohesin subunit SA-2 (xSA-2) (SCC3 homolog 2) (Stromal antigen 2 homolog) stag2 sa2 Xenopus laevis (African clawed frog) 1194 Q9DGN0 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0001517 GO:0001517 N-acetylglucosamine 6-O-sulfotransferase activity other molecular function F ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0006044 GO:0006044 N-acetylglucosamine metabolic process other metabolic processes P ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0006790 GO:0006790 sulfur metabolic process other metabolic processes P ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0008146 GO:0008146 sulfotransferase activity other molecular function F ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0008459 GO:0008459 chondroitin 6-sulfotransferase activity other molecular function F ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2139 sp Q9EP78 CHST7_MOUSE 53.76 173 67 2 9 488 241 413 1E-51 177 Q9EP78 CHST7_MOUSE GO:0000139; GO:0001517; GO:0006044; GO:0005975; GO:0008459; GO:0030206; GO:0016021 Golgi membrane; N-acetylglucosamine 6-O-sulfotransferase activity; N-acetylglucosamine metabolic process; carbohydrate metabolic process; chondroitin 6-sulfotransferase activity; chondroitin sulfate biosynthetic process; integral to membrane reviewed IPR016469; IPR027417; IPR000863; Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (mC6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4) Chst7 Gst5 Mus musculus (Mouse) 484 Q9EP78 GO:0030206 GO:0030206 chondroitin sulfate biosynthetic process other metabolic processes P ConsensusfromContig6367 sp Q9EP89 LACTB_MOUSE 58.96 441 160 5 1310 33 116 550 4E-162 482 Q9EP89 LACTB_MOUSE GO:0016787; GO:0005739 hydrolase activity; mitochondrion reviewed IPR001466; IPR012338; Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-) Lactb Lact1 Mus musculus (Mouse) 551 Q9EP89 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6367 sp Q9EP89 LACTB_MOUSE 58.96 441 160 5 1310 33 116 550 4E-162 482 Q9EP89 LACTB_MOUSE GO:0016787; GO:0005739 hydrolase activity; mitochondrion reviewed IPR001466; IPR012338; Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-) Lactb Lact1 Mus musculus (Mouse) 551 Q9EP89 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008143 GO:0008143 poly(A) RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 84.39 346 49 3 1066 38 148 491 0 610 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:2000623 ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008143 GO:0008143 poly(A) RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 97.03 101 3 0 1496 1194 4 104 3E-77 212 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:2000623 ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0000184 GO:0000184 "nuclear-transcribed mRNA catabolic process, nonsense-mediated decay" RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0003729 GO:0003729 mRNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008143 GO:0008143 poly(A) RNA binding nucleic acid binding activity F ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig5604 sp Q9EPH8 PABP1_RAT 69.12 68 21 0 1197 994 104 171 3E-77 100 Q9EPH8 PABP1_RAT GO:0008380; GO:0010494; GO:0031047; GO:0006397; GO:2000623; GO:0000184; GO:0000166; GO:0008143; GO:1900153; GO:0060213; GO:0005681 P35570 RNA splicing; cytoplasmic stress granule; gene silencing by RNA; mRNA processing; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; nucleotide binding; poly(A) RNA binding; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; spliceosomal complex reviewed IPR012677; IPR006515; IPR002004; IPR000504; Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1) Pabpc1 Pabp1 Rattus norvegicus (Rat) 636 Q9EPH8 GO:2000623 ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5977 sp Q9EPL8 IPO7_MOUSE 81.87 353 58 2 274 1320 61 411 0 583 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006606 GO:0006606 protein import into nucleus transport P ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6361 sp Q9EPL8 IPO7_MOUSE 85.41 610 85 1 1832 3 425 1030 0 987 Q9EPL8 IPO7_MOUSE GO:0005794; GO:0042393; GO:0005634; GO:0006606 Golgi apparatus; histone binding; nucleus; protein import into nucleus reviewed IPR011989; IPR016024; IPR013713; IPR001494; Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7) Ipo7 Ranbp7 Mus musculus (Mouse) 1038 Q9EPL8 GO:0042393 GO:0042393 histone binding other molecular function F ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0003730 GO:0003730 mRNA 3'-UTR binding nucleic acid binding activity F ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0005847 GO:0005847 mRNA cleavage and polyadenylation specificity factor complex nucleus C ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0006378 GO:0006378 mRNA polyadenylation RNA metabolism P ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0006379 GO:0006379 mRNA cleavage RNA metabolism P ConsensusfromContig1418 sp Q9EPU4 CPSF1_MOUSE 85 120 18 0 70 429 1016 1135 5E-65 221 Q9EPU4 CPSF1_MOUSE GO:0003730; GO:0006379; GO:0005847; GO:0006378 mRNA 3'-UTR binding; mRNA cleavage; mRNA cleavage and polyadenylation specificity factor complex; mRNA polyadenylation reviewed IPR004871; Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit) Cpsf1 Cpsf160 Mus musculus (Mouse) 1441 Q9EPU4 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5886 sp Q9EPZ8 RN103_RAT 76.82 384 88 1 4 1152 139 522 0 624 Q9EPZ8 RN103_RAT GO:0005783; GO:0005789; GO:0016021; GO:0004842; GO:0008270 endoplasmic reticulum; endoplasmic reticulum membrane; integral to membrane; ubiquitin-protein ligase activity; zinc ion binding reviewed IPR001841; IPR013083; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase RNF103 (EC 6.3.2.-) (Protein ADRG34) (RING finger protein 103) (Zinc finger protein 103) (Zfp-103) Rnf103 Zfp103 Rattus norvegicus (Rat) 682 Q9EPZ8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0004491 GO:0004491 methylmalonate-semialdehyde dehydrogenase (acylating) activity other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0006210 GO:0006210 thymine catabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0006573 GO:0006573 valine metabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0006574 GO:0006574 valine catabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0016620 GO:0016620 "oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0016790 GO:0016790 thiolester hydrolase activity other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0018478 GO:0018478 malonate-semialdehyde dehydrogenase (acetylating) activity other molecular function F ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0019484 GO:0019484 beta-alanine catabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0019859 GO:0019859 thymine metabolic process other metabolic processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0050873 GO:0050873 brown fat cell differentiation other biological processes P ConsensusfromContig6223 sp Q9EQ20 MMSA_MOUSE 82.36 499 88 0 2225 729 37 535 0 895 Q9EQ20 MMSA_MOUSE GO:0050873; GO:0018478; GO:0004491; GO:0005739 brown fat cell differentiation; malonate-semialdehyde dehydrogenase (acetylating) activity; methylmalonate-semialdehyde dehydrogenase (acylating) activity; mitochondrion reviewed IPR016161; IPR016163; IPR016160; IPR016162; IPR015590; IPR010061; Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) Aldh6a1 Mus musculus (Mouse) 535 Q9EQ20 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0006907 GO:0006907 pinocytosis transport P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0006907 GO:0006907 pinocytosis cell organization and biogenesis P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0030100 GO:0030100 regulation of endocytosis transport P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0030100 GO:0030100 regulation of endocytosis cell organization and biogenesis P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0032456 GO:0032456 endocytic recycling transport P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0050731 GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0055038 GO:0055038 recycling endosome membrane other cytoplasmic organelle C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0055038 GO:0055038 recycling endosome membrane other membranes C ConsensusfromContig1096 sp Q9EQP2 EHD4_MOUSE 85.31 143 21 0 2 430 37 179 2E-84 263 Q9EQP2 EHD4_MOUSE GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0031901; GO:0032456; GO:0005783; GO:0048471; GO:0005886; GO:0051260; GO:0055038 Q9QY17; Q9Z2P6 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; early endosome membrane; endocytic recycling; endoplasmic reticulum; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; recycling endosome membrane reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (PAST homolog 2) (mPAST2) Ehd4 Past2 Mus musculus (Mouse) 541 Q9EQP2 GO:0071363 ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6154 sp Q9ERI6 RDH14_MOUSE 70.99 293 77 2 1284 430 42 334 1E-137 407 Q9ERI6 RDH14_MOUSE GO:0005783; GO:0005739; GO:0016491 endoplasmic reticulum; mitochondrion; oxidoreductase activity reviewed IPR002198; IPR002347; IPR016040; Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) Rdh14 Mus musculus (Mouse) 334 Q9ERI6 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig4791 sp Q9ERW3 FGF13_RAT 90.48 105 10 0 315 1 81 185 2E-67 209 Q9ERW3 FGF13_RAT GO:0030424; GO:0048487; GO:0021795; GO:0005737; GO:0030425; GO:0045200; GO:0005576; GO:0030175; GO:0030426; GO:0021766; GO:0014704; GO:0044325; GO:0007612; GO:0007613; GO:0005874; GO:0008017; GO:0046785; GO:0048671; GO:0007026; GO:0001764; GO:0005634; GO:0005886; GO:0072659; GO:0017080 axon; beta-tubulin binding; cerebral cortex cell migration; cytoplasm; dendrite; establishment of neuroblast polarity; extracellular region; filopodium; growth cone; hippocampus development; intercalated disc; ion channel binding; learning; memory; microtubule; microtubule binding; microtubule polymerization; negative regulation of collateral sprouting; negative regulation of microtubule depolymerization; neuron migration; nucleus; plasma membrane; protein localization to plasma membrane; sodium channel regulator activity reviewed IPR008996; IPR028279; IPR002209; IPR028142; Fibroblast growth factor 13 (FGF-13) Fgf13 Rattus norvegicus (Rat) 245 Q9ERW3 GO:0008083 GO:0008083 growth factor activity signal transduction activity F ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0003222 ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development developmental processes P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development cell organization and biogenesis P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034450 GO:0034450 ubiquitin-ubiquitin ligase activity other molecular function F ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034976 GO:0034976 response to endoplasmic reticulum stress stress response P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0044257 GO:0044257 cellular protein catabolic process protein metabolism P ConsensusfromContig2029 sp Q9ES00 UBE4B_MOUSE 85.45 220 32 0 662 3 722 941 2E-135 415 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0003222 ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development developmental processes P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development cell organization and biogenesis P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034450 GO:0034450 ubiquitin-ubiquitin ligase activity other molecular function F ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034976 GO:0034976 response to endoplasmic reticulum stress stress response P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0044257 GO:0044257 cellular protein catabolic process protein metabolism P ConsensusfromContig2416 sp Q9ES00 UBE4B_MOUSE 74 150 39 0 487 38 305 454 2E-70 237 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000151 GO:0000151 ubiquitin ligase complex other cellular component C ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0000209 GO:0000209 protein polyubiquitination protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0003222 ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0009411 GO:0009411 response to UV other biological processes P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0019899 GO:0019899 enzyme binding other molecular function F ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development developmental processes P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0031175 GO:0031175 neuron projection development cell organization and biogenesis P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034450 GO:0034450 ubiquitin-ubiquitin ligase activity other molecular function F ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0034976 GO:0034976 response to endoplasmic reticulum stress stress response P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0044257 GO:0044257 cellular protein catabolic process protein metabolism P ConsensusfromContig5750 sp Q9ES00 UBE4B_MOUSE 90.68 236 22 0 2061 1354 936 1171 6E-132 424 Q9ES00 UBE4B_MOUSE GO:0005737; GO:0008626; GO:0006457; GO:0042787; GO:0009411; GO:0000151; GO:0034450; GO:0051082 cytoplasm; granzyme-mediated apoptotic signaling pathway; protein folding; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; response to UV; ubiquitin ligase complex; ubiquitin-ubiquitin ligase activity; unfolded protein binding reviewed IPR019474; IPR003613; IPR013083; Ubiquitin conjugation factor E4 B (Ubiquitin fusion degradation protein 2) (Ufd2a) Ube4b Ufd2 Mus musculus (Mouse) 1173 Q9ES00 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005795 GO:0005795 Golgi stack ER/Golgi C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005801 GO:0005801 cis-Golgi network ER/Golgi C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0006888 GO:0006888 ER to Golgi vesicle-mediated transport transport P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0008021 GO:0008021 synaptic vesicle other cellular component C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0016358 GO:0016358 dendrite development developmental processes P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0016358 GO:0016358 dendrite development cell organization and biogenesis P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0030008 GO:0030008 TRAPP complex ER/Golgi C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0030425 GO:0030425 dendrite other cellular component C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0045202 GO:0045202 synapse other cellular component C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0045211 GO:0045211 postsynaptic membrane other membranes C ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0045212 GO:0045212 neurotransmitter receptor biosynthetic process other metabolic processes P ConsensusfromContig2445 sp Q9ES56 TPPC4_MOUSE 83.54 158 26 0 2 475 4 161 5E-97 286 Q9ES56 TPPC4_MOUSE GO:0006888; GO:0005795; GO:0030008; GO:0030054; GO:0005801; GO:0030425; GO:0016358; GO:0005783; GO:0045212; GO:0005886; GO:0045211; GO:0008021; GO:0016192 ER to Golgi vesicle-mediated transport; Golgi stack; TRAPP complex; cell junction; cis-Golgi network; dendrite; dendrite development; endoplasmic reticulum; neurotransmitter receptor biosynthetic process; plasma membrane; postsynaptic membrane; synaptic vesicle; vesicle-mediated transport reviewed IPR011012; IPR007233; Trafficking protein particle complex subunit 4 (Synbindin) (TRS23 homolog) Trappc4 Sbdn Mus musculus (Mouse) 219 Q9ES56 GO:0045212 GO:0045212 neurotransmitter receptor biosynthetic process cell-cell signaling P ConsensusfromContig5942 sp Q9GKV7 FBX15_MACFA 33.77 231 148 4 980 294 115 342 1E-51 146 Q9GKV7 FBX15_MACFA reviewed IPR001810; F-box only protein 15 FBXO15 FBX15 QccE-19736 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 434 ConsensusfromContig5942 sp Q9GKV7 FBX15_MACFA 38.95 95 57 1 303 22 340 434 1E-51 79 Q9GKV7 FBX15_MACFA reviewed IPR001810; F-box only protein 15 FBXO15 FBX15 QccE-19736 Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey) 434 ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0004579 GO:0004579 dolichyl-diphosphooligosaccharide-protein glycotransferase activity other molecular function F ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0006486 GO:0006486 protein amino acid glycosylation protein metabolism P ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig55 sp Q9GMB0 RPN1_PIG 76.54 341 80 0 1289 267 268 608 0 563 Q9GMB0 RPN1_PIG GO:0004579; GO:0005789; GO:0016021; GO:0042470; GO:0006486 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; endoplasmic reticulum membrane; integral to membrane; melanosome; protein glycosylation reviewed IPR007676; Protein modification; protein glycosylation. Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (EC 2.4.99.18) (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1) RPN1 Sus scrofa (Pig) 608 Q9GMB0 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0004190 GO:0004190 aspartic-type endopeptidase activity other molecular function F ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0007586 GO:0007586 digestion other biological processes P ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1554 sp Q9GMY4 PEPC_SORUN 60.28 141 54 1 419 3 143 283 2E-51 173 Q9GMY4 PEPC_SORUN GO:0004190; GO:0007586; GO:0005576; GO:0006508 aspartic-type endopeptidase activity; digestion; extracellular region; proteolysis reviewed IPR001461; IPR001969; IPR012848; IPR021109; Gastricsin (EC 3.4.23.3) (Pepsinogen C) PGC PGNC Sorex unguiculatus (Long-clawed shrew) 389 Q9GMY4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016926 GO:0016926 protein desumoylation protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016929 GO:0016929 SUMO-specific protease activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0070646 GO:0070646 protein modification by small protein removal protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0090169 ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 54.5 211 91 1 508 1125 875 1085 7E-62 223 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0090234 ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016926 GO:0016926 protein desumoylation protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0016929 GO:0016929 SUMO-specific protease activity other molecular function F ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0070646 GO:0070646 protein modification by small protein removal protein metabolism P ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0090169 ConsensusfromContig6272 sp Q9GZR1 SENP6_HUMAN 76.99 113 25 1 2 340 677 788 6E-52 195 Q9GZR1 SENP6_HUMAN GO:0016929; GO:0005737; GO:0005634; GO:0016926; GO:0016925; GO:0006508; GO:0090234; GO:0090169 SUMO-specific protease activity; cytoplasm; nucleus; protein desumoylation; protein sumoylation; proteolysis; regulation of kinetochore assembly; regulation of spindle assembly reviewed IPR003653; Protein modification; protein sumoylation. Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6) SENP6 KIAA0797 SSP1 SUSP1 FKSG6 Homo sapiens (Human) 1112 Q9GZR1 GO:0090234 ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0001649 GO:0001649 osteoblast differentiation developmental processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0001933 GO:0001933 negative regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0003714 GO:0003714 transcription corepressor activity transcription regulatory activity F ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0005667 GO:0005667 transcription factor complex nucleus C ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0006469 GO:0006469 negative regulation of protein kinase activity other metabolic processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0010718 GO:0010718 positive regulation of epithelial to mesenchymal transition developmental processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0010718 GO:0010718 positive regulation of epithelial to mesenchymal transition cell organization and biogenesis P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0017145 GO:0017145 stem cell division other biological processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0032835 GO:0032835 glomerulus development developmental processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0035329 ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0035414 ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0045599 GO:0045599 negative regulation of fat cell differentiation other biological processes P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0060271 GO:0060271 cilium morphogenesis cell organization and biogenesis P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0060390 GO:0060390 regulation of SMAD protein nuclear translocation signal transduction P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0060390 GO:0060390 regulation of SMAD protein nuclear translocation transport P ConsensusfromContig1423 sp Q9GZV5 WWTR1_HUMAN 69.23 143 39 4 444 28 259 400 5E-58 192 Q9GZV5 WWTR1_HUMAN GO:0060271; GO:0005829; GO:0032835; GO:0035329; GO:0090090; GO:0035414; GO:0045599; GO:0006469; GO:0000122; GO:0005654; GO:0001649; GO:0008284; GO:0010718; GO:0045944; GO:0060390; GO:0017145; GO:0003713; GO:0003714; GO:0005667; GO:0006367; GO:0007179 Q8IX12; P35222; O95835; Q15561; Q969T9; P62258 cilium morphogenesis; cytosol; glomerulus development; hippo signaling cascade; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of catenin import into nucleus; negative regulation of fat cell differentiation; negative regulation of protein kinase activity; negative regulation of transcription from RNA polymerase II promoter; nucleoplasm; osteoblast differentiation; positive regulation of cell proliferation; positive regulation of epithelial to mesenchymal transition; positive regulation of transcription from RNA polymerase II promoter; regulation of SMAD protein import into nucleus; stem cell division; transcription coactivator activity; transcription corepressor activity; transcription factor complex; transcription initiation from RNA polymerase II promoter; transforming growth factor beta receptor signaling pathway reviewed IPR001202; WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif) WWTR1 TAZ Homo sapiens (Human) 400 Q9GZV5 GO:0090090 ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0008080 GO:0008080 N-acetyltransferase activity other molecular function F ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2355 sp Q9H0A0 NAT10_HUMAN 80.29 137 27 0 412 2 112 248 6E-58 198 Q9H0A0 NAT10_HUMAN GO:0005524; GO:0008080; GO:0005730; GO:0005634 Q9NX58 ATP binding; N-acetyltransferase activity; nucleolus; nucleus reviewed IPR016181; IPR013562; IPR000182; IPR007807; IPR027992; N-acetyltransferase 10 (EC 2.3.1.-) NAT10 ALP KIAA1709 Homo sapiens (Human) 1025 Q9H0A0 GO:0016746 GO:0016746 "transferase activity, transferring acyl groups" other molecular function F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell cycle and proliferation P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell organization and biogenesis P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007108 GO:0007108 "cytokinesis, initiation of separation" other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008272 GO:0008272 sulfate transport transport P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0035556 ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043015 GO:0043015 gamma-tubulin binding cytoskeletal activity F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051233 GO:0051233 spindle midzone cytoskeleton C ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051988 GO:0051988 regulation of attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0071777 ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0072686 ConsensusfromContig346 sp Q9H0H5 RGAP1_HUMAN 71.21 132 35 1 152 538 409 540 9E-57 194 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0097149 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007108 GO:0007108 "cytokinesis, initiation of separation" other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008272 GO:0008272 sulfate transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0035556 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043015 GO:0043015 gamma-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051233 GO:0051233 spindle midzone cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051988 GO:0051988 regulation of attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0071777 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0072686 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 48.04 306 147 5 1216 2100 325 629 1E-127 281 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0097149 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007108 GO:0007108 "cytokinesis, initiation of separation" other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008272 GO:0008272 sulfate transport transport P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0035556 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043015 GO:0043015 gamma-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051233 GO:0051233 spindle midzone cytoskeleton C ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051988 GO:0051988 regulation of attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0071777 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0072686 ConsensusfromContig5642 sp Q9H0H5 RGAP1_HUMAN 38.79 348 174 9 203 1219 8 325 1E-127 199 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0097149 ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000910 GO:0000910 cytokinesis other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell cycle and proliferation P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0000915 GO:0000915 "cytokinesis, contractile ring formation" cell organization and biogenesis P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0001669 GO:0001669 acrosomal vesicle other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007108 GO:0007108 "cytokinesis, initiation of separation" other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation cell cycle and proliferation P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007405 GO:0007405 neuroblast proliferation developmental processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008017 GO:0008017 microtubule binding cytoskeletal activity F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0008272 GO:0008272 sulfate transport transport P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0033205 GO:0033205 cytokinesis during cell cycle cell cycle and proliferation P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0035556 ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043014 GO:0043014 alpha-tubulin binding cytoskeletal activity F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043015 GO:0043015 gamma-tubulin binding cytoskeletal activity F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0048487 GO:0048487 beta-tubulin binding cytoskeletal activity F ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051056 GO:0051056 regulation of small GTPase mediated signal transduction signal transduction P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051233 GO:0051233 spindle midzone cytoskeleton C ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell cycle and proliferation P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051256 GO:0051256 spindle midzone assembly involved in mitosis cell organization and biogenesis P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0051988 GO:0051988 regulation of attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0071777 ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0072686 ConsensusfromContig6046 sp Q9H0H5 RGAP1_HUMAN 71.16 586 150 9 1795 62 58 632 0 805 Q9H0H5 RGAP1_HUMAN GO:0005096; GO:0001669; GO:0043014; GO:0019886; GO:0048487; GO:0007596; GO:0097149; GO:0032154; GO:0000915; GO:0007108; GO:0005829; GO:0009790; GO:0043015; GO:0046872; GO:0005874; GO:0008017; GO:0007018; GO:0030496; GO:0007405; GO:0005634; GO:0032467; GO:0051988; GO:0051056; GO:0007264; GO:0007283; GO:0051233; GO:0051256; GO:0008272 Q02241; Q16537; O75154; Q96RN1 GTPase activator activity; acrosomal vesicle; alpha-tubulin binding; antigen processing and presentation of exogenous peptide antigen via MHC class II; beta-tubulin binding; blood coagulation; centralspindlin complex; cleavage furrow; cytokinesis, actomyosin contractile ring assembly; cytokinesis, initiation of separation; cytosol; embryo development; gamma-tubulin binding; metal ion binding; microtubule; microtubule binding; microtubule-based movement; midbody; neuroblast proliferation; nucleus; positive regulation of cytokinesis; regulation of attachment of spindle microtubules to kinetochore; regulation of small GTPase mediated signal transduction; small GTPase mediated signal transduction; spermatogenesis; spindle midzone; spindle midzone assembly involved in mitosis; sulfate transport reviewed IPR002219; IPR008936; IPR000198; Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4) RACGAP1 KIAA1478 MGCRACGAP Homo sapiens (Human) 632 Q9H0H5 GO:0097149 ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0006024 GO:0006024 glycosaminoglycan biosynthetic process other metabolic processes P ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0008375 GO:0008375 acetylglucosaminyltransferase activity other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 66.42 137 46 0 413 3 655 791 2E-62 175 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0030158 GO:0030158 protein xylosyltransferase activity other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0006024 GO:0006024 glycosaminoglycan biosynthetic process other metabolic processes P ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0008375 GO:0008375 acetylglucosaminyltransferase activity other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0016757 GO:0016757 "transferase activity, transferring glycosyl groups" other molecular function F ConsensusfromContig1205 sp Q9H1B5 XYLT2_HUMAN 55.56 81 34 2 661 422 572 651 2E-62 85.1 Q9H1B5 XYLT2_HUMAN GO:0000139; GO:0008375; GO:0030206; GO:0005789; GO:0006024; GO:0015012; GO:0016021; GO:0030158 Golgi membrane; acetylglucosaminyltransferase activity; chondroitin sulfate biosynthetic process; endoplasmic reticulum membrane; glycosaminoglycan biosynthetic process; heparan sulfate proteoglycan biosynthetic process; integral to membrane; protein xylosyltransferase activity reviewed IPR003406; IPR024448; Glycan metabolism; chondroitin sulfate biosynthesis. Glycan metabolism; heparan sulfate biosynthesis. Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) XYLT2 XT2 UNQ3058/PRO9878 Homo sapiens (Human) 865 Q9H1B5 GO:0030158 GO:0030158 protein xylosyltransferase activity other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0006907 GO:0006907 pinocytosis transport P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0006907 GO:0006907 pinocytosis cell organization and biogenesis P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0030100 GO:0030100 regulation of endocytosis transport P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0030100 GO:0030100 regulation of endocytosis cell organization and biogenesis P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0032456 GO:0032456 endocytic recycling transport P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0050731 GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation protein metabolism P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0055038 GO:0055038 recycling endosome membrane other cytoplasmic organelle C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0055038 GO:0055038 recycling endosome membrane other membranes C ConsensusfromContig6256 sp Q9H223 EHD4_HUMAN 74.55 275 69 1 3 824 267 541 2E-141 429 Q9H223 EHD4_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0005509; GO:0071363; GO:0031901; GO:0032456; GO:0005783; GO:0003676; GO:0005634; GO:0048471; GO:0006907; GO:0005886; GO:0050731; GO:0051260; GO:0055038; GO:0030100 ATP binding; GTP binding; GTP catabolic process; GTPase activity; calcium ion binding; cellular response to growth factor stimulus; early endosome membrane; endocytic recycling; endoplasmic reticulum; nucleic acid binding; nucleus; perinuclear region of cytoplasm; pinocytosis; plasma membrane; positive regulation of peptidyl-tyrosine phosphorylation; protein homooligomerization; recycling endosome membrane; regulation of endocytosis reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4) EHD4 HCA10 HCA11 PAST4 FKSG7 Homo sapiens (Human) 541 Q9H223 GO:0071363 ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0001558 GO:0001558 regulation of cell growth other biological processes P ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0003854 GO:0003854 3-beta-hydroxy-delta5-steroid dehydrogenase activity other molecular function F ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0006694 GO:0006694 steroid biosynthetic process other metabolic processes P ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0006699 GO:0006699 bile acid biosynthetic process other metabolic processes P ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0008206 GO:0008206 bile acid metabolic process other metabolic processes P ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0044281 ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0047016 GO:0047016 "cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity" other molecular function F ConsensusfromContig2102 sp Q9H2F3 3BHS7_HUMAN 60.51 157 62 0 471 1 89 245 9E-60 196 Q9H2F3 3BHS7_HUMAN GO:0003854; GO:0006699; GO:0047016; GO:0005789; GO:0016021 3-beta-hydroxy-delta5-steroid dehydrogenase activity; bile acid biosynthetic process; cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity; endoplasmic reticulum membrane; integral to membrane reviewed IPR002225; IPR016040; Lipid metabolism; steroid biosynthesis. 3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181) HSD3B7 Homo sapiens (Human) 369 Q9H2F3 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5609 sp Q9H2U1 DHX36_HUMAN 75.29 340 78 2 1147 128 673 1006 0 536 Q9H2U1 DHX36_HUMAN GO:0005524; GO:0008026; GO:0005829; GO:0003725; GO:0045087; GO:0005634; GO:0032481; GO:0043330; GO:0009615 ATP binding; ATP-dependent helicase activity; cytosol; double-stranded RNA binding; innate immune response; nucleus; positive regulation of type I interferon production; response to exogenous dsRNA; response to virus reviewed IPR011545; IPR002464; IPR011709; IPR007502; IPR014001; IPR001650; IPR027417; Probable ATP-dependent RNA helicase DHX36 (EC 3.6.4.13) (DEAH box protein 36) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE) DHX36 DDX36 KIAA1488 MLEL1 RHAU Homo sapiens (Human) 1008 Q9H2U1 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 63.74 433 139 11 937 2211 275 697 0 370 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 96.43 140 5 0 519 938 136 275 0 288 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0007283 GO:0007283 spermatogenesis other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6143 sp Q9H3C7 GGNB2_HUMAN 70 160 46 1 115 588 1 160 2E-60 222 Q9H3C7 GGNB2_HUMAN GO:0030154; GO:0016023; GO:0007275; GO:0005634; GO:0007283 cell differentiation; cytoplasmic membrane-bounded vesicle; multicellular organismal development; nucleus; spermatogenesis reviewed IPR026073; Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403) GGNBP2 LCRG1 LZK1 ZNF403 Homo sapiens (Human) 697 Q9H3C7 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 64.24 302 108 0 17 922 37 338 3E-161 416 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0004180 GO:0004180 carboxypeptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 64.24 302 108 0 17 922 37 338 3E-161 416 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0004185 GO:0004185 serine-type carboxypeptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 64.24 302 108 0 17 922 37 338 3E-161 416 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 64.24 302 108 0 17 922 37 338 3E-161 416 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 64.24 302 108 0 17 922 37 338 3E-161 416 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 57.04 135 58 0 925 1329 340 474 3E-161 175 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0004180 GO:0004180 carboxypeptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 57.04 135 58 0 925 1329 340 474 3E-161 175 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0004185 GO:0004185 serine-type carboxypeptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 57.04 135 58 0 925 1329 340 474 3E-161 175 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 57.04 135 58 0 925 1329 340 474 3E-161 175 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6206 sp Q9H3G5 CPVL_HUMAN 57.04 135 58 0 925 1329 340 474 3E-161 175 Q9H3G5 CPVL_HUMAN GO:0006508; GO:0004185 proteolysis; serine-type carboxypeptidase activity reviewed IPR001563; IPR018202; Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP) CPVL VLP PSEC0124 UNQ197/PRO223 Homo sapiens (Human) 476 Q9H3G5 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0005044 GO:0005044 scavenger receptor activity signal transduction activity F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig472 sp Q9H3S3 TMPS5_HUMAN 60.14 143 56 1 31 459 313 454 2E-54 186 Q9H3S3 TMPS5_HUMAN GO:0016021; GO:0043025; GO:0008233; GO:0005886; GO:0006508; GO:0005044; GO:0004252 integral to membrane; neuronal cell body; peptidase activity; plasma membrane; proteolysis; scavenger receptor activity; serine-type endopeptidase activity reviewed IPR001254; IPR018114; IPR001314; IPR001190; IPR017448; IPR009003; Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin) TMPRSS5 Homo sapiens (Human) 457 Q9H3S3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0016891 GO:0016891 "endoribonuclease activity, producing 5'-phosphomonoesters" other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0042779 GO:0042779 tRNA 3'-trailer cleavage RNA metabolism P ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 56.88 276 116 2 1162 335 91 363 6E-125 316 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0008033 GO:0008033 tRNA processing RNA metabolism P ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0016891 GO:0016891 "endoribonuclease activity, producing 5'-phosphomonoesters" other molecular function F ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0042779 GO:0042779 tRNA 3'-trailer cleavage RNA metabolism P ConsensusfromContig6202 sp Q9H777 RNZ1_HUMAN 86.42 81 11 0 1431 1189 1 81 6E-125 155 Q9H777 RNZ1_HUMAN GO:0005829; GO:0016891; GO:0046872; GO:0005634; GO:0042779 cytosol; endoribonuclease activity, producing 5'-phosphomonoesters; metal ion binding; nucleus; tRNA 3'-trailer cleavage reviewed IPR001279; IPR013471; Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1) ELAC1 D29 Homo sapiens (Human) 363 Q9H777 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0005797 GO:0005797 Golgi medial cisterna ER/Golgi C ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0006996 GO:0006996 organelle organization cell organization and biogenesis P ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0007030 GO:0007030 Golgi organization cell organization and biogenesis P ConsensusfromContig6244 sp Q9H8Y8 GORS2_HUMAN 83.67 300 49 0 949 50 2 301 5E-153 444 Q9H8Y8 GORS2_HUMAN GO:0000139; GO:0000278; GO:0006996 Q99IB8; P13569 Golgi membrane; mitotic cell cycle; organelle organization reviewed IPR024958; IPR007583; IPR001478; Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59) GORASP2 GOLPH6 Homo sapiens (Human) 452 Q9H8Y8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0002039 GO:0002039 p53 binding other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0006306 GO:0006306 DNA methylation DNA metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0009790 GO:0009790 embryonic development developmental processes P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0016279 GO:0016279 protein-lysine N-methyltransferase activity other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0016571 GO:0016571 histone methylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0016571 GO:0016571 histone methylation cell organization and biogenesis P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0018022 GO:0018022 peptidyl-lysine methylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0018024 GO:0018024 histone-lysine N-methyltransferase activity other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0018026 GO:0018026 peptidyl-lysine monomethylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0018027 GO:0018027 peptidyl-lysine dimethylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0034968 GO:0034968 histone lysine methylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0034968 GO:0034968 histone lysine methylation cell organization and biogenesis P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0046974 GO:0046974 histone methyltransferase activity (H3-K9 specific) other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0046976 GO:0046976 histone methyltransferase activity (H3-K27 specific) other molecular function F ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0051567 GO:0051567 histone H3-K9 methylation protein metabolism P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0051567 GO:0051567 histone H3-K9 methylation cell organization and biogenesis P ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0070734 GO:0070734 protein metabolism ConsensusfromContig6217 sp Q9H9B1 EHMT1_HUMAN 67.02 282 93 0 1 846 995 1276 1E-136 431 Q9H9B1 EHMT1_HUMAN GO:0006306; GO:0005694; GO:0009790; GO:0046976; GO:0046974; GO:0000122; GO:0045892; GO:0005634; GO:0018027; GO:0018026; GO:0008270 Q99549; Q04206; Q04207 DNA methylation; chromosome; embryo development; histone methyltransferase activity (H3-K27 specific); histone methyltransferase activity (H3-K9 specific); negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; nucleus; peptidyl-lysine dimethylation; peptidyl-lysine monomethylation; zinc ion binding reviewed IPR002110; IPR020683; IPR007728; IPR003606; IPR001214; Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D) EHMT1 EUHMTASE1 GLP KIAA1876 KMT1D Homo sapiens (Human) 1298 Q9H9B1 GO:0070734 GO:0070734 cell organization and biogenesis ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0031011 GO:0031011 Ino80 complex nucleus C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 65.24 164 54 1 257 748 76 236 7E-75 229 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0070914 ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006302 GO:0006302 double-strand break repair stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006302 GO:0006302 double-strand break repair DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0031011 GO:0031011 Ino80 complex nucleus C ConsensusfromContig724 sp Q9H9F9 ARP5_HUMAN 51.56 64 30 1 40 228 1 64 7E-75 72.8 Q9H9F9 ARP5_HUMAN GO:0006310; GO:0031011; GO:0070914; GO:0005737; GO:0006302; GO:0006355; GO:0006351 Q9H981; Q16531; Q9ULG1 DNA recombination; Ino80 complex; UV-damage excision repair; cytoplasm; double-strand break repair; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; IPR027664; Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16) ACTR5 ARP5 Homo sapiens (Human) 607 Q9H9F9 GO:0070914 ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0003725 GO:0003725 double-stranded RNA binding nucleic acid binding activity F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0004525 GO:0004525 ribonuclease III activity other molecular function F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0006396 GO:0006396 RNA processing RNA metabolism P ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5952 sp Q9H9J2 RM44_HUMAN 55.44 294 128 1 792 1664 24 317 3E-87 282 Q9H9J2 RM44_HUMAN GO:0003723; GO:0006396; GO:0005739; GO:0090305; GO:0004525; GO:0005840 RNA binding; RNA processing; mitochondrion; nucleic acid phosphodiester bond hydrolysis; ribonuclease III activity; ribosome reviewed IPR014720; IPR000999; 39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) MRPL44 Homo sapiens (Human) 332 Q9H9J2 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0000049 GO:0000049 tRNA binding nucleic acid binding activity F ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0006611 GO:0006611 protein export from nucleus transport P ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig330 sp Q9HAV4 XPO5_HUMAN 64.32 185 61 2 2 541 343 527 1E-66 226 Q9HAV4 XPO5_HUMAN GO:0003723; GO:0005829; GO:0010467; GO:0031047; GO:0005654; GO:0006611; GO:0008565; GO:0000049 RNA binding; cytosol; gene expression; gene silencing by RNA; nucleoplasm; protein export from nucleus; protein transporter activity; tRNA binding reviewed IPR011989; IPR016024; IPR013598; IPR001494; Exportin-5 (Exp5) (Ran-binding protein 21) XPO5 KIAA1291 RANBP21 Homo sapiens (Human) 1204 Q9HAV4 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0005545 GO:0005545 phosphatidylinositol binding other molecular function F ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0005547 GO:0005547 "phosphatidylinositol-3,4,5-trisphosphate binding" other molecular function F ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0005795 GO:0005795 Golgi stack ER/Golgi C ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0010923 GO:0010923 negative regulation of phosphatase activity other metabolic processes P ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0043325 GO:0043325 "phosphatidylinositol-3,4-bisphosphate binding" other molecular function F ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig508 sp Q9HBF4 ZFYV1_HUMAN 60.22 181 71 1 149 691 6 185 3E-65 221 Q9HBF4 ZFYV1_HUMAN GO:0005545; GO:0005795; GO:0005783; GO:0010923; GO:0048471; GO:0005547; GO:0043325; GO:0008270 P62136 1-phosphatidylinositol binding; Golgi stack; endoplasmic reticulum; negative regulation of phosphatase activity; perinuclear region of cytoplasm; phosphatidylinositol-3,4,5-trisphosphate binding; phosphatidylinositol-3,4-bisphosphate binding; zinc ion binding reviewed IPR027417; IPR000306; IPR017455; IPR011011; IPR013083; Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1) ZFYVE1 DFCP1 KIAA1589 TAFF1 ZNFN2A1 PP10436 Homo sapiens (Human) 777 Q9HBF4 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 51.81 193 83 3 322 876 250 440 9E-66 173 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 51.81 193 83 3 322 876 250 440 9E-66 173 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 51.81 193 83 3 322 876 250 440 9E-66 173 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 88.68 53 6 0 152 310 193 245 9E-66 99.8 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 88.68 53 6 0 152 310 193 245 9E-66 99.8 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6120 sp Q9HCD5 NCOA5_HUMAN 88.68 53 6 0 152 310 193 245 9E-66 99.8 Q9HCD5 NCOA5_HUMAN GO:0005634; GO:0006355; GO:0006351 Q60674 nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004154; Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) NCOA5 KIAA1637 Homo sapiens (Human) 579 Q9HCD5 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5984 sp Q9HCI7 MSL2_HUMAN 61.16 242 90 4 2082 1366 323 563 5E-75 258 Q9HCI7 MSL2_HUMAN GO:0072487; GO:0043984; GO:0016874; GO:0008270 MSL complex; histone H4-K16 acetylation; ligase activity; zinc ion binding reviewed IPR001841; E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184) MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) 577 Q9HCI7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig5984 sp Q9HCI7 MSL2_HUMAN 61.16 242 90 4 2082 1366 323 563 5E-75 258 Q9HCI7 MSL2_HUMAN GO:0072487; GO:0043984; GO:0016874; GO:0008270 MSL complex; histone H4-K16 acetylation; ligase activity; zinc ion binding reviewed IPR001841; E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184) MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) 577 Q9HCI7 GO:0043984 GO:0043984 histone H4-K16 acetylation protein metabolism P ConsensusfromContig5984 sp Q9HCI7 MSL2_HUMAN 61.16 242 90 4 2082 1366 323 563 5E-75 258 Q9HCI7 MSL2_HUMAN GO:0072487; GO:0043984; GO:0016874; GO:0008270 MSL complex; histone H4-K16 acetylation; ligase activity; zinc ion binding reviewed IPR001841; E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184) MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) 577 Q9HCI7 GO:0043984 GO:0043984 histone H4-K16 acetylation cell organization and biogenesis P ConsensusfromContig5984 sp Q9HCI7 MSL2_HUMAN 61.16 242 90 4 2082 1366 323 563 5E-75 258 Q9HCI7 MSL2_HUMAN GO:0072487; GO:0043984; GO:0016874; GO:0008270 MSL complex; histone H4-K16 acetylation; ligase activity; zinc ion binding reviewed IPR001841; E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184) MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) 577 Q9HCI7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5984 sp Q9HCI7 MSL2_HUMAN 61.16 242 90 4 2082 1366 323 563 5E-75 258 Q9HCI7 MSL2_HUMAN GO:0072487; GO:0043984; GO:0016874; GO:0008270 MSL complex; histone H4-K16 acetylation; ligase activity; zinc ion binding reviewed IPR001841; E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184) MSL2 KIAA1585 MSL2L1 RNF184 Homo sapiens (Human) 577 Q9HCI7 GO:0072487 ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0000932 GO:0000932 cytoplasmic mRNA processing body other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0006402 GO:0006402 mRNA catabolic process RNA metabolism P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 92.86 84 4 1 253 2 444 525 3E-56 161 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0035278 GO:0035278 "gene silencing by miRNA, negative regulation of translation" protein metabolism P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0000932 GO:0000932 cytoplasmic mRNA processing body other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0006402 GO:0006402 mRNA catabolic process RNA metabolism P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0006417 GO:0006417 regulation of translation protein metabolism P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0031047 GO:0031047 gene silencing by RNA other metabolic processes P ConsensusfromContig2476 sp Q9HCK5 AGO4_HUMAN 94.12 34 2 0 333 232 415 448 3E-56 77 Q9HCK5 AGO4_HUMAN GO:0038095; GO:0007219; GO:0003723; GO:0000932; GO:0005829; GO:0007173; GO:0008543; GO:0010467; GO:0045087; GO:0006402; GO:0035068; GO:0035278; GO:0048011; GO:0048015 O15397; Q8NDV7 Fc-epsilon receptor signaling pathway; Notch signaling pathway; RNA binding; cytoplasmic mRNA processing body; cytosol; epidermal growth factor receptor signaling pathway; fibroblast growth factor receptor signaling pathway; gene expression; innate immune response; mRNA catabolic process; micro-ribonucleoprotein complex; negative regulation of translation involved in gene silencing by miRNA; neurotrophin TRK receptor signaling pathway; phosphatidylinositol-mediated signaling reviewed IPR014811; IPR003100; IPR003165; IPR012337; Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4) AGO4 EIF2C4 KIAA1567 Homo sapiens (Human) 861 Q9HCK5 GO:0035278 GO:0035278 "gene silencing by miRNA, negative regulation of translation" protein metabolism P ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig1910 sp Q9HD20 AT131_HUMAN 90.75 173 16 0 21 539 344 516 1E-90 292 Q9HD20 AT131_HUMAN GO:0005524; GO:0006200; GO:0019829; GO:0016021; GO:0046872 ATP binding; ATP catabolic process; cation-transporting ATPase activity; integral to membrane; metal ion binding reviewed IPR006544; IPR023299; IPR018303; IPR008250; IPR001757; IPR023214; Probable cation-transporting ATPase 13A1 (EC 3.6.3.-) ATP13A1 ATP13A KIAA1825 CGI-152 Homo sapiens (Human) 1204 Q9HD20 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0005798 GO:0005798 Golgi-associated vesicle ER/Golgi C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0030117 GO:0030117 membrane coat other membranes C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0030126 GO:0030126 COPI vesicle coat ER/Golgi C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0030126 GO:0030126 COPI vesicle coat other membranes C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0030663 GO:0030663 COPI coated vesicle membrane ER/Golgi C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0030663 GO:0030663 COPI coated vesicle membrane other membranes C ConsensusfromContig6364 sp Q9I8E6 COPG2_TAKRU 91.71 350 29 0 1 1050 524 873 0 637 Q9I8E6 COPG2_TAKRU GO:0030126; GO:0006886; GO:0005198; GO:0016192 COPI vesicle coat; intracellular protein transport; structural molecule activity; vesicle-mediated transport reviewed IPR011989; IPR016024; IPR002553; IPR015873; IPR009028; IPR013041; IPR017106; IPR013040; Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP) copg2 Takifugu rubripes (Japanese pufferfish) (Fugu rubripes) 873 Q9I8E6 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5649 sp Q9I9A7 CDT1_XENLA 63.66 322 116 1 3 965 294 615 3E-135 410 Q9I9A7 CDT1_XENLA GO:0003677; GO:0006260; GO:0007049; GO:0005634 O93352 DNA binding; DNA replication; cell cycle; nucleus reviewed IPR014939; DNA replication factor Cdt1 (XCDT1) cdt1 Xenopus laevis (African clawed frog) 617 Q9I9A7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5649 sp Q9I9A7 CDT1_XENLA 63.66 322 116 1 3 965 294 615 3E-135 410 Q9I9A7 CDT1_XENLA GO:0003677; GO:0006260; GO:0007049; GO:0005634 O93352 DNA binding; DNA replication; cell cycle; nucleus reviewed IPR014939; DNA replication factor Cdt1 (XCDT1) cdt1 Xenopus laevis (African clawed frog) 617 Q9I9A7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5649 sp Q9I9A7 CDT1_XENLA 63.66 322 116 1 3 965 294 615 3E-135 410 Q9I9A7 CDT1_XENLA GO:0003677; GO:0006260; GO:0007049; GO:0005634 O93352 DNA binding; DNA replication; cell cycle; nucleus reviewed IPR014939; DNA replication factor Cdt1 (XCDT1) cdt1 Xenopus laevis (African clawed frog) 617 Q9I9A7 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5649 sp Q9I9A7 CDT1_XENLA 63.66 322 116 1 3 965 294 615 3E-135 410 Q9I9A7 CDT1_XENLA GO:0003677; GO:0006260; GO:0007049; GO:0005634 O93352 DNA binding; DNA replication; cell cycle; nucleus reviewed IPR014939; DNA replication factor Cdt1 (XCDT1) cdt1 Xenopus laevis (African clawed frog) 617 Q9I9A7 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0005391 GO:0005391 sodium:potassium-exchanging ATPase activity transporter activity F ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0005890 GO:0005890 sodium:potassium-exchanging ATPase complex plasma membrane C ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0005890 GO:0005890 sodium:potassium-exchanging ATPase complex other membranes C ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0006813 GO:0006813 potassium ion transport transport P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6228 sp Q9I9C3 AT233_ANGAN 73.06 271 73 0 1180 368 31 301 1E-146 425 Q9I9C3 AT233_ANGAN GO:0005391; GO:0005890 sodium:potassium-exchanging ATPase activity; sodium:potassium-exchanging ATPase complex reviewed IPR000402; IPR015565; Sodium/potassium-transporting ATPase subunit beta-233 (Sodium/potassium-dependent ATPase subunit beta-233) atnb233 Anguilla anguilla (European freshwater eel) (Muraena anguilla) 302 Q9I9C3 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0043065 GO:0043065 positive regulation of apoptosis death P ConsensusfromContig4790 sp Q9I9N5 TRADD_DANRE 79.09 110 23 0 28 357 153 262 8E-58 186 Q9I9N5 TRADD_DANRE GO:0006915; GO:0005737; GO:0005856; GO:0005634; GO:0043123; GO:0043065; GO:0004871 apoptotic process; cytoplasm; cytoskeleton; nucleus; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of apoptotic process; signal transducer activity reviewed IPR011029; IPR000488; IPR009095; Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain protein) tradd Danio rerio (Zebrafish) (Brachydanio rerio) 293 Q9I9N5 GO:0043123 GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB cascade signal transduction P ConsensusfromContig5 sp Q9JHQ5 LZTL1_MOUSE 74.4 125 31 1 7 378 24 148 1E-59 192 Q9JHQ5 LZTL1_MOUSE GO:0005737; GO:0072594; GO:0042802 cytoplasm; establishment of protein localization to organelle; identical protein binding reviewed IPR026157; Leucine zipper transcription factor-like protein 1 Lztfl1 Mus musculus (Mouse) 299 Q9JHQ5 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5 sp Q9JHQ5 LZTL1_MOUSE 74.4 125 31 1 7 378 24 148 1E-59 192 Q9JHQ5 LZTL1_MOUSE GO:0005737; GO:0072594; GO:0042802 cytoplasm; establishment of protein localization to organelle; identical protein binding reviewed IPR026157; Leucine zipper transcription factor-like protein 1 Lztfl1 Mus musculus (Mouse) 299 Q9JHQ5 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig5 sp Q9JHQ5 LZTL1_MOUSE 74.4 125 31 1 7 378 24 148 1E-59 192 Q9JHQ5 LZTL1_MOUSE GO:0005737; GO:0072594; GO:0042802 cytoplasm; establishment of protein localization to organelle; identical protein binding reviewed IPR026157; Leucine zipper transcription factor-like protein 1 Lztfl1 Mus musculus (Mouse) 299 Q9JHQ5 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0004176 GO:0004176 ATP-dependent peptidase activity other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0009841 GO:0009841 mitochondrial endopeptidase Clp complex mitochondrion C ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0010952 GO:0010952 positive regulation of peptidase activity other biological processes P ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0016504 GO:0016504 peptidase activator activity enzyme regulator activity F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0042645 GO:0042645 mitochondrial nucleoid mitochondrion C ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig467 sp Q9JHS4 CLPX_MOUSE 93.04 115 8 0 1 345 242 356 1E-60 202 Q9JHS4 CLPX_MOUSE GO:0005524; GO:0004176; GO:0016887; GO:0046872; GO:0009841; GO:0005743; GO:0042645; GO:0016504; GO:0006457; GO:0051603 ATP binding; ATP-dependent peptidase activity; ATPase activity; metal ion binding; mitochondrial endopeptidase Clp complex; mitochondrial inner membrane; mitochondrial nucleoid; peptidase activator activity; protein folding; proteolysis involved in cellular protein catabolic process reviewed IPR003593; IPR013093; IPR019489; IPR004487; IPR027417; ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial Clpx Mus musculus (Mouse) 634 Q9JHS4 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0003774 GO:0003774 motor activity cytoskeletal activity F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0006200 GO:0006200 ATP catabolic process other metabolic processes P ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0016887 GO:0016887 ATPase activity other molecular function F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0030286 GO:0030286 dynein complex cytoskeleton C ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0033962 GO:0033962 cytoplasmic mRNA processing body assembly cell organization and biogenesis P ConsensusfromContig1522 sp Q9JHU4 DYHC1_MOUSE 93.37 196 12 1 590 3 2515 2709 9E-122 387 Q9JHU4 DYHC1_MOUSE GO:0005524; GO:0006200; GO:0016887; GO:0005794; GO:0005858; GO:0005813; GO:0003341; GO:0005737; GO:0033962; GO:0070062; GO:0030175; GO:0005874; GO:0003777; GO:0034063; GO:0006810 P07141 ATP binding; ATP catabolic process; ATPase activity; Golgi apparatus; axonemal dynein complex; centrosome; cilium movement; cytoplasm; cytoplasmic mRNA processing body assembly; extracellular vesicular exosome; filopodium; microtubule; microtubule motor activity; stress granule assembly; transport reviewed IPR003593; IPR011704; IPR026983; IPR024743; IPR024317; IPR004273; IPR013594; IPR013602; IPR027417; Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) Dync1h1 Dhc1 Dnch1 Dnchc1 Dyhc Mus musculus (Mouse) 4644 Q9JHU4 GO:0034063 GO:0034063 stress granule assembly cell organization and biogenesis P ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0005792 GO:0005792 microsome other membranes C ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0012505 GO:0012505 endomembrane system other cellular component C ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5928 sp Q9JI19 FIBP_MOUSE 71.15 357 103 0 1246 176 1 357 4E-180 521 Q9JI19 FIBP_MOUSE GO:0012505; GO:0016020; GO:0005634 endomembrane system; membrane; nucleus reviewed IPR008614; Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein) Fibp Mus musculus (Mouse) 357 Q9JI19 GO:0017134 GO:0017134 fibroblast growth factor binding other molecular function F ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig1284 sp Q9JJ28 FLII_MOUSE 85.83 120 17 0 3 362 95 214 2E-64 216 Q9JJ28 FLII_MOUSE GO:0030036; GO:0051014; GO:0005813; GO:0005737; GO:0005925; GO:0007275; GO:0005634; GO:0006355; GO:0006351 Q6PHZ2 actin cytoskeleton organization; actin filament severing; centrosome; cytoplasm; focal adhesion; multicellular organismal development; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR007123; IPR001611; IPR025875; IPR007122; Protein flightless-1 homolog Flii Fli1 Fliih Mus musculus (Mouse) 1271 Q9JJ28 GO:0051014 GO:0051014 actin filament severing other biological processes P ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0010941 GO:0010941 regulation of cell death death P ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0032543 GO:0032543 mitochondrial translation protein metabolism P ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0032543 GO:0032543 mitochondrial translation cell organization and biogenesis P ConsensusfromContig6199 sp Q9JJG9 NOA1_MOUSE 56.28 215 90 2 12 653 313 524 9E-76 247 Q9JJG9 NOA1_MOUSE GO:0005525; GO:0003924; GO:0006915; GO:0031314; GO:0005743; GO:0032543; GO:0010941; GO:0043457; GO:0042254 GTP binding; GTPase activity; apoptotic process; extrinsic to mitochondrial inner membrane; mitochondrial inner membrane; mitochondrial translation; regulation of cell death; regulation of cellular respiration; ribosome biogenesis reviewed IPR006073; IPR027417; Nitric oxide-associated protein 1 Noa1 MNCb-4931 Mus musculus (Mouse) 693 Q9JJG9 GO:0043457 GO:0043457 regulation of cellular respiration other metabolic processes P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0030837 GO:0030837 negative regulation of actin filament polymerization protein metabolism P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0030837 GO:0030837 negative regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0030838 GO:0030838 positive regulation of actin filament polymerization protein metabolism P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0030838 GO:0030838 positive regulation of actin filament polymerization cell organization and biogenesis P ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:0043195 GO:0043195 terminal button other cellular component C ConsensusfromContig6019 sp Q9JJV2 PROF2_MOUSE 78.83 137 29 0 2187 1777 4 140 4E-68 227 Q9JJV2 PROF2_MOUSE GO:0030036; GO:0005737; GO:0005856; GO:0030837; GO:0030838; GO:2000300; GO:0043195 P39053 actin cytoskeleton organization; cytoplasm; cytoskeleton; negative regulation of actin filament polymerization; positive regulation of actin filament polymerization; regulation of synaptic vesicle exocytosis; terminal bouton reviewed IPR005454; IPR027310; IPR005455; Profilin-2 (Profilin II) Pfn2 Mus musculus (Mouse) 140 Q9JJV2 GO:2000300 ConsensusfromContig5775 sp Q9JK81 MYG1_MOUSE 62.91 337 123 2 216 1220 29 365 7E-151 441 Q9JK81 MYG1_MOUSE GO:0035641; GO:0005739; GO:0005634 locomotory exploration behavior; mitochondrion; nucleus reviewed IPR003226; UPF0160 protein MYG1, mitochondrial (Protein Gamm1) Myg1 Mus musculus (Mouse) 380 Q9JK81 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig5775 sp Q9JK81 MYG1_MOUSE 62.91 337 123 2 216 1220 29 365 7E-151 441 Q9JK81 MYG1_MOUSE GO:0035641; GO:0005739; GO:0005634 locomotory exploration behavior; mitochondrion; nucleus reviewed IPR003226; UPF0160 protein MYG1, mitochondrial (Protein Gamm1) Myg1 Mus musculus (Mouse) 380 Q9JK81 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5775 sp Q9JK81 MYG1_MOUSE 62.91 337 123 2 216 1220 29 365 7E-151 441 Q9JK81 MYG1_MOUSE GO:0035641; GO:0005739; GO:0005634 locomotory exploration behavior; mitochondrion; nucleus reviewed IPR003226; UPF0160 protein MYG1, mitochondrial (Protein Gamm1) Myg1 Mus musculus (Mouse) 380 Q9JK81 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5775 sp Q9JK81 MYG1_MOUSE 62.91 337 123 2 216 1220 29 365 7E-151 441 Q9JK81 MYG1_MOUSE GO:0035641; GO:0005739; GO:0005634 locomotory exploration behavior; mitochondrion; nucleus reviewed IPR003226; UPF0160 protein MYG1, mitochondrial (Protein Gamm1) Myg1 Mus musculus (Mouse) 380 Q9JK81 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0005080 GO:0005080 protein kinase C binding other molecular function F ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0030018 GO:0030018 Z disc other cellular component C ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0031143 GO:0031143 pseudopodium other cellular component C ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig597 sp Q9JKS4 LDB3_MOUSE 91.73 133 11 0 3 401 591 723 2E-89 281 Q9JKS4 LDB3_MOUSE GO:0030018; GO:0005856; GO:0051371; GO:0048471; GO:0005080; GO:0031143; GO:0045214; GO:0008270 Z disc; cytoskeleton; muscle alpha-actinin binding; perinuclear region of cytoplasm; protein kinase C binding; pseudopodium; sarcomere organization; zinc ion binding reviewed IPR001478; IPR006643; IPR001781; LIM domain-binding protein 3 (Protein cypher) (Protein oracle) (Z-band alternatively spliced PDZ-motif protein) Ldb3 Kiaa0613 Mus musculus (Mouse) 723 Q9JKS4 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005784 GO:0005784 translocon complex ER/Golgi C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005784 GO:0005784 translocon complex other membranes C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0006613 GO:0006613 cotranslational protein targeting to membrane transport P ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5726 sp Q9JKW0 AR6P1_MOUSE 75.92 191 46 0 94 666 1 191 1E-99 301 Q9JKW0 AR6P1_MOUSE GO:0005784; GO:0006613; GO:0005829; GO:0016021 Sec61 translocon complex; cotranslational protein targeting to membrane; cytosol; integral to membrane reviewed IPR003388; ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Protein TBX2) Arl6ip1 Arl6ip Mus musculus (Mouse) 203 Q9JKW0 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2840 sp Q9JLB0 MPP6_MOUSE 65.44 136 47 0 3 410 388 523 4E-58 195 Q9JLB0 MPP6_MOUSE GO:0004385; GO:0016021; GO:0005886 O70318 guanylate kinase activity; integral to membrane; plasma membrane reviewed IPR008145; IPR008144; IPR020590; IPR004172; IPR014775; IPR027417; IPR001478; IPR011511; IPR001452; MAGUK p55 subfamily member 6 (Dlgh4 protein) (P55T protein) (Protein associated with Lin-7 2) Mpp6 Dlgh4 Pals2 Mus musculus (Mouse) 553 Q9JLB0 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2840 sp Q9JLB0 MPP6_MOUSE 65.44 136 47 0 3 410 388 523 4E-58 195 Q9JLB0 MPP6_MOUSE GO:0004385; GO:0016021; GO:0005886 O70318 guanylate kinase activity; integral to membrane; plasma membrane reviewed IPR008145; IPR008144; IPR020590; IPR004172; IPR014775; IPR027417; IPR001478; IPR011511; IPR001452; MAGUK p55 subfamily member 6 (Dlgh4 protein) (P55T protein) (Protein associated with Lin-7 2) Mpp6 Dlgh4 Pals2 Mus musculus (Mouse) 553 Q9JLB0 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2840 sp Q9JLB0 MPP6_MOUSE 65.44 136 47 0 3 410 388 523 4E-58 195 Q9JLB0 MPP6_MOUSE GO:0004385; GO:0016021; GO:0005886 O70318 guanylate kinase activity; integral to membrane; plasma membrane reviewed IPR008145; IPR008144; IPR020590; IPR004172; IPR014775; IPR027417; IPR001478; IPR011511; IPR001452; MAGUK p55 subfamily member 6 (Dlgh4 protein) (P55T protein) (Protein associated with Lin-7 2) Mpp6 Dlgh4 Pals2 Mus musculus (Mouse) 553 Q9JLB0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0004197 GO:0004197 cysteine-type endopeptidase activity other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0004198 GO:0004198 calcium-dependent cysteine-type endopeptidase activity other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3742 sp Q9JLG8 CAN15_MOUSE 87.18 117 15 0 1 351 979 1095 1E-63 214 Q9JLG8 CAN15_MOUSE GO:0004198; GO:0005622; GO:0006508; GO:0008270 calcium-dependent cysteine-type endopeptidase activity; intracellular; proteolysis; zinc ion binding reviewed IPR022684; IPR000169; IPR001300; IPR001876; Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog) Capn15 Solh Mus musculus (Mouse) 1095 Q9JLG8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0001725 GO:0001725 stress fiber cytoskeleton C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005925 GO:0005925 focal adhesion plasma membrane C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005925 GO:0005925 focal adhesion other membranes C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig5628 sp Q9MZD2 FLNB_RABIT 72.59 197 53 1 5 595 99 294 2E-98 305 Q9MZD2 FLNB_RABIT GO:0005938; GO:0005856 cell cortex; cytoskeleton reviewed IPR001298; IPR017868; IPR013783; IPR014756; Filamin-B (FLN-B) (ABP-280-like protein) (Actin-binding-like protein) (Beta-filamin) (C254) (Fragment) FLNB Oryctolagus cuniculus (Rabbit) 294 Q9MZD2 GO:0007519 GO:0007519 skeletal muscle tissue development developmental processes P ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0005975 GO:0005975 carbohydrate metabolic process other metabolic processes P ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0006094 GO:0006094 gluconeogenesis other metabolic processes P ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0042132 GO:0042132 "fructose 1,6-bisphosphate 1-phosphatase activity" other molecular function F ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0042578 GO:0042578 phosphoric ester hydrolase activity other molecular function F ConsensusfromContig245 sp Q9N0J6 F16P2_RABIT 78.91 128 24 1 2 385 41 165 3E-62 199 Q9N0J6 F16P2_RABIT GO:0042132; GO:0006094; GO:0046872 fructose 1,6-bisphosphate 1-phosphatase activity; gluconeogenesis; metal ion binding reviewed IPR000146; IPR028343; IPR020548; Carbohydrate biosynthesis; gluconeogenesis. Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) FBP2 Oryctolagus cuniculus (Rabbit) 339 Q9N0J6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0003735 GO:0003735 structural constituent of ribosome other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0004221 GO:0004221 ubiquitin thiolesterase activity other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0004843 GO:0004843 ubiquitin-specific protease activity other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005840 GO:0005840 ribosome translational apparatus C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005881 GO:0005881 cytoplasmic microtubule cytoskeleton C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0006917 GO:0006917 induction of apoptosis death P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0007346 GO:0007346 regulation of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0019901 GO:0019901 protein kinase binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0030496 GO:0030496 midbody other cellular component C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane plasma membrane C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0031234 GO:0031234 extrinsic to internal side of plasma membrane other membranes C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0032088 GO:0032088 negative regulation of NF-kappaB transcription factor activity RNA metabolism P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0032480 GO:0032480 negative regulation of type I interferon production other biological processes P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0035872 ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0042347 GO:0042347 negative regulation of NF-kappaB import into nucleus transport P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0045087 GO:0045087 innate immune response stress response P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0070064 GO:0070064 proline-rich region binding other molecular function F ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0070423 GO:0070423 nucleotide-binding oligomerization domain containing signaling pathway signal transduction P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0070423 GO:0070423 nucleotide-binding oligomerization domain containing signaling pathway stress response P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0070507 GO:0070507 regulation of microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0070536 GO:0070536 protein K63-linked deubiquitination protein metabolism P ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:0090090 ConsensusfromContig3526 sp Q9NQC7 CYLD_HUMAN 89.6 125 13 0 3 377 653 777 9E-72 235 Q9NQC7 CYLD_HUMAN GO:0016055; GO:0007049; GO:0005829; GO:0031234; GO:0045087; GO:0005874; GO:0042347; GO:0032088; GO:0090090; GO:0032480; GO:0070423; GO:0048471; GO:2001238; GO:0070536; GO:2001242; GO:0070507; GO:0007346; GO:0004221; GO:0006511; GO:0004843; GO:0008270 O95786; Q9UBN7; Q96J02; Q96J02-2; Q71U36 Wnt receptor signaling pathway; cell cycle; cytosol; extrinsic to internal side of plasma membrane; innate immune response; microtubule; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of type I interferon production; nucleotide-binding oligomerization domain containing signaling pathway; perinuclear region of cytoplasm; positive regulation of extrinsic apoptotic signaling pathway; protein K63-linked deubiquitination; regulation of intrinsic apoptotic signaling pathway; regulation of microtubule cytoskeleton organization; regulation of mitotic cell cycle; ubiquitin thiolesterase activity; ubiquitin-dependent protein catabolic process; ubiquitin-specific protease activity; zinc ion binding reviewed IPR000938; IPR018200; IPR001394; Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) CYLD CYLD1 KIAA0849 HSPC057 Homo sapiens (Human) 956 Q9NQC7 GO:2001238 ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0008781 GO:0008781 N-acylneuraminate cytidylyltransferase activity other molecular function F ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0009103 GO:0009103 lipopolysaccharide biosynthetic process other metabolic processes P ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0016051 GO:0016051 carbohydrate biosynthetic process other metabolic processes P ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0047444 GO:0047444 N-acylneuraminate-9-phosphate synthase activity other molecular function F ConsensusfromContig5600 sp Q9NR45 SIAS_HUMAN 78.49 358 77 0 1440 367 1 358 0 587 Q9NR45 SIAS_HUMAN GO:0050462; GO:0008781; GO:0047444; GO:0005737; GO:0005829; GO:0009103 N-acetylneuraminate synthase activity; N-acylneuraminate cytidylyltransferase activity; N-acylneuraminate-9-phosphate synthase activity; cytoplasm; cytosol; lipopolysaccharide biosynthetic process reviewed IPR006190; IPR013785; IPR006013; IPR013132; IPR013974; Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase) NANS SAS Homo sapiens (Human) 359 Q9NR45 GO:0050462 GO:0050462 N-acetylneuraminate synthase activity other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0001655 GO:0001655 urogenital system development developmental processes P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0005721 GO:0005721 centromeric heterochromatin other cellular component C ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006306 GO:0006306 DNA methylation DNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006342 GO:0006342 chromatin silencing RNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006346 GO:0006346 methylation-dependent chromatin silencing RNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006346 GO:0006346 methylation-dependent chromatin silencing cell organization and biogenesis P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0006916 GO:0006916 anti-apoptosis death P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0010216 GO:0010216 maintenance of DNA methylation DNA metabolism P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0031508 GO:0031508 centromeric heterochromatin formation cell organization and biogenesis P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0046651 GO:0046651 lymphocyte proliferation cell cycle and proliferation P ConsensusfromContig6095 sp Q9NRZ9 HELLS_HUMAN 68.55 585 178 4 34 1785 253 832 0 821 Q9NRZ9 HELLS_HUMAN GO:0005524; GO:0003677; GO:0051301; GO:0005721; GO:0031508; GO:0003682; GO:0004386; GO:0046651; GO:0010216; GO:0006346; GO:0007067; GO:0007275; GO:0043066; GO:0005634; GO:0006351; GO:0001655 O00716 ATP binding; DNA binding; cell division; centromeric heterochromatin; centromeric heterochromatin assembly; chromatin binding; helicase activity; lymphocyte proliferation; maintenance of DNA methylation; methylation-dependent chromatin silencing; mitosis; multicellular organismal development; negative regulation of apoptotic process; nucleus; transcription, DNA-dependent; urogenital system development reviewed IPR014001; IPR001650; IPR027417; IPR000330; Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6) HELLS PASG SMARCA6 Nbla10143 Homo sapiens (Human) 838 Q9NRZ9 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0009789 GO:0009789 positive regulation of abscisic acid mediated signaling signal transduction P ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0010314 GO:0010314 phosphatidylinositol-5-phosphate binding other molecular function F ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0030864 GO:0030864 cortical actin cytoskeleton cytoskeleton C ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0032266 GO:0032266 phosphatidylinositol 3-phosphate binding other molecular function F ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1057 sp Q9NS86 LANC2_HUMAN 73.13 227 61 0 8 688 73 299 4E-122 361 Q9NS86 LANC2_HUMAN GO:0005524; GO:0005525; GO:0003824; GO:0030864; GO:0005829; GO:0008152; GO:0045892; GO:0005634; GO:0032266; GO:0070273; GO:0010314; GO:0005886; GO:0009789 ATP binding; GTP binding; catalytic activity; cortical actin cytoskeleton; cytosol; metabolic process; negative regulation of transcription, DNA-dependent; nucleus; phosphatidylinositol-3-phosphate binding; phosphatidylinositol-4-phosphate binding; phosphatidylinositol-5-phosphate binding; plasma membrane; positive regulation of abscisic acid mediated signaling pathway reviewed IPR012341; IPR007822; IPR020464; LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) LANCL2 GPR69B TASP Homo sapiens (Human) 450 Q9NS86 GO:0070273 GO:0070273 phosphatidylinositol-4-phosphate binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0004826 GO:0004826 phenylalanine-tRNA ligase activity other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 78.22 101 21 1 221 523 53 152 6E-63 166 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0004812 GO:0004812 aminoacyl-tRNA ligase activity other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0004826 GO:0004826 phenylalanine-tRNA ligase activity other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006412 GO:0006412 translation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006418 GO:0006418 tRNA aminoacylation for protein translation RNA metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation protein metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0006432 GO:0006432 phenylalanyl-tRNA aminoacylation RNA metabolism P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig238 sp Q9NSD9 SYFB_HUMAN 87.76 49 6 0 64 210 1 49 6E-63 95.5 Q9NSD9 SYFB_HUMAN GO:0005524; GO:0003723; GO:0005829; GO:0000287; GO:0004826; GO:0006432; GO:0006418 ATP binding; RNA binding; cytosol; magnesium ion binding; phenylalanine-tRNA ligase activity; phenylalanyl-tRNA aminoacylation; tRNA aminoacylation for protein translation reviewed IPR005146; IPR009061; IPR004531; IPR020825; IPR005147; Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS) FARSB FARSLB FRSB HSPC173 Homo sapiens (Human) 589 Q9NSD9 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0006357 GO:0006357 regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig3048 sp Q9NSI6 BRWD1_HUMAN 79.23 130 27 0 1 390 147 276 1E-65 222 Q9NSI6 BRWD1_HUMAN GO:0005737; GO:0007010; GO:0005730; GO:0008360; GO:0006357; GO:0006351 cytoplasm; cytoskeleton organization; nucleolus; regulation of cell shape; regulation of transcription from RNA polymerase II promoter; transcription, DNA-dependent reviewed IPR001487; IPR018359; IPR015943; IPR001680; IPR019775; IPR017986; Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9) BRWD1 C21orf107 WDR9 Homo sapiens (Human) 2320 Q9NSI6 GO:0008360 GO:0008360 regulation of cell shape cell organization and biogenesis P ConsensusfromContig616 sp Q9NTX5 ECHD1_HUMAN 65.82 158 54 0 203 676 30 187 6E-68 218 Q9NTX5 ECHD1_HUMAN GO:0016831; GO:0005829; GO:0004492 carboxy-lyase activity; cytosol; methylmalonyl-CoA decarboxylase activity reviewed IPR001753; IPR018376; Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD) (EC 4.1.1.41) ECHDC1 Homo sapiens (Human) 307 Q9NTX5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig616 sp Q9NTX5 ECHD1_HUMAN 65.82 158 54 0 203 676 30 187 6E-68 218 Q9NTX5 ECHD1_HUMAN GO:0016831; GO:0005829; GO:0004492 carboxy-lyase activity; cytosol; methylmalonyl-CoA decarboxylase activity reviewed IPR001753; IPR018376; Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD) (EC 4.1.1.41) ECHDC1 Homo sapiens (Human) 307 Q9NTX5 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1546 sp Q9NUQ9 FA49B_HUMAN 87.77 139 17 0 445 29 186 324 9E-86 260 Q9NUQ9 FA49B_HUMAN GO:0005929 cilium reviewed IPR009828; Protein FAM49B (L1) FAM49B BM-009 Homo sapiens (Human) 324 ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0005643 GO:0005643 nuclear pore nucleus C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0005643 GO:0005643 nuclear pore other membranes C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0031965 GO:0031965 nuclear membrane nucleus C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0031965 GO:0031965 nuclear membrane other membranes C ConsensusfromContig5816 sp Q9NUU7 DD19A_HUMAN 87.65 421 52 0 1737 475 58 478 0 793 Q9NUU7 DD19A_HUMAN GO:0005524; GO:0008026; GO:0003723; GO:0005737; GO:0051028; GO:0031965; GO:0005643; GO:0015031; GO:0010043 ATP binding; ATP-dependent helicase activity; RNA binding; cytoplasm; mRNA transport; nuclear membrane; nuclear pore; protein transport; response to zinc ion reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR014014; ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A) DDX19A DDX19L Homo sapiens (Human) 478 Q9NUU7 GO:0051028 GO:0051028 mRNA transport transport P ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0005096 GO:0005096 GTPase activator activity enzyme regulator activity F ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0005097 GO:0005097 Rab GTPase activator activity enzyme regulator activity F ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0032313 GO:0032313 regulation of Rab GTPase activity signal transduction P ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0032851 GO:0032851 positive regulation of Rab GTPase activity signal transduction P ConsensusfromContig3282 sp Q9NVG8 TBC13_HUMAN 83.58 134 18 2 1 396 121 252 7E-74 233 Q9NVG8 TBC13_HUMAN GO:0005097; GO:0032851 Rab GTPase activator activity; positive regulation of Rab GTPase activity reviewed IPR000195; TBC1 domain family member 13 TBC1D13 Homo sapiens (Human) 400 Q9NVG8 GO:0043547 GO:0043547 positive regulation of GTPase activity other biological processes P ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 79.31 145 30 0 1494 1060 414 558 4E-93 242 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig5961 sp Q9NVH1 DJC11_HUMAN 81.43 70 13 0 1693 1484 348 417 4E-93 123 Q9NVH1 DJC11_HUMAN GO:0005743 mitochondrial inner membrane reviewed IPR024586; IPR001623; IPR018253; DnaJ homolog subfamily C member 11 DNAJC11 Homo sapiens (Human) 559 Q9NVH1 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig6304 sp Q9NVN8 GNL3L_HUMAN 55.14 350 156 1 103 1152 29 377 3E-128 399 Q9NVN8 GNL3L_HUMAN GO:0005525; GO:0003924; GO:0005739; GO:0005730; GO:0042254 Q00987 GTP binding; GTPase activity; mitochondrion; nucleolus; ribosome biogenesis reviewed IPR006073; IPR027417; Guanine nucleotide-binding protein-like 3-like protein GNL3L Homo sapiens (Human) 582 Q9NVN8 GO:0042254 GO:0042254 ribosome biogenesis other biological processes P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0004693 GO:0004693 cyclin-dependent protein kinase activity kinase activity F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0008353 GO:0008353 RNA polymerase II carboxy-terminal domain kinase activity kinase activity F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0016607 GO:0016607 nuclear speck nucleus C ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0019908 GO:0019908 nuclear cyclin-dependent protein kinase holoenzyme complex nucleus C ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0030332 GO:0030332 cyclin binding other molecular function F ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0043405 GO:0043405 regulation of MAP kinase activity other metabolic processes P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig5852 sp Q9NYV4 CDK12_HUMAN 82.84 443 71 2 2201 3514 696 1138 0 746 Q9NYV4 CDK12_HUMAN GO:0005524; GO:0008353; GO:0008380; GO:0002944; GO:0004693; GO:0006397; GO:0019908; GO:0016607; GO:0005730; GO:0070816; GO:0046777; GO:0043405 ATP binding; RNA polymerase II carboxy-terminal domain kinase activity; RNA splicing; cyclin K-CDK12 complex; cyclin-dependent protein serine/threonine kinase activity; mRNA processing; nuclear cyclin-dependent protein kinase holoenzyme complex; nuclear speck; nucleolus; phosphorylation of RNA polymerase II C-terminal domain; protein autophosphorylation; regulation of MAP kinase activity reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) CDK12 CRK7 CRKRS KIAA0904 Homo sapiens (Human) 1490 Q9NYV4 GO:0070816 GO:0070816 protein metabolism ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0006360 GO:0006360 transcription from RNA polymerase I promoter RNA metabolism P ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0006361 GO:0006361 transcription initiation from RNA polymerase I promoter RNA metabolism P ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0006361 GO:0006361 transcription initiation from RNA polymerase I promoter cell organization and biogenesis P ConsensusfromContig3132 sp Q9NYV6 RRN3_HUMAN 69.8 149 45 0 2 448 95 243 2E-58 197 Q9NYV6 RRN3_HUMAN GO:0008283; GO:0007028; GO:0048872; GO:0001701; GO:0043066; GO:0005730; GO:0007000; GO:0005654; GO:0045893; GO:2000142; GO:0042254; GO:0006361 cell proliferation; cytoplasm organization; homeostasis of number of cells; in utero embryonic development; negative regulation of apoptotic process; nucleolus; nucleolus organization; nucleoplasm; positive regulation of transcription, DNA-dependent; regulation of DNA-dependent transcription, initiation; ribosome biogenesis; transcription initiation from RNA polymerase I promoter reviewed IPR007991; RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA) RRN3 TIFIA Homo sapiens (Human) 651 Q9NYV6 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0007596 GO:0007596 blood coagulation stress response P ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0032456 GO:0032456 endocytic recycling transport P ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0051260 GO:0051260 protein homooligomerization cell organization and biogenesis P ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0055038 GO:0055038 recycling endosome membrane other cytoplasmic organelle C ConsensusfromContig3449 sp Q9NZN3 EHD3_HUMAN 90.83 120 11 0 362 3 37 156 4E-75 238 Q9NZN3 EHD3_HUMAN GO:0005524; GO:0005525; GO:0006184; GO:0003924; GO:0007596; GO:0005509; GO:0032456; GO:0030139; GO:0003676; GO:0005634; GO:0048471; GO:0005886; GO:0051260; GO:0072661; GO:0055038; GO:0086036 ATP binding; GTP binding; GTP catabolic process; GTPase activity; blood coagulation; calcium ion binding; endocytic recycling; endocytic vesicle; nucleic acid binding; nucleus; perinuclear region of cytoplasm; plasma membrane; protein homooligomerization; protein targeting to plasma membrane; recycling endosome membrane; regulation of cardiac muscle cell membrane potential reviewed IPR001401; IPR011992; IPR018247; IPR002048; IPR000261; IPR027417; EH domain-containing protein 3 (PAST homolog 3) EHD3 EHD2 PAST3 Homo sapiens (Human) 535 Q9NZN3 GO:0055038 GO:0055038 recycling endosome membrane other membranes C ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0006919 GO:0006919 activation of caspase activity death P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016926 GO:0016926 protein desumoylation protein metabolism P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 63.26 264 86 4 1645 878 315 575 1E-115 332 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016929 GO:0016929 SUMO-specific protease activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0006919 GO:0006919 activation of caspase activity death P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008234 GO:0008234 cysteine-type peptidase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0008624 GO:0008624 induction of apoptosis by extracellular signals death P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016926 GO:0016926 protein desumoylation protein metabolism P ConsensusfromContig5692 sp Q9P0U3 SENP1_HUMAN 83.64 55 9 0 837 673 590 644 1E-115 107 Q9P0U3 SENP1_HUMAN GO:0016929; GO:0006919; GO:0097190; GO:0005737; GO:0004175; GO:0032435; GO:0005654; GO:0045944; GO:0016926; GO:0016925; GO:0006508; GO:0010724 P63165 SUMO-specific protease activity; activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptotic signaling pathway; cytoplasm; endopeptidase activity; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; nucleoplasm; positive regulation of transcription from RNA polymerase II promoter; protein desumoylation; protein sumoylation; proteolysis; regulation of definitive erythrocyte differentiation reviewed IPR003653; Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1) SENP1 Homo sapiens (Human) 644 Q9P0U3 GO:0016929 GO:0016929 SUMO-specific protease activity other molecular function F ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0001932 GO:0001932 regulation of protein amino acid phosphorylation protein metabolism P ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0008630 GO:0008630 "DNA damage response, signal transduction resulting in induction of apoptosis" signal transduction P ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0008630 GO:0008630 "DNA damage response, signal transduction resulting in induction of apoptosis" stress response P ConsensusfromContig1595 sp Q9P278 FNIP2_HUMAN 70.86 151 44 0 1 453 355 505 3E-69 232 Q9P278 FNIP2_HUMAN GO:0005737; GO:0008630; GO:0000122; GO:0005634; GO:0005886; GO:0033138; GO:0006468 cytoplasm; intrinsic apoptotic signaling pathway in response to DNA damage; negative regulation of transcription from RNA polymerase II promoter; nucleus; plasma membrane; positive regulation of peptidyl-serine phosphorylation; protein phosphorylation reviewed IPR028086; IPR026156; IPR028085; IPR028084; Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein) FNIP2 FNIPL KIAA1450 MAPO1 Homo sapiens (Human) 1114 Q9P278 GO:0008630 GO:0008630 "DNA damage response, signal transduction resulting in induction of apoptosis" death P ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig4541 sp Q9P283 SEM5B_HUMAN 64.52 124 42 1 480 109 1022 1143 3E-51 181 Q9P283 SEM5B_HUMAN GO:0030154; GO:0016021; GO:0007399; GO:0004872 cell differentiation; integral to membrane; nervous system development; receptor activity reviewed IPR016201; IPR002165; IPR001627; IPR027231; IPR000884; IPR015943; Semaphorin-5B SEMA5B KIAA1445 SEMAG UNQ5867/PRO34001 Homo sapiens (Human) 1151 Q9P283 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 78.74 127 27 0 170 550 398 524 9E-60 191 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0009405 GO:0009405 pathogenesis other biological processes P ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 78.74 127 27 0 170 550 398 524 9E-60 191 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0015643 GO:0015643 toxin binding other molecular function F ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 78.74 127 27 0 170 550 398 524 9E-60 191 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 78.74 127 27 0 170 550 398 524 9E-60 191 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 94.29 35 2 0 1 105 341 375 9E-60 59.7 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0009405 GO:0009405 pathogenesis other biological processes P ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 94.29 35 2 0 1 105 341 375 9E-60 59.7 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0015643 GO:0015643 toxin binding other molecular function F ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 94.29 35 2 0 1 105 341 375 9E-60 59.7 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig368 sp Q9P2C4 TM181_HUMAN 94.29 35 2 0 1 105 341 375 9E-60 59.7 Q9P2C4 TM181_HUMAN GO:0016021; GO:0009405; GO:0015643 integral to membrane; pathogenesis; toxic substance binding reviewed Transmembrane protein 181 TMEM181 GPR178 KIAA1423 Homo sapiens (Human) 612 Q9P2C4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 94.25 87 5 0 441 181 1253 1339 7E-54 178 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig3646 sp Q9P2P5 HECW2_HUMAN 77.42 31 7 0 508 416 1231 1261 7E-54 53.1 Q9P2P5 HECW2_HUMAN GO:0005737; GO:0005634; GO:0042787; GO:0004842 cytoplasm; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR000008; IPR000569; IPR001202; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECW2 (EC 6.3.2.-) (HECT, C2 and WW domain-containing protein 2) (NEDD4-like E3 ubiquitin-protein ligase 2) HECW2 KIAA1301 NEDL2 Homo sapiens (Human) 1572 Q9P2P5 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0000118 GO:0000118 histone deacetylase complex nucleus C ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0006607 GO:0006607 NLS-bearing substrate import into nucleus transport P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0008267 GO:0008267 poly-glutamine tract binding other molecular function F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig2649 sp Q9P2R6 RERE_HUMAN 91.97 137 11 0 421 11 229 365 4E-86 280 Q9P2R6 RERE_HUMAN GO:0006607; GO:0003682; GO:0006338; GO:0000118; GO:0005739; GO:0007275; GO:0005634; GO:0008267; GO:0043565; GO:0003700; GO:0006351; GO:0008270 P54259; Q96KQ7 NLS-bearing protein import into nucleus; chromatin binding; chromatin remodeling; histone deacetylase complex; mitochondrion; multicellular organismal development; nucleus; poly-glutamine tract binding; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription, DNA-dependent; zinc ion binding reviewed IPR002951; IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein) RERE ARG ARP ATN1L KIAA0458 Homo sapiens (Human) 1566 Q9P2R6 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6274 sp Q9PSI9 MCL1A_DANRE 58.26 242 89 6 2035 1334 14 251 8E-69 238 Q9PSI9 MCL1A_DANRE GO:0003677; GO:0005634; GO:0003700 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR011598; IPR002418; IPR012682; Protein L-Myc-1a (Protein L-Myc 1) (zL-Myc) mycl1a lmyc1 mycl1 zgc:85967 Danio rerio (Zebrafish) (Brachydanio rerio) 372 Q9PSI9 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6274 sp Q9PSI9 MCL1A_DANRE 58.26 242 89 6 2035 1334 14 251 8E-69 238 Q9PSI9 MCL1A_DANRE GO:0003677; GO:0005634; GO:0003700 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR011598; IPR002418; IPR012682; Protein L-Myc-1a (Protein L-Myc 1) (zL-Myc) mycl1a lmyc1 mycl1 zgc:85967 Danio rerio (Zebrafish) (Brachydanio rerio) 372 Q9PSI9 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig6274 sp Q9PSI9 MCL1A_DANRE 58.26 242 89 6 2035 1334 14 251 8E-69 238 Q9PSI9 MCL1A_DANRE GO:0003677; GO:0005634; GO:0003700 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR011598; IPR002418; IPR012682; Protein L-Myc-1a (Protein L-Myc 1) (zL-Myc) mycl1a lmyc1 mycl1 zgc:85967 Danio rerio (Zebrafish) (Brachydanio rerio) 372 Q9PSI9 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig6274 sp Q9PSI9 MCL1A_DANRE 58.26 242 89 6 2035 1334 14 251 8E-69 238 Q9PSI9 MCL1A_DANRE GO:0003677; GO:0005634; GO:0003700 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR011598; IPR002418; IPR012682; Protein L-Myc-1a (Protein L-Myc 1) (zL-Myc) mycl1a lmyc1 mycl1 zgc:85967 Danio rerio (Zebrafish) (Brachydanio rerio) 372 Q9PSI9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6274 sp Q9PSI9 MCL1A_DANRE 58.26 242 89 6 2035 1334 14 251 8E-69 238 Q9PSI9 MCL1A_DANRE GO:0003677; GO:0005634; GO:0003700 DNA binding; nucleus; sequence-specific DNA binding transcription factor activity reviewed IPR011598; IPR002418; IPR012682; Protein L-Myc-1a (Protein L-Myc 1) (zL-Myc) mycl1a lmyc1 mycl1 zgc:85967 Danio rerio (Zebrafish) (Brachydanio rerio) 372 Q9PSI9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0006810 GO:0006810 transport transport P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0008553 GO:0008553 "hydrogen-exporting ATPase activity, phosphorylative mechanism" transporter activity F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0015986 GO:0015986 ATP synthesis coupled proton transport transport P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0015986 GO:0015986 ATP synthesis coupled proton transport other metabolic processes P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0015991 GO:0015991 ATP hydrolysis coupled proton transport transport P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0015992 GO:0015992 proton transport transport P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0016469 GO:0016469 proton-transporting two-sector ATPase complex other membranes C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0033178 GO:0033178 "proton-transporting two-sector ATPase complex, catalytic domain" other membranes C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0045261 GO:0045261 "proton-transporting ATP synthase complex, catalytic core F(1)" other membranes C ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0046034 GO:0046034 ATP metabolic process other metabolic processes P ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0046933 GO:0046933 "hydrogen ion transporting ATP synthase activity, rotational mechanism" transporter activity F ConsensusfromContig5580 sp Q9PTY0 ATPB_CYPCA 93.6 516 33 0 1733 186 1 516 0 928 Q9PTY0 ATPB_CYPCA GO:0005524; GO:0015991; GO:0015986; GO:0005743; GO:0046933; GO:0045261 ATP binding; ATP hydrolysis coupled proton transport; ATP synthesis coupled proton transport; mitochondrial inner membrane; proton-transporting ATP synthase activity, rotational mechanism; proton-transporting ATP synthase complex, catalytic core F(1) reviewed IPR003593; IPR020003; IPR005722; IPR000793; IPR000194; IPR004100; IPR024034; IPR027417; ATP synthase subunit beta, mitochondrial (EC 3.6.3.14) atp5b Cyprinus carpio (Common carp) 518 Q9PTY0 GO:0046961 GO:0046961 "proton-transporting ATPase activity, rotational mechanism" transporter activity F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0001707 GO:0001707 mesoderm formation developmental processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0004871 GO:0004871 signal transducer activity signal transduction activity F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0004888 GO:0004888 transmembrane receptor activity signal transduction activity F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0004930 GO:0004930 G-protein coupled receptor activity signal transduction activity F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0007166 GO:0007166 cell surface receptor linked signal transduction signal transduction P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0007186 GO:0007186 G-protein coupled receptor protein signaling pathway signal transduction P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0008104 GO:0008104 protein localization other biological processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0009950 GO:0009950 dorsal/ventral axis specification developmental processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0017147 GO:0017147 Wnt-protein binding other molecular function F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0045545 GO:0045545 syndecan binding other molecular function F ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0048729 GO:0048729 tissue morphogenesis developmental processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0060027 GO:0060027 convergent extension involved in gastrulation developmental processes P ConsensusfromContig6191 sp Q9PUK8 FZD7A_XENLA 86.65 352 45 1 1 1056 200 549 0 642 Q9PUK8 FZD7A_XENLA GO:0004930; GO:0042813; GO:0060070; GO:0060027; GO:0009950; GO:0016021; GO:0001707; GO:0005886; GO:0045944; GO:0008104 G-protein coupled receptor activity; Wnt-activated receptor activity; canonical Wnt receptor signaling pathway; convergent extension involved in gastrulation; dorsal/ventral axis specification; integral to membrane; mesoderm formation; plasma membrane; positive regulation of transcription from RNA polymerase II promoter; protein localization reviewed IPR000539; IPR015526; IPR020067; IPR026552; IPR017981; Frizzled-7-A (Fz-7-A) (Xfz7-A) fzd7-a fz7-a Xenopus laevis (African clawed frog) 549 Q9PUK8 GO:0060070 GO:0060070 Wnt receptor signaling pathway through beta-catenin signal transduction P ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0000015 GO:0000015 phosphopyruvate hydratase complex cytosol C ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0004634 GO:0004634 phosphopyruvate hydratase activity other molecular function F ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0006096 GO:0006096 glycolysis other metabolic processes P ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0016829 GO:0016829 lyase activity other molecular function F ConsensusfromContig5531 sp Q9PVK2 ENOA_ALLMI 87.99 433 52 0 264 1562 1 433 0 812 Q9PVK2 ENOA_ALLMI GO:0006096; GO:0000287; GO:0004634; GO:0000015 glycolysis; magnesium ion binding; phosphopyruvate hydratase activity; phosphopyruvate hydratase complex reviewed IPR000941; IPR020810; IPR020809; IPR020811; Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase) Alligator mississippiensis (American alligator) 434 Q9PVK2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0004713 GO:0004713 protein tyrosine kinase activity kinase activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0004714 GO:0004714 transmembrane receptor protein tyrosine kinase activity signal transduction activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0004714 GO:0004714 transmembrane receptor protein tyrosine kinase activity kinase activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005009 GO:0005009 insulin receptor activity signal transduction activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005009 GO:0005009 insulin receptor activity kinase activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0007169 GO:0007169 transmembrane receptor protein tyrosine kinase signaling pathway signal transduction P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0008286 GO:0008286 insulin receptor signaling pathway signal transduction P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0042169 GO:0042169 SH2 domain binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0043548 GO:0043548 phosphoinositide 3-kinase binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0043559 GO:0043559 insulin binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0043560 GO:0043560 insulin receptor substrate binding other molecular function F ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0046777 GO:0046777 protein amino acid autophosphorylation protein metabolism P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0051290 GO:0051290 protein heterotetramerization cell organization and biogenesis P ConsensusfromContig10 sp Q9PVZ4 INSR_XENLA 59.65 171 65 2 83 586 255 424 6E-67 228 Q9PVZ4 INSR_XENLA GO:0005524; GO:0051425; GO:0042169; GO:0043559; GO:0043560; GO:0005009; GO:0005887; GO:0007275; GO:0043548; GO:0046777; GO:0051290 ATP binding; PTB domain binding; SH2 domain binding; insulin binding; insulin receptor substrate binding; insulin-activated receptor activity; integral to plasma membrane; multicellular organismal development; phosphatidylinositol 3-kinase binding; protein autophosphorylation; protein heterotetramerization reviewed IPR000494; IPR003961; IPR006211; IPR006212; IPR009030; IPR013783; IPR011009; IPR000719; IPR017441; IPR001245; IPR008266; IPR020635; IPR016246; IPR002011; Insulin receptor (IR) (EC 2.7.10.1) (XTK-1b) (Xe-InsR) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] insr Xenopus laevis (African clawed frog) 1362 Q9PVZ4 GO:0051425 GO:0051425 PTB domain binding other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0000502 GO:0000502 proteasome complex other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0004298 GO:0004298 threonine-type endopeptidase activity other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0005839 GO:0005839 proteasome core complex other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0005844 GO:0005844 polysome other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0007519 GO:0007519 skeletal muscle tissue development developmental processes P ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0016363 GO:0016363 nuclear matrix nucleus C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0019773 GO:0019773 "proteasome core complex, alpha-subunit complex" other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0030016 GO:0030016 myofibril other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0030017 GO:0030017 sarcomere other cellular component C ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0051059 GO:0051059 NF-kappaB binding other molecular function F ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0051092 GO:0051092 positive regulation of NF-kappaB transcription factor activity RNA metabolism P ConsensusfromContig176 sp Q9QUM9 PSA6_MOUSE 94.89 137 7 0 412 2 1 137 2E-93 278 Q9QUM9 PSA6_MOUSE GO:0003723; GO:0000932; GO:0005829; GO:0016363; GO:0005844; GO:0051092; GO:0019773; GO:0051603; GO:0030017; GO:0007519; GO:0004298; GO:0006511 RNA binding; cytoplasmic mRNA processing body; cytosol; nuclear matrix; polysome; positive regulation of NF-kappaB transcription factor activity; proteasome core complex, alpha-subunit complex; proteolysis involved in cellular protein catabolic process; sarcomere; skeletal muscle tissue development; threonine-type endopeptidase activity; ubiquitin-dependent protein catabolic process reviewed IPR000426; IPR023332; IPR001353; Proteasome subunit alpha type-6 (EC 3.4.25.1) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain) Psma6 Mus musculus (Mouse) 246 Q9QUM9 GO:0051603 GO:0051603 proteolysis involved in cellular protein catabolic process protein metabolism P ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 74.67 150 38 0 1022 573 561 710 7E-114 260 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0070008 GO:0070008 serine-type exopeptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig6339 sp Q9QUR6 PPCE_MOUSE 72.73 110 30 0 1360 1031 443 552 7E-114 174 Q9QUR6 PPCE_MOUSE GO:0005737; GO:0005634; GO:0019538; GO:0006508; GO:0004252; GO:0070008 cytoplasm; nucleus; protein metabolic process; proteolysis; serine-type endopeptidase activity; serine-type exopeptidase activity reviewed IPR002471; IPR023302; IPR001375; IPR002470; Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme) Prep Pep Mus musculus (Mouse) 710 Q9QUR6 GO:0070008 GO:0070008 serine-type exopeptidase activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0004518 GO:0004518 nuclease activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0004519 GO:0004519 endonuclease activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0004521 GO:0004521 endoribonuclease activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0005847 GO:0005847 mRNA cleavage and polyadenylation specificity factor complex nucleus C ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0006398 GO:0006398 histone mRNA 3'-end processing RNA metabolism P ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0008409 GO:0008409 5'-3' exonuclease activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0030529 GO:0030529 ribonucleoprotein complex other cellular component C ConsensusfromContig460 sp Q9QXK7 CPSF3_MOUSE 96.74 92 3 0 1 276 220 311 9E-57 190 Q9QXK7 CPSF3_MOUSE GO:0008409; GO:0003723; GO:0004521; GO:0006398; GO:0005847; GO:0046872; GO:0030529 5'-3' exonuclease activity; RNA binding; endoribonuclease activity; histone mRNA 3'-end processing; mRNA cleavage and polyadenylation specificity factor complex; metal ion binding; ribonucleoprotein complex reviewed IPR001279; IPR022712; IPR021718; IPR011108; Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cpsf3 Cpsf73 Mus musculus (Mouse) 684 Q9QXK7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0003333 ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006865 GO:0006865 amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015101 GO:0015101 organic cation transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015171 GO:0015171 amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015179 GO:0015179 L-amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015695 GO:0015695 organic cation transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015807 GO:0015807 L-amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 80.09 211 36 1 1478 864 1 211 0 281 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0019534 GO:0019534 toxin transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0003333 ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006865 GO:0006865 amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015101 GO:0015101 organic cation transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015171 GO:0015171 amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015179 GO:0015179 L-amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015695 GO:0015695 organic cation transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015807 GO:0015807 L-amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 83.7 135 22 0 871 467 209 343 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0019534 GO:0019534 toxin transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0003333 ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0006865 GO:0006865 amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015101 GO:0015101 organic cation transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015171 GO:0015171 amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015179 GO:0015179 L-amino acid transmembrane transporter activity transporter activity F ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015695 GO:0015695 organic cation transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0015807 GO:0015807 L-amino acid transport transport P ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig6129 sp Q9QXW9 LAT2_MOUSE 77.36 159 36 0 482 6 339 497 0 234 Q9QXW9 LAT2_MOUSE GO:0015179; GO:0005275; GO:0016323; GO:0005737; GO:0016021; GO:0015101; GO:0005886; GO:0019534 L-amino acid transmembrane transporter activity; amine transmembrane transporter activity; basolateral plasma membrane; cytoplasm; integral to membrane; organic cation transmembrane transporter activity; plasma membrane; toxin transporter activity reviewed IPR002293; IPR004760; Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (mLAT2) (Solute carrier family 7 member 8) Slc7a8 Lat2 Mus musculus (Mouse) 531 Q9QXW9 GO:0019534 GO:0019534 toxin transporter activity transporter activity F ConsensusfromContig5761 sp Q9QYI4 DJB12_MOUSE 60.36 338 124 4 1132 146 1 337 2E-111 337 Q9QYI4 DJB12_MOUSE GO:0016021 integral to membrane reviewed IPR001623; IPR018253; IPR015399; DnaJ homolog subfamily B member 12 (mDj10) Dnajb12 Mus musculus (Mouse) 376 Q9QYI4 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig5761 sp Q9QYI4 DJB12_MOUSE 60.36 338 124 4 1132 146 1 337 2E-111 337 Q9QYI4 DJB12_MOUSE GO:0016021 integral to membrane reviewed IPR001623; IPR018253; IPR015399; DnaJ homolog subfamily B member 12 (mDj10) Dnajb12 Mus musculus (Mouse) 376 Q9QYI4 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5761 sp Q9QYI4 DJB12_MOUSE 60.36 338 124 4 1132 146 1 337 2E-111 337 Q9QYI4 DJB12_MOUSE GO:0016021 integral to membrane reviewed IPR001623; IPR018253; IPR015399; DnaJ homolog subfamily B member 12 (mDj10) Dnajb12 Mus musculus (Mouse) 376 Q9QYI4 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5761 sp Q9QYI4 DJB12_MOUSE 60.36 338 124 4 1132 146 1 337 2E-111 337 Q9QYI4 DJB12_MOUSE GO:0016021 integral to membrane reviewed IPR001623; IPR018253; IPR015399; DnaJ homolog subfamily B member 12 (mDj10) Dnajb12 Mus musculus (Mouse) 376 Q9QYI4 GO:0031072 GO:0031072 heat shock protein binding other molecular function F ConsensusfromContig5761 sp Q9QYI4 DJB12_MOUSE 60.36 338 124 4 1132 146 1 337 2E-111 337 Q9QYI4 DJB12_MOUSE GO:0016021 integral to membrane reviewed IPR001623; IPR018253; IPR015399; DnaJ homolog subfamily B member 12 (mDj10) Dnajb12 Mus musculus (Mouse) 376 Q9QYI4 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig5997 sp Q9QYL8 LYPA2_RAT 76.29 232 54 1 129 824 1 231 4E-133 390 Q9QYL8 LYPA2_RAT GO:0005737; GO:0006631; GO:0016787 cytoplasm; fatty acid metabolic process; hydrolase activity reviewed IPR003140; Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) Lypla2 Rattus norvegicus (Rat) 231 Q9QYL8 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5997 sp Q9QYL8 LYPA2_RAT 76.29 232 54 1 129 824 1 231 4E-133 390 Q9QYL8 LYPA2_RAT GO:0005737; GO:0006631; GO:0016787 cytoplasm; fatty acid metabolic process; hydrolase activity reviewed IPR003140; Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) Lypla2 Rattus norvegicus (Rat) 231 Q9QYL8 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig5997 sp Q9QYL8 LYPA2_RAT 76.29 232 54 1 129 824 1 231 4E-133 390 Q9QYL8 LYPA2_RAT GO:0005737; GO:0006631; GO:0016787 cytoplasm; fatty acid metabolic process; hydrolase activity reviewed IPR003140; Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) Lypla2 Rattus norvegicus (Rat) 231 Q9QYL8 GO:0006631 GO:0006631 fatty acid metabolic process other metabolic processes P ConsensusfromContig5997 sp Q9QYL8 LYPA2_RAT 76.29 232 54 1 129 824 1 231 4E-133 390 Q9QYL8 LYPA2_RAT GO:0005737; GO:0006631; GO:0016787 cytoplasm; fatty acid metabolic process; hydrolase activity reviewed IPR003140; Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase 2) (Lysophospholipase II) (LPL-II) (LysoPLA II) Lypla2 Rattus norvegicus (Rat) 231 Q9QYL8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001822 GO:0001822 kidney development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001942 GO:0001942 hair follicle development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0008104 GO:0008104 protein localization other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009953 GO:0009953 dorsal/ventral pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009954 GO:0009954 proximal/distal pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030178 GO:0030178 negative regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030326 GO:0030326 embryonic limb morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042475 GO:0042475 odontogenesis of dentine-containing tooth developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0048856 GO:0048856 anatomical structure development other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.42 679 430 18 743 2725 405 1045 5E-87 256 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0090090 ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001822 GO:0001822 kidney development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001942 GO:0001942 hair follicle development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0008104 GO:0008104 protein localization other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009953 GO:0009953 dorsal/ventral pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009954 GO:0009954 proximal/distal pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030178 GO:0030178 negative regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030326 GO:0030326 embryonic limb morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042475 GO:0042475 odontogenesis of dentine-containing tooth developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0048856 GO:0048856 anatomical structure development other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 31.84 223 100 5 87 728 222 401 5E-87 89.7 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0090090 ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001822 GO:0001822 kidney development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0001942 GO:0001942 hair follicle development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0004872 GO:0004872 receptor activity signal transduction activity F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005509 GO:0005509 calcium ion binding other molecular function F ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis transport P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0006897 GO:0006897 endocytosis cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0008104 GO:0008104 protein localization other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009953 GO:0009953 dorsal/ventral pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0009954 GO:0009954 proximal/distal pattern formation developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0016055 GO:0016055 Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030178 GO:0030178 negative regulation of Wnt receptor signaling pathway signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0030326 GO:0030326 embryonic limb morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042475 GO:0042475 odontogenesis of dentine-containing tooth developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0042733 GO:0042733 embryonic digit morphogenesis developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering signal transduction P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering other metabolic processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0043113 GO:0043113 receptor clustering cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0048856 GO:0048856 anatomical structure development other biological processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction developmental processes P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0051124 GO:0051124 synaptic growth at neuromuscular junction cell organization and biogenesis P ConsensusfromContig5706 sp Q9QYP1 LRP4_RAT 28.9 661 423 19 740 2680 1012 1639 1E-63 241 Q9QYP1 LRP4_RAT GO:0016055; GO:0005509; GO:0030154; GO:0009953; GO:0042733; GO:0006897; GO:0001942; GO:0016021; GO:0001822; GO:0090090; GO:0030279; GO:0042475; GO:0005886; GO:0009954; GO:0043113; GO:0001932; GO:0051124 Wnt receptor signaling pathway; calcium ion binding; cell differentiation; dorsal/ventral pattern formation; embryonic digit morphogenesis; endocytosis; hair follicle development; integral to membrane; kidney development; negative regulation of canonical Wnt receptor signaling pathway; negative regulation of ossification; odontogenesis of dentin-containing tooth; plasma membrane; proximal/distal pattern formation; receptor clustering; regulation of protein phosphorylation; synaptic growth at neuromuscular junction reviewed IPR011042; IPR000742; IPR001881; IPR013032; IPR000152; IPR018097; IPR009030; IPR023415; IPR000033; IPR002172; Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7) Lrp4 Megf7 Rattus norvegicus (Rat) 1905 Q9QYP1 GO:0090090 ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005811 GO:0005811 lipid particle other cellular component C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005901 GO:0005901 caveola plasma membrane C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0005901 GO:0005901 caveola other membranes C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0006361 GO:0006361 transcription initiation from RNA polymerase I promoter RNA metabolism P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0006361 GO:0006361 transcription initiation from RNA polymerase I promoter cell organization and biogenesis P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0006363 GO:0006363 termination of RNA polymerase I transcription RNA metabolism P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0006363 GO:0006363 termination of RNA polymerase I transcription cell organization and biogenesis P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0006629 GO:0006629 lipid metabolic process other metabolic processes P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0008202 GO:0008202 steroid metabolic process other metabolic processes P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0008203 GO:0008203 cholesterol metabolic process other metabolic processes P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0016042 GO:0016042 lipid catabolic process other metabolic processes P ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0016298 GO:0016298 lipase activity other molecular function F ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0033878 GO:0033878 hormone-sensitive lipase activity other molecular function F ConsensusfromContig744 sp Q9R101 LIPS_SPETR 67.67 133 43 0 406 8 135 267 2E-63 212 Q9R101 LIPS_SPETR GO:0005901; GO:0008203; GO:0005829; GO:0033878; GO:0016298; GO:0016042; GO:0005811; GO:0005739; GO:0005634; GO:0042134; GO:0006363; GO:0006361; GO:0019433 caveola; cholesterol metabolic process; cytosol; hormone-sensitive lipase activity; lipase activity; lipid catabolic process; lipid particle; mitochondrion; nucleus; rRNA primary transcript binding; termination of RNA polymerase I transcription; transcription initiation from RNA polymerase I promoter; triglyceride catabolic process reviewed IPR013094; IPR010468; IPR002168; Glycerolipid metabolism; triacylglycerol degradation. Hormone-sensitive lipase (HSL) (EC 3.1.1.79) LIPE Spermophilus tridecemlineatus (Thirteen-lined ground squirrel) (Ictidomys tridecemlineatus) 763 Q9R101 GO:0042134 GO:0042134 rRNA primary transcript binding nucleic acid binding activity F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0000118 GO:0000118 histone deacetylase complex nucleus C ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0000122 GO:0000122 negative regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0000989 ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0001085 ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0004407 GO:0004407 histone deacetylase activity other molecular function F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0005667 GO:0005667 transcription factor complex nucleus C ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0006323 GO:0006323 DNA packaging cell organization and biogenesis P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0016575 GO:0016575 histone deacetylation protein metabolism P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0016575 GO:0016575 histone deacetylation cell organization and biogenesis P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0016581 GO:0016581 NuRD complex nucleus C ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0016585 GO:0016585 chromatin remodeling complex nucleus C ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0043565 GO:0043565 sequence-specific DNA binding nucleic acid binding activity F ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0044212 ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0045892 GO:0045892 "negative regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0045944 GO:0045944 positive regulation of transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig4505 sp Q9R190 MTA2_MOUSE 90.91 99 9 0 297 1 1 99 1E-57 193 Q9R190 MTA2_MOUSE GO:0006306; GO:0006323; GO:0016581; GO:0003682; GO:0006338; GO:0004407; GO:0000122; GO:0045944; GO:0043565; GO:0003700; GO:0000989; GO:0005667; GO:0044212; GO:0008270 Q61539; P20263; Q8BX22 DNA methylation; DNA packaging; NuRD complex; chromatin binding; chromatin remodeling; histone deacetylase activity; negative regulation of transcription from RNA polymerase II promoter; positive regulation of transcription from RNA polymerase II promoter; sequence-specific DNA binding; sequence-specific DNA binding transcription factor activity; transcription factor binding transcription factor activity; transcription factor complex; transcription regulatory region DNA binding; zinc ion binding reviewed IPR001025; IPR000949; IPR009057; IPR001005; IPR017884; IPR000679; Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) Mta2 Mta1l1 Mus musculus (Mouse) 668 Q9R190 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0005680 GO:0005680 anaphase-promoting complex nucleus C ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0008284 GO:0008284 positive regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0031145 GO:0031145 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint cell cycle and proliferation P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint signal transduction P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0031572 GO:0031572 G2/M transition DNA damage checkpoint stress response P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0040020 GO:0040020 regulation of meiosis cell cycle and proliferation P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0045732 GO:0045732 positive regulation of protein catabolic process protein metabolism P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0051488 GO:0051488 activation of anaphase-promoting complex activity other biological processes P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0070306 GO:0070306 lens fiber cell differentiation developmental processes P ConsensusfromContig6173 sp Q9R1K5 FZR_MOUSE 94.56 239 13 0 740 24 136 374 6E-147 427 Q9R1K5 FZR_MOUSE GO:0006281; GO:0031572; GO:0051488; GO:0005680; GO:0031145; GO:0051301; GO:0070306; GO:0007067; GO:0090344; GO:0031965; GO:0008284; GO:0045732; GO:0016567; GO:0040020 Q8VDQ8 DNA repair; G2 DNA damage checkpoint; activation of anaphase-promoting complex activity; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; lens fiber cell differentiation; mitosis; negative regulation of cell aging; nuclear membrane; positive regulation of cell proliferation; positive regulation of protein catabolic process; protein ubiquitination; regulation of meiosis reviewed IPR015943; IPR001680; IPR019775; IPR017986; Protein modification; protein ubiquitination. Fizzy-related protein homolog (Fzr) (Cdh1/Hct1 homolog) Fzr1 Fyr Fzr Mus musculus (Mouse) 493 Q9R1K5 GO:0090344 ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0005452 GO:0005452 inorganic anion exchanger activity transporter activity F ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0006810 GO:0006810 transport transport P ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0006820 GO:0006820 anion transport transport P ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0008509 GO:0008509 anion transmembrane transporter activity transporter activity F ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016323 GO:0016323 basolateral plasma membrane plasma membrane C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016323 GO:0016323 basolateral plasma membrane other membranes C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016324 GO:0016324 apical plasma membrane plasma membrane C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0016324 GO:0016324 apical plasma membrane other membranes C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0032420 GO:0032420 stereocilium other cellular component C ConsensusfromContig3450 sp Q9R1N3 S4A7_RAT 94.55 110 6 0 3 332 1004 1113 2E-63 213 Q9R1N3 S4A7_RAT GO:0016324; GO:0016323; GO:0031410; GO:0005452; GO:0016021; GO:0006814; GO:0032420; GO:0015293 apical plasma membrane; basolateral plasma membrane; cytoplasmic vesicle; inorganic anion exchanger activity; integral to membrane; sodium ion transport; stereocilium; symporter activity reviewed IPR013769; IPR011531; IPR003020; IPR016152; Sodium bicarbonate cotransporter 3 (Electroneutral sodium bicarbonate cotransporter 1) (NBC-like protein) (Solute carrier family 4 member 7) Slc4a7 Nbc Nbc2 Nbc3 Nbcn1 Rattus norvegicus (Rat) 1218 Q9R1N3 GO:0042995 GO:0042995 cell projection other cellular component C ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0003989 GO:0003989 acetyl-CoA carboxylase activity other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0004075 GO:0004075 biotin carboxylase activity other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0006084 GO:0006084 acetyl-CoA metabolic process other metabolic processes P ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0006633 GO:0006633 fatty acid biosynthetic process other metabolic processes P ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0008610 GO:0008610 lipid biosynthetic process other metabolic processes P ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1986 sp Q9TTS3 ACACA_BOVIN 82.03 128 23 0 2 385 2080 2207 2E-64 218 Q9TTS3 ACACA_BOVIN GO:0005524; GO:0003989; GO:0006084; GO:0004075; GO:0005829; GO:0006633; GO:2001295; GO:0046872; GO:0051289 ATP binding; acetyl-CoA carboxylase activity; acetyl-CoA metabolic process; biotin carboxylase activity; cytosol; fatty acid biosynthetic process; malonyl-CoA biosynthetic process; metal ion binding; protein homotetramerization reviewed IPR013537; IPR011761; IPR013815; IPR013816; IPR001882; IPR011764; IPR005482; IPR000089; IPR005481; IPR000022; IPR005479; IPR011763; IPR011762; IPR016185; IPR011054; IPR011053; Lipid metabolism; malonyl-CoA biosynthesis; malonyl-CoA from acetyl-CoA: step 1/1. Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)] ACACA ACAC ACCA Bos taurus (Bovine) 2346 Q9TTS3 GO:0051289 GO:0051289 protein homotetramerization cell organization and biogenesis P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0005782 GO:0005782 peroxisomal matrix other cytoplasmic organelle C ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0007588 GO:0007588 excretion transport P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0008465 GO:0008465 glycerate dehydrogenase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016618 GO:0016618 hydroxypyruvate reductase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0030267 GO:0030267 glyoxylate reductase (NADP) activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0044281 ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0046487 GO:0046487 glyoxylate metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0048037 GO:0048037 cofactor binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 68.86 228 70 1 58 738 5 232 2E-116 308 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0005782 GO:0005782 peroxisomal matrix other cytoplasmic organelle C ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0007588 GO:0007588 excretion transport P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0008465 GO:0008465 glycerate dehydrogenase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016616 GO:0016616 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor" other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0016618 GO:0016618 hydroxypyruvate reductase activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0030267 GO:0030267 glyoxylate reductase (NADP) activity other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0034641 GO:0034641 cellular nitrogen compound metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0044281 ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0046487 GO:0046487 glyoxylate metabolic process other metabolic processes P ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0048037 GO:0048037 cofactor binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0051287 GO:0051287 NAD or NADH binding other molecular function F ConsensusfromContig6344 sp Q9UBQ7 GRHPR_HUMAN 74.26 101 26 0 725 1027 228 328 2E-116 134 Q9UBQ7 GRHPR_HUMAN GO:0051287; GO:0070402; GO:0034641; GO:0007588; GO:0008465; GO:0046487; GO:0030267; GO:0016618; GO:0005782; GO:0042803; GO:0051259 NAD binding; NADPH binding; cellular nitrogen compound metabolic process; excretion; glycerate dehydrogenase activity; glyoxylate metabolic process; glyoxylate reductase (NADP) activity; hydroxypyruvate reductase activity; peroxisomal matrix; protein homodimerization activity; protein oligomerization reviewed IPR006139; IPR006140; IPR016040; Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81) GRHPR GLXR MSTP035 Homo sapiens (Human) 328 Q9UBQ7 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5962 sp Q9UFN0 NPS3A_HUMAN 56.18 251 105 4 862 113 1 247 7E-95 288 Q9UFN0 NPS3A_HUMAN GO:0005829 Q9H3D4 cytosol reviewed IPR011008; IPR012577; Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC) NIPSNAP3A NIPSNAP4 HSPC299 Homo sapiens (Human) 247 Q9UFN0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5962 sp Q9UFN0 NPS3A_HUMAN 56.18 251 105 4 862 113 1 247 7E-95 288 Q9UFN0 NPS3A_HUMAN GO:0005829 Q9H3D4 cytosol reviewed IPR011008; IPR012577; Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC) NIPSNAP3A NIPSNAP4 HSPC299 Homo sapiens (Human) 247 Q9UFN0 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5962 sp Q9UFN0 NPS3A_HUMAN 56.18 251 105 4 862 113 1 247 7E-95 288 Q9UFN0 NPS3A_HUMAN GO:0005829 Q9H3D4 cytosol reviewed IPR011008; IPR012577; Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC) NIPSNAP3A NIPSNAP4 HSPC299 Homo sapiens (Human) 247 Q9UFN0 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5962 sp Q9UFN0 NPS3A_HUMAN 56.18 251 105 4 862 113 1 247 7E-95 288 Q9UFN0 NPS3A_HUMAN GO:0005829 Q9H3D4 cytosol reviewed IPR011008; IPR012577; Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC) NIPSNAP3A NIPSNAP4 HSPC299 Homo sapiens (Human) 247 Q9UFN0 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0000086 GO:0000086 G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0000226 GO:0000226 microtubule cytoskeleton organization cell organization and biogenesis P ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005200 GO:0005200 structural constituent of cytoskeleton cytoskeletal activity F ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005813 GO:0005813 centrosome cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0006461 GO:0006461 protein complex assembly cell organization and biogenesis P ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0007020 GO:0007020 microtubule nucleation cell organization and biogenesis P ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0008274 GO:0008274 gamma-tubulin ring complex cytoskeleton C ConsensusfromContig5377 sp Q9UGJ1 GCP4_HUMAN 93.62 94 6 0 2 283 556 649 1E-51 176 Q9UGJ1 GCP4_HUMAN GO:0000086; GO:0005813; GO:0005829; GO:0008274; GO:0005874; GO:0007020; GO:0006461; GO:0000922; GO:0005200 G2/M transition of mitotic cell cycle; centrosome; cytosol; gamma-tubulin ring complex; microtubule; microtubule nucleation; protein complex assembly; spindle pole; structural constituent of cytoskeleton reviewed IPR007259; Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76) TUBGCP4 76P GCP4 Homo sapiens (Human) 667 Q9UGJ1 GO:0015630 GO:0015630 microtubule cytoskeleton cytoskeleton C ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0004177 GO:0004177 aminopeptidase activity other molecular function F ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0008239 GO:0008239 dipeptidyl-peptidase activity other molecular function F ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1295 sp Q9UHL4 DPP2_HUMAN 61.21 165 64 0 495 1 27 191 3E-70 227 Q9UHL4 DPP2_HUMAN GO:0004177; GO:0016023; GO:0005829; GO:0008239; GO:0005576; GO:0005764; GO:0006508; GO:0008236 aminopeptidase activity; cytoplasmic membrane-bounded vesicle; cytosol; dipeptidyl-peptidase activity; extracellular region; lysosome; proteolysis; serine-type peptidase activity reviewed IPR008758; Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase) DPP7 DPP2 QPP Homo sapiens (Human) 492 Q9UHL4 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 88.83 188 21 0 1024 461 1 188 1E-132 359 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 88.83 188 21 0 1024 461 1 188 1E-132 359 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 88.83 188 21 0 1024 461 1 188 1E-132 359 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 70.21 94 27 1 461 180 189 281 1E-132 136 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 70.21 94 27 1 461 180 189 281 1E-132 136 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5792 sp Q9UHW5 GPN3_HUMAN 70.21 94 27 1 461 180 189 281 1E-132 136 Q9UHW5 GPN3_HUMAN GO:0005525; GO:0043234 GTP binding; protein complex reviewed IPR027417; IPR004130; GPN-loop GTPase 3 (ATP-binding domain 1 family member C) GPN3 ATPBD1C AD-009 UNQ1876/PRO4319 Homo sapiens (Human) 284 Q9UHW5 GO:0043234 GO:0043234 protein complex other cellular component C ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0004047 GO:0004047 aminomethyltransferase activity other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0005542 GO:0005542 folic acid binding other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0006544 GO:0006544 glycine metabolic process other metabolic processes P ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0006546 GO:0006546 glycine catabolic process other metabolic processes P ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0009055 GO:0009055 electron carrier activity other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0019695 GO:0019695 choline metabolic process other metabolic processes P ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0047865 GO:0047865 dimethylglycine dehydrogenase activity other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig5475 sp Q9UI17 M2GD_HUMAN 85.15 101 15 0 311 9 57 157 2E-55 188 Q9UI17 M2GD_HUMAN GO:0006579; GO:0004047; GO:0019695; GO:0047865; GO:0009055; GO:0006546; GO:0006544; GO:0005759 amino-acid betaine catabolic process; aminomethyltransferase activity; choline metabolic process; dimethylglycine dehydrogenase activity; electron carrier activity; glycine catabolic process; glycine metabolic process; mitochondrial matrix reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; betaine degradation; sarcosine from betaine: step 2/2. Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH) DMGDH Homo sapiens (Human) 866 Q9UI17 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0003880 GO:0003880 C-terminal protein carboxyl methyltransferase activity other molecular function F ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0006481 GO:0006481 C-terminal protein amino acid methylation protein metabolism P ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0008168 GO:0008168 methyltransferase activity other molecular function F ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0008757 GO:0008757 S-adenosylmethionine-dependent methyltransferase activity other molecular function F ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5728 sp Q9UIC8 LCMT1_HUMAN 64.86 259 91 0 2 778 76 334 3E-117 353 Q9UIC8 LCMT1_HUMAN GO:0008757; GO:0031333; GO:0003880; GO:0042981; GO:0090266 P51116 S-adenosylmethionine-dependent methyltransferase activity; negative regulation of protein complex assembly; protein C-terminal carboxyl O-methyltransferase activity; regulation of apoptotic process; regulation of mitotic cell cycle spindle assembly checkpoint reviewed IPR007213; IPR016651; Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1) LCMT1 LCMT CGI-68 Homo sapiens (Human) 334 Q9UIC8 GO:0032259 GO:0032259 methylation other metabolic processes P ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0008654 GO:0008654 phospholipid biosynthetic process other metabolic processes P ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig5862 sp Q9UJA2 CRLS1_HUMAN 74.63 201 51 0 818 1420 101 301 7E-97 304 Q9UJA2 CRLS1_HUMAN GO:0032049; GO:0016021; GO:0005743; GO:0036148; GO:0016780; GO:0044281 cardiolipin biosynthetic process; integral to membrane; mitochondrial inner membrane; phosphatidylglycerol acyl-chain remodeling; phosphotransferase activity, for other substituted phosphate groups; small molecule metabolic process reviewed IPR000462; Cardiolipin synthase (CLS) (EC 2.7.8.-) (Protein GCD10 homolog) CRLS1 C20orf155 CLS1 Homo sapiens (Human) 301 Q9UJA2 GO:0016780 GO:0016780 "phosphotransferase activity, for other substituted phosphate groups" other molecular function F ConsensusfromContig5547 sp Q9UJJ9 GNPTG_HUMAN 59.86 284 99 3 1541 723 26 305 4E-112 343 Q9UJJ9 GNPTG_HUMAN GO:0005794; GO:0005576 Golgi apparatus; extracellular region reviewed IPR009011; N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma) GNPTG C16orf27 GNPTAG CAB56184 LP2537 Homo sapiens (Human) 305 Q9UJJ9 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig5547 sp Q9UJJ9 GNPTG_HUMAN 59.86 284 99 3 1541 723 26 305 4E-112 343 Q9UJJ9 GNPTG_HUMAN GO:0005794; GO:0005576 Golgi apparatus; extracellular region reviewed IPR009011; N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma) GNPTG C16orf27 GNPTAG CAB56184 LP2537 Homo sapiens (Human) 305 Q9UJJ9 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.35 184 84 0 763 212 489 672 2E-78 206 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 42.52 127 73 0 1131 751 338 464 2E-78 109 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.29 175 80 0 763 239 517 691 4E-74 198 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 40.8 125 74 0 1125 751 368 492 4E-74 103 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 57.92 183 77 0 763 215 405 587 7E-71 215 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 47.3 74 39 0 972 751 335 408 7E-71 75.1 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.55 183 85 0 763 215 461 643 7E-56 205 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 54.4 182 83 0 763 218 433 614 7E-55 202 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig6054 sp Q9UJW8 ZN180_HUMAN 53.89 180 83 0 754 215 352 531 2E-52 196 Q9UJW8 ZN180_HUMAN GO:0003677; GO:0046872; GO:0005634; GO:0006355; GO:0006351 DNA binding; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR001909; IPR007087; IPR015880; IPR013087; Zinc finger protein 180 (HHZ168) ZNF180 Homo sapiens (Human) 692 Q9UJW8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0000075 GO:0000075 cell cycle checkpoint cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0000086 GO:0000086 G2/M transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0000090 GO:0000090 mitotic anaphase cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0000090 GO:0000090 mitotic anaphase cell organization and biogenesis P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0000278 GO:0000278 mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0005680 GO:0005680 anaphase-promoting complex nucleus C ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0007094 GO:0007094 mitotic cell cycle spindle assembly checkpoint cell organization and biogenesis P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0019903 GO:0019903 protein phosphatase binding other molecular function F ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0030071 GO:0030071 regulation of mitotic metaphase/anaphase transition cell organization and biogenesis P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0031145 GO:0031145 anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0051436 GO:0051436 negative regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0051437 GO:0051437 positive regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0051439 GO:0051439 regulation of ubiquitin-protein ligase activity during mitotic cell cycle cell cycle and proliferation P ConsensusfromContig2025 sp Q9UJX5 APC4_HUMAN 65.36 153 53 0 54 512 466 618 9E-64 215 Q9UJX5 APC4_HUMAN GO:0000086; GO:0005680; GO:0031145; GO:0051301; GO:0005829; GO:0007067; GO:0000090; GO:0007094; GO:0051436; GO:0005654; GO:0051437; GO:0070979; GO:0004842 Q8NI77; P51955 G2/M transition of mitotic cell cycle; anaphase-promoting complex; anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process; cell division; cytosol; mitosis; mitotic anaphase; mitotic spindle assembly checkpoint; negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; nucleoplasm; positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle; protein K11-linked ubiquitination; ubiquitin-protein ligase activity reviewed IPR024789; IPR024790; IPR017169; IPR024977; IPR015943; IPR017986; Protein modification; protein ubiquitination. Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4) ANAPC4 APC4 Homo sapiens (Human) 808 Q9UJX5 GO:0070979 ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0003713 GO:0003713 transcription coactivator activity transcription regulatory activity F ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig2667 sp Q9UKD1 GMEB2_HUMAN 79.82 114 22 1 339 1 72 185 3E-62 204 Q9UKD1 GMEB2_HUMAN GO:0003677; GO:0005737; GO:0046872; GO:0005634; GO:0006355; GO:0003713; GO:0006366 DNA binding; cytoplasm; metal ion binding; nucleus; regulation of transcription, DNA-dependent; transcription coactivator activity; transcription from RNA polymerase II promoter reviewed IPR024830; IPR000770; IPR010919; Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79) GMEB2 KIAA1269 Homo sapiens (Human) 530 Q9UKD1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0003674 GO:0003674 molecular_function other molecular function F ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0005575 GO:0005575 cellular_component other cellular component C ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0008150 GO:0008150 biological_process other biological processes P ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig63 sp Q9UKJ3 GPTC8_HUMAN 91.38 116 10 0 1 348 83 198 7E-54 187 Q9UKJ3 GPTC8_HUMAN GO:0046872; GO:0003676 P54253 metal ion binding; nucleic acid binding reviewed IPR000467; IPR007087; IPR015880; IPR022755; G patch domain-containing protein 8 GPATCH8 GPATC8 KIAA0553 Homo sapiens (Human) 1502 Q9UKJ3 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0004047 GO:0004047 aminomethyltransferase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0006546 GO:0006546 glycine catabolic process other metabolic processes P ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0008480 GO:0008480 sarcosine dehydrogenase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 86.14 101 14 0 2 304 73 173 1E-61 191 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0004047 GO:0004047 aminomethyltransferase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0005759 GO:0005759 mitochondrial matrix mitochondrion C ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0006546 GO:0006546 glycine catabolic process other metabolic processes P ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0008480 GO:0008480 sarcosine dehydrogenase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0016491 GO:0016491 oxidoreductase activity other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0050660 GO:0050660 FAD binding other molecular function F ConsensusfromContig3331 sp Q9UL12 SARDH_HUMAN 85.29 34 5 0 298 399 172 205 1E-61 64.7 Q9UL12 SARDH_HUMAN GO:0004047; GO:0006546; GO:0005759; GO:0005739; GO:0008480 aminomethyltransferase activity; glycine catabolic process; mitochondrial matrix; mitochondrion; sarcosine dehydrogenase activity reviewed IPR006076; IPR013977; IPR006222; IPR027266; Amine and polyamine degradation; sarcosine degradation; formaldehyde and glycine from sarcosine: step 1/1. Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2) SARDH DMGDHL1 Homo sapiens (Human) 918 Q9UL12 GO:0055114 GO:0055114 oxidation reduction other metabolic processes P ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0000139 GO:0000139 Golgi membrane ER/Golgi C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0000139 GO:0000139 Golgi membrane other membranes C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0003924 GO:0003924 GTPase activity other molecular function F ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005789 GO:0005789 endoplasmic reticulum membrane ER/Golgi C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005789 GO:0005789 endoplasmic reticulum membrane other membranes C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0006184 GO:0006184 GTP catabolic process other metabolic processes P ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0006810 GO:0006810 transport transport P ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0007264 GO:0007264 small GTPase mediated signal transduction signal transduction P ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0019003 GO:0019003 GDP binding other molecular function F ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0030659 GO:0030659 cytoplasmic vesicle membrane other membranes C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0031410 GO:0031410 cytoplasmic vesicle other cellular component C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig6333 sp Q9UL25 RAB21_HUMAN 90 210 21 0 283 912 16 225 1E-138 401 Q9UL25 RAB21_HUMAN GO:0019003; GO:0005525; GO:0003924; GO:0000139; GO:0032154; GO:0030659; GO:0031901; GO:0005789; GO:0005768; GO:0015031; GO:0007264 Q9UKG1 GDP binding; GTP binding; GTPase activity; Golgi membrane; cleavage furrow; cytoplasmic vesicle membrane; early endosome membrane; endoplasmic reticulum membrane; endosome; protein transport; small GTPase mediated signal transduction reviewed IPR027417; IPR005225; IPR001806; IPR003579; Ras-related protein Rab-21 RAB21 KIAA0118 Homo sapiens (Human) 225 Q9UL25 GO:0032154 GO:0032154 cleavage furrow other cellular component C ConsensusfromContig2846 sp Q9ULI0 ATD2B_HUMAN 70.77 130 33 2 406 17 979 1103 6E-55 191 Q9ULI0 ATD2B_HUMAN GO:0005524; GO:0070577; GO:0017111 ATP binding; histone acetyl-lysine binding; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR001487; IPR018359; IPR027417; ATPase family AAA domain-containing protein 2B ATAD2B KIAA1240 Homo sapiens (Human) 1458 Q9ULI0 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2846 sp Q9ULI0 ATD2B_HUMAN 70.77 130 33 2 406 17 979 1103 6E-55 191 Q9ULI0 ATD2B_HUMAN GO:0005524; GO:0070577; GO:0017111 ATP binding; histone acetyl-lysine binding; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR001487; IPR018359; IPR027417; ATPase family AAA domain-containing protein 2B ATAD2B KIAA1240 Homo sapiens (Human) 1458 Q9ULI0 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2846 sp Q9ULI0 ATD2B_HUMAN 70.77 130 33 2 406 17 979 1103 6E-55 191 Q9ULI0 ATD2B_HUMAN GO:0005524; GO:0070577; GO:0017111 ATP binding; histone acetyl-lysine binding; nucleoside-triphosphatase activity reviewed IPR003593; IPR003959; IPR003960; IPR001487; IPR018359; IPR027417; ATPase family AAA domain-containing protein 2B ATAD2B KIAA1240 Homo sapiens (Human) 1458 Q9ULI0 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 86.51 215 29 0 1115 1759 2394 2608 0 414 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 90.77 195 18 0 5 589 2038 2232 0 353 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0006464 GO:0006464 protein modification process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0016881 GO:0016881 acid-amino acid ligase activity other molecular function F ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0042787 GO:0042787 protein ubiquitination during ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig5595 sp Q9ULT8 HECD1_HUMAN 70.05 187 41 1 579 1139 2230 2401 0 266 Q9ULT8 HECD1_HUMAN GO:0005737; GO:0046872; GO:0001843; GO:0005634; GO:0042787; GO:0004842 cytoplasm; metal ion binding; neural tube closure; nucleus; protein ubiquitination involved in ubiquitin-dependent protein catabolic process; ubiquitin-protein ligase activity reviewed IPR002110; IPR020683; IPR011989; IPR016024; IPR008979; IPR000569; IPR010606; IPR012919; Protein modification; protein ubiquitination. E3 ubiquitin-protein ligase HECTD1 (EC 6.3.2.-) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) HECTD1 KIAA1131 Homo sapiens (Human) 2610 Q9ULT8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0000398 GO:0000398 "nuclear mRNA splicing, via spliceosome" RNA metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0000413 GO:0000413 protein peptidyl-prolyl isomerization protein metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0003755 GO:0003755 peptidyl-prolyl cis-trans isomerase activity other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0005681 GO:0005681 spliceosome nucleus C ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0006397 GO:0006397 mRNA processing RNA metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0008380 GO:0008380 RNA splicing RNA metabolism P ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0016018 GO:0016018 cyclosporin A binding other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0016853 GO:0016853 isomerase activity other molecular function F ConsensusfromContig6255 sp Q9UNP9 PPIE_HUMAN 85.43 302 42 1 129 1034 1 300 0 543 Q9UNP9 PPIE_HUMAN GO:0003723; GO:0071013; GO:0016018; GO:0000398; GO:0000166; GO:0003755; GO:0045070; GO:0006457; GO:0006355 Q03164; Q9HCS7 RNA binding; catalytic step 2 spliceosome; cyclosporin A binding; mRNA splicing, via spliceosome; nucleotide binding; peptidyl-prolyl cis-trans isomerase activity; positive regulation of viral genome replication; protein folding; regulation of transcription, DNA-dependent reviewed IPR002130; IPR020892; IPR016304; IPR012677; IPR000504; Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E) PPIE CYP33 Homo sapiens (Human) 301 Q9UNP9 GO:0071013 GO:0071013 nucleus ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0004222 GO:0004222 metalloendopeptidase activity other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0005178 GO:0005178 integrin binding signal transduction activity F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0005576 GO:0005576 extracellular region non-structural extracellular C ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0005578 GO:0005578 proteinaceous extracellular matrix extracellular matrix C ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0008201 GO:0008201 heparin binding other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0008237 GO:0008237 metallopeptidase activity other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0008285 GO:0008285 negative regulation of cell proliferation cell cycle and proliferation P ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0009673 GO:0009673 low affinity phosphate transmembrane transporter activity transporter activity F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0031012 GO:0031012 extracellular matrix non-structural extracellular C ConsensusfromContig1564 sp Q9UP79 ATS8_HUMAN 63.95 147 51 2 439 2 482 627 3E-57 196 Q9UP79 ATS8_HUMAN GO:0008201; GO:0005178; GO:0009673; GO:0004222; GO:0008237; GO:0008285; GO:0005578; GO:0006508; GO:0008270 heparin binding; integrin binding; low affinity phosphate transmembrane transporter activity; metalloendopeptidase activity; metallopeptidase activity; negative regulation of cell proliferation; proteinaceous extracellular matrix; proteolysis; zinc ion binding reviewed IPR010294; IPR024079; IPR013277; IPR001590; IPR013273; IPR002870; IPR000884; A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8) ADAMTS8 METH2 Homo sapiens (Human) 889 Q9UP79 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0003700 GO:0003700 transcription factor activity transcription regulatory activity F ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0003700 GO:0003700 transcription factor activity nucleic acid binding activity F ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0044212 ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1565 sp Q9W678 P53_BARBU 74.8 123 30 1 370 2 61 182 1E-58 192 Q9W678 P53_BARBU GO:0006915; GO:0007049; GO:0005737; GO:0046872; GO:0005634; GO:0051262; GO:0003700; GO:0044212; GO:0006351 apoptotic process; cell cycle; cytoplasm; metal ion binding; nucleus; protein tetramerization; sequence-specific DNA binding transcription factor activity; transcription regulatory region DNA binding; transcription, DNA-dependent reviewed IPR008967; IPR012346; IPR011615; IPR010991; IPR002117; Cellular tumor antigen p53 (Tumor suppressor p53) tp53 p53 Barbus barbus (Barbel) 369 Q9W678 GO:0051262 GO:0051262 protein tetramerization cell organization and biogenesis P ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0006457 GO:0006457 protein folding protein metabolism P ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0044267 GO:0044267 cellular protein metabolic process protein metabolism P ConsensusfromContig6284 sp Q9W790 TCPA_PALPA 87.46 558 69 1 83 1753 1 558 0 1016 Q9W790 TCPA_PALPA GO:0005524; GO:0005737; GO:0006457 ATP binding; cytoplasm; protein folding reviewed IPR012715; IPR017998; IPR002194; IPR002423; IPR027409; IPR027413; IPR027410; T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha) TCP1 CCT1 Paleosuchus palpebrosus (Cuvier's dwarf caiman) (Red caiman) 559 Q9W790 GO:0051082 GO:0051082 unfolded protein binding other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0019005 GO:0019005 SCF ubiquitin ligase complex other cellular component C ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031146 GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031461 GO:0031461 cullin-RING ubiquitin ligase complex other cellular component C ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031625 GO:0031625 ubiquitin protein ligase binding other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 95.1 102 5 0 120 425 73 174 2E-69 213 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0004842 GO:0004842 ubiquitin-protein ligase activity other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0006511 GO:0006511 ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0006915 GO:0006915 apoptosis death P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0008283 GO:0008283 cell proliferation cell cycle and proliferation P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0009887 GO:0009887 organ morphogenesis developmental processes P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0016567 GO:0016567 protein ubiquitination protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0019005 GO:0019005 SCF ubiquitin ligase complex other cellular component C ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031146 GO:0031146 SCF-dependent proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031461 GO:0031461 cullin-RING ubiquitin ligase complex other cellular component C ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0031625 GO:0031625 ubiquitin protein ligase binding other molecular function F ConsensusfromContig3415 sp Q9WTX6 CUL1_MOUSE 100 31 0 0 1 93 34 64 2E-69 69.7 Q9WTX6 CUL1_MOUSE GO:0019005; GO:0031146; GO:0006915; GO:0008283; GO:0019048; GO:0009887; GO:0006513; GO:0004842 SCF ubiquitin ligase complex; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; apoptotic process; cell proliferation; modulation by virus of host morphology or physiology; organ morphogenesis; protein monoubiquitination; ubiquitin-protein ligase activity reviewed IPR016157; IPR016158; IPR001373; IPR019559; IPR016159; IPR011991; Protein modification; protein ubiquitination. Cullin-1 (CUL-1) Cul1 Mus musculus (Mouse) 776 Q9WTX6 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0003689 GO:0003689 DNA clamp loader activity nucleic acid binding activity F ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0005663 GO:0005663 DNA replication factor C complex other cellular component C ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig5680 sp Q9WUK4 RFC2_MOUSE 85.63 327 47 0 353 1333 13 339 0 586 Q9WUK4 RFC2_MOUSE GO:0005524; GO:0003677; GO:0006260; GO:0005663; GO:0017111; GO:0005634 ATP binding; DNA binding; DNA replication; DNA replication factor C complex; nucleoside-triphosphatase activity; nucleus reviewed IPR003593; IPR003959; IPR008921; IPR027417; IPR013748; Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40) Rfc2 Mus musculus (Mouse) 349 Q9WUK4 GO:0017111 GO:0017111 nucleoside-triphosphatase activity other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0003878 GO:0003878 ATP citrate synthase activity other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0004775 GO:0004775 succinate-CoA ligase (ADP-forming) activity other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0004776 GO:0004776 succinate-CoA ligase (GDP-forming) activity other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0005525 GO:0005525 GTP binding other molecular function F ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0005743 GO:0005743 mitochondrial inner membrane mitochondrion C ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0005743 GO:0005743 mitochondrial inner membrane other membranes C ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0006099 GO:0006099 tricarboxylic acid cycle other metabolic processes P ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig5793 sp Q9WUM5 SUCA_MOUSE 89.23 260 28 0 5 784 87 346 4E-131 384 Q9WUM5 SUCA_MOUSE GO:0003878; GO:0019003; GO:0005525; GO:0048037; GO:0005743; GO:0005886; GO:0006105; GO:0004775; GO:0004776; GO:0045244; GO:0006104; GO:0006099 ATP citrate synthase activity; GDP binding; GTP binding; cofactor binding; mitochondrial inner membrane; plasma membrane; succinate metabolic process; succinate-CoA ligase (ADP-forming) activity; succinate-CoA ligase (GDP-forming) activity; succinate-CoA ligase complex (GDP-forming); succinyl-CoA metabolic process; tricarboxylic acid cycle reviewed IPR017440; IPR003781; IPR005810; IPR005811; IPR016040; IPR016102; Carbohydrate metabolism; tricarboxylic acid cycle. Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha) Suclg1 Mus musculus (Mouse) 346 Q9WUM5 GO:0016874 GO:0016874 ligase activity other molecular function F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005876 GO:0005876 spindle microtubule cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007052 GO:0007052 mitotic spindle organization cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007052 GO:0007052 mitotic spindle organization cell organization and biogenesis P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 72.57 226 58 1 1174 1839 327 552 8E-139 318 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0000922 GO:0000922 spindle pole cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0003777 GO:0003777 microtubule motor activity cytoskeletal activity F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005815 GO:0005815 microtubule organizing center cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005819 GO:0005819 spindle cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005874 GO:0005874 microtubule cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0005876 GO:0005876 spindle microtubule cytoskeleton C ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007018 GO:0007018 microtubule-based movement other biological processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007052 GO:0007052 mitotic spindle organization cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007052 GO:0007052 mitotic spindle organization cell organization and biogenesis P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007275 GO:0007275 multicellular organismal development developmental processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0030154 GO:0030154 cell differentiation other biological processes P ConsensusfromContig6240 sp Q9WV63 KIF2A_RAT 56.33 158 69 0 698 1171 168 325 8E-139 199 Q9WV63 KIF2A_RAT GO:0005524; GO:0030154; GO:0051301; GO:0005737; GO:0005871; GO:0005874; GO:0003777; GO:0005815; GO:0007018; GO:0007067; GO:0007052; GO:0007399; GO:0000922 ATP binding; cell differentiation; cell division; cytoplasm; kinesin complex; microtubule; microtubule motor activity; microtubule organizing center; microtubule-based movement; mitosis; mitotic spindle organization; nervous system development; spindle pole reviewed IPR027640; IPR019821; IPR001752; IPR027417; Kinesin-like protein KIF2A (Kinesin-2) Kif2a Kif2 Rattus norvegicus (Rat) 705 Q9WV63 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0005768 GO:0005768 endosome other cytoplasmic organelle C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0006886 GO:0006886 intracellular protein transport transport P ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0007154 GO:0007154 cell communication other biological processes P ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0008289 GO:0008289 lipid binding other molecular function F ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0008565 GO:0008565 protein transporter activity transporter activity F ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0010008 GO:0010008 endosome membrane other cytoplasmic organelle C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0010008 GO:0010008 endosome membrane other membranes C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0015031 GO:0015031 protein transport transport P ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0031901 GO:0031901 early endosome membrane other cytoplasmic organelle C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0031901 GO:0031901 early endosome membrane other membranes C ConsensusfromContig2396 sp Q9WV80 SNX1_MOUSE 74.81 131 33 0 393 1 141 271 9E-69 223 Q9WV80 SNX1_MOUSE GO:0005794; GO:0007154; GO:0031901; GO:0010008; GO:0006886; GO:0035091; GO:0008565 Golgi apparatus; cell communication; early endosome membrane; endosome membrane; intracellular protein transport; phosphatidylinositol binding; protein transporter activity reviewed IPR001683; IPR005329; IPR015404; Sorting nexin-1 Snx1 Mus musculus (Mouse) 522 Q9WV80 GO:0035091 GO:0035091 phosphoinositide binding other molecular function F ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0000070 GO:0000070 mitotic sister chromatid segregation cell cycle and proliferation P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0000070 GO:0000070 mitotic sister chromatid segregation cell organization and biogenesis P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0000775 GO:0000775 "chromosome, centromeric region" other cellular component C ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0000776 GO:0000776 kinetochore other cellular component C ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0000777 GO:0000777 condensed chromosome kinetochore other cellular component C ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0005694 GO:0005694 chromosome other cellular component C ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0007049 GO:0007049 cell cycle cell cycle and proliferation P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0007059 GO:0007059 chromosome segregation other biological processes P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0007067 GO:0007067 mitosis cell cycle and proliferation P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0007067 GO:0007067 mitosis cell organization and biogenesis P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0007126 GO:0007126 meiosis cell cycle and proliferation P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0008608 GO:0008608 attachment of spindle microtubules to kinetochore cell organization and biogenesis P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0051301 GO:0051301 cell division other biological processes P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0051983 GO:0051983 regulation of chromosome segregation other biological processes P ConsensusfromContig5521 sp Q9WVA3 BUB3_MOUSE 91.02 245 22 0 2 736 82 326 8E-166 476 Q9WVA3 BUB3_MOUSE GO:0008608; GO:0051301; GO:0000777; GO:0007126; GO:0000070; GO:0005634; GO:0051983; GO:0071173 attachment of spindle microtubules to kinetochore; cell division; condensed chromosome kinetochore; meiosis; mitotic sister chromatid segregation; nucleus; regulation of chromosome segregation; spindle assembly checkpoint reviewed IPR020472; IPR015943; IPR001680; IPR017986; Mitotic checkpoint protein BUB3 (WD repeat type I transmembrane protein A72.5) Bub3 Mus musculus (Mouse) 326 Q9WVA3 GO:0071173 ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0000082 GO:0000082 G1/S transition of mitotic cell cycle cell cycle and proliferation P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0000731 GO:0000731 DNA synthesis during DNA repair stress response P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0000731 GO:0000731 DNA synthesis during DNA repair DNA metabolism P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0001701 GO:0001701 in utero embryonic development developmental processes P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0003887 GO:0003887 DNA-directed DNA polymerase activity other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006139 GO:0006139 "nucleobase, nucleoside, nucleotide and nucleic acid metabolic process" other metabolic processes P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006260 GO:0006260 DNA replication DNA metabolism P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006287 GO:0006287 "base-excision repair, gap-filling" stress response P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006287 GO:0006287 "base-excision repair, gap-filling" DNA metabolism P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" stress response P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006297 GO:0006297 "nucleotide-excision repair, DNA gap filling" DNA metabolism P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0016779 GO:0016779 nucleotidyltransferase activity other molecular function F ConsensusfromContig1172 sp Q9WVF7 DPOE1_MOUSE 71.65 127 36 0 383 3 1981 2107 6E-57 197 Q9WVF7 DPOE1_MOUSE GO:0051539; GO:0003677; GO:0006260; GO:0000731; GO:0003887; GO:0000082; GO:0006287; GO:0003682; GO:0008622; GO:0000166; GO:0006297; GO:0008270 4 iron, 4 sulfur cluster binding; DNA binding; DNA replication; DNA synthesis involved in DNA repair; DNA-directed DNA polymerase activity; G1/S transition of mitotic cell cycle; base-excision repair, gap-filling; chromatin binding; epsilon DNA polymerase complex; nucleotide binding; nucleotide-excision repair, DNA gap filling; zinc ion binding reviewed IPR006172; IPR006133; IPR006134; IPR013697; IPR012337; DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A) Pole Pole1 Mus musculus (Mouse) 2283 Q9WVF7 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0004175 GO:0004175 endopeptidase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0004252 GO:0004252 serine-type endopeptidase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0005739 GO:0005739 mitochondrion mitochondrion C ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0005764 GO:0005764 lysosome other cytoplasmic organelle C ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0006508 GO:0006508 proteolysis protein metabolism P ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0007040 GO:0007040 lysosome organization cell organization and biogenesis P ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0008233 GO:0008233 peptidase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0008236 GO:0008236 serine-type peptidase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0008240 GO:0008240 tripeptidyl-peptidase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0042470 GO:0042470 melanosome other cellular component C ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0043171 GO:0043171 peptide catabolic process other metabolic processes P ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0045453 GO:0045453 bone resorption other biological processes P ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig5786 sp Q9XSB8 TPP1_CANFA 56.06 396 167 5 17 1189 1 394 1E-149 442 Q9XSB8 TPP1_CANFA GO:0045453; GO:0004175; GO:0005764; GO:0042470; GO:0046872; GO:0007399; GO:0043171; GO:0006508; GO:0004252; GO:0008240 bone resorption; endopeptidase activity; lysosome; melanosome; metal ion binding; nervous system development; peptide catabolic process; proteolysis; serine-type endopeptidase activity; tripeptidyl-peptidase activity reviewed IPR015366; IPR000209; IPR009020; Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I) TPP1 CLN2 Canis familiaris (Dog) (Canis lupus familiaris) 563 Q9XSB8 GO:0050885 GO:0050885 neuromuscular process controlling balance other biological processes P ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0005215 GO:0005215 transporter activity transporter activity F ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0015293 GO:0015293 symporter activity transporter activity F ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig2430 sp Q9XT77 SC5A6_RABIT 72.38 181 48 1 11 553 10 188 5E-81 259 Q9XT77 SC5A6_RABIT GO:0016021; GO:0006814; GO:0015293 integral to membrane; sodium ion transport; symporter activity reviewed IPR001734; IPR018212; IPR019900; Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6) SLC5A6 SMVT Oryctolagus cuniculus (Rabbit) 636 Q9XT77 GO:0055085 GO:0055085 transmembrane transport transport P ConsensusfromContig6123 sp Q9Y2B0 CNPY2_HUMAN 66.87 163 52 1 204 686 20 182 7E-74 235 Q9Y2B0 CNPY2_HUMAN GO:0005783; GO:0005887; GO:0010629; GO:0045716; GO:0010988 endoplasmic reticulum; integral to plasma membrane; negative regulation of gene expression; positive regulation of low-density lipoprotein particle receptor biosynthetic process; regulation of low-density lipoprotein particle clearance reviewed IPR021852; IPR008139; Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4) CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 Homo sapiens (Human) 182 Q9Y2B0 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6123 sp Q9Y2B0 CNPY2_HUMAN 66.87 163 52 1 204 686 20 182 7E-74 235 Q9Y2B0 CNPY2_HUMAN GO:0005783; GO:0005887; GO:0010629; GO:0045716; GO:0010988 endoplasmic reticulum; integral to plasma membrane; negative regulation of gene expression; positive regulation of low-density lipoprotein particle receptor biosynthetic process; regulation of low-density lipoprotein particle clearance reviewed IPR021852; IPR008139; Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4) CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 Homo sapiens (Human) 182 Q9Y2B0 GO:0005783 GO:0005783 endoplasmic reticulum ER/Golgi C ConsensusfromContig6123 sp Q9Y2B0 CNPY2_HUMAN 66.87 163 52 1 204 686 20 182 7E-74 235 Q9Y2B0 CNPY2_HUMAN GO:0005783; GO:0005887; GO:0010629; GO:0045716; GO:0010988 endoplasmic reticulum; integral to plasma membrane; negative regulation of gene expression; positive regulation of low-density lipoprotein particle receptor biosynthetic process; regulation of low-density lipoprotein particle clearance reviewed IPR021852; IPR008139; Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4) CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 Homo sapiens (Human) 182 Q9Y2B0 GO:0005887 GO:0005887 integral to plasma membrane plasma membrane C ConsensusfromContig6123 sp Q9Y2B0 CNPY2_HUMAN 66.87 163 52 1 204 686 20 182 7E-74 235 Q9Y2B0 CNPY2_HUMAN GO:0005783; GO:0005887; GO:0010629; GO:0045716; GO:0010988 endoplasmic reticulum; integral to plasma membrane; negative regulation of gene expression; positive regulation of low-density lipoprotein particle receptor biosynthetic process; regulation of low-density lipoprotein particle clearance reviewed IPR021852; IPR008139; Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4) CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 Homo sapiens (Human) 182 Q9Y2B0 GO:0005887 GO:0005887 integral to plasma membrane other membranes C ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0008270 GO:0008270 zinc ion binding other molecular function F ConsensusfromContig4394 sp Q9Y2K1 ZBTB1_HUMAN 84.54 97 15 0 361 71 616 712 2E-53 183 Q9Y2K1 ZBTB1_HUMAN GO:0030183; GO:0003677; GO:0033077; GO:0042789; GO:0046872; GO:0000122; GO:0005634; GO:0045582; GO:0002711; GO:0032825; GO:2000176; GO:0046982; GO:0042803; GO:0048538 B cell differentiation; DNA binding; T cell differentiation in thymus; mRNA transcription from RNA polymerase II promoter; metal ion binding; negative regulation of transcription from RNA polymerase II promoter; nucleus; positive regulation of T cell differentiation; positive regulation of T cell mediated immunity; positive regulation of natural killer cell differentiation; positive regulation of pro-T cell differentiation; protein heterodimerization activity; protein homodimerization activity; thymus development reviewed IPR000210; IPR011333; IPR013069; IPR007087; IPR015880; IPR013087; Zinc finger and BTB domain-containing protein 1 ZBTB1 KIAA0997 Homo sapiens (Human) 713 Q9Y2K1 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2769 sp Q9Y2L5 TPPC8_HUMAN 54.77 241 83 6 714 22 778 1002 7E-68 233 Q9Y2L5 TPPC8_HUMAN GO:0006888; GO:0005794; GO:0005801 ER to Golgi vesicle-mediated transport; Golgi apparatus; cis-Golgi network reviewed IPR011990; IPR024420; Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) 1435 Q9Y2L5 GO:0005794 GO:0005794 Golgi apparatus ER/Golgi C ConsensusfromContig2769 sp Q9Y2L5 TPPC8_HUMAN 54.77 241 83 6 714 22 778 1002 7E-68 233 Q9Y2L5 TPPC8_HUMAN GO:0006888; GO:0005794; GO:0005801 ER to Golgi vesicle-mediated transport; Golgi apparatus; cis-Golgi network reviewed IPR011990; IPR024420; Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) 1435 Q9Y2L5 GO:0005801 GO:0005801 cis-Golgi network ER/Golgi C ConsensusfromContig2769 sp Q9Y2L5 TPPC8_HUMAN 54.77 241 83 6 714 22 778 1002 7E-68 233 Q9Y2L5 TPPC8_HUMAN GO:0006888; GO:0005794; GO:0005801 ER to Golgi vesicle-mediated transport; Golgi apparatus; cis-Golgi network reviewed IPR011990; IPR024420; Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) 1435 Q9Y2L5 GO:0006810 GO:0006810 transport transport P ConsensusfromContig2769 sp Q9Y2L5 TPPC8_HUMAN 54.77 241 83 6 714 22 778 1002 7E-68 233 Q9Y2L5 TPPC8_HUMAN GO:0006888; GO:0005794; GO:0005801 ER to Golgi vesicle-mediated transport; Golgi apparatus; cis-Golgi network reviewed IPR011990; IPR024420; Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) 1435 Q9Y2L5 GO:0006888 GO:0006888 ER to Golgi vesicle-mediated transport transport P ConsensusfromContig2769 sp Q9Y2L5 TPPC8_HUMAN 54.77 241 83 6 714 22 778 1002 7E-68 233 Q9Y2L5 TPPC8_HUMAN GO:0006888; GO:0005794; GO:0005801 ER to Golgi vesicle-mediated transport; Golgi apparatus; cis-Golgi network reviewed IPR011990; IPR024420; Trafficking protein particle complex subunit 8 (Protein TRS85 homolog) TRAPPC8 KIAA1012 Homo sapiens (Human) 1435 Q9Y2L5 GO:0016192 GO:0016192 vesicle-mediated transport transport P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0000178 GO:0000178 exosome (RNase complex) other cellular component C ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0000288 GO:0000288 "nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay" RNA metabolism P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0004532 GO:0004532 exoribonuclease activity other molecular function F ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0006364 GO:0006364 rRNA processing RNA metabolism P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0016070 GO:0016070 RNA metabolic process RNA metabolism P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0016071 GO:0016071 mRNA metabolic process RNA metabolism P ConsensusfromContig6064 sp Q9Y3B2 EXOS1_HUMAN 78.87 194 36 1 1008 427 6 194 8E-106 321 Q9Y3B2 EXOS1_HUMAN GO:0003723; GO:0005829; GO:0043928; GO:0000178; GO:0010467; GO:0005730; GO:0006364 Q9NPD3; Q9NQT4; Q15024 RNA binding; cytosol; exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; exosome (RNase complex); gene expression; nucleolus; rRNA processing reviewed IPR019495; IPR025721; IPR012340; IPR022967; Exosome complex component CSL4 (Exosome component 1) EXOSC1 CSL4 CGI-108 Homo sapiens (Human) 195 Q9Y3B2 GO:0043928 GO:0043928 exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay RNA metabolism P ConsensusfromContig5719 sp Q9Y3B6 EMC9_HUMAN 54.15 205 93 1 888 277 1 205 1E-63 207 Q9Y3B6 EMC9_HUMAN GO:0072546 ER membrane protein complex reviewed IPR005366; ER membrane protein complex subunit 9 (Protein FAM158A) EMC9 C14orf122 FAM158A CGI-112 Homo sapiens (Human) 208 ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0005488 GO:0005488 binding other molecular function F ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0008180 GO:0008180 signalosome nucleus C ConsensusfromContig3058 sp Q9Y4B6 VPRBP_HUMAN 69.03 155 44 3 464 3 748 899 2E-55 193 Q9Y4B6 VPRBP_HUMAN GO:0005737; GO:0019048; GO:0005634; GO:0016567 Q16531; P12520; P18045; P19508 cytoplasm; modulation by virus of host morphology or physiology; nucleus; protein ubiquitination reviewed IPR011989; IPR016024; IPR006594; IPR015943; IPR017986; Protein modification; protein ubiquitination. Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Vpr-interacting protein) VPRBP DCAF1 KIAA0800 RIP Homo sapiens (Human) 1507 Q9Y4B6 GO:0044419 GO:0044419 interspecies interaction between organisms other biological processes P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005083 GO:0005083 small GTPase regulator activity enzyme regulator activity F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0007257 GO:0007257 activation of JUN kinase activity signal transduction P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0007257 GO:0007257 activation of JUN kinase activity stress response P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0007257 GO:0007257 activation of JUN kinase activity protein metabolism P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig81 sp Q9Y4K4 M4K5_HUMAN 90.57 106 10 0 478 161 741 846 4E-57 195 Q9Y4K4 M4K5_HUMAN GO:0005524; GO:0007257; GO:0005737; GO:0005886; GO:0004674; GO:0005083 P46108; P62993; P16333 ATP binding; activation of JUN kinase activity; cytoplasm; plasma membrane; protein serine/threonine kinase activity; small GTPase regulator activity reviewed IPR001180; IPR011009; IPR021160; IPR000719; IPR017441; IPR002290; Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5) MAP4K5 Homo sapiens (Human) 846 Q9Y4K4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0003899 GO:0003899 DNA-directed RNA polymerase activity other molecular function F ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0004721 GO:0004721 phosphoprotein phosphatase activity other molecular function F ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0005622 GO:0005622 intracellular other cellular component C ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0005654 GO:0005654 nucleoplasm nucleus C ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0005730 GO:0005730 nucleolus nucleus C ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0006366 GO:0006366 transcription from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0006368 GO:0006368 RNA elongation from RNA polymerase II promoter RNA metabolism P ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0006470 GO:0006470 protein amino acid dephosphorylation protein metabolism P ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0008420 GO:0008420 CTD phosphatase activity other molecular function F ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0010467 GO:0010467 gene expression other metabolic processes P ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0015629 GO:0015629 actin cytoskeleton cytoskeleton C ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0016032 GO:0016032 viral reproduction other biological processes P ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig5139 sp Q9Y5B0 CTDP1_HUMAN 96.94 98 3 0 1 294 216 313 5E-62 207 Q9Y5B0 CTDP1_HUMAN GO:0008420; GO:0003899; GO:0015629; GO:0051301; GO:0005813; GO:0005737; GO:0010458; GO:0030496; GO:0005654; GO:0050434; GO:0006470; GO:0051233; GO:0000922; GO:0006368; GO:0016032 CTD phosphatase activity; DNA-directed RNA polymerase activity; actin cytoskeleton; cell division; centrosome; cytoplasm; exit from mitosis; midbody; nucleoplasm; positive regulation of viral transcription; protein dephosphorylation; spindle midzone; spindle pole; transcription elongation from RNA polymerase II promoter; viral process reviewed IPR001357; IPR015388; IPR011947; IPR023214; IPR004274; RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase) CTDP1 FCP1 Homo sapiens (Human) 961 Q9Y5B0 GO:0050434 GO:0050434 positive regulation of viral transcription RNA metabolism P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005083 GO:0005083 small GTPase regulator activity enzyme regulator activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005911 GO:0005911 cell-cell junction plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005911 GO:0005911 cell-cell junction other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007163 GO:0007163 establishment or maintenance of cell polarity cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031032 GO:0031032 actomyosin structure organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031252 GO:0031252 cell leading edge other cellular component C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0035556 ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0042641 GO:0042641 actomyosin cytoskeleton C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 79.85 134 25 1 585 184 1076 1207 1E-74 230 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0000287 GO:0000287 magnesium ion binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005083 GO:0005083 small GTPase regulator activity enzyme regulator activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005856 GO:0005856 cytoskeleton cytoskeleton C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005911 GO:0005911 cell-cell junction plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0005911 GO:0005911 cell-cell junction other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007010 GO:0007010 cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007163 GO:0007163 establishment or maintenance of cell polarity cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0007165 GO:0007165 signal transduction signal transduction P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016477 GO:0016477 cell migration other biological processes P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0017048 GO:0017048 Rho GTPase binding other molecular function F ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030036 GO:0030036 actin cytoskeleton organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031032 GO:0031032 actomyosin structure organization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031252 GO:0031252 cell leading edge other cellular component C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0031532 GO:0031532 actin cytoskeleton reorganization cell organization and biogenesis P ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0035556 ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0042641 GO:0042641 actomyosin cytoskeleton C ConsensusfromContig2351 sp Q9Y5S2 MRCKB_HUMAN 75 48 12 0 182 39 1208 1255 1E-74 71.2 Q9Y5S2 MRCKB_HUMAN GO:0005524; GO:0031532; GO:0042641; GO:0031032; GO:0031252; GO:0016477; GO:0005911; GO:0005737; GO:0007163; GO:0035556; GO:0000287; GO:0005543; GO:0005886; GO:0004674; GO:0007165; GO:0005083 ATP binding; actin cytoskeleton reorganization; actomyosin; actomyosin structure organization; cell leading edge; cell migration; cell-cell junction; cytoplasm; establishment or maintenance of cell polarity; intracellular signal transduction; magnesium ion binding; phospholipid binding; plasma membrane; protein serine/threonine kinase activity; signal transduction; small GTPase regulator activity reviewed IPR000961; IPR001180; IPR000095; IPR020454; IPR011009; IPR014930; IPR001849; IPR002219; IPR000719; IPR017441; IPR002290; IPR008271; IPR026611; Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta) CDC42BPB KIAA1124 Homo sapiens (Human) 1711 Q9Y5S2 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0000186 GO:0000186 activation of MAPKK activity signal transduction P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0000186 GO:0000186 activation of MAPKK activity protein metabolism P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0004672 GO:0004672 protein kinase activity kinase activity F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0004674 GO:0004674 protein serine/threonine kinase activity kinase activity F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0004709 GO:0004709 MAP kinase kinase kinase activity signal transduction activity F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0004709 GO:0004709 MAP kinase kinase kinase activity kinase activity F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0006468 GO:0006468 protein amino acid phosphorylation protein metabolism P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0006950 GO:0006950 response to stress stress response P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0007243 GO:0007243 protein kinase cascade signal transduction P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0007254 GO:0007254 JNK cascade signal transduction P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0007254 GO:0007254 JNK cascade stress response P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0016301 GO:0016301 kinase activity kinase activity F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0016310 GO:0016310 phosphorylation other metabolic processes P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0016740 GO:0016740 transferase activity other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0016772 GO:0016772 "transferase activity, transferring phosphorus-containing groups" other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0019100 GO:0019100 male germ-line sex determination developmental processes P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0043507 GO:0043507 positive regulation of JUN kinase activity signal transduction P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0043507 GO:0043507 positive regulation of JUN kinase activity stress response P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0043507 GO:0043507 positive regulation of JUN kinase activity protein metabolism P ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig60 sp Q9Y6R4 M3K4_HUMAN 92.79 111 8 0 446 114 1498 1608 4E-67 227 Q9Y6R4 M3K4_HUMAN GO:0005524; GO:0007254; GO:0004709; GO:0060718; GO:0005737; GO:0019100; GO:0046872; GO:0048471; GO:0001890; GO:0043507; GO:0010468 O75369; O75293; Q96B97; P0CG48 ATP binding; JNK cascade; MAP kinase kinase kinase activity; chorionic trophoblast cell differentiation; cytoplasm; male germ-line sex determination; metal ion binding; perinuclear region of cytoplasm; placenta development; positive regulation of JUN kinase activity; regulation of gene expression reviewed IPR011009; IPR000719; IPR017441; IPR002290; IPR008271; Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4) MAP3K4 KIAA0213 MAPKKK4 MEKK4 MTK1 Homo sapiens (Human) 1608 Q9Y6R4 GO:0048471 GO:0048471 perinuclear region of cytoplasm other cellular component C ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0004386 GO:0004386 helicase activity other molecular function F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0008026 GO:0008026 ATP-dependent helicase activity other molecular function F ConsensusfromContig6044 sp Q9Y6V7 DDX49_HUMAN 76.94 451 103 1 3650 2301 1 451 0 749 Q9Y6V7 DDX49_HUMAN GO:0005524; GO:0008026; GO:0003723 ATP binding; ATP-dependent helicase activity; RNA binding reviewed IPR011545; IPR014001; IPR001650; IPR027417; IPR000629; IPR014014; Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49) DDX49 Homo sapiens (Human) 483 Q9Y6V7 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005391 GO:0005391 sodium:potassium-exchanging ATPase activity transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006813 GO:0006813 potassium ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015077 GO:0015077 monovalent inorganic cation transmembrane transporter activity transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015672 GO:0015672 monovalent inorganic cation transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 89.9 99 10 0 354 58 838 936 8E-67 193 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0003824 GO:0003824 catalytic activity other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005391 GO:0005391 sodium:potassium-exchanging ATPase activity transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006754 GO:0006754 ATP biosynthetic process other metabolic processes P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006810 GO:0006810 transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006811 GO:0006811 ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006812 GO:0006812 cation transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006813 GO:0006813 potassium ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0006814 GO:0006814 sodium ion transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0008152 GO:0008152 metabolic process other metabolic processes P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015077 GO:0015077 monovalent inorganic cation transmembrane transporter activity transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015662 GO:0015662 "ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism" transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0015672 GO:0015672 monovalent inorganic cation transport transport P ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016787 GO:0016787 hydrolase activity other molecular function F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0016820 GO:0016820 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances" transporter activity F ConsensusfromContig1373 sp Q9YH26 AT1A1_OREMO 92.68 41 3 0 467 345 800 840 8E-67 80.9 Q9YH26 AT1A1_OREMO GO:0005524; GO:0006754; GO:0016021; GO:0046872; GO:0005886; GO:0005391 ATP binding; ATP biosynthetic process; integral to membrane; metal ion binding; plasma membrane; sodium:potassium-exchanging ATPase activity reviewed IPR006068; IPR004014; IPR023299; IPR005775; IPR018303; IPR023298; IPR008250; IPR001757; IPR023214; Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1) atp1a1 Oreochromis mossambicus (Mozambique tilapia) (Tilapia mossambica) 1023 Q9YH26 GO:0046872 GO:0046872 metal ion binding other molecular function F ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0005198 GO:0005198 structural molecule activity other molecular function F ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0005923 GO:0005923 tight junction plasma membrane C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0005923 GO:0005923 tight junction other membranes C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0016021 GO:0016021 integral to membrane other membranes C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0030054 GO:0030054 cell junction plasma membrane C ConsensusfromContig6352 sp Q9YH92 CLD7B_DANRE 82.84 169 29 0 327 833 28 196 8E-90 272 Q9YH92 CLD7B_DANRE GO:0016021; GO:0005886; GO:0005198; GO:0005923 integral to membrane; plasma membrane; structural molecule activity; tight junction reviewed IPR006187; IPR003556; IPR017974; IPR004031; Claudin-7-B (Claudin-like protein ZF4A22) cldn7b cldn7 Danio rerio (Zebrafish) (Brachydanio rerio) 215 Q9YH92 GO:0030054 GO:0030054 cell junction other membranes C ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0000166 GO:0000166 nucleotide binding other molecular function F ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0003676 GO:0003676 nucleic acid binding nucleic acid binding activity F ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0003677 GO:0003677 DNA binding nucleic acid binding activity F ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0003723 GO:0003723 RNA binding nucleic acid binding activity F ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig340 sp Q9Z130 HNRDL_MOUSE 83.33 114 18 1 339 1 4 117 5E-61 197 Q9Z130 HNRDL_MOUSE GO:0003677; GO:0003723; GO:0005737; GO:0016071; GO:0000166; GO:0005634; GO:0006355; GO:0006351 DNA binding; RNA binding; cytoplasm; mRNA metabolic process; nucleotide binding; nucleus; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR012677; IPR000504; Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (JKT41-binding protein) Hnrnpdl Hnrpdl Jktbp Mus musculus (Mouse) 301 Q9Z130 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0003779 GO:0003779 actin binding cytoskeletal activity F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005102 GO:0005102 receptor binding signal transduction activity F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005624 GO:0005624 membrane fraction other membranes C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005625 GO:0005625 soluble fraction other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005737 GO:0005737 cytoplasm other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005829 GO:0005829 cytosol cytosol C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005903 GO:0005903 brush border other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0005938 GO:0005938 cell cortex other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0006605 GO:0006605 protein targeting transport P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0007268 GO:0007268 synaptic transmission cell-cell signaling P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0008021 GO:0008021 synaptic vesicle other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0012506 GO:0012506 vesicle membrane other membranes C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0014047 GO:0014047 glutamate secretion transport P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0014047 GO:0014047 glutamate secretion cell-cell signaling P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0016020 GO:0016020 membrane other membranes C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0016023 GO:0016023 cytoplasmic membrane-bounded vesicle other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0017022 GO:0017022 myosin binding cytoskeletal activity F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0030139 GO:0030139 endocytic vesicle other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0030165 GO:0030165 PDZ domain binding other molecular function F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0030511 GO:0030511 positive regulation of transforming growth factor beta receptor signaling pathway signal transduction P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0031647 GO:0031647 regulation of protein stability protein metabolism P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0032435 GO:0032435 negative regulation of proteasomal ubiquitin-dependent protein catabolic process protein metabolism P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0042803 GO:0042803 protein homodimerization activity other molecular function F ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0043197 GO:0043197 dendritic spine other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0043198 GO:0043198 dendritic shaft other cellular component C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0043542 GO:0043542 endothelial cell migration other biological processes P ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0044445 GO:0044445 cytosolic part cytosol C ConsensusfromContig1327 sp Q9Z254 GIPC1_RAT 76.67 120 28 0 263 622 97 216 9E-63 204 Q9Z254 GIPC1_RAT GO:0005903; GO:0005938; GO:0005829; GO:0043198; GO:0043197; GO:0030139; GO:0043542; GO:0014047; GO:0016020; GO:0032435; GO:0030511; GO:0006605; GO:0031647; GO:0048167; GO:0007268; GO:0008021; GO:0012506 brush border; cell cortex; cytosol; dendritic shaft; dendritic spine; endocytic vesicle; endothelial cell migration; glutamate secretion; membrane; negative regulation of proteasomal ubiquitin-dependent protein catabolic process; positive regulation of transforming growth factor beta receptor signaling pathway; protein targeting; regulation of protein stability; regulation of synaptic plasticity; synaptic transmission; synaptic vesicle; vesicle membrane reviewed IPR001478; IPR017379; PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (GLUT1 C-terminal-binding protein) (GLUT1CBP) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) Gipc1 Gipc Rgs19ip1 Rattus norvegicus (Rat) 333 Q9Z254 GO:0048167 GO:0048167 regulation of synaptic plasticity cell-cell signaling P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0003407 ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0003682 GO:0003682 chromatin binding other molecular function F ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0005515 GO:0005515 protein binding other molecular function F ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0005524 GO:0005524 ATP binding other molecular function F ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0005634 GO:0005634 nucleus nucleus C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0005886 GO:0005886 plasma membrane plasma membrane C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0005886 GO:0005886 plasma membrane other membranes C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006281 GO:0006281 DNA repair stress response P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006281 GO:0006281 DNA repair DNA metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006310 GO:0006310 DNA recombination DNA metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006338 GO:0006338 chromatin remodeling cell organization and biogenesis P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006351 GO:0006351 "transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006355 GO:0006355 "regulation of transcription, DNA-dependent" RNA metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0006974 GO:0006974 response to DNA damage stimulus stress response P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0007399 GO:0007399 nervous system development developmental processes P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0016514 GO:0016514 SWI/SNF complex nucleus C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0016568 GO:0016568 chromatin modification cell organization and biogenesis P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0016585 GO:0016585 chromatin remodeling complex nucleus C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0031011 GO:0031011 Ino80 complex nucleus C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0035267 GO:0035267 NuA4 histone acetyltransferase complex nucleus C ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0040008 GO:0040008 regulation of growth other biological processes P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0043967 GO:0043967 histone H4 acetylation protein metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0043967 GO:0043967 histone H4 acetylation cell organization and biogenesis P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0043968 GO:0043968 histone H2A acetylation protein metabolism P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0043968 GO:0043968 histone H2A acetylation cell organization and biogenesis P ConsensusfromContig5585 sp Q9Z2N8 ACL6A_MOUSE 91.22 205 18 0 15 629 225 429 6E-133 407 Q9Z2N8 ACL6A_MOUSE GO:0006310; GO:0006281; GO:0031011; GO:0035267; GO:0016514; GO:0003682; GO:0006338; GO:0043968; GO:0043967; GO:0007399; GO:0003407; GO:0071564; GO:0005886; GO:0040008; GO:0006355; GO:0006351 DNA recombination; DNA repair; Ino80 complex; NuA4 histone acetyltransferase complex; SWI/SNF complex; chromatin binding; chromatin remodeling; histone H2A acetylation; histone H4 acetylation; nervous system development; neural retina development; npBAF complex; plasma membrane; regulation of growth; regulation of transcription, DNA-dependent; transcription, DNA-dependent reviewed IPR004000; IPR004001; Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (BRG1-associated factor 53A) (BAF53A) Actl6a Actl6 Baf53a Mus musculus (Mouse) 429 Q9Z2N8 GO:0071564